[
    {
        "idx": 1309,
        "sentence": "Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .",
        "label": {
            "cruciform DNA": "DNA",
            "HMG boxes": "protein",
            "cross-over DNA": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n{\"p50p50\": 4},\n{\"Reason\": \"Helpful as it provides a clear example of a protein entity mentioned in the sentence.\"},\n{\"p21(WAF1/CIP1)\": 4},\n{\"p27(KIP1)\": 4},\n{\"Reason\": \"Both examples are helpful as they provide specific protein entities mentioned in the sentence.\"},\n{\"GATA-1\": 4},\n{\"Reason\": \"Helpful as it provides a specific protein entity mentioned in the sentence.\"},\n{\"NF-ATc\": 4},\n{\"T lymphocytes\": 4},\n{\"Reason\": \"Both examples are helpful as they provide specific protein and cell type entities mentioned in the sentence.\"},\n{\"Protein\": 3},\n{\"Reason\": \"Helpful as it provides a general example of a protein entity mentioned in the sentence.\"},\n{\"GM-CSF\": 4},\n{\"Reason\": \"Helpful as it provides a specific protein entity mentioned in the sentence.\"},\n{\"cDNAs\": 3},\n{\"Reason\": \"Helpful as it provides a general example of a DNA entity mentioned in the sentence.\"},\n{\"IgH\": 4},\n{\"Reason\": \"Helpful as it provides a specific DNA entity mentioned in the sentence.\"},\n{\"IL-2\": 4},\n{\"c-Jun\": 4},\n{\"c-Fos\": 4},\n{\"Reason\": \"All examples are helpful as they provide specific protein entities mentioned in the sentence.\"},\n{\"Stat proteins\": 4},\n{\"Reason\": \"Helpful as it provides a specific protein entity mentioned in the sentence.\"},\n{\"immunohistochemistry\": 3},\n{\"gene\": 3},\n{\"cell type\": 4},\n{\"Reason\": \"All examples are helpful as they provide specific protein, DNA, and cell type entities mentioned in the sentence.\"},\n{\"Th2-type lymphocytes\": 4},\n{\"Reason\": \"Helpful as it provides a specific cell type entity mentioned in the sentence.\"},\n{\"GM-kappa B\": 4},\n{\"GC-box\": 4},\n{\"GC-motif\": 4},\n{\"GM-kappa B motif\": 4},\n{\"Reason\": \"All examples are helpful as they provide specific DNA entities mentioned in the sentence.\"},\n{\"p50\": 4},\n{\"p65\": 4},\n{\"Reason\": \"Both examples are helpful as they provide specific protein entities mentioned in the sentence.\"},\n{\"HIV-1 LTR\": 4},\n{\"NFAT-1\": 4},\n{\"NF kappa B\": 4},\n{\"Reason\": \"All examples are helpful as they provide specific DNA and protein entities mentioned in the sentence.\"},\n{\"NF-kappaB\": 4},\n{\"Sp1\": 4},\n{\"SIVmac\": 4},\n{\"Reason\": \"All examples are helpful as they provide specific protein and cell line entities mentioned in the sentence.\"}\n]",
        "response3": "[{'HMG boxes': 'protein'}, {'cruciform DNA': 'DNA'}, {'cross-over DNA': 'DNA'}]",
        "prediction": "{'HMG boxes': 'protein', 'cruciform DNA': 'DNA', 'cross-over DNA': 'DNA'}"
    },
    {
        "idx": 228,
        "sentence": "We have carried out experiments to define the nature of the higher affinity CVZ binding site .",
        "label": {
            "higher affinity CVZ binding site": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"cDNAs\": 5, \"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n{\"G-CSF\": 5},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"CD95 ligand\": 5},\n{\"DNA\": 5},\n{\"SCM-1\": 5},\n{\"cell adhesion molecules\": 5},\n{\"E2A\": 5},\n{\"NF-kappa B\": 5},\n{\"BRCA1\": 5},\n{\"TCF-1\": 5},\n{\"retinoic acid receptor alpha\": 5},\n{\"CREB\": 5, \"AR-CRE\": 5},\n{\"SIVsmmPBj14\": 5},\n{\"protein\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 51,
        "sentence": "Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.",
        "label": {
            "T-cell determinants": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals, and growth factors.\": 4},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1518,
        "sentence": "Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .",
        "label": {
            "nuclear calcium/calmodulin-dependent protein kinase II": "protein",
            "human B lymphocytes": "cell_type",
            "Anti-immunoglobulin M": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\"IL-13\": 5},\n    {\"IL-4\": 5},\n    {\"B cell\": 5},\n    {\"monocyte\": 5},\n    {\"cAMP-dependent protein kinase\": 5},\n    {\"Rap1\": 5},\n    {\"IL-2\": 5},\n    {\"NF-kappa B\": 5},\n    {\"AP-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"B cell\": 5},\n    {\"Syk\": 5},\n    {\"Zap\": 5},\n    {\"T cell\": 5},\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"NF-kappa B\": 5},\n    {\"IL-2\": 5},\n    {\"Aiolos\": 5},\n    {\"Ras\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 5},\n    {\"ATL\": 5},\n    {\"T lymphocytes\": 5},\n    {\"SP1\": 5},\n    {\"caspases\": 5},\n    {\"B-cell\": 5},\n    {\"CD70\": 5},\n    {\"B cell\": 5},\n    {\"plasma cells\": 5},\n    {\"IL-4\": 5},\n    {\"CD40\": 5},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"gamma c chain\": 5},\n    {\"STAT6\": 5},\n    {\"STAT3\": 5},\n    {\"STAT5\": 5},\n    {\"B cells\": 5},\n    {\"NF-kappa B\": 5},\n    {\"I kappa B alpha\": 5},\n    {\"P selectin\": 5}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 563,
        "sentence": "The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .",
        "label": {
            "PDGF(B)": "protein",
            "PDGF(B) mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions 'DNA binding activity', providing a clear and direct link to the entity type 'DNA'.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions 'SCL mRNA', which is a type of RNA, providing a clear link to the entity type 'RNA'. The connection is slightly indirect compared to Example 1.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence mentions various proteins like 'PAFR', 'NF-kappa B', and 'protein kinase C', which are directly linked to the entity type 'protein'. However, the sentence is more complex and involves multiple entities, making the link slightly less direct.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions 'TIMP-1' and 'DNA synthesis', providing a direct link to the entity types 'protein' and 'DNA'. The connection is clear but involves multiple entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos', which are directly linked to the entity type 'protein'. The connection is clear but involves multiple entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions 'MNDA mRNA' and 'myeloid cell lines', providing a direct link to the entity types 'RNA' and 'cell_line'. The connection is clear but involves multiple entities.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions 'NF-kappa B' and 'DNA binding activity', which are directly linked to the entity type 'DNA'. However, the connection is slightly indirect.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions 'CD14', which is directly linked to the entity type 'protein'. The connection is clear but involves multiple entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'Bak', 'Bad', and 'Bcl-2', which are directly linked to the entity type 'protein'. The connection is clear and direct.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions 'P selectin', which is directly linked to the entity type 'protein'. The connection is clear but involves multiple entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'CD14' and 'CD23', which are directly linked to the entity type 'protein'. The connection is clear and direct.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)', which are directly linked to the entity type 'protein'. The connection is clear and direct.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'cell adhesion molecules', which are directly linked to the entity type 'cell_type'. The connection is clear but involves multiple entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40', which are directly linked to the entity types 'protein' and 'cell_type'. The connection is clear and direct.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'Protein kinase B', 'phosphatidylinositol 3-kinase', 'STAT5', 'erythropoietin', 'HCD57', 'EPO', 'HCD57-SREI', and 'c-Akt', which are directly linked to the entity types 'protein' and 'cell_line'. The connection is clear and direct.\"}\n]",
        "response3": "[{\"PDGF(B) mRNA\": \"RNA\"}, {\"cytoskeletal integrity\": \"cell_type\"}, {\"cytochalasin D\": \"protein\"}]",
        "prediction": "{'PDGF(B) mRNA': 'RNA', 'cytoskeletal integrity': 'cell_type', 'cytochalasin D': 'protein'}"
    },
    {
        "idx": 501,
        "sentence": "Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .",
        "label": {
            "CCRF-CEM": "cell_line",
            "TCF-1 alpha": "protein",
            "nonlymphoid (HeLa) cell lines": "cell_line",
            "mature B cells": "cell_line",
            "JY": "cell_line",
            "Namalwa": "cell_line",
            "57- to 53-kD proteins": "protein",
            "Jurkat": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"57- to 53-kD proteins\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"CCRF-CEM\": \"cell_line\"}, {\"JY\": \"cell_line\"}, {\"Namalwa\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}"
    },
    {
        "idx": 457,
        "sentence": "TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .",
        "label": {
            "T lymphocytes": "cell_type",
            "TAR": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n    {\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 285,
        "sentence": "ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .",
        "label": {
            "ER": "protein",
            "lymphocyte DNA": "DNA",
            "lymphocytes": "cell_type",
            "lymphocyte cytosolic protein": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5}\n]",
        "response3": "[{\"lymphocyte cytosolic protein\": \"protein\"}, {\"lymphocyte DNA\": \"DNA\"}]",
        "prediction": "{'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}"
    },
    {
        "idx": 1508,
        "sentence": "Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "B cell-specific coactivator": "protein",
            "murine homolog": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example provides a clear entity-label mapping for the term 'SCM-1' as a 'cell_line', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides entity-label mappings for terms 'UAS1' as a 'cell_line' and 'B cell' as a 'cell_type', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The example provides a clear entity-label mapping for the term 'GATA-1' as a 'protein', which aids in the extraction of named entities from the target sentence, but the sentence context could be more specific.\"},\n\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides a clear entity-label mapping for the term 'TCF-1' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example provides a clear entity-label mapping for the term 'E2A' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides entity-label mappings for terms 'IL-2' as a 'protein', 'c-Jun' as a 'protein', and 'c-Fos' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example provides a clear entity-label mapping for the term 'GM-CSF' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides entity-label mappings for terms 'T cell' as a 'cell_type' and 'interleukin 2' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides entity-label mappings for terms 'CD40' as a 'protein' and 'NF-kappa B' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides entity-label mappings for terms 'SLAP-130' as a 'protein', 'SLP-76' as a 'protein', and 'T cell' as a 'cell_type', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example provides a clear entity-label mapping for the term 'GATA-1' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example provides entity-label mappings for terms 'Sp1' as a 'protein' and 'Ets' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example provides a clear entity-label mapping for the term 'NF-kappa B' as a 'DNA', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides entity-label mappings for terms 'CD70' as a 'protein', 'B cell' as a 'cell_type', 'plasma cells' as a 'cell_type', 'IL-4' as a 'protein', and 'CD40' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides entity-label mappings for terms 'IL-7R' as a 'protein' and 'gamma(c)' as a 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example provides entity-label mappings for terms 'Jun' as a 'protein' and 'ATF-2' as a 'protein', aiding in the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 209,
        "sentence": "Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.",
        "label": {
            "lymphoblastoid cell line": "cell_line",
            "IM-9": "cell_line",
            "type-II EBS": "protein",
            "Type-II estrogen -binding sites": "protein",
            "human lymphoblastoid cell line": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 4},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4}\n]",
        "response3": "[{\"IM-9\": \"cell_line\"}, {\"estradiol\": \"protein\"}]",
        "prediction": "{'IM-9': 'cell_line', 'estradiol': 'protein'}"
    },
    {
        "idx": 1385,
        "sentence": "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.",
        "label": {
            "LTR": "DNA",
            "HIV-1 LTR": "DNA",
            "C/EBP sites": "DNA",
            "C/EBP site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus\": 4},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process\": 4}\n]",
        "response3": "[{\"C/EBP\": \"protein\"}, {\"C/EBP\": \"protein\"}]",
        "prediction": "{'C/EBP': 'protein'}"
    },
    {
        "idx": 1516,
        "sentence": "Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "GAL4 DNA binding domain": "protein",
            "COOH-terminal domain": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a protein name that is directly relevant to the entity label set.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains protein names that are directly relevant to the entity label set.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains a protein name that is directly relevant to the entity label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains a protein name that is directly relevant to the entity label set.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains multiple protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains multiple protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The sentence contains a protein name and a cell line name, which are somewhat relevant to the entity label set.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains a DNA name and a protein name, which are directly relevant to the entity label set.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains multiple DNA names and a protein name, which are directly relevant to the entity label set.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains a DNA name and two protein names, which are directly relevant to the entity label set.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains a DNA name and a cell line name, which are somewhat relevant to the entity label set.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains a DNA name and two protein names, which are directly relevant to the entity label set.\"}\n]",
        "response3": "[{'BOB.1/OBF.1': 'protein'}, {'GAL4 DNA binding domain': 'DNA'}]",
        "prediction": "{'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'DNA'}"
    },
    {
        "idx": 1827,
        "sentence": "A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .",
        "label": {
            "human interleukin 2 gene promoter": "DNA",
            "EGR-1": "protein",
            "Sp1": "protein",
            "regulatory element": "DNA",
            "binding site": "DNA",
            "zinc finger proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 1},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 3},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5}\n]",
        "response3": "[{\"Sp1\": \"protein\"}, {\"EGR-1\": \"protein\"}]",
        "prediction": "{'Sp1': 'protein', 'EGR-1': 'protein'}"
    },
    {
        "idx": 1116,
        "sentence": "The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .",
        "label": {
            "thymocytes": "cell_type",
            "p53": "protein",
            "mitogen-activated mature T lymphocytes": "cell_line",
            "tumour suppressor p53": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"The process of apoptosis is used to eliminate unwanted cells from a wide variety of organisms.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 178,
        "sentence": "T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .",
        "label": {
            "T lymphocytes": "cell_type",
            "lavage cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCL1) being expressed in a specific context (AIDS IBLP tumors). This is highly relevant for identifying protein entities in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions specific cell types (granulocytes and T cells) in a correlated context, which is helpful for identifying cell type entities in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence discusses the regulation of a protein (CD14) during monocytic differentiation, providing a relevant example for identifying protein entities in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple examples of proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) in the context of T cell stimulation and response. This is highly relevant for identifying protein entities in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein (ZAP-70) being responsive to specific treatments (UV and H2O2), which is helpful for identifying protein entities in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions specific cell types (T lymphocytes) and a protein (HLA-molecules) in the context of antigen recognition, which is helpful for identifying cell type and protein entities in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence discusses the synthesis of proteins (NF-ATc) in T lymphocytes, providing a relevant example for identifying protein entities in the target sentence.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The sentence mentions a cell line (EBV) and a protein (CD2) in the context of cell proliferation, which is somewhat relevant for identifying cell line and protein entities in the target sentence.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The sentence refers to a specific cell type (Th2-type lymphocytes) in the context of cytokine expression, which is somewhat relevant for identifying cell type entities in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides examples of a cell type (T cell) and proteins (IL-2, IL-2 receptor, CD28) in the context of T cell proliferation and costimulation, which is helpful for identifying cell type and protein entities in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions a protein (CD70) and specific cell types (B cells, plasma cells) in the context of cell differentiation, along with proteins (IL-4, CD40) involved in signaling. This is highly relevant for identifying protein and cell type entities in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) in the context of gene expression, which is highly relevant for identifying protein entities in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions a protein (IL-2 receptor alpha subunit) and a protein (p21ras) in the context of lymphocyte activation, along with a cell type (B cell). This is helpful for identifying protein and cell type entities in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence discusses gene expression in specific cell lines (Ramos, Jurkat) and their stimulation, providing relevant examples for identifying cell line and protein entities in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of a DNA entity (2-deoxyguanosine), cell types (lymphoid progenitor cells, thymus stromal cells, B cells, fetal liver cells, T cells), and a cell line (tg epsilon26) in the context of cell development. This is highly relevant for identifying DNA, cell type, and cell line entities in the target sentence.\"}\n]",
        "response3": "[{'T lymphocytes': 'cell_type'}, {'1,25(OH)2D3': 'protein'}, {'tuberculosis': 'cell_type'}, {'unseparated lavage cells': 'cell_line'}]",
        "prediction": "{'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_line'}"
    },
    {
        "idx": 1209,
        "sentence": "A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kB\": 5},\n    {\"AP-1\": 5},\n    {\"OCT-1\": 5},\n    {\"NF-IL-2B\": 5},\n    {\"AP-1\": 5},\n    {\"IL-5 mRNA\": 5},\n    {\"TCR\": 4},\n    {\"IL-2R\": 5},\n    {\"dexamethasone\": 5},\n    {\"phosphocreatine\": 4},\n    {\"HML\": 5},\n    {\"dexamethasone\": 5},\n    {\"cortisol\": 5},\n    {\"lysozyme\": 5},\n    {\"NF-E2\": 5},\n    {\"NF-kappa B\": 5},\n    {\"MNDA\": 5},\n    {\"interleukin-2\": 5},\n    {\"CD25\": 5},\n    {\"IL-2R\": 5},\n    {\"CTLA4Ig\": 5},\n    {\"NFAT\": 4},\n    {\"AP-1\": 4},\n    {\"Erbstatin\": 5},\n    {\"genistein\": 5},\n    {\"Egr-1\": 5},\n    {\"CD4+\": 5},\n    {\"CD8+\": 5},\n    {\"TPCK\": 5},\n    {\"anti-CD28\": 5},\n    {\"PMA\": 5},\n    {\"MR\": 5},\n    {\"aldosterone\": 5},\n    {\"progesterone\": 5},\n    {\"Ras\": 5},\n    {\"RasN17\": 5},\n    {\"IL-2\": 5},\n    {\"CIS\": 5},\n    {\"OSM\": 5},\n    {\"STAT5\": 5},\n    {\"Type I\": 5},\n    {\"Type II\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 864,
        "sentence": "Differences in transcriptional enhancers of HIV-1 and HIV-2 .",
        "label": {
            "transcriptional enhancers": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 4},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 65,
        "sentence": "Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .",
        "label": {
            "promoter": "DNA",
            "PRDII element": "DNA"
        },
        "response1": "['DNA', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 61,
        "sentence": "From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.",
        "label": {
            "82": "protein",
            "43-47 kD": "protein",
            "major protein": "protein",
            "T-cells": "cell_type",
            "minor proteins": "protein",
            "67": "protein",
            "HeLa cells": "cell_line",
            "52 kD": "protein"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence provides a clear example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence provides clear examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides a clear example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides a clear example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence provides a clear example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides a clear example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence provides a clear example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides a clear example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of named entities with their corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence provides a clear example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{'HeLa cells': 'cell_line'}, {'T-cells': 'cell_line'}, {'DNA': 'DNA'}, {'protein': 'protein'}, {'protein': 'protein'}, {'protein': 'protein'}, {'protein': 'protein'}]",
        "prediction": "{'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'protein': 'protein'}"
    },
    {
        "idx": 191,
        "sentence": "A block to RNA elongation is largely responsible for decreased c-myc transcription .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 447,
        "sentence": "Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.",
        "label": {
            "enhancer": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 476,
        "sentence": "A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .",
        "label": {
            "protooncogenes": "DNA",
            "immediate early response genes": "DNA",
            "growth factor": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 3},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 3},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1034,
        "sentence": "p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .",
        "label": {
            "Stat1": "protein",
            "phosphorylation site": "protein",
            "Src homology 2 (SH2) domain": "protein",
            "p94": "protein",
            "p95": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"calcineurin\": 5},\n    {\"Th1\": 4},\n    {\"Th2\": 4},\n    {\"IL-2\": 5},\n    {\"STAT4\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"tyrosine\": 4},\n    {\"IFN-gamma\": 5},\n    {\"Aiolos\": 5},\n    {\"ERK\": 5},\n    {\"CD28\": 5},\n    {\"CD80\": 5},\n    {\"CD86\": 5},\n    {\"CBL\": 5},\n    {\"VAV\": 5},\n    {\"NFAT\": 5},\n    {\"interleukin-2\": 5},\n    {\"granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"interleukin 10\": 5},\n    {\"IL-10R\": 5},\n    {\"IL-6\": 5},\n    {\"STAT3\": 5}\n]",
        "response3": "[{\"Stat1\": \"protein\"}, {\"p94\": \"protein\"}, {\"p95\": \"protein\"}]",
        "prediction": "{'Stat1': 'protein', 'p94': 'protein', 'p95': 'protein'}"
    },
    {
        "idx": 1232,
        "sentence": "IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).",
        "label": {
            "IBR": "protein",
            "transcription factors": "protein",
            "erected wing gene product": "protein",
            "human NRF-1/alpha-Pal factor": "protein",
            "EWG": "protein",
            "P3A2": "protein",
            "503-amino-acid-long acidic protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'IL-4' with the corresponding entity label 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity 'NF-E2' with the corresponding entity label 'protein', providing a clear reference for named entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions multiple entities such as 'IL-2', 'c-Jun', and 'c-Fos' with the corresponding entity label 'protein', making it very helpful for named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'interferon regulatory factor' as a transcription factor with the corresponding entity label 'protein', aiding in named entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides multiple mentions of transcription factors like 'EKLF', 'CBP', 'p300', and 'P/CAF' with the corresponding entity label 'protein', making it highly helpful for named entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'A-myb' as a transcription factor with the corresponding entity label 'protein', aiding in named entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'Protein' with the corresponding entity label 'protein', providing a clear reference for named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)' as proteins, aiding in named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'Drosophila Toll' and 'human Toll' as type I transmembrane proteins, providing clear references for named entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions multiple entities like 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' with the corresponding entity label 'protein', making it highly helpful for named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'NF-kappa B' and 'AP-1' as transcription factors with the corresponding entity label 'protein', aiding in named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'EBNA-2' and 'PU.1' as proteins, providing clear references for named entity extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'NF-ATc' as a transcription factor, along with 'T lymphocytes' and 'embryonic cardiac cells' as cell types, aiding in named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer' as DNA, aiding in named entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'Egr-1' as a zinc finger transcription factor, aiding in named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 54,
        "sentence": "Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .",
        "label": {
            "LTR": "DNA",
            "human T-cell types": "cell_type",
            "T-cell types": "cell_type",
            "element": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "```json\n[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence provides a clear example of cDNAs, which are associated with the entity label 'DNA'.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence clearly mentions IL-2, which is associated with the entity label 'protein'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of cell lines such as SIVmacMER, SIVmac239, and CEMx174, which are associated with the entity label 'cell_line'.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions CD4+ cells and EBV, which are associated with the entity labels 'cell_type' and 'protein' respectively.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides multiple examples of proteins and stimuli related to protein expression, aiding in the extraction of protein entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions TIMP-1 and DNA synthesis, which are associated with the entity labels 'protein' and 'DNA' respectively.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions Th2-type lymphocytes, which are associated with the entity label 'cell_type'.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions EBV and CD2, which are associated with the entity labels 'cell_line' and 'protein' respectively.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of PBMC and adenovirus DNA, aiding in the extraction of 'cell_type' and 'DNA' entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions SIVsmmPBj14, which is associated with the entity label 'cell_line'.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions CD95 ligand, which is associated with the entity label 'protein'.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of HIV-1 LTR, NFAT-1, and NF kappa B, aiding in the extraction of 'DNA' and 'protein' entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions EBV, EBNA2, and estrogen receptor, which are associated with the entity labels 'DNA' and 'protein'.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions TR55, TNF-alpha, and HIV, which are associated with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of NF-kappaB, Sp1, and SIVmac, aiding in the extraction of 'protein' and 'cell_line' entities.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1149,
        "sentence": "The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .",
        "label": {
            "Sp1": "protein",
            "DCs": "cell_type",
            "NF-kappa B": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 3},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 4},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"DCs\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type'}"
    },
    {
        "idx": 407,
        "sentence": "Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ).\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"Furthermore, the two VDR 3'-UTR haplotypes conferred an identical half-life on a heterologous beta-globin reporter gene, in an in vitro assay.\": 4}\n]",
        "response3": "[{\"VDR\": \"protein\"}, {\"VDR\": \"protein\"}, {\"XLH\": \"cell_type\"}]",
        "prediction": "{'VDR': 'protein', 'XLH': 'cell_type'}"
    },
    {
        "idx": 1466,
        "sentence": "As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .",
        "label": {
            "endothelial cells": "cell_type",
            "NFAT": "protein",
            "activated endothelial cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'NF-kappa B' and its corresponding label 'DNA', aiding in the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[{\"NFAT\": \"protein\"}, {\"CsA\": \"protein\"}, {\"endothelial cells\": \"cell_type\"}]",
        "prediction": "{'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}"
    },
    {
        "idx": 1330,
        "sentence": "Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .",
        "label": {
            "I kappa B alpha": "protein",
            "I kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple protein names and a cell type, which are all relevant entity types in the label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a protein name that is relevant to the label set.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains a protein name that is relevant to the label set.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains multiple protein names and a cell type, which are all relevant entity types in the label set.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple protein names and a cell type, which are all relevant entity types in the label set.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains multiple protein names and a cell type, which are all relevant entity types in the label set.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains multiple protein names that are relevant to the label set.\"}\n]\n```",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1436,
        "sentence": "Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .",
        "label": {
            "hTR beta 1 mRNA": "RNA",
            "hTR beta 1": "protein"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 859,
        "sentence": "We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .",
        "label": {
            "inducible": "protein",
            "Jurkat cells": "cell_line",
            "C1": "protein",
            "HIV enhancer": "DNA",
            "C2": "protein",
            "constitutive, C2 , protein": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5}\n]",
        "response3": "[{\"C1\": \"protein\"}, {\"C2\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"HIV\": \"cell_type\"}]",
        "prediction": "{'C1': 'protein', 'C2': 'protein', 'Jurkat': 'cell_line', 'HIV': 'cell_type'}"
    },
    {
        "idx": 451,
        "sentence": "However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .",
        "label": {
            "NF-muE3": "protein",
            "B cells": "cell_type",
            "lymphoid cells": "cell_type",
            "transfected reporter gene": "DNA",
            "Ig heavy chain enhancer": "DNA",
            "non- lymphoid cells": "cell_type",
            "non-B cells": "cell_type",
            "endogenous Ig heavy chain enhancer": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"Egr-1\": 5},\n    {\"IFN A\": 4, \"IFNA\": 4, \"interleukin-2\": 4, \"interleukin-2 receptor\": 4, \"phytohemagglutinin\": 4, \"phorbol myristate acetate\": 4},\n    {\"TCF-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 4, \"p21ras\": 4, \"B cell\": 4},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"IL-2\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"c-kit\": 5, \"IL-4R alpha chain\": 5},\n    {\"IL-2\": 5, \"c-Jun\": 5, \"c-Fos\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"IL-2\": 5, \"IFN-gamma\": 5, \"jak kinases\": 5, \"STAT1(alpha)\": 5},\n    {\"NF-kappaB\": 5, \"rheumatoid arthritis\": 4},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"SIVmac\": 5},\n    {\"CTLA4Ig\": 5, \"NFAT\": 5, \"AP-1\": 5}\n]",
        "response3": "[{\"Ig heavy chain enhancer\": \"DNA\"}, {\"NF-muE3\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"non-B cells\": \"cell_type\"}]",
        "prediction": "{'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type', 'non-B cells': 'cell_type'}"
    },
    {
        "idx": 919,
        "sentence": "The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .",
        "label": {
            "56-kDa protein": "protein",
            "p56": "protein",
            "EC1 antibody": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"EC1 antibody\": \"protein\"}, {\"p56\": \"protein\"}]",
        "prediction": "{'EC1 antibody': 'protein', 'p56': 'protein'}"
    },
    {
        "idx": 1206,
        "sentence": "In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.",
        "label": {
            "androgen receptors": "protein",
            "mononuclear leukocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'RXR' and the entity label 'protein' in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides a clear mapping between the entities 'granulocytes' and 'T cells' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The example provides a mapping between the entity 'lymphoid neoplasms' and the entity label 'cell_type' in the target sentence, but the relevance is slightly less direct compared to other examples.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping between the entity 'CD14' and the entity label 'protein' in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example provides mappings between the entities 'phosphocreatine' to the entity label 'protein' in the target sentence, but the relevance is slightly less direct compared to other examples.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides clear and direct mappings between the entities 'HML', 'dexamethasone', 'cortisol', and 'lysozyme' to the entity labels 'cell_line' and 'protein' in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear and direct mapping between the entity 'NF-E2' and the entity label 'protein' in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear and direct mapping between the entity 'E2A' and the entity label 'protein' in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides clear and direct mappings between the entities 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40' to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides clear and direct mappings between the entities 'cAMP-dependent protein kinase' and 'Rap1' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides clear and direct mappings between the entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides clear and direct mappings between the entities 'PU.1', 'CSF-1 receptor', 'Mono A', and 'Mono B' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example provides mappings between the entities 'nuclear factor-kappa B' and 'NF-kappa B' to the entity label 'DNA' in the target sentence, but the relevance is slightly less direct compared to other examples.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides clear and direct mappings between the entities 'NF-kappa B' and 'fibrinogen' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides clear and direct mappings between the entities 'MNDA', 'monocytes', 'macrophages', and 'leukemia/B lymphoma cell lines' to the entity labels 'protein', 'cell_type', and 'cell_line' in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides clear and direct mappings between the entities 'PMA' and 'U1 cells' to the entity label 'cell_line' in the target sentence.\"}\n]",
        "response3": "[{'androgen receptors': 'protein'}, {'mononuclear leukocytes': 'cell_type'}, {'follicular': 'cell_type'}, {'luteal': 'cell_type'}, {'menstrual cycle': 'cell_type'}, {'flutamide': 'protein'}]",
        "prediction": "{'androgen receptors': 'protein', 'mononuclear leukocytes': 'cell_type', 'follicular': 'cell_type', 'luteal': 'cell_type', 'menstrual cycle': 'cell_type', 'flutamide': 'protein'}"
    },
    {
        "idx": 569,
        "sentence": "In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .",
        "label": {
            "PDGF(B)": "protein",
            "EGR2": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1657,
        "sentence": "HMG-I binds to GATA motifs : implications for an HPFH syndrome .",
        "label": {
            "HMG-I": "protein",
            "GATA motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5}\n]",
        "response3": "[{\"HMG-I\": \"protein\"}, {\"GATA motifs\": \"DNA\"}]",
        "prediction": "{'HMG-I': 'protein', 'GATA motifs': 'DNA'}"
    },
    {
        "idx": 1780,
        "sentence": "Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .",
        "label": {
            "Id3": "protein",
            "Mo": "cell_line",
            "Id2": "protein",
            "4/5 T-cell lines": "cell_line",
            "S-LB1": "cell_line",
            "MT-2": "cell_line",
            "ATL-1k": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence provides clear examples of protein and cell_line entities in the context of cell lines established from patients with chronic myeloid leukemia.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The sentence mentions specific proteins and their interactions, aiding in the identification of protein entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence discusses specific proteins and cell types, providing valuable information for identifying protein and cell_type entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence talks about specific proteins and cell types in the context of T lymphocytes, aiding in the identification of protein and cell_type entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides detailed information about various proteins and their roles in cellular responses, making it highly informative for identifying protein entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions specific cell lines and their testing conditions, aiding in the identification of cell_line entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence discusses specific proteins and cell types, providing valuable information for identifying protein and cell_type entities.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The sentence mentions a specific cell type in the context of cytokine expression, aiding in the identification of cell_type entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides detailed information about various proteins and their expression levels, making it highly informative for identifying protein entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions specific cell types and their association with adenovirus DNA, aiding in the identification of cell_type and DNA entities.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence provides information about the expression of a specific protein, aiding in the identification of protein entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence discusses specific proteins and cell types in the context of HIV-1 infection, providing valuable information for identifying protein and cell_type entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions specific cell lines and the technology used for studying gene expression, aiding in the identification of cell_line and DNA entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides information about the expression of specific proteins and their roles in hematopoiesis, aiding in the identification of protein and cell_type entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence discusses specific DNA sequences and proteins involved in the regulation of the HIV-1 LTR, providing valuable information for identifying DNA and protein entities.\"}\n]",
        "response3": "[{\"Id2\": \"RNA\"}, {\"Id3\": \"None\"}, {\"T-cell lines\": \"cell_line\"}, {\"human T-cell leukemia virus type I (HTLV-I)\": \"cell_type\"}, {\"ATL-1k\": \"cell_line\"}, {\"MT-2\": \"cell_line\"}, {\"S-LB1\": \"cell_line\"}, {\"type II (Mo)\": \"cell_type\"}]",
        "prediction": "{'Id2': 'RNA', 'Id3': 'None', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'cell_type'}"
    },
    {
        "idx": 13,
        "sentence": "We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.",
        "label": {
            "platelet-activating factor": "protein",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1554,
        "sentence": "The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .",
        "label": {
            "GP": "protein",
            "normal platelets": "cell_type",
            "cis-acting elements": "DNA",
            "GP Ib alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1650,
        "sentence": "This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .",
        "label": {
            "PU.1": "protein",
            "myeloid PU.1 binding site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains specific examples of interactions between proteins and binding sites, which directly relate to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'PU.1': 'protein'}, {'myeloid PU.1 binding site': 'protein'}]",
        "prediction": "{'PU.1': 'protein', 'myeloid PU.1 binding site': 'protein'}"
    },
    {
        "idx": 326,
        "sentence": "We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .",
        "label": {
            "EB1": "protein",
            "R-responsive element": "DNA",
            "HeLa cells": "cell_line",
            "domain B": "DNA",
            "EB1 -responsive B-cell-specific element": "DNA"
        },
        "response1": "['cell_line', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (IL-2) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple protein entities (RelA, NF-kappa B) and their corresponding labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions a protein entity (E2A) and its label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes protein entities (IL-2, c-Jun, c-Fos) and their labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides examples of cell type entities (EBV, B-cell) and their labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions a cell line entity (UAS1) and its label, along with a cell type entity (B cell).\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence includes DNA (CCAAT box) and protein (EKLF binding site) entities with their labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions cell type (T cell) and protein (interleukin 2) entities with their labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a protein entity (p50p50) and its label.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence includes cell type (CD4+) and protein (EBV) entities with their labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions a protein entity (EKLF) and its label.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains cell line (EBV) and protein (CD2) entities with their labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides protein (EBNA2) and cell line (TP1) entities with their labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions a protein entity (RXR) and its label, along with cell type (erythroid cells).\"}\n]",
        "response3": "[{'HeLa cells': 'cell_line'}, {'EB1': 'protein'}, {'B-cell': 'cell_type'}]",
        "prediction": "{'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 1429,
        "sentence": "Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .",
        "label": {
            "TR": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL-mediated NF-kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5}\n]",
        "response3": "[{\"TR\": \"protein\"}]",
        "prediction": "{'TR': 'protein'}"
    },
    {
        "idx": 865,
        "sentence": "Response to T cell activation signals .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 696,
        "sentence": "First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .",
        "label": {
            "TRE -DNA fragment": "DNA",
            "nuclear proteins": "protein",
            "TRE": "DNA"
        },
        "response1": "['protein', 'DNA', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 318,
        "sentence": "Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.",
        "label": {
            "estrogen receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (RXR) and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein (E2A) and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of proteins (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of proteins (TCRzeta, p56(lck)) and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of proteins (Erbstatin, genistein, Egr-1) and RNA (Egr-1) with their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear examples of DNA (EBV) and proteins (EBNA2, estrogen receptor) with their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of cell lines (PMA, U1 cells) with their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of DNA (nuclear factor-kappa B, NF-kappa B) with their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of proteins (CD3.TcR, CD18, CD29) with their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of DNA (DNA) and proteins (PCNA, E2F1) with their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of proteins (MR, aldosterone, progesterone) with their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides clear examples of proteins (E2F, E2F-4, DP-1, p130) and a cell type (AML) with their corresponding entity labels, which directly match the entity types in the target sentence.\"}\n]",
        "response3": "[{\"estrogen receptor\": \"protein\"}]",
        "prediction": "{'estrogen receptor': 'protein'}"
    },
    {
        "idx": 440,
        "sentence": "All three proteins show the same sequence specificity and binding affinity .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain .\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 5},\n{\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease .\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n{\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n{\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1563,
        "sentence": "Pathogenesis of atherosclerosis .",
        "label": {},
        "response1": "None.",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a clear and direct mapping of the entity 'IFN-gamma' to the entity label 'protein' in the target sentence, aiding in understanding the relationship between the entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example includes multiple entities such as 'NF-kappaB', 'Tax', and 'ATL' with their corresponding entity labels, which helps in identifying different types of entities present in the sentence.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example links the entity 'AP-1' to the entity label 'DNA', providing some insight into the entity type, but the context could be clearer for better understanding.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example correctly identifies 'P selectin' as a protein entity, aiding in the extraction of protein-related entities from the sentence.\"\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Reason 5\": \"The example associates 'NF-kappaB' with the entity label 'protein' and 'rheumatoid arthritis' with the entity label 'cell_type', providing valuable information for entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example covers multiple entities including 'PKC isoforms', 'human alveolar macrophages', and 'blood monocytes' with their respective entity labels, offering a comprehensive view for entity extraction.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The example highlights the entity 'NF-kappa B' as a protein entity, aiding in the identification of protein-related entities in the sentence.\"\n    },\n    {\n        \"Example 8\": 3\n    },\n    {\n        \"Reason 8\": \"The example mentions 'cell adhesion molecules' as a cell_type entity, providing some insight into the entity type, but the context could be clearer for better understanding.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example correctly identifies 'NF-kappa B' as a protein entity and 'ARDS' as a cell_type entity, aiding in the extraction of relevant entities from the sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example provides a clear mapping of entities 'IkappaBbeta' and 'NF-kappaB' to the entity label 'protein', aiding in understanding the protein-related entities in the sentence.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The example correctly identifies 'IL-12' as a protein entity and 'macrophages' as a cell_type entity, providing valuable information for entity extraction.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example covers multiple entities including 'Stat3', 'Stat5', and 'c-Mpl' with their respective entity labels, offering a comprehensive view for entity extraction.\"\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Reason 13\": \"The example correctly identifies 'Eosinophils' as a cell_type entity, aiding in the extraction of cell_type-related entities from the sentence.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The example includes entities 'alpha-tocopherol', 'monocyte', and 'endothelial cells' with their corresponding entity labels, providing valuable information for entity extraction.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example provides a clear mapping of entities 'SP1', 'caspases', and 'B-cell' to the entity label 'protein' and 'cell_type', aiding in understanding the relationship between the entities.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 689,
        "sentence": "High-risk patients can be recognized morphologically.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"PBMC\": 5, \"adenovirus\": 5},\n    {\"WT1\": 5},\n    {\"CD70\": 5, \"B cell\": 5, \"plasma cells\": 5, \"IL-4\": 5, \"CD40\": 5},\n    {\"TCL1\": 5},\n    {\"myeloperoxidase\": 5, \"lysozyme\": 5, \"PU.1\": 5},\n    {\"Ras\": 5},\n    {\"T-PLL\": 5},\n    {\"T lymphocytes\": 5, \"HLA-molecules\": 5},\n    {\"MNDA\": 5, \"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"granulocytes\": 5, \"T cells\": 5},\n    {\"TCRzeta\": 5, \"p56(lck)\": 5},\n    {\"PBMC\": 5, \"adenovirus DNA\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"SIVmacMER\": 5, \"SIVmac239\": 5, \"CEMx174\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"SIVsmmPBj14\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 189,
        "sentence": "Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .",
        "label": {
            "human T lymphoblastic tumor cell line": "cell_line",
            "c-myc": "DNA"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"c-myc\": \"protein\"}, {\"T lymphoblastic tumor cell line\": \"cell_line\"}]",
        "prediction": "{'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}"
    },
    {
        "idx": 778,
        "sentence": "Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .",
        "label": {
            "OTF-1": "protein",
            "pre-B cells": "cell_line",
            "immunoglobulin gene": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"T cell blasts treated with PMA are now responsive to IFN-gamma .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .\": 5}\n]",
        "response3": "[{\"OTF-1\": \"protein\"}, {\"pre-B cells\": \"cell_type\"}, {\"HeLa cells\": \"cell_line\"}, {\"immunoglobulin gene\": \"protein\"}]",
        "prediction": "{'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}"
    },
    {
        "idx": 198,
        "sentence": "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence contains the term 'lymphoid neoplasms' which is likely to be a cell_type entity based on the context.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific terms like 'IL-2', 'NF-kappa B', and 'AP-1' which are likely to be protein entities based on their functions and characteristics.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions 'TCRzeta' and 'p56(lck)' which are proteins commonly associated with T cells.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence refers to 'TAL1' and 'T-ALL' which are likely to be protein and cell_type entities respectively based on their roles in the context.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions 'STAT1' which is likely to be a protein entity based on its function in immunosuppression and antineoplastic activities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' which are likely to be protein and cell_line entities respectively based on their context.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions 'NF-E2' which is likely to be a protein entity based on its role in transcriptional regulation.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence refers to 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and 'B cells' which are likely to be protein and cell_type entities based on their functions and context.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions 'T lymphocytes' which are likely to be cell_type entities based on their immune function.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R' which are likely to be protein entities based on their signaling pathways and roles in cancer cells.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence refers to 'WT1' and 'myeloid cell lines' which are likely to be protein and cell_line entities respectively based on their context.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions 'Erbstatin', 'genistein', and 'Egr-1' which are likely to be protein and RNA entities based on their functions and context.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains 'PMA', 'IFN-gamma', and 'T cell blasts' which are likely to be protein and cell_type entities based on their functions and context.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions 'EBV', 'EBNA2', and 'estrogen receptor' which are likely to be DNA and protein entities based on their roles in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence refers to 'TCL1' and 'MTCP1/c6.1B' which are likely to be protein entities based on their context.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains 'CD4+', 'CD8+', 'TPCK', 'anti-CD28', and 'PMA' which are likely to be cell_type and protein entities based on their functions and context.\"}\n]",
        "response3": "[{'CLL': 'cell_type'}, {'Hodgkin\\'s disease': 'cell_type'}]",
        "prediction": "{'CLL': 'cell_type', \"Hodgkin's disease\": 'cell_type'}"
    },
    {
        "idx": 735,
        "sentence": "This prompted us to analyze the octamer-binding proteins in the latter cells.",
        "label": {
            "octamer-binding proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence directly mentions the entity 'DNA' and provides context about its binding activity, making it highly relevant for extracting named entities from the target sentence.\"},\n\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions 'CD95 ligand promoter', which is related to a protein, providing relevant information for extracting named entities from the target sentence.\"},\n\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence mentions 'EBNA-2' and 'PU.1' as proteins and describes their interaction, which is crucial for understanding the protein entities in the target sentence.\"},\n\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence mentions 'cDNAs', which are related to DNA, providing relevant information for extracting named entities from the target sentence.\"},\n\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' as proteins and provides information about their presence in nuclear factors, aiding in extracting named entities from the target sentence.\"},\n\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence mentions 'NF-kappa B' as a protein and its activation, providing relevant information for extracting named entities from the target sentence.\"},\n\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions 'c-kit' and 'IL-4R alpha chain' as proteins, along with 'monocytes' and 'macrophages' as cell types, providing crucial information for extracting named entities from the target sentence.\"},\n\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence mentions 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and 'B cells' as proteins and cell types, providing essential information for extracting named entities from the target sentence.\"},\n\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions 'EKLF', 'CBP', 'p300', and 'P/CAF' as proteins, providing valuable information for extracting named entities from the target sentence.\"},\n\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions 'IL-4', 'LPS', and 'AP-1' as proteins, providing relevant information for extracting named entities from the target sentence.\"},\n\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence mentions 'granulocytes' and 'T cells' as cell types, providing crucial information for extracting named entities from the target sentence.\"},\n\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions 'SCM-1' as a cell line, providing relevant information for extracting named entities from the target sentence.\"},\n\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions 'CD40' and 'NF-kappa B' as proteins, providing essential information for extracting named entities from the target sentence.\"},\n\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)' as proteins, providing valuable information for extracting named entities from the target sentence.\"},\n\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions 'E2A' as a protein, providing crucial information for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{'octamer-binding proteins': 'protein'}, {'latter cells': 'cell_type'}]",
        "prediction": "{'octamer-binding proteins': 'protein', 'latter cells': 'cell_type'}"
    },
    {
        "idx": 1735,
        "sentence": "We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .",
        "label": {
            "VDR": "protein",
            "IL-2 promoter/reporter constructs": "DNA",
            "Jurkat cells": "cell_line",
            "VDR overexpression vector": "DNA",
            "IL-2": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 4},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"IL-2\": \"DNA\"}, {\"VDR\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'IL-2': 'DNA', 'Jurkat': 'cell_line', 'VDR': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 704,
        "sentence": "Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .",
        "label": {
            "ubiquitous and developmentally regulated proteins": "protein",
            "ubiquitous": "protein",
            "developmentally regulated proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"immunoglobulin heavy and kappa light chain gene enhancers\": \"DNA\"}]",
        "prediction": "{'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}"
    },
    {
        "idx": 1236,
        "sentence": "Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .",
        "label": {
            "direct-repeat palindrome": "DNA",
            "IBR/F": "protein",
            "IBR/F binding sites": "DNA",
            "optimal site": "DNA",
            "alternating RCGCRYGCGY consensus": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"T cell\": 4, \"interleukin 2\": 3},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"CREB\": 4, \"AR-CRE\": 3},\n    {\"SIVsmmPBj14\": 5},\n    {\"EBNA2\": 4, \"TP1\": 3},\n    {\"BRCA1\": 5},\n    {\"p50p50\": 4},\n    {\"GM-CSF\": 3},\n    {\"retinoic acid receptor alpha\": 5},\n    {\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n    {\"Protein\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"IgH\": 5},\n    {\"VDR\": 5, \"RXR\": 5, \"GRIP-1\": 5, \"DRIP205\": 5, \"DRIP\": 4},\n    {\"GM-kappa B\": 4, \"GC-box\": 4, \"GC-motif\": 4, \"GM-kappa B motif\": 4},\n    {\"NF-kappaB\": 4, \"Sp1\": 4, \"SIVmac\": 5}\n]",
        "response3": "[{\"RCGCRYGCGY\": \"DNA\"}, {\"TGCGCATGCGCA\": \"DNA\"}]",
        "prediction": "{'RCGCRYGCGY': 'DNA', 'TGCGCATGCGCA': 'DNA'}"
    },
    {
        "idx": 541,
        "sentence": "To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains specific protein names like Syk, Zap, myeloperoxidase, lysozyme, PU.1, Egr-1, MIP-1 alpha, GOS19, LD78, AT464, GM-CSF, IFN A, interleukin-2, interleukin-2 receptor, IFN-gamma, IL-2, TCF-1, IL-4, IL-12, c-Jun, c-Fos, ZAP-70, G0S24, which are directly related to the 'protein' entity label in the target sentence.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence contains cell type names like T lymphocytes, Th2-type lymphocytes, macrophages, PBL (peripheral blood T cells), which are directly related to the 'cell_type' entity label in the target sentence.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The sentence contains protein names like HLA-molecules, which are directly related to the 'protein' entity label in the target sentence.\"\n    },\n    {\n        \"Example 4\": 2\n    },\n    {\n        \"Reason 4\": \"The sentence contains a protein name, IFNA, which is directly related to the 'protein' entity label in the target sentence.\"\n    },\n    {\n        \"Example 5\": 1\n    },\n    {\n        \"Reason 5\": \"The sentence does not contain any entity names related to the entity labels in the target sentence.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1652,
        "sentence": "Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.",
        "label": {
            "PU.1": "protein",
            "PU-SF complex": "protein",
            "myeloid promoters": "DNA",
            "PU.1 site": "DNA",
            "PU-SF": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"UAS1\": 4},\n    {\"B cell\": 3},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"GM-CSF\": 5},\n    {\"AP-1\": 5},\n    {\"PMA\": 5},\n    {\"monocytes\": 3},\n    {\"macrophages\": 3},\n    {\"PNU156804\": 4},\n    {\"EKLF\": 5},\n    {\"CBP\": 5},\n    {\"p300\": 5},\n    {\"P/CAF\": 5},\n    {\"CD14\": 5},\n    {\"UAS3\": 4},\n    {\"UAS2\": 4},\n    {\"YY1\": 5},\n    {\"EBNA2\": 5},\n    {\"TP1\": 4},\n    {\"Jun\": 5},\n    {\"ATF-2\": 5},\n    {\"SCM-1\": 4},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"PU.1\": 5},\n    {\"M-CSF receptor\": 5},\n    {\"macrophage\": 4}\n]",
        "response3": "[{\"PU-SF complex\": \"protein\"}, {\"PU.1\": \"protein\"}, {\"myeloid\": \"cell_type\"}]",
        "prediction": "{'PU-SF complex': 'protein', 'PU.1': 'protein', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 88,
        "sentence": "TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .",
        "label": {
            "TNF alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and cell types that are directly mentioned, making it highly relevant for extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1494,
        "sentence": "Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .",
        "label": {
            "latent NF-kappa B": "protein",
            "cytokine": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 940,
        "sentence": "Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .",
        "label": {
            "PBMC": "cell_type",
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (NF-E2) and its corresponding label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains multiple examples of protein entities (alpha-tocopherol) and cell type entities (monocyte, endothelial cells) which can aid in entity extraction.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence includes protein entities (NF-kappa B, AP-1) which are clearly mentioned and can help in entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence provides protein entities (IL-2, NF-kappa B, AP-1) which are explicitly mentioned and can assist in entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains RNA entity (IL-5 mRNA), cell type entities (TCR), protein entity (IL-2R), and chemical compound entity (dexamethasone) which are clearly stated and can aid in entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence includes a protein entity (retinoic acid receptor alpha) which is explicitly mentioned and can help in entity extraction.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides protein entity (WT1) and cell line entity (myeloid cell lines) which can assist in entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains a protein entity (E2A) which is clearly mentioned and can aid in entity extraction.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence includes protein entities (NF-kappa B, I kappa B beta) which are explicitly stated and can help in entity extraction.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence mentions cell type entity (lymphocytes) and chemical compound entities (benzene, benzoquinone) which may provide some assistance in entity extraction.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence provides a protein entity (NF-kappa B) which is clearly mentioned and can aid in entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains cell line entity (Ter 119) and protein entities (beta-globin, glycoprotein IIb, platelet factor 4) which can assist in entity extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence includes protein entities (Erbstatin, genistein) and RNA entity (Egr-1) which are explicitly mentioned and can help in entity extraction.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides cell type entity (B cell) and protein entities (Ig, Transforming growth factor-beta) which can aid in entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions DNA entity (EBV) and protein entities (EBNA2, estrogen receptor) which are clearly stated and can assist in entity extraction.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence contains cell line entities (PMA, U1 cells) which are explicitly mentioned and can help in entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1098,
        "sentence": "Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .",
        "label": {
            "microtubules": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 1},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n{\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 255,
        "sentence": "c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.",
        "label": {
            "c-myc RNA": "RNA",
            "RWLeu-4 cells": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5}\n]",
        "response3": "[{\"c-myc RNA\": \"RNA\"}, {\"RWLeu-4 cells\": \"cell_line\"}, {\"VD3\": \"protein\"}]",
        "prediction": "{'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}"
    },
    {
        "idx": 775,
        "sentence": "Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.",
        "label": {
            "OTF-1": "protein",
            "OTF-2": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"NF-ATc isoforms\": 4},\n    {\"T lymphocytes\": 3},\n    {\"IL-4\": 3},\n    {\"Protein\": 2},\n    {\"WT1\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"GATA-1\": 4},\n    {\"Syk\": 4},\n    {\"Zap\": 4},\n    {\"T cell\": 3},\n    {\"RXR\": 4},\n    {\"E2A\": 4},\n    {\"Th2-type lymphocytes\": 4},\n    {\"TCF-1\": 4},\n    {\"immunohistochemistry\": 4},\n    {\"gene\": 1},\n    {\"DNA\": 1},\n    {\"cell type\": 4},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"Th1\": 4},\n    {\"Th2\": 4},\n    {\"Egr-1\": 4},\n    {\"CD70\": 4},\n    {\"B cell\": 4},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4}\n]",
        "response3": "[{\"OTF-2\": \"protein\"}, {\"OTF-1\": \"protein\"}]",
        "prediction": "{'OTF-2': 'protein', 'OTF-1': 'protein'}"
    },
    {
        "idx": 161,
        "sentence": "Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific terms that directly correspond to the entity labels in the entity label set, making it highly relevant for named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1130,
        "sentence": "B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .",
        "label": {
            "B-lymphoblastoid cell lines": "cell_line"
        },
        "response1": "['cell_line', 'virus']",
        "response2": "[\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 1},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 3},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 3},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 4},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4}\n]",
        "response3": "[{\"B-lymphoblastoid cell lines\": \"cell_line\"}, {\"human retrovirus\": \"protein\"}, {\"Epstein-Barr virus\": \"protein\"}]",
        "prediction": "{'B-lymphoblastoid cell lines': 'cell_line', 'human retrovirus': 'protein', 'Epstein-Barr virus': 'protein'}"
    },
    {
        "idx": 600,
        "sentence": "Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .",
        "label": {
            "immunoglobulin heavy-chain gene": "DNA",
            "lymphoid-specific enhancer element": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 3},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5}\n]",
        "response3": "[{\"immunoglobulin heavy-chain gene\": \"DNA\"}]",
        "prediction": "{'immunoglobulin heavy-chain gene': 'DNA'}"
    },
    {
        "idx": 1698,
        "sentence": "Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .",
        "label": {
            "natural killer cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 5},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 4},\n{\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n{\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 4},\n{\"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal , calphostin C , and ceramide .\": 5},\n{\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 5},\n{\"To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils .\": 4},\n{\"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence .\": 5},\n{\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\": 4}\n]",
        "response3": "[{\"human papillomavirus- or adenovirus- transformed cells\": \"cell_type\"}, {\"natural killer cells\": \"cell_type\"}]",
        "prediction": "{'human papillomavirus- or adenovirus- transformed cells': 'cell_type', 'natural killer cells': 'cell_type'}"
    },
    {
        "idx": 1287,
        "sentence": "Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .",
        "label": {
            "Platelet thromboxane receptors": "protein",
            "Platelet": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 3},\n{\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 4},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n{\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 5},\n{\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n{\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 5},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1266,
        "sentence": "Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .",
        "label": {
            "EBV -positive B cell lines": "cell_line"
        },
        "response1": "['cell_line', 'cell_line']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 4}\n]",
        "response3": "[{\"Human herpesvirus 6\": \"cell_type\"}, {\"EBV\": \"cell_line\"}, {\"B cell lines\": \"cell_line\"}, {\"EBV\": \"cell_type\"}]",
        "prediction": "{'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_type', 'B cell lines': 'cell_line'}"
    },
    {
        "idx": 1813,
        "sentence": "Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .",
        "label": {
            "BLR2 mRNA": "RNA",
            "BLR2": "protein"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity along with its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple entities with their corresponding labels explicitly mentioned.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions entities along with their labels and provides context for their roles.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly mentions entities with their labels and provides information on their increase in cells.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple entities with their labels mentioned clearly and provides information on their expression levels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions multiple entities with their labels and describes their roles in promoting differentiation.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear mentions of entities with their labels and describes their roles in signal transduction events.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions entities with their labels and describes their roles in activating proteins in B cells.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions entities with their labels and describes their roles in gel-shift analysis.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions entities with their labels and describes their roles in cytokine expression.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions entities with their labels and describes their roles in infection and proliferation.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions entities with their labels and describes the method used for detection.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions entities with their labels and describes their roles in cellular responses.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions entities with their labels and describes the study focus on gene expression.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions entities with their labels and describes the association between reduced mitogenic response and expression levels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions entities with their labels and describes the effect of CD40 stimulation on factors in B lymphocytes.\"}\n]",
        "response3": "[{'BLR2 mRNA': 'RNA'}, {'mitogen': 'protein'}, {'anti-CD3': 'protein'}, {'peripheral blood lymphocytes': 'cell_type'}]",
        "prediction": "{'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1764,
        "sentence": "The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .",
        "label": {
            "AP-1": "protein",
            "NF-kappa B": "protein",
            "transcription factor": "protein",
            "mitogen-stimulated cells": "cell_type"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding entity labels, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides multiple protein names and cell line names along with their corresponding entity labels, making it highly helpful for extracting named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence includes various protein names and stimuli names with their corresponding entity labels, making it highly helpful for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions specific protein names and their corresponding entity labels, making it highly helpful for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names and their corresponding entity labels, making it highly helpful for extracting named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a specific transcription factor name with its corresponding entity label, making it highly helpful for extracting named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions a specific protein name and its corresponding entity label, making it highly helpful for extracting named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence includes specific protein names and their corresponding entity labels, making it highly helpful for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions a specific protein name with its corresponding entity label, making it highly helpful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides specific protein names and their corresponding entity labels, making it highly helpful for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names and their corresponding entity labels, making it highly helpful for extracting named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence includes specific protein names and their corresponding entity labels, making it highly helpful for extracting named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions a specific protein name and its corresponding entity label, making it highly helpful for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides a specific protein name with its corresponding entity label, making it highly helpful for extracting named entities.\"}\n]",
        "response3": "[{'AP-1': 'DNA'}, {'NF-kappa B': 'protein'}]",
        "prediction": "{'AP-1': 'DNA', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 740,
        "sentence": "On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.",
        "label": {
            "ubiquitous Oct-1": "protein",
            "Oct-1": "protein",
            "Oct-2A": "protein",
            "lymphoid-specific Oct-2A": "protein",
            "N-Oct-factors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1182,
        "sentence": "Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .",
        "label": {
            "IL-2": "protein",
            "T cells": "cell_type",
            "COOH-terminal region": "protein",
            "human T cells": "cell_type",
            "Ser386-Val525": "protein",
            "JAK3": "protein",
            "STAT transcription factor": "protein",
            "STAT5": "protein",
            "IL-2R beta": "protein",
            "IL-2R gamma": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5}\n]",
        "response3": "[{\"STAT5\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"JAK3\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'STAT5': 'protein', 'IL-2': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 393,
        "sentence": "We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.",
        "label": {
            "HNP-1": "protein",
            "pag": "DNA",
            "NP-1": "protein",
            "defensins": "protein",
            "NP-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 3},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Example 16\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1442,
        "sentence": "T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .",
        "label": {
            "interleukin 3": "protein",
            "transcriptional start site": "DNA",
            "IL-3": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"IL-3\": \"protein\"}]",
        "prediction": "{'IL-3': 'protein'}"
    },
    {
        "idx": 142,
        "sentence": "This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .",
        "label": {
            "U937 cells": "cell_line",
            "NF-kappa B": "protein",
            "viral RNA": "RNA",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"TIMP-1\": 5},\n    {\"DNA\": 4},\n    {\"NF-kB\": 4},\n    {\"AP-1\": 4},\n    {\"OCT-1\": 4},\n    {\"NF-IL-2B\": 4},\n    {\"RelA\": 4},\n    {\"NF-kappa B\": 5},\n    {\"Tax\": 4},\n    {\"ATL\": 4},\n    {\"IkappaBbeta\": 5},\n    {\"IL-2\": 4},\n    {\"AP-1\": 4},\n    {\"I kappa B alpha\": 5},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"HIV-1\": 4},\n    {\"PKR\": 4},\n    {\"IkappaBalpha\": 5},\n    {\"CD40\": 4},\n    {\"Rel/nuclear factor kappaB\": 4},\n    {\"B lymphocytes\": 4},\n    {\"TR55\": 4},\n    {\"SIVmac\": 4},\n    {\"Sp1\": 4}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"HIV type 1\": \"cell_type\"}, {\"HIV-1\": \"cell_type\"}, {\"RNA\": \"RNA\"}, {\"U937 cells\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'RNA': 'RNA', 'U937 cells': 'cell_line'}"
    },
    {
        "idx": 93,
        "sentence": "The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .",
        "label": {
            "canonical TATA box": "DNA",
            "\"housekeeping\" promoter": "DNA",
            "methylation-free island": "DNA",
            "5'-end termini": "RNA",
            "Thy-1 gene promoter": "DNA",
            "mRNA": "RNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.\": 5},\n    {\"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5}\n]",
        "response3": "[{\"Thy-1 gene\": \"protein\"}]",
        "prediction": "{'Thy-1 gene': 'protein'}"
    },
    {
        "idx": 1354,
        "sentence": "In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .",
        "label": {
            "TCF-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct link between the entity 'AP-1' and its corresponding entity type 'DNA', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides multiple entity-label pairs that are relevant to the target sentence, aiding in the extraction of named entities. However, the presence of multiple entities may slightly reduce the overall helpfulness score.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example directly links the entity 'WT1' to its corresponding entity type 'protein', which is helpful for entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides a clear link between the entity 'TCL1' and its corresponding entity type 'protein', aiding in entity extraction.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example offers relevant entity-label pairs for 'NF-ATc' and 'T lymphocytes', contributing to the extraction of named entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example directly associates the entity 'TCF-1' with its entity type 'protein', which is beneficial for named entity extraction.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The example provides a link between the entity 'lymphoid neoplasms' and its entity type 'cell_type', but the specificity could be improved for higher helpfulness.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example connects the entity 'Th2-type lymphocytes' with its entity type 'cell_type', aiding in named entity extraction.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example directly links the entity 'TCF-1' to its corresponding entity type 'protein', which is helpful for entity extraction.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example provides multiple relevant entity-label pairs for 'NF-ATc', 'T lymphocytes', and 'embryonic cardiac cells', contributing to named entity extraction.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example directly associates the entity 'RXR' with its entity type 'protein', aiding in named entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example offers relevant entity-label pairs for 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia', contributing to the extraction of named entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example provides a clear link between the entities 'granulocytes' and 'T cells' with their corresponding entity type 'cell_type', aiding in named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example offers multiple entity-label pairs that are directly relevant to the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example provides a clear link between the entities 'TAL1' and 'T-ALL' with their corresponding entity types, aiding in named entity extraction.\"}\n]",
        "response3": "[{\"TCF-1\": \"protein\"}, {\"lymphoid malignancies\": \"cell_type\"}]",
        "prediction": "{'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}"
    },
    {
        "idx": 466,
        "sentence": "(ABSTRACT TRUNCATED AT 250 WORDS)",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear example of a mutated human retinoic acid receptor alpha, which falls under the 'protein' entity label.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions alpha-tocopherol, monocyte, and endothelial cells, which correspond to the 'protein' and 'cell_type' entity labels.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence talks about genes encoding eosinophil granule proteins and GATA-1 binding transcription factor, which are related to the 'protein' entity label.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence directly mentions retinoic acid receptor alpha, which is classified as a 'protein' entity.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence refers to nonhuman primates, which is associated with the 'cell_type' entity label.\"},\n{\"Example 6\": 3},\n{\"Reason 6\": \"The sentence discusses AP-1 DNA binding activity, which is linked to the 'DNA' entity label.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence provides multiple examples of proteins such as IL-2, IFN-gamma, jak kinases, and STAT1(alpha), which are relevant to the 'protein' entity label.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence mentions RXR, which is classified as a 'protein' entity.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence talks about the unique phenotype of SIVsmmPBj14, which is associated with the 'cell_line' entity label.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The sentence refers to the regulatory mechanism of the SCM-1 genes, which is related to the 'cell_line' entity label.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides examples of proteins such as IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are relevant to the 'protein' entity label.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions A-myb, which is classified as a 'protein' entity.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence provides examples of proteins such as IL-2, c-Jun, and c-Fos, which are relevant to the 'protein' entity label.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence directly mentions WT1, which is classified as a 'protein' entity.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence talks about TCF-1 knock-out mice and antiserum titers against human and mouse TCF-1 protein, which are associated with the 'protein' entity label.\"},\n{\"Example 16\": 4},\n{\"Reason 16\": \"The sentence mentions B and T cell activation, Ramos, Jurkat cells, and cDNA microarray technology, which correspond to the 'cell_type', 'cell_line', and 'DNA' entity labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1583,
        "sentence": "Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.",
        "label": {
            "ribonucleoproteins": "protein",
            "Ro(SSA)": "protein",
            "autoantibodies": "protein",
            "HLA class II antigens": "protein",
            "La(SSB)": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence clearly mentions the protein 'TCL1' and its association with AIDS IBLP tumors, making it highly relevant for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence explicitly refers to the protein 'WT1' and its exclusive paternal expression, providing a clear context for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly discusses the proteins 'RXR' and 'RXR mutants' in relation to erythroid cells, making it very helpful for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'lymphoid neoplasms' as a cell type, which is crucial information for named entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence explicitly mentions the protein 'NF-kappa B' and its involvement in the activation of human monocytic cells, making it highly relevant for entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence discusses the proteins 'TCRzeta' and 'p56(lck)' in relation to peripheral blood T cells, providing valuable information for entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence talks about the DNA binding activity of the transcription factor 'AP-1' in lymphocytes, which is crucial for named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions the proteins 'EBNA-2' and 'PU.1' and their interaction, providing important context for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence discusses the proteins 'IL-2 receptor alpha subunit' and 'p21ras' in relation to B cell activation, making it highly relevant for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions the proteins 'SLAP-130', 'SLP-76', and the T cell antigen receptor, providing valuable information for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence talks about the protein 'NF-kappaB' and its role in the pathogenesis of rheumatoid arthritis, which is crucial for named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions the proteins 'myeloperoxidase', 'lysozyme', and the transcription factor 'PU.1' in relation to granulomonocyte-associated lysosomal proteins, providing important context for entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence explicitly discusses the protein 'retinoic acid receptor alpha' and its wild-type or mutated forms, making it highly relevant for entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions the proteins 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and their activation in B cells, providing valuable information for entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence talks about 'T lymphocytes' and their recognition of antigens bound to HLA-molecules, which is crucial for named entity extraction.\"}\n]",
        "response3": "[{\"HLA class II antigens\": \"protein\"}, {\"ribonucleoproteins Ro(SSA)\": \"protein\"}, {\"La(SSB)\": \"protein\"}]",
        "prediction": "{'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}"
    },
    {
        "idx": 592,
        "sentence": "The DNA isolated contained an open reading frame encoding 108 amino acid residues .",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 3},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4}\n]",
        "response3": "[{\"DNA\": \"DNA\"}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 163,
        "sentence": "This phenomenon can be mimicked by administering MP in divided doses.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'IL-2' and its corresponding entity type 'protein' in the sentence.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The example 'phosphocreatine' is directly associated with the entity type 'protein' in the sentence, but the relevance may not be as strong as in other examples.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides multiple mappings between entities and their corresponding entity types in the sentence, showing a clear relationship between the terms.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a direct mapping between the entities 'granulocytes' and 'T cells' with their corresponding entity types in the sentence, aiding in entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a direct mapping between the entities 'NF-kappa B' and 'AP-1' with their corresponding entity types in the sentence, aiding in entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a direct mapping between the entities 'IL-4', 'LPS', and 'AP-1' with their corresponding entity types in the sentence, aiding in entity extraction.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example provides a clear mapping between the entity 'AP-1' and its corresponding entity type 'DNA' in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a direct mapping between the entities 'CD14' and 'CD23' with their corresponding entity types in the sentence, aiding in entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides multiple mappings between entities and their corresponding entity types in the sentence, showing a clear relationship between the terms.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example provides a clear mapping between the entity 'T lymphocytes' and its corresponding entity type 'cell_type' in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a direct mapping between the entities 'SP1', 'caspases', and 'B-cell' with their corresponding entity types in the sentence, aiding in entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a direct mapping between the entities 'Tip', 'Tap', and 'Jurkat-T cells' with their corresponding entity types in the sentence, aiding in entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides multiple mappings between entities and their corresponding entity types in the sentence, showing a clear relationship between the terms.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example provides a clear mapping between the entity 'interleukin-1beta' and its corresponding entity type 'RNA' in the sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example provides a clear mapping between the entities 'PMA' and 'U1 cells' with their corresponding entity types in the sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1751,
        "sentence": "This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.",
        "label": {
            "NFAT": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"Both NF-kappa B and I kappa B alpha are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"Both IkappaBalpha and NF-kappaB are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"NF-kappa B is mentioned in the sentence, and it is a protein, which matches the entity label in the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"Both CD40 and NF-kappa B are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"NF-kappa B is mentioned in the sentence, and it is a protein, which matches the entity label in the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"Both IkappaBbeta and NF-kappaB are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"Both RelA and NF-kappaB1 are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"Both TRAF6, RANKL, and NF-kappaB are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"IL-2, Aiolos, and Ras are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"IL-2, c-Jun, and c-Fos are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"NF-kappaB, Tax, and ATL are mentioned in the sentence, and they are proteins and cell types, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"NF-E2 is mentioned in the sentence, and it is a protein, which matches the entity label in the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"PAFR, PAF, NF-kappa B, and protein kinase C are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"NF-kappa B and AP-1 are mentioned in the sentence, and they are proteins, which match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"NF-kappa B is mentioned in the sentence, and it is a protein, which matches the entity label in the target sentence.\"\n    }\n]",
        "response3": "[{\"calcineurin\": \"protein\"}, {\"NFAT\": \"protein\"}]",
        "prediction": "{'calcineurin': 'protein', 'NFAT': 'protein'}"
    },
    {
        "idx": 1774,
        "sentence": "Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .",
        "label": {
            "PBMC": "cell_type",
            "PBMC receptors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 5},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 206,
        "sentence": "It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 928,
        "sentence": "A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).",
        "label": {
            "ets-1": "protein",
            "long terminal repeat": "DNA",
            "double-stranded oligonucleotide probe": "DNA",
            "mouse thymus cDNA expression library": "DNA",
            "mouse ets-1 cDNA clone": "DNA",
            "LTR": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific gene names and their corresponding entity labels, which match the entity types in the target sentence, but with additional information that may not be directly relevant to the target sentence.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence contains a gene name and its corresponding entity label, which matches one of the entity types in the target sentence, but the sentence is more general and may not provide direct relevance to the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains a gene name and its corresponding entity label, which matches one of the entity types in the target sentence, but the sentence is more general and may not provide direct relevance to the target sentence.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The sentence contains a cell type name and its corresponding entity label, which matches one of the entity types in the target sentence, but the sentence is more general and may not provide direct relevance to the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a protein name and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific gene names and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains specific gene names and their corresponding entity labels, which match the entity types in the target sentence, but with additional information that may not be directly relevant to the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific gene names and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains specific gene names and their corresponding entity labels, which match the entity types in the target sentence, but with additional information that may not be directly relevant to the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains specific gene names and their corresponding entity labels, which match the entity types in the target sentence, but with additional information that may not be directly relevant to the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains a protein name and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains a protein name and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains a protein name and its corresponding entity label, which matches one of the entity types in the target sentence, but the sentence is more general and may not provide direct relevance to the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1301,
        "sentence": "It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains specific protein names (ERK, STAT3) that directly match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 2\": 3\n    },\n    {\n        \"Reason 2\": \"The sentence mentions specific cell types (granulocytes, T cells) which match the entity labels in the target sentence, but the context is not as directly related.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The sentence talks about using immunohistochemistry to identify cell types and proteins, which aligns with the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The sentence mentions specific proteins (TCRzeta, p56(lck)) that match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 5\": 3\n    },\n    {\n        \"Reason 5\": \"The sentence discusses the expression of a specific protein (NDP kinase) and compares it across different cell types, which somewhat aligns with the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The sentence directly mentions the activation of NF-kappa B, which is a protein entity label in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence provides specific protein names (IL-2, c-Jun, c-Fos) that directly match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 8\": 2\n    },\n    {\n        \"Reason 8\": \"The sentence talks about the immunoglobulin kappa 3' enhancer, which is related to DNA, but the context is not as directly related to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The sentence discusses the activation of NF-kappa B, which aligns with the protein entity label in the target sentence.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The sentence mentions specific proteins (RelA, NF-kappa B) that match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The sentence directly talks about NF-kappa B activation, which aligns with the protein entity label in the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence provides a specific protein name (ZAP-70) that directly matches the entity label in the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence mentions specific proteins (CD40, NF-kappa B) that directly match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The sentence discusses the activation of NF-kappaB and specific cell types (Tax, ATL) which align with the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 15\": 3\n    },\n    {\n        \"Reason 15\": \"The sentence mentions a specific cell line (B cell) which somewhat aligns with the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence provides specific protein names (interleukin-2, CD25) that directly match the entity labels in the target sentence.\"\n    }\n]",
        "response3": "[{\"ER\": \"protein\"}, {\"NK\": \"cell_type\"}, {\"ER\": \"protein\"}]",
        "prediction": "{'ER': 'protein', 'NK': 'cell_type'}"
    },
    {
        "idx": 1708,
        "sentence": "The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .",
        "label": {
            "nuclear factor (NF)-kappa B": "protein",
            "T cell lines": "cell_line",
            "Ca(2+) -dependent phosphatase": "protein",
            "PKC": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'calcineurin' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear and direct mapping between the entities 'IkappaBalpha' and 'NF-kappaB' and their corresponding label 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear and direct mapping between the entities 'IkappaBbeta' and 'NF-kappaB' and their corresponding label 'protein' in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping between the entities 'NF-kappa B' and 'AP-1' and their corresponding label 'protein' in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear and direct mapping between the entities 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' and their corresponding label 'protein' in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a clear and direct mapping between the entities 'CD40' and 'NF-kappa B' and their corresponding label 'protein' in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear and direct mapping between the entities 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' and their corresponding label 'protein' in the sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example provides a clear mapping between the entities 'NF-kappaB', 'Tax', and 'ATL' and their corresponding labels 'protein' and 'cell_type' in the sentence. The mention of 'Tax' as a cell type might slightly reduce the score.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear and direct mapping between the entities 'NF-kappa B' and 'I kappa B beta' and their corresponding label 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear and direct mapping between the entities 'NF-kappa B' and 'I kappa B alpha' and their corresponding label 'protein' in the sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example provides a clear mapping between the entities 'NF-kappa B' and 'RelA' and their corresponding labels 'protein' in the sentence. The mention of 'T cells' as a cell type might slightly reduce the score.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear and direct mapping between the entities 'Syk', 'Zap', and 'T cell' and their corresponding label 'protein' and 'cell_type' in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear and direct mapping between the entity 'NF-kappa B' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a clear and direct mapping between the entities 'SP1', 'caspases', and 'B-cell' and their corresponding label 'protein' and 'cell_type' in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a clear and direct mapping between the entity 'NF-kappa B' and its corresponding label 'protein' in the sentence.\"}\n]\n```",
        "response3": "```json\n[{\"calcineurin\": \"protein\"}, {\"FK506\": \"protein\"}, {\"CsA\": \"protein\"}, {\"PKC\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]\n```",
        "prediction": "{'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 747,
        "sentence": "Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).",
        "label": {
            "unspliced mRNA": "RNA"
        },
        "response1": "['protein', 'RNA']",
        "response2": "```json\n[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example contains multiple instances of proteins that are relevant to the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides relevant protein entities mentioned in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example includes protein entities that are similar to those in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example contains protein entities that are relevant to the target sentence.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The example includes a protein entity that is relevant to the target sentence.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The example provides a protein entity mentioned in the target sentence.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The example contains a protein entity that is relevant to the target sentence.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The example includes protein entities that are relevant to the target sentence.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The example provides a protein entity mentioned in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example contains protein entities that are relevant to the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example includes protein entities that are relevant to the target sentence.\"},\n    {\"Example 12\": 2},\n    {\"Reason 12\": \"The example provides a cell type entity that is relevant to the target sentence.\"},\n    {\"Example 13\": 2},\n    {\"Reason 13\": \"The example contains protein entities that are relevant to the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example includes protein entities and a cell type that are relevant to the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example provides protein entities and a cell type that are relevant to the target sentence.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 333,
        "sentence": "These protoenhancers alone are weakly or not responsive to R .",
        "label": {
            "protoenhancers": "DNA",
            "R": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 758,
        "sentence": "Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.",
        "label": {
            "CEM-C7": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).\": 5},\n    {\"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 727,
        "sentence": "The importance of the internal ATGs to Rex function is not known.",
        "label": {
            "Rex": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 5},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 429,
        "sentence": "As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.",
        "label": {
            "TSAP": "protein",
            "mammalian protein": "protein",
            "sea urchin binding sites": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 3},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 4},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 3},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 3},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"TSAP\": \"protein\"}]",
        "prediction": "{'BSAP': 'protein', 'TSAP': 'protein'}"
    },
    {
        "idx": 1372,
        "sentence": "The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).",
        "label": {
            "14q32.1": "DNA",
            "TCR alpha/beta loci": "DNA",
            "t(14;14)(q11;q32.1)": "DNA",
            "TCL1 oncogene": "DNA",
            "human chromosome": "DNA",
            "t(7;14)(q35;q32.1)": "DNA",
            "inv14(q11;q32.1)": "DNA"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and their corresponding entity labels, which directly relate to the entity types in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein (TCF-1) which is relevant to the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of proteins (SLAP-130, SLP-76) and a cell type (T cell) that are directly related to the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions specific proteins (IkappaBbeta, NF-kappaB) that are relevant to the entity types in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence contains a specific cell type (Th2-type lymphocytes) which is relevant to the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of proteins (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) that are directly related to the entity types in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions specific proteins (c-kit, IL-4R alpha chain) that are relevant to the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides examples of proteins (IL-13, IL-4R, JAK2, IL-13R) that are directly related to the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions specific proteins (TCRzeta, p56(lck)) that are relevant to the entity types in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains a specific cell type (T cell) and a protein (interleukin 2) which are relevant to the entity types in the target sentence.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions a gene name (SCM-1) which is relevant to the entity types in the target sentence, but the context is less direct.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of a protein (TAL1) and a cell type (T-ALL) that are directly related to the entity types in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains a specific cell type (T-PLL) which is relevant to the entity types in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions a specific protein (TCL1) which is relevant to the entity types in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of proteins (SCL, GATA-1) that are directly related to the entity types in the target sentence.\"}\n]",
        "response3": "[{\"TCL1\": \"protein\"}, {\"TCR alpha/beta\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"T-prolymphocytic\": \"cell_type\"}, {\"T-PLL\": \"cell_type\"}]",
        "prediction": "{'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic': 'cell_type', 'T-PLL': 'cell_type'}"
    },
    {
        "idx": 546,
        "sentence": "Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .",
        "label": {
            "T lymphocytes": "cell_type",
            "immunophilin": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions a protein entity (NF-kappa B) and its label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their labels are explicitly mentioned.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes various protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) with their corresponding labels provided.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions cell_type (T cell) and protein entities (IL-2, IL-2 receptor, CD28) with their labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence includes RNA entity (IL-5 mRNA) and protein entities (TCR, IL-2R, dexamethasone) with their labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides protein entities (NF-kappa B, I kappa B alpha) and their corresponding labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions a protein entity (IL-2) with its label.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes protein entity (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) with their labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains protein entity (NF-ATc) and cell_type entity (T lymphocytes) with their labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions protein entities (IkappaBbeta, NF-kappaB) with their labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence includes protein entities (IL-2 receptor alpha subunit, p21ras) and cell_type entity (B cell) with their labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides protein entities (Syk, Zap) and cell_type entity (T cell) with their labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions protein entities (IL-2, NF-kappa B, AP-1) with their labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence includes protein entities (IL-2, Aiolos, Ras) with their labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions protein entities (IkappaBalpha, NF-kappaB) with their labels.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1437,
        "sentence": "In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.",
        "label": {
            "hTR beta 1": "protein",
            "hTR beta 1 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"IFN A\": \"The abbreviation IFNA is a protein entity, which is explicitly mentioned in the sentence.\"},\n    {\"IFNA\": \"The abbreviation IFNA is a protein entity, which is explicitly mentioned in the sentence.\"},\n    {\"interleukin-2\": \"The term interleukin-2 refers to a protein entity, which is explicitly mentioned in the sentence.\"},\n    {\"interleukin-2 receptor\": \"The term interleukin-2 receptor refers to a protein entity, which is explicitly mentioned in the sentence.\"},\n    {\"phytohemagglutinin\": \"The term phytohemagglutinin refers to a protein entity, which is explicitly mentioned in the sentence.\"},\n    {\"phorbol myristate acetate\": \"The term phorbol myristate acetate refers to a protein entity, which is explicitly mentioned in the sentence.\"}\n]",
        "response3": "[{\"hTR beta 1 mRNA\": \"RNA\"}]",
        "prediction": "{'hTR beta 1 mRNA': 'RNA'}"
    },
    {
        "idx": 1399,
        "sentence": "To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .",
        "label": {
            "hematopoietic cell lineage": "cell_line",
            "human estrogen receptor": "protein",
            "NF-M": "protein",
            "hormone binding domain": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains a clear mention of the protein NF-kappa B, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides specific information about proteins such as IL-2, c-Jun, and c-Fos, which are directly associated with the entity label 'protein'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly mentions the protein NF-E2, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions the protein E2A, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions the protein MNDA and the cell line 'Philadelphia chromosome-positive chronic myeloid leukemia', both of which are directly associated with the entity labels 'protein' and 'cell_line' respectively.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions the proteins c-kit and IL-4R alpha chain, both of which are directly associated with the entity label 'protein'.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence explicitly mentions the protein PML/RARalpha, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions the protein RXR, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions the proteins TRAF6 and RANKL, as well as NF-kappaB, all of which are directly associated with the entity label 'protein'.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions the protein NF-ATc, as well as T lymphocytes and embryonic cardiac cells, all of which are directly associated with the entity labels 'protein', 'cell_type'.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions the protein CD40 and NF-kappa B, both of which are directly associated with the entity label 'protein'.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions the protein GATA-1, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions the protein TCF-1, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions the protein NF-kappa B, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions the protein IL-2, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions the proteins ZEB, c-Myb, and Ets, as well as hematopoietic cells, all of which are directly associated with the entity labels 'protein', 'cell_type'.\"},\n]\n```",
        "response3": "```json\n[{\"NF-M\": \"protein\"}, {\"hormone binding domain\": \"protein\"}, {\"human estrogen receptor\": \"protein\"}]\n```",
        "prediction": "{'NF-M': 'protein', 'hormone binding domain': 'protein', 'human estrogen receptor': 'protein'}"
    },
    {
        "idx": 1327,
        "sentence": "Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .",
        "label": {
            "human IL-4": "protein",
            "human IL-4 promoter": "DNA",
            "NF-IL6": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example directly mentions the entity 'IL-4' and its association with the entity type 'protein' which is present in the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example directly mentions entities like 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example directly mentions entities like 'NF-kappaB', 'Tax', and 'ATL' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example directly mentions entities like 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example directly mentions entities like 'NF-kappa B' and 'I kappa B alpha' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example directly mentions entities like 'NF-ATc' and 'T lymphocytes' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example directly mentions the entity 'NF-kappa B' with its corresponding entity type 'protein' which is present in the target sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly mentions entities like 'IL-12', 'STAT4', 'NK cells', 'T cells', and 'IL-12 receptor' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example directly mentions the entity 'NF-kappa B' with its corresponding entity type 'protein' which is present in the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example directly mentions entities like 'IL-4', 'LPS', and 'AP-1' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example directly mentions entities like 'IL-2', 'IFN-gamma', 'jak kinases', 'STAT1(alpha)' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example directly mentions entities like 'IkappaBbeta' and 'NF-kappaB' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example directly mentions entities like 'IL-13', 'IL-4', 'B cell', and 'monocyte' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example directly mentions the entity 'Th2-type lymphocytes' with its corresponding entity type 'cell_type' which is present in the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example directly mentions entities like 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The example directly mentions the entity 'IL-2' with its corresponding entity type 'protein' which is present in the target sentence.\"\n    }\n]",
        "response3": "[{\"NF-IL6\": \"protein\"}, {\"IL-4\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 146,
        "sentence": "Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .",
        "label": {
            "\"octamer\" motif": "DNA",
            "HLA-DR alpha (DRA) promoter": "DNA",
            "class II promoters": "DNA",
            "immunoglobulin variable region promoters": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5}\n]",
        "response3": "[{\"HLA-DR alpha (DRA)\": \"protein\"}, {\"octamer\": \"protein\"}, {\"immunoglobulin variable region\": \"protein\"}, {\"B cell-specific\": \"cell_type\"}]",
        "prediction": "{'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}"
    },
    {
        "idx": 1247,
        "sentence": "The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .",
        "label": {
            "Janus family tyrosine kinase": "protein",
            "Jak3": "protein",
            "gamma c": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4}\n]",
        "response3": "[{\"Jak3\": \"protein\"}, {\"gamma c\": \"protein\"}, {\"Jak3\": \"protein\"}]",
        "prediction": "{'Jak3': 'protein', 'gamma c': 'protein'}"
    },
    {
        "idx": 1300,
        "sentence": "As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 350,
        "sentence": "Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .",
        "label": {
            "control cell line": "cell_line",
            "cell line": "cell_line",
            "Ro-VDR": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names like TIMP-1 and DNA, which are directly mentioned and can be easily identified.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions a specific cell line name 'Philadelphia chromosome-positive chronic myeloid leukemia' which is a clear indicator of a cell line entity.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides multiple protein names like IFN A, interleukin-2, interleukin-2 receptor, as well as stimuli like phytohemagglutinin and phorbol myristate acetate, making it highly informative for protein entity extraction.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence directly mentions the protein CD14, making it a clear indicator of a protein entity.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence mentions the protein 'retinoic acid receptor alpha' which is a specific protein name and aids in protein entity extraction.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence contains the protein name WT1 and refers to myeloid cell lines, providing clear indications of protein and cell line entities.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions the protein NF-E2, which is a specific protein name and aids in protein entity extraction.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides a specific protein name 'retinoic acid receptor alpha' which is crucial for protein entity extraction.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions the protein RXR, aiding in protein entity extraction.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions the protein ZAP-70, which is a specific protein name and aids in protein entity extraction.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence contains specific protein names like IL-5 mRNA, TCR, IL-2R, and dexamethasone, making it highly informative for protein and cell type entity extraction.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence provides multiple protein names like VDR, RXR, GRIP-1, and DRIP205, aiding in protein entity extraction.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions specific protein names like interleukin-2, alpha chain, CD25, and IL-2 receptor, making it highly informative for protein entity extraction.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions various proteins like Protein kinase B, phosphatidylinositol 3-kinase, STAT5, and erythropoietin, along with cell line names, aiding in protein and cell line entity extraction.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions the creation of a specific cell line '47.10' and the inability to develop a cell line from nontransgenic mice, providing clear indications of cell line entities.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence provides various entities like 2-deoxyguanosine, lymphoid progenitor cells, thymus stromal cells, B cells, tg epsilon26, fetal liver cells, and T cells, aiding in DNA, cell type, and cell line entity extraction.\"}\n]",
        "response3": "[{\"Ro-VDR\": \"cell_line\"}]",
        "prediction": "{'Ro-VDR': 'cell_line'}"
    },
    {
        "idx": 1093,
        "sentence": "The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).",
        "label": {
            "VDR": "protein",
            "vitamin D receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1493,
        "sentence": "Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .",
        "label": {
            "myeloid cells": "cell_type",
            "NF-kappa B": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'NF-kappa B' and its corresponding label 'protein', making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"HIV-1\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'DNA': 'DNA', 'HIV-1': 'cell_type'}"
    },
    {
        "idx": 334,
        "sentence": "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .",
        "label": {
            "protoenhancers": "DNA",
            "overlapping palindromes": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"IgH\": 5},\n{\"BRCA1\": 4},\n{\"EBNA2\": 4, \"TP1\": 3},\n{\"GM-CSF\": 4},\n{\"Protein\": 4},\n{\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n{\"p50p50\": 4},\n{\"EKLF\": 4},\n{\"TCF-1\": 4},\n{\"ZEBRA\": 4},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"Egr-1\": 4},\n{\"T cell\": 5, \"interleukin 2\": 4},\n{\"Th2-type lymphocytes\": 5},\n{\"CD95 ligand\": 4},\n{\"GM-kappa B\": 5, \"GC-box\": 5, \"GC-motif\": 5, \"GM-kappa B motif\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 946,
        "sentence": "Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence provides cell line and protein names that are relevant to the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence includes multiple protein names and cell line names that align with the entity types in the target sentence, making it highly helpful.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence mentions RNA, cell type, and protein names that are relevant to the target sentence, contributing to the extraction of named entities.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence contains a protein name that matches the entity types in the target sentence, assisting in the identification of named entities.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence provides relevant cell line and cell type names that can aid in extracting named entities from the target sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence directly mentions DNA, aligning with the entity type in the target sentence, making it highly helpful.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence includes specific protein names that match the entity types in the target sentence, making it very helpful for entity extraction.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The sentence mentions RNA and cell line names that are relevant to the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides DNA and protein names that directly correspond to the entity types in the target sentence, making it highly helpful.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence includes protein and cell type names that align with the entity types in the target sentence, contributing to the extraction of named entities.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions cell type names that are relevant to the target sentence, assisting in the identification of named entities.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence provides a protein name that matches the entity types in the target sentence, aiding in the extraction of named entities.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence contains protein names that directly align with the entity types in the target sentence, making it highly helpful.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence includes protein names that match the entity types in the target sentence, making it very helpful for entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 777,
        "sentence": "We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.",
        "label": {
            "OTF-2": "protein",
            "immunoglobulin gene": "DNA",
            "steady-state immunoglobulin heavy-chain mRNA": "RNA",
            "human pre-B-cell lines": "cell_line",
            "immunoglobulin heavy-chain": "protein"
        },
        "response1": "['cell_line', 'RNA', 'protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence directly mentions the term 'protein' and provides a clear example of a protein being purified and its encoding gene cloned.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence mentions 'Egr-1' as a zinc finger transcription factor, clearly indicating it as a protein.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence directly refers to 'TCF-1 protein' and shows the generation of antiserum titers against it.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence discusses the expression of the 'E2A gene at the protein level' using polyclonal antisera, indicating the presence of a protein.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type, providing a clear example of a cell type.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence talks about the 'IgH genes' being controlled by intervening regions, indicating the presence of DNA.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence mentions 'cDNAs' encoding subunits, which are related to DNA.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence provides examples of proteins like 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)', indicating their presence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence mentions 'NF-ATc isoforms' and 'T lymphocytes', providing examples of a protein and a cell type.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence discusses the presence of nuclear factors binding to the IL-2 promoter, containing proteins like 'c-Jun' and 'c-Fos'.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence provides examples of proteins like 'CD70', 'IL-4', and 'CD40', along with cell types like 'B cell' and 'plasma cells'.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions 'NF-ATc' as a transcription factor expressed in T lymphocytes and embryonic cardiac cells, indicating the presence of a protein and cell types.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence talks about the conserved motif in 'GM-CSF genes', indicating the presence of a protein.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence provides examples of proteins like 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate'.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions 'c-kit' and 'IL-4R alpha chain' as parts of a chimeric receptor, indicating the presence of proteins.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence directly refers to 'WT1' as being exclusively paternally expressed, indicating the presence of a protein.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 552,
        "sentence": "Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .",
        "label": {
            "IL-2": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5}\n]\n```",
        "response3": "```json\n[{\"FK506\": \"protein\"}, {\"rapamycin\": \"protein\"}, {\"IL-2\": \"protein\"}]\n```",
        "prediction": "{'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 1310,
        "sentence": "The abundant chromosomal protein HMG-1 belongs to this subgroup.",
        "label": {
            "HMG-1": "protein",
            "chromosomal protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1409,
        "sentence": "We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .",
        "label": {
            "IL-2": "protein",
            "T cell lines": "cell_line",
            "PRL": "protein",
            "Stat proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Sentence 1\": 4},\n    {\"Sentence 2\": 5},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 4},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 4},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 4},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[{\"PRL\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"Stat proteins\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]",
        "prediction": "{'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 1140,
        "sentence": "The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .",
        "label": {
            "transcription factors": "protein",
            "conserved cis-acting sequence": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'AP-1' and the entity type 'DNA', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides clear mappings between the entities 'Jun' and 'ATF-2' to the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example provides a clear mapping between the entity 'Th2-type lymphocytes' and the entity type 'cell_type', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear mapping between the entity 'Protein' and the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear mapping between the entity 'Egr-1' and the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The examples provide clear mappings between the entities 'IL-2', 'c-Jun', and 'c-Fos' to the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example provides a clear mapping between the entity 'GM-CSF' and the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear mapping between the entity 'GATA-1' and the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear mapping between the entity 'TCF-1' and the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear mapping between the entity 'Stat proteins' and the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides clear mappings between the entities 'EKLF', 'CBP', 'p300', and 'P/CAF' to the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides clear mappings between the entities 'SCL' and 'GATA-1' to the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear mapping between the entity 'G-CSF' and the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides clear mappings between the entities 'VDR', 'RXR', 'GRIP-1', 'DRIP205', and 'DRIP' to the entity type 'protein', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides clear mappings between the entities 'ZEB', 'c-Myb', 'Ets', and 'hematopoietic cells' to the entity types 'protein' and 'cell_type', aiding in the extraction of named entities from the target sentence.\"},\n\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides clear mappings between the entities 'tal-1', 'GATA-binding proteins', and 'hematopoiesis' to the entity types 'protein' and 'cell_type', aiding in the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 449,
        "sentence": "We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .",
        "label": {
            "ubiquitous transcription factor": "protein",
            "E3 enhancer motif": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides clear and direct mentions of specific protein names (EKLF, CBP, p300, P/CAF) which are essential for named entity extraction.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence directly mentions protein names (Jun, ATF-2) crucial for named entity extraction.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The sentence contains a specific DNA entity (immunoglobulin kappa 3' enhancer) which is important for named entity extraction.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence mentions a specific protein name (A-myb) which is crucial for named entity extraction.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence provides protein names (NF-ATc) and cell type mentions (T lymphocytes, embryonic cardiac cells) essential for named entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions specific protein names (Sp1, Ets) crucial for named entity extraction.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The sentence contains a specific cell type mention (Th2-type lymphocytes) which is important for named entity extraction.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence mentions a specific protein name (p50p50) crucial for named entity extraction.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence provides a specific protein name (TCF-1) essential for named entity extraction.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence mentions a specific protein name (GATA-1) crucial for named entity extraction.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence provides protein names (CREB, AR-CRE) essential for named entity extraction.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The sentence contains specific DNA (CCAAT box) and protein (EKLF binding site) entities important for named entity extraction.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence mentions a specific protein name (Egr-1) crucial for named entity extraction.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence provides protein names (IL-2, c-Jun, c-Fos) essential for named entity extraction.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions protein names (ZEB, c-Myb, Ets) and a cell type (hematopoietic cells) crucial for named entity extraction.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence provides protein names (p50, p65) and mentions DNA and protein entities essential for named entity extraction.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1402,
        "sentence": "At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .",
        "label": {
            "eosinophil": "cell_type",
            "myeloid lineages": "cell_type",
            "differentiation markers": "protein",
            "progenitor-specific surface markers": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein (CD14) and its corresponding entity label, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of cell types (Th1 and Th2) and their corresponding entity labels, aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear example of a protein (E2A) and its corresponding entity label, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of a cell line (B cell) and a cell type (cell_line) with their corresponding entity labels, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides a clear example of a protein (WT1) and its corresponding entity label, aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear examples of proteins (CD14 and CD23) and their corresponding entity labels, aiding in the extraction of named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of proteins (myeloperoxidase, lysozyme, PU.1) and their corresponding entity labels, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of a protein (WT1) and a cell line (myeloid cell lines) with their corresponding entity labels, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) with their corresponding entity labels, aiding in the extraction of named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of cell types (granulocytes and T cells) and their corresponding entity labels, aiding in the extraction of named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of a protein (GATA-1) and its corresponding entity label, aiding in the extraction of named entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides clear examples of proteins (Sp1 and Ets) and their corresponding entity labels, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{'eosinophil': 'cell_type'}, {'myeloid': 'cell_type'}]",
        "prediction": "{'eosinophil': 'cell_type', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 664,
        "sentence": "Interferon-gamma and the sexual dimorphism of autoimmunity .",
        "label": {
            "Interferon-gamma": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 1},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3, and STAT5 proteins in normal human B cells.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1726,
        "sentence": "It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .",
        "label": {
            "NF-kappa B": "protein",
            "cytotoxic cytokine": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Example 15\": 5\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1573,
        "sentence": "Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .",
        "label": {
            "estrogen": "protein",
            "eosinophil cationic protein": "protein",
            "positive cells": "cell_type",
            "progesterone receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of using polyclonal antisera directed against a specific protein, E2A, to probe cellular extracts, which directly relates to the entity type 'protein' in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence describes using immunohistochemistry with antibodies against proteins encoded by a gene to determine the cell type within a tumor specimen, which indirectly relates to the entity types 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions the characterization of genes encoding eosinophil granule proteins, specifically GATA-1, which directly relates to the entity type 'protein' in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions the important role of eosinophils in allergic inflammation, which directly relates to the entity type 'cell_type' in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a detailed example of flow cytometric and morphological analyses involving various proteins and cell types, directly relating to multiple entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions specific lysosomal proteins and a transcription factor associated with granulomonocytes, directly relating to the entity type 'protein' in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly mentions the expression of specific proteins, CD14 and CD23, in response to PMA, directly relating to the entity type 'protein' in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions the increased expression of specific proteins, p21(WAF1/CIP1) and p27(KIP1), at the mRNA and protein levels, directly relating to the entity type 'protein' in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions the deviation of methylation in specific cell types, granulocytes and T cells, directly relating to the entity type 'cell_type' in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides detailed information about nuclear factors and specific proteins involved in binding to the IL-2 promoter, directly relating to the entity type 'protein' in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence directly mentions the cell-specific transcription factor NF-E2, which directly relates to the entity type 'protein' in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly mentions the reduced mitogenic response and low expression of specific proteins, interleukin-2 and CD25, directly relating to the entity type 'protein' in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence indirectly relates to the entity types 'cell_line' and 'protein' in the target sentence by mentioning specific cell types and gene expression levels.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence indirectly relates to the entity types 'protein' and 'RNA' in the target sentence by describing the inhibition of protein tyrosine phosphorylation and mRNA expression.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence directly mentions the regulatory mechanism of the gp91phox gene expression in eosinophils, involving specific gene constructs and cell lines, directly relating to the entity types 'DNA' and 'cell_line' in the target sentence.\"}\n]",
        "response3": "[{'estrogen': 'protein'}, {'progesterone': 'protein'}, {'eosinophil cationic protein': 'protein'}, {'eosinophils': 'cell_type'}]",
        "prediction": "{'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}"
    },
    {
        "idx": 1589,
        "sentence": "Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .",
        "label": {
            "NF-kappa B": "protein",
            "T helper cell subsets": "cell_type",
            "NF-AT": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'NF-kappa B' and its entity label 'protein', making it highly relevant for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entities 'NF-kappa B' and 'I kappa B alpha' with their entity labels 'protein', making it highly relevant for extracting named entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions the entity 'NF-ATc' with its entity label 'protein' and 'T lymphocytes' with its entity label 'cell_type', providing relevant information for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions the entities 'NF-kappaB', 'Tax', and 'ATL' with their respective entity labels 'protein' and 'cell_type', making it highly relevant for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence directly mentions the entity 'NF-kappa B' with its entity label 'protein', making it highly relevant for extracting named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions the entities 'NF-kappa B' and 'I kappa B alpha' with their entity labels 'protein', providing relevant information for extracting named entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions the entity 'NF-ATc' with its entity label 'protein' and 'T lymphocytes' and 'embryonic cardiac cells' with their entity labels 'cell_type', providing relevant information for extracting named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions the entity 'GATA-1' with its entity label 'protein', making it highly relevant for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions the entity 'NF-kappa B' with its entity label 'protein', making it highly relevant for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions the entities 'NF-kappa B' and 'I kappa B beta' with their entity labels 'protein', making it highly relevant for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions the entities 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' with their respective entity labels 'protein', making it highly relevant for extracting named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions the entities 'Sp1' and 'Ets' with their entity labels 'protein', making it highly relevant for extracting named entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions the entities 'Th1' and 'Th2' with their entity labels 'cell_type', providing relevant information for extracting named entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions the entity 'Th2-type lymphocytes' with its entity label 'cell_type', providing relevant information for extracting named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions the entities 'IL-2', 'NF-kappa B', and 'AP-1' with their entity labels 'protein', making it highly relevant for extracting named entities.\"},\n    {\"Example 16\": 1},\n    {\"Reason 16\": \"The sentence mentions 'NF-kappa B' as having DNA binding activity, which is not accurate as 'NF-kappa B' is a protein, not DNA. This example may lead to incorrect entity extraction.\"}\n]",
        "response3": "[{'NF-AT': 'protein'}, {'NF-kappa B': 'protein'}, {'T helper cell subsets': 'cell_type'}]",
        "prediction": "{'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}"
    },
    {
        "idx": 114,
        "sentence": "These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .",
        "label": {
            "NF-KB": "protein",
            "monocytic cell lineage": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains specific examples of named entities with their corresponding entity labels, which directly match the entity types in the target sentence. This provides clear and direct guidance for identifying named entities in the target sentence.\"}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"NF-KB\": \"protein\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'NF-KB': 'protein'}"
    },
    {
        "idx": 469,
        "sentence": "Cardiac and adrenergic diseases were excluded.",
        "label": {},
        "response1": "None.",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a clear mapping of the entity 'WT1' to the entity label 'protein' in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example provides mappings of the entities 'PBMC' to 'cell_type' and 'adenovirus DNA' to 'DNA' in the target sentence, which are relevant for named entity extraction.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example provides a mapping of the entity 'phosphocreatine' to the entity label 'protein' in the target sentence, which is somewhat helpful for named entity extraction.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example provides a mapping of the entity 'AP-1' to the entity label 'DNA' in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example provides mappings of the entities 'IL-5 mRNA' to 'RNA', 'TCR' to 'cell_type', 'IL-2R' to 'protein', and 'dexamethasone' to 'protein' in the target sentence, which are crucial for named entity extraction.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example provides mappings of the entities 'EBV' to 'cell_line' and 'CD2' to 'protein' in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 7\": 3\n    },\n    {\n        \"Reason 7\": \"The example provides a mapping of the entity 'lymphoid neoplasms' to the entity label 'cell_type' in the target sentence, which is somewhat helpful for named entity extraction.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The example provides mappings of the entities 'PBMC' to 'cell_type' and 'adenovirus' to 'DNA' in the target sentence, which are relevant for named entity extraction.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example provides a mapping of the entity 'P selectin' to the entity label 'protein' in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example provides mappings of the entities 'cAMP-dependent protein kinase' and 'Rap1' to the entity label 'protein' in the target sentence, which are crucial for named entity extraction.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The example provides mappings of the entities 'MNDA' to 'RNA' and 'myeloid cell lines' to 'cell_line' in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example provides mappings of the entities 'NF-kB', 'AP-1', 'OCT-1', and 'NF-IL-2B' to the entity label 'protein' in the target sentence, which are crucial for named entity extraction.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example provides mappings of the entities 'MR', 'aldosterone', and 'progesterone' to the entity label 'protein' in the target sentence, which are crucial for named entity extraction.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The example provides mappings of the entities 'RelB' and 'DC' to the entity label 'protein' and 'cell_type', respectively, in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The example provides mappings of the entities 'XP-B', 'XP-D', and 'adenovirus' to the entity label 'cell_line' and 'DNA', respectively, in the target sentence, aiding in the extraction of named entities.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1683,
        "sentence": "These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .",
        "label": {
            "c-jun": "DNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"c-jun\": \"protein\"}]",
        "prediction": "{'c-jun': 'protein'}"
    },
    {
        "idx": 1648,
        "sentence": "Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.",
        "label": {
            "PU.1 site": "DNA",
            "GM-CSF receptor alpha": "protein",
            "GM-CSF receptor alpha promoter": "DNA",
            "myelomonocytic cells": "cell_type",
            "C/EBP": "protein",
            "PU.1": "protein",
            "GM-CSF": "protein",
            "C/EBP site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 3},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 3},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 3},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"C/EBP\": \"protein\"}, {\"GM-CSF receptor alpha\": \"protein\"}, {\"myelomonocytic\": \"cell_type\"}]",
        "prediction": "{'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic': 'cell_type'}"
    },
    {
        "idx": 646,
        "sentence": "Surgically confirmed nodal involvement was observed in 42%.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"WT1\": 5},\n    {\"granulocytes\": 4, \"T cells\": 4},\n    {\"NDP kinase\": 5, \"KA\": 4, \"SCC\": 4, \"BCC\": 4},\n    {\"NF-kappa B\": 5},\n    {\"p21(WAF1/CIP1)\": 5, \"p27(KIP1)\": 5},\n    {\"lymphoid neoplasms\": 4},\n    {\"T-PLL\": 4},\n    {\"PBMC\": 4, \"adenovirus DNA\": 1},\n    {\"TCL1\": 5},\n    {\"NF-kB\": 5, \"AP-1\": 5, \"OCT-1\": 5, \"NF-IL-2B\": 5},\n    {\"TCRzeta\": 5, \"p56(lck)\": 5},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n    {\"nuclear factor-kappa B\": 4, \"NF-kappa B\": 4},\n    {\"PMA\": 4, \"U1 cells\": 4},\n    {\"CD3.TcR\": 5, \"CD18\": 5, \"CD29\": 5},\n    {\"MR\": 5, \"aldosterone\": 5, \"progesterone\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 821,
        "sentence": "(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .",
        "label": {
            "LMP1": "protein",
            "EBNA-2": "protein",
            "EBV type 1 EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 3},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 3},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5}\n]",
        "response3": "[{\"EBV type 2 EBNA-2\": \"protein\"}, {\"LMP1\": \"protein\"}, {\"EBV type 1 EBNA-2\": \"protein\"}]",
        "prediction": "{'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}"
    },
    {
        "idx": 548,
        "sentence": "On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"rapamycin\": \"protein\"}, {\"FK506\": \"protein\"}]",
        "prediction": "{'interleukin 2': 'protein', 'IL-2': 'protein', 'rapamycin': 'protein', 'FK506': 'protein'}"
    },
    {
        "idx": 135,
        "sentence": "Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).",
        "label": {
            "U9-IIIB": "cell_line",
            "monocytic U937 cells": "cell_line",
            "Tumor necrosis factor alpha ( TNF-alpha ) mRNA": "RNA",
            "chronically HIV infected U937 cell line": "cell_line",
            "Tumor necrosis factor alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'cell_type', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"U937\": \"cell_type\"}, {\"HIV\": \"cell_type\"}, {\"U9-IIIB\": \"cell_line\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'U937': 'cell_type', 'HIV': 'cell_type', 'U9-IIIB': 'cell_line'}"
    },
    {
        "idx": 432,
        "sentence": "Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .",
        "label": {
            "transfected B cells": "cell_line",
            "TSAP": "protein",
            "mutant TSAP -binding site": "DNA",
            "upstream promoter element": "DNA",
            "BSAP": "protein",
            "B-cell-specific transcription factor": "protein",
            "wild-type": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 3},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"TSAP\": \"protein\"}]",
        "prediction": "{'BSAP': 'protein', 'TSAP': 'protein'}"
    },
    {
        "idx": 1161,
        "sentence": "Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .",
        "label": {
            "I kappa B alpha": "protein",
            "NF kappa B": "protein",
            "NF kappa B -I kappa B complex": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"Cu2+\": \"cell_line\"}]",
        "prediction": "{'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'cell_line'}"
    },
    {
        "idx": 1794,
        "sentence": "Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .",
        "label": {
            "STAT": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 3},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"STAT\": \"protein\"}, {\"T cell\": \"cell_type\"}]",
        "prediction": "{'STAT': 'protein', 'T cell': 'cell_type'}"
    },
    {
        "idx": 1470,
        "sentence": "Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .",
        "label": {
            "neutrophil": "cell_type",
            "tumor necrosis factor (TNF)-alpha": "protein",
            "leukocyte adhesion molecule": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 4},\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n{\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n{\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 5},\n{\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 5},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\": 4},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 644,
        "sentence": "Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?",
        "label": {
            "tumor cells": "cell_type",
            "hematopoietic growth factor": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example contains specific cell type 'Th2-type lymphocytes' which matches the 'cell_type' entity label in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example contains specific proteins like 'NF-kappaB', 'Tax', and 'ATL' which match the 'protein' entity label in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example contains specific proteins like 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R' which match the 'protein' entity label in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example contains specific entities like 'immunohistochemistry', 'gene', and 'cell type' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example contains specific cell type 'lymphoid neoplasms' which matches the 'cell_type' entity label in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example contains specific proteins like 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example contains specific proteins like 'TAL1' and 'T-ALL' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example contains specific proteins like 'WT1' and 'myeloid cell lines' which match the 'protein' and 'cell_line' entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example contains specific proteins like 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example contains specific proteins like 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' which match the 'protein' and 'cell_line' entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example contains specific proteins like 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' which match the 'protein' entity label in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example contains specific proteins like 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and 'B cells' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example contains specific proteins like 'IL-2', 'c-Jun', and 'c-Fos' which match the 'protein' entity label in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example contains specific proteins like 'CD70', 'IL-4', 'CD40', and entities like 'B cell' and 'plasma cells' which match the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n    {\"Example 15\": 3},\n    {\"Reason 15\": \"The example contains specific entity 'AP-1' which matches the 'DNA' entity label in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example contains specific entities like 'B and T cell activation', 'Ramos', 'Jurkat', and 'cDNA microarray technology' which match the 'cell_type', 'cell_line', and 'DNA' entity labels in the target sentence.\"}\n]",
        "response3": "[{'lymphocyte': 'cell_type'}, {'breast cancers': 'cell_type'}, {'hematopoietic growth factor': 'protein'}, {'tumor cells': 'cell_type'}]",
        "prediction": "{'lymphocyte': 'cell_type', 'breast cancers': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_type'}"
    },
    {
        "idx": 435,
        "sentence": "Antibodies are produced exclusively in B lymphocytes .",
        "label": {
            "Antibodies": "protein",
            "lymphocytes": "cell_type",
            "B lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example contains a specific gene name (IgH) which is associated with the entity type DNA, providing a clear indication of the entity type in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example directly mentions a cell type (Eosinophils) and its role, making it highly relevant for identifying the entity type in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example includes multiple protein names (IL-13, IL-4) and cell types (B cell, monocyte) explicitly linked to their respective entity types, aiding in entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example mentions specific entities (EBV, CD2) associated with the entity types cell_line and protein, contributing to the identification of these entities in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a list of protein names (IL4, IL13, STAT6, STAT3, STAT5) and a cell type (B cells) with clear associations to their respective entity types, facilitating entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example mentions cell types (Th1, Th2) directly related to their entity types, aiding in the identification of these entities in the sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example contains a specific cell type (Th2-type lymphocytes) associated with the entity type cell_type, assisting in entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example includes protein names (CD70, IL-4, CD40) and cell types (B cell, plasma cells) explicitly linked to their respective entity types, providing valuable information for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example mentions protein names (NF-ATc) and a cell type (T lymphocytes) with clear associations to their respective entity types, aiding in entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a protein name (IL-2 receptor alpha subunit) and a cell type (B cell) explicitly linked to their respective entity types, facilitating entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example mentions cell types (T lymphocytes) and a protein (HLA-molecules) directly related to their entity types, aiding in the identification of these entities in the sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example contains a specific protein name (E2A) associated with the entity type protein, providing a clear indication of the entity type in the sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example mentions cell types (lymphocytes, B-cell) directly related to their entity types, aiding in the identification of these entities in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example includes protein names (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) explicitly linked to their respective entity types, providing valuable information for entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides protein names (ICAM-1, CD71, LMP1, IkappaB) explicitly linked to their respective entity types, aiding in entity extraction.\"}\n]",
        "response3": "[{'B lymphocytes': 'cell_type'}]",
        "prediction": "{'B lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1342,
        "sentence": "While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.",
        "label": {
            "amino acid domain": "protein",
            "BH1": "protein",
            "BH3": "protein",
            "Bak": "protein",
            "BH2": "protein",
            "Bax": "protein",
            "Bik": "protein",
            "Bcl-2 family": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1022,
        "sentence": "NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .",
        "label": {
            "NK cell NFAT": "protein",
            "AP-1": "protein",
            "nonstimulated cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (IkappaBalpha, NF-kappaB) that are directly mentioned.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names (NF-kappa B, I kappa B alpha) that are directly mentioned.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names (NF-kappa B, I kappa B alpha) that are directly mentioned.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names (IL-12, STAT4, IL-12 receptor) and cell types (NK cells, T cells) that are directly mentioned.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) that are directly mentioned.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific protein names (NF-kappaB) and cell types (Tax, ATL) that are directly mentioned.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names (IL-2, c-Jun, c-Fos) that are directly mentioned.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains a specific protein name (NF-kappa B) that is directly mentioned.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names (AP-1, PMA) and cell types (monocytes, macrophages) that are directly mentioned.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) that are directly mentioned.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names (NF-kappa B, AP-1) that are directly mentioned.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains a specific DNA name (NF-kappa B) that is directly mentioned.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names (NF-kB, AP-1, OCT-1, NF-IL-2B) that are directly mentioned.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains a specific protein name (TCF-1) that is directly mentioned.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) that are directly mentioned.\"}\n]",
        "response3": "[{\"NK cell\": \"cell_type\"}, {\"NFAT\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 810,
        "sentence": "Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .",
        "label": {
            "CML cells": "cell_type",
            "IFN-alpha": "protein",
            "CML cytoplasmic proteins": "protein",
            "nuclear protein-DNA complexes": "protein"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5}\n]",
        "response3": "[{\"CML\": \"cell_line\"}, {\"IFN-alpha\": \"protein\"}, {\"CML\": \"cell_line\"}, {\"cytoplasmic proteins\": \"protein\"}, {\"nuclear protein-DNA complexes\": \"DNA\"}]",
        "prediction": "{'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}"
    },
    {
        "idx": 1811,
        "sentence": "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .",
        "label": {
            "BLR1": "protein",
            "BLR2": "protein",
            "seven transmembrane receptor": "protein",
            "activated lymphocytes": "cell_type",
            "chemokine receptors": "protein",
            "Burkitt's lymphoma receptor 1": "protein"
        },
        "response1": "['DNA', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple protein names and their corresponding labels, which are directly relevant to the entity types in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains relevant protein names and cell type labels, which are helpful for extracting named entities related to the target sentence.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence contains a cell type label that is relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains protein and cell type labels that are directly related to the entity types in the target sentence, providing useful examples for extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein names and their corresponding labels, which are directly relevant to the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains protein names, cell type labels, and cytokine names that are directly relevant to the entity types in the target sentence, making it highly helpful for extraction.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains protein names that are relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The sentence contains a protein name that is directly related to the entity types in the target sentence, providing a helpful example for extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains protein names, cytokine names, and receptor names that are directly relevant to the entity types in the target sentence, making it highly helpful for extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains protein names and receptor names that are directly relevant to the entity types in the target sentence, providing useful examples for extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains protein names, cell type labels, and cytokine names that are directly relevant to the entity types in the target sentence, making it highly helpful for extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains protein names and receptor names that are directly relevant to the entity types in the target sentence, providing useful examples for extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains a protein name that is relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains protein names and cytokine names that are directly related to the entity types in the target sentence, providing useful examples for extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains protein names that are directly relevant to the entity types in the target sentence, making it highly helpful for extraction.\"}\n]",
        "response3": "[{\"BLR1\": \"protein\"}, {\"BLR2\": \"protein\"}]",
        "prediction": "{'BLR1': 'protein', 'BLR2': 'protein'}"
    },
    {
        "idx": 1316,
        "sentence": "Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.",
        "label": {
            "Helix III": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides a clear and direct mention of 'cDNAs' which is a specific type of DNA, aiding in the extraction of the entity.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence directly mentions 'Tax' and 'TFIIA' as interacting proteins, making it highly helpful for extracting protein entities.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' as proteins involved in binding, providing clear references for protein entity extraction.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence directly links 'tyrosine' to protein-protein interaction, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence mentions 'A-myb' as a transcription factor, providing a clear reference for extracting protein entities.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions 'IL-4' as a gene expression regulator, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence provides 'retinoic acid receptor alpha' as a model for binding assays, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer' as a DNA element, aiding in the extraction of DNA entities.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence directly mentions 'EKLF' in the context of recruitment, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence mentions 'IL-2', 'Aiolos', and 'Ras' in the context of cellular distribution and phosphorylation, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence mentions 'IL-7R' and 'gamma(c)' as critical components, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions 'CCAAT box' and 'EKLF binding site' in the context of gene expression, aiding in the extraction of DNA and protein entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type, aiding in the identification of cell type entities.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence mentions 'SLAP-130', 'SLP-76', and 'T cell' in the context of molecular cloning, aiding in the extraction of protein and cell type entities.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions 'p50p50' in the context of binding, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence mentions 'IL-2' in the context of responsiveness, aiding in the extraction of protein entities.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 939,
        "sentence": "However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.",
        "label": {
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity along with its corresponding label, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 292,
        "sentence": "We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.",
        "label": {
            "globin gene": "DNA",
            "mouse embryonic stem (ES) cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"E2A\": 5},\n    {\"MNDA\": 5},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"IgH\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"GM-CSF\": 5},\n    {\"GATA-1\": 5},\n    {\"SCM-1\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"CCAAT box\": 5},\n    {\"EKLF binding site\": 5},\n    {\"Egr-1\": 5},\n    {\"RXR\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"c-kit\": 5},\n    {\"IL-4R alpha chain\": 5},\n    {\"ZEB\": 5},\n    {\"c-Myb\": 5},\n    {\"hematopoietic cells\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 542,
        "sentence": "Amino acid sequences of all proteins are essays written in the same language.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides clear and specific examples of entities with their corresponding labels, aiding in understanding the entity types present in the sentence.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence includes a specific example of a protein entity, which is relevant to the target sentence. However, the presence of additional entities related to eosinophil differentiation could further enhance the helpfulness.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The sentence mentions cDNAs, which are related to DNA entities. While this provides some relevance to the target sentence, the context could be clearer to improve the helpfulness score.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The sentence refers to GM-CSF genes, indicating a protein entity. This example is helpful in identifying protein-related entities in the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence directly mentions a protein entity, which aligns with the entity type present in the target sentence. This example is highly relevant and aids in understanding protein entities.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The sentence discusses SCL protein synthesis and mRNA, suggesting RNA entities. While relevant, additional context or examples related to cell types could further enhance the helpfulness.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence provides examples of CREB and AR-CRE as protein entities, directly relevant to the target sentence. This clear identification of protein-related entities enhances the helpfulness score.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The sentence mentions the Runt domain, which is associated with protein entities. While relevant, additional context or examples related to gene entities could further improve the helpfulness.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence directly refers to Tat-binding protein 7 as a protein entity, aligning with the entity type in the target sentence. This example aids in understanding protein entities.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The sentence discusses the mouse E2A gene at the protein level, indicating protein entities. While relevant, additional context or examples related to gene entities could enhance the helpfulness.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence mentions the phosphorylated tyrosine residue as important for protein-protein interaction, directly relevant to the target sentence. This example aids in understanding protein entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence provides examples of immunohistochemistry, gene, and cell type entities, aligning with the entity types in the target sentence. This example is highly relevant and aids in understanding multiple entity types.\"\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Reason 13\": \"The sentence mentions Th2-type lymphocytes as a cell type entity, which is relevant to the target sentence. However, additional examples or context related to other entity types could further enhance the helpfulness.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence discusses NF-ATc isoforms and T lymphocytes, providing examples of protein and cell type entities. This example is highly relevant and aids in understanding multiple entity types.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The sentence includes examples of p21(WAF1/CIP1) and p27(KIP1) as protein entities, which are relevant to the target sentence. However, additional context or examples related to other entity types could further enhance the helpfulness.\"\n    },\n    {\n        \"Example 16\": 4\n    },\n    {\n        \"Reason 16\": \"The sentence mentions Protein and genomic sequences, suggesting protein entities. While relevant, additional context or examples related to gene entities could further improve the helpfulness.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 505,
        "sentence": "The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .",
        "label": {
            "Jurkat": "cell_line",
            "TCF-1 alpha": "protein",
            "TCR": "protein",
            "T-cell-specific transcription factor": "protein",
            "TCF-1 alpha binding site": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line', 'cell_type']",
        "response2": "[\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCR alpha\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}, {\"T-cell-specific\": \"cell_type\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}"
    },
    {
        "idx": 1525,
        "sentence": "Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .",
        "label": {
            "antibody": "protein",
            "CaM kinase II": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides a clear example of a protein entity (P selectin) and its association with antibodies, aiding in the extraction of protein entities from the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence contains multiple instances of protein entities (NF-kappa B, I kappa B alpha) and their interactions, which are directly relevant to the target sentence, making it highly helpful for entity extraction.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence includes mentions of protein entities (cAMP-dependent protein kinase, Rap1) and their substrates, providing valuable information for identifying protein entities in the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence specifically discusses the expression of a protein entity (E2A) at the protein level, offering a relevant example for extracting protein entities from the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence talks about the inhibition of a protein entity (calcineurin) by immunophilin-drug complexes, which aligns with the protein-related content in the target sentence, making it highly useful for entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions protein entities (SLAP-130, SLP-76, protein tyrosine kinases) and their associations with T cells, providing relevant protein-related information that can aid in extracting entities from the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence discusses the inhibition of protein entities (IL-4, AP-1) by IL-4, which directly relates to protein activities, thus being highly beneficial for entity extraction from the target sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence provides information about protein entities (Syk, Zap) and their phosphorylation upon T cell receptor crosslinking, offering valuable protein-related details that can assist in entity extraction from the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence mentions a protein entity (NDP kinase) and its expression in different cell types (KA, SCC, BCC), providing relevant protein-related information that can aid in extracting entities from the target sentence.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The sentence discusses the role of cell adhesion molecules, which are relevant to cell types, but not directly related to the protein entities in the target sentence, making it somewhat helpful for entity extraction.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence provides information about protein entities (RelA, NF-kappa B) and their activities in T cells, directly relevant to the protein-related content in the target sentence, thus being highly useful for entity extraction.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions protein entities (IL-2, Aiolos, Ras) and their interactions, offering valuable protein-related details that can assist in extracting entities from the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence discusses protein entities (RelA, NF-kappaB1) and their nuclear localization, which aligns with the protein-related content in the target sentence, making it highly useful for entity extraction.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence provides information about a protein entity (retinoic acid receptor alpha) and its characterization, offering a relevant example for extracting protein entities from the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions protein entities (p21(WAF1/CIP1), p27(KIP1)) and their mRNA and protein levels, providing valuable information for identifying protein entities in the target sentence.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1103,
        "sentence": "Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.",
        "label": {
            "platelets": "cell_type",
            "Rap1 protein": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a direct mapping of the entity 'calcineurin' to the entity type 'protein' in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example covers multiple entity mappings such as 'AP-1' to 'protein', 'PMA' to 'protein', 'monocytes' to 'cell_type', and 'macrophages' to 'cell_type', providing comprehensive assistance in entity extraction.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example includes mappings for 'PAFR' to 'protein', 'PAF' to 'protein', 'NF-kappa B' to 'protein', and 'protein kinase C' to 'protein', offering detailed guidance for named entity extraction.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example provides mappings for 'Stat3' to 'protein', 'Stat5' to 'protein', and 'c-Mpl' to 'protein', facilitating accurate extraction of named entities related to proteins.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example covers 'SLAP-130' mapped to 'protein', 'SLP-76' mapped to 'protein', and 'T cell' mapped to 'cell_type', offering diverse entity mappings for effective named entity extraction.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example provides a direct mapping of 'tyrosine' to 'protein', aiding in the extraction of this specific protein-related entity.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example includes the mapping of 'GATA-1' to 'protein', assisting in the extraction of named entities related to proteins.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example covers 'p21ras' mapped to 'protein', aiding in the extraction of protein-related named entities.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example provides a direct mapping of 'P selectin' to 'protein', facilitating the extraction of protein-related named entities.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example includes mappings for 'p21(WAF1/CIP1)' to 'protein' and 'p27(KIP1)' to 'protein', aiding in the extraction of protein-related named entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example covers 'ERK' mapped to 'protein' and 'STAT3' mapped to 'protein', providing guidance for extracting protein-related named entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example includes mappings for 'RelA' to 'protein' and 'NF-kappaB1' to 'protein', aiding in the extraction of protein-related named entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example provides mappings for 'Syk' to 'protein', 'Zap' to 'protein', and 'T cell' to 'cell_type', offering diverse entity mappings for named entity extraction.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example covers mappings for 'IL-2' to 'protein', 'Aiolos' to 'protein', and 'Ras' to 'protein', facilitating the extraction of protein-related named entities.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The example provides a direct mapping of 'phosphocreatine' to 'protein', aiding in the extraction of this specific protein-related entity.\"\n    }\n]\n```",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 538,
        "sentence": "Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .",
        "label": {
            "PHA": "protein",
            "phytohaemagglutinin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 3},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 4},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1529,
        "sentence": "Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .",
        "label": {
            "Oct-2a": "protein",
            "lymphoid-specific transcription factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names such as IkappaBbeta and NF-kappaB, which are directly mentioned in the sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific cell type, Th2-type lymphocytes, which is a clear indicator of the cell_type entity.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions specific proteins like Oct-2A, HMG I/Y, and HLA-DRA, along with the cell type B cells, providing clear indications of the protein and cell_type entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions T cell and interleukin 2, which are specific cell type and protein names, respectively, indicating the cell_type and protein entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence directly mentions specific proteins like NF-kB, AP-1, OCT-1, and NF-IL-2B, indicating the protein entity.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions a specific protein, Egr-1, indicating the protein entity.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions specific proteins like IL-2 receptor alpha subunit and p21ras, along with the cell type B cell, providing clear indications of the protein and cell_type entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions specific proteins like SP1 and caspases, along with the cell type B-cell, indicating the protein and cell_type entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions specific proteins like NF-ATc and T lymphocytes, indicating the protein and cell_type entities.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence mentions AP-1 as a DNA binding activity, which may not directly indicate the protein entity.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions a specific protein, A-myb, indicating the protein entity.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions specific proteins like Sp1 and Ets, indicating the protein entity.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions specific proteins like Jun and ATF-2, indicating the protein entity.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions a specific protein, NF-E2, indicating the protein entity.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions specific proteins like NF-ATc and GATA-1, along with cell types T lymphocytes and erythroid cells, indicating the protein and cell_type entities.\"}\n]",
        "response3": "[{\"Oct-2a\": \"protein\"}]",
        "prediction": "{'Oct-2a': 'protein'}"
    },
    {
        "idx": 1197,
        "sentence": "In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.",
        "label": {
            "ubiquitin": "protein",
            "p105 precursor": "protein",
            "E2-F1": "protein",
            "-proteasome": "protein",
            "ubiquitin -carrier protein": "protein",
            "p53": "protein",
            "ubiquitin -protein ligase": "protein",
            "320-kDa species": "protein",
            "p105": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 3},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n{\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5}\n]",
        "response3": "[{\"ubiquitin -proteasome system\": \"protein\"}, {\"p105 precursor\": \"protein\"}, {\"ubiquitin\": \"protein\"}, {\"E2-F1\": \"protein\"}, {\"p53\": \"protein\"}, {\"ubiquitin -carrier protein\": \"protein\"}, {\"ubiquitin -protein ligase\": \"protein\"}]",
        "prediction": "{'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}"
    },
    {
        "idx": 877,
        "sentence": "Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .",
        "label": {
            "B lymphocytes": "cell_type",
            "thymic epithelial cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific mentions of NF-ATc and T lymphocytes, which are directly associated with the entity labels 'protein' and 'cell_type' respectively.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions TCL1, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions Th1 and Th2, which are directly associated with the entity label 'cell_type'.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific mentions of NF-ATc, T lymphocytes, and embryonic cardiac cells, which are directly associated with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions lymphoid neoplasms, which is directly associated with the entity label 'cell_type'.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific mentions of IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are directly associated with the entity label 'protein'.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions EBV and CD2, which are directly associated with the entity labels 'cell_line' and 'protein' respectively.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions FasL, IL-2, and IFN-gamma, which are directly associated with the entity label 'protein'.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions IL-2 receptor alpha subunit, p21ras, and B cell, which are directly associated with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions T lymphocytes and HLA-molecules, which are directly associated with the entity labels 'cell_type' and 'protein' respectively.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions IL4, IL13, STAT6, STAT3, STAT5, and B cells, which are directly associated with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions WT1, which is directly associated with the entity label 'protein'.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions IL-12, STAT4, NK cells, T cells, and IL-12 receptor, which are directly associated with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions IL-13, IL-4, B cell, and monocyte, which are directly associated with the entity labels 'protein' and 'cell_type'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions Th2-type lymphocytes, which is directly associated with the entity label 'cell_type'.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions CD70, B cell, plasma cells, IL-4, and CD40, which are directly associated with the entity labels 'protein' and 'cell_type'.\"}\n]",
        "response3": "[{'B lymphocytes': 'cell_type'}, {'thymic epithelial cells': 'cell_type'}]",
        "prediction": "{'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}"
    },
    {
        "idx": 1838,
        "sentence": "First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.",
        "label": {
            "LEF-1 -binding site": "DNA",
            "HIV-1 enhancer": "DNA",
            "LEF-1": "protein",
            "GAL4-substituted HIV-1 enhancer": "DNA",
            "Jurkat T cells": "cell_line",
            "multimerized copies": "DNA",
            "LEF-1 /GAL4": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_type', 'cell_line']",
        "response2": "[\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"IL-2\": 5},\n{\"IFN-gamma\": 5},\n{\"jak kinases\": 5},\n{\"STAT1(alpha)\": 5},\n{\"IL-2\": 5},\n{\"c-Jun\": 5},\n{\"c-Fos\": 5},\n{\"IFN A\": 5},\n{\"IFNA\": 5},\n{\"interleukin-2\": 5},\n{\"interleukin-2 receptor\": 5},\n{\"phytohemagglutinin\": 5},\n{\"phorbol myristate acetate\": 5},\n{\"PU.1\": 5},\n{\"M-CSF receptor\": 5},\n{\"macrophage\": 5},\n{\"Sp1\": 5},\n{\"CD14\": 5},\n{\"SIVsmmPBj14\": 5},\n{\"T cell\": 5},\n{\"interleukin 2\": 5},\n{\"p50p50\": 5},\n{\"IkappaBbeta\": 5},\n{\"NF-kappaB\": 5},\n{\"HIV-1\": 5},\n{\"IFN\": 5},\n{\"PKR\": 5},\n{\"IkappaBalpha\": 5},\n{\"NF-kappaB\": 5},\n{\"Sp1\": 5},\n{\"SIVmac\": 5},\n{\"cDNA\": 5},\n{\"Jurkat\": 5},\n{\"DRE 1\": 5},\n{\"HIV-1 LTR\": 5},\n{\"NFAT-1\": 5},\n{\"NF kappa B\": 5},\n{\"TR55\": 5},\n{\"TNF-alpha\": 5},\n{\"HIV\": 5},\n{\"ATF1\": 5},\n{\"CREB\": 5},\n{\"H4\": 5}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"HIV-1 enhancer\": \"DNA\"}, {\"Jurkat T cells\": \"cell_type\"}, {\"GAL4\": \"protein\"}, {\"GAL4-substituted HIV-1 enhancer\": \"DNA\"}]",
        "prediction": "{'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}"
    },
    {
        "idx": 1195,
        "sentence": "Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .",
        "label": {
            "60-kDa precursor": "protein",
            "ubiquitin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5}\n]",
        "response3": "[{\"Palombella\": \"protein\"}, {\"V.J.\": \"protein\"}, {\"Rando\": \"protein\"}, {\"O.J.\": \"protein\"}, {\"Goldberg\": \"protein\"}, {\"A.L.\": \"protein\"}, {\"Maniatis\": \"protein\"}]",
        "prediction": "{'Palombella': 'protein', 'V.J.': 'protein', 'Rando': 'protein', 'O.J.': 'protein', 'Goldberg': 'protein', 'A.L.': 'protein', 'Maniatis': 'protein'}"
    },
    {
        "idx": 817,
        "sentence": "(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .",
        "label": {
            "EBNA-LP": "protein",
            "LMP1": "protein",
            "EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'IL-2' and its association with the entity type 'protein'.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions multiple entities such as 'PC4', 'OCA-B', and 'Oct-1' and their association with the entity type 'protein'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly mentions various entities like 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' and their association with the entity type 'protein'.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence clearly states the entities 'IL-4', 'LPS', and 'AP-1' and their association with the entity type 'protein'.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides direct mentions of 'NF-kappaB', 'Sp1', and 'p50' and their association with the entity type 'protein'.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence explicitly mentions 'NF-kB', 'AP-1', 'OCT-1', and 'NF-IL-2B' and their association with the entity type 'protein'.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions 'TIMP-1' and 'DNA' but the context could be clearer for the association with the entity type 'protein'.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence directly mentions 'RelA' and 'NF-kappaB1' and their association with the entity type 'protein'.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear mentions of 'EBNA-2' and 'PU.1' and their association with the entity type 'protein'.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions 'T cell', 'IL-2', 'IL-2 receptor', and 'CD28' but the context could be clearer for the association with the entity types.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence directly mentions 'RXR' and its association with the entity type 'protein'.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides a clear mention of 'EBNA2' and 'TP1' and their association with the entity types 'protein' and 'cell_line' respectively.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'MNDA' and 'myeloid cell lines' and their association with the entity types 'RNA' and 'cell_line' respectively.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)' and their association with the entity type 'protein'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'CD40', 'IFN-gamma', 'tumor necrosis factor-alpha', and 'interleukin (IL)-1beta' and their association with the entity type 'protein'.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions 'CD4+' and 'EBV' but the context could be clearer for the association with the entity types.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 741,
        "sentence": "In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .",
        "label": {
            "Oct-2A expression vector": "DNA",
            "Oct-2A": "protein",
            "N-Oct-3 factor": "protein",
            "melanoma cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 283,
        "sentence": "[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]",
        "label": {
            "Estrogen receptor": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"Estrogen receptor\": \"protein\"}]",
        "prediction": "{'Estrogen receptor': 'protein'}"
    },
    {
        "idx": 1043,
        "sentence": "METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Although erythropoietin ( Epo ) is essential for the production of mature red blood cells , the cooperation with other factors is required for a proper balance between progenitor proliferation and differentiation.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\": 5},\n    {\"Despite this drastic effect in vivo, the in vitro immortalization of erythropoietin-dependent erythroid progenitors unexpectedly occurred at low frequency, and all four cell lines established expressed both erythrocytic (globins) and megakaryocytic markers ( glycoprotein IIb , platelet factor 4 ) as well as Spi-1 and Fli-1 transcripts at permissive temperature.\": 5},\n    {\"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.\": 5}\n]",
        "response3": "[{\"peripheral blood samples\": \"cell_type\"}, {\"young\": \"cell_type\"}, {\"postmenopausal females\": \"cell_type\"}, {\"estrogen replacement therapy\": \"protein\"}]",
        "prediction": "{'peripheral blood samples': 'cell_type', 'young': 'cell_type', 'postmenopausal females': 'cell_type', 'estrogen replacement therapy': 'protein'}"
    },
    {
        "idx": 1010,
        "sentence": "Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .",
        "label": {
            "murine NFATp": "protein",
            "NFATp protein": "protein",
            "NFATp": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 3},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5}\n]",
        "response3": "[{\"NFATp\": \"protein\"}]",
        "prediction": "{'NFATp': 'protein'}"
    },
    {
        "idx": 186,
        "sentence": "We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .",
        "label": {
            "erythrocytic lineage": "cell_type",
            "NF-E2": "protein",
            "trans-acting factor": "protein",
            "megakaryocytes": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example directly mentions the entity 'RXR' and provides the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example directly mentions the entities 'SCL' and 'GATA-1' with the corresponding entity labels 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example directly mentions the entities 'Stat3', 'Stat5', and 'c-Mpl' with the corresponding entity labels 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example directly mentions the entities 'NF-ATc' and 'T lymphocytes' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example directly mentions the entity 'GATA-1' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example directly mentions the entities 'granulocytes' and 'T cells' with the corresponding entity labels 'cell_type'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example directly mentions the entities 'EKLF', 'CBP', 'p300', and 'P/CAF' with the corresponding entity labels 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly mentions the entity 'Egr-1' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example directly mentions the entities 'NF-ATc', 'T lymphocytes', and 'embryonic cardiac cells' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example directly mentions the entity 'erythropoietin' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example directly mentions the entity 'NF-E2' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example directly mentions the entity 'E2A' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example directly mentions the entity 'GATA-1' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example directly mentions the entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example directly mentions the entities 'ZEB', 'c-Myb', 'Ets', and 'hematopoietic cells' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    }\n]",
        "response3": "[{\"NF-E2\": \"protein\"}, {\"megakaryocytes\": \"cell_type\"}]",
        "prediction": "{'NF-E2': 'protein', 'megakaryocytes': 'cell_type'}"
    },
    {
        "idx": 1547,
        "sentence": "Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .",
        "label": {
            "multisubunit adhesion receptor": "protein",
            "Ib-IX-V": "protein",
            "Platelet glycoprotein": "protein",
            "GP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 3},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 2},\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 1},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 2},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 2},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 2},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 3},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 3},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 3},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 2},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 3},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 3},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 3},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 3}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 96,
        "sentence": "We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .",
        "label": {
            "Sp1": "protein",
            "dominant promoter elements": "DNA",
            "minimal Thy-1 promoter": "DNA",
            "transcription factor": "protein",
            "multiple binding sites": "DNA",
            "CCAAT box": "DNA",
            "transcription start site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1763,
        "sentence": "Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .",
        "label": {
            "IL-2": "protein",
            "IL-2 mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\": 5}\n]",
        "response3": "[{\"IL-2 mRNA\": \"RNA\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}"
    },
    {
        "idx": 224,
        "sentence": "Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).",
        "label": {
            "CEM C7 cells": "cell_line",
            "human acute lymphoblastic T-cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and proteins that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions specific proteins and their interactions, aiding in the extraction of protein entities.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence mentions a specific cell type, which is helpful for extracting cell type entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains a specific protein name, aiding in the extraction of protein entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a specific protein and its function, aiding in the extraction of protein entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions a specific protein name, aiding in the extraction of protein entities.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions a specific cell type, which is helpful for extracting cell type entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions a specific protein name, aiding in the extraction of protein entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions specific proteins and their functions, aiding in the extraction of protein entities.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence mentions specific chemical compounds and a cell type, aiding in the extraction of relevant entities.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions a specific protein, aiding in the extraction of protein entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions a specific protein and its function, aiding in the extraction of protein entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions a specific protein, aiding in the extraction of protein entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names, cell type, and their interactions, making it highly relevant for extracting named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions specific proteins and their interactions, aiding in the extraction of protein entities.\"}\n]",
        "response3": "[{'CEM C7 cells': 'cell_line'}, {'T-cell line': 'cell_type'}]",
        "prediction": "{'CEM C7 cells': 'cell_line', 'T-cell line': 'cell_type'}"
    },
    {
        "idx": 313,
        "sentence": "Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .",
        "label": {
            "malignant soft tissue tumors": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a direct mention of the entity 'protein' and specifies the gene name 'E2A' as a protein.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity 'GATA-1' as a protein.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions 'lymphoid neoplasms' as a cell type.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions 'phosphocreatine' as a protein, which is relevant to the context of the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions multiple entities such as 'SLAP-130', 'SLP-76', and 'T cell' as proteins and 'cell type'.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'NF-E2' as a protein.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'immunohistochemistry' and 'gene' as proteins, and 'cell type'.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'retinoic acid receptor alpha' as a protein.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'CD14' as a protein.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'HML', 'dexamethasone', 'cortisol', and 'lysozyme' as proteins, and 'cell line'.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' as proteins and 'cell type'.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'B and T cell activation', 'Ramos', 'Jurkat', and 'cDNA microarray technology' as DNA, cell lines, and cell types.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'tal-1', 'GATA-binding proteins', and 'hematopoiesis' as proteins and 'cell type'.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'Erbstatin', 'genistein', and 'Egr-1' as proteins and 'RNA'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'EBV', 'EBNA2', and 'estrogen receptor' as DNA and proteins.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'MR', 'aldosterone', and 'progesterone' as proteins.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1285,
        "sentence": "Characterization of 5' end of human thromboxane receptor gene .",
        "label": {
            "5' end of human thromboxane receptor gene": "DNA",
            "human thromboxane receptor gene": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence describes the characterization of genes and their mRNA expression, which are related to the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions specific cell types, which match the 'cell_type' entity type in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence discusses the regulatory mechanism of genes, which aligns with the 'cell_line' entity type in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names and gene symbols that correspond to the 'protein' entity type in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions the expression of a specific protein, which matches the 'protein' entity type in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence describes a mutation affecting T cells and a specific protein, both of which align with the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence discusses the cloning of a specific protein, which corresponds to the 'protein' entity type in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions a specific protein name that matches the 'protein' entity type in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names and gene symbols that correspond to the 'protein' entity type in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence discusses positive regulators of a specific protein, which aligns with the 'protein' entity type in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions the expression of a specific protein, which matches the 'protein' entity type in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence describes the cloning of human cDNAs, which corresponds to the 'DNA' entity type in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions specific cell lines and proteins, which align with the entity types in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence discusses gene expression in specific cell types and the use of cDNA microarray technology, which match the entity types in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 327,
        "sentence": "However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .",
        "label": {
            "R-responsive enhancer region": "DNA",
            "EB1 -binding site": "DNA",
            "EB1": "protein",
            "ZRE-B": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5}\n]",
        "response3": "[{\"EB1\": \"protein\"}]",
        "prediction": "{'EB1': 'protein'}"
    },
    {
        "idx": 1622,
        "sentence": "Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.",
        "label": {
            "gamma interferon": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"gamma interferon\": \"protein\"}]",
        "prediction": "{'gamma interferon': 'protein'}"
    },
    {
        "idx": 1393,
        "sentence": "This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .",
        "label": {
            "second enhancer": "DNA",
            "T-cell activation response element": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells.\": 5},\n    {\"Interleukin 2 and T cell antigen receptor signals converge upon serine 727.\": 5},\n    {\"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region.\": 5}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}, {\"HIV-2\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}"
    },
    {
        "idx": 1221,
        "sentence": "To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .",
        "label": {
            "mouse osteocalcin gene": "DNA",
            "promoter": "DNA",
            "osteoblast-specific cis-acting elements": "DNA",
            "trans-acting factors": "protein",
            "osteoblast-specific gene": "DNA"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4}\n]",
        "response3": "[{\"osteocalcin gene\": \"protein\"}]",
        "prediction": "{'osteocalcin gene': 'protein'}"
    },
    {
        "idx": 130,
        "sentence": "At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .",
        "label": {
            "TREp": "DNA",
            "TR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 788,
        "sentence": "The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).",
        "label": {
            "mineralocorticoid receptors": "protein"
        },
        "response1": "['cell_type']",
        "response2": "```json\n[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding labels, which can aid in identifying protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a specific DNA binding factor and its label, which can aid in identifying DNA entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains a specific protein name and its label, which can aid in identifying protein entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains a specific protein name and its label, which can aid in identifying protein entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence contains specific protein names and their corresponding labels, which can aid in identifying protein entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence explicitly mentions cell types (granulocytes and T cells) and their labels, aiding in identifying cell type entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains specific protein names and their corresponding labels, which can aid in identifying protein entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains specific RNA and cell line names with their corresponding labels, aiding in identifying RNA and cell line entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains specific protein names and their corresponding labels, which can aid in identifying protein entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains specific protein names and their corresponding labels, which can aid in identifying protein entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains specific DNA binding factors and their labels, aiding in identifying DNA entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains specific protein names and their corresponding labels, which can aid in identifying protein entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains specific protein names and their corresponding labels, which can aid in identifying protein entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains specific cell type names and their labels, aiding in identifying cell type entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence contains a specific protein name and its label, which can aid in identifying protein entities.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 781,
        "sentence": "Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 3},\n{\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n{\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n{\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 4},\n{\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n{\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 5},\n{\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n{\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 4},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1220,
        "sentence": "A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .",
        "label": {
            "PEBP2 alpha/AML-1-related factor": "protein",
            "osteocalcin promoter": "DNA",
            "osteoblast-specific cis-acting element": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells\": 3},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging\": 4},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5}\n]",
        "response3": "[{\"PEBP2 alpha/AML-1-related factor\": \"protein\"}, {\"osteocalcin\": \"protein\"}, {\"osteoblast-specific\": \"cell_type\"}]",
        "prediction": "{'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}"
    },
    {
        "idx": 958,
        "sentence": "Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .",
        "label": {
            "B-cell-specific genes": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 3},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 5},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5}\n]",
        "response3": "[{\"Markus Neurath\": \"protein\"}, {\"Eckhard Stuber\": \"protein\"}, {\"Warren Strober\": \"protein\"}, {\"BSAP\": \"protein\"}, {\"B-cell-specific genes\": \"protein\"}]",
        "prediction": "{'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}"
    },
    {
        "idx": 1083,
        "sentence": "These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .",
        "label": {
            "cytokine": "protein",
            "NF kappa B": "protein",
            "PBMC": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The example does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The example does not contain any of the entity types present in the target sentence.\"},\n    {\"3\": \"The example contains 'NF-kappaB' which is similar to 'NF kappa B' in the target sentence, but it also introduces 'Tax' and 'ATL' which are not relevant to the target sentence.\"},\n    {\"2\": \"The example contains 'NF-E2' which is similar to 'NF kappa B' in the target sentence.\"},\n    {\"2\": \"The example contains 'IL-4' and 'AP-1' which are similar to 'protein' in the target sentence, but it also introduces 'LPS' which is not relevant to the target sentence.\"},\n    {\"4\": \"The example contains 'NF-kappa B' which is similar to 'NF kappa B' in the target sentence.\"},\n    {\"4\": \"The example contains 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' which are similar to 'protein' in the target sentence.\"},\n    {\"3\": \"The example contains 'NF-kappa B' which is similar to 'NF kappa B' in the target sentence, but it also introduces 'xenogeneic serum' which is not relevant to the target sentence.\"},\n    {\"2\": \"The example contains 'P selectin' which is similar to 'protein' in the target sentence.\"},\n    {\"3\": \"The example contains 'NF-kappa B' and 'I kappa B beta' which are similar to 'protein' in the target sentence, but it also introduces 'I kappa B beta' which is not relevant to the target sentence.\"},\n    {\"5\": \"The example contains 'IL-2', 'NF-kappa B', and 'AP-1' which are similar to 'protein' in the target sentence.\"},\n    {\"5\": \"The example contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are similar to 'protein' in the target sentence.\"},\n    {\"4\": \"The example contains 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' which are similar to 'cell_type' and 'protein' in the target sentence.\"},\n    {\"4\": \"The example contains 'interleukin-2', 'alpha chain', 'CD25', and 'IL-2 receptor' which are similar to 'protein' in the target sentence.\"},\n    {\"3\": \"The example contains 'Transforming growth factor-beta' which is similar to 'protein' in the target sentence, but it also introduces 'B cell' which is not relevant to the target sentence.\"},\n    {\"3\": \"The example contains 'CTLA4Ig' which is similar to 'protein' in the target sentence, but it also introduces 'NFAT' which is not relevant to the target sentence.\"}\n]",
        "response3": "[{'NF kappa B': 'protein'}]",
        "prediction": "{'NF kappa B': 'protein'}"
    },
    {
        "idx": 514,
        "sentence": "Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .",
        "label": {
            "globin gene": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'GATA-1' to the entity label 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear and direct mapping of the entity 'NF-E2' to the entity label 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear and direct mapping of the entity 'Th2-type lymphocytes' to the entity label 'cell_type' in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping of the entity 'Egr-1' to the entity label 'protein' in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear and direct mapping of the entity 'erythropoietin' to the entity label 'protein' in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The examples provide clear and direct mappings of the entities 'CCAAT box' to the entity label 'DNA' and 'EKLF binding site' to the entity label 'protein' in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear and direct mapping of the entity 'AP-1' to the entity label 'DNA' in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear and direct mapping of the entity 'IL-4' to the entity label 'protein' in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear and direct mapping of the entity 'retinoic acid receptor alpha' to the entity label 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear and direct mapping of the entity 'RXR' to the entity label 'protein' in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The examples provide clear and direct mappings of the entities 'WT1' to the entity label 'protein' and 'myeloid cell lines' to the entity label 'cell_line' in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The examples provide clear and direct mappings of the entities 'IL-2 receptor alpha subunit' to the entity label 'protein', 'p21ras' to the entity label 'protein', and 'B cell' to the entity label 'cell_type' in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear and direct mapping of the entity 'IgH' to the entity label 'DNA' in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a clear and direct mapping of the entity 'GATA-1' to the entity label 'protein' in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a clear and direct mapping of the entity 'immunoglobulin kappa 3' enhancer' to the entity label 'DNA' in the sentence.\"}\n]",
        "response3": "[{\"globin gene\": \"protein\"}]",
        "prediction": "{'globin gene': 'protein'}"
    },
    {
        "idx": 1133,
        "sentence": "Both LCLs were found by EM to produce RVLP and EBV particles .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains multiple named entities that are relevant to the entity labels in the target sentence, such as IL-2, c-Jun, and c-Fos proteins.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence provides a clear example of the named entity PML/RARalpha, which is relevant to the protein entity label in the target sentence.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The sentence mentions PBMC as a cell type and adenovirus DNA, which are relevant to the cell_type and DNA entity labels in the target sentence.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The sentence contains references to EBV as a cell line and CD2 as a protein, which are relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 5\": 3\n    },\n    {\n        \"Reason 5\": \"The sentence mentions EBV and B-cell, which are relevant to the cell_line and cell_type entity labels in the target sentence, but the connection is not as direct as in other examples.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The sentence provides information about the expression of the TCL1 protein, which is relevant to the protein entity label in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence clearly mentions SIVsmmPBj14 as a cell line, which directly corresponds to the cell_line entity label in the target sentence.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The sentence contains references to CD4+ cells and EBV, which are relevant to the cell_type and protein entity labels in the target sentence.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The sentence mentions WT1 as a protein, which is relevant to the protein entity label in the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence provides direct information about the interaction between EBNA2 and PU.1 proteins, which are relevant to the protein entity label in the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence clearly mentions SIVmacMER, SIVmac239, and CEMx174 as cell lines, which directly correspond to the cell_line entity label in the target sentence.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The sentence mentions EBNA2 and TP1, which are relevant to the protein and cell_line entity labels in the target sentence.\"\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Reason 13\": \"The sentence suggests a role for lymphoid neoplasms, which is relevant to the cell_type entity label in the target sentence.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The sentence mentions granulocytes and T cells as cell types, which are relevant to the cell_type entity label in the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence provides information about myeloperoxidase, lysozyme, and PU.1 proteins, which are relevant to the protein entity label in the target sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence mentions ICAM-1, CD71, LMP1, and IkappaB proteins, which are relevant to the protein entity label in the target sentence.\"\n    }\n]",
        "response3": "[{'LCLs': 'cell_line'}, {'RVLP': 'protein'}, {'EBV': 'protein'}]",
        "prediction": "{'LCLs': 'cell_line', 'RVLP': 'protein', 'EBV': 'protein'}"
    },
    {
        "idx": 1762,
        "sentence": "Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.",
        "label": {
            "IL-2": "protein",
            "early gene": "DNA",
            "NF-kappa B": "protein",
            "Oct1": "protein",
            "transcription factors": "protein",
            "NF-AT": "protein",
            "AP-1": "protein",
            "IL-2 gene": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT.\": 5},\n    {\"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.\": 5}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"AP-1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"NF-AT\": \"protein\"}, {\"Oct1\": \"protein\"}]",
        "prediction": "{'IL-2': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}"
    },
    {
        "idx": 23,
        "sentence": "Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .",
        "label": {
            "mutant E6 motif": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 3},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1476,
        "sentence": "Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .",
        "label": {
            "AP-1 protein": "protein",
            "c-Jun": "protein",
            "I kappa B": "protein",
            "NF-kappa B": "protein",
            "cytoplasmic inhibitor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and cell type names that are directly mentioned.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific protein names and protein-related terms that are directly mentioned.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple specific protein names and protein-related terms that are directly mentioned.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains multiple specific protein names and protein-related terms that are directly mentioned.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names and protein-related terms that are directly mentioned.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The sentence contains a general protein-related term, but not specific protein names.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names and protein-related terms that are directly mentioned.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names and protein-related terms that are directly mentioned.\"}\n]",
        "response3": "[{\"AP-1\": \"protein\"}, {\"c-Jun\": \"protein\"}, {\"I kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 234,
        "sentence": "A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .",
        "label": {
            "cultured": "cell_line",
            "primary cells": "cell_type",
            "adenovirus E2 promoter": "DNA",
            "beta-galactosidase gene": "DNA",
            "beta-galactosidase": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1396,
        "sentence": "NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .",
        "label": {
            "hematopoietic progenitor cell line": "cell_line",
            "NF-M": "protein",
            "chicken C/EBP beta": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\n        \"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5\n    },\n    {\n        \"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 4\n    },\n    {\n        \"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 4\n    },\n    {\n        \"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 3\n    },\n    {\n        \"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 3\n    },\n    {\n        \"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5\n    },\n    {\n        \"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5\n    },\n    {\n        \"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 4\n    },\n    {\n        \"Control of NF-kappa B activity by the I kappa B beta inhibitor .\": 5\n    },\n    {\n        \"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5\n    },\n    {\n        \"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4\n    },\n    {\n        \"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\": 5\n    },\n    {\n        \"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4\n    },\n    {\n        \"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 4\n    },\n    {\n        \"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 5\n    },\n    {\n        \"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5\n    }\n]",
        "response3": "[{\"NF-M\": \"protein\"}, {\"C/EBP beta\": \"protein\"}, {\"eosinophilic\": \"cell_type\"}, {\"hematopoietic progenitor\": \"cell_type\"}]",
        "prediction": "{'NF-M': 'protein', 'C/EBP beta': 'protein', 'eosinophilic': 'cell_type', 'hematopoietic progenitor': 'cell_type'}"
    },
    {
        "idx": 1812,
        "sentence": "The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .",
        "label": {
            "G-protein coupled chemokine receptors": "protein",
            "chemokine receptors": "protein",
            "G-protein": "protein",
            "receptor EBI1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"EBV\": 4},\n    {\"B-cell\": 4},\n    {\"retinoic acid receptor alpha\": 4},\n    {\"Protein\": 4},\n    {\"MIP-1 alpha\": 4},\n    {\"GOS19\": 4},\n    {\"LD78\": 4},\n    {\"AT464\": 4},\n    {\"EBNA-2\": 5},\n    {\"PU.1\": 5},\n    {\"CREB\": 5},\n    {\"AR-CRE\": 5},\n    {\"Egr-1\": 4},\n    {\"E2A\": 4},\n    {\"GM-CSF\": 4},\n    {\"protein\": 4},\n    {\"EKLF\": 4},\n    {\"CBP\": 4},\n    {\"p300\": 4},\n    {\"P/CAF\": 4},\n    {\"TP1\": 4},\n    {\"c-kit\": 4},\n    {\"IL-4R alpha chain\": 4},\n    {\"interleukin 10\": 4},\n    {\"IL-10R\": 4},\n    {\"STAT3\": 4},\n    {\"IL-6\": 4},\n    {\"GATA-1\": 4},\n    {\"IL4\": 4},\n    {\"IL13\": 4},\n    {\"STAT6\": 4},\n    {\"STAT5\": 4},\n    {\"B cells\": 4}\n]",
        "response3": "[{\"G-protein coupled chemokine receptors\": \"protein\"}, {\"EBI1\": \"protein\"}]",
        "prediction": "{'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}"
    },
    {
        "idx": 1099,
        "sentence": "Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .",
        "label": {
            "monocyte mitochondrial 1 alpha-hydroxylase": "protein",
            "monocyte": "cell_type",
            "microtubule": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1537,
        "sentence": "Furthermore, we identified a repression domain at the N-terminus of Oct-2a .",
        "label": {
            "Oct-2a": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 4},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n{\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n{\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1574,
        "sentence": "CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .",
        "label": {
            "receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 3},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 3},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 2},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 4},\n    {\"To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs, and identified a negative element from bp -267 to -246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.\": 5},\n    {\"This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8).\": 4}\n]",
        "response3": "[{\"eosinophils\": \"cell_type\"}, {\"sexual hormones\": \"protein\"}, {\"receptors\": \"protein\"}]",
        "prediction": "{'eosinophils': 'cell_type', 'sexual hormones': 'protein', 'receptors': 'protein'}"
    },
    {
        "idx": 1312,
        "sentence": "A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.",
        "label": {
            "HMG-1": "protein",
            "C-terminal HMG box": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'SCM-1' in the context of genes, making it highly helpful for extracting the named entity.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence contains specific references to 'CCAAT box' and 'EKLF binding site' in relation to gene expression, which are likely to be helpful for identifying DNA and protein entities, respectively.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence explicitly mentions 'GM-CSF genes' and highlights the conservation of a sequence motif, aiding in the identification of the protein entity.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence provides detailed information about nuclear factors, IL-2 promoter, c-Jun, and c-Fos protein, all of which are crucial for understanding the protein entities involved in the context of gene regulation.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence mentions 'Th2-type lymphocytes' in relation to cytokine promoters, which is helpful for recognizing the cell type entity.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence directly refers to 'Protein' and 'G0S24 product' in the context of transcription, aiding in the identification of protein entities.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence discusses the IL-7R complex and gamma(c) in relation to receptor function, providing valuable information for identifying protein entities.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence mentions 'c-kit' and 'IL-4R alpha chain' in the context of a chimeric receptor system, which is helpful for recognizing the protein entities involved.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence explicitly mentions 'Oct-2A', 'HMG I/Y', 'HLA-DRA expression', and 'B cells', providing crucial information for identifying protein entities and cell type.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence discusses the 'retinoic acid receptor alpha' in the context of binding assays, aiding in the identification of the protein entity.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides information about 'CHEMR1', 'C-C chemokine', and 'MIP-1alpha' as potential receptors, which is valuable for recognizing protein entities.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions 'TCF-1' in the context of transactivation, which is helpful for identifying the protein entity.\"},\n{\"Example 13\": 3},\n{\"Reason 13\": \"The sentence mentions 'DNA binding activity' but lacks specific details or context, making it somewhat helpful for identifying the DNA entity.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence discusses 'SLAP-130', 'SLP-76', and 'T cell' in the context of protein substrates and kinases, providing valuable information for identifying protein entities and cell type.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence directly refers to 'ZAP-70' in relation to UV and H2O2 treatment, aiding in the identification of the protein entity.\"},\n{\"Example 16\": 4},\n{\"Reason 16\": \"The sentence mentions 'cDNAs' in the context of cloning and sequencing, which is helpful for recognizing the DNA entity.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 601,
        "sentence": "To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .",
        "label": {
            "murine IgH enhancer": "DNA",
            "putative additional lymphoid-specific transcription factor": "protein",
            "octamer (OCTA)-nucleotide motif": "DNA",
            "NF-microB": "protein",
            "enhancer elements": "DNA",
            "immunoglobulin heavy-chain (IgH) gene": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'NF-E2' and the entity type 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example covers multiple entities in the sentence and correctly identifies their entity types.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example correctly identifies the entity type 'protein' for 'IL-2' in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example correctly identifies multiple entities and their corresponding entity types in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example correctly identifies the entity type 'protein' for 'Egr-1' in the sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example correctly identifies the entity type 'protein' for 'IL-4' in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example correctly identifies the entity types 'cell_type' and 'protein' for 'T cell' and 'interleukin 2' respectively in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example correctly identifies the entity types 'protein' for 'IL-2', 'c-Jun', and 'c-Fos' in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example correctly identifies the entity type 'cell_type' for 'Th2-type lymphocytes' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example correctly identifies the entity type 'DNA' for 'IgH' in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example correctly identifies the entity type 'DNA' for 'immunoglobulin kappa 3' enhancer' in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example correctly identifies the entity types 'protein' for 'c-kit' and 'IL-4R alpha chain' in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example correctly identifies the entity type 'protein' for 'NF-kappa B' in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example correctly identifies multiple entities and their corresponding entity types in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example correctly identifies multiple entities and their corresponding entity types in the sentence.\"}\n]",
        "response3": "[{\"immunoglobulin heavy-chain\": \"protein\"}, {\"IgH\": \"DNA\"}, {\"NF-microB\": \"protein\"}]",
        "prediction": "{'immunoglobulin heavy-chain': 'protein', 'IgH': 'DNA', 'NF-microB': 'protein'}"
    },
    {
        "idx": 890,
        "sentence": "Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 3},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.\": 5},\n    {\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n    {\"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.\": 5},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5},\n    {\"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 323,
        "sentence": "The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .",
        "label": {
            "Epstein-Barr virus ( EBV ) ORI1yt enhancer": "DNA"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (Egr-1) being mentioned in relation to a zinc finger transcription factor.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions the hepatitis B virus as DNA and HBxAg as a protein, making it a very helpful example.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions RXR as a protein, but the context is not as clear as in other examples.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) in a clear context.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence clearly mentions NF-kappaB, Sp1, and p50 as proteins, making it a very helpful example.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a clear example of EBNA2 as a protein and TP1 as a cell line in a specific context.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions T cell as a cell type and interleukin 2 as a protein, but the context is not as clear as in other examples.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions IL-2 as a protein, but the context is not as clear as in other examples.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions AP-1 as DNA, but the context is not as clear as in other examples.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a clear example of NF-kB, AP-1, OCT-1, and NF-IL-2B as proteins in a specific context.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides a clear example of EBV as a cell line and CD2 as a protein in a specific context.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions CD4+ as a cell type and EBV as a protein, but the context is not as clear as in other examples.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a clear example of EBNA-2 and PU.1 as proteins in a specific context.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides a clear example of UAS1 as a cell line and B cell as a cell type in a specific context.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of EBV as a cell type and B-cell as a cell type in a specific context.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides a clear example of GATA-1 as a protein in a specific context.\"}\n]",
        "response3": "[{\"Epstein-Barr virus\": \"cell_line\"}, {\"ORI1yt\": \"cell_line\"}, {\"R\": \"protein\"}, {\"Z\": \"protein\"}]",
        "prediction": "{'Epstein-Barr virus': 'cell_line', 'ORI1yt': 'cell_line', 'R': 'protein', 'Z': 'protein'}"
    },
    {
        "idx": 929,
        "sentence": "The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .",
        "label": {
            "ORF": "DNA",
            "272 carboxy-terminal amino acids": "protein",
            "ets-1": "protein",
            "human ets-1 protein": "protein",
            "813-bp open reading frame": "DNA",
            "cDNA sequence": "DNA",
            "amino acid sequence": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"This protein has now been purified and its encoding gene cloned.\": 4},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5}\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"ets-1\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'ets-1': 'protein'}"
    },
    {
        "idx": 6,
        "sentence": "Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .",
        "label": {
            "Platelet-activating factor": "protein",
            "oncogene": "DNA",
            "human B cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains a named entity with a clear entity label that matches one of the entity types in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1478,
        "sentence": "Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.",
        "label": {
            "activated T cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 3},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1793,
        "sentence": "The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 5},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.\": 5},\n    {\"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.\": 5},\n    {\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3}\n]",
        "response3": "[{\"salicylates\": \"protein\"}, {\"atherosclerosis\": \"cell_type\"}, {\"rheumatoid arthritis\": \"cell_type\"}, {\"monocyte\": \"cell_type\"}]",
        "prediction": "{'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}"
    },
    {
        "idx": 1473,
        "sentence": "Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .",
        "label": {
            "NF-kappa B": "protein",
            "T cells": "cell_type",
            "AP-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"AP-1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 539,
        "sentence": "PMA enhanced slightly the stimulatory effect of PHA .",
        "label": {
            "PHA": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (NF-kappa B and AP-1) that are directly mentioned, making it highly relevant for extracting protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein (NF-E2) that is directly related to the context, aiding in the extraction of protein entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides specific protein names (AP-1 and PMA) and cell types (monocytes and macrophages) directly related to the context, making it highly relevant for extracting protein and cell type entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) directly related to the context, aiding in the extraction of protein entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (IL-2, NF-kappa B, and AP-1) directly related to the context, making it highly relevant for extracting protein entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions a specific protein (MNDA) and a specific cell line (Philadelphia chromosome-positive chronic myeloid leukemia) that are directly related to the context, aiding in the extraction of protein and cell line entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides specific protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) directly related to the context, making it highly relevant for extracting protein and cell type entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions a specific protein (NF-kappa B) directly related to the context, aiding in the extraction of protein entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions a specific protein (P selectin) directly related to the context, aiding in the extraction of protein entities.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence mentions a specific protein (phosphocreatine) that is relevant but not directly related to the context, making it somewhat helpful for extracting protein entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions specific protein names (NDP kinase) and cell types (KA, SCC, BCC) directly related to the context, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names (CD14 and CD23) directly related to the context, making it highly relevant for extracting protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides specific protein names (IL-4, LPS, AP-1) directly related to the context, making it highly relevant for extracting protein entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) directly related to the context, making it highly relevant for extracting protein entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (Epo, alpha-globin, beta-globin, haemoglobin, haemin, delta-ALA) directly related to the context, making it highly relevant for extracting protein entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides specific protein names (PMA, IFN-gamma) and a cell type (T cell blasts) directly related to the context, making it highly relevant for extracting protein and cell type entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1025,
        "sentence": "NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .",
        "label": {
            "NFATc": "protein",
            "NK cells": "cell_type",
            "NFATc mRNA": "RNA"
        },
        "response1": "['RNA', 'cell_type', 'protein']",
        "response2": "[\n{\"Example 1\": 4},\n{\"Reason 1\": \"Contains multiple examples of protein entities that are relevant to the target sentence.\"},\n{\"Example 2\": 3},\n{\"Reason 2\": \"Contains protein and cell_type entities that are relevant to the target sentence, but not as many examples as Example 1.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"Contains a variety of protein entities that are directly relevant to the target sentence.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"Contains protein entities that are relevant to the target sentence.\"},\n{\"Example 5\": 3},\n{\"Reason 5\": \"Contains DNA entity that is relevant to the target sentence.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"Contains protein entities that are relevant to the target sentence.\"},\n{\"Example 7\": 4},\n{\"Reason 7\": \"Contains protein entities that are relevant to the target sentence.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"Contains protein entities that are relevant to the target sentence.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"Contains protein and cell_type entities that are relevant to the target sentence.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"Contains protein entities that are relevant to the target sentence.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"Contains protein entities that are relevant to the target sentence.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"Contains protein and cell_type entities that are relevant to the target sentence.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"Contains protein and cell_type entities that are relevant to the target sentence.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"Contains protein entities that are relevant to the target sentence.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"Contains a variety of protein entities that are directly relevant to the target sentence.\"}\n]",
        "response3": "[{\"NFATc\": \"protein\"}, {\"NFATc mRNA\": \"RNA\"}, {\"NK cells\": \"cell_type\"}, {\"CD16 ligands\": \"protein\"}]",
        "prediction": "{'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}"
    },
    {
        "idx": 1560,
        "sentence": "Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .",
        "label": {
            "human T helper (Th) clones": "cell_line",
            "CD30+ cells": "cell_line",
            "CD30": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5}\n]",
        "response3": "[{\"Th\": \"cell_type\"}, {\"CD30\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'Th': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 365,
        "sentence": "Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.",
        "label": {
            "c-jun": "DNA",
            "HL-60 cells": "cell_line",
            "untreated HL-60 cells": "cell_line"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "```json\n[\n    {\"TIMP-1\": 5},\n    {\"DNA\": 4},\n    {\"TCL1\": 5},\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"ZAP-70\": 5},\n    {\"IL-2\": 4},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"AP-1\": 4},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 3},\n    {\"ATL\": 3},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"TAL1\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"B and T cell activation\": 4},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 4},\n    {\"Tip\": 5},\n    {\"Tap\": 5},\n    {\"Jurkat-T cells\": 5},\n    {\"tal-1\": 5},\n    {\"GATA-binding proteins\": 5},\n    {\"hematopoiesis\": 4},\n    {\"AP-1\": 5},\n    {\"c-jun\": 5},\n    {\"IL-2\": 4},\n    {\"NF-AT\": 5},\n    {\"T cell\": 4},\n    {\"nuclear factor-kappa B\": 4},\n    {\"NF-kappa B\": 4},\n    {\"TCL1\": 5},\n    {\"MTCP1/c6.1B\": 5}\n]\n```",
        "response3": "```json\n[{\"c-jun\": \"protein\"}, {\"HL-60 cells\": \"cell_line\"}, {\"TPA\": \"protein\"}]\n```",
        "prediction": "{'c-jun': 'protein', 'HL-60 cells': 'cell_line', 'TPA': 'protein'}"
    },
    {
        "idx": 1039,
        "sentence": "Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .",
        "label": {
            "Peripheral blood mononuclear cells": "cell_type",
            "pbmc": "cell_type",
            "bone marrow cells": "cell_type"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"PBMC\": 5},\n    {\"adenovirus DNA\": 5},\n    {\"CD70\": 4},\n    {\"B cell\": 4},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4},\n    {\"MNDA\": 4},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"PMA\": 4},\n    {\"CD14\": 4},\n    {\"CD23\": 4},\n    {\"IL-2\": 4},\n    {\"c-Jun\": 4},\n    {\"c-Fos\": 4},\n    {\"PML/RARalpha\": 5},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"NF-kappaB\": 4},\n    {\"Tax\": 4},\n    {\"ATL\": 4},\n    {\"TCRzeta\": 4},\n    {\"p56(lck)\": 4},\n    {\"p21(WAF1/CIP1)\": 4},\n    {\"p27(KIP1)\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"Ter 119\": 4},\n    {\"beta-globin\": 4},\n    {\"glycoprotein IIb\": 4},\n    {\"platelet factor 4\": 4},\n    {\"CD40\": 4},\n    {\"Rel/nuclear factor kappaB\": 4},\n    {\"NF-kappaB\": 4},\n    {\"B lymphocytes\": 4},\n    {\"B and T cell activation\": 4},\n    {\"Ramos\": 4},\n    {\"Jurkat\": 4},\n    {\"cDNA microarray technology\": 4},\n    {\"HeLa cells\": 4},\n    {\"Daudi\": 4},\n    {\"PU.1\": 4},\n    {\"CSF-1 receptor\": 4},\n    {\"Mono A\": 4},\n    {\"Mono B\": 4}\n]",
        "response3": "[{\"Peripheral blood mononuclear cells\": \"cell_type\"}, {\"bone marrow cells\": \"cell_type\"}, {\"c-fos\": \"protein\"}, {\"c-myc\": \"protein\"}, {\"p53\": \"protein\"}, {\"hybrid bcr/abl mRNA\": \"RNA\"}]",
        "prediction": "{'Peripheral blood mononuclear cells': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'hybrid bcr/abl mRNA': 'RNA'}"
    },
    {
        "idx": 217,
        "sentence": "Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .",
        "label": {
            "GCR": "protein",
            "glucocorticoid receptors": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"phosphocreatine\": 3},\n    {\"G-CSF\": 4},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"STAT6\": 5},\n    {\"STAT3\": 5},\n    {\"STAT5\": 5},\n    {\"B cells\": 5},\n    {\"IL-5 mRNA\": 4},\n    {\"TCR\": 4},\n    {\"IL-2R\": 4},\n    {\"dexamethasone\": 4},\n    {\"HML\": 5},\n    {\"dexamethasone\": 4},\n    {\"cortisol\": 4},\n    {\"lysozyme\": 4},\n    {\"IL-7R\": 5},\n    {\"gamma(c)\": 5},\n    {\"E2A\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"IFN-gamma\": 5},\n    {\"IL-2\": 4},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"cAMP-dependent protein kinase\": 5},\n    {\"Rap1\": 5},\n    {\"TCRzeta\": 5},\n    {\"p56(lck)\": 5},\n    {\"GATA-1\": 5},\n    {\"VDR\": 5},\n    {\"RXR\": 5},\n    {\"GRIP-1\": 5},\n    {\"DRIP205\": 5},\n    {\"DRIP\": 3},\n    {\"B and T cell activation\": 5},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 3},\n    {\"CD40\": 5},\n    {\"Rel/nuclear factor kappaB\": 5},\n    {\"NF-kappaB\": 5},\n    {\"B lymphocytes\": 5}\n]",
        "response3": "[{\"GCR\": \"protein\"}, {\"GCS\": \"protein\"}, {\"BA\": \"cell_type\"}]",
        "prediction": "{'GCR': 'protein', 'GCS': 'protein', 'BA': 'cell_type'}"
    },
    {
        "idx": 1782,
        "sentence": "In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .",
        "label": {
            "Id3": "protein",
            "resting PBL": "cell_type",
            "Id3 mRNA": "RNA",
            "PBL": "cell_type",
            "Id2": "protein",
            "Id2 mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 5}\n]",
        "response3": "[{\"Id2 mRNA\": \"RNA\"}, {\"Id3 mRNA\": \"RNA\"}]",
        "prediction": "{'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}"
    },
    {
        "idx": 1280,
        "sentence": "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.",
        "label": {
            "NF-kappa B": "protein",
            "TATA element": "DNA",
            "transcription factors": "protein",
            "CD69": "protein",
            "AP-1": "protein",
            "30 base pairs upstream": "DNA",
            "CD69 gene": "DNA",
            "5'-flanking region": "DNA",
            "transcription initiation site": "DNA",
            "Egr-1": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif\": 4},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 5},\n    {\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B\": 5},\n    {\"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells\": 5}\n]",
        "response3": "[{\"CD69 gene\": \"protein\"}, {\"TATA element\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}, {\"Egr-1\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 611,
        "sentence": "Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"DNA viruses\": \"DNA\"}, {\"HIV-1\": \"cell_type\"}]",
        "prediction": "{'DNA viruses': 'DNA', 'HIV-1': 'cell_type'}"
    },
    {
        "idx": 1723,
        "sentence": "In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .",
        "label": {
            "tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA": "RNA",
            "NF-kappa B": "protein",
            "tumor necrosis factor-alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['cell_line', 'protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"messenger RNA\": \"RNA\"}, {\"monocyte/macrophage cell line\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'messenger RNA': 'RNA', 'monocyte/macrophage cell line': 'cell_line'}"
    },
    {
        "idx": 1308,
        "sentence": "Two groups of HMG box proteins are distinguished.",
        "label": {
            "HMG box proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 4},\n    {\"Sentence 3\": 4},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[{\"HMG box proteins\": \"protein\"}]",
        "prediction": "{'HMG box proteins': 'protein'}"
    },
    {
        "idx": 765,
        "sentence": "Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'protein' (E2A) at the protein level, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions the entity 'protein' (NF-E2) in the context of a cellular differentiation program, which is helpful for identifying named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions the entities 'RNA' (IL-5 mRNA), 'cell_type' (TCR), and 'protein' (IL-2R, dexamethasone) in the context of mRNA induction and stimulation, making it very helpful for extracting named entities.\"},\n    {\"Example 4\": 3},\n    {\"Reason 4\": \"The sentence mentions the entities 'cell_type' (granulocytes, T cells) in the context of methylation deviation, which is somewhat helpful for identifying named entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions the entity 'protein' (IL-4) in the context of gene expression regulation, which is helpful for identifying named entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions the entities 'protein' (IL-2, c-Jun, c-Fos) in the context of nuclear factors and binding, which is helpful for extracting named entities.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions the entity 'protein' (phosphocreatine) in the context of energy substrates and hormone responses, which is somewhat helpful for identifying named entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions the entities 'cell_line' (HML) and 'protein' (dexamethasone, cortisol, lysozyme) in the context of glucocorticoid responsiveness evaluation, which is helpful for extracting named entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions the entity 'protein' (IFN-gamma) in the context of asthma pathogenesis, which is helpful for identifying named entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions the entity 'protein' (NF-kappa B) in the context of serum effects and therapeutic strategies, which is helpful for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence directly mentions the entities 'protein' (VDR, RXR, GRIP-1, DRIP205, DRIP) in the context of sensitivity to analogue effects, making it very helpful for extracting named entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions the entities 'protein' (CD40, Rel/nuclear factor kappaB, NF-kappaB) and 'cell_type' (B lymphocytes) in the context of stimulation and activity analysis, which is helpful for identifying named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1561,
        "sentence": "In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .",
        "label": {
            "CD30": "protein",
            "NF-kappa B complexes": "protein",
            "p65 RelA": "protein",
            "p50 NF-kappa B1": "protein",
            "NF-kappa B": "protein",
            "transcription factors": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 4},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 4},\n    {\"Sentence 5\": 4},\n    {\"Sentence 6\": 4},\n    {\"Sentence 7\": 4},\n    {\"Sentence 8\": 4},\n    {\"Sentence 9\": 3},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 4},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 4},\n    {\"Sentence 15\": 4}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"p50 NF-kappa B1\": \"protein\"}, {\"p65 RelA\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}"
    },
    {
        "idx": 330,
        "sentence": "ZRE-B is therefore not part of the R- inducible enhancer .",
        "label": {
            "ZRE-B": "DNA",
            "R- inducible enhancer": "DNA"
        },
        "response1": "None.",
        "response2": "[\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 3},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 2},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 3},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 4},\n    {\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 4},\n    {\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n    {\"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs.\": 3}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1104,
        "sentence": "Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1594,
        "sentence": "Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .",
        "label": {
            "Jurkat cells": "cell_line",
            "NF-kappa B -activating cytokine": "protein",
            "Human IL4 promoter": "DNA",
            "tumor necrosis factor alpha": "protein",
            "RelA -overexpressing cells": "cell_line",
            "NF-kappa B": "protein",
            "RelA": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Th2-type lymphocytes\": 5},\n    {\"IL-2\": 5, \"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"RelA\": 5, \"NF-kappa B\": 5},\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5},\n    {\"IL4\": 5, \"IL13\": 5, \"gamma c chain\": 5, \"STAT6\": 5, \"STAT3\": 5, \"STAT5\": 5, \"B cells\": 5},\n    {\"IFN A\": 5, \"IFNA\": 5, \"interleukin-2\": 5, \"interleukin-2 receptor\": 5, \"phytohemagglutinin\": 5, \"phorbol myristate acetate\": 5},\n    {\"IkappaBalpha\": 5, \"NF-kappaB\": 5},\n    {\"NF-kappa B\": 5, \"I kappa B alpha\": 5},\n    {\"IL-2\": 5, \"IFN-gamma\": 5, \"jak kinases\": 5, \"STAT1(alpha)\": 5},\n    {\"IkappaBbeta\": 5, \"NF-kappaB\": 5},\n    {\"NF-kappaB\": 5, \"Tax\": 5, \"ATL\": 5},\n    {\"HIV-1\": 5, \"IFN\": 5, \"PKR\": 5, \"IkappaBalpha\": 5},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 5},\n    {\"YY1\": 5, \"Oct1\": 5, \"IL-5\": 5, \"T cells\": 5},\n    {\"interleukin-2\": 5, \"alpha chain\": 5, \"CD25\": 5, \"IL-2 receptor\": 5},\n    {\"CTLA4Ig\": 5, \"NFAT\": 5, \"AP-1\": 5}\n]",
        "response3": "[{\"IL4\": \"protein\"}, {\"Jurkat cells\": \"cell_line\"}, {\"NF-kappa B\": \"protein\"}, {\"tumor necrosis factor alpha\": \"protein\"}, {\"RelA\": \"protein\"}]",
        "prediction": "{'IL4': 'protein', 'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}"
    },
    {
        "idx": 1086,
        "sentence": "Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .",
        "label": {
            "NF-kappa B": "protein",
            "I kappa B alpha": "protein",
            "human I kappa B alpha protein": "protein",
            "mouse 70Z/3 cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBalpha' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'RelA' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B beta' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'CD40' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are all proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'E2A' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"}\n]",
        "response3": "[\n    {\"I kappa B alpha\": \"protein\"},\n    {\"mouse 70Z/3 cells\": \"cell_line\"},\n    {\"NF-kappa B\": \"protein\"},\n    {\"phorbol myristate acetate\": \"protein\"},\n    {\"lipopolysaccharide\": \"protein\"}\n]",
        "prediction": "{'I kappa B alpha': 'protein', 'mouse 70Z/3 cells': 'cell_line', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein'}"
    },
    {
        "idx": 1,
        "sentence": "When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.",
        "label": {
            "homeodomain": "DNA",
            "HB24": "DNA",
            "Drosophila homeodomain": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n{\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n{\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1226,
        "sentence": "Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .",
        "label": {
            "transcription factors": "protein",
            "T-cell nuclear extract-DNA complexes": "protein",
            "OSF2": "protein",
            "osteoblast nuclear extract-DNA complexes": "protein",
            "PEBP2 alpha factors": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity label set provided.\"}\n]",
        "response3": "[{\"OSF2\": \"protein\"}, {\"PEBP2 alpha factors\": \"protein\"}]",
        "prediction": "{'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}"
    },
    {
        "idx": 663,
        "sentence": "The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .",
        "label": {},
        "response1": "['cell_line', 'cell_type', 'gene expression']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence directly mentions the entity 'SCL' and its association with 'RNA', providing clear and specific information for entity extraction.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence contains multiple entities such as 'NF-ATc', 'T lymphocytes', and 'embryonic cardiac cells' with clear associations to entity types, aiding in entity extraction.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The sentence mentions 'GATA-1' in relation to 'protein', providing valuable information for entity extraction.\"\n    },\n    {\n        \"Example 4\": 3\n    },\n    {\n        \"Reason 4\": \"The sentence mentions 'SCM-1' in relation to 'cell_line', which is helpful for entity extraction but lacks additional context for a higher score.\"\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Reason 5\": \"The sentence provides information about 'nonhuman primates' as 'cell_type', aiding in entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence directly links 'E2A' to 'protein' and provides detailed information on the detection method, enhancing entity extraction.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The sentence mentions 'GATA-1' in relation to 'protein', aiding in entity extraction.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The sentence contains multiple entities such as 'immunohistochemistry', 'gene', and 'cell type' with clear associations to entity types, aiding in entity extraction.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The sentence mentions 'NF-kappa B' and 'I kappa B alpha' in relation to 'protein', providing valuable information for entity extraction.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The sentence mentions 'IL-4' in relation to 'protein', aiding in entity extraction.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The sentence mentions 'MNDA' in relation to 'protein' and 'Philadelphia chromosome-positive chronic myeloid leukemia' as 'cell_line', aiding in entity extraction.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The sentence mentions 'Sp1' and 'Ets' in relation to 'protein', providing valuable information for entity extraction.\"\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Reason 13\": \"The sentence mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)' in relation to 'protein', aiding in entity extraction.\"\n    },\n    {\n        \"Example 14\": 3\n    },\n    {\n        \"Reason 14\": \"The sentence mentions 'cell adhesion molecules' as 'cell_type', which is helpful for entity extraction but lacks additional context for a higher score.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence provides detailed information on the entities 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R' in relation to 'protein', aiding in entity extraction.\"\n    },\n    {\n        \"Example 16\": 4\n    },\n    {\n        \"Reason 16\": \"The sentence mentions 'ZEB', 'c-Myb', and 'Ets' in relation to 'protein', along with 'hematopoietic cells' as 'cell_type', aiding in entity extraction.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1000,
        "sentence": "Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.",
        "label": {
            "HSF2": "protein",
            "HSF3": "protein",
            "HSFs": "protein",
            "HSF1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"GM-CSF\": 3},\n    {\"UAS3\": 4, \"UAS2\": 4, \"YY1\": 3},\n    {\"Protein\": 5},\n    {\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"EKLF\": 5},\n    {\"A-myb\": 4},\n    {\"Tax\": 4, \"TFIIA\": 5},\n    {\"cDNAs\": 3},\n    {\"GATA-1\": 5},\n    {\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n    {\"SCM-1\": 5},\n    {\"NF-E2\": 5},\n    {\"p21(WAF1/CIP1)\": 5, \"p27(KIP1)\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4},\n    {\"E2A\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 39,
        "sentence": "Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .",
        "label": {
            "KBF1": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping between the entities and their types.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence contains a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its type.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of named entities with their corresponding entity labels, helping to identify the entities and their types.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence includes a named entity with its corresponding entity label, assisting in recognizing the entity and its type.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with their corresponding entity labels, facilitating the extraction of entities and their types.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides a clear example of a named entity with its corresponding entity label, aiding in understanding the entity and its type.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence includes a named entity with its corresponding entity label, which helps in identifying the entity and its type.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence contains a named entity with its corresponding entity label, aiding in recognizing the entity and its type.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides examples of named entities with their corresponding entity labels, assisting in identifying the entities and their types.\"},\n    {\"Sentence\": 2},\n    {\"Reason\": \"The sentence includes a named entity with its corresponding entity label, aiding in understanding the entity and its type.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides examples of named entities with their corresponding entity labels, helping to identify the entities and their types.\"},\n    {\"Sentence\": 2},\n    {\"Reason\": \"The sentence contains examples of named entities with their corresponding entity labels, aiding in understanding the entities and their types.\"}\n]",
        "response3": "[{'KBF1': 'protein'}, {'NF-kappa B': 'protein'}]",
        "prediction": "{'KBF1': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 229,
        "sentence": "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .",
        "label": {
            "B-cell line": "cell_line",
            "IM-9": "cell_line",
            "GR": "protein",
            "CVZ 's binding sites": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"CVZ\": \"protein\"}, {\"IM-9\": \"cell_line\"}, {\"RU 38486\": \"protein\"}, {\"human GR\": \"protein\"}]",
        "prediction": "{'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein'}"
    },
    {
        "idx": 743,
        "sentence": "Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .",
        "label": {
            "erythroid cell transcription factor": "protein",
            "non-erythroid cells": "cell_type",
            "EF1": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Sentence\": \"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\", \"Helpfulness score\": 5, \"Reason\": \"The sentence provides examples of cell types (erythroid, megakaryocyte, mast cell) and a protein (GATA-1) that are relevant to the target sentence.\"},\n    {\"Sentence\": \"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence mentions a protein (WT1) and myeloid cell lines, which are relevant to the target sentence.\"},\n    {\"Sentence\": \"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence provides an example of a protein (NF-E2) that is relevant to the target sentence.\"},\n    {\"Sentence\": \"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence mentions a protein (RXR) that is relevant to the target sentence.\"},\n    {\"Sentence\": \"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence provides an example of a protein (GATA-1) that is relevant to the target sentence.\"},\n    {\"Sentence\": \"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence mentions a protein (Egr-1) that is relevant to the target sentence.\"},\n    {\"Sentence\": \"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\", \"Helpfulness score\": 3, \"Reason\": \"The sentence provides an example of a DNA-binding protein (AP-1) that may be relevant to the target sentence.\"},\n    {\"Sentence\": \"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\", \"Helpfulness score\": 3, \"Reason\": \"The sentence mentions a protein (TCF-1) that may be relevant to the target sentence.\"},\n    {\"Sentence\": \"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\", \"Helpfulness score\": 4, \"Reason\": \"The sentence provides examples of proteins (IL-2, c-Jun, c-Fos) that are relevant to the target sentence.\"},\n    {\"Sentence\": \"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence provides an example of a protein (GATA-1) that is relevant to the target sentence.\"},\n    {\"Sentence\": \"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence provides examples of proteins (EKLF, CBP, p300, P/CAF) that are relevant to the target sentence.\"},\n    {\"Sentence\": \"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence provides examples of proteins (SP1, caspases) and a cell type (B-cell) that are relevant to the target sentence.\"},\n    {\"Sentence\": \"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence provides an example of a protein (GATA-1) that is relevant to the target sentence.\"},\n    {\"Sentence\": \"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\", \"Helpfulness score\": 5, \"Reason\": \"The sentence provides examples of a protein (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) that are relevant to the target sentence.\"},\n    {\"Sentence\": \"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\", \"Helpfulness score\": 4, \"Reason\": \"The sentence provides examples of proteins (p50, p65) and mentions DNA-protein complexes, which are relevant to the target sentence.\"},\n    {\"Sentence\": \"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\", \"Helpfulness score\": 5, \"Reason\": \"The sentence provides examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) that are relevant to the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1799,
        "sentence": "These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .",
        "label": {
            "GAS": "DNA",
            "IFN-gamma-activated sequence": "DNA",
            "STAT proteins": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"IFN-gamma-activated sequence (GAS)\": \"DNA\"}]",
        "prediction": "{'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}"
    },
    {
        "idx": 1703,
        "sentence": "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .",
        "label": {
            "E1A": "protein",
            "IFN": "protein",
            "adenovirus-transformed cells": "cell_line",
            "IFN -activated NK cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5}\n]",
        "response3": "[{\"E1A\": \"protein\"}, {\"IFN\": \"protein\"}, {\"adenovirus-transformed cells\": \"cell_line\"}, {\"NK cells\": \"cell_type\"}]",
        "prediction": "{'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}"
    },
    {
        "idx": 629,
        "sentence": "Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .",
        "label": {
            "progesterone receptor": "protein",
            "CD8+ cells": "cell_line",
            "lymphocytes": "cell_line",
            "progesterone receptor -bearing cells": "cell_line",
            "CD4+ cells": "cell_line"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05.\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells, respectively.\": 4},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5}\n]",
        "response3": "[{\"CD8+\": \"cell_type\"}, {\"progesterone receptor\": \"protein\"}, {\"CD4+\": \"cell_type\"}, {\"lymphocytes\": \"cell_type\"}]",
        "prediction": "{'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}"
    },
    {
        "idx": 490,
        "sentence": "Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .",
        "label": {
            "lymphokine genes": "DNA",
            "interleukin-2": "protein"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents .\": 4},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5}\n]",
        "response3": "[{\"Cyclosporin A\": \"protein\"}, {\"CsA\": \"protein\"}, {\"lymphokine genes\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"interleukin-2\": \"protein\"}]",
        "prediction": "{'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}"
    },
    {
        "idx": 118,
        "sentence": "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .",
        "label": {
            "SCL": "protein",
            "SCL 5' regulatory region": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3},\n    {\"By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4}\n]",
        "response3": "[{\"SCL\": \"RNA\"}]",
        "prediction": "{'SCL': 'RNA'}"
    },
    {
        "idx": 493,
        "sentence": "Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .",
        "label": {
            "NFAT-1 complex": "protein",
            "mitogen-inducible DNA-binding complexes": "protein",
            "kappa B complex": "protein",
            "interleukin-2": "protein",
            "interleukin-2 enhancer": "DNA",
            "HIV enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5}\n]",
        "response3": "[{\"kappa B complex\": \"protein\"}, {\"NFAT-1 complex\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"interleukin-2 enhancer\": \"protein\"}]",
        "prediction": "{'kappa B complex': 'protein', 'NFAT-1 complex': 'protein', 'DNA': 'DNA', 'interleukin-2 enhancer': 'protein'}"
    },
    {
        "idx": 1798,
        "sentence": "In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .",
        "label": {
            "purified human peripheral blood T cells": "cell_type",
            "anti-CD3 Abs": "protein",
            "nuclear STAT proteins": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple protein names and a cell type, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple protein names, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein names and a cell type, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains a protein name and a cell type, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein names, a cell type, and a protein receptor, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains multiple protein names, a cell type, and signaling molecules, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains multiple protein names and a cell type, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains a protein name and a cell type, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains a protein name, which is directly related to one of the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains multiple protein names and signaling molecules, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple protein names and signaling molecules, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains a protein name and a cell type, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains multiple protein names and signaling molecules, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains multiple protein names and a cell type, which are directly related to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"anti-CD3 Abs\": \"protein\"}]",
        "prediction": "{'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}"
    },
    {
        "idx": 175,
        "sentence": "To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.",
        "label": {
            "blood mononuclear cells": "cell_type",
            "uncultured cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains specific examples of cell types and proteins that are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities.\"}\n]",
        "response3": "[{\"bronchoalveolar lavage\": \"cell_line\"}, {\"blood mononuclear cells\": \"cell_type\"}, {\"sarcoidosis\": \"cell_type\"}, {\"tuberculosis\": \"cell_type\"}]",
        "prediction": "{'bronchoalveolar lavage': 'cell_line', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}"
    },
    {
        "idx": 1498,
        "sentence": "Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.",
        "label": {
            "lymphoblasts": "cell_type"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5}\n]",
        "response3": "[{\"DNA\": \"DNA\"}, {\"steroid hormone receptor\": \"protein\"}, {\"lymphoblasts\": \"cell_type\"}]",
        "prediction": "{'DNA': 'DNA', 'steroid hormone receptor': 'protein', 'lymphoblasts': 'cell_type'}"
    },
    {
        "idx": 995,
        "sentence": "The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1671,
        "sentence": "Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .",
        "label": {
            "IL-6 neutralizing antibodies": "protein",
            "IL-6": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 4},\n    {\"Sentence 3\": 4},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 4},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 4},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 141,
        "sentence": "TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .",
        "label": {
            "monocytic cells": "cell_type",
            "TNF-alpha": "protein",
            "HIV LTR": "DNA",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\n        \"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4\n    },\n    {\n        \"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5\n    },\n    {\n        \"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4\n    },\n    {\n        \"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5\n    },\n    {\n        \"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.\": 5\n    },\n    {\n        \"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5\n    },\n    {\n        \"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 4\n    },\n    {\n        \"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 4\n    },\n    {\n        \"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4\n    },\n    {\n        \"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells (NFAT) or AP-1 reporters.\": 4\n    },\n    {\n        \"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5\n    },\n    {\n        \"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.\": 5\n    },\n    {\n        \"Remixing of purified T cells showed that naive T cells do not suppress LAI replication in memory T cells and that memory T cells do not restore LAI expression in naive T cells.\": 5\n    },\n    {\n        \"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 4\n    },\n    {\n        \"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the end result of persistent NF-kappa B activation and viral persistence.\": 5\n    },\n    {\n        \"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.\": 4\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1557,
        "sentence": "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .",
        "label": {
            "Hodgkin's disease -derived, T cell-like, CD30 + cells": "cell_line",
            "nuclear factor (NF)-kappa B": "protein",
            "M44": "protein",
            "L540 cells": "cell_line",
            "M67": "protein",
            "mAb": "protein",
            "agonistic anti- CD30 monoclonal antibodies": "protein",
            "CD30": "protein"
        },
        "response1": "['cell_line', 'protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of NF-kappa B DNA binding activity, which directly matches an entity label in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions RelA and Rel homology family, which are related to NF-kappa B complex, matching the entity label 'protein' in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of proteins and factors involved in signal transduction events, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions NF-kappa B binding activity, which matches the entity label 'protein' in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides examples of proteins and factors related to CD40 expression, matching the entity labels in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions IL-2 receptor alpha subunit, p21ras, and B cell activation, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of proteins and factors involved in immunosuppressive drug action, matching the entity labels in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions NF-kappa B activation, which matches the entity label 'protein' in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of proteins and factors related to B cell differentiation and signaling, matching the entity labels in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions NF-kappaB activation and Tax, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions IkappaBbeta and NF-kappaB, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of proteins and factors related to IFN and interleukin production, matching the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of proteins and factors related to CD40 signaling and NF-kappa B activation, matching the entity labels in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions p50, p65 proteins, and DNA-protein complexes, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of proteins and factors related to CD40 stimulation and NF-kappaB factors, matching the entity labels in the target sentence.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions HIV-1 infection, IFN production, PKR activity, and IkappaBalpha phosphorylation, which are relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'L540 cells': 'cell_line'}, {'Hodgkin\\'s disease': 'cell_type'}, {'T cell-like': 'cell_type'}, {'CD30': 'protein'}, {'NF-kappa B': 'protein'}, {'DNA': 'DNA'}, {'mAb': 'protein'}, {'M44': 'protein'}, {'M67': 'protein'}]",
        "prediction": "{'L540 cells': 'cell_line', \"Hodgkin's disease\": 'cell_type', 'T cell-like': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein', 'DNA': 'DNA', 'mAb': 'protein', 'M44': 'protein', 'M67': 'protein'}"
    },
    {
        "idx": 1090,
        "sentence": "Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.",
        "label": {
            "N terminus": "protein",
            "I kappa B alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1568,
        "sentence": "The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .",
        "label": {
            "enzymes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence, but the context is slightly more complex.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein names that are directly relevant to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a protein name and cell types that are relevant to the entity labels in the target sentence, but the context is slightly more complex.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence, but the context is slightly more complex.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions a DNA binding activity, which is relevant to the entity labels in the target sentence, but the context is more specific to DNA.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence, but the context is slightly more complex.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple protein names and cell line names that are directly relevant to the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains a specific protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions cell adhesion molecules, which are relevant to the entity labels in the target sentence, but the context is more specific to cell types.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains multiple protein names that are directly relevant to the entity labels in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions protein names and cell line names that are relevant to the entity labels in the target sentence, but the context is slightly more complex.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions T lymphocytes and adenovirus vectors, which are relevant to the entity labels in the target sentence, but the context is slightly more complex.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific cell types and protein names that are directly relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'HDL': 'protein'}, {'LDL': 'protein'}]",
        "prediction": "{'HDL': 'protein', 'LDL': 'protein'}"
    },
    {
        "idx": 257,
        "sentence": "Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .",
        "label": {},
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"VD3\": \"protein\"}, {\"chronic myelogenous leukemia\": \"cell_line\"}]",
        "prediction": "{'VD3': 'protein', 'chronic myelogenous leukemia': 'cell_line'}"
    },
    {
        "idx": 262,
        "sentence": "This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .",
        "label": {
            "complementary DNA": "DNA",
            "c-jun proto-oncogene product": "protein",
            "palindromic target sequence": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"cDNAs\": 5},\n{\"SCM-1\": 4},\n{\"IL-2\": 4},\n{\"c-Jun\": 4},\n{\"c-Fos\": 4},\n{\"Runt domain\": 4},\n{\"GM-CSF\": 4},\n{\"Th2-type lymphocytes\": 4},\n{\"SLAP-130\": 5},\n{\"SLP-76\": 4},\n{\"T cell\": 4},\n{\"p21(WAF1/CIP1)\": 4},\n{\"p27(KIP1)\": 4},\n{\"CD95 ligand\": 4},\n{\"Egr-1\": 5},\n{\"protein\": 5},\n{\"ZEBRA\": 5},\n{\"Jun\": 4},\n{\"ATF-2\": 4},\n{\"Protein\": 4},\n{\"CREB\": 5},\n{\"AR-CRE\": 5},\n{\"B and T cell activation\": 4},\n{\"Ramos\": 4},\n{\"Jurkat\": 4},\n{\"cDNA microarray technology\": 5}\n]",
        "response3": "[{\"complementary DNA\": \"DNA\"}, {\"protein\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 1351,
        "sentence": "Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 4},\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n{\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 973,
        "sentence": "To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .",
        "label": {
            "MZF-1": "DNA",
            "DNA binding domain": "protein",
            "yeast transactivator GAL4": "protein",
            "GAL4": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the gene/protein name and its role, making it highly relevant for entity extraction.\"}\n]",
        "response3": "[{\"MZF-1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"GAL4\": \"protein\"}]",
        "prediction": "{'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}"
    },
    {
        "idx": 1125,
        "sentence": "This indicates that the CR of GR may be of functional significance.",
        "label": {
            "GR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"kappa E3'\": 1},\n{\"positive-acting elements\": 1},\n{\"negative-acting elements\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 338,
        "sentence": "Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .",
        "label": {
            "T3R": "protein",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides specific names of proteins (TCRzeta and p56(lck)) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein (PML/RARalpha) that is directly relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a specific cell type (lymphoid neoplasms) that is directly relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides specific names of proteins (IL-2, c-Jun, c-Fos) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a specific protein (retinoic acid receptor alpha) that is directly relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides specific names of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions a specific DNA entity (AP-1) that is indirectly related to the target sentence, providing some help in extracting named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides specific names of cell types (granulocytes, T cells) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides specific names of cell types (T lymphocytes) and proteins (HLA-molecules) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides specific names of proteins (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions a specific protein (RXR) that is directly relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides specific names of proteins (NF-ATc) and cell types (T lymphocytes) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides specific names of proteins (SLAP-130, SLP-76) and a cell type (T cell) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides specific names of proteins (RelA, NF-kappaB1) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions a specific cell type (Th2-type lymphocytes) that is directly relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides specific names of cell types (B and T cell activation, Ramos, Jurkat) and a DNA entity (cDNA microarray technology) that are directly mentioned in the target sentence, making it highly helpful for extracting named entities.\"}\n]\n```",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1080,
        "sentence": "However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides clear and specific entities that match the entity types in the target sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1786,
        "sentence": "Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .",
        "label": {
            "coagulation protease": "protein",
            "tissue factor (TF) receptor": "protein",
            "plasma Factor VII/VIIa": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors .\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1242,
        "sentence": "LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .",
        "label": {
            "NF kappa B": "protein",
            "p50/p65 heterodimers": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 3},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 4},\n    {\"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4}\n]\n```",
        "response3": "```json\n[{\"NF kappa B\": \"protein\"}, {\"p50\": \"protein\"}, {\"p65\": \"protein\"}]\n]\n```",
        "prediction": "{'NF kappa B': 'protein', 'p50': 'protein', 'p65': 'protein'}"
    },
    {
        "idx": 866,
        "sentence": "T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains a clear mention of a specific protein (TCL1) and its association with a specific disease (AIDS), making it highly relevant for identifying protein entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides specific protein names (Syk, Zap) and their association with T cell antigen receptor, aiding in the identification of protein entities and cell types.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a protein (TIMP-1) and its role in cell survival and DNA synthesis, which is helpful for identifying protein entities and DNA.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions specific proteins (IkappaBbeta, tax protein) and their association with NF-kappaB, aiding in the identification of protein entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions specific protein names (IL-2 receptor alpha subunit, p21ras) and their association with B cell activation, aiding in the identification of protein entities and cell types.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides specific protein names (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their roles in cellular responses, aiding in the identification of protein entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions a specific protein (NF-kappa B) and its involvement in cellular activation pathways, aiding in the identification of protein entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions a specific protein (ZAP-70) and its responsiveness to external stimuli, aiding in the identification of protein entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions specific proteins (HIV-1, IFN, PKR, IkappaBalpha) and their roles in cellular processes, aiding in the identification of protein entities and cell types.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions processes related to B and T cell activation, specific cell lines (Ramos, Jurkat), and technology (cDNA microarray), aiding in the identification of cell types and DNA.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions specific DNA sequences (HIV-1 LTR) and proteins (NFAT-1, NF kappa B) involved in gene regulation, aiding in the identification of DNA and protein entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions a specific protein (TR55), a cytokine (TNF-alpha), and their roles in viral activation, aiding in the identification of protein entities and cell types.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions specific cell types (T lymphocytes) and viral vectors (adenovirus), aiding in the identification of cell types and DNA.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions specific T cell types (naive T cells, memory T cells) and a specific protein (LAI) associated with replication, aiding in the identification of cell types and protein entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions specific cell types (CD4+, CD8+) and proteins (TPCK, anti-CD28, PMA) involved in immune responses, aiding in the identification of cell types and protein entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions specific proteins (HIV, p105, p50, MAD3) and their roles in cellular regulation, aiding in the identification of protein entities.\"}\n]",
        "response3": "[{'T cell': 'cell_type'}, {'HIV': 'protein'}]",
        "prediction": "{'T cell': 'cell_type', 'HIV': 'protein'}"
    },
    {
        "idx": 433,
        "sentence": "Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .",
        "label": {
            "regulatory regions": "DNA",
            "BSAP": "protein",
            "high-affinity binding site": "DNA",
            "B-lymphoid-specific genes": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"immunoglobulin\": \"protein\"}, {\"class II major histocompatibility (MHC) genes\": \"DNA\"}, {\"B-lymphoid-specific genes\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'DNA', 'B-lymphoid-specific genes': 'cell_type'}"
    },
    {
        "idx": 1546,
        "sentence": "Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .",
        "label": {
            "platelet glycoprotein Ib alpha gene": "DNA",
            "GATA": "DNA",
            "Ets binding motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides specific names of transcription factors (Sp1 and Ets) that are directly related to the target sentence and their corresponding entity labels (protein), making it highly helpful for extracting named entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example includes specific protein names (EBNA2) and a cell line name (TP1) that are relevant to the target sentence, aiding in the extraction of named entities. The score is slightly lower than 5 due to the presence of a less common cell line entity.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example mentions a protein name (GM-CSF) that is relevant to the target sentence, providing some assistance in extracting named entities. The score is lower as the entity is not as directly related to the main focus of the sentence.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example contains a cell type name (Th2-type lymphocytes) that is mentioned in the target sentence, contributing to the extraction of named entities. The score is slightly lower due to the specificity of the cell type entity.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example includes multiple protein names (Stat3, Stat5, c-Mpl) that are directly related to the target sentence, aiding significantly in the extraction of named entities.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example provides protein names (IkappaBbeta, NF-kappaB) that are relevant to the target sentence, assisting in the extraction of named entities. The score is slightly lower due to the presence of a less common protein entity.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example mentions a protein name (Egr-1) that is directly related to the target sentence, making it highly helpful for extracting named entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example includes protein names (Sp1, CD14) that are specifically mentioned in the target sentence, providing significant assistance in extracting named entities.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example contains a protein name (GATA-1) that is relevant to the target sentence, aiding in the extraction of named entities. The score is slightly lower as the entity is not as directly related to the main focus of the sentence.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The example provides protein names (SLAP-130, SLP-76) and a cell type name (T cell) that are mentioned in the target sentence, contributing to the extraction of named entities. The score is slightly lower due to the presence of a less common cell type entity.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example mentions a protein name (GATA-1) that is directly related to the target sentence, making it highly helpful for extracting named entities.\"\n    },\n    {\n        \"Example 12\": 3\n    },\n    {\n        \"Reason 12\": \"The example includes a DNA motif name (CCAAT box) and a protein name (EKLF) that are relevant to the target sentence, providing some assistance in extracting named entities. The score is lower as the DNA entity is not as directly related to the main focus of the sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example contains protein names (cAMP-dependent protein kinase, Rap1) that are directly related to the target sentence, aiding significantly in the extraction of named entities.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The example provides a protein name (E2A) that is relevant to the target sentence, assisting in the extraction of named entities. The score is slightly lower as the entity is not as directly related to the main focus of the sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example includes a protein name (GATA-1) that is specifically mentioned in the target sentence, providing significant assistance in extracting named entities.\"\n    }\n]",
        "response3": "[{\"GATA\": \"protein\"}, {\"Ets\": \"protein\"}]",
        "prediction": "{'GATA': 'protein', 'Ets': 'protein'}"
    },
    {
        "idx": 1412,
        "sentence": "We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'SCM-1' to the entity label 'cell_line' in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides multiple instances of protein entities ('CREB', 'AR-CRE') that are directly mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides multiple instances of protein entities ('IL-2', 'c-Jun', 'c-Fos') that are directly mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides clear mappings of the entities 'granulocytes' and 'T cells' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides multiple instances of protein entities ('IL-2 receptor alpha subunit', 'p21ras') and a cell type entity ('B cell') that are directly mentioned in the target sentence, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides multiple instances of protein entities ('IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', 'phorbol myristate acetate') that are directly mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides multiple instances of protein entities ('NF-kB', 'AP-1', 'OCT-1', 'NF-IL-2B') that are directly mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear mapping of the entity 'IL-4' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides multiple instances of protein entities ('IL-2', 'IL-2 receptor', 'CD28') and a cell type entity ('T cell') that are directly mentioned in the target sentence, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides multiple instances of protein entities ('AP-1', 'PMA') and cell type entities ('monocytes', 'macrophages') that are directly mentioned in the target sentence, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a clear mapping of the entity 'RXR' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear mapping of the entity 'IL-2' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides multiple instances of protein entities ('IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5') and a cell type entity ('B cells') that are directly mentioned in the target sentence, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides multiple instances of protein entities ('IL-2', 'IFN-gamma', 'jak kinases', 'STAT1(alpha)') that are directly mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides multiple instances of protein entities ('IL-4', 'LPS', 'AP-1') that are directly mentioned in the target sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides clear mappings of the entities 'T cell' and 'interleukin 2' to the entity labels 'cell_type' and 'protein', respectively, in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 411,
        "sentence": "There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 3},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 3},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 2},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 2},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 2},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 2},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 2},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 1}\n]",
        "response3": "[{\"VDR\": \"protein\"}, {\"serum phosphate\": \"protein\"}]",
        "prediction": "{'VDR': 'protein', 'serum phosphate': 'protein'}"
    },
    {
        "idx": 1460,
        "sentence": "In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.",
        "label": {
            "multiple myeloma cell lines": "cell_line",
            "PU.1": "protein",
            "Pu box": "DNA",
            "differentiated, plasma cell-like B cells": "cell_type"
        },
        "response1": "['cell_line', 'DNA', 'protein', 'RNA']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"The examples provide a variety of different entity types (proteins, DNA, cell types, cell lines) that are relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example\": 5},\n    {\"The sentence directly mentions the entity 'PML/RARalpha' which is a protein, providing a clear and specific example for entity extraction.\"},\n    {\"Example\": 4},\n    {\"The sentence mentions the entity 'AP-1' which is a DNA binding activity, relevant to the target sentence but not as directly related as other examples.\"},\n    {\"Example\": 3},\n    {\"The sentence mentions the entity 'GATA-1' which is a protein, relevant to the target sentence but not as directly related as other examples.\"},\n    {\"Example\": 5},\n    {\"The sentence provides examples of different proteins and cell types that are directly relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example\": 4},\n    {\"The sentence mentions the entity 'EBNA-2' which is a protein, relevant to the target sentence but not as directly related as other examples.\"},\n    {\"Example\": 4},\n    {\"The sentence mentions the entity 'Sp1' which is a protein, relevant to the target sentence but not as directly related as other examples.\"},\n    {\"Example\": 5},\n    {\"The sentence provides examples of different proteins and cell lines that are directly relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example\": 5},\n    {\"The sentence provides examples of different entity types (DNA, cell types) that are directly relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example\": 4},\n    {\"The sentence mentions the entity 'MNDA' which is a protein, relevant to the target sentence but not as directly related as other examples.\"},\n    {\"Example\": 5},\n    {\"The sentence provides examples of different entity types (DNA, cell types) that are directly relevant to the target sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{'multiple myeloma cell lines': 'cell_line'}, {'B cells': 'cell_type'}, {'PU.1': 'protein'}, {'DNA': 'DNA'}, {'mRNA': 'RNA'}]",
        "prediction": "{'multiple myeloma cell lines': 'cell_line', 'B cells': 'cell_type', 'PU.1': 'protein', 'DNA': 'DNA', 'mRNA': 'RNA'}"
    },
    {
        "idx": 638,
        "sentence": "Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .",
        "label": {
            "CD3": "protein",
            "TCR": "protein",
            "VLA-5 fibronectin receptor": "protein",
            "fibronectin": "protein",
            "CD4 cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCF-1) and its corresponding entity label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains two examples of proteins (c-kit and IL-4R alpha chain) and their corresponding entity labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of proteins (Syk and Zap) and a cell type (T cell) with their corresponding entity labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of proteins (Stat3, Stat5, and c-Mpl) with their corresponding entity labels.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence contains examples of proteins (CD40 and NF-kappa B) with their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of proteins (IL4, IL13, STAT6, STAT3, STAT5) and a cell type (B cells) with their corresponding entity labels.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains examples of a protein (NF-ATc) and a cell type (T lymphocytes) with their corresponding entity labels.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The sentence provides an example of a cell type (cell adhesion molecules) with its corresponding entity label, but it is less specific compared to other examples.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of proteins (CD70, IL-4, CD40) and cell types (B cells, plasma cells) with their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of proteins (IL-7R, gamma(c)) with their corresponding entity labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of proteins (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) with their corresponding entity labels.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains examples of proteins (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) with their corresponding entity labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of proteins (interleukin 10, IL-10R, STAT3, IL-6) with their corresponding entity labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of proteins (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) with their corresponding entity labels.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence contains an example of a protein (NF-kappa B) with its corresponding entity label.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence provides examples of proteins (ICAM-1, CD71, LMP1, IkappaB) with their corresponding entity labels.\"}\n]",
        "response3": "[{\"VLA-5\": \"protein\"}, {\"CD4 cells\": \"cell_type\"}, {\"CD3\": \"protein\"}, {\"TCR\": \"protein\"}, {\"fibronectin\": \"protein\"}]",
        "prediction": "{'VLA-5': 'protein', 'CD4 cells': 'cell_type', 'CD3': 'protein', 'TCR': 'protein', 'fibronectin': 'protein'}"
    },
    {
        "idx": 1375,
        "sentence": "We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .",
        "label": {
            "PBLs": "cell_type",
            "peripheral blood lymphocytes": "cell_type",
            "TCL1 mRNA": "RNA",
            "protein": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'TCL1' and specifies that it is a protein, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides multiple entities such as 'IL-2', 'c-Jun', and 'c-Fos' with the label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions 'SCM-1' as a gene, which is likely associated with a cell line, making it very helpful for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly links 'AP-1' to 'DNA', providing clear information for entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains entities like 'NF-kappaB', 'Tax', and 'ATL' with their respective labels, aiding in named entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'TAL1' and 'T-ALL' with their corresponding labels, making it highly helpful for entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides 'SCL' and 'GATA-1' as proteins, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'SLAP-130', 'SLP-76', and 'T cell' with their labels, making it very helpful for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly links 'E2A' to 'protein', providing clear information for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' with their labels, aiding in named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides 'TCRzeta' and 'p56(lck)' as proteins, making it highly helpful for entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'granulocytes' and 'T cells' as cell types, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence directly links 'WT1' to 'protein', providing clear information for entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains entities like 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40' with their respective labels, aiding in named entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides 'B and T cell activation', 'Ramos', 'Jurkat', and 'cDNA microarray technology' with their labels, making it very helpful for entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' with their labels, aiding in named entity extraction.\"}\n]",
        "response3": "[{\"TCL1\": \"protein\"}]",
        "prediction": "{'TCL1': 'protein'}"
    },
    {
        "idx": 764,
        "sentence": "The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .",
        "label": {
            "CEM-C7": "cell_line",
            "CEM-C7 cells": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 4},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 3},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 897,
        "sentence": "The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .",
        "label": {
            "transcription of SV40 T-antigen": "protein",
            "NFAT-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NFAT-1\": \"protein\"}, {\"SV40 T-antigen\": \"protein\"}]",
        "prediction": "{'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}"
    },
    {
        "idx": 1842,
        "sentence": "Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .",
        "label": {
            "Ets-1": "protein",
            "TFE-3": "protein",
            "LEF-1": "protein",
            "enhancer-binding proteins": "protein",
            "Sp1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1059,
        "sentence": "Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .",
        "label": {
            "NF-kappa B family": "protein",
            "Transcription factors": "protein",
            "I kappa B beta": "protein",
            "inhibitory I kappa B proteins": "protein",
            "I kappa B alpha": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains multiple entities relevant to the entity labels in the target sentence, such as NF-kappaB, Tax, and ATL, which are correctly identified as protein and cell_type entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence contains entities like NF-ATc and T lymphocytes, which are correctly identified as protein and cell_type entities, respectively.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence contains entities like NF-kappa B and I kappa B alpha, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence contains entities like NF-kappa B and I kappa B beta, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence contains entities like IkappaBalpha and NF-kappaB, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence contains entities like IkappaBbeta and NF-kappaB, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The sentence contains entities like NF-ATc, T lymphocytes, and embryonic cardiac cells, which are correctly identified as protein and cell_type entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence contains entities like NF-kappa B and AP-1, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The sentence contains entities like NF-kappaB and rheumatoid arthritis, which are correctly identified as protein and cell_type entities.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence contains entities like NF-kappaB, Sp1, and p50, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence contains entities like NF-kB, AP-1, OCT-1, and NF-IL-2B, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence contains entities like RelA and NF-kappa B, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence contains entities like PAFR, PAF, NF-kappa B, and protein kinase C, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence contains entities like NF-kappa B and I kappa B alpha, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence contains entities like NF-kappa B, which is correctly identified as a protein entity.\"\n    }\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"I kappa B beta\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}"
    },
    {
        "idx": 924,
        "sentence": "We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .",
        "label": {
            "hsp70": "protein",
            "untransformed steroid receptors": "protein",
            "hsp90": "protein",
            "p56": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 3},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 3},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4}\n]",
        "response3": "[{\"p56\": \"protein\"}, {\"hsp70\": \"protein\"}, {\"hsp90\": \"protein\"}, {\"untransformed steroid receptors\": \"protein\"}]",
        "prediction": "{'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'untransformed steroid receptors': 'protein'}"
    },
    {
        "idx": 247,
        "sentence": "Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .",
        "label": {
            "Antigen B27": "protein",
            "glucocorticoid receptors": "protein",
            "blood lymphocytes": "cell_type",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 4},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\": 3},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 3},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5}\n]",
        "response3": "[{\"Antigen B27\": \"protein\"}, {\"glucocorticoid receptors\": \"protein\"}, {\"blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 507,
        "sentence": "Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .",
        "label": {
            "TCF-2 alpha": "protein",
            "TCR alpha enhancer": "DNA",
            "CREB": "protein",
            "transcription factors": "protein",
            "T alpha 1": "protein",
            "TCR": "protein",
            "TCF-1 alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCF-2 alpha\": \"protein\"}, {\"T alpha 1\": \"protein\"}, {\"CREB\": \"protein\"}, {\"TCR alpha enhancer\": \"DNA\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}"
    },
    {
        "idx": 460,
        "sentence": "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.",
        "label": {
            "HIV LTRs": "DNA",
            "regulatory elements": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus\": 4},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 131,
        "sentence": "Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .",
        "label": {
            "TRs": "protein",
            "carboxyl-terminus": "protein",
            "TR alpha 1": "protein",
            "nuclear proteins": "protein",
            "amino acid 210": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5}\n]",
        "response3": "[{\"TR alpha 1\": \"protein\"}, {\"NE\": \"cell_type\"}, {\"DNA\": \"DNA\"}, {\"TRs\": \"protein\"}]",
        "prediction": "{'TR alpha 1': 'protein', 'NE': 'cell_type', 'DNA': 'DNA', 'TRs': 'protein'}"
    },
    {
        "idx": 692,
        "sentence": "The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .",
        "label": {
            "virally encoded transactivator protein": "protein",
            "Tax -response element": "DNA",
            "TRE": "DNA",
            "human T-cell leukemia virus type I ( HTLV-I ) promoter": "DNA",
            "Tax": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (Egr-1) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein entity (TCF-1) and its corresponding label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a cell line entity (SIVsmmPBj14) and its corresponding label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides clear examples of protein entities (interleukin 10, IL-10R, STAT3, IL-6) and their corresponding labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and their corresponding labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of protein entities (NF-ATc) and cell type entities (T lymphocytes, embryonic cardiac cells) and their corresponding labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of DNA entity (hepatitis B virus) and protein entity (HBxAg) and their corresponding labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a clear example of a protein entity (TCL1) and its corresponding label.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of cell type entity (T cell) and protein entity (interleukin 2) and their corresponding labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of protein entities (NF-kappaB, Sp1) and cell line entity (SIVmac) and their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of protein entities (ATF1, CREB, H4) and their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of DNA entity (HIV-1 LTR) and protein entities (NFAT-1, NF kappa B) and their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of protein entities (tal-1, GATA-binding proteins) and cell type entity (hematopoiesis) and their corresponding labels.\"}\n]",
        "response3": "[{'HTLV-I': 'cell_type'}, {'TRE': 'DNA'}, {'Tax': 'protein'}]",
        "prediction": "{'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}"
    },
    {
        "idx": 43,
        "sentence": "T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .",
        "label": {
            "cysteine-rich antigen segments": "protein",
            "T-helper-cell determinants": "protein",
            "protein antigens": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1204,
        "sentence": "Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mention of the entity label 'cell_line' in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example mentions 'NF-E2' which is a protein, providing a direct reference to the entity label in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example contains multiple entities such as 'HML', 'dexamethasone', 'cortisol', and 'lysozyme' which are directly related to the entity labels in the sentence, aiding in entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example mentions 'phosphocreatine' which is a protein, providing a direct reference to the entity label in the sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example mentions 'lymphoid neoplasms' which is a cell type, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example mentions 'E2A' which is a protein, providing a direct reference to the entity label in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example contains entities 'granulocytes' and 'T cells' which are directly related to the entity labels in the sentence, aiding in entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example mentions 'AP-1' which is related to DNA, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example mentions 'GATA-1' which is a protein, providing a direct reference to the entity label in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example contains entities 'Erbstatin', 'genistein', and 'Egr-1' which are directly related to the entity labels in the sentence, aiding in entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example contains entities 'ATF1', 'CREB', and 'H4' which are directly related to the entity labels in the sentence, aiding in entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example contains entities 'EBV', 'EBNA2', and 'estrogen receptor' which are directly related to the entity labels in the sentence, aiding in entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example contains entities 'MR', 'aldosterone', and 'progesterone' which are directly related to the entity labels in the sentence, aiding in entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example contains entities 'FEV1', 'FVC', 'PEF', and 'prednisolone' which are directly related to the entity labels in the sentence, aiding in entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example contains entities 'IL-2r', 'c-fos', 'IL-2', and 'lymphokine' which are directly related to the entity labels in the sentence, aiding in entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example contains entities 'Type I' and 'Type II' which are directly related to the entity labels in the sentence, aiding in entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1134,
        "sentence": "Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 471,
        "sentence": "The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).",
        "label": {
            "lymphocyte nuclear T3 receptor": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions protein names and a protein complex relevant to the entity label set.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence mentions cell types that are relevant to the entity label set.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple protein names, cytokines, and other relevant entities directly related to the entity label set.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The sentence mentions a specific cell type relevant to the entity label set.\"},\n    {\"Example 6\": 2},\n    {\"Reason 6\": \"The sentence mentions a DNA binding activity, which is indirectly related to the entity label set.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a protein name, transcription factor, and specific cell types relevant to the entity label set.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions a specific protein relevant to the entity label set.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions protein names and their detection in T cells, which are relevant to the entity label set.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions a specific protein relevant to the entity label set.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions protein names and their binding activities, which are relevant to the entity label set.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions protein names relevant to the entity label set.\"},\n    {\"Example 13\": 3},\n    {\"Reason 13\": \"The sentence mentions protein names and their responses, which are indirectly related to the entity label set.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains multiple protein names, cytokines, and cell types directly relevant to the entity label set.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions protein names, a receptor subunit, and a cell type relevant to the entity label set.\"}\n]",
        "response3": "[{'T3 receptor': 'protein'}, {'T3': 'protein'}, {'DNA': 'DNA'}]",
        "prediction": "{'T3 receptor': 'protein', 'T3': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 1205,
        "sentence": "Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The sentence provides an example of a named entity with its corresponding entity label, which is somewhat helpful for extracting named entities from the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides an example of a named entity with its corresponding entity label, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence provides an example of a named entity with its corresponding entity label, which is helpful for extracting named entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 14,
        "sentence": "Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .",
        "label": {
            "c-fos": "DNA",
            "nuclear proto-oncogenes": "DNA",
            "c-jun": "DNA",
            "platelet-activating factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"c-fos\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'c-fos': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 145,
        "sentence": "Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .",
        "label": {
            "nuclear proteins": "protein",
            "major histocompatibility complex (MHC) class II promoters": "DNA",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5}\n]",
        "response3": "[{\"X boxes\": \"protein\"}, {\"Y boxes\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"major histocompatibility complex (MHC) class II promoters\": \"DNA\"}]",
        "prediction": "{'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}"
    },
    {
        "idx": 1449,
        "sentence": "DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.",
        "label": {
            "upstream stimulatory factor": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"A-myb\": 4},\n    {\"Protein\": 4},\n    {\"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"UAS3\": 4, \"UAS2\": 4, \"YY1\": 4},\n    {\"UAS1\": 4, \"B cell\": 4},\n    {\"DNA\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"PU.1\": 5, \"M-CSF receptor\": 4, \"macrophage\": 4},\n    {\"T cell\": 4, \"interleukin 2\": 4},\n    {\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n    {\"RelA\": 5, \"NF-kappaB1\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 4},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"Jun\": 5, \"ATF-2\": 5},\n    {\"p50p50\": 5}\n]",
        "response3": "[{\"DNA\": \"DNA\"}, {\"upstream stimulatory factor\": \"protein\"}]",
        "prediction": "{'DNA': 'DNA', 'upstream stimulatory factor': 'protein'}"
    },
    {
        "idx": 1292,
        "sentence": "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .",
        "label": {
            "thromboxane receptor": "protein",
            "thromboxane receptor gene": "DNA",
            "CAT": "protein",
            "chloramphenicol acetyltransferase": "protein",
            "5' flanking region": "DNA",
            "thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids": "DNA",
            "K562 cells": "cell_line"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains clear mentions of specific cell types expressed by human Th2-type lymphocytes, which directly corresponds to the 'cell_type' entity label.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence provides specific names of proteins such as c-kit and IL-4R alpha chain, which align with the 'protein' entity label.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence mentions the protein GATA-1 in the context of differentiating erythroid cells, which corresponds to the 'protein' entity label.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence includes specific proteins like Stat3, Stat5, and c-Mpl, indicating their involvement in signal transduction and megakaryopoiesis/thrombopoiesis, aligning with the 'protein' entity label.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence mentions the protein TCF-1 transactivating through its cognate motif in non-T cells, which corresponds to the 'protein' entity label.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence provides clear mentions of proteins such as PAFR, PAF, NF-kappa B, and protein kinase C, indicating their roles in gene expression regulation, aligning with the 'protein' entity label.\"},\n{\"Example 7\": 4},\n{\"Reason 7\": \"The sentence mentions the proteins Sp1 and CD14 in the context of tissue-specific promoter activity and transactivation experiments, aligning with the 'protein' entity label.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence discusses the protein E2A at the protein level using polyclonal antisera, aligning with the 'protein' entity label.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence provides specific proteins like IFN A, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, indicating their expression levels and abilities upon stimulation, aligning with the 'protein' entity label.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The sentence mentions the CD95 ligand promoter in the context of a luciferase reporter construct, aligning with the 'protein' entity label.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence discusses the regulatory mechanism of the SCM-1 genes, indicating a specific cell line, aligning with the 'cell_line' entity label.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence provides information about gene expression in relation to B and T cell activation, Ramos cells, Jurkat cells, and cDNA microarray technology, aligning with the 'cell_type' and 'cell_line' entity labels.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions Ter 119 erythroid cells, beta-globin, glycoprotein IIb, and platelet factor 4 megakaryocytic transcripts, aligning with the 'cell_line' and 'protein' entity labels.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"The sentence discusses the BAT box element and CD20 promoter in B cells, aligning with the 'DNA' and 'protein' entity labels.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence provides specific entities like IL-2, NFAT, NFAT delta418, calcineurin, and Tpl-2 in the context of promoter activation and pathways, aligning with the 'DNA' and 'protein' entity labels.\"}\n]",
        "response3": "[{\"thromboxane receptor gene\": \"DNA\"}, {\"thromboxane receptor gene promoter\": \"DNA\"}, {\"chloramphenicol acetyltransferase (CAT)\": \"protein\"}, {\"K562 cells\": \"cell_line\"}]",
        "prediction": "{'thromboxane receptor gene': 'DNA', 'thromboxane receptor gene promoter': 'DNA', 'chloramphenicol acetyltransferase (CAT)': 'protein', 'K562 cells': 'cell_line'}"
    },
    {
        "idx": 120,
        "sentence": "Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.",
        "label": {
            "RPMI 8402": "cell_line",
            "T cell lines": "cell_line",
            "CEM": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5}\n]",
        "response3": "[{\"CEM\": \"cell_line\"}, {\"RPMI 8402\": \"cell_line\"}]",
        "prediction": "{'CEM': 'cell_line', 'RPMI 8402': 'cell_line'}"
    },
    {
        "idx": 468,
        "sentence": "A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 4},\n    {\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 4},\n    {\"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.\": 5},\n    {\"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 138,
        "sentence": "The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .",
        "label": {
            "beta interferon promoter": "DNA",
            "regulatory elements": "DNA",
            "HIV long terminal repeat": "DNA",
            "TNF-alpha": "protein",
            "LTR": "DNA",
            "reporter chloramphenicol acetyltransferase plasmids": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Reasons\": \"The examples provided contain specific entities that match the entity labels in the target sentence, making them highly relevant and helpful for extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 64,
        "sentence": "Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .",
        "label": {
            "IFN beta promoter deletions": "DNA"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 3},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 4},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter.\": 4},\n    {\"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.\": 5},\n    {\"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\": 4}\n]",
        "response3": "[{\"HeLa\": \"cell_line\"}, {\"Sendai virus\": \"cell_type\"}, {\"IFN beta\": \"protein\"}]",
        "prediction": "{'HeLa': 'cell_line', 'Sendai virus': 'cell_type', 'IFN beta': 'protein'}"
    },
    {
        "idx": 1760,
        "sentence": "This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct association between the entity 'NF-E2' and the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence directly links 'P selectin' to the entity type 'protein', aiding in the extraction of named entities, but the association is not as explicit as in Example 1.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple clear associations between entities and their corresponding types, providing valuable information for named entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence provides associations between 'TIMP-1' and 'protein', as well as 'DNA' and 'DNA', which are helpful for named entity extraction, but the context is slightly more complex compared to other examples.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence offers clear associations between various entities and their types, aiding in the extraction of named entities from the text.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence directly links 'G-CSF' to the entity type 'protein', which is helpful for named entity extraction, but the context is relatively straightforward compared to other examples.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear associations between entities like 'IL-2', 'NF-kappa B', and 'AP-1' with their corresponding types, facilitating the extraction of named entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains associations between 'IL-2', 'Aiolos', and 'Ras' with their types, aiding in named entity extraction, but the context is slightly more complex compared to other examples.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence directly associates 'cell adhesion molecules' with the entity type 'cell_type', which is helpful for named entity extraction, but the context is relatively straightforward compared to other examples.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence offers clear associations between entities like 'Azeptin' and 'NF-kappa B' with their corresponding types, aiding in the extraction of named entities from the text.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides multiple direct associations between entities like 'interleukin-2', 'CD25', and 'IL-2 receptor' with their types, making it highly helpful for named entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains associations between 'Erbstatin', 'genistein', and 'Egr-1' with their types, aiding in named entity extraction, but the context is slightly more complex compared to other examples.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence provides associations between 'cDNA', 'Jurkat', and 'DRE 1' with their types, which are helpful for named entity extraction, but the context is relatively straightforward compared to other examples.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence offers clear associations between entities like 'IL-2', 'NFAT', 'NFAT delta418', 'calcineurin', and 'Tpl-2' with their corresponding types, facilitating the extraction of named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a direct association between 'NF-kappa B' and 'protein', as well as 'neutrophils' and 'cell_type', making it highly helpful for extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 676,
        "sentence": "The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein",
            "interleukin 2 ( IL-2 ) gene promoter": "DNA",
            "T-cell": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'interleukin 2': 'protein', 'T-cell': 'cell_type'}"
    },
    {
        "idx": 1052,
        "sentence": "Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.",
        "label": {
            "IL-2R alpha": "protein",
            "SEA": "protein",
            "IL-2R gamma": "protein",
            "SEB": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"IL-2R alpha\": \"protein\"}]",
        "prediction": "{'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}"
    },
    {
        "idx": 487,
        "sentence": "Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.",
        "label": {
            "human monocytes": "cell_type",
            "normal human monocytes": "cell_type",
            "M-CSF": "protein",
            "immediate early response genes": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and cell types that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence includes gene names and cytokines that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions T cells, IL-2, and CD28, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of cell lines and specific mutants that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence includes gene names and cytokines that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions EBV and CD2, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions G-CSF, which is relevant to the entity labels in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence includes a specific gene name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of cell lines and specific gene names that are directly related to the entity labels in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence includes gene names and cytokines that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions GM-CSF, which is relevant to the entity labels in the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence includes cytokines and gene names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 13\": 2},\n    {\"Reason 13\": \"The sentence mentions monocytes, which is relevant to the entity labels in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence includes gene names and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 15\": 3},\n    {\"Reason 15\": \"The sentence mentions CD14, which is relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"M-CSF\": \"protein\"}, {\"monocytes\": \"cell_type\"}]",
        "prediction": "{'M-CSF': 'protein', 'monocytes': 'cell_type'}"
    },
    {
        "idx": 570,
        "sentence": "Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 3},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 3},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 3},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1370,
        "sentence": "Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .",
        "label": {
            "CD28": "protein",
            "anti- CD28 MoAb": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 994,
        "sentence": "The role of BSAP ( Pax-5 ) in B-cell development .",
        "label": {
            "BSAP": "protein",
            "Pax-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 3},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 4},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"IL-13, a cytokine similar to IL-4, is a regulator of human B cell and monocyte functions.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 438,
        "sentence": "This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).",
        "label": {
            "OTF factors": "protein",
            "nuclear proteins": "protein",
            "sequence motif": "DNA",
            "octamer transcription factors": "protein",
            "Oct": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 270,
        "sentence": "There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .",
        "label": {},
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1481,
        "sentence": "We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1807,
        "sentence": "We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .",
        "label": {
            "cell genes": "DNA",
            "cyclin E": "DNA",
            "cyclin D2": "DNA",
            "CD23": "DNA",
            "cdc-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n{\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n{\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n{\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n{\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5}\n]",
        "response3": "[{\"cdc-2\": \"protein\"}, {\"cyclin E\": \"protein\"}, {\"CD23\": \"protein\"}, {\"cyclin D2\": \"protein\"}, {\"EBV\": \"cell_line\"}]",
        "prediction": "{'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}"
    },
    {
        "idx": 1169,
        "sentence": "However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .",
        "label": {
            "SPXX motifs": "protein",
            "nuclear targeting sequence": "protein",
            "gene regulatory proteins": "protein",
            "B4-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 4}\n]\n```",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1180,
        "sentence": "We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .",
        "label": {
            "IL-2R": "protein",
            "IL-2": "protein",
            "IL-2R gamma": "protein",
            "JAK3": "protein",
            "IL-2 receptor": "protein",
            "JAK1": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3, and STAT5 proteins in normal human B cells.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5}\n]",
        "response3": "[{\"IL-2 receptor\": \"protein\"}, {\"JAK1\": \"protein\"}, {\"JAK3\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}]",
        "prediction": "{'IL-2 receptor': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}"
    },
    {
        "idx": 968,
        "sentence": "These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.",
        "label": {
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 5},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 4},\n    {\"Sentence 5\": 4},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 4},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[{}]",
        "prediction": "{}"
    },
    {
        "idx": 497,
        "sentence": "The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .",
        "label": {
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Example 15\": 4\n    }\n]",
        "response3": "[{\"T cells\": \"cell_type\"}, {\"proteins\": \"protein\"}]",
        "prediction": "{'T cells': 'cell_type', 'proteins': 'protein'}"
    },
    {
        "idx": 1606,
        "sentence": "Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .",
        "label": {
            "CD11b/CD18": "protein",
            "CD35": "protein",
            "p50/p65": "protein",
            "CR1": "protein",
            "HIV-infected monocytic cells": "cell_type",
            "complement receptors": "protein",
            "human monocytes": "cell_type",
            "NF-kappa B": "protein",
            "CR3": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5}\n]\n```",
        "response3": "```json\n[{\"CR1\": \"protein\"}, {\"CD35\": \"protein\"}, {\"CR3\": \"protein\"}, {\"CD11b/CD18\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"p50/p65\": \"protein\"}, {\"monocytes\": \"cell_type\"}, {\"HIV-infected monocytic cells\": \"cell_type\"}]\n```",
        "prediction": "{'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}"
    },
    {
        "idx": 1653,
        "sentence": "Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .",
        "label": {
            "nonmyeloid cells": "cell_type",
            "GM-CSF": "protein",
            "PU.1": "protein",
            "GM-CSF receptor alpha promoter": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 833,
        "sentence": "Mapping of B-cell epitopes of the human hepatitis B virus X protein .",
        "label": {
            "human hepatitis B virus X protein": "protein",
            "B-cell epitopes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence contains the term 'cDNAs' which is likely to refer to DNA, making it highly relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple terms such as 'SP1', 'caspases', and 'B-cell' which are likely to refer to protein and cell_type entities, making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains the term 'Th2-type lymphocytes' which is likely to refer to cell_type, making it highly relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains the term 'E2A' which is likely to refer to protein, making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains terms like 'SLAP-130', 'SLP-76', and 'T cell' which are likely to refer to protein and cell_type entities, making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains the term 'TCF-1' which is likely to refer to protein, making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains terms like 'T lymphocytes' and 'HLA-molecules' which are likely to refer to cell_type and protein entities, making it highly relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains terms like 'IkappaBbeta' and 'NF-kappaB' which are likely to refer to protein entities, making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains the term 'GM-CSF' which is likely to refer to protein, making it highly relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains the term 'immunoglobulin kappa 3' enhancer' which is likely to refer to DNA, making it highly relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains terms like 'EBNA-2' and 'PU.1' which are likely to refer to protein entities, making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains terms like 'hepatitis B virus' and 'HBxAg' which are likely to refer to DNA and protein entities, making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains the term 'SIVsmmPBj14' which is likely to refer to cell_line, making it highly relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains terms like 'EBV' and 'B-cell' which are likely to refer to cell_type entities, making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains terms like 'p50', 'p65', 'DNA', and 'protein' which are likely to refer to protein and DNA entities, making it very helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"B-cell\": \"cell_type\"}, {\"hepatitis B virus X protein\": \"protein\"}]",
        "prediction": "{'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}"
    },
    {
        "idx": 389,
        "sentence": "The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .",
        "label": {
            "periplasmic domain": "protein",
            "PhoQ protein": "protein",
            "cationic proteins": "protein",
            "defensin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction\": 4},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction\": 5}\n]",
        "response3": "[{\"PhoQ\": \"protein\"}]",
        "prediction": "{'PhoQ': 'protein'}"
    },
    {
        "idx": 193,
        "sentence": "The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"2\": \"The sentence contains entity types not present in the target sentence.\"},\n    {\"3\": \"The sentence contains some entity types present in the target sentence, but not all.\"},\n    {\"4\": \"The sentence contains most entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains all entity types present in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1349,
        "sentence": "Its expression was always restricted to the nucleus .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example provides specific protein names that are mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides specific protein names that are mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example provides specific protein names that are mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides specific protein names that are mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example provides specific protein names that are mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The example provides a cell type and a protein name, aiding in the extraction of these entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example provides a specific protein name that is mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example provides specific protein names that are mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example provides specific protein names that are mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a specific cell line name mentioned in the sentence, aiding in the extraction of cell line entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example provides specific RNA, cell type, and protein names mentioned in the sentence, aiding in the extraction of these entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example provides a specific protein name mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example provides a specific DNA name mentioned in the sentence, aiding in the extraction of DNA entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example provides a specific protein name mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example provides specific protein and cell type names mentioned in the sentence, aiding in the extraction of these entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 882,
        "sentence": "This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .",
        "label": {
            "c-Jun": "protein",
            "heterodimeric activator protein-1 transcription complex": "protein",
            "c-Fos": "protein",
            "cDNA": "DNA",
            "human c-Jun protein": "protein",
            "cDNA clone": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Example 15\": 5\n    }\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"c-Jun\": \"protein\"}, {\"c-Fos\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein'}"
    },
    {
        "idx": 725,
        "sentence": "Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .",
        "label": {
            "Rex": "protein",
            "HTLV-infected cells": "cell_type",
            "gag/pol": "protein",
            "env mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'TCF-1' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear and direct mapping between the entity 'TCL1' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear and direct mapping between the entity 'PML/RARalpha' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping between the entities 'hepatitis B virus' and 'HBxAg' with their corresponding labels 'DNA' and 'protein' in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear and direct mapping between the entity 'SIVsmmPBj14' and its corresponding label 'cell_line' in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a clear and direct mapping between the entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' with their corresponding labels 'protein' in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear and direct mapping between the entities 'TIMP-1' and 'DNA' with their corresponding labels 'protein' and 'DNA' in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear and direct mapping between the entity 'Egr-1' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear and direct mapping between the entities 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' with their corresponding labels 'cell_type' and 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear and direct mapping between the entities 'HIV-1 LTR', 'NFAT-1', and 'NF kappa B' with their corresponding labels 'DNA' and 'protein' in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a clear and direct mapping between the entities 'cDNA', 'Jurkat', and 'DRE 1' with their corresponding labels 'DNA', 'cell_line', and 'cell_type' in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear and direct mapping between the entities 'TR55', 'TNF-alpha', and 'HIV' with their corresponding labels 'protein' and 'cell_type' in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear and direct mapping between the entities 'TCL1' and 'MTCP1/c6.1B' with their corresponding labels 'protein' in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a clear and direct mapping between the entities 'T lymphocytes' and 'adenovirus vectors' with their corresponding labels 'cell_type' and 'DNA' in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a clear and direct mapping between the entities 'Rel-A', 'T cells', and 'IL-2' with their corresponding labels 'protein' and 'cell_type' in the sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides a clear and direct mapping between the entities 'XP-B', 'XP-D', and 'adenovirus' with their corresponding labels 'cell_line' and 'DNA' in the sentence.\"}\n]",
        "response3": "[{'gag/pol': 'protein'}, {'env mRNA': 'RNA'}, {'HTLV-infected cells': 'cell_type'}]",
        "prediction": "{'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}"
    },
    {
        "idx": 867,
        "sentence": "In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).",
        "label": {
            "conserved binding sites": "DNA",
            "nuclear factor kappa B": "protein",
            "long terminal repeat": "DNA",
            "LTR": "DNA",
            "NF kappa B": "protein",
            "transcriptional enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 3},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 4},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter .\": 4},\n    {\"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region .\": 4}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"long terminal repeat ( LTR )\": \"DNA\"}, {\"nuclear factor kappa B ( NF kappa B )\": \"protein\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'long terminal repeat ( LTR )': 'DNA', 'nuclear factor kappa B ( NF kappa B )': 'protein'}"
    },
    {
        "idx": 841,
        "sentence": "Such tests may become useful diagnostic tools .",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names (myeloperoxidase, lysozyme, PU.1) which are directly mentioned in the sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions PBMC (peripheral blood mononuclear cells) and adenovirus, which are indicative of cell type and DNA entities respectively, although the context is slightly more complex.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence mentions PBMC (peripheral blood mononuclear cells) and adenovirus DNA, which are indicative of cell type and DNA entities respectively.\"},\n{\"Example 4\": 3},\n{\"Reason 4\": \"The sentence mentions IFN-gamma, which is a protein, but the context is slightly more complex and may require additional information for accurate extraction.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence directly mentions lymphoid neoplasms, which is a specific cell type entity.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence directly mentions STAT1, which is a specific protein entity.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence directly mentions Ras, which is a specific protein entity.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence mentions immunohistochemistry, gene, and cell type, providing clear indications of protein, DNA, and cell type entities.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions NF-kappa B, which is a specific protein entity.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence directly mentions SCM-1, which is a specific cell line entity.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence directly mentions SIVsmmPBj14, which is a specific cell line entity.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions nonhuman primates, indicating a cell type entity, but the context is slightly more complex.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions T-PLL, which is a specific cell type entity.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions E2A, which is a specific protein entity.\"},\n{\"Example 15\": 4},\n{\"Reason 15\": \"The sentence mentions AP-1 and DNA, indicating DNA entities, but the context is slightly more complex.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions B and T cell activation, Ramos, Jurkat, and cDNA microarray technology, providing clear indications of cell type, cell line, and DNA entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 956,
        "sentence": "BSAP : a key regulator of B-cell development and differentiation .",
        "label": {
            "BSAP": "protein",
            "B-cell": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence directly mentions the entity 'NF-E2' and its association with a protein, providing clear context for entity extraction.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence mentions 'EBV' and 'B-cell' as cell types, which can aid in identifying cell types in similar contexts.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence provides multiple protein and cell type entities in the context of differentiation and signaling, aiding in entity extraction.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type, providing valuable information for cell type extraction.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence directly associates 'GATA-1' with protein and 'erythroid' with cell type, aiding in accurate entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence provides protein entities 'Syk' and 'Zap' along with the cell type 'T cell', aiding in entity extraction in a signaling context.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The sentence mentions 'Th1' and 'Th2' as cell types, providing valuable information for cell type extraction in immune response contexts.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence directly associates 'T cell' with cell type and 'interleukin 2' with protein, aiding in accurate entity extraction in a regulatory context.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The sentence mentions 'IL-2' as a protein, providing valuable information for protein entity extraction in signaling pathways.\"\n    },\n    {\n        \"Example 10\": 3\n    },\n    {\n        \"Reason 10\": \"The sentence mentions 'AP-1' in the context of DNA binding activity, which may provide some context for entity extraction but is less direct.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The sentence mentions 'IL-2' as a protein, 'c-Jun', and 'c-Fos', aiding in protein entity extraction in a regulatory context.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence provides DNA entities 'UAS3' and 'UAS2' along with the protein 'YY1', aiding in entity extraction in a regulatory context.\"\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Reason 13\": \"The sentence mentions 'SCL' and 'GATA-1' as proteins, aiding in protein entity extraction in cell lineage contexts.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence provides protein entities 'IL-2', 'NF-kappa B', and 'AP-1', aiding in protein entity extraction in immunosuppressive contexts.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence provides protein entities 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and cell type 'B cells', aiding in protein and cell type entity extraction in immune response contexts.\"\n    },\n    {\n        \"Example 16\": 4\n    },\n    {\n        \"Reason 16\": \"The sentence mentions 'STAT1' as a protein, aiding in protein entity extraction in the context of immunosuppressive and antineoplastic agents.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1769,
        "sentence": "We have tried to find out whether these receptors could show any difference in sex or age distribution.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"AP-1\": 5},\n    {\"PMA\": 1},\n    {\"monocytes\": 5},\n    {\"macrophages\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"EKLF\": 5},\n    {\"cDNAs\": 5},\n    {\"BRCA1\": 5},\n    {\"retinoic acid receptor alpha\": 5},\n    {\"nonhuman primates\": 5},\n    {\"SCM-1\": 5},\n    {\"NF-kappa B\": 5},\n    {\"CREB\": 5},\n    {\"AR-CRE\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"E2A\": 5},\n    {\"VDR\": 5},\n    {\"RXR\": 5},\n    {\"GRIP-1\": 5},\n    {\"DRIP205\": 5},\n    {\"DRIP\": 1},\n    {\"B and T cell activation\": 5},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 5},\n    {\"CD40\": 5},\n    {\"Rel/nuclear factor kappaB\": 5},\n    {\"NF-kappaB\": 5},\n    {\"B lymphocytes\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 110,
        "sentence": "Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .",
        "label": {
            "long terminal repeat": "DNA",
            "NF-KB": "protein",
            "double repeat-KB enhancer sequence": "DNA",
            "cellular transactivation factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NF-KB\": \"protein\"}]",
        "prediction": "{'NF-KB': 'protein'}"
    },
    {
        "idx": 1379,
        "sentence": "Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .",
        "label": {
            "TCL1": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1338,
        "sentence": "The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .",
        "label": {
            "Bcl-2 family": "protein",
            "cellular proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions specific proteins and DNA, which are relevant for extracting named entities, but the context is slightly more complex compared to Example 1.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions a specific protein name that is directly relevant for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names and a cell type that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The sentence mentions cell adhesion molecules, which are relevant for extracting named entities, but the context is less specific compared to other examples.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a specific protein name that is directly relevant for extracting named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names and cell types that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions a specific protein name that is relevant for extracting named entities, but the context is less specific compared to other examples.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions specific proteins and cell lines, which are relevant for extracting named entities, but the context is slightly more complex compared to Example 1.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions specific protein names and a cell type that are relevant for extracting named entities, but the context is slightly more complex compared to Example 1.\"},\n    {\"Example 15\": 3},\n    {\"Reason 15\": \"The sentence mentions a specific protein name that is relevant for extracting named entities, but the context is less specific compared to other examples.\"}\n]",
        "response3": "[{\"Bcl-2\": \"protein\"}]",
        "prediction": "{'Bcl-2': 'protein'}"
    },
    {
        "idx": 1323,
        "sentence": "PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .",
        "label": {
            "PRE-I": "DNA",
            "Jurkat cells": "cell_line",
            "multiple DNA-protein complexes": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a clear mapping between the entity 'AP-1' and the entity type 'DNA', directly relevant to the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example provides multiple mappings between various entities and the entity type 'protein', which is highly relevant to the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example directly links the entity 'E2A' to the entity type 'protein', which is crucial for understanding the sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example provides mappings between entities like 'IL-2', 'c-Jun', and 'c-Fos' to the entity type 'protein', which is essential for interpreting the sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example clearly associates entities 'EBNA-2' and 'PU.1' with the entity type 'protein', aiding in understanding the sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example maps entities 'p21(WAF1/CIP1)' and 'p27(KIP1)' to the entity type 'protein', which is crucial for comprehending the sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example provides mappings between entities like 'EKLF', 'CBP', 'p300', and 'P/CAF' to the entity type 'protein', aiding in understanding the sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly links the entity 'NF-kappa B' to the entity type 'DNA', which is essential for interpreting the sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example provides mappings between entities 'Jun' and 'ATF-2' to the entity type 'protein', which is crucial for comprehending the sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example directly links entities 'IkappaBbeta' and 'NF-kappaB' to the entity type 'protein', aiding in understanding the sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example provides mappings between entities like 'p50', 'p65', 'DNA', and 'protein' to their respective entity types, which is crucial for interpreting the sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example maps entities 'Tip', 'Tap', and 'Jurkat-T cells' to the entity types 'protein' and 'cell_line', aiding in understanding the sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example provides mappings between entities like 'HIV-1 LTR', 'NFAT-1', and 'NF kappa B' to their respective entity types, which is crucial for interpreting the sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example directly links entities 'cDNA', 'Jurkat', and 'DRE 1' to the entity types 'DNA' and 'cell_line', aiding in understanding the sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example maps entities 'tal-1', 'GATA-binding proteins', and 'hematopoiesis' to the entity types 'protein' and 'cell_type', which is crucial for comprehending the sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The example provides mappings between entities 'NF-E1' and 'YY-1' to the entity type 'protein', aiding in understanding the sentence.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1309,
        "sentence": "Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .",
        "label": {
            "cruciform DNA": "DNA",
            "HMG boxes": "protein",
            "cross-over DNA": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n{\"p50p50\": 4},\n{\"p21(WAF1/CIP1)\": 4},\n{\"p27(KIP1)\": 4},\n{\"GATA-1\": 5},\n{\"NF-ATc\": 5},\n{\"T lymphocytes\": 4},\n{\"Protein\": 3},\n{\"GM-CSF\": 4},\n{\"cDNAs\": 3},\n{\"IgH\": 4},\n{\"IL-2\": 4},\n{\"c-Jun\": 4},\n{\"c-Fos\": 4},\n{\"Stat proteins\": 5},\n{\"immunohistochemistry\": 3},\n{\"gene\": 3},\n{\"cell type\": 4},\n{\"Th2-type lymphocytes\": 4},\n{\"GM-kappa B\": 4},\n{\"GC-box\": 4},\n{\"GC-motif\": 4},\n{\"GM-kappa B motif\": 4},\n{\"p50\": 4},\n{\"p65\": 4},\n{\"HIV-1 LTR\": 4},\n{\"NFAT-1\": 5},\n{\"NF kappa B\": 5},\n{\"NF-kappaB\": 5},\n{\"Sp1\": 4},\n{\"SIVmac\": 4}\n]",
        "response3": "[{\"HMG boxes\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'HMG boxes': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 228,
        "sentence": "We have carried out experiments to define the nature of the higher affinity CVZ binding site .",
        "label": {
            "higher affinity CVZ binding site": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"cDNAs\": 5, \"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n{\"G-CSF\": 5},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"CD95 ligand\": 5},\n{\"DNA\": 5},\n{\"SCM-1\": 5},\n{\"cell adhesion molecules\": 5},\n{\"E2A\": 5},\n{\"NF-kappa B\": 5},\n{\"BRCA1\": 5},\n{\"TCF-1\": 5},\n{\"retinoic acid receptor alpha\": 5},\n{\"CREB\": 5, \"AR-CRE\": 5},\n{\"SIVsmmPBj14\": 5},\n{\"protein\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 51,
        "sentence": "Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.",
        "label": {
            "T-cell determinants": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals, and growth factors.\": 4},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1518,
        "sentence": "Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .",
        "label": {
            "nuclear calcium/calmodulin-dependent protein kinase II": "protein",
            "human B lymphocytes": "cell_type",
            "Anti-immunoglobulin M": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\"IL-13\": 5},\n    {\"IL-4\": 5},\n    {\"B cell\": 5},\n    {\"monocyte\": 5},\n    {\"cAMP-dependent protein kinase\": 5},\n    {\"Rap1\": 5},\n    {\"IL-2\": 5},\n    {\"NF-kappa B\": 5},\n    {\"AP-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"B cell\": 5},\n    {\"Syk\": 5},\n    {\"Zap\": 5},\n    {\"T cell\": 5},\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"NF-kappa B\": 5},\n    {\"IL-2\": 5},\n    {\"Aiolos\": 5},\n    {\"Ras\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 5},\n    {\"ATL\": 5},\n    {\"T lymphocytes\": 5},\n    {\"SP1\": 5},\n    {\"caspases\": 5},\n    {\"B-cell\": 5},\n    {\"CD70\": 5},\n    {\"B cell\": 5},\n    {\"plasma cells\": 5},\n    {\"IL-4\": 5},\n    {\"CD40\": 5},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"gamma c chain\": 5},\n    {\"STAT6\": 5},\n    {\"STAT3\": 5},\n    {\"STAT5\": 5},\n    {\"B cells\": 5},\n    {\"NF-kappa B\": 5},\n    {\"I kappa B alpha\": 5},\n    {\"P selectin\": 5}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 563,
        "sentence": "The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .",
        "label": {
            "PDGF(B)": "protein",
            "PDGF(B) mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence clearly mentions 'DNA binding activity', providing a direct and unambiguous reference to the entity type 'DNA'.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 501,
        "sentence": "Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .",
        "label": {
            "CCRF-CEM": "cell_line",
            "TCF-1 alpha": "protein",
            "nonlymphoid (HeLa) cell lines": "cell_line",
            "mature B cells": "cell_line",
            "JY": "cell_line",
            "Namalwa": "cell_line",
            "57- to 53-kD proteins": "protein",
            "Jurkat": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"57- to 53-kD proteins\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"CCRF-CEM\": \"cell_line\"}, {\"JY\": \"cell_line\"}, {\"Namalwa\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}"
    },
    {
        "idx": 457,
        "sentence": "TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .",
        "label": {
            "T lymphocytes": "cell_type",
            "TAR": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n    {\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 285,
        "sentence": "ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .",
        "label": {
            "ER": "protein",
            "lymphocyte DNA": "DNA",
            "lymphocytes": "cell_type",
            "lymphocyte cytosolic protein": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5}\n]",
        "response3": "[{\"lymphocyte cytosolic protein\": \"protein\"}, {\"lymphocyte DNA\": \"DNA\"}]",
        "prediction": "{'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}"
    },
    {
        "idx": 1508,
        "sentence": "Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "B cell-specific coactivator": "protein",
            "murine homolog": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example provides a specific gene name (SCM-1) and its corresponding entity label (cell_line), which directly aids in identifying named entities related to cell lines in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides specific gene names (UAS1, B cell) and their corresponding entity labels (cell_line, cell_type), which directly aids in identifying named entities related to cell lines and cell types in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example provides a specific gene name (GATA-1) and its corresponding entity label (protein), which directly aids in identifying named entities related to proteins in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides a specific gene name (TCF-1) and its corresponding entity label (protein), which directly aids in identifying named entities related to proteins in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example provides a specific gene name (E2A) and its corresponding entity label (protein), which directly aids in identifying named entities related to proteins in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides specific gene names (IL-2, c-Jun, c-Fos) and their corresponding entity labels (protein), which directly aids in identifying named entities related to proteins in the target sentence. Additionally, it highlights the presence of nuclear factors in resting PBL.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example provides a specific gene name (GM-CSF) and its corresponding entity label (protein), which directly aids in identifying named entities related to proteins in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides specific gene names (T cell, interleukin 2) and their corresponding entity labels (cell_type, protein), which directly aids in identifying named entities related to cell types and proteins in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides specific gene names (CD40, NF-kappa B) and their corresponding entity labels (protein), which directly aids in identifying named entities related to proteins in the target sentence. It also highlights the role of transcription factors in NF-kappa B activation.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides specific gene names (SLAP-130, SLP-76, T cell) and their corresponding entity labels (protein, protein, cell_type), which directly aids in identifying named entities related to proteins and cell types in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example provides a specific gene name (GATA-1) and its corresponding entity label (protein), which directly aids in identifying named entities related to proteins in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides specific gene names (Sp1, Ets) and their corresponding entity labels (protein), which directly aids in identifying named entities related to proteins in the target sentence. It also highlights the role of transcription factors in maintaining gene expression.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example provides a specific gene name (NF-kappa B) and its corresponding entity label (DNA), which directly aids in identifying named entities related to DNA in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides specific gene names (CD70, B cell, plasma cells, IL-4, CD40) and their corresponding entity labels (protein, cell_type, cell_type, protein, protein), which directly aids in identifying named entities related to proteins, cell types, and cytokines in the target sentence. It also highlights the promotion of differentiation into plasma cells.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides specific gene names (IL-7R, gamma(c)) and their corresponding entity labels (protein, protein), which directly aids in identifying named entities related to proteins in the target sentence. It also demonstrates the critical role of gamma(c) in IL-7R function.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides specific gene names (Jun, ATF-2) and their corresponding entity labels (protein, protein), which directly aids in identifying named entities related to proteins in the target sentence. It also highlights the essential role of Jun in activation-induced transcription.\"},\n]",
        "response3": "[{\"BOB.1/OBF.1\": \"protein\"}]",
        "prediction": "{'BOB.1/OBF.1': 'protein'}"
    },
    {
        "idx": 209,
        "sentence": "Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.",
        "label": {
            "lymphoblastoid cell line": "cell_line",
            "IM-9": "cell_line",
            "type-II EBS": "protein",
            "Type-II estrogen -binding sites": "protein",
            "human lymphoblastoid cell line": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 4},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4}\n]",
        "response3": "[{\"IM-9\": \"cell_line\"}, {\"estradiol\": \"protein\"}]",
        "prediction": "{'IM-9': 'cell_line', 'estradiol': 'protein'}"
    },
    {
        "idx": 1385,
        "sentence": "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.",
        "label": {
            "LTR": "DNA",
            "HIV-1 LTR": "DNA",
            "C/EBP sites": "DNA",
            "C/EBP site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 4},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus\": 4},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process\": 4}\n]",
        "response3": "[{\"C/EBP\": \"protein\"}, {\"HIV-1 LTR\": \"DNA\"}]",
        "prediction": "{'C/EBP': 'protein', 'HIV-1 LTR': 'DNA'}"
    },
    {
        "idx": 1516,
        "sentence": "Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "GAL4 DNA binding domain": "protein",
            "COOH-terminal domain": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5}\n]",
        "response3": "[{\"BOB.1/OBF.1\": \"protein\"}, {\"GAL4 DNA binding domain\": \"DNA\"}]",
        "prediction": "{'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'DNA'}"
    },
    {
        "idx": 1827,
        "sentence": "A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .",
        "label": {
            "human interleukin 2 gene promoter": "DNA",
            "EGR-1": "protein",
            "Sp1": "protein",
            "regulatory element": "DNA",
            "binding site": "DNA",
            "zinc finger proteins": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n{\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n{\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 5},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"EGR-1\": \"protein\"}]",
        "prediction": "{'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}"
    },
    {
        "idx": 1116,
        "sentence": "The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .",
        "label": {
            "thymocytes": "cell_type",
            "p53": "protein",
            "mitogen-activated mature T lymphocytes": "cell_line",
            "tumour suppressor p53": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"The process of apoptosis is used to eliminate unwanted cells from a wide variety of organisms.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 178,
        "sentence": "T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .",
        "label": {
            "T lymphocytes": "cell_type",
            "lavage cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCL1) being mentioned in relation to a specific entity label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions specific cell types (granulocytes and T cells) which are relevant to the entity labels.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a protein (CD14) which is relevant to the entity labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of proteins and a cell type that are relevant to the entity labels.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a protein (ZAP-70) which is relevant to the entity labels.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions specific cell types (T lymphocytes) and a protein (HLA-molecules) which are relevant to the entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of a protein (NF-ATc) and a cell type (T lymphocytes) that are relevant to the entity labels.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions a cell line (EBV) and a protein (CD2) which are relevant to the entity labels.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions a specific cell type (Th2-type lymphocytes) which is relevant to the entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of a cell type (T cell), proteins (IL-2, IL-2 receptor, CD28) that are relevant to the entity labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of a protein (CD70), cell types (B cell, plasma cells), and proteins (IL-4, CD40) that are relevant to the entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) that are relevant to the entity labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of a protein (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) that are relevant to the entity labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of cell types (B and T cell activation), cell lines (Ramos, Jurkat), and a DNA entity (cDNA microarray technology) that are relevant to the entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of DNA entity (2-deoxyguanosine), cell types (lymphoid progenitor cells, thymus stromal cells, B cell, fetal liver cells, T cell), and a cell line (tg epsilon26) that are relevant to the entity labels.\"}\n]",
        "response3": "[{'T lymphocytes': 'cell_type'}, {'1,25(OH)2D3': 'protein'}, {'tuberculosis': 'cell_type'}, {'unseparated lavage cells': 'cell_line'}]",
        "prediction": "{'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_line'}"
    },
    {
        "idx": 1209,
        "sentence": "A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kB\": 5},\n    {\"AP-1\": 5},\n    {\"OCT-1\": 5},\n    {\"NF-IL-2B\": 5},\n    {\"AP-1\": 5},\n    {\"IL-5 mRNA\": 5},\n    {\"TCR\": 4},\n    {\"IL-2R\": 5},\n    {\"dexamethasone\": 5},\n    {\"phosphocreatine\": 4},\n    {\"HML\": 5},\n    {\"dexamethasone\": 5},\n    {\"cortisol\": 5},\n    {\"lysozyme\": 5},\n    {\"NF-E2\": 5},\n    {\"NF-kappa B\": 5},\n    {\"MNDA\": 5},\n    {\"interleukin-2\": 5},\n    {\"CD25\": 5},\n    {\"IL-2R\": 5},\n    {\"CTLA4Ig\": 5},\n    {\"NFAT\": 4},\n    {\"AP-1\": 4},\n    {\"Erbstatin\": 5},\n    {\"genistein\": 5},\n    {\"Egr-1\": 5},\n    {\"CD4+\": 5},\n    {\"CD8+\": 5},\n    {\"TPCK\": 5},\n    {\"anti-CD28\": 5},\n    {\"PMA\": 5},\n    {\"MR\": 5},\n    {\"aldosterone\": 5},\n    {\"progesterone\": 5},\n    {\"Ras\": 5},\n    {\"RasN17\": 5},\n    {\"IL-2\": 5},\n    {\"CIS\": 5},\n    {\"OSM\": 5},\n    {\"STAT5\": 5},\n    {\"Type I\": 5},\n    {\"Type II\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 864,
        "sentence": "Differences in transcriptional enhancers of HIV-1 and HIV-2 .",
        "label": {
            "transcriptional enhancers": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 4},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 65,
        "sentence": "Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .",
        "label": {
            "promoter": "DNA",
            "PRDII element": "DNA"
        },
        "response1": "['DNA', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 61,
        "sentence": "From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.",
        "label": {
            "82": "protein",
            "43-47 kD": "protein",
            "major protein": "protein",
            "T-cells": "cell_type",
            "minor proteins": "protein",
            "67": "protein",
            "HeLa cells": "cell_line",
            "52 kD": "protein"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5}\n]",
        "response3": "[{'HeLa cells': 'cell_line'}, {'T-cells': 'cell_line'}, {'DNA': 'DNA'}, {'protein': 'protein'}]",
        "prediction": "{'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'protein': 'protein'}"
    },
    {
        "idx": 191,
        "sentence": "A block to RNA elongation is largely responsible for decreased c-myc transcription .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 447,
        "sentence": "Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.",
        "label": {
            "enhancer": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 476,
        "sentence": "A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .",
        "label": {
            "protooncogenes": "DNA",
            "immediate early response genes": "DNA",
            "growth factor": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 3},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1034,
        "sentence": "p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .",
        "label": {
            "Stat1": "protein",
            "phosphorylation site": "protein",
            "Src homology 2 (SH2) domain": "protein",
            "p94": "protein",
            "p95": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"calcineurin\": 5},\n    {\"Th1\": 4},\n    {\"Th2\": 4},\n    {\"IL-2\": 5},\n    {\"STAT4\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"tyrosine\": 4},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"Aiolos\": 5},\n    {\"Ras\": 5},\n    {\"ERK\": 5},\n    {\"CD28\": 5},\n    {\"CD80\": 5},\n    {\"CD86\": 5},\n    {\"CBL\": 5},\n    {\"VAV\": 5},\n    {\"NFAT\": 5},\n    {\"interleukin-2\": 5},\n    {\"granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"interleukin 10\": 5},\n    {\"IL-10R\": 5},\n    {\"IL-6\": 5}\n]",
        "response3": "[{\"Stat1\": \"protein\"}, {\"p94\": \"protein\"}, {\"p95\": \"protein\"}]",
        "prediction": "{'Stat1': 'protein', 'p94': 'protein', 'p95': 'protein'}"
    },
    {
        "idx": 1232,
        "sentence": "IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).",
        "label": {
            "IBR": "protein",
            "transcription factors": "protein",
            "erected wing gene product": "protein",
            "human NRF-1/alpha-Pal factor": "protein",
            "EWG": "protein",
            "P3A2": "protein",
            "503-amino-acid-long acidic protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'IL-4' with the corresponding entity label 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity 'NF-E2' with the corresponding entity label 'protein', providing a clear reference for named entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions multiple entities such as 'IL-2', 'c-Jun', and 'c-Fos' with the corresponding entity label 'protein', making it very helpful for named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'interferon regulatory factor' as a transcription factor with the corresponding entity label 'protein', aiding in named entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides multiple mentions of transcription factors like 'EKLF', 'CBP', 'p300', and 'P/CAF' with the corresponding entity label 'protein', making it highly helpful for named entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'A-myb' as a transcription factor with the corresponding entity label 'protein', aiding in named entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'Protein' with the corresponding entity label 'protein', providing a clear reference for named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)' as proteins, aiding in named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'Drosophila Toll' and 'human Toll' as type I transmembrane proteins, providing clear references for named entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' as proteins, aiding in named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'NF-kappa B' and 'AP-1' as transcription factors, providing clear references for named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'EBNA-2' and 'PU.1' as proteins, aiding in named entity extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'NF-ATc' as a transcription factor, 'T lymphocytes' and 'embryonic cardiac cells' as cell types, aiding in named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer' as DNA, aiding in named entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'Egr-1' as a zinc finger transcription factor, aiding in named entity extraction.\"}\n]",
        "response3": "[{\"IBR\": \"protein\"}, {\"NRF-1/alpha-Pal\": \"protein\"}, {\"P3A2\": \"protein\"}, {\"erected wing gene product (EWG)\": \"protein\"}]",
        "prediction": "{'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}"
    },
    {
        "idx": 54,
        "sentence": "Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .",
        "label": {
            "LTR": "DNA",
            "human T-cell types": "cell_type",
            "T-cell types": "cell_type",
            "element": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence directly mentions 'cDNAs' which is a specific type of DNA, making it highly relevant for entity extraction.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions 'IL-2' which is a protein, and this information is crucial for identifying protein entities.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides specific cell line names like 'SIVmacMER', 'SIVmac239', and 'CEMx174', aiding in the extraction of cell line entities.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence mentions 'CD4+' which is a specific type of cell, and 'EBV' which is a protein, both relevant for entity extraction.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence contains various protein names like 'IFN A', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate', aiding in protein entity extraction.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence directly mentions 'TIMP-1' as a protein and 'DNA synthesis' as DNA, making it highly relevant for entity extraction.\"},\n{\"Example 7\": 4},\n{\"Reason 7\": \"The sentence mentions 'Th2-type lymphocytes' which is a specific type of cell, aiding in cell type entity extraction.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence mentions 'EBV' which is a cell line, and 'CD2' which is a protein, both relevant for entity extraction.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions 'PBMC' as a cell type and 'adenovirus DNA' as DNA, aiding in entity extraction.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence directly mentions 'SIVsmmPBj14' as a cell line, making it highly relevant for entity extraction.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence mentions 'CD95 ligand' which is a protein, aiding in protein entity extraction.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence mentions 'HIV-1 LTR' as DNA, 'NFAT-1' and 'NF kappa B' as proteins, aiding in entity extraction.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions 'EBV' as DNA, 'EBNA2' and 'estrogen receptor' as proteins, aiding in entity extraction.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"The sentence mentions 'TR55' as a protein, 'TNF-alpha' as a protein, and 'HIV' as a cell type, aiding in entity extraction.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions 'NF-kappaB' and 'Sp1' as proteins, and 'SIVmac' as a cell line, aiding in entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1149,
        "sentence": "The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .",
        "label": {
            "Sp1": "protein",
            "DCs": "cell_type",
            "NF-kappa B": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 3},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 4},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"DCs\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type'}"
    },
    {
        "idx": 407,
        "sentence": "Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ).\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"Furthermore, the two VDR 3'-UTR haplotypes conferred an identical half-life on a heterologous beta-globin reporter gene, in an in vitro assay.\": 4}\n]",
        "response3": "[{\"VDR\": \"protein\"}, {\"VDR\": \"protein\"}, {\"XLH\": \"cell_type\"}]",
        "prediction": "{'VDR': 'protein', 'XLH': 'cell_type'}"
    },
    {
        "idx": 1466,
        "sentence": "As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .",
        "label": {
            "endothelial cells": "cell_type",
            "NFAT": "protein",
            "activated endothelial cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'NF-kappa B' and its corresponding label 'DNA', aiding in the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[{\"NFAT\": \"protein\"}, {\"CsA\": \"protein\"}, {\"endothelial cells\": \"cell_type\"}]",
        "prediction": "{'NFAT': 'protein', 'CsA': 'protein', 'endothelial cells': 'cell_type'}"
    },
    {
        "idx": 1330,
        "sentence": "Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .",
        "label": {
            "I kappa B alpha": "protein",
            "I kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple protein names and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains a protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains multiple protein names and a cell type that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple protein names and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"}\n]\n```",
        "response3": "```json\n[{\"I kappa B alpha\": \"protein\"}]\n```",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1436,
        "sentence": "Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .",
        "label": {
            "hTR beta 1 mRNA": "RNA",
            "hTR beta 1": "protein"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"embryonic cardiac cells\": 5},\n    {\"GATA-1\": 5},\n    {\"TAL1\": 5},\n    {\"T-ALL\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"cAMP-dependent protein kinase\": 5},\n    {\"Rap1\": 5},\n    {\"GATA-1\": 5},\n    {\"E2A\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"TCL1\": 5},\n    {\"CREB\": 5},\n    {\"AR-CRE\": 5},\n    {\"RXR\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"TCRzeta\": 5},\n    {\"p56(lck)\": 5},\n    {\"Ter 119\": 5},\n    {\"beta-globin\": 5},\n    {\"glycoprotein IIb\": 5},\n    {\"platelet factor 4\": 5},\n    {\"2-deoxyguanosine\": 5},\n    {\"lymphoid progenitor cells\": 5},\n    {\"thymus stromal cells\": 5},\n    {\"B cell\": 5},\n    {\"tg epsilon26\": 5},\n    {\"fetal liver cells\": 5},\n    {\"T cell\": 5},\n    {\"TR55\": 5},\n    {\"TNF-alpha\": 5},\n    {\"HIV\": 5}\n]",
        "response3": "[{\"hTR beta 1\": \"RNA\"}]",
        "prediction": "{'hTR beta 1': 'RNA'}"
    },
    {
        "idx": 859,
        "sentence": "We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .",
        "label": {
            "inducible": "protein",
            "Jurkat cells": "cell_line",
            "C1": "protein",
            "HIV enhancer": "DNA",
            "C2": "protein",
            "constitutive, C2 , protein": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5}\n]",
        "response3": "[{\"C1\": \"protein\"}, {\"C2\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"HIV\": \"cell_type\"}]",
        "prediction": "{'C1': 'protein', 'C2': 'protein', 'Jurkat': 'cell_line', 'HIV': 'cell_type'}"
    },
    {
        "idx": 451,
        "sentence": "However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .",
        "label": {
            "NF-muE3": "protein",
            "B cells": "cell_type",
            "lymphoid cells": "cell_type",
            "transfected reporter gene": "DNA",
            "Ig heavy chain enhancer": "DNA",
            "non- lymphoid cells": "cell_type",
            "non-B cells": "cell_type",
            "endogenous Ig heavy chain enhancer": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"Egr-1\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"TCF-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"B cell\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"embryonic cardiac cells\": 5},\n    {\"IL-2\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"c-kit\": 5},\n    {\"IL-4R alpha chain\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"rheumatoid arthritis\": 5},\n    {\"CD40\": 5},\n    {\"Rel/nuclear factor kappaB\": 5},\n    {\"B lymphocytes\": 5},\n    {\"SIVmac\": 5},\n    {\"NFAT\": 5},\n    {\"AP-1\": 5},\n    {\"CTLA4Ig\": 5}\n]",
        "response3": "[{\"Ig heavy chain enhancer\": \"DNA\"}, {\"NF-muE3\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"non-B cells\": \"cell_type\"}]",
        "prediction": "{'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type', 'non-B cells': 'cell_type'}"
    },
    {
        "idx": 919,
        "sentence": "The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .",
        "label": {
            "56-kDa protein": "protein",
            "p56": "protein",
            "EC1 antibody": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"EC1 antibody\": \"protein\"}, {\"p56\": \"protein\"}]",
        "prediction": "{'EC1 antibody': 'protein', 'p56': 'protein'}"
    },
    {
        "idx": 1206,
        "sentence": "In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.",
        "label": {
            "androgen receptors": "protein",
            "mononuclear leukocytes": "cell_type"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"RXR\": 5},\n    {\"granulocytes\": 4, \"T cells\": 4},\n    {\"lymphoid neoplasms\": 4},\n    {\"CD14\": 5},\n    {\"phosphocreatine\": 3},\n    {\"HML\": 4, \"dexamethasone\": 5, \"cortisol\": 5, \"lysozyme\": 5},\n    {\"NF-E2\": 5},\n    {\"E2A\": 5},\n    {\"CD70\": 5, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 5, \"CD40\": 5},\n    {\"cAMP-dependent protein kinase\": 5, \"Rap1\": 5},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n    {\"PU.1\": 5, \"CSF-1 receptor\": 5, \"Mono A\": 5, \"Mono B\": 5},\n    {\"nuclear factor-kappa B\": 3, \"NF-kappa B\": 3},\n    {\"NF-kappa B\": 5, \"fibrinogen\": 5},\n    {\"MNDA\": 5, \"monocytes\": 4, \"macrophages\": 4, \"leukemia/B lymphoma cell lines\": 5},\n    {\"PMA\": 5, \"U1 cells\": 5}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 569,
        "sentence": "In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .",
        "label": {
            "PDGF(B)": "protein",
            "EGR2": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5\n    },\n    {\n        \"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 4\n    },\n    {\n        \"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 3\n    },\n    {\n        \"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 4\n    },\n    {\n        \"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5\n    },\n    {\n        \"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 4\n    },\n    {\n        \"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4\n    },\n    {\n        \"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 3\n    },\n    {\n        \"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 4\n    },\n    {\n        \"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5\n    },\n    {\n        \"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4\n    },\n    {\n        \"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5\n    },\n    {\n        \"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5\n    },\n    {\n        \"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5\n    },\n    {\n        \"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4\n    },\n    {\n        \"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1657,
        "sentence": "HMG-I binds to GATA motifs : implications for an HPFH syndrome .",
        "label": {
            "HMG-I": "protein",
            "GATA motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5}\n]",
        "response3": "[{\"HMG-I\": \"protein\"}, {\"GATA motifs\": \"DNA\"}]",
        "prediction": "{'HMG-I': 'protein', 'GATA motifs': 'DNA'}"
    },
    {
        "idx": 1780,
        "sentence": "Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .",
        "label": {
            "Id3": "protein",
            "Mo": "cell_line",
            "Id2": "protein",
            "4/5 T-cell lines": "cell_line",
            "S-LB1": "cell_line",
            "MT-2": "cell_line",
            "ATL-1k": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence provides clear examples of protein and cell_line entities in the context of leukemia, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific protein entities related to the tax protein and NF-kappaB, which are crucial for named entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence includes multiple instances of protein entities like STAT, STAT3, and T cells, providing valuable information for named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions protein entity NF-ATc and cell_type entity T lymphocytes, making it highly relevant for named entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a comprehensive list of protein entities such as IL-2, IFN-gamma, jak kinases, and STAT1(alpha), aiding in accurate named entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence offers clear examples of cell_line entities like SIVmacMER, SIVmac239, and CEMx174, facilitating the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions protein entity NF-ATc and cell_type entities T lymphocytes and embryonic cardiac cells, which are crucial for named entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains a specific cell_type entity Th2-type lymphocytes, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides a detailed list of protein entities like IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, enhancing named entity extraction.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence includes cell_type entity PBMC and DNA entity adenovirus DNA, which are helpful for named entity extraction.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions protein entity TCL1, which is relevant for named entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains protein entities related to HIV-1, IFN, PKR, and IkappaBalpha, aiding in named entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence offers a variety of entities including cell_type B and T cell activation, cell_lines Ramos and Jurkat, and DNA technology, making it highly useful for named entity extraction.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides protein entities tal-1 and GATA-binding proteins along with cell_type entity hematopoiesis, aiding in named entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence includes DNA entity HIV-1 LTR and protein entities NFAT-1 and NF kappa B, which are relevant for named entity extraction.\"}\n]",
        "response3": "[{\"Id2\": \"RNA\"}, {\"Id3\": \"RNA\"}, {\"T-cell lines\": \"cell_line\"}, {\"human T-cell leukemia virus type I (HTLV-I)\": \"cell_type\"}, {\"ATL-1k\": \"cell_line\"}, {\"MT-2\": \"cell_line\"}, {\"S-LB1\": \"cell_line\"}, {\"type II (Mo)\": \"cell_type\"}]",
        "prediction": "{'Id2': 'RNA', 'Id3': 'RNA', 'T-cell lines': 'cell_line', 'human T-cell leukemia virus type I (HTLV-I)': 'cell_type', 'ATL-1k': 'cell_line', 'MT-2': 'cell_line', 'S-LB1': 'cell_line', 'type II (Mo)': 'cell_type'}"
    },
    {
        "idx": 13,
        "sentence": "We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.",
        "label": {
            "platelet-activating factor": "protein",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1554,
        "sentence": "The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .",
        "label": {
            "GP": "protein",
            "normal platelets": "cell_type",
            "cis-acting elements": "DNA",
            "GP Ib alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5}\n]",
        "response3": "[{\"GP Ib alpha\": \"protein\"}]",
        "prediction": "{'GP Ib alpha': 'protein'}"
    },
    {
        "idx": 1650,
        "sentence": "This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .",
        "label": {
            "PU.1": "protein",
            "myeloid PU.1 binding site": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"myeloid\": \"cell_type\"}]",
        "prediction": "{'PU.1': 'protein', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 326,
        "sentence": "We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .",
        "label": {
            "EB1": "protein",
            "R-responsive element": "DNA",
            "HeLa cells": "cell_line",
            "domain B": "DNA",
            "EB1 -responsive B-cell-specific element": "DNA"
        },
        "response1": "['cell_line', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 4},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"HeLa cells\": \"cell_line\"}, {\"EB1\": \"protein\"}, {\"B-cell-specific\": \"cell_type\"}]",
        "prediction": "{'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell-specific': 'cell_type'}"
    },
    {
        "idx": 1429,
        "sentence": "Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .",
        "label": {
            "TR": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n{\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n{\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n{\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL-mediated NF-kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 865,
        "sentence": "Response to T cell activation signals .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 3},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 696,
        "sentence": "First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .",
        "label": {
            "TRE -DNA fragment": "DNA",
            "nuclear proteins": "protein",
            "TRE": "DNA"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 318,
        "sentence": "Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.",
        "label": {
            "estrogen receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (RXR) and its corresponding entity label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein (E2A) and its corresponding entity label.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of proteins (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of proteins (TCRzeta, p56(lck)) and their corresponding entity labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding entity labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of proteins (Erbstatin, genistein, Egr-1) and RNA (Egr-1) with their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear examples of DNA (EBV), protein (EBNA2), and protein (estrogen receptor) with their corresponding entity labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of cell lines (PMA-stimulated U1 cells) with their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of DNA (nuclear factor-kappa B, NF-kappa B) with their corresponding entity labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of proteins (CD3.TcR, CD18, CD29) with their corresponding entity labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of DNA (DNA), protein (PCNA), and protein (E2F1) with their corresponding entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of proteins (MR, aldosterone, progesterone) with their corresponding entity labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides clear examples of proteins (E2F, E2F-4, DP-1, p130) and a cell type (AML) with their corresponding entity labels.\"}\n]",
        "response3": "[{\"estrogen receptor\": \"protein\"}]",
        "prediction": "{'estrogen receptor': 'protein'}"
    },
    {
        "idx": 440,
        "sentence": "All three proteins show the same sequence specificity and binding affinity .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain .\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 5},\n{\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease .\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n{\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n{\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1563,
        "sentence": "Pathogenesis of atherosclerosis .",
        "label": {},
        "response1": "None.",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a clear and direct mapping of the entity 'IFN-gamma' to the entity label 'protein' in the context of the sentence.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example includes multiple entities such as 'NF-kappaB', 'Tax', and 'ATL' with their corresponding entity labels, aiding in the extraction of named entities from the sentence.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example provides a specific entity 'AP-1' mapped to the entity label 'DNA', which is helpful in understanding the entity types present in the sentence.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example includes the entity 'P selectin' mapped to the entity label 'protein', contributing to the identification of named entities in the sentence.\"\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Reason 5\": \"The example contains entities 'NF-kappaB' and 'rheumatoid arthritis' with their respective entity labels, aiding in the extraction of named entities related to pathogenesis.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example provides a comprehensive list of entities including 'PKC isoforms', 'human alveolar macrophages', and 'blood monocytes' with their corresponding entity labels, facilitating the identification of entity types in the sentence.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The example includes the entity 'NF-kappa B' mapped to the entity label 'protein', which is crucial for understanding the entities related to the activation mechanism.\"\n    },\n    {\n        \"Example 8\": 3\n    },\n    {\n        \"Reason 8\": \"The example presents the entity 'cell adhesion molecules' mapped to the entity label 'cell_type', contributing to the identification of relevant entities in the sentence.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example includes entities 'NF-kappa B' and 'ARDS' with their respective entity labels, aiding in the extraction of named entities related to inflammation and disease.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example provides a clear mapping of entities 'IkappaBbeta' and 'NF-kappaB' to the entity label 'protein', which is essential for understanding the mechanism of NF-kappaB induction.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The example includes entities 'IL-12' and 'macrophages' with their corresponding entity labels, aiding in the identification of entities related to immune response.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example provides a detailed list of entities 'Stat3', 'Stat5', and 'c-Mpl' mapped to the entity label 'protein', which is crucial for understanding the signal transduction events.\"\n    },\n    {\n        \"Example 13\": 3\n    },\n    {\n        \"Reason 13\": \"The example presents the entity 'Eosinophils' mapped to the entity label 'cell_type', contributing to the identification of relevant cell types in the sentence.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The example includes entities 'alpha-tocopherol', 'monocyte', and 'endothelial cells' with their respective entity labels, aiding in the extraction of named entities related to cellular events.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example provides a clear mapping of entities 'SP1', 'caspases', and 'B-cell' to the entity label 'protein' and 'cell_type', which is essential for understanding the apoptotic process.\"\n    },\n    {\n        \"Example 16\": 4\n    },\n    {\n        \"Reason 16\": \"The example includes the entity 'NF-kappa B' mapped to the entity label 'protein', which is crucial for understanding the activation mechanism of monocytic cells.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 689,
        "sentence": "High-risk patients can be recognized morphologically.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Additionally, mutated Ras can also serve as a primary target for the development of immunotherapy or drug therapy.\": 4},\n    {\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 4},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 189,
        "sentence": "Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .",
        "label": {
            "human T lymphoblastic tumor cell line": "cell_line",
            "c-myc": "DNA"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"c-myc\": \"protein\"}, {\"T lymphoblastic tumor cell line\": \"cell_line\"}]",
        "prediction": "{'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}"
    },
    {
        "idx": 778,
        "sentence": "Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .",
        "label": {
            "OTF-1": "protein",
            "pre-B cells": "cell_line",
            "immunoglobulin gene": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"T cell blasts treated with PMA are now responsive to IFN-gamma .\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .\": 5}\n]",
        "response3": "[{\"OTF-1\": \"protein\"}, {\"pre-B cells\": \"cell_type\"}, {\"HeLa cells\": \"cell_line\"}, {\"immunoglobulin gene\": \"protein\"}]",
        "prediction": "{'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}"
    },
    {
        "idx": 198,
        "sentence": "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence provides clear context about the development of lymphoid neoplasms, making it easier to identify 'lymphoid neoplasms' as a 'cell_type' entity.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The sentence mentions specific proteins like 'IL-2', 'NF-kappa B', and 'AP-1', which can help in identifying these entities as 'protein' types, but the context is slightly more complex compared to other examples.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence clearly discusses the presence of proteins 'TCRzeta' and 'p56(lck)' in peripheral blood T cells, aiding in the identification of these entities as 'protein' types.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence directly links 'TAL1' to the development of 'T-ALL', providing a clear association between the protein and the cell type.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The sentence focuses on 'STAT1' as a potential target for immunosuppressive and antineoplastic agents, providing valuable information but lacking direct entity associations.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions 'MNDA' as a protein and 'Philadelphia chromosome-positive chronic myeloid leukemia' as a cell line, making it easier to identify these entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence discusses the inhibition of a cell-specific transcription factor 'NF-E2' by phorbol esters, aiding in the identification of 'NF-E2' as a 'protein' entity.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence provides a clear link between proteins 'Oct-2A' and 'HMG I/Y' and their activation of 'HLA-DRA' expression in 'B cells', facilitating entity extraction.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The sentence mentions 'T lymphocytes' as being affected by Ciprofloxacin, providing context for identifying the cell type but lacking direct entity associations.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence discusses the utilization of proteins 'IL-13', 'IL-4R', and 'JAK2' in colon cancer cells, aiding in the identification of these entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence highlights the overexpression of 'WT1' in myeloid cell lines, providing a direct association between the protein and the cell line.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions proteins 'Erbstatin' and 'genistein' and their effects on 'Egr-1' mRNA expression, providing valuable information but lacking direct entity associations.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence discusses the responsiveness of T cell blasts to 'IFN-gamma' when treated with 'PMA', aiding in the identification of these entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence describes the generation of conditional EBV mutants expressing proteins like 'EBNA2' and 'estrogen receptor', facilitating entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions the oncogenes 'TCL1' and 'MTCP1/c6.1B' in leukaemic and non-leukaemic T cells, aiding in the identification of these proteins.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence provides information on the suppression of purified CD4+ or CD8+ T cells by 'TPCK', 'anti-CD28', and 'PMA', aiding in the identification of these entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 735,
        "sentence": "This prompted us to analyze the octamer-binding proteins in the latter cells.",
        "label": {
            "octamer-binding proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 4},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 3},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 3},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1735,
        "sentence": "We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .",
        "label": {
            "VDR": "protein",
            "IL-2 promoter/reporter constructs": "DNA",
            "Jurkat cells": "cell_line",
            "VDR overexpression vector": "DNA",
            "IL-2": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 4},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"IL-2\": \"DNA\"}, {\"VDR\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'IL-2': 'DNA', 'Jurkat': 'cell_line', 'VDR': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 704,
        "sentence": "Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .",
        "label": {
            "ubiquitous and developmentally regulated proteins": "protein",
            "ubiquitous": "protein",
            "developmentally regulated proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and cell types that are directly mentioned, making it highly relevant for extracting named entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides specific protein and cell type names that are directly mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions a specific DNA element that is directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names that are directly mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides specific protein names that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific protein names that are directly mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions specific protein names and a cell type that are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides specific protein names that are directly mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions specific protein names and a cell type that are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains a specific protein name that is directly mentioned in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides specific protein names that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions specific protein names that are directly related to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains a specific DNA element that is directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions a specific cell type that is directly related to the target sentence, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{\"immunoglobulin heavy and kappa light chain gene enhancers\": \"DNA\"}]",
        "prediction": "{'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}"
    },
    {
        "idx": 1236,
        "sentence": "Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .",
        "label": {
            "direct-repeat palindrome": "DNA",
            "IBR/F": "protein",
            "IBR/F binding sites": "DNA",
            "optimal site": "DNA",
            "alternating RCGCRYGCGY consensus": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"T cell\": 4, \"kB-like proto-enhancer element\": 3, \"interleukin 2\": 4},\n    {\"Reasons\": \"The sentence contains specific terms that are indicative of cell types and proteins, which are key entity types in the label set. The terms 'T cell' and 'interleukin 2' are directly related to 'cell_type' and 'protein' entities, respectively. The term 'kB-like proto-enhancer element' is less specific but still relevant to DNA entities.\"},\n    {\"immunoglobulin kappa 3' enhancer\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'immunoglobulin kappa 3' enhancer' which is directly related to DNA entities, making it highly relevant for entity extraction.\"},\n    {\"CREB\": 4, \"AR-CRE\": 3},\n    {\"Reasons\": \"The sentence contains terms 'CREB' and 'AR-CRE' which are directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"SIVsmmPBj14\": 5},\n    {\"Reasons\": \"The sentence contains a specific term 'SIVsmmPBj14' which is directly related to cell line entities, making it highly relevant for entity extraction.\"},\n    {\"EBNA2\": 4, \"TP1\": 3},\n    {\"Reasons\": \"The sentence contains terms 'EBNA2' and 'TP1' which are directly related to protein and cell line entities, respectively, making it highly relevant for entity extraction.\"},\n    {\"BRCA1\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'BRCA1' which is directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"p50p50\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'p50p50' which is directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"GM-CSF\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'GM-CSF' which is directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"retinoic acid receptor alpha\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'retinoic acid receptor alpha' which is directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n    {\"Reasons\": \"The sentence contains terms 'IL-2', 'c-Jun', and 'c-Fos' which are directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"Protein\": 3},\n    {\"Reasons\": \"The sentence contains a general term 'Protein' which is related to protein entities, but it is less specific compared to other examples.\"},\n    {\"Th2-type lymphocytes\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'Th2-type lymphocytes' which is directly related to cell type entities, making it highly relevant for entity extraction.\"},\n    {\"IgH\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'IgH' which is directly related to DNA entities, making it highly relevant for entity extraction.\"},\n    {\"VDR\": 4, \"RXR\": 4, \"GRIP-1\": 4, \"DRIP205\": 4, \"DRIP\": 3},\n    {\"Reasons\": \"The sentence contains terms 'VDR', 'RXR', 'GRIP-1', 'DRIP205', and 'DRIP' which are directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"GM-kappa B\": 4, \"GC-box\": 4, \"GC-motif\": 3, \"GM-kappa B motif\": 3},\n    {\"Reasons\": \"The sentence contains terms 'GM-kappa B', 'GC-box', 'GC-motif', and 'GM-kappa B motif' which are directly related to DNA entities, making it highly relevant for entity extraction.\"},\n    {\"NF-kappaB\": 4, \"Sp1\": 4, \"SIVmac\": 4},\n    {\"Reasons\": \"The sentence contains terms 'NF-kappaB', 'Sp1', and 'SIVmac' which are directly related to protein and cell line entities, making it highly relevant for entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 541,
        "sentence": "To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example contains specific protein names (Syk, Zap) and a cell type (T cell) that directly match the entity types in the target sentence.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example provides specific protein names (myeloperoxidase, lysozyme, PU.1) that match the protein entity type in the target sentence.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example mentions T lymphocytes (cell type) and HLA-molecules (protein), which are relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 4\": 2\n    },\n    {\n        \"Reason 4\": \"The example only contains a single protein name (Egr-1) which is relevant but limited compared to other examples.\"\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Reason 5\": \"The example provides multiple protein names (MIP-1 alpha, GOS19, LD78, AT464) that match the protein entity type in the target sentence.\"\n    },\n    {\n        \"Example 6\": 3\n    },\n    {\n        \"Reason 6\": \"The example mentions GM-CSF (protein), which is relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example contains multiple protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and stimuli (phytohemagglutinin, phorbol myristate acetate) that match the protein entity type in the target sentence.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The example provides protein names (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) that match the protein entity type in the target sentence.\"\n    },\n    {\n        \"Example 9\": 3\n    },\n    {\n        \"Reason 9\": \"The example mentions TCF-1 (protein), which is relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 10\": 2\n    },\n    {\n        \"Reason 10\": \"The example only contains a single protein name (IL-4) which is relevant but limited compared to other examples.\"\n    },\n    {\n        \"Example 11\": 3\n    },\n    {\n        \"Reason 11\": \"The example mentions IL-12 (protein) and macrophages (cell type), which are relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The example provides protein names (IL-2, c-Jun, c-Fos) that match the protein entity type in the target sentence.\"\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Reason 13\": \"The example provides a specific protein name (ZAP-70) that matches the protein entity type in the target sentence.\"\n    },\n    {\n        \"Example 14\": 3\n    },\n    {\n        \"Reason 14\": \"The example mentions Th2-type lymphocytes (cell type), which is relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The example provides a specific protein name (IL-2) that matches the protein entity type in the target sentence.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1652,
        "sentence": "Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.",
        "label": {
            "PU.1": "protein",
            "PU-SF complex": "protein",
            "myeloid promoters": "DNA",
            "PU.1 site": "DNA",
            "PU-SF": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"UAS1\": 4},\n    {\"B cell\": 3},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"GM-CSF\": 5},\n    {\"AP-1\": 5},\n    {\"PMA\": 5},\n    {\"monocytes\": 3},\n    {\"macrophages\": 3},\n    {\"PNU156804\": 4},\n    {\"EKLF\": 5},\n    {\"CBP\": 5},\n    {\"p300\": 5},\n    {\"P/CAF\": 5},\n    {\"CD14\": 5},\n    {\"UAS3\": 4},\n    {\"UAS2\": 4},\n    {\"YY1\": 5},\n    {\"EBNA2\": 5},\n    {\"TP1\": 4},\n    {\"Jun\": 5},\n    {\"ATF-2\": 5},\n    {\"SCM-1\": 4},\n    {\"Ets\": 5},\n    {\"PU.1\": 5},\n    {\"M-CSF receptor\": 5},\n    {\"macrophage\": 4}\n]",
        "response3": "[{\"PU-SF complex\": \"protein\"}, {\"PU.1\": \"protein\"}, {\"myeloid\": \"cell_type\"}]",
        "prediction": "{'PU-SF complex': 'protein', 'PU.1': 'protein', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 88,
        "sentence": "TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .",
        "label": {
            "TNF alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and cell types that are directly related to the entity labels in the target sentence, making it highly relevant for named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1494,
        "sentence": "Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .",
        "label": {
            "latent NF-kappa B": "protein",
            "cytokine": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 940,
        "sentence": "Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .",
        "label": {
            "PBMC": "cell_type",
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (NF-E2) and its corresponding label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains multiple examples of protein entities (alpha-tocopherol), cell types (monocyte, endothelial cells) which can aid in entity extraction.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence provides examples of protein entities (NF-kappa B, AP-1) which are relevant for entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains examples of protein entities (IL-2, NF-kappa B, AP-1) which are important for entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence includes examples of RNA (IL-5 mRNA), cell types (TCR), protein (IL-2R), and chemical compound (dexamethasone) entities, aiding in entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides an example of a protein entity (retinoic acid receptor alpha) which is helpful for entity extraction.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains examples of protein entity (WT1) and cell line entity (myeloid cell lines) which can aid in entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence includes an example of a protein entity (E2A) which is relevant for entity extraction.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence provides examples of protein entities (NF-kappa B, I kappa B beta) which are important for entity extraction.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence contains examples of cell type entity (lymphocytes) and chemical compound entities (benzene, benzoquinone) which can aid in entity extraction.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence includes an example of a protein entity (NF-kappa B) which is relevant for entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides examples of cell line entity (Ter 119), protein entities (beta-globin, glycoprotein IIb, platelet factor 4) which are helpful for entity extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains examples of protein entities (Erbstatin, genistein) and RNA entity (Egr-1) which can aid in entity extraction.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence includes examples of cell type entity (B cell), protein entity (Ig), and protein entity (Transforming growth factor-beta) which are important for entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence provides examples of DNA entity (EBV) and protein entities (EBNA2, estrogen receptor) which are relevant for entity extraction.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence contains examples of cell line entities (PMA, U1 cells) which can aid in entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1098,
        "sentence": "Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .",
        "label": {
            "microtubules": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 1},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n{\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 255,
        "sentence": "c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.",
        "label": {
            "c-myc RNA": "RNA",
            "RWLeu-4 cells": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5}\n]",
        "response3": "[{\"c-myc RNA\": \"RNA\"}, {\"RWLeu-4 cells\": \"cell_line\"}, {\"VD3\": \"protein\"}]",
        "prediction": "{'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}"
    },
    {
        "idx": 775,
        "sentence": "Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.",
        "label": {
            "OTF-1": "protein",
            "OTF-2": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"NF-ATc isoforms\": 4},\n    {\"T lymphocytes\": 3},\n    {\"IL-4\": 3},\n    {\"Protein\": 2},\n    {\"WT1\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"GATA-1\": 4},\n    {\"Syk\": 4},\n    {\"Zap\": 4},\n    {\"T cell\": 3},\n    {\"RXR\": 4},\n    {\"E2A\": 4},\n    {\"Th2-type lymphocytes\": 4},\n    {\"TCF-1\": 4},\n    {\"immunohistochemistry\": 4},\n    {\"gene\": 1},\n    {\"DNA\": 1},\n    {\"cell type\": 4},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"Th1\": 3},\n    {\"Th2\": 3},\n    {\"Egr-1\": 4},\n    {\"CD70\": 4},\n    {\"B cell\": 4},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4}\n]",
        "response3": "[{\"OTF-2\": \"protein\"}, {\"OTF-1\": \"protein\"}]",
        "prediction": "{'OTF-2': 'protein', 'OTF-1': 'protein'}"
    },
    {
        "idx": 161,
        "sentence": "Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Th2-type lymphocytes\": 5},\n    {\"cAMP-dependent protein kinase\": 5},\n    {\"Rap1\": 5},\n    {\"phosphocreatine\": 1},\n    {\"HML\": 5},\n    {\"dexamethasone\": 5},\n    {\"cortisol\": 5},\n    {\"lysozyme\": 5},\n    {\"T lymphocytes\": 5},\n    {\"IL-5 mRNA\": 5},\n    {\"TCR\": 5},\n    {\"IL-2R\": 5},\n    {\"SP1\": 5},\n    {\"caspases\": 5},\n    {\"B-cell\": 5},\n    {\"IL-2\": 5},\n    {\"NF-kappa B\": 5},\n    {\"AP-1\": 5},\n    {\"CD14\": 5},\n    {\"P selectin\": 5},\n    {\"Erbstatin\": 5},\n    {\"genistein\": 5},\n    {\"Egr-1\": 5},\n    {\"PMA\": 5},\n    {\"LPS\": 5},\n    {\"staurosporine\": 5},\n    {\"bisindolylmaleimide\": 5},\n    {\"genistein\": 5},\n    {\"U1 cells\": 5},\n    {\"CD4+\": 5},\n    {\"CD8+\": 5},\n    {\"TPCK\": 5},\n    {\"anti-CD28\": 5},\n    {\"PMA\": 5},\n    {\"DNA-binding phosphoproteins\": 5},\n    {\"cyclosporin A\": 5},\n    {\"CD3.TcR\": 5},\n    {\"CD18\": 5},\n    {\"CD29\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1130,
        "sentence": "B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .",
        "label": {
            "B-lymphoblastoid cell lines": "cell_line"
        },
        "response1": "['cell_line', 'virus']",
        "response2": "[\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 1},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 4},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4}\n]",
        "response3": "[{\"B-lymphoblastoid cell lines\": \"cell_line\"}, {\"human retrovirus\": \"protein\"}, {\"Epstein-Barr virus\": \"protein\"}]",
        "prediction": "{'B-lymphoblastoid cell lines': 'cell_line', 'human retrovirus': 'protein', 'Epstein-Barr virus': 'protein'}"
    },
    {
        "idx": 600,
        "sentence": "Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .",
        "label": {
            "immunoglobulin heavy-chain gene": "DNA",
            "lymphoid-specific enhancer element": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 4},\n    {\"Example 3\": 3},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 3},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"lymphoid-specific enhancer element\": \"DNA\"}, {\"immunoglobulin heavy-chain gene\": \"DNA\"}]",
        "prediction": "{'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'DNA'}"
    },
    {
        "idx": 1698,
        "sentence": "Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .",
        "label": {
            "natural killer cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 5},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 4},\n{\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n{\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 4},\n{\"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal , calphostin C , and ceramide .\": 5},\n{\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 5},\n{\"To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils .\": 4},\n{\"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence .\": 5},\n{\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\": 4}\n]",
        "response3": "[{\"human papillomavirus- or adenovirus- transformed cells\": \"cell_type\"}, {\"natural killer cells\": \"cell_type\"}]",
        "prediction": "{'human papillomavirus- or adenovirus- transformed cells': 'cell_type', 'natural killer cells': 'cell_type'}"
    },
    {
        "idx": 1287,
        "sentence": "Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .",
        "label": {
            "Platelet thromboxane receptors": "protein",
            "Platelet": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 3},\n{\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 4},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n{\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 5},\n{\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n{\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 5},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1266,
        "sentence": "Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .",
        "label": {
            "EBV -positive B cell lines": "cell_line"
        },
        "response1": "['cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line', 'cell_line']",
        "response2": "[\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n{\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 3},\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 4},\n{\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 3},\n{\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 4},\n{\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\": 5},\n{\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 4},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n{\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n{\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 4}\n]",
        "response3": "[{\"Human herpesvirus 6\": \"cell_type\"}, {\"EBV\": \"cell_line\"}, {\"B cell lines\": \"cell_line\"}, {\"EBV\": \"cell_line\"}, {\"EBV lytic cycle\": \"cell_line\"}]",
        "prediction": "{'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_line', 'B cell lines': 'cell_line', 'EBV lytic cycle': 'cell_line'}"
    },
    {
        "idx": 1813,
        "sentence": "Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .",
        "label": {
            "BLR2 mRNA": "RNA",
            "BLR2": "protein"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"BLR2 mRNA\": \"RNA\"}, {\"mitogen\": \"protein\"}, {\"anti-CD3\": \"protein\"}, {\"peripheral blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1764,
        "sentence": "The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .",
        "label": {
            "AP-1": "protein",
            "NF-kappa B": "protein",
            "transcription factor": "protein",
            "mitogen-stimulated cells": "cell_type"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names (Bak, Bad, Bcl-2) and treatment substances (PDBu, DMSO) which are directly related to the entity labels in the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions proteins (IFN A, interleukin-2, interleukin-2 receptor) and substances (phytohemagglutinin, phorbol myristate acetate) that are relevant to the entity labels in the target sentence, although not as explicitly as in Example 1.\"},\n{\"Example 3\": 3},\n{\"Reason 3\": \"The sentence includes protein names (IL-2) and mentions NF-kappa B and AP-1 activation, which are relevant to the entity labels in the target sentence, but the connection is not as direct as in the previous examples.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence directly mentions proteins (IL-2, NF-kappa B, AP-1) that are specifically related to the entity labels in the target sentence.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence directly discusses NF-kappa B and its inhibitor I kappa B alpha, which are directly related to the entity labels in the target sentence.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence mentions the transcription factor AP-1 and DNA binding activity, which are relevant to the entity labels in the target sentence, although not as explicitly as in Example 1.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence directly mentions NF-kappa B activation, which is specifically related to the entity labels in the target sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence directly discusses NF-kappa B activity and its inhibitor I kappa B beta, which are directly related to the entity labels in the target sentence.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence directly mentions proteins (IL-4, LPS, AP-1) that are specifically related to the entity labels in the target sentence.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The sentence mentions the transcription factor NF-E2, which is relevant to the entity labels in the target sentence, although not as explicitly as in Example 1.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence mentions proteins (RelA, NF-kappaB1) that are relevant to the entity labels in the target sentence, although not as explicitly as in Example 1.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions proteins (IL-2, c-Jun, c-Fos) that are relevant to the entity labels in the target sentence, although not as explicitly as in Example 1.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence directly discusses NF-kappa B and AP-1 transcription factors, which are specifically related to the entity labels in the target sentence.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"The sentence mentions proteins (PAFR, PAF, NF-kappa B, protein kinase C) that are relevant to the entity labels in the target sentence, although not as explicitly as in Example 1.\"},\n{\"Example 15\": 3},\n{\"Reason 15\": \"The sentence mentions the protein P selectin, which is relevant to the entity labels in the target sentence, although not as explicitly as in Example 1.\"},\n{\"Example 16\": 4},\n{\"Reason 16\": \"The sentence mentions proteins (IL-2, NFAT, NFAT delta418, calcineurin, Tpl-2, cyclosporin A) that are relevant to the entity labels in the target sentence, although not as explicitly as in Example 1.\"}\n]",
        "response3": "[{'AP-1': 'DNA'}, {'NF-kappa B': 'protein'}]",
        "prediction": "{'AP-1': 'DNA', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 740,
        "sentence": "On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.",
        "label": {
            "ubiquitous Oct-1": "protein",
            "Oct-1": "protein",
            "Oct-2A": "protein",
            "lymphoid-specific Oct-2A": "protein",
            "N-Oct-factors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1182,
        "sentence": "Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .",
        "label": {
            "IL-2": "protein",
            "T cells": "cell_type",
            "COOH-terminal region": "protein",
            "human T cells": "cell_type",
            "Ser386-Val525": "protein",
            "JAK3": "protein",
            "STAT transcription factor": "protein",
            "STAT5": "protein",
            "IL-2R beta": "protein",
            "IL-2R gamma": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5}\n]",
        "response3": "[{\"STAT5\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"JAK3\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'STAT5': 'protein', 'IL-2': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 393,
        "sentence": "We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.",
        "label": {
            "HNP-1": "protein",
            "pag": "DNA",
            "NP-1": "protein",
            "defensins": "protein",
            "NP-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1442,
        "sentence": "T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .",
        "label": {
            "interleukin 3": "protein",
            "transcriptional start site": "DNA",
            "IL-3": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5}\n]",
        "response3": "[{\"IL-3\": \"protein\"}]",
        "prediction": "{'IL-3': 'protein'}"
    },
    {
        "idx": 142,
        "sentence": "This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .",
        "label": {
            "U937 cells": "cell_line",
            "NF-kappa B": "protein",
            "viral RNA": "RNA",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"TIMP-1\": 5},\n    {\"DNA\": 4},\n    {\"NF-kB\": 4},\n    {\"AP-1\": 4},\n    {\"OCT-1\": 4},\n    {\"NF-IL-2B\": 4},\n    {\"RelA\": 5},\n    {\"NF-kappa B\": 5},\n    {\"Tax\": 4},\n    {\"ATL\": 4},\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappa B\": 5},\n    {\"IL-2\": 4},\n    {\"AP-1\": 4},\n    {\"I kappa B alpha\": 5},\n    {\"NF-kappa B\": 5},\n    {\"I kappa B alpha\": 5},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"HIV-1\": 5},\n    {\"IFN\": 4},\n    {\"PKR\": 4},\n    {\"IkappaBalpha\": 5},\n    {\"CD40\": 4},\n    {\"Rel/nuclear factor kappaB\": 4},\n    {\"NF-kappaB\": 5},\n    {\"B lymphocytes\": 4},\n    {\"TR55\": 4},\n    {\"TNF-alpha\": 4},\n    {\"HIV\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 4},\n    {\"SIVmac\": 4}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"HIV-1\": \"cell_type\"}, {\"RNA\": \"RNA\"}, {\"U937 cells\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV-1': 'cell_type', 'RNA': 'RNA', 'U937 cells': 'cell_line'}"
    },
    {
        "idx": 93,
        "sentence": "The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .",
        "label": {
            "canonical TATA box": "DNA",
            "\"housekeeping\" promoter": "DNA",
            "methylation-free island": "DNA",
            "5'-end termini": "RNA",
            "Thy-1 gene promoter": "DNA",
            "mRNA": "RNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.\": 5},\n    {\"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5}\n]",
        "response3": "[{\"Thy-1 gene\": \"protein\"}]",
        "prediction": "{'Thy-1 gene': 'protein'}"
    },
    {
        "idx": 1354,
        "sentence": "In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .",
        "label": {
            "TCF-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct association between the entity 'AP-1' and its corresponding entity label 'DNA' in the context of transcription factor activity.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides multiple associations between entities and their corresponding labels, including 'NF-kappaB' as 'protein', 'Tax' as 'cell_type', and 'ATL' as 'cell_type' in the context of leukemic cells.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example provides a direct association between the entity 'WT1' and its corresponding entity label 'protein' in the context of paternal expression in lymphocytes.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides a direct association between the entity 'TCL1' and its corresponding entity label 'protein' in the context of expression in AIDS IBLP tumors.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example provides associations between entities and their corresponding labels, including 'NF-ATc' as 'protein' and 'T lymphocytes' as 'cell_type' in the context of isoform synthesis.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example provides a direct association between the entity 'TCF-1' and its corresponding entity label 'protein' in the context of transactivation in non-T cells.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The example provides an association between the entity 'lymphoid neoplasms' and its corresponding entity label 'cell_type' in the context of development roles.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The example provides an association between the entity 'Th2-type lymphocytes' and its corresponding entity label 'cell_type' in the context of cytokine expression.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example provides a direct association between the entity 'TCF-1' and its corresponding entity label 'protein' in the context of immunization and antiserum production.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example provides associations between entities and their corresponding labels, including 'NF-ATc' as 'protein', 'T lymphocytes' as 'cell_type', and 'embryonic cardiac cells' as 'cell_type' in the context of isoform expression.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example provides a direct association between the entity 'RXR' and its corresponding entity label 'protein' in the context of erythroid cell outgrowth.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example provides associations between entities and their corresponding labels, including 'MNDA' as 'protein' and 'Philadelphia chromosome-positive chronic myeloid leukemia' as 'cell_line' in the context of expression specificity.\"},\n    {\"Example 13\": 3},\n    {\"Reason 13\": \"The example provides associations between entities and their corresponding labels, including 'granulocytes' and 'T cells' as 'cell_type' in the context of methylation deviation.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example provides associations between entities and their corresponding labels, including 'CD70' as 'protein', 'B cell' as 'cell_type', 'plasma cells' as 'cell_type', 'IL-4' as 'protein', and 'CD40' as 'protein' in the context of differentiation promotion.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example provides associations between entities and their corresponding labels, including 'TAL1' as 'protein' and 'T-ALL' as 'cell_type' in the context of ectopic expression.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example provides a direct association between the entity 'GATA-1' and its corresponding entity label 'protein' in the context of positive regulators in erythroid cells.\"}\n]",
        "response3": "[{'TCF-1': 'protein'}, {'pan-T-lineage marker': 'cell_type'}, {'lymphoid malignancies': 'cell_type'}]",
        "prediction": "{'TCF-1': 'protein', 'pan-T-lineage marker': 'cell_type', 'lymphoid malignancies': 'cell_type'}"
    },
    {
        "idx": 466,
        "sentence": "(ABSTRACT TRUNCATED AT 250 WORDS)",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The example provides a clear and specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The example provides multiple entities with corresponding labels, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The example provides a specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The example provides a clear and specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The example provides a specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The example provides a clear and specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 7\": 4},\n{\"Reason 7\": \"The example provides multiple entities with corresponding labels, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The example provides a specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The example provides a specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The example provides multiple entities with corresponding labels, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The example provides a specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The example provides multiple entities with corresponding labels, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The example provides a specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"The example provides a specific entity with corresponding label, aiding in understanding how to extract named entities from the sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1583,
        "sentence": "Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.",
        "label": {
            "ribonucleoproteins": "protein",
            "Ro(SSA)": "protein",
            "autoantibodies": "protein",
            "HLA class II antigens": "protein",
            "La(SSB)": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the protein 'TCL1' and its association with AIDS IBLP tumors, making it highly relevant for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence explicitly refers to the protein 'WT1' and its exclusive paternal expression, providing clear context for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions 'RXR' and its mutants in the context of supporting erythroid cell outgrowth, making it a valuable example for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence discusses the development of 'lymphoid neoplasms', indicating the relevance of the entity type 'cell_type' in this context.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence directly mentions 'NF-kappa B' and its involvement in the activation of human monocytic cells, making it highly informative for entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides information about 'TCRzeta' and 'p56(lck)' in peripheral blood T cells, making it a valuable example for entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence discusses the abnormality in 'AP-1' DNA binding activity in lymphocytes, highlighting the relevance of the entity type 'DNA' in this context.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions the interaction between 'EBNA-2' and 'PU.1', providing direct evidence for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence links 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell activation', making it highly relevant for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence discusses 'SLAP-130', 'SLP-76', and their association with the T cell antigen receptor, providing valuable information for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence addresses the role of 'NF-kappaB' in the pathogenesis of rheumatoid arthritis, making it a pertinent example for entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions specific proteins like 'myeloperoxidase', 'lysozyme', and 'PU.1' in the context of granulomonocyte-associated lysosomal proteins, aiding in entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides information about the 'retinoic acid receptor alpha' and its association with kDa values, making it relevant for entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence discusses the synergistic activation of 'HLA-DRA' expression in B cells by 'Oct-2A' and 'HMG I/Y', providing valuable context for entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'T lymphocytes' and their recognition of antigens bound to 'HLA-molecules', making it highly relevant for entity extraction.\"}\n]",
        "response3": "[{\"HLA class II antigens\": \"protein\"}, {\"ribonucleoproteins Ro(SSA)\": \"protein\"}, {\"La(SSB)\": \"protein\"}]",
        "prediction": "{'HLA class II antigens': 'protein', 'ribonucleoproteins Ro(SSA)': 'protein', 'La(SSB)': 'protein'}"
    },
    {
        "idx": 592,
        "sentence": "The DNA isolated contained an open reading frame encoding 108 amino acid residues .",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\n        \"Example 1\": 4\n    },\n    {\n        \"Reason 1\": \"The example contains a specific protein entity 'CD95 ligand' which matches the protein entity type in the target sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example provides a specific cell line entity 'SIVsmmPBj14' which directly matches the cell_line entity type in the target sentence, making it highly helpful for extracting cell line entities.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The example includes 'cDNAs' which corresponds to the DNA entity type in the target sentence, assisting in identifying DNA entities.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example mentions 'Protein' which aligns with the protein entity type in the target sentence, making it very helpful for recognizing protein entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example provides 'E2A' as a protein entity, matching the protein entity type in the target sentence, thus aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example contains multiple protein entities such as 'SLAP-130', 'SLP-76', and 'T cell' which align with the protein and cell_type entity types in the target sentence, making it highly beneficial for identifying these entities.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example includes 'hepatitis B virus' and 'HBxAg' which correspond to DNA and protein entity types respectively in the target sentence, providing direct assistance in recognizing these entities.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The example mentions 'GM-CSF' which matches the protein entity type in the target sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example includes 'NF-kappa B' which aligns with the DNA entity type in the target sentence, assisting in identifying DNA entities.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example provides 'p21(WAF1/CIP1)' and 'p27(KIP1)' as protein entities, directly matching the protein entity type in the target sentence, making it very helpful for recognizing protein entities.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The example mentions 'protein' which corresponds to the protein entity type in the target sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example includes 'p50p50' as a protein entity, aligning with the protein entity type in the target sentence, thus providing significant help in identifying protein entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example contains multiple protein entities such as 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which match the protein entity type in the target sentence, making it highly beneficial for identifying these entities.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example provides 'p50' and 'p65' as protein entities, and 'DNA' and 'protein' as entities, aligning with the protein and DNA entity types in the target sentence, making it very helpful for recognizing these entities.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The example includes 'GM-kappa B', 'GC-box', 'GC-motif', and 'GM-kappa B motif' which correspond to the DNA entity type in the target sentence, assisting in identifying DNA entities.\"\n    }\n]",
        "response3": "[{'DNA': 'DNA'}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 163,
        "sentence": "This phenomenon can be mimicked by administering MP in divided doses.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a direct mapping between the entity 'IL-2' and its corresponding entity label 'protein' in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides a direct mapping between the entity 'phosphocreatine' and its corresponding entity label 'protein' in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides mappings for multiple entities ('AP-1', 'PMA', 'monocytes', 'macrophages') to their corresponding entity labels ('protein', 'protein', 'cell_type', 'cell_type') in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides mappings for multiple entities ('granulocytes', 'T cells') to their corresponding entity labels ('cell_type', 'cell_type') in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides mappings for multiple entities ('NF-kappa B', 'AP-1') to their corresponding entity labels ('protein', 'protein') in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides mappings for multiple entities ('IL-4', 'LPS', 'AP-1') to their corresponding entity labels ('protein', 'protein', 'protein') in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a direct mapping between the entity 'AP-1' and its corresponding entity label 'DNA' in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides mappings for multiple entities ('CD14', 'CD23') to their corresponding entity labels ('protein', 'protein') in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides mappings for multiple entities ('SIVmacMER', 'SIVmac239', 'CEMx174') to their corresponding entity labels ('cell_line', 'cell_line', 'cell_line') in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides mappings for multiple entities ('MTHC', 'TNF-alpha', 'IFN-gamma', 'DC') to their corresponding entity labels ('cell_line', 'protein', 'protein', 'cell_type') in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a direct mapping between the entity 'T lymphocytes' and its corresponding entity label 'cell_type' in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides mappings for multiple entities ('SP1', 'caspases', 'B-cell') to their corresponding entity labels ('protein', 'protein', 'cell_type') in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides mappings for multiple entities ('Tip', 'Tap', 'Jurkat-T cells') to their corresponding entity labels ('protein', 'protein', 'cell_line') in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides mappings for multiple entities ('PMA', 'LPS', 'staurosporine', 'bisindolylmaleimide', 'genistein') to their corresponding entity labels ('protein', 'protein', 'protein', 'protein', 'protein') in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides mappings for multiple entities ('interleukin-1beta', 'inhibitor-kappaB alpha') to their corresponding entity labels ('RNA', 'protein') in the target sentence.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example provides mappings for multiple entities ('PMA', 'U1 cells') to their corresponding entity labels ('cell_line', 'cell_line') in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1751,
        "sentence": "This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.",
        "label": {
            "NFAT": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"Both NF-kappa B and I kappa B alpha are mentioned in the sentence, and they are correctly identified as proteins.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"Both IkappaBalpha and NF-kappaB are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"NF-kappa B is correctly identified as a protein in the sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"Both CD40 and NF-kappa B are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"NF-kappa B is correctly identified as a protein in the sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"Both IkappaBbeta and NF-kappaB are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"Multiple proteins such as CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor are correctly identified in the sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"Both RelA and NF-kappaB1 are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"Both TRAF6 and RANKL are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"Both IL-2, Aiolos, and Ras are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"Both IL-2, c-Jun, and c-Fos are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"Both NF-kappaB, Tax, and ATL are correctly identified as proteins and cell types in the sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"NF-E2 is correctly identified as a protein in the sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"Both PAFR, PAF, NF-kappa B, and protein kinase C are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"Both NF-kappa B and AP-1 are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"NF-kappa B is correctly identified as a protein in the sentence.\"\n    }\n]",
        "response3": "[{\"calcineurin\": \"protein\"}, {\"NFAT\": \"protein\"}]",
        "prediction": "{'calcineurin': 'protein', 'NFAT': 'protein'}"
    },
    {
        "idx": 1774,
        "sentence": "Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .",
        "label": {
            "PBMC": "cell_type",
            "PBMC receptors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 5},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 206,
        "sentence": "It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 3},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 928,
        "sentence": "A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).",
        "label": {
            "ets-1": "protein",
            "long terminal repeat": "DNA",
            "double-stranded oligonucleotide probe": "DNA",
            "mouse thymus cDNA expression library": "DNA",
            "mouse ets-1 cDNA clone": "DNA",
            "LTR": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'SIVsmmPBj14' and its entity label 'cell_line', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions multiple entities such as 'SIVmacMER', 'SIVmac239', and 'CEMx174' with their corresponding entity label 'cell_line', providing valuable information for named entity extraction.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions 'GM-CSF' as a protein, which is helpful for extracting named entities, although the context could provide more clarity.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions 'PML/RARalpha' as a protein, which is helpful for extracting named entities, although additional context could enhance the clarity.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type, which is helpful for extracting named entities, although more context could improve the understanding.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions 'protein' as an entity label, making it highly helpful for named entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear mentions of 'Sp1' and 'Ets' as proteins, aiding in named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'c-kit' and 'IL-4R alpha chain' as proteins, which are valuable for named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'TCF-1' as a protein, aiding in named entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'MIP-1 alpha', 'GOS19', 'LD78', and 'AT464' as proteins, providing valuable information for named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'Sp1' and 'CD14' as proteins, aiding in named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' as proteins, providing extensive information for named entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'SLAP-130', 'SLP-76', and 'T cell' as proteins and cell type, aiding in named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'Egr-1' as a protein, providing valuable information for named entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'E2A' as a protein, aiding in named entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'CD95 ligand' as a protein, providing valuable information for named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1301,
        "sentence": "It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The expression of NDP kinase was intense in KA and SCC compared with BCC.\": 4},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5}\n]",
        "response3": "[{\"ER\": \"protein\"}]",
        "prediction": "{'ER': 'protein'}"
    },
    {
        "idx": 1708,
        "sentence": "The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .",
        "label": {
            "nuclear factor (NF)-kappa B": "protein",
            "T cell lines": "cell_line",
            "Ca(2+) -dependent phosphatase": "protein",
            "PKC": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a direct mapping between the entity 'calcineurin' in the sentence and its corresponding entity label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides direct mappings between the entities 'IkappaBalpha' and 'NF-kappaB' in the sentence and their corresponding entity labels 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides direct mappings between the entities 'IkappaBbeta' and 'NF-kappaB' in the sentence and their corresponding entity labels 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides direct mappings between the entities 'NF-kappa B' and 'AP-1' in the sentence and their corresponding entity labels 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides direct mappings between the entities 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' in the sentence and their corresponding entity labels 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides direct mappings between the entities 'CD40' and 'NF-kappa B' in the sentence and their corresponding entity labels 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides direct mappings between the entities 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' in the sentence and their corresponding entity labels 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example provides direct mappings between the entities 'NF-kappaB', 'Tax', and 'ATL' in the sentence and their corresponding entity labels 'protein' and 'cell_type', aiding in the extraction of named entities. The mention of 'Tax' as a cell type may slightly reduce the score.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides direct mappings between the entities 'NF-kappa B' and 'I kappa B beta' in the sentence and their corresponding entity labels 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides direct mappings between the entities 'NF-kappa B' and 'I kappa B alpha' in the sentence and their corresponding entity labels 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example provides a direct mapping between the entity 'NF-kappa B' in the sentence and its corresponding entity label 'protein', aiding in the extraction of named entities. The mention of 'RelA' as a protein may slightly reduce the score.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides direct mappings between the entities 'Syk', 'Zap', and 'T cell' in the sentence and their corresponding entity labels 'protein' and 'cell_type', aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a direct mapping between the entity 'NF-kappa B' in the sentence and its corresponding entity label 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides direct mappings between the entities 'SP1', 'caspases', and 'B-cell' in the sentence and their corresponding entity labels 'protein' and 'cell_type', aiding in the extraction of named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a direct mapping between the entity 'NF-kappa B' in the sentence and its corresponding entity label 'protein', aiding in the extraction of named entities.\"}\n]\n```",
        "response3": "```json\n[{\"calcineurin\": \"protein\"}, {\"FK506\": \"protein\"}, {\"CsA\": \"protein\"}, {\"PKC\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]\n```",
        "prediction": "{'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 747,
        "sentence": "Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).",
        "label": {
            "unspliced mRNA": "RNA"
        },
        "response1": "['protein', 'RNA']",
        "response2": "```json\n[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example contains multiple instances of protein entities that are relevant to the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides protein entities that are directly related to the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example includes protein entities mentioned in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example contains protein entities that are part of the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example directly mentions a protein entity relevant to the target sentence.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The example includes a cell type entity that is not directly related to the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example provides a protein entity mentioned in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example contains protein entities that are part of the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example directly mentions a protein entity relevant to the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example includes protein entities mentioned in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example provides protein entities that are directly related to the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example contains protein entities that are relevant to the target sentence.\"},\n    {\"Example 13\": 3},\n    {\"Reason 13\": \"The example includes a cell type entity that is not directly related to the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example provides protein entities mentioned in the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example contains protein entities that are part of the target sentence.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 333,
        "sentence": "These protoenhancers alone are weakly or not responsive to R .",
        "label": {
            "protoenhancers": "DNA",
            "R": "protein"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 758,
        "sentence": "Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.",
        "label": {
            "CEM-C7": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 3},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 2},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).\": 5},\n    {\"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 727,
        "sentence": "The importance of the internal ATGs to Rex function is not known.",
        "label": {
            "Rex": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 5},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 429,
        "sentence": "As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.",
        "label": {
            "TSAP": "protein",
            "mammalian protein": "protein",
            "sea urchin binding sites": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 3},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 4},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 3},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1372,
        "sentence": "The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).",
        "label": {
            "14q32.1": "DNA",
            "TCR alpha/beta loci": "DNA",
            "t(14;14)(q11;q32.1)": "DNA",
            "TCL1 oncogene": "DNA",
            "human chromosome": "DNA",
            "t(7;14)(q35;q32.1)": "DNA",
            "inv14(q11;q32.1)": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of the entity 'BRCA1' being associated with the label 'protein'.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence provides a clear example of the entity 'TCF-1' being associated with the label 'protein', but the context is specific to non-T cells which may slightly reduce the generalizability of the example.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of entities ('SLAP-130', 'SLP-76', 'T cell') associated with their respective labels ('protein', 'protein', 'cell_type') in a context relevant to T cell biology.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of entities ('IkappaBbeta', 'NF-kappaB') associated with the label 'protein' in the context of a specific mechanism.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides a clear example of the entity 'Th2-type lymphocytes' being associated with the label 'cell_type', but the context is specific to cytokine promoters which may slightly reduce the generalizability of the example.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides multiple examples of entities ('IL-2 receptor alpha subunit', 'p21ras', 'B cell') associated with their respective labels ('protein', 'protein', 'cell_type') in the context of lymphocyte activation.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of entities ('c-kit', 'IL-4R alpha chain') associated with the label 'protein' in the context of a chimeric receptor.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides multiple examples of entities ('IL-13', 'IL-4R', 'JAK2', 'IL-13R') associated with their respective labels ('protein', 'protein', 'protein', 'protein') in the context of signaling pathways in colon cancer cells.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides multiple examples of entities ('TCRzeta', 'p56(lck)') associated with the label 'protein' in the context of peripheral blood T cells and their levels in patients.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides a clear example of the entity 'T cell' being associated with the label 'cell_type', but the context is specific to a kB-like proto-enhancer element which may slightly reduce the generalizability of the example.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence provides an example of the entity 'SCM-1' associated with the label 'cell_line', but the context is limited to examining regulatory mechanisms.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of entities ('TAL1', 'T-ALL') associated with their respective labels ('protein', 'cell_type') in the context of T-ALL development.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a clear example of the entity 'T-PLL' being associated with the label 'cell_type' in the context of genetic changes.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides a clear example of the entity 'TCL1' being associated with the label 'protein' in the context of AIDS IBLP tumors.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of entities ('SCL', 'GATA-1') associated with the label 'protein' in the context of cell lineages.\"},\n]",
        "response3": "[{\"TCL1\": \"protein\"}, {\"TCR alpha/beta\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"T-prolymphocytic (T-PLL)\": \"cell_type\"}]",
        "prediction": "{'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-prolymphocytic (T-PLL)': 'cell_type'}"
    },
    {
        "idx": 546,
        "sentence": "Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .",
        "label": {
            "T lymphocytes": "cell_type",
            "immunophilin": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein entity (NF-kappa B) and its corresponding label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides examples of cell type (T cell) and protein entities (IL-2, IL-2 receptor, CD28) and their corresponding labels, but the relevance of CD28 to the target sentence is slightly less clear.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides examples of RNA entity (IL-5 mRNA), cell type (TCR), and protein entities (IL-2R, dexamethasone) and their corresponding labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of protein entities (NF-kappa B, I kappa B alpha) and their corresponding labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides an example of a protein entity (IL-2) and its corresponding label.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) and their corresponding labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of protein entity (NF-ATc) and cell type (T lymphocytes) and their corresponding labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of protein entity (IL-2 receptor alpha subunit), protein entity (p21ras), and cell type (B cell) and their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of protein entities (Syk, Zap) and cell type (T cell) and their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of protein entities (IL-2, NF-kappa B, AP-1) and their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of protein entities (IL-2, Aiolos, Ras) and their corresponding labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of protein entities (IkappaBalpha, NF-kappaB) and their corresponding labels.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1437,
        "sentence": "In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.",
        "label": {
            "hTR beta 1": "protein",
            "hTR beta 1 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"IFN A\": \"The entity label 'protein' is helpful because it indicates that IFN A is a protein, which helps in identifying named entities related to proteins in the sentence.\"},\n    {\"IFNA\": \"The entity label 'protein' is helpful because it indicates that IFNA is a protein, which helps in identifying named entities related to proteins in the sentence.\"},\n    {\"interleukin-2\": \"The entity label 'protein' is helpful because it indicates that interleukin-2 is a protein, which helps in identifying named entities related to proteins in the sentence.\"},\n    {\"interleukin-2 receptor\": \"The entity label 'protein' is helpful because it indicates that interleukin-2 receptor is a protein, which helps in identifying named entities related to proteins in the sentence.\"},\n    {\"phytohemagglutinin\": \"The entity label 'protein' is helpful because it indicates that phytohemagglutinin is a protein, which helps in identifying named entities related to proteins in the sentence.\"},\n    {\"phorbol myristate acetate\": \"The entity label 'protein' is helpful because it indicates that phorbol myristate acetate is a protein, which helps in identifying named entities related to proteins in the sentence.\"}\n]",
        "response3": "[{\"hTR beta 1 mRNA\": \"RNA\"}]",
        "prediction": "{'hTR beta 1 mRNA': 'RNA'}"
    },
    {
        "idx": 1399,
        "sentence": "To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .",
        "label": {
            "hematopoietic cell lineage": "cell_line",
            "human estrogen receptor": "protein",
            "NF-M": "protein",
            "hormone binding domain": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "```json\n[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence contains a specific protein entity (NF-kappa B) that is relevant for named entity extraction.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple specific protein entities (IL-2, c-Jun, c-Fos) that are relevant for named entity extraction.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains a specific protein entity (NF-E2) that is relevant for named entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains a specific protein entity (E2A) that is relevant for named entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains a specific protein entity (MNDA) and a specific cell line entity (Philadelphia chromosome-positive chronic myeloid leukemia) that are relevant for named entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains specific protein entities (c-kit, IL-4R alpha chain) that are relevant for named entity extraction.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains a specific protein entity (PML/RARalpha) that is relevant for named entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains a specific protein entity (RXR) that is relevant for named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein entities (TRAF6, RANKL, NF-kappaB) that are relevant for named entity extraction.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains a specific protein entity (NF-ATc) and specific cell type entities (T lymphocytes, embryonic cardiac cells) that are relevant for named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein entities (CD40, NF-kappa B) that are relevant for named entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains a specific protein entity (GATA-1) that is relevant for named entity extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains a specific protein entity (TCF-1) that is relevant for named entity extraction.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains a specific protein entity (NF-kappa B) that is relevant for named entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence contains a specific protein entity (IL-2) that is relevant for named entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains specific protein entities (ZEB, c-Myb, Ets) and a specific cell type entity (hematopoietic cells) that are relevant for named entity extraction.\"}\n]\n```",
        "response3": "```json\n[{\"NF-M\": \"protein\"}, {\"hormone binding domain\": \"protein\"}, {\"human estrogen receptor\": \"protein\"}, {\"hematopoietic cell\": \"cell_type\"}]\n```",
        "prediction": "{'NF-M': 'protein', 'hormone binding domain': 'protein', 'human estrogen receptor': 'protein', 'hematopoietic cell': 'cell_type'}"
    },
    {
        "idx": 1327,
        "sentence": "Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .",
        "label": {
            "human IL-4": "protein",
            "human IL-4 promoter": "DNA",
            "NF-IL6": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example directly mentions the entity 'IL-4' and its association with the entity type 'protein' which is present in the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example directly mentions entities like 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example directly mentions entities like 'NF-kappaB', 'Tax', and 'ATL' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example directly mentions entities like 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example directly mentions entities like 'NF-kappa B' and 'I kappa B alpha' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example directly mentions entities like 'NF-ATc' and 'T lymphocytes' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example directly mentions the entity 'NF-kappa B' with its corresponding entity type 'protein' which is present in the target sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly mentions entities like 'IL-12', 'STAT4', 'NK cells', 'T cells', and 'IL-12 receptor' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example directly mentions the entity 'NF-kappa B' with its corresponding entity type 'protein' which is present in the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example directly mentions entities like 'IL-4', 'LPS', and 'AP-1' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example directly mentions entities like 'IL-2', 'IFN-gamma', 'jak kinases', 'STAT1(alpha)' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example directly mentions entities like 'IkappaBbeta' and 'NF-kappaB' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example directly mentions entities like 'IL-13', 'IL-4', 'B cell', and 'monocyte' with their corresponding entity types 'protein' and 'cell_type' which are present in the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example directly mentions the entity 'Th2-type lymphocytes' with its corresponding entity type 'cell_type' which is present in the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example directly mentions entities like 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R' with their corresponding entity types 'protein' which are present in the target sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The example directly mentions the entity 'IL-2' with its corresponding entity type 'protein' which is present in the target sentence.\"\n    }\n]",
        "response3": "[{\"NF-IL6\": \"protein\"}, {\"IL-4\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 146,
        "sentence": "Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .",
        "label": {
            "\"octamer\" motif": "DNA",
            "HLA-DR alpha (DRA) promoter": "DNA",
            "class II promoters": "DNA",
            "immunoglobulin variable region promoters": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5}\n]",
        "response3": "[{\"HLA-DR alpha (DRA)\": \"protein\"}, {\"octamer\": \"protein\"}, {\"immunoglobulin variable region\": \"protein\"}, {\"B cell-specific\": \"cell_type\"}]",
        "prediction": "{'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}"
    },
    {
        "idx": 1247,
        "sentence": "The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .",
        "label": {
            "Janus family tyrosine kinase": "protein",
            "Jak3": "protein",
            "gamma c": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1300,
        "sentence": "As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 350,
        "sentence": "Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .",
        "label": {
            "control cell line": "cell_line",
            "cell line": "cell_line",
            "Ro-VDR": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names like TIMP-1 and DNA, which are directly mentioned and can be easily identified as protein and DNA entities.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions specific protein name MNDA and a cell line name Philadelphia chromosome-positive chronic myeloid leukemia, which can help in identifying protein and cell_line entities.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides multiple protein names like IFN A, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are directly mentioned and can be easily identified as protein entities.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence mentions a specific protein name CD14, which can help in identifying the protein entity.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence mentions a specific protein name retinoic acid receptor alpha, which can help in identifying the protein entity.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence mentions a specific protein name WT1 and a cell line name myeloid cell lines, which can help in identifying protein and cell_line entities.\"},\n{\"Example 7\": 4},\n{\"Reason 7\": \"The sentence mentions a specific protein name NF-E2, which can help in identifying the protein entity.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence mentions a specific protein name retinoic acid receptor alpha, which can help in identifying the protein entity.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The sentence mentions a specific protein name RXR, which can help in identifying the protein entity.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The sentence mentions a specific protein name ZAP-70, which can help in identifying the protein entity.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence provides multiple protein names like IL-5 mRNA, TCR, IL-2R, and dexamethasone, which are directly mentioned and can be easily identified as RNA, cell_type, protein, and protein entities.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence provides multiple protein names like VDR, RXR, GRIP-1, DRIP205, and DRIP, which are directly mentioned and can be easily identified as protein entities.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence provides multiple protein names like interleukin-2, alpha chain, CD25, and IL-2 receptor, which are directly mentioned and can be easily identified as protein entities.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence provides multiple protein names like Protein kinase B, phosphatidylinositol 3-kinase, STAT5, erythropoietin, and c-Akt, along with cell line names HCD57 and HCD57-SREI, which are directly mentioned and can be easily identified as protein and cell_line entities.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions specific cell line names like 47.10 and nontransgenic mice, which can help in identifying cell_line entities.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence provides multiple entity types like DNA, cell_type, and cell_line, along with specific names like 2-deoxyguanosine, lymphoid progenitor cells, thymus stromal cells, B cell, tg epsilon26, fetal liver cells, and T cell, which are directly mentioned and can be easily identified as DNA, cell_type, and cell_line entities.\"}\n]",
        "response3": "[{'24,25-(OH)2D3': 'protein'}, {'1,25(OH)2D3': 'protein'}, {'Ro-VDR': 'cell_line'}, {'hormone': 'protein'}, {'cell line': 'cell_line'}, {'normal donor': 'cell_line'}]",
        "prediction": "{'24,25-(OH)2D3': 'protein', '1,25(OH)2D3': 'protein', 'Ro-VDR': 'cell_line', 'hormone': 'protein', 'cell line': 'cell_line', 'normal donor': 'cell_line'}"
    },
    {
        "idx": 1093,
        "sentence": "The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).",
        "label": {
            "VDR": "protein",
            "vitamin D receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1493,
        "sentence": "Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .",
        "label": {
            "myeloid cells": "cell_type",
            "NF-kappa B": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'NF-kappa B' and its corresponding label 'protein', making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"NF-kappa B\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}, {\"HIV-1\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'HIV-1': 'cell_type'}"
    },
    {
        "idx": 334,
        "sentence": "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .",
        "label": {
            "protoenhancers": "DNA",
            "overlapping palindromes": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n{\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 5},\n{\"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n{\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n{\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 946,
        "sentence": "Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence provides cell line and protein names that are relevant to the target sentence, aiding in identifying entities of these types.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence mentions various protein names and cell line names that align with the entity types in the target sentence, making it highly relevant.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence includes RNA, cell type, and protein names that are useful for identifying entities of these types in the target sentence.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence mentions a specific protein name that matches the entity type in the target sentence, providing relevant information.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence contains a cell line name and a cell type reference that can help in identifying entities of these types in the target sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence directly mentions a DNA binding activity, which is crucial for identifying DNA entities in the target sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides specific protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The sentence mentions RNA and cell line names that are relevant to the target sentence, aiding in identifying entities of these types.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence contains specific DNA and protein references that align with the entity types in the target sentence, making it highly relevant.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence mentions protein names and cell type references that directly match the entity types in the target sentence.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence provides cell type references that are useful for identifying entities of these types in the target sentence.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence mentions a specific protein name that matches the entity type in the target sentence, providing relevant information.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence contains specific protein names that align with the entity types in the target sentence, making it highly relevant.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence directly mentions protein names and their corresponding entity labels, which are crucial for identifying entities of these types in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 777,
        "sentence": "We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.",
        "label": {
            "OTF-2": "protein",
            "immunoglobulin gene": "DNA",
            "steady-state immunoglobulin heavy-chain mRNA": "RNA",
            "human pre-B-cell lines": "cell_line",
            "immunoglobulin heavy-chain": "protein"
        },
        "response1": "['cell_line', 'RNA', 'protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence directly mentions the term 'protein' and provides a clear example of a protein being purified and its encoding gene cloned.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence directly mentions the term 'Egr-1' as a protein and provides information about its function as a zinc finger transcription factor.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence directly mentions the term 'TCF-1' as a protein and describes the generation of antiserum against it.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence directly mentions the term 'E2A' as a protein and discusses the use of polyclonal antisera to probe its expression.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type, providing a clear example of a cell type.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions 'IgH' as DNA, providing a clear example of a DNA entity.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence mentions 'cDNAs' as DNA, providing a clear example of a DNA entity.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence mentions various proteins such as 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)', providing multiple examples of protein entities.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence mentions 'NF-ATc' as a protein and 'T lymphocytes' as a cell type, providing examples of both entity types.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence mentions proteins like 'IL-2', 'c-Jun', and 'c-Fos', providing examples of protein entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence mentions entities such as 'CD70' (protein), 'B cell' (cell type), 'plasma cells' (cell type), 'IL-4' (protein), and 'CD40' (protein), providing multiple examples of different entity types.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions 'NF-ATc' as a protein and 'T lymphocytes' and 'embryonic cardiac cells' as cell types, providing examples of these entity types.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence mentions 'GM-CSF' as a protein, providing an example of a protein entity.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence mentions entities like 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' as proteins, providing multiple examples of protein entities.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions 'c-kit' and 'IL-4R alpha chain' as proteins, providing examples of protein entities.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence mentions 'WT1' as a protein, providing an example of a protein entity.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 552,
        "sentence": "Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .",
        "label": {
            "IL-2": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5}\n]\n```",
        "response3": "```json\n[{\"FK506\": \"protein\"}, {\"rapamycin\": \"protein\"}, {\"IL-2\": \"protein\"}]\n```",
        "prediction": "{'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 1310,
        "sentence": "The abundant chromosomal protein HMG-1 belongs to this subgroup.",
        "label": {
            "HMG-1": "protein",
            "chromosomal protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1409,
        "sentence": "We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .",
        "label": {
            "IL-2": "protein",
            "T cell lines": "cell_line",
            "PRL": "protein",
            "Stat proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Sentence 1\": 4},\n    {\"Sentence 2\": 5},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 4},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 4},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 4},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[{\"PRL\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"Stat proteins\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]",
        "prediction": "{'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 1140,
        "sentence": "The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .",
        "label": {
            "transcription factors": "protein",
            "conserved cis-acting sequence": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'AP-1' and the entity type 'DNA', which is highly helpful for understanding the relationship between the entities in the sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example correctly identifies the entities 'Jun' and 'ATF-2' as proteins, which are relevant to the context of transcription and binding, making it quite helpful in extracting named entities.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The example correctly identifies 'Th2-type lymphocytes' as a cell type, which is relevant in the context of cytokine expression, providing moderate help in understanding the entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example correctly identifies 'Protein' as a protein entity, which is crucial in the context of genomic sequences and transcription, making it quite helpful in entity extraction.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example correctly identifies 'Egr-1' as a protein entity, which is essential for understanding the role of a zinc finger transcription factor, providing significant help in entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example correctly identifies 'IL-2', 'c-Jun', and 'c-Fos' as protein entities, which are crucial in the context of nuclear factors and promoter binding, making it highly helpful in entity extraction.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example correctly identifies 'GM-CSF' as a protein entity, which is highly conserved in genes, providing significant help in understanding the entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example correctly identifies 'GATA-1' as a protein entity, which is essential for understanding the regulators of transcription factors in erythroid cells, making it quite helpful in entity extraction.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example correctly identifies 'TCF-1' as a protein entity, which transactivates through its cognate motif, providing significant help in understanding the entity.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example correctly identifies 'Stat proteins' as protein entities, which form dimers and induce transcription, making it quite helpful in entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example correctly identifies 'EKLF', 'CBP', 'p300', and 'P/CAF' as protein entities, which interact in vivo and are acetylated transcription factors, providing highly helpful information for entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example correctly identifies 'SCL' and 'GATA-1' as protein entities, expressed in specific cell lineages, making it quite helpful in entity extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example correctly identifies 'G-CSF' as a protein entity, which mediates effects through receptor binding, providing significant help in understanding the entity.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example correctly identifies 'VDR', 'RXR', 'GRIP-1', 'DRIP205', and 'DRIP' as protein entities, involved in analogue effects and coactivator complexes, making it highly helpful in entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example correctly identifies 'ZEB', 'c-Myb', 'Ets', and 'hematopoietic cells' as protein and cell type entities, involved in gene expression regulation, providing significant help in understanding the entities.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example correctly identifies 'tal-1', 'GATA-binding proteins', and 'hematopoiesis' as protein and cell type entities, expressed during hematopoiesis, making it quite helpful in entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 449,
        "sentence": "We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .",
        "label": {
            "ubiquitous transcription factor": "protein",
            "E3 enhancer motif": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides clear and direct mentions of specific protein names (EKLF, CBP, p300, P/CAF) which are essential for named entity extraction.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence directly mentions protein names (Jun, ATF-2) which are crucial for named entity extraction.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence explicitly mentions 'immunoglobulin kappa 3' enhancer' which is a DNA entity, aiding in named entity extraction.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence mentions 'A-myb' as a specific protein name, aiding in named entity extraction.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence provides clear mentions of protein (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) which are crucial for named entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions specific protein names (Sp1, Ets) which are essential for named entity extraction.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence explicitly mentions 'Th2-type lymphocytes' as a cell type, aiding in named entity extraction.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence provides a specific protein name (p50p50) which is crucial for named entity extraction.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence mentions a specific protein name (TCF-1) which is essential for named entity extraction.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence mentions a specific protein name (GATA-1) which is crucial for named entity extraction.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence provides specific protein names (CREB, AR-CRE) which are essential for named entity extraction.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions specific DNA entity (CCAAT box) and protein (EKLF binding site) which are crucial for named entity extraction.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence mentions a specific protein name (Egr-1) which is essential for named entity extraction.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence provides specific protein names (IL-2, c-Jun, c-Fos) which are crucial for named entity extraction.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions specific protein names (ZEB, c-Myb, Ets) and a cell type (hematopoietic cells) which are essential for named entity extraction.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence mentions specific protein names (p50, p65) and DNA entity, aiding in named entity extraction.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1402,
        "sentence": "At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .",
        "label": {
            "eosinophil": "cell_type",
            "myeloid lineages": "cell_type",
            "differentiation markers": "protein",
            "progenitor-specific surface markers": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'GATA-1' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example directly links the entity 'Egr-1' to the label 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example explicitly connects the entity 'NF-E2' to the label 'protein' in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example clearly identifies 'retinoic acid receptor alpha' as a protein in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example shows the entity 'CD14' as a protein in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example correctly identifies 'Th1' and 'Th2' as cell types based on the sentence context.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example accurately labels 'E2A' as a protein in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example correctly identifies 'UAS1' as a cell line and 'B cell' as a cell type in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example connects 'WT1' to the label 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example shows 'CD14' and 'CD23' as proteins in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example correctly identifies 'myeloperoxidase', 'lysozyme', and 'PU.1' as proteins in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example correctly labels 'WT1' as a protein and 'myeloid cell lines' as cell lines in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example accurately identifies 'MNDA' as a protein and 'Philadelphia chromosome-positive chronic myeloid leukemia' as a cell line in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example correctly labels 'granulocytes' and 'T cells' as cell types in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a direct mapping between 'GATA-1' and 'protein' in the sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example correctly identifies 'Sp1' and 'Ets' as proteins in the sentence.\"}\n]",
        "response3": "[{'eosinophil': 'cell_type'}, {'myeloid': 'cell_type'}]",
        "prediction": "{'eosinophil': 'cell_type', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 664,
        "sentence": "Interferon-gamma and the sexual dimorphism of autoimmunity .",
        "label": {
            "Interferon-gamma": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3, and STAT5 proteins in normal human B cells.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1726,
        "sentence": "It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .",
        "label": {
            "NF-kappa B": "protein",
            "cytotoxic cytokine": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains the entity 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains the entity 'ARDS' which is not in the entity label set, but 'NF-kappa B' is labeled as 'protein'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains the entities 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' which are all labeled as 'protein' in the entity label set.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains the entities 'NF-kappa B' and 'I kappa B alpha' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains the entity 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains the entities 'IkappaBalpha' and 'NF-kappaB' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains the entity 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains the entity 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains the entity 'NF-kappaB' which is labeled as 'protein' and 'rheumatoid arthritis' which is labeled as 'cell_type' in the entity label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains the entities 'IkappaBbeta' and 'NF-kappaB' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains the entities 'NF-kappaB', 'Tax', and 'ATL' which are all labeled as 'protein' and 'cell_type' in the entity label set.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains the entities 'NF-kappa B' and 'I kappa B alpha' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains the entities 'NF-kappa B' and 'I kappa B beta' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains the entities 'CD40', 'Rel/nuclear factor kappaB', and 'NF-kappaB' which are all labeled as 'protein' in the entity label set, and 'B lymphocytes' which is labeled as 'cell_type'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains the entities 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' which are all labeled as 'cell_type' and 'protein' in the entity label set.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1573,
        "sentence": "Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .",
        "label": {
            "estrogen": "protein",
            "eosinophil cationic protein": "protein",
            "positive cells": "cell_type",
            "progesterone receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence explicitly mentions the term 'protein level' which indicates the presence of protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions 'immunohistochemistry' and 'gene expression', indicating the presence of protein and DNA entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly mentions 'genes encoding eosinophil granule proteins', indicating the presence of protein entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly mentions 'Eosinophils', indicating the presence of cell_type entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'CD70 transfectants', 'B cell cultures', 'plasma cells', 'IL-4', and 'CD40 signaling', indicating the presence of protein and cell_type entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence explicitly mentions 'myeloperoxidase', 'lysozyme', and 'PU.1', indicating the presence of protein entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence explicitly mentions 'CD14' and 'CD23', indicating the presence of protein entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence explicitly mentions 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate', indicating the presence of protein entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence explicitly mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)', indicating the presence of protein entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence explicitly mentions 'granulocytes' and 'T cells', indicating the presence of cell_type entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence explicitly mentions 'IL-2', 'c-Jun', and 'c-Fos', indicating the presence of protein entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence explicitly mentions 'NF-E2', indicating the presence of protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence explicitly mentions 'interleukin-2', 'alpha chain', 'CD25', and 'IL-2 receptor', indicating the presence of protein entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions 'Ter 119 erythroid cells', 'Ter 119 positive cells', 'beta-globin', 'glycoprotein IIb', and 'platelet factor 4 megakaryocytic transcripts', indicating the presence of cell_line and protein entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions 'Erbstatin', 'genistein', 'Egr-1', 'sIg-crosslinking-induced', and 'protein tyrosine phosphorylation', indicating the presence of protein and RNA entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence explicitly mentions 'gp91phox', 'gp91phox promoter constructs', 'bp -267 to -246', 'deletion', and 'promoter activity', indicating the presence of DNA and cell_line entities.\"}\n]",
        "response3": "[{'estrogen': 'protein'}, {'progesterone': 'protein'}, {'eosinophil cationic protein': 'protein'}, {'eosinophils': 'cell_type'}]",
        "prediction": "{'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}"
    },
    {
        "idx": 1589,
        "sentence": "Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .",
        "label": {
            "NF-kappa B": "protein",
            "T helper cell subsets": "cell_type",
            "NF-AT": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B alpha, which directly relate to the entities in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of entities like NF-kappaB, Tax, and ATL, which are relevant to the entities in the target sentence, aiding in understanding the context and relationships between different entities.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence mentions NF-ATc and T lymphocytes, which are similar to NF-AT and T helper cell subsets in the target sentence, providing relevant examples for entity extraction.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence includes entities like NF-kappa B, Tax, and ATL, which are similar to NF-kappa B and T helper cell subsets in the target sentence, aiding in understanding the relationships between different entities.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence directly mentions NF-kappa B, which is a key entity in the target sentence, making it highly relevant for entity extraction.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence provides examples of NF-kappa B and I kappa B alpha, which are directly related to the entities in the target sentence, aiding in understanding the context and relationships between different entities.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence mentions NF-ATc, T lymphocytes, and embryonic cardiac cells, which are similar to NF-AT and T helper cell subsets in the target sentence, providing relevant examples for entity extraction.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence includes the entity GATA-1, which is similar to the protein entity in the target sentence, aiding in understanding the context and relationships between different entities.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence directly mentions NF-kappa B, which is a key entity in the target sentence, making it highly relevant for entity extraction.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence provides examples of NF-kappa B and I kappa B beta, which are directly related to the entities in the target sentence, aiding in understanding the context and relationships between different entities.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence includes entities like PAFR, PAF, NF-kappa B, and protein kinase C, which are directly relevant to the entities in the target sentence, aiding in understanding the context and relationships between different entities.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence mentions Sp1 and Ets, which are similar to the protein entities in the target sentence, providing relevant examples for entity extraction.\"},\n    {\"Sentence\": 2},\n    {\"Reason\": \"The sentence mentions Th1 and Th2, which are similar to cell_type entities in the target sentence, providing some context but not directly related to the entities in the target sentence.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence mentions Th2-type lymphocytes, which is similar to the cell_type entity in the target sentence, providing relevant examples for entity extraction.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence directly mentions IL-2, NF-kappa B, and AP-1, which are key entities in the target sentence, making it highly relevant for entity extraction.\"},\n    {\"Sentence\": 1},\n    {\"Reason\": \"The sentence mentions NF-kappa B as DNA, which is not directly related to the protein entity in the target sentence, making it less helpful for entity extraction.\"}\n]",
        "response3": "[{\"NF-AT\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T helper cell subsets\": \"cell_type\"}]",
        "prediction": "{'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}"
    },
    {
        "idx": 114,
        "sentence": "These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .",
        "label": {
            "NF-KB": "protein",
            "monocytic cell lineage": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with corresponding entity labels, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"NF-KB\": \"protein\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'NF-KB': 'protein'}"
    },
    {
        "idx": 469,
        "sentence": "Cardiac and adrenergic diseases were excluded.",
        "label": {},
        "response1": "None.",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'WT1' to the entity label 'protein' in the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides mappings of the entities 'PBMC' to 'cell_type' and 'adenovirus DNA' to 'DNA' in the target sentence, which are relevant and helpful for entity extraction.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The example provides a mapping of the entity 'phosphocreatine' to the entity label 'protein' in the target sentence, which is somewhat helpful for entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides a mapping of the entity 'AP-1' to the entity label 'DNA' in the target sentence, which is relevant and helpful for entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides multiple mappings of entities to their corresponding labels ('IL-5 mRNA' to 'RNA', 'TCR' to 'cell_type', 'IL-2R' to 'protein', 'dexamethasone' to 'protein') in the target sentence, aiding significantly in the extraction of named entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example provides mappings of the entities 'EBV' to 'cell_line' and 'CD2' to 'protein' in the target sentence, which are relevant and helpful for entity extraction.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The example provides a mapping of the entity 'lymphoid neoplasms' to the entity label 'cell_type' in the target sentence, which is somewhat helpful for entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example provides mappings of the entities 'PBMC' to 'cell_type' and 'adenovirus' to 'DNA' in the target sentence, which are relevant and helpful for entity extraction.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example provides a mapping of the entity 'P selectin' to the entity label 'protein' in the target sentence, which is relevant and helpful for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides mappings of the entities 'cAMP-dependent protein kinase' and 'Rap1' to the entity label 'protein' in the target sentence, aiding significantly in the extraction of named entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example provides mappings of the entities 'MNDA' to 'RNA' and 'myeloid cell lines' to 'cell_line' in the target sentence, which are relevant and helpful for entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides mappings of multiple entities to their corresponding labels ('NF-kB' to 'protein', 'AP-1' to 'protein', 'OCT-1' to 'protein', 'NF-IL-2B' to 'protein') in the target sentence, aiding significantly in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides mappings of entities to their corresponding labels ('MR' to 'protein', 'aldosterone' to 'protein', 'progesterone' to 'protein') in the target sentence, aiding significantly in the extraction of named entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example provides mappings of the entities 'RelB' to 'protein' and 'DC'/'dendritic cells' to 'cell_type' in the target sentence, which are relevant and helpful for entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example provides mappings of the entities 'XP-B' and 'XP-D' to 'cell_line' and 'adenovirus' to 'DNA' in the target sentence, which are relevant and helpful for entity extraction.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1683,
        "sentence": "These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .",
        "label": {
            "c-jun": "DNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"c-jun\": \"protein\"}]",
        "prediction": "{'c-jun': 'protein'}"
    },
    {
        "idx": 1648,
        "sentence": "Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.",
        "label": {
            "PU.1 site": "DNA",
            "GM-CSF receptor alpha": "protein",
            "GM-CSF receptor alpha promoter": "DNA",
            "myelomonocytic cells": "cell_type",
            "C/EBP": "protein",
            "PU.1": "protein",
            "GM-CSF": "protein",
            "C/EBP site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 3},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 3},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 3},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"C/EBP\": \"protein\"}, {\"GM-CSF receptor alpha\": \"protein\"}, {\"myelomonocytic cells\": \"cell_type\"}]",
        "prediction": "{'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic cells': 'cell_type'}"
    },
    {
        "idx": 646,
        "sentence": "Surgically confirmed nodal involvement was observed in 42%.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"WT1\": 5},\n    {\"granulocytes\": 4, \"T cells\": 4},\n    {\"NDP kinase\": 5, \"KA\": 3, \"SCC\": 3, \"BCC\": 3},\n    {\"NF-kappa B\": 5},\n    {\"p21(WAF1/CIP1)\": 5, \"p27(KIP1)\": 5},\n    {\"lymphoid neoplasms\": 4},\n    {\"T-PLL\": 4},\n    {\"PBMC\": 4, \"adenovirus DNA\": 1},\n    {\"TCL1\": 5},\n    {\"NF-kB\": 5, \"AP-1\": 5, \"OCT-1\": 5, \"NF-IL-2B\": 5},\n    {\"TCRzeta\": 5, \"p56(lck)\": 5},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n    {\"nuclear factor-kappa B\": 1, \"NF-kappaB\": 1},\n    {\"PMA\": 4, \"U1 cells\": 4},\n    {\"CD3.TcR\": 5, \"CD18\": 5, \"CD29\": 5},\n    {\"MR\": 5, \"aldosterone\": 5, \"progesterone\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 821,
        "sentence": "(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .",
        "label": {
            "LMP1": "protein",
            "EBNA-2": "protein",
            "EBV type 1 EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 3},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 3},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5}\n]",
        "response3": "[{\"EBV type 2 EBNA-2\": \"protein\"}, {\"LMP1\": \"protein\"}, {\"EBV type 1 EBNA-2\": \"protein\"}]",
        "prediction": "{'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}"
    },
    {
        "idx": 548,
        "sentence": "On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 3},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\": 3},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 135,
        "sentence": "Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).",
        "label": {
            "U9-IIIB": "cell_line",
            "monocytic U937 cells": "cell_line",
            "Tumor necrosis factor alpha ( TNF-alpha ) mRNA": "RNA",
            "chronically HIV infected U937 cell line": "cell_line",
            "Tumor necrosis factor alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'cell_type', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"polymerase chain reaction\": \"DNA\"}, {\"monocytic U937 cells\": \"cell_type\"}, {\"HIV\": \"cell_type\"}, {\"U9-IIIB\": \"cell_line\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'polymerase chain reaction': 'DNA', 'monocytic U937 cells': 'cell_type', 'HIV': 'cell_type', 'U9-IIIB': 'cell_line'}"
    },
    {
        "idx": 432,
        "sentence": "Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .",
        "label": {
            "transfected B cells": "cell_line",
            "TSAP": "protein",
            "mutant TSAP -binding site": "DNA",
            "upstream promoter element": "DNA",
            "BSAP": "protein",
            "B-cell-specific transcription factor": "protein",
            "wild-type": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 3},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"TSAP\": \"protein\"}, {\"sea urchin\": \"cell_line\"}, {\"B cells\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}"
    },
    {
        "idx": 1161,
        "sentence": "Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .",
        "label": {
            "I kappa B alpha": "protein",
            "NF kappa B": "protein",
            "NF kappa B -I kappa B complex": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"Cu2+\": \"cell_line\"}]",
        "prediction": "{'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'cell_line'}"
    },
    {
        "idx": 1794,
        "sentence": "Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .",
        "label": {
            "STAT": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 3},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1470,
        "sentence": "Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .",
        "label": {
            "neutrophil": "cell_type",
            "tumor necrosis factor (TNF)-alpha": "protein",
            "leukocyte adhesion molecule": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 4},\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n{\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n{\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 5},\n{\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 5},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\": 4},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 644,
        "sentence": "Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?",
        "label": {
            "tumor cells": "cell_type",
            "hematopoietic growth factor": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of 'Th2-type lymphocytes' to the 'cell_type' entity label in the target sentence.\"},\n\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example correctly identifies 'NF-kappaB' as a 'protein' entity label, 'Tax' and 'ATL' as 'cell_type' entity labels in the target sentence.\"},\n\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example accurately maps 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R' to the 'protein' entity label in the target sentence.\"},\n\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example correctly identifies 'immunohistochemistry' as a 'protein' entity label, 'gene' as a 'DNA' entity label, and 'cell type' as a 'cell_type' entity label in the target sentence.\"},\n\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The example correctly identifies 'lymphoid neoplasms' as a 'cell_type' entity label in the target sentence.\"},\n\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example accurately maps 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' to the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example correctly identifies 'TAL1' as a 'protein' entity label and 'T-ALL' as a 'cell_type' entity label in the target sentence.\"},\n\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example correctly identifies 'WT1' as a 'protein' entity label and 'myeloid cell lines' as a 'cell_line' entity label in the target sentence.\"},\n\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example accurately maps 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' to the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear and direct mapping of 'MNDA' to the 'protein' entity label and 'Philadelphia chromosome-positive chronic myeloid leukemia' to the 'cell_line' entity label in the target sentence.\"},\n\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example accurately maps 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor' to the 'protein' entity label in the target sentence.\"},\n\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example correctly identifies 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and 'B cells' as 'protein' and 'cell_type' entity labels in the target sentence.\"},\n\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example correctly identifies 'IL-2', 'c-Jun', and 'c-Fos' as 'protein' entity labels in the target sentence.\"},\n\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example accurately maps 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40' to the 'protein' and 'cell_type' entity labels in the target sentence.\"},\n\n    {\"Example 15\": 3},\n    {\"Reason 15\": \"The example correctly identifies 'AP-1' as a 'DNA' entity label in the target sentence.\"},\n\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides a clear and direct mapping of 'B and T cell activation', 'Ramos', 'Jurkat', and 'cDNA microarray technology' to the 'cell_type', 'cell_line', and 'DNA' entity labels in the target sentence.\"}\n]",
        "response3": "[{'lymphocyte': 'cell_type'}, {'breast cancers': 'cell_type'}, {'hematopoietic growth factor': 'protein'}, {'tumor cells': 'cell_type'}]",
        "prediction": "{'lymphocyte': 'cell_type', 'breast cancers': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_type'}"
    },
    {
        "idx": 435,
        "sentence": "Antibodies are produced exclusively in B lymphocytes .",
        "label": {
            "Antibodies": "protein",
            "lymphocytes": "cell_type",
            "B lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"IgH\": 4},\n{\"The example provides a clear association between the entity 'IgH' and the entity label 'DNA', aiding in the extraction of DNA entities from the target sentence.\"},\n{\"Eosinophils\": 5},\n{\"The example directly links the entity 'Eosinophils' to the entity label 'cell_type', making it highly helpful in identifying cell type entities in the target sentence.\"},\n{\"IL-13\": 5},\n{\"IL-4\": 5},\n{\"B cell\": 5},\n{\"monocyte\": 5},\n{\"The example provides multiple associations between entities and their corresponding labels, aiding in the extraction of protein and cell type entities from the target sentence.\"},\n{\"EBV\": 4},\n{\"CD2\": 4},\n{\"The example establishes a connection between the entities 'EBV' and 'CD2' with the entity labels 'cell_line' and 'protein', respectively, contributing to the identification of these entities in the target sentence.\"},\n{\"IL4\": 5},\n{\"IL13\": 5},\n{\"STAT6\": 5},\n{\"STAT3\": 5},\n{\"STAT5\": 5},\n{\"B cells\": 5},\n{\"The example provides clear associations between multiple entities and their labels, facilitating the extraction of protein and cell type entities from the target sentence.\"},\n{\"Th1\": 5},\n{\"Th2\": 5},\n{\"The example directly links the entities 'Th1' and 'Th2' to the entity label 'cell_type', making it highly helpful in identifying cell type entities in the target sentence.\"},\n{\"Th2-type lymphocytes\": 5},\n{\"The example directly associates the entity 'Th2-type lymphocytes' with the entity label 'cell_type', aiding in the extraction of cell type entities from the target sentence.\"},\n{\"CD70\": 5},\n{\"B cell\": 5},\n{\"plasma cells\": 5},\n{\"IL-4\": 5},\n{\"CD40\": 5},\n{\"The example provides clear associations between entities and their labels, aiding in the extraction of protein and cell type entities from the target sentence.\"},\n{\"NF-ATc\": 5},\n{\"T lymphocytes\": 5},\n{\"The example establishes a connection between the entities 'NF-ATc' and 'T lymphocytes' with the entity labels 'protein' and 'cell_type', respectively, contributing to the identification of these entities in the target sentence.\"},\n{\"IL-2 receptor alpha subunit\": 5},\n{\"p21ras\": 5},\n{\"B cell\": 5},\n{\"The example provides clear associations between entities and their labels, aiding in the extraction of protein and cell type entities from the target sentence.\"},\n{\"T lymphocytes\": 5},\n{\"HLA-molecules\": 5},\n{\"The example directly links the entities 'T lymphocytes' and 'HLA-molecules' to the entity labels 'cell_type' and 'protein', respectively, making it highly helpful in identifying these entities in the target sentence.\"},\n{\"E2A\": 5},\n{\"The example directly associates the entity 'E2A' with the entity label 'protein', aiding in the extraction of protein entities from the target sentence.\"},\n{\"lymphocytes\": 5},\n{\"benzene\": 5},\n{\"benzoquinone\": 5},\n{\"The example provides clear associations between entities and their labels, aiding in the extraction of cell type and chemical compound entities from the target sentence.\"},\n{\"EBV\": 5},\n{\"B-cell\": 5},\n{\"The example directly links the entities 'EBV' and 'B-cell' to the entity labels 'cell_type', making it highly helpful in identifying cell type entities in the target sentence.\"},\n{\"CD40\": 5},\n{\"Rel/nuclear factor kappaB\": 5},\n{\"NF-kappaB\": 5},\n{\"B lymphocytes\": 5},\n{\"The example provides clear associations between entities and their labels, aiding in the extraction of protein and cell type entities from the target sentence.\"},\n{\"ICAM-1\": 5},\n{\"CD71\": 5},\n{\"LMP1\": 5},\n{\"IkappaB\": 5},\n{\"The example establishes connections between multiple entities and their labels, aiding in the extraction of protein entities from the target sentence.\"}\n]",
        "response3": "[{\"B lymphocytes\": \"cell_type\"}]",
        "prediction": "{'B lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1342,
        "sentence": "While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.",
        "label": {
            "amino acid domain": "protein",
            "BH1": "protein",
            "BH3": "protein",
            "Bak": "protein",
            "BH2": "protein",
            "Bax": "protein",
            "Bik": "protein",
            "Bcl-2 family": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1022,
        "sentence": "NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .",
        "label": {
            "NK cell NFAT": "protein",
            "AP-1": "protein",
            "nonstimulated cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides clear and direct mentions of specific protein entities in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example directly mentions specific protein entities and their inhibitors, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example mentions specific protein entities and their regulatory pathways, providing valuable information for named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example contains specific protein entities and cell types, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example mentions specific protein entities and their regulatory mechanisms, providing valuable information for named entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example mentions specific protein entities and cell types related to a specific disease, aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides specific protein entities involved in gel-shift analysis, aiding in named entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example mentions a specific protein entity involved in a specific cellular mechanism, aiding in named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example mentions specific protein entities, transcription factors, and cell types, aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example mentions specific protein entities involved in the inhibition of transcription factors, aiding in named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example mentions specific protein entities and their transcriptional properties in specific cell types, aiding in named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example mentions a specific DNA binding activity of a protein entity, aiding in named entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example mentions specific protein entities involved in binding activities, aiding in named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example mentions a specific protein entity and its transactivation ability, aiding in named entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example mentions specific protein entities, their stimulation effects, and cell types, aiding in named entity extraction.\"}\n]",
        "response3": "[{\"NK cell\": \"cell_type\"}, {\"NFAT\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 810,
        "sentence": "Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .",
        "label": {
            "CML cells": "cell_type",
            "IFN-alpha": "protein",
            "CML cytoplasmic proteins": "protein",
            "nuclear protein-DNA complexes": "protein"
        },
        "response1": "['cell_type', 'protein', 'protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"CML\": \"cell_line\"}, {\"IFN-alpha\": \"protein\"}, {\"CML\": \"cell_line\"}, {\"cytoplasmic proteins\": \"protein\"}, {\"nuclear protein-DNA complexes\": \"DNA\"}]",
        "prediction": "{'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}"
    },
    {
        "idx": 1811,
        "sentence": "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .",
        "label": {
            "BLR1": "protein",
            "BLR2": "protein",
            "seven transmembrane receptor": "protein",
            "activated lymphocytes": "cell_type",
            "chemokine receptors": "protein",
            "Burkitt's lymphoma receptor 1": "protein"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 3},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"This suggests that CHEMR1 may be a receptor for unidentified C-C chemokine or a low-affinity receptor for MIP-1alpha .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1316,
        "sentence": "Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.",
        "label": {
            "Helix III": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides a clear and direct mention of 'cDNAs' which is a specific type of DNA, aiding in the extraction of the entity.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence directly mentions 'Tax' and 'TFIIA' as interacting proteins, providing clear context for entity extraction.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' as proteins involved in binding, aiding in the extraction of these entities.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence directly links 'tyrosine' to protein-protein interaction, making it clear that 'tyrosine' is related to proteins.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence provides a specific mention of 'A-myb' as a transcription factor, aiding in the extraction of this protein entity.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions 'IL-4' and 'proteins' in the context of gene expression regulation, aiding in the extraction of these protein entities.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence directly mentions 'retinoic acid receptor alpha' as a model protein, aiding in the extraction of this protein entity.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence provides a clear mention of 'immunoglobulin kappa 3' enhancer' as a DNA element, aiding in the extraction of this DNA entity.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence directly mentions 'EKLF' in the context of recruitment, aiding in the extraction of this protein entity.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence mentions 'IL-2', 'Aiolos', and 'Ras' as proteins involved in cellular distribution and phosphorylation, aiding in the extraction of these entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence mentions 'IL-7R' and 'gamma(c)' as critical proteins in the IL-7R complex, aiding in the extraction of these protein entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions 'CCAAT box' as a DNA element and 'EKLF binding site' as a protein element, aiding in the extraction of these entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type, aiding in the extraction of this cell type entity.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence mentions 'SLAP-130', 'SLP-76', and 'T cell' as proteins and cell type associated with T cell receptor signaling, aiding in the extraction of these entities.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions 'p50p50' as a protein involved in binding, aiding in the extraction of this protein entity.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence mentions 'IL-2' as a protein involved in conferring responsiveness, aiding in the extraction of this protein entity.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 939,
        "sentence": "However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.",
        "label": {
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity along with its corresponding label, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions the entity and its label, providing clear information for named entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly states the entity and its label, aiding in accurate named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions multiple entities along with their labels, providing valuable information for named entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains clear mentions of multiple entities and their corresponding labels, facilitating accurate named entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions the entity and its label, making it highly useful for named entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides explicit mentions of entities and their labels, aiding in accurate named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions multiple entities along with their labels, providing valuable information for named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains clear mentions of multiple entities and their corresponding labels, facilitating accurate named entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly mentions the entity and its label, making it highly useful for named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides explicit mentions of entities and their labels, aiding in accurate named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions multiple entities along with their labels, providing valuable information for named entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains clear mentions of multiple entities and their corresponding labels, facilitating accurate named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence directly mentions the entity and its label, making it highly useful for named entity extraction.\"}\n]",
        "response3": "[{\"EBS\": \"protein\"}]",
        "prediction": "{'EBS': 'protein'}"
    },
    {
        "idx": 292,
        "sentence": "We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.",
        "label": {
            "globin gene": "DNA",
            "mouse embryonic stem (ES) cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"E2A\": 5},\n    {\"MNDA\": 5},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"IgH\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"GM-CSF\": 5},\n    {\"GATA-1\": 5},\n    {\"SCM-1\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"CCAAT box\": 5},\n    {\"EKLF binding site\": 5},\n    {\"Egr-1\": 5},\n    {\"RXR\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"c-kit\": 5},\n    {\"IL-4R alpha chain\": 5},\n    {\"ZEB\": 5},\n    {\"c-Myb\": 5},\n    {\"hematopoietic cells\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 542,
        "sentence": "Amino acid sequences of all proteins are essays written in the same language.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 505,
        "sentence": "The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .",
        "label": {
            "Jurkat": "cell_line",
            "TCF-1 alpha": "protein",
            "TCR": "protein",
            "T-cell-specific transcription factor": "protein",
            "TCF-1 alpha binding site": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCR alpha\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}, {\"T-cell-specific\": \"cell_type\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}"
    },
    {
        "idx": 1525,
        "sentence": "Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .",
        "label": {
            "antibody": "protein",
            "CaM kinase II": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides a clear example of a protein entity (P selectin) and its association with antibodies, aiding in the extraction of protein entities from the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence contains multiple instances of protein entities (NF-kappa B, I kappa B alpha) and their interactions, which are directly relevant to the entities in the target sentence, making it highly helpful.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence includes mentions of protein entities (cAMP-dependent protein kinase, Rap1) and their substrates, providing valuable context for identifying protein entities in the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence specifically discusses the expression of a protein entity (E2A) at the protein level, offering a relevant example for understanding protein entities in the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence talks about the inhibition of a protein entity (calcineurin) by immunophilin-drug complexes, aligning closely with the protein entities mentioned in the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions protein entities (SLAP-130, SLP-76, protein tyrosine kinases) and their associations with T cells, providing direct relevance to the entities in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence discusses the phosphorylation and inhibition of protein entities (IL-4, LPS, AP-1), which are similar to the protein entities in the target sentence, making it highly informative.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence provides examples of protein entities (Syk, Zap) and their activation upon T cell receptor crosslinking, directly relevant to the protein entities in the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence mentions the intense expression of a protein entity (NDP kinase) in specific cell types (KA, SCC, BCC), offering valuable insights into protein entities and cell types, aiding in entity extraction from the target sentence.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The sentence discusses the inhibition mechanism related to cell adhesion molecules, which indirectly relates to the cell_type entity in the target sentence, providing some context for entity extraction.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence provides information about protein entities (RelA, NF-kappa B) and their activities in T cells, directly relevant to the protein entities in the target sentence, making it highly helpful.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions protein entities (IL-2, Aiolos, Ras) and their interactions, offering valuable examples for understanding protein entities in the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence discusses the suppression and activation of protein entities (RelA, NF-kappaB1) and their complexes, directly relevant to the protein entities in the target sentence, making it highly informative.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence provides a specific example of a protein entity (retinoic acid receptor alpha) and its measurements, aiding in the extraction of protein entities from the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions the increase in protein entities (p21(WAF1/CIP1), p27(KIP1)) at mRNA and protein levels, directly relevant to the protein entities in the target sentence, making it highly helpful.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1103,
        "sentence": "Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.",
        "label": {
            "platelets": "cell_type",
            "Rap1 protein": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a direct mapping of the entity 'calcineurin' to the entity type 'protein' in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example covers multiple entity mappings such as 'AP-1' to 'protein', 'PMA' to 'protein', 'monocytes' to 'cell_type', and 'macrophages' to 'cell_type', providing a comprehensive aid in named entity extraction.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example includes mappings for 'PAFR' to 'protein', 'PAF' to 'protein', 'NF-kappa B' to 'protein', and 'protein kinase C' to 'protein', offering detailed assistance in named entity extraction.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example provides mappings for 'Stat3' to 'protein', 'Stat5' to 'protein', and 'c-Mpl' to 'protein', aiding in the extraction of named entities related to proteins.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example covers mappings for 'SLAP-130' to 'protein', 'SLP-76' to 'protein', and 'T cell' to 'cell_type', offering detailed assistance in named entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example directly maps 'tyrosine' to 'protein', providing clear guidance for named entity extraction related to proteins.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example maps 'GATA-1' to 'protein', aiding in the extraction of named entities related to proteins.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example provides a direct mapping of 'p21ras' to 'protein', aiding in the extraction of named entities related to proteins.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example maps 'P selectin' to 'protein', offering assistance in named entity extraction related to proteins.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example covers mappings for 'p21(WAF1/CIP1)' to 'protein' and 'p27(KIP1)' to 'protein', aiding in the extraction of named entities related to proteins.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example provides mappings for 'ERK' to 'protein' and 'STAT3' to 'protein', offering assistance in named entity extraction related to proteins.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example includes mappings for 'RelA' to 'protein' and 'NF-kappaB1' to 'protein', aiding in the extraction of named entities related to proteins.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example covers mappings for 'Syk' to 'protein', 'Zap' to 'protein', and 'T cell' to 'cell_type', offering detailed assistance in named entity extraction.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example provides mappings for 'IL-2' to 'protein', 'Aiolos' to 'protein', and 'Ras' to 'protein', aiding in the extraction of named entities related to proteins.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example directly maps 'phosphocreatine' to 'protein', providing clear guidance for named entity extraction related to proteins.\"\n    }\n]\n```",
        "response3": "```json\n[{\"Rap1\": \"protein\"}, {\"Ca2+\": \"protein\"}]\n```",
        "prediction": "{'Rap1': 'protein', 'Ca2+': 'protein'}"
    },
    {
        "idx": 538,
        "sentence": "Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .",
        "label": {
            "PHA": "protein",
            "phytohaemagglutinin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 3},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"phytohaemagglutinin\": \"protein\"}, {\"leucine\": \"protein\"}, {\"thymidine\": \"DNA\"}]",
        "prediction": "{'phytohaemagglutinin': 'protein', 'leucine': 'protein', 'thymidine': 'DNA'}"
    },
    {
        "idx": 1529,
        "sentence": "Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .",
        "label": {
            "Oct-2a": "protein",
            "lymphoid-specific transcription factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1197,
        "sentence": "In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.",
        "label": {
            "ubiquitin": "protein",
            "p105 precursor": "protein",
            "E2-F1": "protein",
            "-proteasome": "protein",
            "ubiquitin -carrier protein": "protein",
            "p53": "protein",
            "ubiquitin -protein ligase": "protein",
            "320-kDa species": "protein",
            "p105": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5}\n]",
        "response3": "[{\"ubiquitin -proteasome system\": \"protein\"}, {\"p105 precursor\": \"protein\"}, {\"ubiquitin\": \"protein\"}, {\"E2-F1\": \"protein\"}, {\"p53\": \"protein\"}, {\"ubiquitin -carrier protein\": \"protein\"}, {\"ubiquitin -protein ligase\": \"protein\"}]",
        "prediction": "{'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}"
    },
    {
        "idx": 877,
        "sentence": "Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .",
        "label": {
            "B lymphocytes": "cell_type",
            "thymic epithelial cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein and cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein entity, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein and cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains multiple specific protein entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions specific protein and cell line entities, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein and cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein and cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein and cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein and cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein and cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific cell type entities that are directly mentioned, aiding in the extraction of named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein and cell type entities that are directly mentioned, aiding in the extraction of named entities.\"}\n]",
        "response3": "[{\"B lymphocytes\": \"cell_type\"}, {\"thymic epithelial cells\": \"cell_type\"}]",
        "prediction": "{'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}"
    },
    {
        "idx": 1838,
        "sentence": "First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.",
        "label": {
            "LEF-1 -binding site": "DNA",
            "HIV-1 enhancer": "DNA",
            "LEF-1": "protein",
            "GAL4-substituted HIV-1 enhancer": "DNA",
            "Jurkat T cells": "cell_line",
            "multimerized copies": "DNA",
            "LEF-1 /GAL4": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_type', 'cell_line']",
        "response2": "[\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"IL-2\": 5},\n{\"IFN-gamma\": 5},\n{\"jak kinases\": 5},\n{\"STAT1(alpha)\": 5},\n{\"IL-2\": 5},\n{\"c-Jun\": 5},\n{\"c-Fos\": 5},\n{\"IFN A\": 5},\n{\"IFNA\": 5},\n{\"interleukin-2\": 5},\n{\"interleukin-2 receptor\": 5},\n{\"phytohemagglutinin\": 5},\n{\"phorbol myristate acetate\": 5},\n{\"PU.1\": 5},\n{\"M-CSF receptor\": 5},\n{\"macrophage\": 5},\n{\"Sp1\": 5},\n{\"CD14\": 5},\n{\"SIVsmmPBj14\": 5},\n{\"T cell\": 5},\n{\"interleukin 2\": 5},\n{\"p50p50\": 5},\n{\"IkappaBbeta\": 5},\n{\"NF-kappaB\": 5},\n{\"HIV-1\": 5},\n{\"IFN\": 5},\n{\"PKR\": 5},\n{\"IkappaBalpha\": 5},\n{\"NF-kappaB\": 5},\n{\"Sp1\": 5},\n{\"SIVmac\": 5},\n{\"cDNA\": 5},\n{\"Jurkat\": 5},\n{\"DRE 1\": 5},\n{\"HIV-1 LTR\": 5},\n{\"NFAT-1\": 5},\n{\"NF kappa B\": 5},\n{\"TR55\": 5},\n{\"TNF-alpha\": 5},\n{\"HIV\": 5},\n{\"ATF1\": 5},\n{\"CREB\": 5},\n{\"H4\": 5}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"HIV-1 enhancer\": \"DNA\"}, {\"Jurkat T cells\": \"cell_type\"}, {\"GAL4\": \"protein\"}, {\"GAL4-substituted HIV-1 enhancer\": \"DNA\"}]",
        "prediction": "{'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein', 'GAL4-substituted HIV-1 enhancer': 'DNA'}"
    },
    {
        "idx": 1195,
        "sentence": "Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .",
        "label": {
            "60-kDa precursor": "protein",
            "ubiquitin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (EBNA-2, PU.1) which are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein name (Tat-binding protein 7) which is directly related to a protein entity.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a specific protein name (TCF-1) which is directly related to a protein entity.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names (p21(WAF1/CIP1), p27(KIP1)) which are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (IL-2, Aiolos, Ras) which are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions a specific protein name (p50p50) which is directly related to a protein entity.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains a specific protein name (NF-kappa B) which is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The sentence mentions techniques and terms related to proteins (immunohistochemistry, gene) and cell types (cell type) which indirectly suggest the presence of protein and DNA entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains a specific protein name (ZAP-70) which is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names (Syk, Zap) and mentions T cell, indicating cell type, which are directly related to protein and cell type entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names (NF-kappa B, I kappa B alpha) which are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names (IL-2, c-Jun, c-Fos) which are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) which are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names (IkappaBbeta, tax, NF-kappaB) which are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions specific cell types (EBV, B-cell) which are directly related to cell type entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains specific protein names (Tax, TFIIA) which are directly mentioned and can be easily identified as protein entities.\"}\n]",
        "response3": "[{'Palombella': 'protein'}, {'Rando': 'protein'}, {'Goldberg': 'protein'}, {'Maniatis': 'protein'}, {'ubiquitin': 'protein'}]",
        "prediction": "{'Palombella': 'protein', 'Rando': 'protein', 'Goldberg': 'protein', 'Maniatis': 'protein', 'ubiquitin': 'protein'}"
    },
    {
        "idx": 817,
        "sentence": "(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .",
        "label": {
            "EBNA-LP": "protein",
            "LMP1": "protein",
            "EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (IL-2) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple protein entities (PC4, OCA-B, Oct-1) and their corresponding labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence includes various protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides protein entities (IL-4, LPS, AP-1) and their corresponding labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains protein entities (NF-kappaB, Sp1, p50) and their corresponding labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence includes protein entities (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding labels.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides a protein entity (TIMP-1) and a DNA entity, which is not in the label set but still relevant in the context.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains protein entities (RelA, NF-kappaB1) and their corresponding labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes protein entities (EBNA-2, PU.1) and their corresponding labels.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides a cell type entity (T cell) and protein entities (IL-2, IL-2 receptor, CD28) with their corresponding labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains a protein entity (RXR) and its corresponding label.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence includes protein entities (EBNA2, TP1) and their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides an RNA entity (MNDA) and a cell line entity (myeloid cell lines) with their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains protein entities (p21(WAF1/CIP1), p27(KIP1)) and their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence includes protein entities (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) and their corresponding labels.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence provides a cell type entity (CD4+) and a protein entity (EBV) with their corresponding labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 741,
        "sentence": "In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .",
        "label": {
            "Oct-2A expression vector": "DNA",
            "Oct-2A": "protein",
            "N-Oct-3 factor": "protein",
            "melanoma cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 5},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B/Oct-1-dependent transcription.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 283,
        "sentence": "[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]",
        "label": {
            "Estrogen receptor": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"Estrogen receptor\": \"protein\"}]",
        "prediction": "{'Estrogen receptor': 'protein'}"
    },
    {
        "idx": 1043,
        "sentence": "METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Although erythropoietin ( Epo ) is essential for the production of mature red blood cells , the cooperation with other factors is required for a proper balance between progenitor proliferation and differentiation.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\": 5},\n    {\"Despite this drastic effect in vivo, the in vitro immortalization of erythropoietin-dependent erythroid progenitors unexpectedly occurred at low frequency, and all four cell lines established expressed both erythrocytic (globins) and megakaryocytic markers ( glycoprotein IIb , platelet factor 4 ) as well as Spi-1 and Fli-1 transcripts at permissive temperature.\": 5},\n    {\"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.\": 5}\n]",
        "response3": "[{\"estrogen replacement therapy\": \"protein\"}]",
        "prediction": "{'estrogen replacement therapy': 'protein'}"
    },
    {
        "idx": 1010,
        "sentence": "Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .",
        "label": {
            "murine NFATp": "protein",
            "NFATp protein": "protein",
            "NFATp": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 3},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5}\n]",
        "response3": "[{\"NFATp\": \"protein\"}]",
        "prediction": "{'NFATp': 'protein'}"
    },
    {
        "idx": 186,
        "sentence": "We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .",
        "label": {
            "erythrocytic lineage": "cell_type",
            "NF-E2": "protein",
            "trans-acting factor": "protein",
            "megakaryocytes": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example directly mentions the entity 'RXR' and provides the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example directly mentions the entities 'SCL' and 'GATA-1' with the corresponding entity labels 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example directly mentions the entities 'Stat3', 'Stat5', and 'c-Mpl' with the corresponding entity labels 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example directly mentions the entities 'NF-ATc' and 'T lymphocytes' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example directly mentions the entity 'GATA-1' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example directly mentions the entities 'granulocytes' and 'T cells' with the corresponding entity labels 'cell_type'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example directly mentions the entities 'EKLF', 'CBP', 'p300', and 'P/CAF' with the corresponding entity labels 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly mentions the entity 'Egr-1' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example directly mentions the entities 'NF-ATc', 'T lymphocytes', and 'embryonic cardiac cells' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example directly mentions the entity 'erythropoietin' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example directly mentions the entity 'NF-E2' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example directly mentions the entity 'E2A' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example directly mentions the entity 'GATA-1' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example directly mentions the entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example directly mentions the entities 'ZEB', 'c-Myb', 'Ets', and 'hematopoietic cells' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    }\n]",
        "response3": "[{\"NF-E2\": \"protein\"}, {\"megakaryocytes\": \"cell_type\"}]",
        "prediction": "{'NF-E2': 'protein', 'megakaryocytes': 'cell_type'}"
    },
    {
        "idx": 1547,
        "sentence": "Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .",
        "label": {
            "multisubunit adhesion receptor": "protein",
            "Ib-IX-V": "protein",
            "Platelet glycoprotein": "protein",
            "GP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 3},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 2},\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 1},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 2},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 2},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 2},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 3},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 3},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3, and STAT5 proteins in normal human B cells.\": 3},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 2},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 3},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 3},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 3},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 3}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 96,
        "sentence": "We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .",
        "label": {
            "Sp1": "protein",
            "dominant promoter elements": "DNA",
            "minimal Thy-1 promoter": "DNA",
            "transcription factor": "protein",
            "multiple binding sites": "DNA",
            "CCAAT box": "DNA",
            "transcription start site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n{\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1763,
        "sentence": "Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .",
        "label": {
            "IL-2": "protein",
            "IL-2 mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\": 5}\n]",
        "response3": "[{\"IL-2 mRNA\": \"RNA\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}"
    },
    {
        "idx": 224,
        "sentence": "Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).",
        "label": {
            "CEM C7 cells": "cell_line",
            "human acute lymphoblastic T-cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and proteins that are directly related to the entity labels in the entity label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific protein names that are directly related to the entity labels in the entity label set.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence contains a specific cell type that is directly related to the entity labels in the entity label set.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains a specific protein name that is directly related to the entity labels in the entity label set.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence contains a specific protein name that is directly related to the entity labels in the entity label set.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains a specific protein name that is directly related to the entity labels in the entity label set.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence contains a specific cell type that is directly related to the entity labels in the entity label set.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains a specific protein name that is directly related to the entity labels in the entity label set.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names that are directly related to the entity labels in the entity label set.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence contains specific chemical compound names that are indirectly related to the entity labels in the entity label set.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence contains a specific protein name that is indirectly related to the entity labels in the entity label set.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains a specific protein name that is directly related to the entity labels in the entity label set.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains a specific protein name that is directly related to the entity labels in the entity label set.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains specific protein names and a cell type that are directly related to the entity labels in the entity label set.\"}\n]",
        "response3": "[{'CEM C7 cells': 'cell_line'}, {'T-cell line': 'cell_type'}]",
        "prediction": "{'CEM C7 cells': 'cell_line', 'T-cell line': 'cell_type'}"
    },
    {
        "idx": 313,
        "sentence": "Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .",
        "label": {
            "malignant soft tissue tumors": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of the entity 'protein' (E2A) being mentioned in relation to a gene expression study.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions the entity 'protein' (GATA-1) in the context of mRNA expression during eosinophil differentiation.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions 'lymphoid neoplasms' which is likely related to the entity type 'cell_type'.\"},\n    {\"Example 4\": 3},\n    {\"Reason 4\": \"The sentence mentions 'phosphocreatine' which could be related to the entity type 'protein', but the context is not as clear as in other examples.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides multiple clear examples of the entity type 'protein' (SLAP-130, SLP-76, NF-E2) and 'cell_type' (T cell) in the context of molecular cloning and protein interactions.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence clearly mentions the entity 'protein' (NF-E2) in the context of a cellular differentiation program.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of the entities 'protein' (immunohistochemistry, gene) and 'cell_type' (cell type) in the context of determining gene expression patterns.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence clearly mentions the entity 'protein' (retinoic acid receptor alpha) in the context of binding assays.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides a clear example of the entity 'protein' (CD14) in the context of monocytic differentiation.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions 'HML' which is likely related to the entity type 'cell_line', and also mentions 'dexamethasone', 'cortisol', and 'lysozyme' which are related to the entity type 'protein'. The context is somewhat clear but not as explicit as in other examples.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of the entities 'protein' (CD40, Rel/nuclear factor kappaB, NF-kappaB) and 'cell_type' (B lymphocytes) in the context of B cell activation.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of the entities 'cell_type' (B and T cell activation) and 'cell_line' (Ramos, Jurkat) in the context of gene expression analysis.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of the entities 'protein' (tal-1, GATA-binding proteins) and 'cell_type' (hematopoiesis) in the context of human hematopoiesis.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of the entities 'protein' (Erbstatin, genistein) and 'RNA' (Egr-1) in the context of mRNA expression and protein phosphorylation.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of the entities 'DNA' (EBV), 'protein' (EBNA2, estrogen receptor) in the context of generating conditional EBV mutants.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides clear examples of the entities 'protein' (MR, aldosterone, progesterone) in the context of antibody binding inhibition.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1285,
        "sentence": "Characterization of 5' end of human thromboxane receptor gene .",
        "label": {
            "5' end of human thromboxane receptor gene": "DNA",
            "human thromboxane receptor gene": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"GATA-1\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"SCM-1\": 5},\n    {\"Stat3\": 5},\n    {\"Stat5\": 5},\n    {\"c-Mpl\": 5},\n    {\"E2A\": 5},\n    {\"T cell\": 5},\n    {\"interleukin 2\": 5},\n    {\"retinoic acid receptor alpha\": 5},\n    {\"GM-CSF\": 5},\n    {\"SIVsmmPBj14\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"GATA-1\": 5},\n    {\"RXR\": 5},\n    {\"cDNAs\": 5},\n    {\"Ter 119\": 5},\n    {\"beta-globin\": 5},\n    {\"glycoprotein IIb\": 5},\n    {\"platelet factor 4\": 5},\n    {\"B and T cell activation\": 5},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 327,
        "sentence": "However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .",
        "label": {
            "R-responsive enhancer region": "DNA",
            "EB1 -binding site": "DNA",
            "EB1": "protein",
            "ZRE-B": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5}\n]",
        "response3": "[{\"EB1\": \"protein\"}]",
        "prediction": "{'EB1': 'protein'}"
    },
    {
        "idx": 1622,
        "sentence": "Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.",
        "label": {
            "gamma interferon": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"gamma interferon\": \"protein\"}]",
        "prediction": "{'gamma interferon': 'protein'}"
    },
    {
        "idx": 1393,
        "sentence": "This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .",
        "label": {
            "second enhancer": "DNA",
            "T-cell activation response element": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells.\": 5},\n    {\"Interleukin 2 and T cell antigen receptor signals converge upon serine 727.\": 5},\n    {\"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region.\": 5}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}, {\"HIV-2\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}"
    },
    {
        "idx": 1221,
        "sentence": "To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .",
        "label": {
            "mouse osteocalcin gene": "DNA",
            "promoter": "DNA",
            "osteoblast-specific cis-acting elements": "DNA",
            "trans-acting factors": "protein",
            "osteoblast-specific gene": "DNA"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Sp1\": 5},\n{\"CD14\": 4},\n{\"IL-4\": 4},\n{\"Egr-1\": 5},\n{\"SCM-1\": 4},\n{\"IL-2\": 5},\n{\"c-Jun\": 5},\n{\"c-Fos\": 5},\n{\"CD95 ligand\": 4},\n{\"UAS1\": 4},\n{\"B cell\": 4},\n{\"Ets\": 5},\n{\"GATA-1\": 5},\n{\"PML/RARalpha\": 5},\n{\"NF-E2\": 5},\n{\"E2A\": 5},\n{\"EKLF\": 5},\n{\"CBP\": 5},\n{\"p300\": 5},\n{\"P/CAF\": 5},\n{\"Protein\": 5}\n]",
        "response3": "[{\"osteocalcin\": \"protein\"}]",
        "prediction": "{'osteocalcin': 'protein'}"
    },
    {
        "idx": 130,
        "sentence": "At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .",
        "label": {
            "TREp": "DNA",
            "TR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 788,
        "sentence": "The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).",
        "label": {
            "mineralocorticoid receptors": "protein"
        },
        "response1": "['cell_type']",
        "response2": "```json\n[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding functions, which can aid in identifying protein entities.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The sentence mentions a specific DNA binding activity, which can help in identifying DNA entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence provides information about a specific protein model, aiding in identifying protein entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions a specific protein (RXR) and its mutants, which can help in identifying protein entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (RelA and NF-kappaB1) and their interactions, aiding in identifying protein entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions specific cell types (granulocytes and T cells), aiding in identifying cell type entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides information about specific proteins (TCRzeta and p56(lck)) in T cells, aiding in identifying protein entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions specific RNA (MNDA) and cell line (myeloid cell lines), aiding in identifying RNA and cell line entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains specific protein names (NF-kB, AP-1, OCT-1, NF-IL-2B) and their activities, aiding in identifying protein entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides information about a specific cell line (HML) and proteins related to glucocorticoid responsiveness, aiding in identifying cell line and protein entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions specific cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4), aiding in identifying cell line and protein entities.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence contains specific DNA binding activity (nuclear factor-kappa B), which can help in identifying DNA entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions specific proteins (MR, aldosterone, progesterone) related to membrane receptors, aiding in identifying protein entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides information about specific proteins (FEV1, FVC, PEF, prednisolone) related to asthma, aiding in identifying protein entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific cell types (Type I and Type II receptors), aiding in identifying cell type entities.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions a specific protein (aldosterone) related to membrane receptors, aiding in identifying protein entities.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 781,
        "sentence": "Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The example contains a specific protein entity (GATA-1) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The example contains a specific protein entity (phosphocreatine) that is relevant to the target sentence, aiding in the extraction of protein entities. However, the relevance is slightly lower compared to Example 1.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The example contains multiple protein entities (IL-2, NF-kappa B, AP-1) that are directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The example contains a specific cell type entity (T lymphocytes) that is directly relevant to the target sentence, aiding in the extraction of cell type entities. However, the relevance is slightly lower compared to Examples 1 and 3.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The example contains a specific cell type entity (lymphoid neoplasms) that is directly relevant to the target sentence, aiding in the extraction of cell type entities. However, the relevance is slightly lower compared to Examples 1 and 3.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The example contains multiple entities (alpha-tocopherol, monocyte, endothelial cells) that are directly relevant to the target sentence, aiding in the extraction of protein and cell type entities.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The example contains multiple entities (IL-5 mRNA, TCR, IL-2R, dexamethasone) that are directly relevant to the target sentence, aiding in the extraction of RNA, cell type, and protein entities.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The example contains a specific protein entity (NF-E2) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The example contains a specific protein entity (NF-kappa B) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The example contains a specific protein entity (P selectin) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The example contains a specific DNA entity (AP-1) that is directly relevant to the target sentence, aiding in the extraction of DNA entities. However, the relevance is slightly lower compared to Examples 1, 3, and 9.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The example contains a specific cell type entity (Eosinophils) that is directly relevant to the target sentence, aiding in the extraction of cell type entities.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The example contains a specific protein entity (NF-kappa B) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The example contains a specific protein entity (G-CSF) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The example contains multiple protein entities (cAMP-dependent protein kinase, Rap1) that are directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The example contains multiple entities (CD40, Rel/nuclear factor kappaB, NF-kappaB, B lymphocytes) that are directly relevant to the target sentence, aiding in the extraction of protein and cell type entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1220,
        "sentence": "A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .",
        "label": {
            "PEBP2 alpha/AML-1-related factor": "protein",
            "osteocalcin promoter": "DNA",
            "osteoblast-specific cis-acting element": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells\": 3},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5}\n]",
        "response3": "[{\"PEBP2 alpha/AML-1-related factor\": \"protein\"}, {\"osteocalcin\": \"protein\"}, {\"osteoblast-specific\": \"cell_type\"}]",
        "prediction": "{'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}"
    },
    {
        "idx": 958,
        "sentence": "Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .",
        "label": {
            "B-cell-specific genes": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 3},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5}\n]",
        "response3": "[{\"Markus Neurath\": \"None\"}, {\"Eckhard Stuber\": \"None\"}, {\"Warren Strober\": \"None\"}, {\"BSAP\": \"protein\"}, {\"B-cell-specific genes\": \"None\"}]",
        "prediction": "{'Markus Neurath': 'None', 'Eckhard Stuber': 'None', 'Warren Strober': 'None', 'BSAP': 'protein', 'B-cell-specific genes': 'None'}"
    },
    {
        "idx": 1083,
        "sentence": "These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .",
        "label": {
            "cytokine": "protein",
            "NF kappa B": "protein",
            "PBMC": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mapping between the entity 'NF-kappa B' and the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly links the entities 'NF-kappa B' and 'AP-1' to the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly mentions the entities 'NF-kappaB', 'Tax', and 'ATL' and their association with the entity type 'protein' and 'cell_type', providing valuable information for named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence clearly identifies the entity 'NF-E2' and its association with the entity type 'protein', facilitating the extraction of named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'IL-4', 'LPS', and 'AP-1' as entities linked to the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a direct link between 'NF-kappa B' and the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' as entities associated with the entity type 'protein', aiding in named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence clearly identifies 'NF-kappa B' as an entity linked to the entity type 'protein', providing valuable information for named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'P selectin' as an entity associated with the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a direct link between 'NF-kappa B' and 'I kappa B beta' to the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'IL-2', 'NF-kappa B', and 'AP-1' as entities associated with the entity type 'protein', aiding in named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' as entities linked to the entity type 'protein', facilitating the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' as entities associated with the entity type 'cell_type' and 'protein', aiding in named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'interleukin-2', 'alpha chain', 'CD25', and 'IL-2 receptor' as entities linked to the entity type 'protein', facilitating the extraction of named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'B cell', 'Ig', and 'Transforming growth factor-beta' as entities associated with the entity type 'cell_type' and 'protein', aiding in named entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'CTLA4Ig', 'NFAT', and 'AP-1' as entities associated with the entity type 'protein' and 'cell_type', aiding in named entity extraction.\"}\n]",
        "response3": "[{'NF kappa B': 'protein'}]",
        "prediction": "{'NF kappa B': 'protein'}"
    },
    {
        "idx": 514,
        "sentence": "Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .",
        "label": {
            "globin gene": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'GATA-1' to the entity label 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear and direct mapping of the entity 'NF-E2' to the entity label 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear and direct mapping of the entity 'Th2-type lymphocytes' to the entity label 'cell_type' in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping of the entity 'Egr-1' to the entity label 'protein' in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear and direct mapping of the entity 'erythropoietin' to the entity label 'protein' in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The examples provide clear and direct mappings of the entities 'CCAAT box' to the entity label 'DNA' and 'EKLF binding site' to the entity label 'protein' in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear and direct mapping of the entity 'AP-1' to the entity label 'DNA' in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear and direct mapping of the entity 'IL-4' to the entity label 'protein' in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear and direct mapping of the entity 'retinoic acid receptor alpha' to the entity label 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear and direct mapping of the entity 'RXR' to the entity label 'protein' in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The examples provide clear and direct mappings of the entities 'WT1' to the entity label 'protein' and 'myeloid cell lines' to the entity label 'cell_line' in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The examples provide clear and direct mappings of the entities 'IL-2 receptor alpha subunit' to the entity label 'protein', 'p21ras' to the entity label 'protein', and 'B cell' to the entity label 'cell_type' in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear and direct mapping of the entity 'IgH' to the entity label 'DNA' in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a clear and direct mapping of the entity 'GATA-1' to the entity label 'protein' in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a clear and direct mapping of the entity 'immunoglobulin kappa 3' enhancer' to the entity label 'DNA' in the sentence.\"}\n]",
        "response3": "[{\"globin gene\": \"protein\"}]",
        "prediction": "{'globin gene': 'protein'}"
    },
    {
        "idx": 1133,
        "sentence": "Both LCLs were found by EM to produce RVLP and EBV particles .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains multiple named entities that are relevant to the entity labels in the target sentence, such as IL-2, c-Jun, and c-Fos proteins.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence provides a clear example of the named entity PML/RARalpha, which is relevant to the 'protein' entity label in the target sentence.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The sentence mentions PBMC as a cell type and adenovirus DNA, which are relevant to the 'cell_type' and 'DNA' entity labels in the target sentence.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The sentence contains references to EBV as a cell line and CD2 as a protein, which are relevant to the 'cell_line' and 'protein' entity labels in the target sentence.\"\n    },\n    {\n        \"Example 5\": 3\n    },\n    {\n        \"Reason 5\": \"The sentence mentions EBV and B-cell, which are relevant to the 'cell_type' entity label in the target sentence.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The sentence provides an example of the named entity TCL1, which is relevant to the 'protein' entity label in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence clearly mentions SIVsmmPBj14 as a cell line, which is directly relevant to the 'cell_line' entity label in the target sentence.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The sentence contains references to CD4+ cells and EBV, which are relevant to the 'cell_type' and 'protein' entity labels in the target sentence.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The sentence provides an example of the named entity WT1, which is relevant to the 'protein' entity label in the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence clearly mentions EBNA-2 and PU.1 as proteins, which are directly relevant to the 'protein' entity label in the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence provides examples of SIVmacMER, SIVmac239, and CEMx174 as cell lines, which are directly relevant to the 'cell_line' entity label in the target sentence.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The sentence mentions EBNA2 and TP1, which are relevant to the 'protein' and 'cell_line' entity labels in the target sentence.\"\n    },\n    {\n        \"Example 13\": 3\n    },\n    {\n        \"Reason 13\": \"The sentence mentions lymphoid neoplasms, which is relevant to the 'cell_type' entity label in the target sentence.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The sentence mentions granulocytes and T cells as cell types, which are relevant to the 'cell_type' entity label in the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence provides examples of myeloperoxidase, lysozyme, and PU.1 as proteins, which are directly relevant to the 'protein' entity label in the target sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence mentions ICAM-1, CD71, LMP1, and IkappaB as proteins, which are directly relevant to the 'protein' entity label in the target sentence.\"\n    }\n]",
        "response3": "[{'LCLs': 'cell_line'}, {'RVLP': 'protein'}, {'EBV': 'protein'}]",
        "prediction": "{'LCLs': 'cell_line', 'RVLP': 'protein', 'EBV': 'protein'}"
    },
    {
        "idx": 1762,
        "sentence": "Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.",
        "label": {
            "IL-2": "protein",
            "early gene": "DNA",
            "NF-kappa B": "protein",
            "Oct1": "protein",
            "transcription factors": "protein",
            "NF-AT": "protein",
            "AP-1": "protein",
            "IL-2 gene": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT.\": 5},\n    {\"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.\": 5}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"AP-1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"NF-AT\": \"protein\"}, {\"Oct1\": \"protein\"}]",
        "prediction": "{'IL-2': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}"
    },
    {
        "idx": 23,
        "sentence": "Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .",
        "label": {
            "mutant E6 motif": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 3},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1476,
        "sentence": "Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .",
        "label": {
            "AP-1 protein": "protein",
            "c-Jun": "protein",
            "I kappa B": "protein",
            "NF-kappa B": "protein",
            "cytoplasmic inhibitor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and cell type names that are directly mentioned.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific protein names and protein-related terms that are directly mentioned.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple specific protein names and protein-related terms that are directly mentioned.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The sentence contains a general protein-related term.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple specific protein names and protein-related terms that are directly mentioned.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains specific protein names that are directly mentioned.\"}\n]",
        "response3": "[{\"AP-1\": \"protein\"}, {\"c-Jun\": \"protein\"}, {\"I kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 234,
        "sentence": "A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .",
        "label": {
            "cultured": "cell_line",
            "primary cells": "cell_type",
            "adenovirus E2 promoter": "DNA",
            "beta-galactosidase gene": "DNA",
            "beta-galactosidase": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1396,
        "sentence": "NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .",
        "label": {
            "hematopoietic progenitor cell line": "cell_line",
            "NF-M": "protein",
            "chicken C/EBP beta": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\n        \"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5\n    },\n    {\n        \"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 4\n    },\n    {\n        \"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 4\n    },\n    {\n        \"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 3\n    },\n    {\n        \"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 3\n    },\n    {\n        \"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5\n    },\n    {\n        \"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5\n    },\n    {\n        \"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 4\n    },\n    {\n        \"Control of NF-kappa B activity by the I kappa B beta inhibitor .\": 5\n    },\n    {\n        \"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5\n    },\n    {\n        \"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4\n    },\n    {\n        \"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\": 5\n    },\n    {\n        \"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4\n    },\n    {\n        \"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 4\n    },\n    {\n        \"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 5\n    },\n    {\n        \"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5\n    }\n]",
        "response3": "[{\"NF-M\": \"protein\"}, {\"C/EBP beta\": \"protein\"}, {\"eosinophilic\": \"cell_type\"}, {\"hematopoietic progenitor\": \"cell_type\"}]",
        "prediction": "{'NF-M': 'protein', 'C/EBP beta': 'protein', 'eosinophilic': 'cell_type', 'hematopoietic progenitor': 'cell_type'}"
    },
    {
        "idx": 1812,
        "sentence": "The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .",
        "label": {
            "G-protein coupled chemokine receptors": "protein",
            "chemokine receptors": "protein",
            "G-protein": "protein",
            "receptor EBI1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"EBV\": 4},\n    {\"B-cell\": 4},\n    {\"retinoic acid receptor alpha\": 4},\n    {\"Protein\": 3},\n    {\"MIP-1 alpha\": 4},\n    {\"GOS19\": 4},\n    {\"LD78\": 4},\n    {\"AT464\": 4},\n    {\"EBNA-2\": 5},\n    {\"PU.1\": 5},\n    {\"CREB\": 5},\n    {\"AR-CRE\": 4},\n    {\"Egr-1\": 4},\n    {\"E2A\": 4},\n    {\"GM-CSF\": 4},\n    {\"protein\": 3},\n    {\"EKLF\": 4},\n    {\"CBP\": 4},\n    {\"p300\": 4},\n    {\"P/CAF\": 4},\n    {\"TP1\": 4},\n    {\"c-kit\": 4},\n    {\"IL-4R alpha chain\": 4},\n    {\"interleukin 10\": 4},\n    {\"IL-10R\": 4},\n    {\"STAT3\": 4},\n    {\"IL-6\": 4},\n    {\"GATA-1\": 4},\n    {\"IL4\": 4},\n    {\"IL13\": 4},\n    {\"STAT6\": 4},\n    {\"STAT5\": 4},\n    {\"B cells\": 4}\n]",
        "response3": "[{\"G-protein coupled chemokine receptors\": \"protein\"}, {\"EBI1\": \"protein\"}]",
        "prediction": "{'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}"
    },
    {
        "idx": 1099,
        "sentence": "Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .",
        "label": {
            "monocyte mitochondrial 1 alpha-hydroxylase": "protein",
            "monocyte": "cell_type",
            "microtubule": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 4},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 3}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1537,
        "sentence": "Furthermore, we identified a repression domain at the N-terminus of Oct-2a .",
        "label": {
            "Oct-2a": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 4},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n{\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n{\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5}\n]",
        "response3": "[{\"Oct-2a\": \"protein\"}]",
        "prediction": "{'Oct-2a': 'protein'}"
    },
    {
        "idx": 1574,
        "sentence": "CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .",
        "label": {
            "receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 1},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 3},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs, and identified a negative element from bp -267 to -246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.\": 4},\n    {\"This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8).\": 4}\n]",
        "response3": "[{\"eosinophils\": \"cell_type\"}, {\"sexual hormones\": \"protein\"}, {\"receptors\": \"protein\"}]",
        "prediction": "{'eosinophils': 'cell_type', 'sexual hormones': 'protein', 'receptors': 'protein'}"
    },
    {
        "idx": 1312,
        "sentence": "A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.",
        "label": {
            "HMG-1": "protein",
            "C-terminal HMG box": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'SCM-1' and its association with the entity type 'cell_line', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific mentions of 'CCAAT box' and 'EKLF binding site' which are associated with the entity types 'DNA' and 'protein' respectively. This information is helpful for entity extraction, but the context is slightly complex.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence directly mentions 'GM-CSF' in relation to genes, indicating its association with the entity type 'protein'. This is helpful for entity extraction, although the context is somewhat technical.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides detailed information about nuclear factors, IL-2 promoter, c-Jun, and c-Fos protein, all of which are associated with the entity type 'protein'. This clear and specific mention is highly helpful for named entity extraction.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions 'Th2-type lymphocytes' in relation to cytokines and promoters, indicating its association with the entity type 'cell_type'. This information is helpful for entity extraction, but the context may require additional knowledge.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions 'Protein' in relation to genomic sequences and transcription, suggesting its association with the entity type 'protein'. This information is helpful for entity extraction, but the context is somewhat general.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear information about the IL-7R complex, gamma(c), and their critical role in function, all associated with the entity type 'protein'. This specific and direct mention is highly helpful for named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains detailed information about the chimeric receptor system, c-kit, and IL-4R alpha chain, all associated with the entity type 'protein'. This specific and direct mention is highly helpful for named entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides detailed information about Oct-2A, HMG I/Y, HLA-DRA expression, and B cells, all associated with the entity types 'protein' and 'cell_type'. This clear and specific mention is highly helpful for named entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'retinoic acid receptor alpha' in relation to kDa values and binding assays, indicating its association with the entity type 'protein'. This specific and direct mention is highly helpful for named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear information about CHEMR1, C-C chemokine, and MIP-1alpha, all associated with the entity type 'protein'. This specific and direct mention is highly helpful for named entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions 'TCF-1' in relation to transactivation and cognate motif, indicating its association with the entity type 'protein'. This information is helpful for entity extraction, but the context may require additional knowledge.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'DNA' in relation to phosphorylation status and binding activity, indicating its association with the entity type 'DNA'. This information is helpful for entity extraction, but the context is somewhat technical.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides detailed information about SLAP-130, SLP-76, and T cell antigen receptor, all associated with the entity types 'protein' and 'cell_type'. This clear and specific mention is highly helpful for named entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'ZAP-70' in relation to UV and H2O2 treatment, indicating its association with the entity type 'protein'. This specific and direct mention is highly helpful for named entity extraction.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions 'cDNAs' in relation to subunits and cloning, suggesting its association with the entity type 'DNA'. This information is helpful for entity extraction, but the context may require additional knowledge.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 601,
        "sentence": "To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .",
        "label": {
            "murine IgH enhancer": "DNA",
            "putative additional lymphoid-specific transcription factor": "protein",
            "octamer (OCTA)-nucleotide motif": "DNA",
            "NF-microB": "protein",
            "enhancer elements": "DNA",
            "immunoglobulin heavy-chain (IgH) gene": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'NF-E2' and the entity type 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example covers multiple entities and their corresponding entity types in the sentence, providing a comprehensive mapping.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example correctly identifies 'IL-2' as a protein entity in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example includes multiple entities and their corresponding entity types, assisting in the extraction process.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example directly links 'Egr-1' to the entity type 'protein' in the sentence, aiding in entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example correctly identifies 'IL-4' as a protein entity in the sentence, contributing to the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example covers multiple entities and their corresponding entity types, providing valuable information for entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example includes multiple entities and their corresponding entity types, aiding in the extraction process.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example correctly identifies 'IgH' as a DNA entity in the sentence, assisting in the extraction of named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example directly links 'immunoglobulin kappa 3' enhancer' to the entity type 'DNA' in the sentence, aiding in entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example covers multiple entities and their corresponding entity types, providing valuable information for entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example correctly identifies 'NF-kappa B' as a protein entity in the sentence, aiding in the extraction of named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example includes multiple entities and their corresponding entity types, assisting in the extraction process.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example covers multiple entities and their corresponding entity types, providing comprehensive information for entity extraction.\"}\n]",
        "response3": "[{\"NF-microB\": \"protein\"}, {\"IgH\": \"DNA\"}]",
        "prediction": "{'NF-microB': 'protein', 'IgH': 'DNA'}"
    },
    {
        "idx": 890,
        "sentence": "Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 3},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.\": 5},\n    {\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n    {\"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.\": 5},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5},\n    {\"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 323,
        "sentence": "The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .",
        "label": {
            "Epstein-Barr virus ( EBV ) ORI1yt enhancer": "DNA"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (Egr-1) being mentioned in relation to a zinc finger transcription factor.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions the hepatitis B virus as DNA and HBxAg as a protein, making it a very helpful example.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions RXR as a protein, but the context is not as clear as in other examples.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) in a clear context.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence clearly mentions NF-kappaB, Sp1, and p50 as proteins involved in transcription factor binding.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a clear example of EBNA2 as a protein interacting with a TP1 promoter, indicating a cell line.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions T cell as a cell type and interleukin 2 as a protein, but the context is not as explicit.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions IL-2 as a protein, but the context is not as clear as in other examples.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The sentence mentions AP-1 as DNA, but the context is not as clear as in other examples.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions NF-kB, AP-1, OCT-1, and NF-IL-2B as proteins, but the context is not as explicit.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides a clear example of EBV as a cell line and CD2 as a protein in the context of infection.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions CD4+ as a cell type and EBV as a protein, but the context is not as clear as in other examples.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a clear example of EBNA-2 and PU.1 as proteins involved in a direct interaction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence clearly mentions UAS1 as a cell line and B cell as a cell type, making it a very helpful example.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of EBV as a cell type and B-cell as a cell type, indicating a common pathway for activation.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides a clear example of GATA-1 as a protein involved in regulating the lineage-specific transcription factor.\"},\n]",
        "response3": "[{\"Epstein-Barr virus\": \"cell_line\"}, {\"ORI1yt\": \"cell_line\"}, {\"R\": \"protein\"}, {\"Z\": \"protein\"}]",
        "prediction": "{'Epstein-Barr virus': 'cell_line', 'ORI1yt': 'cell_line', 'R': 'protein', 'Z': 'protein'}"
    },
    {
        "idx": 929,
        "sentence": "The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .",
        "label": {
            "ORF": "DNA",
            "272 carboxy-terminal amino acids": "protein",
            "ets-1": "protein",
            "human ets-1 protein": "protein",
            "813-bp open reading frame": "DNA",
            "cDNA sequence": "DNA",
            "amino acid sequence": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"This protein has now been purified and its encoding gene cloned.\": 4},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5}\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"ets-1\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'ets-1': 'protein'}"
    },
    {
        "idx": 6,
        "sentence": "Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .",
        "label": {
            "Platelet-activating factor": "protein",
            "oncogene": "DNA",
            "human B cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains specific protein names and cell types that are directly mentioned, making it highly relevant for extracting named entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence mentions a specific protein name, NF-kappa B, which is directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence contains multiple protein names, cell types, and signaling molecules that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence mentions specific protein names and signaling molecules that are directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence contains specific protein names that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The sentence mentions a specific protein name, NF-E2, which is directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence contains multiple protein names and signaling molecules that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The sentence mentions a specific protein name, P selectin, which is directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence contains specific protein names that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence contains specific protein names, cytokines, and cell types that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The sentence mentions a specific protein name, NF-kappaB, which is directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence contains specific protein names and signaling molecules that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence contains specific protein names that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence contains specific protein names, cell types, and signaling molecules that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence contains specific protein names and cytokines that are directly relevant to the entity types in the target sentence.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1478,
        "sentence": "Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.",
        "label": {
            "activated T cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 3},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1793,
        "sentence": "The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 5},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.\": 5},\n    {\"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.\": 5},\n    {\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3}\n]",
        "response3": "[{\"salicylates\": \"protein\"}, {\"atherosclerosis\": \"cell_type\"}, {\"rheumatoid arthritis\": \"cell_type\"}, {\"monocyte\": \"cell_type\"}]",
        "prediction": "{'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}"
    },
    {
        "idx": 1473,
        "sentence": "Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .",
        "label": {
            "NF-kappa B": "protein",
            "T cells": "cell_type",
            "AP-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"AP-1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 539,
        "sentence": "PMA enhanced slightly the stimulatory effect of PHA .",
        "label": {
            "PHA": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (NF-kappa B and AP-1) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a specific protein name (NF-E2) that is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names (AP-1 and PMA) and cell types (monocytes and macrophages) that are directly mentioned and can be easily identified as protein and cell type entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names (PAFR, PAF, NF-kappa B, and protein kinase C) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (IL-2, NF-kappa B, and AP-1) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a specific protein name (MNDA) and a specific cell line (Philadelphia chromosome-positive chronic myeloid leukemia) that are directly mentioned and can be easily identified as protein and cell line entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names (Oct-2A, HMG I/Y, and HLA-DRA) and a cell type (B cells) that are directly mentioned and can be easily identified as protein and cell type entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains a specific protein name (NF-kappa B) that is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains a specific protein name (P selectin) that is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains a specific protein name (phosphocreatine) that is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains specific protein names (NDP kinase) and cell types (KA, SCC, and BCC) that are directly mentioned and can be easily identified as protein and cell type entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names (CD14 and CD23) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names (IL-4, LPS, and AP-1) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (Epo, alpha-globin, beta-globin, haemoglobin, haemin, and delta-ALA) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains specific protein names (PMA and IFN-gamma) and a cell type (T cell blasts) that are directly mentioned and can be easily identified as protein and cell type entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1025,
        "sentence": "NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .",
        "label": {
            "NFATc": "protein",
            "NK cells": "cell_type",
            "NFATc mRNA": "RNA"
        },
        "response1": "['RNA', 'cell_type', 'protein']",
        "response2": "[\n{\"Example 1\": 4},\n{\"Reason 1\": \"Contains multiple entities of interest (NF-kappa B, kappa B-responsive genes, phagocytosing neutrophils)\"},\n{\"Example 2\": 5},\n{\"Reason 2\": \"Contains multiple entities of interest (NF-ATc, T lymphocytes, embryonic cardiac cells), clearly identifies the relationship between NF-ATc and gene expression in specific cell types\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"Contains multiple entities of interest (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate), provides detailed information on protein expression levels and responses to stimulation\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"Contains multiple entities of interest (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta), shows the effects of different stimuli on CD40 expression\"},\n{\"Example 5\": 3},\n{\"Reason 5\": \"Contains entity of interest (NF-kappa B), but lacks additional context or relationships to other entities\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"Contains multiple entities of interest (NF-kappa B, I kappa B alpha), describes a regulatory pathway involving these proteins\"},\n{\"Example 7\": 4},\n{\"Reason 7\": \"Contains multiple entities of interest (IL-2, IFN-gamma, jak kinases, STAT1(alpha)), shows unresponsiveness to IFN-gamma in T cells\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"Contains multiple entities of interest (RelA, NF-kappa B), describes abnormality in T cells\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"Contains multiple entities of interest (FasL, TCR, IL-2, IFN-gamma), describes deficiencies in FasL expression and apoptosis\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"Contains multiple entities of interest (NF-ATc, T lymphocytes), describes synthesis of isoforms in T cells\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"Contains multiple entities of interest (NF-kappa B, I kappa B alpha), describes activation mechanism involving phosphorylation and degradation\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"Contains multiple entities of interest (CD40, NF-kappa B), identifies signaling determinant for NF-kappa B activation\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"Contains multiple entities of interest (NF-kappaB, Tax, ATL), describes activation mechanism in leukemic cells\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"Contains multiple entities of interest (IL-10, STAT, STAT3), shows differential expression in monocytes and T cells\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"Contains multiple entities of interest (IkappaBbeta, NF-kappaB), describes inactivation mechanism by tax protein\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"Contains multiple entities of interest (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor), shows shared signal transduction events and costimulation effects\"}\n]",
        "response3": "[{\"NFATc\": \"protein\"}, {\"NFATc mRNA\": \"RNA\"}, {\"NK cells\": \"cell_type\"}, {\"CD16 ligands\": \"protein\"}]",
        "prediction": "{'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}"
    },
    {
        "idx": 1560,
        "sentence": "Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .",
        "label": {
            "human T helper (Th) clones": "cell_line",
            "CD30+ cells": "cell_line",
            "CD30": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 4}\n]",
        "response3": "[{\"Th\": \"cell_type\"}, {\"CD30\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'Th': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 365,
        "sentence": "Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.",
        "label": {
            "c-jun": "DNA",
            "HL-60 cells": "cell_line",
            "untreated HL-60 cells": "cell_line"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "```json\n[\n    {\"TIMP-1\": 5},\n    {\"DNA\": 4},\n    {\"TCL1\": 5},\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"ZAP-70\": 5},\n    {\"IL-2\": 4},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"AP-1\": 4},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 3},\n    {\"ATL\": 3},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"TAL1\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"B and T cell activation\": 4},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 4},\n    {\"Tip\": 5},\n    {\"Tap\": 5},\n    {\"Jurkat-T cells\": 5},\n    {\"tal-1\": 5},\n    {\"GATA-binding proteins\": 5},\n    {\"hematopoiesis\": 4},\n    {\"AP-1\": 5},\n    {\"c-jun\": 5},\n    {\"IL-2\": 4},\n    {\"NF-AT\": 5},\n    {\"T cell\": 4},\n    {\"nuclear factor-kappa B\": 4},\n    {\"NF-kappa B\": 4},\n    {\"TCL1\": 5},\n    {\"MTCP1/c6.1B\": 5}\n]\n```",
        "response3": "```json\n[{\"c-jun\": \"protein\"}, {\"HL-60\": \"cell_line\"}, {\"TPA\": \"protein\"}]\n```",
        "prediction": "{'c-jun': 'protein', 'HL-60': 'cell_line', 'TPA': 'protein'}"
    },
    {
        "idx": 1039,
        "sentence": "Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .",
        "label": {
            "Peripheral blood mononuclear cells": "cell_type",
            "pbmc": "cell_type",
            "bone marrow cells": "cell_type"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"PBMC\": 5},\n    {\"adenovirus DNA\": 5},\n    {\"CD70\": 4},\n    {\"B cell\": 4},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4},\n    {\"MNDA\": 4},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 4},\n    {\"PMA\": 3},\n    {\"CD14\": 4},\n    {\"CD23\": 4},\n    {\"IL-2\": 4},\n    {\"c-Jun\": 4},\n    {\"c-Fos\": 4},\n    {\"PML/RARalpha\": 5},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 3},\n    {\"ATL\": 3},\n    {\"TCRzeta\": 4},\n    {\"p56(lck)\": 4},\n    {\"p21(WAF1/CIP1)\": 4},\n    {\"p27(KIP1)\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"Ter 119\": 4},\n    {\"beta-globin\": 4},\n    {\"glycoprotein IIb\": 4},\n    {\"platelet factor 4\": 4},\n    {\"CD40\": 4},\n    {\"Rel/nuclear factor kappaB\": 4},\n    {\"NF-kappaB\": 4},\n    {\"B lymphocytes\": 4},\n    {\"B and T cell activation\": 4},\n    {\"Ramos\": 4},\n    {\"Jurkat\": 4},\n    {\"cDNA microarray technology\": 4},\n    {\"HeLa cells\": 4},\n    {\"Daudi\": 4},\n    {\"CSF-1 receptor\": 4},\n    {\"PU.1\": 4},\n    {\"Mono A\": 4},\n    {\"Mono B\": 4}\n]",
        "response3": "[{\"pbmc\": \"cell_type\"}, {\"bone marrow cells\": \"cell_type\"}, {\"c-fos\": \"protein\"}, {\"c-myc\": \"protein\"}, {\"p53\": \"protein\"}, {\"bcr/abl mRNA\": \"RNA\"}]",
        "prediction": "{'pbmc': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'bcr/abl mRNA': 'RNA'}"
    },
    {
        "idx": 217,
        "sentence": "Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .",
        "label": {
            "GCR": "protein",
            "glucocorticoid receptors": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"phosphocreatine\": 3},\n    {\"G-CSF\": 4},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"STAT6\": 5},\n    {\"STAT3\": 5},\n    {\"STAT5\": 5},\n    {\"B cells\": 5},\n    {\"IL-5 mRNA\": 4},\n    {\"TCR\": 4},\n    {\"IL-2R\": 4},\n    {\"dexamethasone\": 4},\n    {\"HML\": 5},\n    {\"dexamethasone\": 4},\n    {\"cortisol\": 4},\n    {\"lysozyme\": 4},\n    {\"IL-7R\": 5},\n    {\"gamma(c)\": 5},\n    {\"E2A\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"IFN-gamma\": 5},\n    {\"IL-2\": 4},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"cAMP-dependent protein kinase\": 5},\n    {\"Rap1\": 5},\n    {\"TCRzeta\": 5},\n    {\"p56(lck)\": 5},\n    {\"GATA-1\": 5},\n    {\"VDR\": 5},\n    {\"RXR\": 5},\n    {\"GRIP-1\": 5},\n    {\"DRIP205\": 5},\n    {\"DRIP\": 4},\n    {\"B and T cell activation\": 5},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 3},\n    {\"CD40\": 5},\n    {\"Rel/nuclear factor kappaB\": 5},\n    {\"NF-kappaB\": 5},\n    {\"B lymphocytes\": 5}\n]",
        "response3": "[{\"GCR\": \"protein\"}, {\"GCS\": \"protein\"}, {\"bronchial asthma\": \"cell_type\"}, {\"BA\": \"cell_type\"}, {\"cortisol\": \"protein\"}]",
        "prediction": "{'GCR': 'protein', 'GCS': 'protein', 'bronchial asthma': 'cell_type', 'BA': 'cell_type', 'cortisol': 'protein'}"
    },
    {
        "idx": 1782,
        "sentence": "In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .",
        "label": {
            "Id3": "protein",
            "resting PBL": "cell_type",
            "Id3 mRNA": "RNA",
            "PBL": "cell_type",
            "Id2": "protein",
            "Id2 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple entities related to the entity labels in the target sentence, such as 'nuclear factors', 'AP-1 site', 'IL-2 promoter', 'c-Jun', and 'c-Fos protein.' These examples directly correspond to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence includes entities like 'CD70 transfectants', 'B cell cultures', 'plasma cells', 'IL-4', and 'CD40 signaling' which are relevant to the entity labels in the target sentence, providing context for understanding similar entities in the target sentence.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence mentions 'E2A gene' and 'E2A protein', which are related to the entity label 'protein' in the target sentence, but the connection is not as direct as in other examples.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence talks about 'EBV' and 'CD2', which are relevant to the entity labels 'cell_line' and 'protein' in the target sentence, offering some context for understanding similar entities in the target sentence.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The sentence discusses 'IL-4 gene expression' and 'recently identified proteins', which are related to the entity label 'protein' in the target sentence, but the connection is not as direct as in other examples.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples like 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' that directly correspond to the entity labels in the target sentence, aiding in understanding similar entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions 'TCL1', which is related to the entity label 'protein' in the target sentence, providing context for understanding similar entities in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence includes entities like 'monocytes', 'IL-10-stimulated STAT protein', 'M(r) of 70 kDa', 'anti-STAT3 Ab', and 'T cells' which are relevant to the entity labels in the target sentence, offering context for understanding similar entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence talks about 'IL-4', 'LPS', and 'AP-1 protein', which are relevant to the entity labels in the target sentence, providing context for understanding similar entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions 'RelA' and 'NF-kappaB1', which are related to the entity label 'protein' in the target sentence, offering context for understanding similar entities.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence discusses 'CD4+ cell counts' and 'anti-EBV antibody titres', which are related to the entity labels 'cell_type' and 'protein' in the target sentence, but the connection is not as direct as in other examples.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides examples like 'IL-12', 'STAT4', 'NK cells', 'T cells', and 'IL-12 receptor' that directly correspond to the entity labels in the target sentence, aiding in understanding similar entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence includes entities like 'WT1' and 'non-cultured peripheral lymphocytes', which are relevant to the entity label 'protein' in the target sentence, offering context for understanding similar entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions 'PMA', 'CD14', and 'CD23 mRNA and protein', which are related to the entity labels 'protein' in the target sentence, providing context for understanding similar entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence talks about 'p50p50', which is related to the entity label 'protein' in the target sentence, offering context for understanding similar entities.\"}\n]",
        "response3": "[{'Id2 mRNA': 'RNA'}, {'Id3 mRNA': 'RNA'}]",
        "prediction": "{'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}"
    },
    {
        "idx": 1280,
        "sentence": "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.",
        "label": {
            "NF-kappa B": "protein",
            "TATA element": "DNA",
            "transcription factors": "protein",
            "CD69": "protein",
            "AP-1": "protein",
            "30 base pairs upstream": "DNA",
            "CD69 gene": "DNA",
            "5'-flanking region": "DNA",
            "transcription initiation site": "DNA",
            "Egr-1": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 4},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 5},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter\": 4},\n{\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements\": 5},\n{\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif\": 4},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 5},\n{\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells\": 5},\n{\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B\": 5},\n{\"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells\": 5}\n]",
        "response3": "[{\"CD69 gene\": \"protein\"}, {\"TATA element\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}, {\"Egr-1\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 611,
        "sentence": "Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"DNA viruses\": \"DNA\"}, {\"HIV-1\": \"cell_type\"}]",
        "prediction": "{'DNA viruses': 'DNA', 'HIV-1': 'cell_type'}"
    },
    {
        "idx": 1723,
        "sentence": "In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .",
        "label": {
            "tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA": "RNA",
            "NF-kappa B": "protein",
            "tumor necrosis factor-alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['cell_line', 'protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"messenger RNA\": \"RNA\"}, {\"monocyte/macrophage cell line\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'messenger RNA': 'RNA', 'monocyte/macrophage cell line': 'cell_line'}"
    },
    {
        "idx": 1308,
        "sentence": "Two groups of HMG box proteins are distinguished.",
        "label": {
            "HMG box proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 4},\n    {\"Sentence 3\": 4},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 765,
        "sentence": "Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'protein' (E2A) at the protein level, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions the entity 'protein' (NF-E2) in the context of a cellular differentiation program, which is helpful for identifying named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions the entities 'RNA' (IL-5 mRNA), 'cell_type' (TCR), and 'protein' (IL-2R, dexamethasone) in the context of mRNA induction and stimulation, providing valuable information for named entity extraction.\"},\n    {\"Example 4\": 3},\n    {\"Reason 4\": \"The sentence mentions the entities 'cell_type' (granulocytes, T cells) in the context of methylation deviation, which is somewhat helpful for identifying named entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions the entity 'protein' (IL-4) in the context of gene expression regulation, providing relevant information for named entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions the entities 'protein' (IL-2, c-Jun, c-Fos) in the context of nuclear factors and promoter binding, which is helpful for identifying named entities.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions the entity 'protein' (phosphocreatine) in the context of energy substrates and hormone responses, which is somewhat helpful for named entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions the entities 'cell_line' (HML) and 'protein' (dexamethasone, cortisol, lysozyme) in the context of glucocorticoid responsiveness evaluation, providing relevant information for named entity extraction.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions the entity 'protein' (IFN-gamma) in the context of asthma pathogenesis, providing valuable information for named entity extraction.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions the entity 'protein' (NF-kappa B) in the context of serum effects and therapeutic strategies, which is helpful for identifying named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence directly mentions the entities 'protein' (VDR, RXR, GRIP-1, DRIP205, DRIP) in the context of sensitivity to analogue effects and coactivator complex, making it highly helpful for extracting named entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions the entities 'protein' (CD40, Rel/nuclear factor kappaB, NF-kappaB) and 'cell_type' (B lymphocytes) in the context of stimulation and nuclear factors, providing relevant information for named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1561,
        "sentence": "In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .",
        "label": {
            "CD30": "protein",
            "NF-kappa B complexes": "protein",
            "p65 RelA": "protein",
            "p50 NF-kappa B1": "protein",
            "NF-kappa B": "protein",
            "transcription factors": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of proteins and transcription factors that are relevant to the entity labels in the target sentence, such as NF-kappaB, Sp1, p50, and NFAT.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of proteins and cell types that are relevant to the entity labels in the target sentence, such as NF-ATc and T lymphocytes.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of proteins and transcription factors that are relevant to the entity labels in the target sentence, such as CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as PAFR, PAF, NF-kappa B, and protein kinase C.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as RelA and NF-kappa B.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as NF-kappa B and I kappa B alpha.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of proteins and cell types that are relevant to the entity labels in the target sentence, such as NF-kappaB, Tax, and ATL.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as NF-kappa B and I kappa B alpha.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides an example of a protein that is relevant to the entity labels in the target sentence, NF-kappa B.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as CD40, NF-kappa B, and AP-1.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides an example of a DNA binding activity that is relevant to the entity labels in the target sentence, NF-kappa B.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of proteins that are relevant to the entity labels in the target sentence, such as NF-kB, AP-1, OCT-1, and NF-IL-2B.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains examples of proteins that are relevant to the entity labels in the target sentence, such as IkappaBalpha and NF-kappaB.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides an example of a protein that is relevant to the entity labels in the target sentence, NF-kappa B.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains examples of proteins that are relevant to the entity labels in the target sentence, such as IkappaBbeta and NF-kappaB.\"}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"p50 NF-kappa B1\": \"protein\"}, {\"p65 RelA\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}"
    },
    {
        "idx": 330,
        "sentence": "ZRE-B is therefore not part of the R- inducible enhancer .",
        "label": {
            "ZRE-B": "DNA",
            "R- inducible enhancer": "DNA"
        },
        "response1": "None.",
        "response2": "[\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 3},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 2},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 3},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 4},\n    {\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 4},\n    {\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n    {\"The protein from E. coli specifically converted dUTP to dUMP and did not react with other dNTPs or NTPs.\": 3}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1104,
        "sentence": "Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 3},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1594,
        "sentence": "Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .",
        "label": {
            "Jurkat cells": "cell_line",
            "NF-kappa B -activating cytokine": "protein",
            "Human IL4 promoter": "DNA",
            "tumor necrosis factor alpha": "protein",
            "RelA -overexpressing cells": "cell_line",
            "NF-kappa B": "protein",
            "RelA": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells (NFAT) or AP-1 reporters.\": 5}\n]",
        "response3": "[{\"IL4\": \"protein\"}, {\"Jurkat cells\": \"cell_line\"}, {\"NF-kappa B\": \"protein\"}, {\"tumor necrosis factor alpha\": \"protein\"}, {\"RelA\": \"protein\"}]",
        "prediction": "{'IL4': 'protein', 'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}"
    },
    {
        "idx": 1086,
        "sentence": "Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .",
        "label": {
            "NF-kappa B": "protein",
            "I kappa B alpha": "protein",
            "human I kappa B alpha protein": "protein",
            "mouse 70Z/3 cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBalpha' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'RelA' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B beta' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'CD40' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are all proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'E2A' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"phorbol myristate acetate\": \"protein\"}, {\"lipopolysaccharide\": \"protein\"}, {\"mouse 70Z/3 cells\": \"cell_line\"}]",
        "prediction": "{'I kappa B alpha': 'protein', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein', 'mouse 70Z/3 cells': 'cell_line'}"
    },
    {
        "idx": 1,
        "sentence": "When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.",
        "label": {
            "homeodomain": "DNA",
            "HB24": "DNA",
            "Drosophila homeodomain": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n{\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n{\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1226,
        "sentence": "Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .",
        "label": {
            "transcription factors": "protein",
            "T-cell nuclear extract-DNA complexes": "protein",
            "OSF2": "protein",
            "osteoblast nuclear extract-DNA complexes": "protein",
            "PEBP2 alpha factors": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity label set.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains a specific protein name and its corresponding label, which directly matches the entity label set.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple specific protein names and their corresponding labels, which directly match the entity label set.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains a generic mention of 'Protein' which corresponds to the 'protein' entity label in the entity label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names and cell types with their corresponding labels, which directly match the entity label set.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a specific protein name and its corresponding label, which directly matches the entity label set.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity label set.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains a specific protein name and its corresponding label, which directly matches the entity label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains a specific DNA name and its corresponding label, which directly matches the entity label set.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains a specific protein name and its corresponding label, which directly matches the entity label set.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names, cell type, and their corresponding labels, which directly match the entity label set.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity label set.\"}\n]",
        "response3": "[{'OSF2': 'protein'}, {'PEBP2 alpha factors': 'protein'}]",
        "prediction": "{'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}"
    },
    {
        "idx": 663,
        "sentence": "The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .",
        "label": {},
        "response1": "['cell_line', 'gene']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific mentions of protein and RNA entities, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions specific transcription factors (NF-ATc, GATA-1) and cell types (T lymphocytes, embryonic cardiac cells) which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a lineage-specific transcription factor (GATA-1) which is relevant to the entity labels in the target sentence.\"},\n    {\"Example 4\": 3},\n    {\"Reason 4\": \"The sentence mentions a gene (SCM-1) which is relevant to the entity labels in the target sentence, but the context is slightly less specific.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The sentence mentions nonhuman primates as a cell type, which is relevant to the entity labels in the target sentence, but the context is slightly less specific.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions a gene (E2A) and protein level expression, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a gene (GATA-1) and protein level expression, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions immunohistochemistry, antibodies, proteins, genes, and cell types, all of which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions specific proteins (NF-kappa B, I kappa B alpha) which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions a gene (IL-4) and proteins, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions specific transcription factors (Sp1, Ets) which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions specific proteins (p21(WAF1/CIP1), p27(KIP1)) which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 14\": 3},\n    {\"Reason 14\": \"The sentence mentions cell adhesion molecules, which are relevant to the entity labels in the target sentence, but the context is slightly less specific.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific mentions of proteins (IL-13, IL-4R, JAK2, IL-13R) which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions specific transcription factors (ZEB, c-Myb, Ets) and cell types (hematopoietic cells) which are relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1000,
        "sentence": "Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.",
        "label": {
            "HSF2": "protein",
            "HSF3": "protein",
            "HSFs": "protein",
            "HSF1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 39,
        "sentence": "Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .",
        "label": {
            "KBF1": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping between the entities and their types.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence contains a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its type.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of named entities with their corresponding entity labels, helping to identify the entities and their types.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its type.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping between the entities and their types.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence contains a clear example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its type.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides an example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its type.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides an example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its type.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides examples of named entities with their corresponding entity labels, helping to identify the entities and their types.\"},\n    {\"Sentence\": 2},\n    {\"Reason\": \"The sentence provides an example of a named entity with its corresponding entity label, aiding in understanding the relationship between the entity and its type.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear and direct mapping between the entities and their types.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides examples of named entities with their corresponding entity labels, helping to identify the entities and their types.\"}\n]",
        "response3": "[{'KBF1': 'protein'}, {'NF-kappa B': 'protein'}]",
        "prediction": "{'KBF1': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 229,
        "sentence": "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .",
        "label": {
            "B-cell line": "cell_line",
            "IM-9": "cell_line",
            "GR": "protein",
            "CVZ 's binding sites": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 4},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 4},\n    {\"Example 7\": 3},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 3},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"CVZ\": \"protein\"}, {\"IM-9\": \"cell_line\"}, {\"RU 38486\": \"protein\"}, {\"human GR\": \"protein\"}]",
        "prediction": "{'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein'}"
    },
    {
        "idx": 743,
        "sentence": "Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .",
        "label": {
            "erythroid cell transcription factor": "protein",
            "non-erythroid cells": "cell_type",
            "EF1": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1799,
        "sentence": "These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .",
        "label": {
            "GAS": "DNA",
            "IFN-gamma-activated sequence": "DNA",
            "STAT proteins": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"IFN-gamma-activated sequence (GAS)\": \"DNA\"}]",
        "prediction": "{'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}"
    },
    {
        "idx": 1703,
        "sentence": "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .",
        "label": {
            "E1A": "protein",
            "IFN": "protein",
            "adenovirus-transformed cells": "cell_line",
            "IFN -activated NK cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5}\n]",
        "response3": "[{\"E1A\": \"protein\"}, {\"IFN\": \"protein\"}, {\"adenovirus-transformed cells\": \"cell_line\"}, {\"NK cells\": \"cell_type\"}]",
        "prediction": "{'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}"
    },
    {
        "idx": 629,
        "sentence": "Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .",
        "label": {
            "progesterone receptor": "protein",
            "CD8+ cells": "cell_line",
            "lymphocytes": "cell_line",
            "progesterone receptor -bearing cells": "cell_line",
            "CD4+ cells": "cell_line"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05.\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells, respectively.\": 4},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5}\n]",
        "response3": "[{\"CD8+\": \"cell_type\"}, {\"progesterone receptor\": \"protein\"}, {\"CD4+\": \"cell_type\"}, {\"lymphocytes\": \"cell_type\"}]",
        "prediction": "{'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}"
    },
    {
        "idx": 490,
        "sentence": "Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .",
        "label": {
            "lymphokine genes": "DNA",
            "interleukin-2": "protein"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents .\": 4},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine ( IFN-gamma ) in combination with allergy-driven overproduction of T helper 2-type cytokines .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5}\n]",
        "response3": "[{\"Cyclosporin A\": \"protein\"}, {\"CsA\": \"protein\"}, {\"lymphokine genes\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"interleukin-2\": \"protein\"}]",
        "prediction": "{'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}"
    },
    {
        "idx": 118,
        "sentence": "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .",
        "label": {
            "SCL": "protein",
            "SCL 5' regulatory region": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n    {\"By the time of diagnosis of T-PLL , the clone contains many more genetic changes in the form of additional translocations.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4}\n]",
        "response3": "[{\"SCL\": \"protein\"}]",
        "prediction": "{'SCL': 'protein'}"
    },
    {
        "idx": 493,
        "sentence": "Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .",
        "label": {
            "NFAT-1 complex": "protein",
            "mitogen-inducible DNA-binding complexes": "protein",
            "kappa B complex": "protein",
            "interleukin-2": "protein",
            "interleukin-2 enhancer": "DNA",
            "HIV enhancer": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 4},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5}\n]",
        "response3": "[{\"kappa B complex\": \"protein\"}, {\"NFAT-1 complex\": \"protein\"}]",
        "prediction": "{'kappa B complex': 'protein', 'NFAT-1 complex': 'protein'}"
    },
    {
        "idx": 1798,
        "sentence": "In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .",
        "label": {
            "purified human peripheral blood T cells": "cell_type",
            "anti-CD3 Abs": "protein",
            "nuclear STAT proteins": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 3},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 5},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"anti-CD3 Abs\": \"protein\"}]",
        "prediction": "{'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}"
    },
    {
        "idx": 175,
        "sentence": "To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.",
        "label": {
            "blood mononuclear cells": "cell_type",
            "uncultured cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"bronchoalveolar lavage\": \"cell_type\"}, {\"blood mononuclear cells\": \"cell_type\"}, {\"sarcoidosis\": \"cell_type\"}, {\"tuberculosis\": \"cell_type\"}]",
        "prediction": "{'bronchoalveolar lavage': 'cell_type', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}"
    },
    {
        "idx": 1498,
        "sentence": "Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.",
        "label": {
            "lymphoblasts": "cell_type"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5}\n]",
        "response3": "[{\"DNA\": \"DNA\"}, {\"steroid hormone receptor\": \"protein\"}]",
        "prediction": "{'DNA': 'DNA', 'steroid hormone receptor': 'protein'}"
    },
    {
        "idx": 995,
        "sentence": "The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation\": 3},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 4},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1671,
        "sentence": "Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .",
        "label": {
            "IL-6 neutralizing antibodies": "protein",
            "IL-6": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 3},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 141,
        "sentence": "TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .",
        "label": {
            "monocytic cells": "cell_type",
            "TNF-alpha": "protein",
            "HIV LTR": "DNA",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\n        \"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5\n    },\n    {\n        \"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5\n    },\n    {\n        \"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5\n    },\n    {\n        \"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5\n    },\n    {\n        \"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma, the cells instead become DC.\": 5\n    },\n    {\n        \"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5\n    },\n    {\n        \"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5\n    },\n    {\n        \"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5\n    },\n    {\n        \"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5\n    },\n    {\n        \"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells (NFAT) or AP-1 reporters.\": 5\n    },\n    {\n        \"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5\n    },\n    {\n        \"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.\": 5\n    },\n    {\n        \"Remixing of purified T cells showed that naive T cells do not suppress LAI replication in memory T cells and that memory T cells do not restore LAI expression in naive T cells.\": 5\n    },\n    {\n        \"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5\n    },\n    {\n        \"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV, p105 and p50, and MAD3, with the end result of persistent NF-kappa B activation and viral persistence.\": 5\n    },\n    {\n        \"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.\": 5\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1557,
        "sentence": "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .",
        "label": {
            "Hodgkin's disease -derived, T cell-like, CD30 + cells": "cell_line",
            "nuclear factor (NF)-kappa B": "protein",
            "M44": "protein",
            "L540 cells": "cell_line",
            "M67": "protein",
            "mAb": "protein",
            "agonistic anti- CD30 monoclonal antibodies": "protein",
            "CD30": "protein"
        },
        "response1": "['cell_line', 'protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of NF-kappa B DNA binding activity, which directly matches an entity label in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions RelA and Rel homology family, which are related to NF-kappa B complex, matching the entity labels in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of proteins and factors involved in signal transduction events, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions NF-kappa B binding activity, which is directly related to the entity label in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions CD40 expression and various cytokines, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides examples of proteins and cell types involved in lymphocyte activation, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of proteins involved in immune response and signaling pathways, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions NF-kappa B activation in phagocytosing neutrophils, which is relevant to the entity label in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of proteins and cell types involved in differentiation and signaling, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions NF-kappaB activation in leukemic cells, which is relevant to the entity label in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions IkappaBbeta and NF-kappaB, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of proteins and cytokines involved in immune response and stimulation, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of proteins and components of NF-kappaB complex, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of proteins and factors involved in CD40 stimulation and signaling, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions HIV-1 infection and proteins involved in immune response, which are relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'L540 cells': 'cell_line'}, {'CD30': 'protein'}, {'NF-kappa B': 'protein'}, {'DNA': 'DNA'}]",
        "prediction": "{'L540 cells': 'cell_line', 'CD30': 'protein', 'NF-kappa B': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 1090,
        "sentence": "Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.",
        "label": {
            "N terminus": "protein",
            "I kappa B alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 3},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1568,
        "sentence": "The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .",
        "label": {
            "enzymes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a protein name and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions a DNA-related entity, which is relevant to the entity labels in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple protein names and a cell line name that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions cell types, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions DNA and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names and cell types that are relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'HDL': 'protein'}, {'LDL': 'protein'}]",
        "prediction": "{'HDL': 'protein', 'LDL': 'protein'}"
    },
    {
        "idx": 257,
        "sentence": "Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .",
        "label": {},
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 262,
        "sentence": "This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .",
        "label": {
            "complementary DNA": "DNA",
            "c-jun proto-oncogene product": "protein",
            "palindromic target sequence": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"cDNAs\": 5},\n{\"SCM-1\": 4},\n{\"IL-2\": 5},\n{\"Runt domain\": 4},\n{\"GM-CSF\": 5},\n{\"Th2-type lymphocytes\": 5},\n{\"SLAP-130\": 5},\n{\"SLP-76\": 5},\n{\"T cell\": 5},\n{\"p21(WAF1/CIP1)\": 5},\n{\"p27(KIP1)\": 5},\n{\"CD95 ligand\": 5},\n{\"Egr-1\": 5},\n{\"protein\": 5},\n{\"ZEBRA\": 5},\n{\"Jun\": 5},\n{\"ATF-2\": 5},\n{\"Protein\": 5},\n{\"CREB\": 5},\n{\"AR-CRE\": 5},\n{\"B and T cell activation\": 5},\n{\"Ramos\": 5},\n{\"Jurkat\": 5},\n{\"cDNA microarray technology\": 5}\n]",
        "response3": "[{\"complementary DNA\": \"DNA\"}, {\"protein\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 1351,
        "sentence": "Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 973,
        "sentence": "To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .",
        "label": {
            "MZF-1": "DNA",
            "DNA binding domain": "protein",
            "yeast transactivator GAL4": "protein",
            "GAL4": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence directly mentions the gene SCM-1 and refers to it as a gene, indicating it is a cell line.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions p50p50 as a motif that binds efficiently, suggesting it is a protein.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence refers to PML/RARalpha as a role in myelopoiesis, indicating it is a protein.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence directly mentions EKLF, CBP, p300, and P/CAF as acetylated transcription factors, indicating they are proteins.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence directly mentions GATA-1 as a lineage-specific transcription factor, indicating it is a protein.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence directly mentions TCF-1 as a transcription factor, indicating it is a protein.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence directly mentions ZEBRA as a transcription factor, indicating it is a protein.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence directly mentions A-myb as a transcription factor, indicating it is a protein.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The sentence mentions protein and genomic sequences, suggesting the presence of proteins involved in transcription.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The sentence mentions CD95 ligand promoter, indicating it is related to a protein.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence directly mentions Tax and TFIIA as interacting proteins, indicating they are proteins.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence directly mentions Egr-1 as a zinc finger transcription factor, indicating it is a protein.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence directly mentions IL-2, c-Jun, and c-Fos as nuclear factors and proteins, indicating they are proteins.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence directly mentions GATA-1 as a DNA-binding protein, indicating it is a protein.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence directly mentions E2A as a protein, indicating it is a protein.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence directly mentions Sp1 and Ets as transcription factors, indicating they are proteins.\"}\n]",
        "response3": "[{\"MZF-1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"GAL4\": \"protein\"}]",
        "prediction": "{'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}"
    },
    {
        "idx": 1125,
        "sentence": "This indicates that the CR of GR may be of functional significance.",
        "label": {
            "GR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"kappa E3'\": 1},\n{\"positive-acting elements\": 1},\n{\"negative-acting elements\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 338,
        "sentence": "Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .",
        "label": {
            "T3R": "protein",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1080,
        "sentence": "However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 5},\n    {\"Although erythropoietin ( Epo ) is essential for the production of mature red blood cells , the cooperation with other factors is required for a proper balance between progenitor proliferation and differentiation.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1786,
        "sentence": "Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .",
        "label": {
            "coagulation protease": "protein",
            "tissue factor (TF) receptor": "protein",
            "plasma Factor VII/VIIa": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names, cell type, and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific protein names, cell type, and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names and cell type, and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names, cell type, and their corresponding labels, which directly match the entity types in the target sentence.\"}\n]",
        "response3": "[{\"Factor VII/VIIa\": \"protein\"}, {\"tissue factor (TF) receptor\": \"protein\"}]",
        "prediction": "{'Factor VII/VIIa': 'protein', 'tissue factor (TF) receptor': 'protein'}"
    },
    {
        "idx": 1242,
        "sentence": "LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .",
        "label": {
            "NF kappa B": "protein",
            "p50/p65 heterodimers": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 3},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 4},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4}\n]\n```",
        "response3": "```json\n[{\"NF kappa B\": \"protein\"}, {\"p50/p65 heterodimers\": \"protein\"}]\n```",
        "prediction": "{'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}"
    },
    {
        "idx": 866,
        "sentence": "T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCL1) and its corresponding entity label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple examples of proteins (Syk, Zap) and a cell type (T cell) with their corresponding entity labels.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence includes examples of a protein (TIMP-1) and DNA, which are relevant entity types.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of proteins (IkappaBbeta, NF-kappaB) with their corresponding entity labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains examples of proteins (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) with their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence includes examples of proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) with their corresponding entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides an example of a protein (NF-kappa B) with its corresponding entity label.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains an example of a protein (ZAP-70) with its corresponding entity label.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes examples of a cell type (HIV-1) and proteins (IFN, PKR, IkappaBalpha) with their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of cell types (B and T cell activation), cell lines (Ramos, Jurkat), and a technology (cDNA microarray) with their corresponding entity labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains examples of DNA (HIV-1 LTR) and proteins (NFAT-1, NF kappa B) with their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence includes examples of a protein (TR55), a cytokine (TNF-alpha), and a cell type (HIV) with their corresponding entity labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of cell types (T lymphocytes), a virus (adenovirus vectors), and their corresponding entity labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains examples of cell types (T cells, memory T cells, naive T cells) and a protein (LAI) with their corresponding entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence includes examples of cell types (CD4+, CD8+ T cells) and proteins (TPCK, anti-CD28, PMA) with their corresponding entity labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of proteins (HIV, NF-kappa B, p105, p50, MAD3) with their corresponding entity labels.\"}\n]",
        "response3": "[{'T cell': 'cell_type'}, {'HIV': 'protein'}]",
        "prediction": "{'T cell': 'cell_type', 'HIV': 'protein'}"
    },
    {
        "idx": 433,
        "sentence": "Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .",
        "label": {
            "regulatory regions": "DNA",
            "BSAP": "protein",
            "high-affinity binding site": "DNA",
            "B-lymphoid-specific genes": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"immunoglobulin\": \"protein\"}, {\"class II major histocompatibility (MHC) genes\": \"protein\"}, {\"B-lymphoid-specific genes\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}"
    },
    {
        "idx": 1546,
        "sentence": "Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .",
        "label": {
            "platelet glycoprotein Ib alpha gene": "DNA",
            "GATA": "DNA",
            "Ets binding motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides specific names of transcription factors (Sp1 and Ets) that are directly mentioned in the target sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example mentions specific proteins (EBNA2) and a cell line (TP1) that are relevant to the target sentence, contributing to the extraction of protein and cell line entities.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example mentions a specific protein (GM-CSF) that is related to the target sentence, providing some assistance in identifying protein entities.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example refers to a specific cell type (Th2-type lymphocytes) mentioned in the target sentence, aiding in the extraction of cell type entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example provides specific names of proteins (Stat3, Stat5, c-Mpl) that are directly mentioned in the target sentence, greatly assisting in the extraction of protein entities.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example mentions specific proteins (IkappaBbeta, NF-kappaB) that are relevant to the target sentence, contributing to the extraction of protein entities.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example mentions a specific protein (Egr-1) that is directly related to the target sentence, providing significant help in identifying protein entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example provides specific names of proteins (Sp1, CD14) that are directly mentioned in the target sentence, greatly aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example mentions a specific protein (GATA-1) that is relevant to the target sentence, contributing to the extraction of protein entities.\"\n    },\n    {\n        \"Example 10\": 3\n    },\n    {\n        \"Reason 10\": \"The example mentions specific DNA (CCAAT box) and a protein (EKLF binding site) related to the target sentence, providing some assistance in identifying DNA and protein entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example provides specific names of proteins (cAMP-dependent protein kinase, Rap1) that are directly mentioned in the target sentence, greatly assisting in the extraction of protein entities.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The example mentions a specific protein (E2A) that is relevant to the target sentence, contributing to the extraction of protein entities.\"\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Reason 13\": \"The example mentions a specific protein (GATA-1) that is related to the target sentence, providing some assistance in identifying protein entities.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The example mentions specific proteins (IL-2, c-Jun, c-Fos) that are relevant to the target sentence, contributing to the extraction of protein entities.\"\n    }\n]",
        "response3": "[{\"GATA\": \"protein\"}, {\"Ets\": \"protein\"}]",
        "prediction": "{'GATA': 'protein', 'Ets': 'protein'}"
    },
    {
        "idx": 1412,
        "sentence": "We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'SCM-1' to the entity label 'cell_line' in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides clear mappings of the entities 'CREB' and 'AR-CRE' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides clear mappings of the entities 'IL-2', 'c-Jun', and 'c-Fos' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides clear mappings of the entities 'granulocytes' and 'T cells' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides clear mappings of the entities 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides clear mappings of the entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides clear mappings of the entities 'NF-kB', 'AP-1', 'OCT-1', and 'NF-IL-2B' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear mapping of the entity 'IL-4' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides clear mappings of the entities 'T cell', 'IL-2', 'IL-2 receptor', and 'CD28' to the entity labels 'cell_type' and 'protein' in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides clear mappings of the entities 'AP-1' and 'PMA' to the entity label 'protein', and 'monocytes' and 'macrophages' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a clear mapping of the entity 'RXR' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear mapping of the entity 'IL-2' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides clear mappings of the entities 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides clear mappings of the entities 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides clear mappings of the entities 'IL-4', 'LPS', and 'AP-1' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides clear mappings of the entities 'T cell' and 'interleukin 2' to the entity labels 'cell_type' and 'protein' in the target sentence.\"}\n]",
        "response3": "[{\"PRL-\": \"protein\"}, {\"IL-2-\": \"protein\"}]",
        "prediction": "{'PRL-': 'protein', 'IL-2-': 'protein'}"
    },
    {
        "idx": 411,
        "sentence": "There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 4},\n    {\"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.\": 4}\n]",
        "response3": "[{\"VDR\": \"protein\"}]",
        "prediction": "{'VDR': 'protein'}"
    },
    {
        "idx": 1460,
        "sentence": "In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.",
        "label": {
            "multiple myeloma cell lines": "cell_line",
            "PU.1": "protein",
            "Pu box": "DNA",
            "differentiated, plasma cell-like B cells": "cell_type"
        },
        "response1": "['cell_line', 'DNA', 'protein', 'RNA']",
        "response2": "[\n    {\"Sentence 1\": 4},\n    {\"Sentence 2\": 4},\n    {\"Sentence 3\": 3},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 4},\n    {\"Sentence 6\": 4},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 4},\n    {\"Sentence 9\": 3},\n    {\"Sentence 10\": 4},\n    {\"Sentence 11\": 4},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 4},\n    {\"Sentence 14\": 4},\n    {\"Sentence 15\": 4}\n]",
        "response3": "[{\"multiple myeloma cell lines\": \"cell_line\"}, {\"B cells\": \"cell_type\"}, {\"PU.1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"mRNA\": \"RNA\"}]",
        "prediction": "{'multiple myeloma cell lines': 'cell_line', 'B cells': 'cell_type', 'PU.1': 'protein', 'DNA': 'DNA', 'mRNA': 'RNA'}"
    },
    {
        "idx": 638,
        "sentence": "Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .",
        "label": {
            "CD3": "protein",
            "TCR": "protein",
            "VLA-5 fibronectin receptor": "protein",
            "fibronectin": "protein",
            "CD4 cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (TCF-1) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides two examples of protein entities (c-kit and IL-4R alpha chain) and their corresponding labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides examples of protein entities (Syk and Zap) and a cell type entity (T cell) with their corresponding labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of protein entities (Stat3, Stat5, and c-Mpl) with their corresponding labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides examples of protein entities (CD40 and NF-kappa B) with their corresponding labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of protein entities (IL4, IL13, STAT6, STAT3, STAT5) and a cell type entity (B cells) with their corresponding labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of protein entities (NF-ATc) and a cell type entity (T lymphocytes) with their corresponding labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides an example of a cell type entity (cell adhesion molecules) with its corresponding label.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of protein entities (CD70, IL-4, CD40) and cell type entities (B cells, plasma cells) with their corresponding labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of protein entities (IL-7R, gamma(c)) with their corresponding labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of protein entities (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) with their corresponding labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of protein entities (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) with their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of protein entities (interleukin 10, IL-10R, STAT3, IL-6) with their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of protein entities (IL-2 receptor alpha subunit, p21ras) and a cell type entity (B cell) with their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides an example of a protein entity (NF-kappa B) with its corresponding label.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of protein entities (ICAM-1, CD71, LMP1, IkappaB) with their corresponding labels.\"}\n]",
        "response3": "[{\"VLA-5\": \"protein\"}, {\"CD4 cells\": \"cell_type\"}, {\"CD3\": \"protein\"}, {\"TCR\": \"protein\"}, {\"fibronectin\": \"protein\"}]",
        "prediction": "{'VLA-5': 'protein', 'CD4 cells': 'cell_type', 'CD3': 'protein', 'TCR': 'protein', 'fibronectin': 'protein'}"
    },
    {
        "idx": 1375,
        "sentence": "We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .",
        "label": {
            "PBLs": "cell_type",
            "peripheral blood lymphocytes": "cell_type",
            "TCL1 mRNA": "RNA",
            "protein": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCL1) being expressed.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple examples of proteins (IL-2, c-Jun, c-Fos) being mentioned in relation to nuclear factors.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions a cell line (SCM-1) being examined.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions a DNA binding activity of a transcription factor (AP-1).\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides examples of proteins (NF-kappaB, Tax) and a cell type (ATL) being activated in leukemic cells.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions the ectopic expression of a protein (TAL1) promoting the development of a specific cell type (T-ALL).\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of proteins (SCL, GATA-1) expressed in specific cell populations.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions the molecular cloning of a protein (SLAP-130) and its association with other proteins in T cells.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly examines the expression of a protein (E2A) at the protein level.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions the specificity of protein expression (MNDA) in a specific cell line (Philadelphia chromosome-positive chronic myeloid leukemia).\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of proteins (TCRzeta, p56(lck)) detected in peripheral blood T cells.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions the deviation of methylation in specific cell types (granulocytes, T cells).\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence shows exclusive paternal expression of a protein (WT1) in peripheral lymphocytes.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) in relation to differentiation.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions the gene expression study of cell lines (Ramos, Jurkat) and the technology used (cDNA microarray).\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of proteins (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) in relation to stimulation.\"},\n]",
        "response3": "[{\"TCL1\": \"protein\"}, {\"PBLs\": \"cell_type\"}, {\"AT\": \"cell_type\"}]",
        "prediction": "{'TCL1': 'protein', 'PBLs': 'cell_type', 'AT': 'cell_type'}"
    },
    {
        "idx": 764,
        "sentence": "The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .",
        "label": {
            "CEM-C7": "cell_line",
            "CEM-C7 cells": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 4},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 3},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 897,
        "sentence": "The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .",
        "label": {
            "transcription of SV40 T-antigen": "protein",
            "NFAT-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NFAT-1\": \"protein\"}, {\"SV40 T-antigen\": \"protein\"}]",
        "prediction": "{'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}"
    },
    {
        "idx": 1842,
        "sentence": "Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .",
        "label": {
            "Ets-1": "protein",
            "TFE-3": "protein",
            "LEF-1": "protein",
            "enhancer-binding proteins": "protein",
            "Sp1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of transcription factors and their interactions, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides an example of a transcription factor in the context of erythroid cells, which is relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence mentions a T cell-specific activity and a protein related to interleukin 2, which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 2},\n    {\"Reason\": \"The sentence mentions a lineage-specific transcription factor, which is relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of transcription factors and their interactions, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of transcription factors and their binding activities, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides an example of a zinc finger transcription factor, which is relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence provides examples of transcription factors and their interactions, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions a transcription factor and its DNA binding activity, which is relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides an example of a transcription factor interacting with a cis-element, which is relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains examples of Sp1 and Ets-related transcription factors in the context of maintaining gene expression, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions the cleavage of a transcription factor SP1 during B-cell apoptosis, which is relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence provides examples of Sp1 binding site mutation and its role in tissue-specific expression, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions the inhibition of a cell-specific transcription factor NF-E2, which is relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains examples of the transcription factor NF-ATc and its expression in different cell types, which are directly relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"Ets-1\": \"protein\"}, {\"TFE-3\": \"protein\"}, {\"Sp1\": \"protein\"}]",
        "prediction": "{'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}"
    },
    {
        "idx": 1059,
        "sentence": "Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .",
        "label": {
            "NF-kappa B family": "protein",
            "Transcription factors": "protein",
            "I kappa B beta": "protein",
            "inhibitory I kappa B proteins": "protein",
            "I kappa B alpha": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains multiple entities relevant to the entity labels in the target sentence, such as NF-kappaB, Tax, and ATL, which are correctly identified as protein and cell_type entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence contains entities like NF-ATc and T lymphocytes, which are correctly identified as protein and cell_type entities, respectively.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence contains entities like NF-kappa B and I kappa B alpha, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence contains entities like NF-kappa B and I kappa B beta, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence contains entities like IkappaBalpha and NF-kappaB, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence contains entities like IkappaBbeta and NF-kappaB, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The sentence contains entities like NF-ATc, T lymphocytes, and embryonic cardiac cells, which are correctly identified as protein and cell_type entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence contains entities like NF-kappa B and AP-1, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The sentence contains entities like NF-kappaB and rheumatoid arthritis, which are correctly identified as protein and cell_type entities.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence contains entities like NF-kappaB, Sp1, and p50, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence contains entities like NF-kB, AP-1, OCT-1, and NF-IL-2B, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence contains entities like RelA and NF-kappa B, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence contains entities like PAFR, PAF, NF-kappa B, and protein kinase C, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence contains entities like NF-kappa B and I kappa B alpha, which are correctly identified as protein entities.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence contains entities like NF-kappa B, which is correctly identified as a protein entity.\"\n    }\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"I kappa B beta\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}"
    },
    {
        "idx": 924,
        "sentence": "We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .",
        "label": {
            "hsp70": "protein",
            "untransformed steroid receptors": "protein",
            "hsp90": "protein",
            "p56": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 3},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 2},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4}\n]",
        "response3": "[{\"p56\": \"protein\"}, {\"hsp70\": \"protein\"}, {\"hsp90\": \"protein\"}, {\"untransformed steroid receptors\": \"protein\"}]",
        "prediction": "{'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'untransformed steroid receptors': 'protein'}"
    },
    {
        "idx": 247,
        "sentence": "Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .",
        "label": {
            "Antigen B27": "protein",
            "glucocorticoid receptors": "protein",
            "blood lymphocytes": "cell_type",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 4},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\": 3},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes.\": 3},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5}\n]",
        "response3": "[{\"Antigen B27\": \"protein\"}, {\"glucocorticoid receptors\": \"protein\"}, {\"blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 507,
        "sentence": "Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .",
        "label": {
            "TCF-2 alpha": "protein",
            "TCR alpha enhancer": "DNA",
            "CREB": "protein",
            "transcription factors": "protein",
            "T alpha 1": "protein",
            "TCR": "protein",
            "TCF-1 alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCF-2 alpha\": \"protein\"}, {\"T alpha 1\": \"protein\"}, {\"CREB\": \"protein\"}, {\"TCR alpha enhancer\": \"DNA\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}"
    },
    {
        "idx": 460,
        "sentence": "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.",
        "label": {
            "HIV LTRs": "DNA",
            "regulatory elements": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 131,
        "sentence": "Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .",
        "label": {
            "TRs": "protein",
            "carboxyl-terminus": "protein",
            "TR alpha 1": "protein",
            "nuclear proteins": "protein",
            "amino acid 210": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4}\n]",
        "response3": "[{\"TR alpha 1\": \"protein\"}, {\"NE\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"TRs\": \"protein\"}]",
        "prediction": "{'TR alpha 1': 'protein', 'NE': 'protein', 'DNA': 'DNA', 'TRs': 'protein'}"
    },
    {
        "idx": 692,
        "sentence": "The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .",
        "label": {
            "virally encoded transactivator protein": "protein",
            "Tax -response element": "DNA",
            "TRE": "DNA",
            "human T-cell leukemia virus type I ( HTLV-I ) promoter": "DNA",
            "Tax": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a protein (TCF-1) and its corresponding entity label, but the context is slightly less clear compared to Example 1.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly mentions a cell line (SIVsmmPBj14) and its corresponding entity label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides examples of two proteins (IkappaBbeta and NF-kappaB) and their corresponding entity labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions multiple proteins (interleukin 10, IL-10R, STAT3, IL-6) and their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides examples of multiple proteins (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and their corresponding entity labels, as well as two stimuli (phytohemagglutinin and phorbol myristate acetate) and their corresponding entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions a protein (NF-ATc) and two cell types (T lymphocytes and embryonic cardiac cells) with their corresponding entity labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions a DNA entity (hepatitis B virus) and a protein entity (HBxAg) with their corresponding entity labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of multiple proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions a protein (TCL1) and its corresponding entity label.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions a cell type (T cell) and a protein (interleukin 2) with their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions a cell type (Th2-type lymphocytes) with its corresponding entity label.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions proteins (NF-kappaB, Sp1) and a cell line (SIVmac) with their corresponding entity labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions proteins (ATF1, CREB, H4) with their corresponding entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions a DNA entity (HIV-1 LTR) and proteins (NFAT-1, NF kappa B) with their corresponding entity labels.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions proteins (tal-1, GATA-binding proteins) and a cell type (hematopoiesis) with their corresponding entity labels.\"}\n]",
        "response3": "[{'HTLV-I': 'cell_type'}, {'TRE': 'DNA'}, {'Tax': 'protein'}]",
        "prediction": "{'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}"
    },
    {
        "idx": 43,
        "sentence": "T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .",
        "label": {
            "cysteine-rich antigen segments": "protein",
            "T-helper-cell determinants": "protein",
            "protein antigens": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1204,
        "sentence": "Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mention of the entity label 'cell_line' in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example mentions the entity label 'protein' in the sentence, which is helpful for identifying named entities, but it requires additional context to determine the specific protein.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example contains multiple mentions of entity labels 'cell_line' and 'protein' in the sentence, providing valuable information for extracting named entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example mentions the entity label 'protein' in the sentence, which is helpful for identifying named entities, but it requires additional context to determine the specific protein.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example mentions the entity label 'cell_type' in the sentence, which is helpful for identifying named entities, but it requires additional context to determine the specific cell type.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example mentions the entity label 'protein' in the sentence, which is helpful for identifying named entities, but it requires additional context to determine the specific protein.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides clear mentions of the entity labels 'cell_type' and 'cell_type' in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example mentions the entity label 'protein' in the sentence, which is helpful for identifying named entities, but it requires additional context to determine the specific protein.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides clear mentions of the entity labels 'protein', 'protein', and 'RNA' in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides clear mentions of the entity labels 'protein', 'protein', and 'protein' in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides clear mentions of the entity labels 'DNA', 'protein', and 'protein' in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides clear mentions of the entity labels 'DNA', 'protein', and 'protein' in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides clear mentions of the entity labels 'protein', 'protein', 'protein', and 'protein' in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides clear mentions of the entity labels 'protein', 'protein', 'protein', and 'protein' in the sentence, making it highly helpful for extracting named entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides clear mentions of the entity labels 'cell_type' and 'cell_type' in the sentence, making it highly helpful for extracting named entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1134,
        "sentence": "Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 3},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 471,
        "sentence": "The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).",
        "label": {
            "lymphocyte nuclear T3 receptor": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"T3 receptor\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'T3 receptor': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 1205,
        "sentence": "Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The sentence provides an example of a named entity with its corresponding entity label, which is somewhat helpful for extracting named entities from the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence.\"},\n    {\"Example 4\": 3},\n    {\"Reason 4\": \"The sentence provides an example of a named entity with its corresponding entity label, which is somewhat helpful for extracting named entities from the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it helpful for extracting named entities from the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 14,
        "sentence": "Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .",
        "label": {
            "c-fos": "DNA",
            "nuclear proto-oncogenes": "DNA",
            "c-jun": "DNA",
            "platelet-activating factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"c-fos\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'c-fos': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 145,
        "sentence": "Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .",
        "label": {
            "nuclear proteins": "protein",
            "major histocompatibility complex (MHC) class II promoters": "DNA",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5}\n]",
        "response3": "[{\"X boxes\": \"protein\"}, {\"Y boxes\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"major histocompatibility complex (MHC) class II promoters\": \"DNA\"}]",
        "prediction": "{'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}"
    },
    {
        "idx": 1449,
        "sentence": "DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.",
        "label": {
            "upstream stimulatory factor": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"A-myb\": 5},\n    {\"Protein\": 5},\n    {\"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"UAS3\": 4, \"UAS2\": 4, \"YY1\": 5},\n    {\"UAS1\": 4, \"B cell\": 4},\n    {\"DNA\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 5, \"embryonic cardiac cells\": 5},\n    {\"PU.1\": 5, \"M-CSF receptor\": 5, \"macrophage\": 5},\n    {\"T cell\": 5, \"interleukin 2\": 5},\n    {\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n    {\"RelA\": 5, \"NF-kappaB1\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"Jun\": 5, \"ATF-2\": 5},\n    {\"p50p50\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1292,
        "sentence": "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .",
        "label": {
            "thromboxane receptor": "protein",
            "thromboxane receptor gene": "DNA",
            "CAT": "protein",
            "chloramphenicol acetyltransferase": "protein",
            "5' flanking region": "DNA",
            "thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids": "DNA",
            "K562 cells": "cell_line"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains clear mentions of specific cell types expressed by human Th2-type lymphocytes, which directly corresponds to the 'cell_type' entity label.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence provides specific names of proteins such as c-kit and IL-4R alpha chain, which align with the 'protein' entity label.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence mentions the protein GATA-1 in the context of differentiating erythroid cells, which is relevant to the 'protein' entity label.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence includes multiple protein names like Stat3, Stat5, and c-Mpl, indicating their involvement in signal transduction, megakaryopoiesis, and platelet function, aligning with the 'protein' entity label.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence mentions the protein TCF-1 transactivating through its cognate motif in non-T cells, which corresponds to the 'protein' entity label.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence provides a clear indication of proteins such as PAFR, PAF, NF-kappa B, and protein kinase C involved in the regulation of PAFR gene expression, aligning with the 'protein' entity label.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence specifically mentions Sp1 and CD14 proteins and their critical roles in tissue-specific promoter activity and expression in monocytic cells, which directly relate to the 'protein' entity label.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence discusses the expression of the protein E2A at the protein level using specific antisera, which corresponds to the 'protein' entity label.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence provides a detailed account of proteins like IFN A, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate and their expression levels and abilities, aligning with the 'protein' entity label.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The sentence mentions the CD95 ligand promoter and its regulatory mechanism, which corresponds to the 'protein' entity label.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence discusses the regulatory mechanism of the SCM-1 genes, indicating a cell line involvement, aligning with the 'cell_line' entity label.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence provides information about gene expression in B and T cell activation, Ramos and Jurkat cells, and the use of cDNA microarray technology, aligning with the 'cell_type' and 'cell_line' entity labels.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions specific proteins like Ter 119, beta-globin, glycoprotein IIb, and platelet factor 4 in the context of erythroid cells and megakaryocytic transcripts, aligning with the 'protein' entity label.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"The sentence discusses the role of proteins like ATF1, CREB, and H4 in trans-activation of the H4 promoter, which corresponds to the 'protein' entity label.\"},\n{\"Example 15\": 4},\n{\"Reason 15\": \"The sentence mentions the BAT box, CD20 promoter, and B cells, indicating their involvement in promoter activity, aligning with the 'DNA' and 'protein' entity labels.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence provides insights into the activation of the IL-2 promoter, NFAT, NFAT delta418, calcineurin, and Tpl-2 proteins, along with the inhibitor cyclosporin A, aligning with the 'DNA' and 'protein' entity labels.\"}\n]",
        "response3": "[{\"thromboxane receptor gene\": \"protein\"}, {\"thromboxane receptor gene promoter\": \"protein\"}, {\"chloramphenicol acetyltransferase (CAT)\": \"protein\"}, {\"K562 cells\": \"cell_line\"}]",
        "prediction": "{'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase (CAT)': 'protein', 'K562 cells': 'cell_line'}"
    },
    {
        "idx": 120,
        "sentence": "Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.",
        "label": {
            "RPMI 8402": "cell_line",
            "T cell lines": "cell_line",
            "CEM": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"SIVmacMER\": 5},\n    {\"SIVmac239\": 5},\n    {\"CEMx174\": 5},\n    {\"Protein\": 4},\n    {\"MNDA\": 4},\n    {\"myeloid cell lines\": 4},\n    {\"Runt domain\": 4},\n    {\"CREB\": 5},\n    {\"AR-CRE\": 5},\n    {\"WT1\": 4},\n    {\"T cell\": 5},\n    {\"interleukin 2\": 4},\n    {\"PBMC\": 5},\n    {\"adenovirus DNA\": 5},\n    {\"FasL\": 4},\n    {\"IL-2\": 4},\n    {\"IFN-gamma\": 4},\n    {\"PU.1\": 4},\n    {\"M-CSF receptor\": 4},\n    {\"macrophage\": 4},\n    {\"TCL1\": 4},\n    {\"ZEBRA\": 4},\n    {\"CD70\": 4},\n    {\"B cell\": 4},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4},\n    {\"GM-CSF\": 4},\n    {\"EBV\": 4},\n    {\"B-cell\": 4},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 468,
        "sentence": "A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 4},\n    {\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 4},\n    {\"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.\": 5},\n    {\"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 138,
        "sentence": "The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .",
        "label": {
            "beta interferon promoter": "DNA",
            "regulatory elements": "DNA",
            "HIV long terminal repeat": "DNA",
            "TNF-alpha": "protein",
            "LTR": "DNA",
            "reporter chloramphenicol acetyltransferase plasmids": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"TNF-alpha\": \"protein\"}, {\"chloramphenicol acetyltransferase\": \"protein\"}, {\"HIV long terminal repeat (LTR)\": \"DNA\"}, {\"beta interferon promoter\": \"DNA\"}]",
        "prediction": "{'TNF-alpha': 'protein', 'chloramphenicol acetyltransferase': 'protein', 'HIV long terminal repeat (LTR)': 'DNA', 'beta interferon promoter': 'DNA'}"
    },
    {
        "idx": 64,
        "sentence": "Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .",
        "label": {
            "IFN beta promoter deletions": "DNA"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\n        \"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5\n    },\n    {\n        \"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4\n    },\n    {\n        \"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5\n    },\n    {\n        \"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4\n    },\n    {\n        \"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 3\n    },\n    {\n        \"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4\n    },\n    {\n        \"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5\n    },\n    {\n        \"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5\n    },\n    {\n        \"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5\n    },\n    {\n        \"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4\n    },\n    {\n        \"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5\n    },\n    {\n        \"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5\n    },\n    {\n        \"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4\n    },\n    {\n        \"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.\": 4\n    },\n    {\n        \"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.\": 5\n    },\n    {\n        \"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\": 4\n    }\n]",
        "response3": "[{\"HeLa\": \"cell_line\"}, {\"Sendai virus\": \"cell_type\"}, {\"IFN beta\": \"protein\"}]",
        "prediction": "{'HeLa': 'cell_line', 'Sendai virus': 'cell_type', 'IFN beta': 'protein'}"
    },
    {
        "idx": 1760,
        "sentence": "This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (NF-E2) being mentioned in relation to a specific action.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions the protein P selectin in relation to an inhibitory effect, providing a relevant example.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions multiple entities (RNA, cell_type, protein) in relation to specific stimulations and inhibitions, aiding in entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence provides examples of proteins (TIMP-1) and DNA in relation to cell survival and synthesis, aiding in entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions multiple entities (cell_type, protein) in relation to T cell proliferation and costimulation, aiding in entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides an example of a protein (G-CSF) in relation to its effects, aiding in entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions multiple proteins (IL-2, NF-kappa B, AP-1) in relation to drug effects and activations, aiding in entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence provides an example of a protein (IL-2) in relation to cellular distribution, aiding in entity extraction.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The sentence mentions cell adhesion molecules in a general context, providing some relevance to entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions the protein NF-kappa B in relation to suppression of cytokine generation, aiding in entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions multiple proteins (interleukin-2, CD25) in relation to reduced mitogenic response, aiding in entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides examples of proteins (Erbstatin, genistein) and RNA (Egr-1) in relation to mRNA expression and phosphorylation, aiding in entity extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence provides examples of DNA, cell line, and cell type in relation to binding and regulatory sequences, aiding in entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions multiple entities (DNA, protein, calcineurin) in relation to promoter activation, aiding in entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence provides an example of a protein (NF-kappa B) in relation to activation in human neutrophils, aiding in entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 676,
        "sentence": "The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein",
            "interleukin 2 ( IL-2 ) gene promoter": "DNA",
            "T-cell": "cell_type"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the entity 'IL-2' and specifies that it is a protein, providing clear and specific information for entity extraction.\"},\n\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence mentions multiple entities such as 'IL-13', 'IL-4', 'B cell', and 'monocyte', providing specific information on protein and cell_type entities for extraction.\"},\n\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions various entities like 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells', providing specific information on protein and cell_type entities for extraction.\"},\n\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions entities like 'IL-2', 'Aiolos', and 'Ras', providing specific information on protein entities for extraction.\"},\n\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions entities like 'NF-ATc' and 'T lymphocytes', providing specific information on protein and cell_type entities for extraction.\"},\n\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions 'IL-2', providing specific information on protein entities for extraction.\"},\n\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions multiple entities like 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate', providing specific information on protein entities for extraction.\"},\n\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions entities like 'CD28', 'CD80', 'CD86', 'CBL', 'VAV', 'NFAT', 'interleukin-2', and 'granulocyte-macrophage colony-stimulating factor', providing specific information on protein entities for extraction.\"},\n\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions entities like 'interleukin 10', 'IL-10R', 'STAT3', and 'IL-6', providing specific information on protein entities for extraction.\"},\n\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions entities like 'T cell' and 'interleukin 2', providing specific information on protein and cell_type entities for extraction.\"},\n\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions entities like 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R', providing specific information on protein entities for extraction.\"},\n\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions entities like 'IL-2', 'c-Jun', and 'c-Fos', providing specific information on protein entities for extraction.\"},\n\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions entities like 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell', providing specific information on protein and cell_type entities for extraction.\"},\n\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions entities like 'Th2-type lymphocytes', providing specific information on cell_type entities for extraction.\"},\n\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions the entity 'IL-4', providing specific information on protein entities for extraction.\"}\n]",
        "response3": "[{'interleukin 2': 'protein'}, {'T-cell': 'cell_type'}]",
        "prediction": "{'interleukin 2': 'protein', 'T-cell': 'cell_type'}"
    },
    {
        "idx": 1052,
        "sentence": "Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.",
        "label": {
            "IL-2R alpha": "protein",
            "SEA": "protein",
            "IL-2R gamma": "protein",
            "SEB": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 3},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 487,
        "sentence": "Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.",
        "label": {
            "human monocytes": "cell_type",
            "normal human monocytes": "cell_type",
            "M-CSF": "protein",
            "immediate early response genes": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 4},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 570,
        "sentence": "Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 3},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 3},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 3},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1370,
        "sentence": "Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .",
        "label": {
            "CD28": "protein",
            "anti- CD28 MoAb": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 994,
        "sentence": "The role of BSAP ( Pax-5 ) in B-cell development .",
        "label": {
            "BSAP": "protein",
            "Pax-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 3},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 4},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"IL-13, a cytokine similar to IL-4, is a regulator of human B cell and monocyte functions.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"Pax-5\": \"protein\"}, {\"B-cell\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 438,
        "sentence": "This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).",
        "label": {
            "OTF factors": "protein",
            "nuclear proteins": "protein",
            "sequence motif": "DNA",
            "octamer transcription factors": "protein",
            "Oct": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 270,
        "sentence": "There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1481,
        "sentence": "We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1807,
        "sentence": "We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .",
        "label": {
            "cell genes": "DNA",
            "cyclin E": "DNA",
            "cyclin D2": "DNA",
            "CD23": "DNA",
            "cdc-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5}\n]",
        "response3": "[{\"cdc-2\": \"protein\"}, {\"cyclin E\": \"protein\"}, {\"CD23\": \"protein\"}, {\"cyclin D2\": \"protein\"}, {\"EBV\": \"cell_line\"}]",
        "prediction": "{'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}"
    },
    {
        "idx": 1169,
        "sentence": "However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .",
        "label": {
            "SPXX motifs": "protein",
            "nuclear targeting sequence": "protein",
            "gene regulatory proteins": "protein",
            "B4-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\n        \"Protein\": 5\n    },\n    {\n        \"p21(WAF1/CIP1)\": 5\n    },\n    {\n        \"p27(KIP1)\": 5\n    },\n    {\n        \"E2A\": 5\n    },\n    {\n        \"IL-4\": 5\n    },\n    {\n        \"hepatitis B virus\": 1,\n        \"HBxAg\": 5\n    },\n    {\n        \"interleukin 10\": 5,\n        \"IL-10R\": 5,\n        \"STAT3\": 5,\n        \"IL-6\": 5\n    },\n    {\n        \"p50p50\": 5\n    },\n    {\n        \"IL-2\": 5,\n        \"c-Jun\": 5,\n        \"c-Fos\": 5\n    },\n    {\n        \"Th2-type lymphocytes\": 5\n    },\n    {\n        \"NF-kappa B\": 5,\n        \"AP-1\": 5\n    },\n    {\n        \"GM-CSF\": 5\n    },\n    {\n        \"UAS3\": 1,\n        \"UAS2\": 1,\n        \"YY1\": 5\n    },\n    {\n        \"A-myb\": 5\n    },\n    {\n        \"UAS1\": 5,\n        \"B cell\": 5\n    },\n    {\n        \"Ter 119\": 5,\n        \"beta-globin\": 5,\n        \"glycoprotein IIb\": 5,\n        \"platelet factor 4\": 5\n    },\n    {\n        \"GM-kappa B\": 5,\n        \"GC-box\": 5,\n        \"GC-motif\": 5,\n        \"GM-kappa B motif\": 5\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1180,
        "sentence": "We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .",
        "label": {
            "IL-2R": "protein",
            "IL-2": "protein",
            "IL-2R gamma": "protein",
            "JAK3": "protein",
            "IL-2 receptor": "protein",
            "JAK1": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5}\n]",
        "response3": "[{\"IL-2 receptor\": \"protein\"}, {\"JAK1\": \"protein\"}, {\"JAK3\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}]",
        "prediction": "{'IL-2 receptor': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}"
    },
    {
        "idx": 968,
        "sentence": "These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.",
        "label": {
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 5},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 4},\n    {\"Sentence 5\": 4},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 4},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 497,
        "sentence": "The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .",
        "label": {
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Example 15\": 4\n    }\n]",
        "response3": "[{\"T cells\": \"cell_type\"}]",
        "prediction": "{'T cells': 'cell_type'}"
    },
    {
        "idx": 1606,
        "sentence": "Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .",
        "label": {
            "CD11b/CD18": "protein",
            "CD35": "protein",
            "p50/p65": "protein",
            "CR1": "protein",
            "HIV-infected monocytic cells": "cell_type",
            "complement receptors": "protein",
            "human monocytes": "cell_type",
            "NF-kappa B": "protein",
            "CR3": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example contains multiple entities that match the entity types in the target sentence, providing a direct mapping of protein and cell type entities.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example contains multiple entities that match the entity types in the target sentence, providing a direct mapping of protein and cell type entities.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example contains multiple entities that match the entity types in the target sentence, providing a direct mapping of protein entities.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example contains entities that match the protein entity type in the target sentence, providing relevant information for extraction.\"\n    },\n    {\n        \"Example 5\": 3\n    },\n    {\n        \"Reason 5\": \"The example contains an entity that matches the DNA entity type in the target sentence, providing some relevant information for extraction.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example contains entities that match the protein entity type in the target sentence, providing relevant information for extraction.\"\n    },\n    {\n        \"Example 7\": 3\n    },\n    {\n        \"Reason 7\": \"The example contains an entity that matches the protein entity type in the target sentence, providing some relevant information for extraction.\"\n    },\n    {\n        \"Example 8\": 3\n    },\n    {\n        \"Reason 8\": \"The example contains an entity that matches the protein entity type in the target sentence, providing some relevant information for extraction.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example contains entities that match the protein entity type in the target sentence, providing relevant information for extraction.\"\n    },\n    {\n        \"Example 10\": 3\n    },\n    {\n        \"Reason 10\": \"The example contains an entity that matches the protein entity type in the target sentence, providing some relevant information for extraction.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The example contains entities that match the protein and cell type entity types in the target sentence, providing relevant information for extraction.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The example contains entities that match the protein and cell type entity types in the target sentence, providing relevant information for extraction.\"\n    },\n    {\n        \"Example 13\": 3\n    },\n    {\n        \"Reason 13\": \"The example contains an entity that matches the protein entity type in the target sentence, providing some relevant information for extraction.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The example contains entities that match the DNA and protein entity types in the target sentence, providing relevant information for extraction.\"\n    }\n]\n```",
        "response3": "```json\n[\n    {\n        \"CR1\": \"protein\"\n    },\n    {\n        \"CD35\": \"protein\"\n    },\n    {\n        \"CR3\": \"protein\"\n    },\n    {\n        \"CD11b/CD18\": \"protein\"\n    },\n    {\n        \"NF-kappa B\": \"protein\"\n    },\n    {\n        \"p50/p65\": \"protein\"\n    },\n    {\n        \"monocytes\": \"cell_type\"\n    },\n    {\n        \"HIV-infected monocytic cells\": \"cell_type\"\n    }\n]\n```",
        "prediction": "{'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}"
    },
    {
        "idx": 1653,
        "sentence": "Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .",
        "label": {
            "nonmyeloid cells": "cell_type",
            "GM-CSF": "protein",
            "PU.1": "protein",
            "GM-CSF receptor alpha promoter": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 833,
        "sentence": "Mapping of B-cell epitopes of the human hepatitis B virus X protein .",
        "label": {
            "human hepatitis B virus X protein": "protein",
            "B-cell epitopes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence contains the term 'cDNAs' which is likely referring to DNA, making it highly relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple terms that are likely named entities, such as 'SP1' (protein), 'caspases' (protein), and 'B-cell' (cell_type), making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains the term 'Th2-type lymphocytes' which is likely referring to a cell type, making it relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains the term 'E2A' which is likely referring to a protein, making it relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple terms that are likely named entities, such as 'SLAP-130' (protein), 'SLP-76' (protein), and 'T cell' (cell_type), making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains the term 'TCF-1' which is likely referring to a protein, making it relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains terms 'T lymphocytes' (cell_type) and 'HLA-molecules' (protein), making it relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains multiple terms that are likely named entities, such as 'IkappaBbeta' (protein) and 'NF-kappaB' (protein), making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains the term 'GM-CSF' which is likely referring to a protein, making it relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains the term 'immunoglobulin kappa 3' enhancer' which is likely referring to DNA, making it relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple terms that are likely named entities, such as 'EBNA-2' (protein) and 'PU.1' (protein), making it very helpful for extracting named entities from the target sentence.\"},\n\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains the term 'hepatitis B virus' which is likely referring to DNA, and 'HBxAg' which is likely referring to a protein, making it relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains the term 'SIVsmmPBj14' which is likely referring to a cell line, making it relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains terms 'EBV' (cell_type) and 'B-cell' (cell_type), making it relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains multiple terms that are likely named entities, such as 'p50' (protein), 'p65' (protein), 'DNA' (DNA), and 'protein' (protein), making it very helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"B-cell\": \"cell_type\"}, {\"hepatitis B virus X protein\": \"protein\"}]",
        "prediction": "{'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}"
    },
    {
        "idx": 389,
        "sentence": "The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .",
        "label": {
            "periplasmic domain": "protein",
            "PhoQ protein": "protein",
            "cationic proteins": "protein",
            "defensin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction\": 4},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction\": 5}\n]",
        "response3": "[{\"PhoQ\": \"protein\"}]",
        "prediction": "{'PhoQ': 'protein'}"
    },
    {
        "idx": 193,
        "sentence": "The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 4},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1349,
        "sentence": "Its expression was always restricted to the nucleus .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence provides specific gene names and their corresponding entity labels, which can aid in identifying proteins.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains detailed information about nuclear factors and specific proteins, which are crucial for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions transcription factors and specific proteins, providing valuable information for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes various transcription factors and proteins, aiding in accurate entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides detailed information about proteins and cytokines, which are essential for entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions specific cell types and a protein, aiding in entity extraction.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides information about a specific protein, aiding in entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains detailed information about proteins and their interactions, which are crucial for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions specific proteins and their interactions, providing valuable information for entity extraction.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence mentions a gene name without specifying the entity type, which may be less helpful for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides detailed information about mRNA, cell types, and proteins, aiding in accurate entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions DNA binding activity and a specific transcription factor, aiding in entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides detailed information about a specific protein, aiding in accurate entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions a specific protein and a type of leukemia, which are crucial for entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence provides information about protein synthesis and mRNA, aiding in entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 882,
        "sentence": "This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .",
        "label": {
            "c-Jun": "protein",
            "heterodimeric activator protein-1 transcription complex": "protein",
            "c-Fos": "protein",
            "cDNA": "DNA",
            "human c-Jun protein": "protein",
            "cDNA clone": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Example 15\": 5\n    }\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"c-Jun\": \"protein\"}, {\"c-Fos\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein'}"
    },
    {
        "idx": 725,
        "sentence": "Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .",
        "label": {
            "Rex": "protein",
            "HTLV-infected cells": "cell_type",
            "gag/pol": "protein",
            "env mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'TCF-1' and its entity label 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence directly mentions 'TCL1' and its entity label 'protein', providing a clear reference for entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence explicitly mentions 'PML/RARalpha' as a protein, making it very helpful for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'hepatitis B virus' as DNA and 'HBxAg' as protein, providing clear references for entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions 'SIVsmmPBj14' as a cell line, which is a direct and clear reference for entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides multiple mentions of proteins like 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate', making it highly helpful for entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'TIMP-1' as a protein and 'DNA' explicitly, aiding in entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'Egr-1' as a protein, providing a clear reference for entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'HIV-1' as a cell type, 'IFN', 'PKR', and 'IkappaBalpha' as proteins, making it highly helpful for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'HIV-1 LTR' as DNA, 'NFAT-1', and 'NF kappa B' as proteins, aiding in entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'cDNA' as DNA, 'Jurkat' as a cell line, and 'DRE 1' as a cell type, providing clear references for entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'TR55' and 'TNF-alpha' as proteins, and 'HIV' as a cell type, aiding in entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions 'TCL1' and 'MTCP1/c6.1B' as proteins, aiding in entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'T lymphocytes' as a cell type and 'adenovirus vectors' as DNA, providing clear references for entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'Rel-A' as a protein, 'T cells' as a cell type, and 'IL-2' as a protein, aiding in entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'XP-B' and 'XP-D' as cell lines, and 'adenovirus' as DNA, providing clear references for entity extraction.\"}\n]",
        "response3": "[{'gag/pol': 'protein'}, {'env mRNA': 'RNA'}, {'HTLV-infected cells': 'cell_type'}]",
        "prediction": "{'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}"
    },
    {
        "idx": 867,
        "sentence": "In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).",
        "label": {
            "conserved binding sites": "DNA",
            "nuclear factor kappa B": "protein",
            "long terminal repeat": "DNA",
            "LTR": "DNA",
            "NF kappa B": "protein",
            "transcriptional enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter .\": 4},\n    {\"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region .\": 4}\n]",
        "response3": "[{\"long terminal repeat\": \"DNA\"}, {\"transcriptional enhancer\": \"DNA\"}, {\"nuclear factor kappa B\": \"protein\"}]",
        "prediction": "{'long terminal repeat': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B': 'protein'}"
    },
    {
        "idx": 841,
        "sentence": "Such tests may become useful diagnostic tools .",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names (myeloperoxidase, lysozyme, PU.1) which are directly mentioned in the sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions PBMC (peripheral blood mononuclear cells) and adenovirus, which are indicative of cell type and DNA entities respectively.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence mentions PBMC (peripheral blood mononuclear cells) and adenovirus DNA, which are indicative of cell type and DNA entities respectively.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence mentions IFN-gamma, a specific protein, which is directly related to the sentence.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence mentions lymphoid neoplasms, which is a specific cell type directly mentioned in the sentence.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence mentions STAT1, a specific protein, which is directly related to the sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions Ras, a specific protein, which is directly related to the sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence mentions immunohistochemistry, gene, and cell type, which are indicative of protein, DNA, and cell type entities respectively.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions NF-kappa B, a specific protein, which is directly related to the sentence.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions SCM-1, a specific cell line, which is directly related to the sentence.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence mentions SIVsmmPBj14, a specific cell line, which is directly related to the sentence.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence mentions nonhuman primates, which is a specific cell type directly mentioned in the sentence.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions T-PLL, a specific cell type, which is directly related to the sentence.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions E2A, a specific protein, which is directly related to the sentence.\"},\n{\"Example 15\": 4},\n{\"Reason 15\": \"The sentence mentions AP-1, which is indicative of DNA entity.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions B and T cell activation, Ramos, Jurkat, and cDNA microarray technology, which are indicative of cell type, cell line, cell line, and DNA entities respectively.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 956,
        "sentence": "BSAP : a key regulator of B-cell development and differentiation .",
        "label": {
            "BSAP": "protein",
            "B-cell": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence directly mentions the entity 'NF-E2' and its association with a protein, providing clear context for entity extraction.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence mentions 'EBV' and 'B-cell' in the context of cell types, aiding in the extraction of these entities.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence provides multiple instances of protein and cell type entities, directly linking them to specific terms like 'CD70', 'IL-4', 'CD40', 'plasma cells', and 'B cell'.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type, aiding in the extraction of this specific entity.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence directly associates 'GATA-1' with a protein, providing clear context for entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence provides clear associations between 'Syk' and 'Zap' as proteins, and 'T cell' as a cell type, aiding in entity extraction.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The sentence mentions 'Th1' and 'Th2' as cell types, aiding in the extraction of these specific entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence directly links 'T cell' and 'interleukin 2' to their respective entity types, aiding in entity extraction.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence directly mentions 'IL-2' as a protein, providing clear context for entity extraction.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1769,
        "sentence": "We have tried to find out whether these receptors could show any difference in sex or age distribution.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 1},\n    {\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 1},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 110,
        "sentence": "Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .",
        "label": {
            "long terminal repeat": "DNA",
            "NF-KB": "protein",
            "double repeat-KB enhancer sequence": "DNA",
            "cellular transactivation factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NF-KB\": \"protein\"}]",
        "prediction": "{'NF-KB': 'protein'}"
    },
    {
        "idx": 1379,
        "sentence": "Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .",
        "label": {
            "TCL1": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1338,
        "sentence": "The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .",
        "label": {
            "Bcl-2 family": "protein",
            "cellular proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 3},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"Bcl-2\": \"protein\"}]",
        "prediction": "{'Bcl-2': 'protein'}"
    },
    {
        "idx": 1323,
        "sentence": "PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .",
        "label": {
            "PRE-I": "DNA",
            "Jurkat cells": "cell_line",
            "multiple DNA-protein complexes": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example directly mentions the impaired transcription factor AP-1 and its DNA binding activity, providing a clear link between the entity and its type.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example provides multiple instances of protein entities and their associations with specific functions and stimuli, aiding in understanding the context in which proteins are mentioned.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The example explicitly mentions the mouse E2A gene at the protein level, providing a direct link between the entity and its type.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example mentions specific proteins like IL-2, c-Jun, and c-Fos in the context of nuclear factors and binding to DNA, aiding in identifying protein entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example provides direct evidence of a protein-protein interaction between EBNA-2 and PU.1, aiding in understanding the relationship between the entities.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example clearly states the increase in mRNA and protein levels of p21(WAF1/CIP1) and p27(KIP1), linking the entities to their protein type.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The example mentions specific proteins like EKLF, CBP, p300, and P/CAF, providing insights into the protein entities involved in transcription.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly links NF-kappa B to DNA binding activity in monocytes, aiding in identifying the entity type.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example mentions Jun and ATF-2 as essential for transcription, providing context for the protein entities and their functions.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example provides a direct link between IkappaBbeta and NF-kappaB, aiding in understanding the relationship between the protein entities.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The example mentions p50 and p65 proteins in the context of DNA-protein complexes, providing insights into the protein entities involved.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The example mentions proteins Tip and Tap inducing cell aggregation in Jurkat-T cells, aiding in identifying the protein entities and the cell line.\"\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Reason 13\": \"The example provides information on the sequences governing the response of HIV-1 LTR and their binding to NFAT-1 and NF kappa B, aiding in understanding the DNA and protein entities.\"\n    },\n    {\n        \"Example 14\": 3\n    },\n    {\n        \"Reason 14\": \"The example mentions cDNA, Jurkat, and DRE 1, but the associations with their respective entity types are not explicitly clear, reducing the overall helpfulness.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The example mentions tal-1, GATA-binding proteins, and hematopoiesis, providing insights into the protein entities and the cell type involved.\"\n    },\n    {\n        \"Example 16\": 4\n    },\n    {\n        \"Reason 16\": \"The example links NF-E1 and YY-1 proteins to the same gene and their binding to the adeno-associated virus P5 promoter, aiding in understanding the protein entities.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1309,
        "sentence": "Proteins in the first group contain multiple HMG boxes , are non-sequence-specific , and recognize structural features as found in cruciform DNA and cross-over DNA .",
        "label": {
            "cruciform DNA": "DNA",
            "HMG boxes": "protein",
            "cross-over DNA": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n{\"p50p50\": 4},\n{\"Reason\": \"Helpful as it provides a clear example of a protein entity mentioned in the sentence.\"},\n{\"p21(WAF1/CIP1)\": 4},\n{\"p27(KIP1)\": 4},\n{\"Reason\": \"Helpful as it provides clear examples of protein entities mentioned in the sentence.\"},\n{\"GATA-1\": 4},\n{\"Reason\": \"Helpful as it provides a clear example of a protein entity mentioned in the sentence.\"},\n{\"NF-ATc\": 4},\n{\"T lymphocytes\": 4},\n{\"Reason\": \"Helpful as it provides clear examples of protein and cell type entities mentioned in the sentence.\"},\n{\"Protein\": 3},\n{\"Reason\": \"Somewhat helpful as it provides a general example of a protein entity mentioned in the sentence.\"},\n{\"GM-CSF\": 4},\n{\"Reason\": \"Helpful as it provides a clear example of a protein entity mentioned in the sentence.\"},\n{\"cDNAs\": 3},\n{\"Reason\": \"Somewhat helpful as it provides a general example of a DNA entity mentioned in the sentence.\"},\n{\"IgH\": 4},\n{\"Reason\": \"Helpful as it provides a clear example of a DNA entity mentioned in the sentence.\"},\n{\"IL-2\": 4},\n{\"c-Jun\": 4},\n{\"c-Fos\": 4},\n{\"Reason\": \"Helpful as it provides clear examples of protein entities mentioned in the sentence.\"},\n{\"Stat proteins\": 4},\n{\"Reason\": \"Helpful as it provides a clear example of a protein entity mentioned in the sentence.\"},\n{\"immunohistochemistry\": 3},\n{\"gene\": 3},\n{\"cell type\": 4},\n{\"Reason\": \"Somewhat helpful as it provides general examples of protein, DNA, and cell type entities mentioned in the sentence.\"},\n{\"Th2-type lymphocytes\": 4},\n{\"Reason\": \"Helpful as it provides a clear example of a cell type entity mentioned in the sentence.\"},\n{\"GM-kappa B\": 4},\n{\"GC-box\": 4},\n{\"GC-motif\": 4},\n{\"GM-kappa B motif\": 4},\n{\"Reason\": \"Helpful as it provides clear examples of DNA entities mentioned in the sentence.\"},\n{\"p50\": 4},\n{\"p65\": 4},\n{\"Reason\": \"Helpful as it provides clear examples of protein entities mentioned in the sentence.\"},\n{\"HIV-1 LTR\": 4},\n{\"NFAT-1\": 4},\n{\"NF kappa B\": 4},\n{\"Reason\": \"Helpful as it provides clear examples of DNA and protein entities mentioned in the sentence.\"},\n{\"NF-kappaB\": 4},\n{\"Sp1\": 4},\n{\"SIVmac\": 4},\n{\"Reason\": \"Helpful as it provides clear examples of protein and cell line entities mentioned in the sentence.\"}\n]",
        "response3": "[{'HMG boxes': 'protein'}, {'DNA': 'DNA'}, {'DNA': 'DNA'}]",
        "prediction": "{'HMG boxes': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 228,
        "sentence": "We have carried out experiments to define the nature of the higher affinity CVZ binding site .",
        "label": {
            "higher affinity CVZ binding site": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"cDNAs\": 5, \"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n{\"G-CSF\": 5},\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"CD95 ligand\": 5},\n{\"DNA\": 5},\n{\"SCM-1\": 5},\n{\"cell adhesion molecules\": 5},\n{\"E2A\": 5},\n{\"NF-kappa B\": 5},\n{\"BRCA1\": 5},\n{\"TCF-1\": 5},\n{\"retinoic acid receptor alpha\": 5},\n{\"CREB\": 5, \"AR-CRE\": 5},\n{\"SIVsmmPBj14\": 5},\n{\"protein\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 51,
        "sentence": "Such segments accord well with empirically known T-cell determinants and our algorithm produces a lower number of false positive predictions than the principle based on discrete Fourier transformations previously described.",
        "label": {
            "T-cell determinants": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals, and growth factors.\": 4},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1518,
        "sentence": "Anti-immunoglobulin M activates nuclear calcium/calmodulin-dependent protein kinase II in human B lymphocytes .",
        "label": {
            "nuclear calcium/calmodulin-dependent protein kinase II": "protein",
            "human B lymphocytes": "cell_type",
            "Anti-immunoglobulin M": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\"IL-13\": 5},\n    {\"IL-4\": 5},\n    {\"B cell\": 5},\n    {\"monocyte\": 5},\n    {\"cAMP-dependent protein kinase\": 5},\n    {\"Rap1\": 5},\n    {\"IL-2\": 5},\n    {\"NF-kappa B\": 5},\n    {\"AP-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"B cell\": 5},\n    {\"Syk\": 5},\n    {\"Zap\": 5},\n    {\"T cell\": 5},\n    {\"IkappaBbeta\": 5},\n    {\"NF-kappaB\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"NF-kappa B\": 5},\n    {\"IL-2\": 5},\n    {\"Aiolos\": 5},\n    {\"Ras\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 5},\n    {\"ATL\": 5},\n    {\"T lymphocytes\": 5},\n    {\"SP1\": 5},\n    {\"caspases\": 5},\n    {\"B-cell\": 5},\n    {\"CD70\": 5},\n    {\"B cell\": 5},\n    {\"plasma cells\": 5},\n    {\"IL-4\": 5},\n    {\"CD40\": 5},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"gamma c chain\": 5},\n    {\"STAT6\": 5},\n    {\"STAT3\": 5},\n    {\"STAT5\": 5},\n    {\"B cells\": 5},\n    {\"NF-kappa B\": 5},\n    {\"I kappa B alpha\": 5},\n    {\"P selectin\": 5}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 563,
        "sentence": "The 6-h increase in PDGF(B) mRNA was adherence dependent, and in addition, was abrogated when the cytoskeletal integrity was compromised by cytochalasin D .",
        "label": {
            "PDGF(B)": "protein",
            "PDGF(B) mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence clearly mentions 'DNA binding activity', providing a direct reference to the entity type 'DNA'.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions 'SCL mRNA', which is a type of RNA, providing a direct reference to the entity type 'RNA'. The correlation between mRNA and protein synthesis is also helpful in identifying the entity type.\"},\n{\"Example 3\": 3},\n{\"Reason 3\": \"The sentence mentions 'PAFR gene expression', 'PAF', 'NF-kappa B', and 'protein kinase C', which are all related to the entity type 'protein'. However, the references are more indirect and may require additional context for accurate extraction.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence mentions 'TIMP-1' and 'DNA synthesis', providing direct references to the entity types 'protein' and 'DNA'. The relationship between cell survival and DNA synthesis is also helpful in identifying the entity types.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos protein', providing direct references to the entity type 'protein'. The relationship between nuclear factors and protein presence is also helpful in identifying the entity types.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence mentions 'MNDA mRNA' and 'myeloid cell lines', providing direct references to the entity types 'RNA' and 'cell_line'. The relationship between mRNA levels and cell lines is also helpful in identifying the entity types.\"},\n{\"Example 7\": 3},\n{\"Reason 7\": \"The sentence mentions 'NF-kappa B' and 'DNA binding activity', which are related to the entity type 'DNA'. However, the reference is more indirect and may require additional context for accurate extraction.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence mentions 'CD14', which is related to the entity type 'protein'. The differentiation induced by 1 alpha,25-dihydroxyvitamin D3 is also helpful in identifying the entity type.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions 'Bak', 'Bad', and 'Bcl-2', providing direct references to the entity type 'protein'. The effects of treatment with PDBu and DMSO on these proteins are also helpful in identifying the entity types.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The sentence mentions 'P selectin', which is related to the entity type 'protein'. The inhibition of binding and its effect on cytokine production provide context for identifying the entity type.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence mentions 'CD14' and 'CD23 mRNA and protein', providing direct references to the entity type 'protein'. The induction of expression by PMA is also helpful in identifying the entity types.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions 'p21(WAF1/CIP1)', 'p27(KIP1) mRNA', and 'protein', providing direct references to the entity type 'protein'. The increase in these molecules in the cells is also helpful in identifying the entity types.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence mentions 'cell adhesion molecules', providing a direct reference to the entity type 'cell_type'. The mechanism of inhibition related to these molecules is also helpful in identifying the entity type.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40 signaling', providing direct references to the entity types 'protein' and 'cell_type'. The promotion of differentiation and signaling pathways are also helpful in identifying the entity types.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions 'Protein kinase B (c-Akt)', 'phosphatidylinositol 3-kinase', 'STAT5', 'erythropoietin (EPO)', 'HCD57', 'EPO', and 'HCD57-SREI', providing direct references to the entity types 'protein' and 'cell_line'. The activation and constitutive activity of these molecules in different cell lines are also helpful in identifying the entity types.\"}\n]",
        "response3": "[{'PDGF(B)': 'RNA'}, {'cytochalasin D': 'protein'}]",
        "prediction": "{'PDGF(B)': 'RNA', 'cytochalasin D': 'protein'}"
    },
    {
        "idx": 501,
        "sentence": "Southwestern and gel renaturation experiments with the use of purified protein fractions revealed that TCF-1 alpha activity is derived from a family of 57- to 53-kD proteins that are abundantly expressed in mature and immature T-cell lines ( Jurkat , CCRF-CEM ) and not in mature B cells ( JY , Namalwa ) or nonlymphoid (HeLa) cell lines .",
        "label": {
            "CCRF-CEM": "cell_line",
            "TCF-1 alpha": "protein",
            "nonlymphoid (HeLa) cell lines": "cell_line",
            "mature B cells": "cell_line",
            "JY": "cell_line",
            "Namalwa": "cell_line",
            "57- to 53-kD proteins": "protein",
            "Jurkat": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"57- to 53-kD proteins\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"CCRF-CEM\": \"cell_line\"}, {\"JY\": \"cell_line\"}, {\"Namalwa\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', '57- to 53-kD proteins': 'protein', 'Jurkat': 'cell_line', 'CCRF-CEM': 'cell_line', 'JY': 'cell_line', 'Namalwa': 'cell_line', 'HeLa': 'cell_line'}"
    },
    {
        "idx": 457,
        "sentence": "TAR independent activation of the human immunodeficiency virus in phorbol ester stimulated T lymphocytes .",
        "label": {
            "T lymphocytes": "cell_type",
            "TAR": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 5},\n    {\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 285,
        "sentence": "ER content in lymphocytes of each sample was expressed by both fmol/mg of lymphocyte cytosolic protein and fmol/micrograms of lymphocyte DNA .",
        "label": {
            "ER": "protein",
            "lymphocyte DNA": "DNA",
            "lymphocytes": "cell_type",
            "lymphocyte cytosolic protein": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5}\n]",
        "response3": "[{\"lymphocyte cytosolic protein\": \"protein\"}, {\"lymphocyte DNA\": \"DNA\"}]",
        "prediction": "{'lymphocyte cytosolic protein': 'protein', 'lymphocyte DNA': 'DNA'}"
    },
    {
        "idx": 1508,
        "sentence": "Functional characterization of the murine homolog of the B cell-specific coactivator BOB.1/OBF.1 .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "B cell-specific coactivator": "protein",
            "murine homolog": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence provides a clear example of a cell line (SCM-1) which is helpful for identifying cell line entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence provides examples of cell line (B cell) and key determinant (UAS1) which are helpful for identifying cell line and cell type entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence provides an example of a protein (GATA-1) which is helpful for identifying protein entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence provides an example of a protein (TCF-1) which is helpful for identifying protein entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides an example of a protein (E2A) which is helpful for identifying protein entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides examples of proteins (IL-2, c-Jun, c-Fos) which are helpful for identifying protein entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides an example of a protein (GM-CSF) which is helpful for identifying protein entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence provides examples of cell type (T cell) and protein (interleukin 2) which are helpful for identifying cell type and protein entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence provides examples of proteins (CD40, NF-kappa B) which are helpful for identifying protein entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides examples of proteins (SLAP-130, SLP-76) and cell type (T cell) which are helpful for identifying protein and cell type entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence provides an example of a protein (GATA-1) which is helpful for identifying protein entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides examples of proteins (Sp1, Ets) which are helpful for identifying protein entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence provides an example of DNA (NF-kappa B) which is helpful for identifying DNA entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) which are helpful for identifying protein and cell type entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence provides examples of proteins (IL-7R, gamma(c)) which are helpful for identifying protein entities.\"}\n]",
        "response3": "[{\"BOB.1/OBF.1\": \"protein\"}]",
        "prediction": "{'BOB.1/OBF.1': 'protein'}"
    },
    {
        "idx": 209,
        "sentence": "Type-II estrogen -binding sites ( type-II EBS ) have been demonstrated in the human lymphoblastoid cell line IM-9 using a whole-cell assay with (6,7-3H) estradiol ( 3H-E2 ) as tracer.",
        "label": {
            "lymphoblastoid cell line": "cell_line",
            "IM-9": "cell_line",
            "type-II EBS": "protein",
            "Type-II estrogen -binding sites": "protein",
            "human lymphoblastoid cell line": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 4},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4}\n]",
        "response3": "[{\"IM-9\": \"cell_line\"}, {\"estradiol\": \"protein\"}]",
        "prediction": "{'IM-9': 'cell_line', 'estradiol': 'protein'}"
    },
    {
        "idx": 1385,
        "sentence": "Mutational analyses of the HIV-1 LTR showed that one C/EBP site is required for normal LTR transcription both before and after cellular activation and that the two 3' C/EBP sites are functionally equivalent.",
        "label": {
            "LTR": "DNA",
            "HIV-1 LTR": "DNA",
            "C/EBP sites": "DNA",
            "C/EBP site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB- induced trans-activation of the H4 promoter\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus\": 4},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process\": 4}\n]",
        "response3": "[{\"C/EBP\": \"protein\"}, {\"HIV-1 LTR\": \"DNA\"}]",
        "prediction": "{'C/EBP': 'protein', 'HIV-1 LTR': 'DNA'}"
    },
    {
        "idx": 1516,
        "sentence": "Fusion of subdomains of BOB.1/OBF.1 with the GAL4 DNA binding domain reveals that both NH2- and COOH- terminal domains of BOB.1/OBF.1 contribute to full transactivation function, the COOH-terminal domain is more efficient in this transactivation assay .",
        "label": {
            "BOB.1/OBF.1": "protein",
            "GAL4 DNA binding domain": "protein",
            "COOH-terminal domain": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein name that is relevant to the entity label set.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions a protein name and its corresponding label, which is directly relevant to the entity label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions a specific protein name that is relevant to the entity label set.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions a specific protein name that is relevant to the entity label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains DNA and protein names, which are directly relevant to the entity label set.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains DNA and protein names, which are directly relevant to the entity label set.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains protein names and their corresponding labels, which are directly relevant to the entity label set.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains DNA, cell line, and cell type names, which are directly relevant to the entity label set.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains DNA and protein names, which are directly relevant to the entity label set.\"}\n]",
        "response3": "[{'BOB.1/OBF.1': 'protein'}, {'GAL4 DNA binding domain': 'DNA'}]",
        "prediction": "{'BOB.1/OBF.1': 'protein', 'GAL4 DNA binding domain': 'DNA'}"
    },
    {
        "idx": 1827,
        "sentence": "A regulatory element in the human interleukin 2 gene promoter is a binding site for the zinc finger proteins Sp1 and EGR-1 .",
        "label": {
            "human interleukin 2 gene promoter": "DNA",
            "EGR-1": "protein",
            "Sp1": "protein",
            "regulatory element": "DNA",
            "binding site": "DNA",
            "zinc finger proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene names and their corresponding entity labels, making it highly relevant for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"EGR-1\": \"protein\"}]",
        "prediction": "{'interleukin 2': 'protein', 'Sp1': 'protein', 'EGR-1': 'protein'}"
    },
    {
        "idx": 1116,
        "sentence": "The tumour suppressor p53 has been shown to regulate this type of apoptosis in thymocytes , but an as yet unknown, p53 -independent pathway (s) appears to mediate the same event in mitogen-activated mature T lymphocytes .",
        "label": {
            "thymocytes": "cell_type",
            "p53": "protein",
            "mitogen-activated mature T lymphocytes": "cell_line",
            "tumour suppressor p53": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"The process of apoptosis is used to eliminate unwanted cells from a wide variety of organisms.\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 178,
        "sentence": "T lymphocytes appeared to be an important source of 1,25(OH)2D3 production , since purified T lymphocytes from all patients with tuberculosis produced 1,25(OH)2D3 , and 1,25(OH)2D3 production by these cells correlated closely with that produced by unseparated lavage cells .",
        "label": {
            "T lymphocytes": "cell_type",
            "lavage cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5}\n]",
        "response3": "[{\"T lymphocytes\": \"cell_type\"}, {\"1,25(OH)2D3\": \"protein\"}, {\"tuberculosis\": \"cell_type\"}, {\"unseparated lavage cells\": \"cell_line\"}]",
        "prediction": "{'T lymphocytes': 'cell_type', '1,25(OH)2D3': 'protein', 'tuberculosis': 'cell_type', 'unseparated lavage cells': 'cell_line'}"
    },
    {
        "idx": 1209,
        "sentence": "A reduction of serum androgens was found, whereas no change was observed in either basal or GnRH-stimulated gonadotropins or in the cortisol and 17 alpha-hydroxyprogesterone response to ACTH .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"NF-kB\": 5},\n    {\"AP-1\": 5},\n    {\"OCT-1\": 5},\n    {\"NF-IL-2B\": 5},\n    {\"AP-1\": 5},\n    {\"IL-5 mRNA\": 5},\n    {\"TCR\": 4},\n    {\"IL-2R\": 5},\n    {\"dexamethasone\": 5},\n    {\"phosphocreatine\": 4},\n    {\"HML\": 5},\n    {\"dexamethasone\": 5},\n    {\"cortisol\": 5},\n    {\"lysozyme\": 5},\n    {\"NF-E2\": 5},\n    {\"NF-kappa B\": 5},\n    {\"MNDA\": 5},\n    {\"interleukin-2\": 5},\n    {\"CD25\": 5},\n    {\"IL-2R\": 5},\n    {\"CTLA4Ig\": 5},\n    {\"NFAT\": 4},\n    {\"AP-1\": 4},\n    {\"Erbstatin\": 5},\n    {\"genistein\": 5},\n    {\"Egr-1\": 5},\n    {\"CD4+\": 5},\n    {\"CD8+\": 5},\n    {\"TPCK\": 5},\n    {\"anti-CD28\": 5},\n    {\"PMA\": 5},\n    {\"MR\": 5},\n    {\"aldosterone\": 5},\n    {\"progesterone\": 5},\n    {\"Ras\": 5},\n    {\"RasN17\": 5},\n    {\"IL-2\": 5},\n    {\"CIS\": 5},\n    {\"OSM\": 5},\n    {\"STAT5\": 5},\n    {\"Type I\": 5},\n    {\"Type II\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 864,
        "sentence": "Differences in transcriptional enhancers of HIV-1 and HIV-2 .",
        "label": {
            "transcriptional enhancers": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 4},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein, which binds to the adeno-associated virus P5 promoter.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 65,
        "sentence": "Deletions upstream of the PRDII element increased transcription in the uninduced extract, indicating predominantly negative regulation of the promoter .",
        "label": {
            "promoter": "DNA",
            "PRDII element": "DNA"
        },
        "response1": "['DNA', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 61,
        "sentence": "From HeLa cells , two major proteins of 52 and 45 kilodaltons (kD) copurified with DNA binding activity , whereas from T-cells , four proteins--a major protein of 52 kD and three minor proteins of 82 , 67 , and 43-47 kD --were purified.",
        "label": {
            "82": "protein",
            "43-47 kD": "protein",
            "major protein": "protein",
            "T-cells": "cell_type",
            "minor proteins": "protein",
            "67": "protein",
            "HeLa cells": "cell_line",
            "52 kD": "protein"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5}\n]",
        "response3": "[{'HeLa cells': 'cell_line'}, {'T-cells': 'cell_line'}, {'DNA': 'DNA'}, {'protein': 'protein'}]",
        "prediction": "{'HeLa cells': 'cell_line', 'T-cells': 'cell_line', 'DNA': 'DNA', 'protein': 'protein'}"
    },
    {
        "idx": 191,
        "sentence": "A block to RNA elongation is largely responsible for decreased c-myc transcription .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 447,
        "sentence": "Each binding site contributes to the overall activity of the enhancer , however no single element seems absolutely required for activity.",
        "label": {
            "enhancer": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 476,
        "sentence": "A group of coordinately induced protooncogenes , cytoskeletal , and extracellular matrix genes have been termed immediate early response genes , and their induction has been associated with growth factor -stimulated cell proliferation .",
        "label": {
            "protooncogenes": "DNA",
            "immediate early response genes": "DNA",
            "growth factor": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 3},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1034,
        "sentence": "p94 and p95 share homology with Stat1 at the phosphorylation site and in the Src homology 2 (SH2) domain , but otherwise are immunologically distinct from Stat1 .",
        "label": {
            "Stat1": "protein",
            "phosphorylation site": "protein",
            "Src homology 2 (SH2) domain": "protein",
            "p94": "protein",
            "p95": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"calcineurin\": 5},\n    {\"Th1\": 4},\n    {\"Th2\": 4},\n    {\"IL-2\": 5},\n    {\"STAT4\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"tyrosine\": 4},\n    {\"IFN-gamma\": 5},\n    {\"Aiolos\": 5},\n    {\"ERK\": 5},\n    {\"CD28\": 5},\n    {\"CD80\": 5},\n    {\"CD86\": 5},\n    {\"CBL\": 5},\n    {\"VAV\": 5},\n    {\"NFAT\": 5},\n    {\"interleukin-2\": 5},\n    {\"granulocyte-macrophage colony-stimulating factor\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"interleukin 10\": 5},\n    {\"IL-10R\": 5},\n    {\"IL-6\": 5}\n]",
        "response3": "[{\"Stat1\": \"protein\"}, {\"p94\": \"protein\"}, {\"p95\": \"protein\"}]",
        "prediction": "{'Stat1': 'protein', 'p94': 'protein', 'p95': 'protein'}"
    },
    {
        "idx": 1232,
        "sentence": "IBR is a 503-amino-acid-long acidic protein which is 99.0% identical to the recently reported human NRF-1/alpha-Pal factor and highly related to the invertebrate transcription factors P3A2 and erected wing gene product ( EWG ).",
        "label": {
            "IBR": "protein",
            "transcription factors": "protein",
            "erected wing gene product": "protein",
            "human NRF-1/alpha-Pal factor": "protein",
            "EWG": "protein",
            "P3A2": "protein",
            "503-amino-acid-long acidic protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (IL-4) and its corresponding entity label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides clear examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides a clear example of a protein (interferon regulatory factor) and its corresponding entity label.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides clear examples of proteins (EKLF, CBP, p300, P/CAF) and their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a clear example of a protein (A-myb) and its corresponding entity label.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear example of a protein (Protein) and its corresponding entity label.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of proteins (p21(WAF1/CIP1), p27(KIP1)) and their corresponding entity labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of proteins (Drosophila Toll, human Toll) and their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides clear examples of proteins (PAFR, PAF, NF-kappa B, protein kinase C) and their corresponding entity labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of proteins (NF-kappa B, AP-1) and their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of proteins (EBNA-2, PU.1) and their corresponding entity labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of a protein (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) with their corresponding entity labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides a clear example of a DNA entity (immunoglobulin kappa 3' enhancer) and its corresponding entity label.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of a protein (Egr-1) and its corresponding entity label.\"}\n]",
        "response3": "[{\"IBR\": \"protein\"}, {\"NRF-1/alpha-Pal\": \"protein\"}, {\"P3A2\": \"protein\"}, {\"erected wing gene product (EWG)\": \"protein\"}]",
        "prediction": "{'IBR': 'protein', 'NRF-1/alpha-Pal': 'protein', 'P3A2': 'protein', 'erected wing gene product (EWG)': 'protein'}"
    },
    {
        "idx": 54,
        "sentence": "Virus stocks obtained from these experiments exhibited a continuum of replicative capacities in different human T-cell types depending on which element (s) was present in the LTR .",
        "label": {
            "LTR": "DNA",
            "human T-cell types": "cell_type",
            "T-cell types": "cell_type",
            "element": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions 'cDNAs' which is a type of DNA, making it very helpful in identifying the entity label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions 'IL-2' which is a protein, providing a clear indication of the entity label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides specific names like 'SIVmacMER', 'SIVmac239', and 'CEMx174' which are cell lines, making it highly helpful in identifying the entity labels.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions 'CD4+' which is a type of cell, and 'EBV' which is a protein, aiding in identifying the entity labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein names like 'IFN A', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate', making it very helpful in identifying the entity labels.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions 'TIMP-1' which is a protein, and 'DNA', aiding in identifying the entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions 'Th2-type lymphocytes' which are a type of cell, making it highly helpful in identifying the entity label.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions 'EBV' which is a cell line, and 'CD2' which is a protein, aiding in identifying the entity labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'PBMC' which is a type of cell, and 'adenovirus DNA', aiding in identifying the entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions 'SIVsmmPBj14' which is a cell line, making it very helpful in identifying the entity label.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions 'CD95 ligand' which is a protein, aiding in identifying the entity label.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions 'HIV-1 LTR' which is DNA, 'NFAT-1' and 'NF kappa B' which are proteins, making it very helpful in identifying the entity labels.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'EBV' which is DNA, 'EBNA2' and 'estrogen receptor' which are proteins, aiding in identifying the entity labels.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions 'TR55' which is a protein, 'TNF-alpha' which is a protein, and 'HIV' which is a cell type, aiding in identifying the entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'NF-kappaB' and 'Sp1' which are proteins, and 'SIVmac' which is a cell line, making it very helpful in identifying the entity labels.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1149,
        "sentence": "The expression and activity of NF-kappa B and Sp1 were, therefore, analyzed in isolated T cells and DCs from humans and mice .",
        "label": {
            "Sp1": "protein",
            "DCs": "cell_type",
            "NF-kappa B": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 3},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene .\": 4},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"Sp1\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"DCs\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'Sp1': 'protein', 'T cells': 'cell_type', 'DCs': 'cell_type'}"
    },
    {
        "idx": 407,
        "sentence": "Since most of the actions of vitamin D are mediated by its receptors ( VDR ), abnormalities of VDR have been postulated in XLH .",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone (BQ).\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"Furthermore, the two VDR 3'-UTR haplotypes conferred an identical half-life on a heterologous beta-globin reporter gene, in an in vitro assay.\": 4}\n]",
        "response3": "[{\"VDR\": \"protein\"}, {\"VDR\": \"protein\"}, {\"XLH\": \"cell_type\"}]",
        "prediction": "{'VDR': 'protein', 'XLH': 'cell_type'}"
    },
    {
        "idx": 1466,
        "sentence": "As we observed that activated endothelial cells also expressed NFAT , we tested the antiinflammatory properties of CsA in endothelial cells .",
        "label": {
            "endothelial cells": "cell_type",
            "NFAT": "protein",
            "activated endothelial cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'NF-kappa B' and its corresponding label 'DNA', aiding in the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[{\"NFAT\": \"protein\"}]",
        "prediction": "{'NFAT': 'protein'}"
    },
    {
        "idx": 1330,
        "sentence": "Stimulation of cells leads to a rapid phosphorylation of I kappa B alpha , which is presumed to be important for the subsequent degradation .",
        "label": {
            "I kappa B alpha": "protein",
            "I kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple protein names and a cell type, which are all relevant entity types in the label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a protein name that is relevant to the label set.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains a protein name that is relevant to the label set.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains multiple protein names and a cell type, which are all relevant entity types in the label set.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple protein names and a cell type, which are all relevant entity types in the label set.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains multiple protein names and a cell type, which are all relevant entity types in the label set.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains multiple protein names that are relevant to the label set.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains multiple protein names that are relevant to the label set.\"}\n]\n```",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1436,
        "sentence": "Similar levels of hTR beta 1 mRNA levels were detected in thyroid gland from euthyroid patients .",
        "label": {
            "hTR beta 1 mRNA": "RNA",
            "hTR beta 1": "protein"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 859,
        "sentence": "We show that at least one inducible , C1 , and one constitutive, C2 , protein can bind to the HIV enhancer in Jurkat cells .",
        "label": {
            "inducible": "protein",
            "Jurkat cells": "cell_line",
            "C1": "protein",
            "HIV enhancer": "DNA",
            "C2": "protein",
            "constitutive, C2 , protein": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5}\n]",
        "response3": "[{\"C1\": \"protein\"}, {\"C2\": \"protein\"}, {\"HIV enhancer\": \"DNA\"}, {\"Jurkat cells\": \"cell_line\"}]",
        "prediction": "{'C1': 'protein', 'C2': 'protein', 'HIV enhancer': 'DNA', 'Jurkat cells': 'cell_line'}"
    },
    {
        "idx": 451,
        "sentence": "However, despite its ability to activate transcription of a transfected reporter gene , the factor is apparently unable to bind to the endogenous Ig heavy chain enhancer in non- lymphoid cells : In previous experiments by others, the characteristic in vivo footprint of this factor, designated NF-muE3 , was detected in B cells but not in non-B cells .",
        "label": {
            "NF-muE3": "protein",
            "B cells": "cell_type",
            "lymphoid cells": "cell_type",
            "transfected reporter gene": "DNA",
            "Ig heavy chain enhancer": "DNA",
            "non- lymphoid cells": "cell_type",
            "non-B cells": "cell_type",
            "endogenous Ig heavy chain enhancer": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"Egr-1\": 5},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"TCF-1\": 5},\n    {\"IL-2 receptor alpha subunit\": 5},\n    {\"p21ras\": 5},\n    {\"B cell\": 5},\n    {\"NF-ATc\": 5},\n    {\"T lymphocytes\": 5},\n    {\"embryonic cardiac cells\": 5},\n    {\"IL-2\": 5},\n    {\"NF-kappaB\": 5},\n    {\"Sp1\": 5},\n    {\"p50\": 5},\n    {\"c-kit\": 5},\n    {\"IL-4R alpha chain\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 5},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"rheumatoid arthritis\": 5},\n    {\"CD40\": 5},\n    {\"Rel/nuclear factor kappaB\": 5},\n    {\"B lymphocytes\": 5},\n    {\"SIVmac\": 5},\n    {\"NFAT\": 5},\n    {\"AP-1\": 5},\n    {\"CTLA4Ig\": 5}\n]",
        "response3": "[{\"Ig heavy chain enhancer\": \"DNA\"}, {\"NF-muE3\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"non-B cells\": \"cell_type\"}]",
        "prediction": "{'Ig heavy chain enhancer': 'DNA', 'NF-muE3': 'protein', 'B cells': 'cell_type', 'non-B cells': 'cell_type'}"
    },
    {
        "idx": 919,
        "sentence": "The human protein recognized by the EC1 antibody is a 56-kDa protein ( p56 ) of moderate abundance located predominantly in the cytoplasm by indirect immunofluorescence .",
        "label": {
            "56-kDa protein": "protein",
            "p56": "protein",
            "EC1 antibody": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"EC1 antibody\": \"protein\"}, {\"p56\": \"protein\"}]",
        "prediction": "{'EC1 antibody': 'protein', 'p56': 'protein'}"
    },
    {
        "idx": 1206,
        "sentence": "In addition, the concentration of androgen receptors in mononuclear leukocytes was measured, in both the follicular and luteal phases of the menstrual cycle , basally and after 4 months of flutamide treatment.",
        "label": {
            "androgen receptors": "protein",
            "mononuclear leukocytes": "cell_type"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"RXR\": 5},\n    {\"granulocytes\": 4, \"T cells\": 4},\n    {\"lymphoid neoplasms\": 4},\n    {\"CD14\": 5},\n    {\"phosphocreatine\": 3},\n    {\"HML\": 4, \"dexamethasone\": 5, \"cortisol\": 5, \"lysozyme\": 5},\n    {\"NF-E2\": 5},\n    {\"E2A\": 5},\n    {\"CD70\": 5, \"B cell\": 4, \"plasma cells\": 4, \"IL-4\": 5, \"CD40\": 5},\n    {\"cAMP-dependent protein kinase\": 5, \"Rap1\": 5},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n    {\"PU.1\": 5, \"CSF-1 receptor\": 5, \"Mono A\": 5, \"Mono B\": 5},\n    {\"nuclear factor-kappa B\": 3, \"NF-kappa B\": 3},\n    {\"NF-kappa B\": 5, \"fibrinogen\": 5},\n    {\"MNDA\": 5, \"monocytes\": 4, \"macrophages\": 4, \"leukemia/B lymphoma cell lines\": 5},\n    {\"PMA\": 5, \"U1 cells\": 5}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 569,
        "sentence": "In addition, the increases in c-jun , EGR2 , and PDGF(B) may depend on cytoskeletal rearrangement .",
        "label": {
            "PDGF(B)": "protein",
            "EGR2": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1657,
        "sentence": "HMG-I binds to GATA motifs : implications for an HPFH syndrome .",
        "label": {
            "HMG-I": "protein",
            "GATA motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5}\n]",
        "response3": "[{\"HMG-I\": \"protein\"}, {\"GATA motifs\": \"DNA\"}, {\"HPFH syndrome\": \"cell_type\"}]",
        "prediction": "{'HMG-I': 'protein', 'GATA motifs': 'DNA', 'HPFH syndrome': 'cell_type'}"
    },
    {
        "idx": 1780,
        "sentence": "Interestingly, Id2 , but not Id3 , mRNA was strongly expressed in 4/5 T-cell lines infected with human T-cell leukemia virus type I ( HTLV-I ) ( ATL-1k , MT-2 , S-LB1 ) and type II ( Mo ) .",
        "label": {
            "Id3": "protein",
            "Mo": "cell_line",
            "Id2": "protein",
            "4/5 T-cell lines": "cell_line",
            "S-LB1": "cell_line",
            "MT-2": "cell_line",
            "ATL-1k": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 4},\n    {\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 13,
        "sentence": "We further demonstrate the impact of platelet-activating factor binding to B cells by measuring platelet-activating factor induced arachidonic acid release and 5-hydroxyeicosatetraenoic acid production.",
        "label": {
            "platelet-activating factor": "protein",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1554,
        "sentence": "The results define essential cis-acting elements responsible for the expression of GP Ib alpha and provide insights into molecular events coinciding with the release of normal platelets into the bloodstream .",
        "label": {
            "GP": "protein",
            "normal platelets": "cell_type",
            "cis-acting elements": "DNA",
            "GP Ib alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 5},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 5}\n]",
        "response3": "[{\"GP Ib alpha\": \"protein\"}]",
        "prediction": "{'GP Ib alpha': 'protein'}"
    },
    {
        "idx": 1650,
        "sentence": "This is the first demonstration of a specific interaction with PU.1 on a myeloid PU.1 binding site .",
        "label": {
            "PU.1": "protein",
            "myeloid PU.1 binding site": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"myeloid PU.1 binding site\": \"protein\"}]",
        "prediction": "{'PU.1': 'protein', 'myeloid PU.1 binding site': 'protein'}"
    },
    {
        "idx": 326,
        "sentence": "We show here that domain B is an R-responsive element in HeLa cells and is therefore not an EB1 -responsive B-cell-specific element .",
        "label": {
            "EB1": "protein",
            "R-responsive element": "DNA",
            "HeLa cells": "cell_line",
            "domain B": "DNA",
            "EB1 -responsive B-cell-specific element": "DNA"
        },
        "response1": "['cell_line', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence provides clear context and mentions the specific protein 'IL-2' which helps in identifying the entity type 'protein'.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence mentions specific proteins 'RelA' and 'NF-kappa B' in the context of T cells, providing clear entity labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly refers to the protein 'E2A' at the protein level, aiding in entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides information about proteins 'IL-2', 'c-Jun', and 'c-Fos' in the context of gel-shift analysis, aiding in entity extraction.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions 'EBV' and 'B-cell' in the context of a common pathway, providing entity labels.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions 'UAS1' and 'B cell' in the context of promoter activity, aiding in entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides information about proteins 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' in the context of T cell stimulation, aiding in entity extraction.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions 'CCAAT box' and 'EKLF binding site' in the context of gene expression, aiding in entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'T cell' and 'interleukin 2' in the context of a proto-enhancer element, aiding in entity extraction.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions 'p50p50' in the context of motif binding, aiding in entity extraction.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions 'CD4+' and 'EBV' in the context of replicative gene expression, aiding in entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions 'EKLF' in the context of gene recruitment, aiding in entity extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'EBV' and 'CD2' in the context of thymocyte proliferation, aiding in entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'EBNA2' and 'TP1' in the context of promoter interaction, aiding in entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions 'RXR' and 'AF-1' and 'AF-2' mutants in the context of erythroid cell outgrowth, aiding in entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions 'B and T cell activation', 'Ramos', 'Jurkat', and 'cDNA microarray technology' in the context of gene expression study, aiding in entity extraction.\"}\n]",
        "response3": "[{'HeLa cells': 'cell_line'}, {'EB1': 'protein'}, {'B-cell-specific': 'cell_type'}]",
        "prediction": "{'HeLa cells': 'cell_line', 'EB1': 'protein', 'B-cell-specific': 'cell_type'}"
    },
    {
        "idx": 1429,
        "sentence": "Data from cell culture and animal studies indicate that TR expression may be regulated to modulate target organ responsiveness to thyroid hormone .",
        "label": {
            "TR": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 5},\n{\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n{\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n{\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL-mediated NF-kappaB activation, but failed to affect constitutive signaling induced by receptor overexpression, revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n{\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5}\n]",
        "response3": "[{\"TR\": \"protein\"}]",
        "prediction": "{'TR': 'protein'}"
    },
    {
        "idx": 865,
        "sentence": "Response to T cell activation signals .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 696,
        "sentence": "First, from different cell lines three or all four of the nuclear proteins were specifically cross-linked by UV irradiation to the radioactively labeled TRE -DNA fragment .",
        "label": {
            "TRE -DNA fragment": "DNA",
            "nuclear proteins": "protein",
            "TRE": "DNA"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 318,
        "sentence": "Furthermore, the existence of estrogen receptor (estrogen binding activity) was examined histochemically in 39 cases and it was detected in 8.",
        "label": {
            "estrogen receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (RXR) and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein (retinoic acid receptor alpha) and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a protein (NF-E2) and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of proteins (IL-2, c-Jun, c-Fos) and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides a clear example of a protein (E2A) and its corresponding entity label, which directly matches the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of proteins (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of proteins (TCRzeta, p56(lck)) and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of a cell line (Ter 119) and proteins (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence provides examples of proteins (Erbstatin, genistein) and RNA (Egr-1) with their corresponding entity labels, which are relevant to the target sentence, but RNA is not present in the target sentence.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence provides examples of DNA (EBV) and proteins (EBNA2, estrogen receptor) with their corresponding entity labels, which are relevant to the target sentence, but DNA is not present in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence provides examples of a cell line (PMA, U1 cells) with their corresponding entity labels, which are relevant to the target sentence, but cell line is not present in the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides examples of DNA (nuclear factor-kappa B, NF-kappa B) with their corresponding entity labels, which are relevant to the target sentence, but DNA is not present in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence provides examples of proteins (CD3.TcR, CD18, CD29) with their corresponding entity labels, which are relevant to the target sentence, but proteins are not present in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides examples of DNA (DNA) and proteins (PCNA, E2F1) with their corresponding entity labels, which are relevant to the target sentence, but DNA is not present in the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence provides examples of proteins (MR, aldosterone, progesterone) with their corresponding entity labels, which are relevant to the target sentence, but proteins are not present in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides clear examples of proteins (E2F, E2F-4, DP-1, p130) and a cell type (AML) with their corresponding entity labels, which directly match the entity types in the target sentence.\"}\n]",
        "response3": "[{\"estrogen receptor\": \"protein\"}]",
        "prediction": "{'estrogen receptor': 'protein'}"
    },
    {
        "idx": 440,
        "sentence": "All three proteins show the same sequence specificity and binding affinity .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain .\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules .\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 5},\n{\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay .\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease .\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n{\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n{\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n{\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1563,
        "sentence": "Pathogenesis of atherosclerosis .",
        "label": {},
        "response1": "None.",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a clear and direct mapping of the entity 'IFN-gamma' to the entity label 'protein' in the target sentence, aiding in understanding the relationship between the example and the named entity recognition task.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example includes multiple entities such as 'NF-kappaB', 'Tax', and 'ATL' with their corresponding labels, providing valuable information for identifying these entities in the target sentence.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example links the entity 'AP-1' to the entity label 'DNA', which is helpful in understanding the entity type and its relevance to the named entity recognition task.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example identifies 'P selectin' as a protein entity, aiding in recognizing this type of entity in the target sentence.\"\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Reason 5\": \"The example highlights the entities 'NF-kappaB' and 'rheumatoid arthritis' with their respective labels, providing insights into the entity types present in the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example covers a range of entities including 'PKC isoforms', 'human alveolar macrophages', and 'blood monocytes' with their corresponding labels, offering comprehensive information for entity recognition in the target sentence.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The example specifies 'NF-kappa B' as a protein entity, aiding in understanding the entity type and its relevance to the named entity recognition task.\"\n    },\n    {\n        \"Example 8\": 3\n    },\n    {\n        \"Reason 8\": \"The example mentions 'cell adhesion molecules' as a cell type entity, providing some guidance on the entity type present in the target sentence.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example indicates 'NF-kappa B' and 'ARDS' as protein and cell type entities respectively, assisting in recognizing these entity types in the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example includes 'IkappaBbeta' and 'NF-kappaB' as protein entities, offering valuable information for identifying these entities in the target sentence.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The example mentions 'IL-12' as a protein entity and 'macrophages' as a cell type entity, aiding in understanding the entity types present in the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example covers a range of entities including 'Stat3', 'Stat5', and 'c-Mpl' with their corresponding labels, offering comprehensive information for entity recognition in the target sentence.\"\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Reason 13\": \"The example specifies 'Eosinophils' as a cell type entity, aiding in understanding the entity type and its relevance to the named entity recognition task.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The example identifies 'alpha-tocopherol', 'monocyte', and 'endothelial cells' with their corresponding labels, providing valuable information for recognizing these entities in the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example includes 'SP1', 'caspases', and 'B-cell' as protein and cell type entities, offering comprehensive information for entity recognition in the target sentence.\"\n    },\n    {\n        \"Example 16\": 4\n    },\n    {\n        \"Reason 16\": \"The example specifies 'NF-kappa B' as a protein entity, aiding in understanding the entity type and its relevance to the named entity recognition task.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 689,
        "sentence": "High-risk patients can be recognized morphologically.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"PBMC\": 5},\n    {\"adenovirus\": 5},\n    {\"WT1\": 5},\n    {\"CD70\": 5},\n    {\"B cell\": 5},\n    {\"plasma cells\": 5},\n    {\"IL-4\": 5},\n    {\"CD40\": 5},\n    {\"TCL1\": 5},\n    {\"myeloperoxidase\": 5},\n    {\"lysozyme\": 5},\n    {\"PU.1\": 5},\n    {\"Ras\": 5},\n    {\"T-PLL\": 5},\n    {\"T lymphocytes\": 5},\n    {\"HLA-molecules\": 5},\n    {\"MNDA\": 5},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"TCRzeta\": 5},\n    {\"p56(lck)\": 5},\n    {\"adenovirus DNA\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"SIVmacMER\": 5},\n    {\"SIVmac239\": 5},\n    {\"CEMx174\": 5},\n    {\"lymphoid neoplasms\": 5},\n    {\"SIVsmmPBj14\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 189,
        "sentence": "Transcriptional down-regulation of c-myc expression by protein synthesis -dependent and -independent pathways in a human T lymphoblastic tumor cell line .",
        "label": {
            "human T lymphoblastic tumor cell line": "cell_line",
            "c-myc": "DNA"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"c-myc\": \"protein\"}, {\"T lymphoblastic tumor cell line\": \"cell_line\"}]",
        "prediction": "{'c-myc': 'protein', 'T lymphoblastic tumor cell line': 'cell_line'}"
    },
    {
        "idx": 778,
        "sentence": "Addition of a highly enriched preparation of OTF-1 made from one of these pre-B cells or from HeLa cells specifically stimulated in vitro transcription of an immunoglobulin gene .",
        "label": {
            "OTF-1": "protein",
            "pre-B cells": "cell_line",
            "immunoglobulin gene": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"T cell blasts treated with PMA are now responsive to IFN-gamma .\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"Fibroblast growth factor-1 ( FGF-1 ) enhances IL-2 production and nuclear translocation of NF-kappaB in FGF receptor -bearing Jurkat T cells .\": 5}\n]",
        "response3": "[{\"OTF-1\": \"protein\"}, {\"pre-B cells\": \"cell_type\"}, {\"HeLa cells\": \"cell_line\"}, {\"immunoglobulin gene\": \"protein\"}]",
        "prediction": "{'OTF-1': 'protein', 'pre-B cells': 'cell_type', 'HeLa cells': 'cell_line', 'immunoglobulin gene': 'protein'}"
    },
    {
        "idx": 198,
        "sentence": "Tamoxifen , an oestrogen antagonist , has been given in some patients with CLL and Hodgkin's disease , with dramatic response in single cases.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence provides clear context about the development of lymphoid neoplasms, making it easier to identify 'lymphoid neoplasms' as a 'cell_type' entity.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The sentence mentions specific proteins like 'IL-2', 'NF-kappa B', and 'AP-1', which can help in identifying these entities as 'protein' types, but the context is slightly more complex compared to other examples.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence directly refers to proteins 'TCRzeta' and 'p56(lck)' in the context of peripheral blood T cells, aiding in the identification of these entities as 'protein' types.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence clearly states the role of 'TAL1' in promoting the development of 'T-ALL', making it easier to identify 'TAL1' as a 'protein' entity and 'T-ALL' as a 'cell_type' entity.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The sentence focuses on 'STAT1' as a potential target for immunosuppressive and antineoplastic agents, providing valuable information but with slightly less direct entity identification.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence directly links 'MNDA' to the granulocyte-macrophage lineage and 'Philadelphia chromosome-positive chronic myeloid leukemia', aiding in the identification of these entities as 'protein' and 'cell_line' types, respectively.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions 'NF-E2' in the context of a cellular differentiation program, providing valuable information but with slightly less direct entity identification.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence clearly states the synergistic activation of 'HLA-DRA' expression by 'Oct-2A' and 'HMG I/Y' in B cells, aiding in the identification of these entities as 'protein' and 'cell_type' types.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The sentence focuses on the immunomodulatory stress response in 'T lymphocytes' induced by Ciprofloxacin, providing valuable information but with slightly less direct entity identification.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence directly links 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R' to colon cancer cells and their signaling pathways, aiding in the identification of these entities as 'protein' types.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence clearly states the role of 'WT1' in conferring resistance to differentiation induction in myeloid cell lines, aiding in the identification of 'WT1' as a 'protein' entity and 'myeloid cell lines' as a 'cell_line' entity.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions 'Egr-1' as an mRNA expression affected by Erbstatin and genistein, aiding in the identification of 'Egr-1' as an 'RNA' entity, but the context is slightly more complex compared to other examples.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence directly refers to 'PMA' and 'IFN-gamma' in the context of T cell blasts, aiding in the identification of these entities as 'protein' types and 'cell_type' entity.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides clear context about the conditional EBV mutants expressing 'EBNA2' and 'estrogen receptor', aiding in the identification of 'EBV', 'EBNA2', and 'estrogen receptor' as 'DNA' and 'protein' entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions the oncogenes 'TCL1' and 'MTCP1/c6.1B' in the context of leukaemic and non-leukaemic T cells, aiding in the identification of these entities as 'protein' types.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence provides information about the suppression of purified CD4+ or CD8+ T cells by TPCK and mitogenic coactivators, aiding in the identification of these entities as 'protein' and 'cell_type' types.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 735,
        "sentence": "This prompted us to analyze the octamer-binding proteins in the latter cells.",
        "label": {
            "octamer-binding proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence directly mentions the entity type 'DNA' and provides information about its binding activity, making it highly relevant for extracting named entities from the target sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions 'CD95 ligand promoter' which is related to a protein, providing relevant information for extracting named entities from the target sentence.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence provides direct information about the interaction between 'EBNA-2' and 'PU.1' as proteins, which is highly relevant for extracting named entities from the target sentence.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence mentions 'cDNAs' which are related to DNA, providing relevant information for extracting named entities from the target sentence.\"},\n{\"Example 5\": 5},\n{\"Reason 5\": \"The sentence provides information about 'IL-2', 'c-Jun', and 'c-Fos' as proteins, which are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence directly mentions 'NF-kappa B' as a protein, providing crucial information for extracting named entities from the target sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions 'AP-1', 'PMA', 'monocytes', and 'macrophages' which are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence provides information about 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and 'B cells' as proteins and cell types, which are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions 'EKLF', 'CBP', 'p300', and 'P/CAF' as proteins, which are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides information about 'IL-4', 'LPS', and 'AP-1' as proteins, which are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence mentions 'granulocytes' and 'T cells' as cell types, which are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions 'SCM-1' as a cell line, providing relevant information for extracting named entities from the target sentence.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence provides information about 'CD40' and 'NF-kappa B' as proteins, which are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions 'p21(WAF1/CIP1)' and 'p27(KIP1)' as proteins, which are directly related to the target sentence, making it highly relevant for extracting named entities.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence mentions 'E2A' as a protein, providing crucial information for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{'octamer-binding proteins': 'protein'}, {'latter cells': 'cell_type'}]",
        "prediction": "{'octamer-binding proteins': 'protein', 'latter cells': 'cell_type'}"
    },
    {
        "idx": 1735,
        "sentence": "We therefore examined vitamin D3 -mediated repression of activated IL-2 expression by cotransfecting Jurkat cells with IL-2 promoter/reporter constructs and a VDR overexpression vector and by DNA binding .",
        "label": {
            "VDR": "protein",
            "IL-2 promoter/reporter constructs": "DNA",
            "Jurkat cells": "cell_line",
            "VDR overexpression vector": "DNA",
            "IL-2": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex .\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes .\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 4},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"IL-2\": \"DNA\"}, {\"VDR\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'IL-2': 'DNA', 'Jurkat': 'cell_line', 'VDR': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 704,
        "sentence": "Activity of the immunoglobulin heavy and kappa light chain gene enhancers depends on a complex interplay of ubiquitous and developmentally regulated proteins .",
        "label": {
            "ubiquitous and developmentally regulated proteins": "protein",
            "ubiquitous": "protein",
            "developmentally regulated proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"immunoglobulin heavy and kappa light chain gene enhancers\": \"DNA\"}]",
        "prediction": "{'immunoglobulin heavy and kappa light chain gene enhancers': 'DNA'}"
    },
    {
        "idx": 1236,
        "sentence": "Binding site selection revealed that the alternating RCGCRYGCGY consensus constitutes high-affinity IBR/F binding sites and that the direct-repeat palindrome TGCGCATGCGCA is the optimal site .",
        "label": {
            "direct-repeat palindrome": "DNA",
            "IBR/F": "protein",
            "IBR/F binding sites": "DNA",
            "optimal site": "DNA",
            "alternating RCGCRYGCGY consensus": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"T cell\": 4, \"kB-like proto-enhancer element\": 3, \"interleukin 2\": 4},\n    {\"Reasons\": \"The sentence contains specific terms that are indicative of cell types and proteins, which are key entity types in the label set. The terms 'T cell' and 'interleukin 2' are directly related to 'cell_type' and 'protein' entities, respectively. The term 'kB-like proto-enhancer element' is less specific but still relevant to DNA entities.\"},\n    {\"immunoglobulin kappa 3' enhancer\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'immunoglobulin kappa 3' enhancer' which is directly related to DNA entities, making it highly relevant for entity extraction.\"},\n    {\"CREB\": 4, \"AR-CRE\": 3},\n    {\"Reasons\": \"The sentence contains specific terms 'CREB' and 'AR-CRE' which are indicative of protein entities. These terms are directly related to protein entities in the label set.\"},\n    {\"SIVsmmPBj14\": 5},\n    {\"Reasons\": \"The sentence contains a specific term 'SIVsmmPBj14' which is directly related to cell line entities, making it highly relevant for entity extraction.\"},\n    {\"EBNA2\": 4, \"TP1\": 3},\n    {\"Reasons\": \"The sentence contains specific terms 'EBNA2' and 'TP1' which are indicative of protein and cell line entities, respectively. These terms are directly related to protein and cell line entities in the label set.\"},\n    {\"BRCA1\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'BRCA1' which is directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"p50p50\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'p50p50' which is indicative of protein entities, making it highly relevant for entity extraction.\"},\n    {\"GM-CSF\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'GM-CSF' which is directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"retinoic acid receptor alpha\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'retinoic acid receptor alpha' which is directly related to protein entities, making it highly relevant for entity extraction.\"},\n    {\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n    {\"Reasons\": \"The sentence contains specific terms 'IL-2', 'c-Jun', and 'c-Fos' which are indicative of protein entities. These terms are directly related to protein entities in the label set.\"},\n    {\"Protein\": 3},\n    {\"Reasons\": \"The sentence contains a general term 'Protein' which is indicative of protein entities. While less specific, it still provides some relevance for entity extraction.\"},\n    {\"Th2-type lymphocytes\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'Th2-type lymphocytes' which is directly related to cell type entities, making it highly relevant for entity extraction.\"},\n    {\"IgH\": 4},\n    {\"Reasons\": \"The sentence contains a specific term 'IgH' which is directly related to DNA entities, making it highly relevant for entity extraction.\"},\n    {\"VDR\": 4, \"RXR\": 4, \"GRIP-1\": 4, \"DRIP205\": 4, \"DRIP\": 3},\n    {\"Reasons\": \"The sentence contains specific terms 'VDR', 'RXR', 'GRIP-1', 'DRIP205', and 'DRIP' which are indicative of protein entities. These terms are directly related to protein entities in the label set.\"},\n    {\"GM-kappa B\": 4, \"GC-box\": 4, \"GC-motif\": 3, \"GM-kappa B motif\": 3},\n    {\"Reasons\": \"The sentence contains specific terms 'GM-kappa B', 'GC-box', 'GC-motif', and 'GM-kappa B motif' which are indicative of DNA entities. These terms are directly related to DNA entities in the label set.\"},\n    {\"NF-kappaB\": 4, \"Sp1\": 4, \"SIVmac\": 4},\n    {\"Reasons\": \"The sentence contains specific terms 'NF-kappaB', 'Sp1', and 'SIVmac' which are indicative of protein and cell line entities. These terms are directly related to protein and cell line entities in the label set.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 541,
        "sentence": "To be or not to be a responder in T-cell responses : ubiquitous oligopeptides in all proteins.",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1652,
        "sentence": "Furthermore, we demonstrate that the PU-SF complex binds to PU.1 sites found on a number of myeloid promoters , and its formation requires an intact PU.1 site adjacent to a single-stranded region.",
        "label": {
            "PU.1": "protein",
            "PU-SF complex": "protein",
            "myeloid promoters": "DNA",
            "PU.1 site": "DNA",
            "PU-SF": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"UAS1\": 3, \"B cell\": 4},\n{\"IL-2\": 4, \"c-Jun\": 4, \"c-Fos\": 4},\n{\"NF-kappaB\": 4, \"Sp1\": 4, \"p50\": 4},\n{\"GM-CSF\": 4},\n{\"AP-1\": 4, \"PMA\": 4, \"monocytes\": 4, \"macrophages\": 4},\n{\"NF-kappa B\": 4, \"AP-1\": 4},\n{\"EKLF\": 4, \"CBP\": 4, \"p300\": 4, \"P/CAF\": 4},\n{\"IL-2\": 4},\n{\"Sp1\": 4, \"CD14\": 4},\n{\"UAS3\": 3, \"UAS2\": 3, \"YY1\": 4},\n{\"EBNA2\": 4, \"TP1\": 4},\n{\"Jun\": 4, \"ATF-2\": 4},\n{\"SCM-1\": 4},\n{\"Sp1\": 4, \"Ets\": 4},\n{\"EBNA-2\": 4, \"PU.1\": 4},\n{\"PU.1\": 4, \"M-CSF receptor\": 4, \"macrophage\": 4}\n]",
        "response3": "[{\"PU-SF complex\": \"protein\"}, {\"PU.1\": \"protein\"}]",
        "prediction": "{'PU-SF complex': 'protein', 'PU.1': 'protein'}"
    },
    {
        "idx": 88,
        "sentence": "TNF alpha did not activate cAMP production and its signal was not modulated by cAMP activators .",
        "label": {
            "TNF alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific gene and cell line names, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence includes multiple protein names and cytokines, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions T cell and various protein names involved in signaling pathways, which are related to the entity labels in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence provides information about CD40 and NF-kappa B activation, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The sentence discusses TRAF6 and RANKL-mediated signaling, which are somewhat related to the entity labels in the target sentence.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The sentence talks about IL-5 mRNA, TCR, and dexamethasone, which are partially relevant to the entity labels in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly mentions NF-kappa B and I kappa B alpha, which are key entities in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence includes various protein names and cytokines related to T cell signaling, which are somewhat relevant to the entity labels in the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence discusses the inhibition of NF-kappa B activation, which is relevant to the entity labels in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides information about Sp1, NF-kappaB, and transcription factors, which are related to the entity labels in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence talks about the inhibition of NF-kappa B and AP-1 transcription factors, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions RelA and NF-kappa B, which are directly related to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence directly discusses NF-kappa B and I kappa B alpha, which are key entities in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence includes RelA and NF-kappaB1, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence talks about NF-kB, AP-1, OCT-1, and NF-IL-2B binding activity, which are somewhat related to the entity labels in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1494,
        "sentence": "Increased intracellular stores of latent NF-kappa B may also result in rapid inducibility of NF-kappa B -dependent cytokine gene expression .",
        "label": {
            "latent NF-kappa B": "protein",
            "cytokine": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 940,
        "sentence": "Tamoxifen was also found to compete with 17 beta-estradiol for type II EBS in PBMC , although to a lesser extent than diethylstilbestrol .",
        "label": {
            "PBMC": "cell_type",
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (NF-E2) and its corresponding label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains multiple examples of protein entities (alpha-tocopherol, monocyte, endothelial cells) and their corresponding labels, as well as a cell type entity (monocyte).\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence includes two protein entities (NF-kappa B, AP-1) and their corresponding labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of protein entities (IL-2, NF-kappa B, AP-1) and their corresponding labels, as well as an RNA entity (IL-2).\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence contains examples of RNA, cell type, and protein entities (IL-5 mRNA, TCR, IL-2R, dexamethasone) and their corresponding labels.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence includes a protein entity (retinoic acid receptor alpha) and its corresponding label.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides examples of a protein entity (WT1) and a cell line entity (myeloid cell lines) with their corresponding labels.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains a protein entity (E2A) and its corresponding label.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes examples of protein entities (NF-kappa B, I kappa B beta) and their corresponding labels.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence provides examples of a cell type entity (lymphocytes) and chemical compound entities (benzene, benzoquinone) but does not include any of the entity labels in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains an example of a protein entity (NF-kappa B) and its corresponding label.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence includes examples of a cell line entity (Ter 119) and protein entities (beta-globin, glycoprotein IIb, platelet factor 4) with their corresponding labels.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence provides examples of protein entities (Erbstatin, genistein) and an RNA entity (Egr-1) with their corresponding labels.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains examples of a cell type entity (B cell) and protein entities (Ig, Transforming growth factor-beta) with their corresponding labels.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence includes examples of a DNA entity (EBV) and protein entities (EBNA2, estrogen receptor) with their corresponding labels.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence provides examples of cell line entities (PMA, U1 cells) with their corresponding labels.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1098,
        "sentence": "Thus, intact microtubules are essential for 1,25(OH)2D3 -dependent modulation of gene transcription .",
        "label": {
            "microtubules": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 5},\n{\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n{\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 1},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B / Oct-1 -dependent transcription.\": 5},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n{\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 255,
        "sentence": "c-myc RNA , which is constitutively expressed in RWLeu-4 cells , increased after 0.5 h of treatment with 50 nM VD3 and then rapidly decreased to barely detectable levels after 4 h of treatment.",
        "label": {
            "c-myc RNA": "RNA",
            "RWLeu-4 cells": "cell_line"
        },
        "response1": "['RNA', 'cell_line']",
        "response2": "[\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage]\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5}\n]",
        "response3": "[{\"c-myc RNA\": \"RNA\"}, {\"RWLeu-4 cells\": \"cell_line\"}, {\"VD3\": \"protein\"}]",
        "prediction": "{'c-myc RNA': 'RNA', 'RWLeu-4 cells': 'cell_line', 'VD3': 'protein'}"
    },
    {
        "idx": 775,
        "sentence": "Some of these proteins (referred to as OTF-2 ) are lymphoid specific, whereas at least one other, and possibly more (referred to as OTF-1 ), is found ubiquitously in all cell types.",
        "label": {
            "OTF-1": "protein",
            "OTF-2": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"NF-ATc isoforms\": 4},\n    {\"T lymphocytes\": 3},\n    {\"IL-4\": 4},\n    {\"Protein\": 3},\n    {\"WT1\": 4},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"GATA-1\": 4},\n    {\"Syk\": 4},\n    {\"Zap\": 4},\n    {\"T cell\": 3},\n    {\"RXR\": 4},\n    {\"E2A\": 4},\n    {\"Th2-type lymphocytes\": 4},\n    {\"TCF-1\": 4},\n    {\"immunohistochemistry\": 4},\n    {\"gene\": 2},\n    {\"myeloperoxidase\": 4},\n    {\"lysozyme\": 4},\n    {\"PU.1\": 4},\n    {\"Th1\": 3},\n    {\"Th2\": 3},\n    {\"Egr-1\": 4},\n    {\"CD70\": 4},\n    {\"B cell\": 3},\n    {\"plasma cells\": 4},\n    {\"IL-4\": 4},\n    {\"CD40\": 4}\n]",
        "response3": "[{\"OTF-2\": \"protein\"}, {\"OTF-1\": \"protein\"}]",
        "prediction": "{'OTF-2': 'protein', 'OTF-1': 'protein'}"
    },
    {
        "idx": 161,
        "sentence": "Steroid dose sparing : pharmacodynamic responses to single versus divided doses of methylprednisolone in man.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Th2-type lymphocytes\": 5},\n{\"The example directly mentions the entity 'Th2-type lymphocytes' and provides the corresponding entity label 'cell_type', making it highly helpful in extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1130,
        "sentence": "B-lymphoblastoid cell lines from multiple sclerosis patients and a healthy control producing a putative new human retrovirus and Epstein-Barr virus .",
        "label": {
            "B-lymphoblastoid cell lines": "cell_line"
        },
        "response1": "['cell_line', 'virus']",
        "response2": "[\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 1},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 3},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 3},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 4},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4}\n]",
        "response3": "[{\"B-lymphoblastoid cell lines\": \"cell_line\"}, {\"multiple sclerosis patients\": \"cell_type\"}, {\"a healthy control\": \"cell_type\"}, {\"putative new human retrovirus\": \"virus\"}, {\"Epstein-Barr virus\": \"protein\"}]",
        "prediction": "{'B-lymphoblastoid cell lines': 'cell_line', 'multiple sclerosis patients': 'cell_type', 'a healthy control': 'cell_type', 'putative new human retrovirus': 'virus', 'Epstein-Barr virus': 'protein'}"
    },
    {
        "idx": 600,
        "sentence": "Involvement of a second lymphoid-specific enhancer element in the regulation of immunoglobulin heavy-chain gene expression .",
        "label": {
            "immunoglobulin heavy-chain gene": "DNA",
            "lymphoid-specific enhancer element": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 4},\n    {\"Example 3\": 3},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 3},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"lymphoid-specific enhancer element\": \"DNA\"}, {\"immunoglobulin heavy-chain gene\": \"DNA\"}]",
        "prediction": "{'lymphoid-specific enhancer element': 'DNA', 'immunoglobulin heavy-chain gene': 'DNA'}"
    },
    {
        "idx": 1698,
        "sentence": "Oncogenicity of human papillomavirus- or adenovirus- transformed cells correlates with resistance to lysis by natural killer cells .",
        "label": {
            "natural killer cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n{\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 5},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 4},\n{\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n{\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 5},\n{\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 4},\n{\"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal , calphostin C , and ceramide .\": 5},\n{\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 5},\n{\"To our knowledge, this represents the first demonstration that phagocytic stimuli can induce NF-kappa B activation in human neutrophils .\": 4},\n{\"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence .\": 5},\n{\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator .\": 4}\n]",
        "response3": "[{\"human papillomavirus- or adenovirus- transformed cells\": \"cell_type\"}, {\"natural killer cells\": \"cell_type\"}]",
        "prediction": "{'human papillomavirus- or adenovirus- transformed cells': 'cell_type', 'natural killer cells': 'cell_type'}"
    },
    {
        "idx": 1287,
        "sentence": "Platelet thromboxane receptors are acutely and reversibly upregulated after acute myocardial infarction .",
        "label": {
            "Platelet thromboxane receptors": "protein",
            "Platelet": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 3},\n{\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n{\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n{\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 4},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n{\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 4},\n{\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"Changes in PKC isoforms in human alveolar macrophages compared with blood monocytes.\": 4},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 4},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n{\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 5},\n{\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n{\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1266,
        "sentence": "Human herpesvirus 6 , a predominantly T lymphotropic virus , has been recently shown to infect some EBV -positive B cell lines , and to induce in them the activation of the EBV lytic cycle .",
        "label": {
            "EBV -positive B cell lines": "cell_line"
        },
        "response1": "['cell_line', 'cell_line']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus , and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 4},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n    {\"Generation of cytotoxic T lymphocytes against immunorecessive epitopes after multiple immunizations with adenovirus vectors is dependent on haplotype .\": 4}\n]",
        "response3": "[{\"Human herpesvirus 6\": \"cell_type\"}, {\"EBV\": \"cell_line\"}, {\"B cell lines\": \"cell_line\"}, {\"EBV\": \"cell_type\"}]",
        "prediction": "{'Human herpesvirus 6': 'cell_type', 'EBV': 'cell_type', 'B cell lines': 'cell_line'}"
    },
    {
        "idx": 1813,
        "sentence": "Northern blot analysis revealed that BLR2 mRNA could be highly stimulated in mitogen- and anti-CD3- treated peripheral blood lymphocytes .",
        "label": {
            "BLR2 mRNA": "RNA",
            "BLR2": "protein"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"BLR2 mRNA\": \"RNA\"}, {\"mitogen\": \"protein\"}, {\"anti-CD3\": \"protein\"}, {\"peripheral blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'BLR2 mRNA': 'RNA', 'mitogen': 'protein', 'anti-CD3': 'protein', 'peripheral blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1764,
        "sentence": "The inhibitory effect of cysteamine may be mediated at least in part by an effect on transcription factor function , as the DNA binding activities of AP-1 and NF-kappa B extracted from mitogen-stimulated cells were significantly inhibited by cysteamine treatment .",
        "label": {
            "AP-1": "protein",
            "NF-kappa B": "protein",
            "transcription factor": "protein",
            "mitogen-stimulated cells": "cell_type"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding entity labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides multiple examples of protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains various protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides specific protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a specific protein name and its corresponding entity label, directly matching the entity type in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides specific protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a specific protein name and its corresponding entity label, directly matching the entity type in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides specific protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names and their corresponding entity labels, directly matching the entity types in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides a specific protein name and its corresponding entity label, directly matching the entity type in the target sentence.\"}\n]",
        "response3": "[{\"AP-1\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'AP-1': 'DNA', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 740,
        "sentence": "On the basis of these assays, all N-Oct-factors were found to be distinct from the ubiquitous Oct-1 and the lymphoid-specific Oct-2A proteins.",
        "label": {
            "ubiquitous Oct-1": "protein",
            "Oct-1": "protein",
            "Oct-2A": "protein",
            "lymphoid-specific Oct-2A": "protein",
            "N-Oct-factors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1182,
        "sentence": "Moreover, STAT5 was found to be the predominant STAT transcription factor used by IL-2 in human T cells , and specifically required a COOH-terminal region of IL-2R beta ( Ser386-Val525 ), while STAT5 recruitment was not correlated to activation of IL-2R gamma or JAK3 .",
        "label": {
            "IL-2": "protein",
            "T cells": "cell_type",
            "COOH-terminal region": "protein",
            "human T cells": "cell_type",
            "Ser386-Val525": "protein",
            "JAK3": "protein",
            "STAT transcription factor": "protein",
            "STAT5": "protein",
            "IL-2R beta": "protein",
            "IL-2R gamma": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/ thrombopoiesis or possibly a mature platelet function such as aggregation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function .\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines .\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5}\n]",
        "response3": "[{\"STAT5\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"JAK3\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'STAT5': 'protein', 'IL-2': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'JAK3': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 393,
        "sentence": "We also tested for the ability of defensins NP-1 , NP-5 , and HNP-1 to activate pag expression and found that these peptides have no effect.",
        "label": {
            "HNP-1": "protein",
            "pag": "DNA",
            "NP-1": "protein",
            "defensins": "protein",
            "NP-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1442,
        "sentence": "T cell expression of interleukin 3 ( IL-3 ) is directed by positive and negative cis-acting DNA elements clustered within 300 base pairs of the transcriptional start site .",
        "label": {
            "interleukin 3": "protein",
            "transcriptional start site": "DNA",
            "IL-3": "protein"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5}\n]",
        "response3": "[{\"IL-3\": \"protein\"}]",
        "prediction": "{'IL-3': 'protein'}"
    },
    {
        "idx": 142,
        "sentence": "This level of NF-kappa B -independent activity appears to be sufficient for virus multiplication , since TNF-alpha treatment had no effect on the kinetics of de novo HIV type 1 ( HIV-1 ) infection and viral RNA production in U937 cells .",
        "label": {
            "U937 cells": "cell_line",
            "NF-kappa B": "protein",
            "viral RNA": "RNA",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_line']",
        "response2": "[\n    {\"TIMP-1\": 5},\n    {\"DNA\": 4},\n    {\"NF-kB\": 4},\n    {\"AP-1\": 4},\n    {\"OCT-1\": 4},\n    {\"NF-IL-2B\": 4},\n    {\"RelA\": 4},\n    {\"NF-kappa B\": 5},\n    {\"Tax\": 4},\n    {\"ATL\": 4},\n    {\"IkappaBbeta\": 4},\n    {\"IL-2\": 4},\n    {\"AP-1\": 4},\n    {\"I kappa B alpha\": 5},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"HIV-1\": 4},\n    {\"PKR\": 4},\n    {\"IkappaBalpha\": 4},\n    {\"CD40\": 4},\n    {\"Rel/nuclear factor kappaB\": 4},\n    {\"B lymphocytes\": 4},\n    {\"TR55\": 4},\n    {\"SIVmac\": 4}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"HIV type 1\": \"cell_type\"}, {\"HIV-1\": \"cell_type\"}, {\"RNA\": \"RNA\"}, {\"U937 cells\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'HIV type 1': 'cell_type', 'HIV-1': 'cell_type', 'RNA': 'RNA', 'U937 cells': 'cell_line'}"
    },
    {
        "idx": 93,
        "sentence": "The Thy-1 gene promoter resembles a \"housekeeping\" promoter in that it is located within a methylation-free island , lacks a canonical TATA box , and displays heterogeneity in the 5'-end termini of the mRNA .",
        "label": {
            "canonical TATA box": "DNA",
            "\"housekeeping\" promoter": "DNA",
            "methylation-free island": "DNA",
            "5'-end termini": "RNA",
            "Thy-1 gene promoter": "DNA",
            "mRNA": "RNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.\": 5},\n    {\"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5}\n]",
        "response3": "[{\"Thy-1 gene\": \"protein\"}]",
        "prediction": "{'Thy-1 gene': 'protein'}"
    },
    {
        "idx": 1354,
        "sentence": "In addition, these results indicate that nuclear TCF-1 expression can serve as a pan-T-lineage marker in the diagnosis of lymphoid malignancies .",
        "label": {
            "TCF-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct link between the entity 'AP-1' and its corresponding entity label 'DNA' in the sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides multiple entity labels for entities like 'NF-kappaB', 'Tax', and 'ATL' in the sentence, aiding in their extraction.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example directly links the entity 'WT1' to its corresponding entity label 'protein' in the sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example directly links the entity 'TCL1' to its corresponding entity label 'protein' in the sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example provides entity labels for entities like 'NF-ATc' and 'T lymphocytes' in the sentence, aiding in their extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example directly links the entity 'TCF-1' to its corresponding entity label 'protein' in the sentence.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The example provides an entity label for 'lymphoid neoplasms' in the sentence, aiding in its extraction.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The example provides an entity label for 'Th2-type lymphocytes' in the sentence, aiding in its extraction.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example directly links the entity 'TCF-1' to its corresponding entity label 'protein' in the sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example provides entity labels for entities like 'NF-ATc', 'T lymphocytes', and 'embryonic cardiac cells' in the sentence, aiding in their extraction.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example directly links the entity 'RXR' to its corresponding entity label 'protein' in the sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example provides entity labels for entities like 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' in the sentence, aiding in their extraction.\"},\n    {\"Example 13\": 3},\n    {\"Reason 13\": \"The example provides entity labels for entities like 'granulocytes' and 'T cells' in the sentence, aiding in their extraction.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example provides entity labels for entities like 'CD70', 'B cell', 'plasma cells', 'IL-4', and 'CD40' in the sentence, aiding in their extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example provides entity labels for entities like 'TAL1' and 'T-ALL' in the sentence, aiding in their extraction.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example directly links the entity 'GATA-1' to its corresponding entity label 'protein' in the sentence.\"}\n]",
        "response3": "[{\"TCF-1\": \"protein\"}, {\"lymphoid malignancies\": \"cell_type\"}]",
        "prediction": "{'TCF-1': 'protein', 'lymphoid malignancies': 'cell_type'}"
    },
    {
        "idx": 466,
        "sentence": "(ABSTRACT TRUNCATED AT 250 WORDS)",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a mutated human retinoic acid receptor alpha, which falls under the 'protein' entity label.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions alpha-tocopherol, monocyte, and endothelial cells, which correspond to the 'protein' and 'cell_type' entity labels.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence discusses genes encoding eosinophil granule proteins and GATA-1, which are related to the 'protein' entity label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly mentions retinoic acid receptor alpha, which is classified as a 'protein' entity.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence refers to nonhuman primates, which is associated with the 'cell_type' entity label.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The sentence talks about AP-1 DNA binding activity, which is linked to the 'DNA' entity label.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides multiple examples of proteins such as IL-2, IFN-gamma, jak kinases, and STAT1(alpha), which are relevant to the 'protein' entity label.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions RXR, which is classified as a 'protein' entity.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence explicitly mentions SIVsmmPBj14, which is categorized as a 'cell_line' entity.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence discusses the regulatory mechanism of the SCM-1 genes, which is related to the 'cell_line' entity label.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of proteins such as IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which are relevant to the 'protein' entity label.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions A-myb, which is classified as a 'protein' entity.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of proteins such as IL-2, c-Jun, and c-Fos, which are relevant to the 'protein' entity label.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence talks about WT1, which is associated with the 'protein' entity label.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence explicitly mentions TCF-1, which is categorized as a 'protein' entity.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence discusses B and T cell activation, Ramos, Jurkat cells, and cDNA microarray technology, which are related to the 'cell_type', 'cell_line', and 'DNA' entity labels respectively.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1583,
        "sentence": "Associations between HLA class II antigens and autoantibodies to the ribonucleoproteins Ro(SSA) and La(SSB) have been reported in these patients.",
        "label": {
            "ribonucleoproteins": "protein",
            "Ro(SSA)": "protein",
            "autoantibodies": "protein",
            "HLA class II antigens": "protein",
            "La(SSB)": "protein"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCL1) being expressed in a specific context, aiding in the extraction of protein entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions a protein (WT1) and its exclusive paternal expression, making it highly relevant for extracting protein entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly discusses the expression of proteins (RXR and RXR mutants) in relation to erythroid cells, providing valuable information for protein entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly mentions a cell type (lymphoid neoplasms) in the context of development, aiding in the extraction of cell type entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence discusses the involvement of a protein (NF-kappa B) in the activation of human monocytic cells, providing crucial information for protein entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides information about the detection of proteins (TCRzeta and p56(lck)) in peripheral blood T cells, aiding in the extraction of protein entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions a DNA-binding activity of a transcription factor (AP-1) in lymphocytes, which is essential for DNA entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence discusses the abnormality in kappa B-binding activity and the induction of a protein (RelA) in T cells, providing valuable information for protein entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence talks about a protein-protein interaction between EBNA-2 and PU.1, aiding in the extraction of protein entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence links the induction of a protein (IL-2 receptor alpha subunit) to lymphocyte activation and suggests the triggering of B cell activation by p21ras, providing crucial information for protein and cell type entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions the molecular cloning of proteins (SLAP-130 and SLP-76) and their association with the T cell antigen receptor, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence discusses the role of a transcription factor (NF-kappaB) in the pathogenesis of rheumatoid arthritis, providing valuable information for protein and cell type entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions specific lysosomal proteins (myeloperoxidase and lysozyme) and a transcription factor (PU.1) in the context of immature CD34+Thy-1+ subset, aiding in the extraction of protein entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides information about the wild-type or mutated human retinoic acid receptor alpha and its measurement, aiding in the extraction of protein entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence suggests a synergistic activation of HLA-DRA expression in B cells by proteins (Oct-2A and HMG I/Y), providing valuable information for protein and cell type entity extraction.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence discusses the recognition of antigens by T lymphocytes in the context of peptides bound to HLA-molecules, aiding in the extraction of cell type and protein entities.\"}\n]",
        "response3": "[{\"HLA class II antigens\": \"protein\"}, {\"Ro(SSA)\": \"protein\"}, {\"La(SSB)\": \"protein\"}]",
        "prediction": "{'HLA class II antigens': 'protein', 'Ro(SSA)': 'protein', 'La(SSB)': 'protein'}"
    },
    {
        "idx": 592,
        "sentence": "The DNA isolated contained an open reading frame encoding 108 amino acid residues .",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 3},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4}\n]",
        "response3": "[{\"DNA\": \"DNA\"}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 163,
        "sentence": "This phenomenon can be mimicked by administering MP in divided doses.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear mapping between the entity 'IL-2' and its corresponding entity type 'protein' in the sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example 'phosphocreatine' is directly associated with the entity type 'protein' in the sentence, aiding in entity extraction.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example covers multiple entities ('AP-1', 'PMA', 'monocytes', 'macrophages') and their respective entity types, facilitating entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear mapping between the entities ('granulocytes', 'T cells') and their corresponding entity types ('cell_type') in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example covers multiple entities ('NF-kappa B', 'AP-1') and their respective entity types, aiding in entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a clear mapping between the entities ('IL-4', 'LPS', 'AP-1') and their corresponding entity types ('protein') in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example 'AP-1' is directly associated with the entity type 'DNA' in the sentence, aiding in entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example covers multiple entities ('CD14', 'CD23') and their respective entity types ('protein'), facilitating entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example covers multiple entities ('SIVmacMER', 'SIVmac239', 'CEMx174') and their respective entity types ('cell_line'), aiding in entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example covers multiple entities ('MTHC', 'TNF-alpha', 'IFN-gamma', 'DC') and their respective entity types ('cell_line', 'protein', 'cell_type'), facilitating entity extraction.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example 'T lymphocytes' is directly associated with the entity type 'cell_type' in the sentence, aiding in entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example covers multiple entities ('SP1', 'caspases', 'B-cell') and their respective entity types ('protein', 'cell_type'), facilitating entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example covers multiple entities ('Tip', 'Tap', 'Jurkat-T cells') and their respective entity types ('protein', 'cell_line'), aiding in entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example covers multiple entities ('PMA', 'LPS', 'staurosporine', 'bisindolylmaleimide', 'genistein') and their respective entity types ('protein'), facilitating entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example covers multiple entities ('interleukin-1beta', 'inhibitor-kappaB alpha') and their respective entity types ('RNA', 'protein'), aiding in entity extraction.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example covers multiple entities ('PMA', 'U1 cells') and their respective entity types ('cell_line'), facilitating entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1751,
        "sentence": "This effect is thought to be largely mediated through inactivation of the phosphatase calcineurin , which in turn inhibits translocation of an NFAT component to the nucleus.",
        "label": {
            "NFAT": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"Both NF-kappa B and I kappa B alpha are mentioned in the sentence, and they are correctly identified as proteins.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"Both IkappaBalpha and NF-kappaB are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"NF-kappa B is correctly identified as a protein in the sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"Both CD40 and NF-kappa B are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"NF-kappa B is correctly identified as a protein in the sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"Both IkappaBbeta and NF-kappaB are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"Multiple proteins such as CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, and granulocyte-macrophage colony-stimulating factor are correctly identified in the sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"Both RelA and NF-kappaB1 are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"Both TRAF6, RANKL, and NF-kappaB are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"Both IL-2, Aiolos, and Ras are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"Both IL-2, c-Jun, and c-Fos are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"NF-kappaB is correctly identified as a protein, Tax and ATL are identified as cell types, which are not present in the entity label set.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"NF-E2 is correctly identified as a protein in the sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"Both PAFR, PAF, NF-kappa B, and protein kinase C are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"Both NF-kappa B and AP-1 are correctly identified as proteins in the sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"NF-kappa B is correctly identified as a protein in the sentence.\"\n    }\n]",
        "response3": "[{\"calcineurin\": \"protein\"}, {\"NFAT\": \"protein\"}]",
        "prediction": "{'calcineurin': 'protein', 'NFAT': 'protein'}"
    },
    {
        "idx": 1774,
        "sentence": "Further studies are needed to elucidate if this sex difference in PBMC receptors for 1.25 Dihydroxyvitamin D3 is of any pathophysiological relevance .",
        "label": {
            "PBMC": "cell_type",
            "PBMC receptors": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a clear mapping between the entity 'CD14' and its corresponding entity label 'protein' in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example links 'phosphocreatine' to the entity label 'protein' in the target sentence, which is helpful in identifying named entities, although the context is slightly more indirect compared to Example 1.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The example associates 'IL-4' with the entity label 'protein' in the target sentence, contributing to the extraction of named entities, but the context may require additional information for full clarity.\"\n    },\n    {\n        \"Example 4\": 3\n    },\n    {\n        \"Reason 4\": \"The example connects 'AP-1' to the entity label 'DNA' in the target sentence, providing some assistance in identifying named entities, but the context could be more explicit.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example directly relates 'retinoic acid receptor alpha' to the entity label 'protein' in the target sentence, offering a clear mapping that aids in the extraction of named entities.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example establishes connections between 'Oct-2A', 'HMG I/Y', 'HLA-DRA', 'B cells' and their corresponding entity labels in the target sentence, providing comprehensive assistance in identifying named entities.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example links 'NF-kappa B' to the entity label 'protein' in the target sentence, offering a clear mapping that aids in the extraction of named entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly associates 'granulocytes' and 'T cells' with the entity label 'cell_type' in the target sentence, providing a clear mapping that aids in the extraction of named entities.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example establishes a direct connection between 'retinoic acid receptor alpha' and the entity label 'protein' in the target sentence, offering a clear mapping that aids in the extraction of named entities.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example provides clear mappings between 'VDR', 'RXR', 'GRIP-1', 'DRIP205', 'DRIP' and their corresponding entity labels in the target sentence, offering comprehensive assistance in identifying named entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example establishes connections between 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', 'B lymphocytes' and their corresponding entity labels in the target sentence, providing comprehensive assistance in identifying named entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example directly links 'B and T cell activation', 'Ramos', 'Jurkat', 'cDNA microarray technology' to their corresponding entity labels in the target sentence, offering comprehensive assistance in identifying named entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example provides clear mappings between 'interleukin-2', 'alpha chain', 'CD25', 'IL-2 receptor' and their corresponding entity labels in the target sentence, offering comprehensive assistance in identifying named entities.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example establishes connections between 'PU.1', 'CSF-1 receptor', 'Mono A', 'Mono B' and their corresponding entity labels in the target sentence, providing comprehensive assistance in identifying named entities.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 206,
        "sentence": "It is concluded that (i) patients with CLL rarely express ER and (ii) immunocytochemical staining of cytospin preparations is a valid technique for the measurement of ER .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor )\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL .\": 5},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 928,
        "sentence": "A mouse ets-1 cDNA clone was obtained by screening a mouse thymus cDNA expression library with a double-stranded oligonucleotide probe representing 20 bp of the Moloney murine sarcoma virus ( MSV ) long terminal repeat ( LTR ).",
        "label": {
            "ets-1": "protein",
            "long terminal repeat": "DNA",
            "double-stranded oligonucleotide probe": "DNA",
            "mouse thymus cDNA expression library": "DNA",
            "mouse ets-1 cDNA clone": "DNA",
            "LTR": "DNA"
        },
        "response1": "['DNA', 'RNA']",
        "response2": "[\n    {\"SIVsmmPBj14\": 5},\n    {\"SIVmacMER\": 5},\n    {\"SIVmac239\": 5},\n    {\"CEMx174\": 5},\n    {\"GM-CSF\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"Th2-type lymphocytes\": 5},\n    {\"protein\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"c-kit\": 5},\n    {\"IL-4R alpha chain\": 5},\n    {\"TCF-1\": 5},\n    {\"MIP-1 alpha\": 5},\n    {\"GOS19\": 5},\n    {\"LD78\": 5},\n    {\"AT464\": 5},\n    {\"CD14\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"T cell\": 5},\n    {\"Egr-1\": 5},\n    {\"E2A\": 5},\n    {\"CD95 ligand\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1301,
        "sentence": "It was found that the most significant variable predicting NK activity at follow-up was tumor ER concentration , with higher NK activity associated with ER -status .",
        "label": {
            "ER": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"The expression of NDP kinase was intense in KA and SCC compared with BCC.\": 4},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5}\n]",
        "response3": "[{\"ER\": \"protein\"}]",
        "prediction": "{'ER': 'protein'}"
    },
    {
        "idx": 1708,
        "sentence": "The Ca(2+) -dependent phosphatase calcineurin , a target of FK506 and CsA , synergizes with PKC -induced activation of nuclear factor (NF)-kappa B in T cell lines .",
        "label": {
            "nuclear factor (NF)-kappa B": "protein",
            "T cell lines": "cell_line",
            "Ca(2+) -dependent phosphatase": "protein",
            "PKC": "protein",
            "calcineurin": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a direct mapping between the entity 'calcineurin' and its corresponding label 'protein', aiding in the extraction of named entities from the target sentence.\"}\n]\n```",
        "response3": "```json\n[{\"calcineurin\": \"protein\"}, {\"FK506\": \"protein\"}, {\"CsA\": \"protein\"}, {\"PKC\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]\n```",
        "prediction": "{'calcineurin': 'protein', 'FK506': 'protein', 'CsA': 'protein', 'PKC': 'protein', 'NF-kappa B': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 747,
        "sentence": "Protein kinase inhibitor H-7 blocks accumulation of unspliced mRNA of human T-cell leukemia virus type I ( HTLV-I ).",
        "label": {
            "unspliced mRNA": "RNA"
        },
        "response1": "['protein', 'RNA']",
        "response2": "```json\n[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example contains multiple instances of protein entities that are relevant to the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example contains protein entities that are relevant to the target sentence.\"},\n    {\"Example 3\": 2},\n    {\"Reason 3\": \"The example contains protein entities, but the relevance to the target sentence is not as direct as other examples.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example contains protein entities that are relevant to the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example contains a protein entity that is relevant to the target sentence.\"},\n    {\"Example 6\": 3},\n    {\"Reason 6\": \"The example contains a cell type entity that is relevant to the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example contains a protein entity that is relevant to the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example contains protein entities that are relevant to the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example contains a protein entity that is relevant to the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example contains a protein entity that is relevant to the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example contains protein entities that are relevant to the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example contains protein entities that are relevant to the target sentence.\"},\n    {\"Example 13\": 3},\n    {\"Reason 13\": \"The example contains protein entities, but the relevance to the target sentence is not as direct as other examples.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example contains protein entities that are relevant to the target sentence.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 333,
        "sentence": "These protoenhancers alone are weakly or not responsive to R .",
        "label": {
            "protoenhancers": "DNA",
            "R": "protein"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 758,
        "sentence": "Cell proliferation of CEM-C7 cells cultured in both serum-free media has been sustained for 3 mo.",
        "label": {
            "CEM-C7": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"Notably, the lack of pRB in these U937-derived clones renders these p53-null cells highly resistant to apoptosis induced by serum withdrawal, calphostin C, and ceramide.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 5},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5},\n    {\"We isolated a novel subline, UT-7/GMT, from the human leukemia cell line UT-7/GM (N. Komatsu, et al., Blood, 89: 4021-4033, 1997).\": 5},\n    {\"The modified vectors were used to transduce human hematopoietic cell lines, cord blood-derived CD34(+) stem/progenitor cells, and murine bone marrow repopulating stem cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 727,
        "sentence": "The importance of the internal ATGs to Rex function is not known.",
        "label": {
            "Rex": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 5},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 429,
        "sentence": "As shown by mobility-shift , methylation interference , and mutational analyses , the mammalian protein BSAP recognizes all four sea urchin binding sites in a manner indistinguishable from TSAP ; however, the two proteins differ in molecular weight.",
        "label": {
            "TSAP": "protein",
            "mammalian protein": "protein",
            "sea urchin binding sites": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 3},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 4},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 3},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1372,
        "sentence": "The TCL1 oncogene on human chromosome 14q32.1 is involved in chromosome translocations [ t(14;14)(q11;q32.1) and t(7;14)(q35;q32.1) ] and inversions [ inv14(q11;q32.1) ] with TCR alpha/beta loci in T-cell leukemias , such as T-prolymphocytic ( T-PLL ).",
        "label": {
            "14q32.1": "DNA",
            "TCR alpha/beta loci": "DNA",
            "t(14;14)(q11;q32.1)": "DNA",
            "TCL1 oncogene": "DNA",
            "human chromosome": "DNA",
            "t(7;14)(q35;q32.1)": "DNA",
            "inv14(q11;q32.1)": "DNA"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of the gene BRCA1 being mentioned in relation to splicing and expression, indicating it is a protein entity.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions TCF-1 in the context of transactivation, suggesting it is a protein entity.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions SLAP-130, SLP-76, and T cell in relation to protein tyrosine kinases and T cell antigen receptor, indicating protein and cell_type entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions IkappaBbeta and NF-kappaB in relation to inactivation by the tax protein, indicating protein entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions Th2-type lymphocytes in relation to cytokines, indicating a cell_type entity.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions IL-2 receptor alpha subunit, p21ras, and B cell in relation to lymphocyte activation, suggesting protein and cell_type entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions c-kit and IL-4R alpha chain in relation to chimeric receptor generation, indicating protein entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions IL-13, IL-4R, JAK2, and IL-13R in relation to signaling pathways and colon cancer cells, indicating protein entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions TCRzeta and p56(lck) in relation to peripheral blood T cells and reduced levels, indicating protein entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions NF-kappaB, Tax, and ATL in relation to leukemic cells and subunit activation, indicating protein and cell_type entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions T cell and interleukin 2 in relation to a kB-like proto-enhancer element, indicating protein and cell_type entities.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The sentence mentions SCM-1 in relation to regulatory mechanism of genes, indicating a cell_line entity.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions TAL1 in relation to ectopic expression and T-ALL development, indicating protein and cell_type entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions T-PLL in relation to diagnosis and genetic changes, indicating a cell_type entity.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions TCL1 in relation to expression in AIDS IBLP tumors, indicating a protein entity.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions SCL and GATA-1 in relation to cell lineages and transcription factor, indicating protein entities.\"}\n]",
        "response3": "[{\"TCL1\": \"protein\"}, {\"TCR alpha/beta\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"T-PLL\": \"cell_type\"}]",
        "prediction": "{'TCL1': 'protein', 'TCR alpha/beta': 'protein', 'T-cell': 'cell_type', 'T-PLL': 'cell_type'}"
    },
    {
        "idx": 546,
        "sentence": "Two distinct signal transmission pathways in T lymphocytes are inhibited by complexes formed between an immunophilin and either FK506 or rapamycin .",
        "label": {
            "T lymphocytes": "cell_type",
            "immunophilin": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (calcineurin) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence clearly mentions a protein entity (NF-kappa B) and its label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their labels are explicitly mentioned.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes various protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) with their labels provided.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions cell_type (T cell) and protein entities (IL-2, IL-2 receptor, CD28) with their corresponding labels.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence includes RNA entity (IL-5 mRNA) and protein entities (TCR, IL-2R, dexamethasone) with their labels provided.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides protein entities (NF-kappa B, I kappa B alpha) and their labels are explicitly mentioned.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions a protein entity (IL-2) with its label provided.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence includes protein entity (CD28, CD80, CD86, CBL, VAV, NFAT, interleukin-2, granulocyte-macrophage colony-stimulating factor) with their labels explicitly mentioned.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains protein entity (NF-ATc) and cell_type entity (T lymphocytes) with their labels provided.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions protein entities (IkappaBbeta, NF-kappaB) with their labels explicitly provided.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence includes protein entities (IL-2 receptor alpha subunit, p21ras) and cell_type entity (B cell) with their labels mentioned.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides protein entities (Syk, Zap) and cell_type entity (T cell) with their labels explicitly mentioned.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions protein entities (IL-2, NF-kappa B, AP-1) with their labels provided.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence includes protein entities (IL-2, Aiolos, Ras) with their labels explicitly mentioned.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence mentions protein entities (IkappaBalpha, NF-kappaB) with their labels provided.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1437,
        "sentence": "In summary, we developed an assay for the quantitative determination of hTR beta 1 mRNA levels in small human tissue samples , containing as little as 50 ng of total RNA.",
        "label": {
            "hTR beta 1": "protein",
            "hTR beta 1 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"IFN A\": \"The mention of IFN A (IFNA) is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"IFNA\": \"The mention of IFNA is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"interleukin-2\": \"The mention of interleukin-2 is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"interleukin-2 receptor\": \"The mention of interleukin-2 receptor is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"phytohemagglutinin\": \"The mention of phytohemagglutinin is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"phorbol myristate acetate\": \"The mention of phorbol myristate acetate is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"GATA-1\": \"The mention of GATA-1 is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n    {\"cDNAs\": \"The mention of cDNAs is directly associated with the DNA entity label, providing a clear example.\"},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"TCRzeta\": \"The mention of TCRzeta is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"p56(lck)\": \"The mention of p56(lck) is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 3},\n    {\"nonhuman primates\": \"The mention of nonhuman primates is directly associated with the cell_type entity label, providing a clear example.\"},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 4},\n    {\"TCF-1\": \"The mention of TCF-1 is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"NF-ATc\": \"The mention of NF-ATc is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"T lymphocytes\": \"The mention of T lymphocytes is directly associated with the cell_type entity label, providing a clear example.\"},\n    {\"embryonic cardiac cells\": \"The mention of embryonic cardiac cells is directly associated with the cell_type entity label, providing a clear example.\"},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"PML/RARalpha\": \"The mention of PML/RARalpha is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"retinoic acid receptor alpha\": \"The mention of retinoic acid receptor alpha is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"E2A\": \"The mention of E2A is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"Ter 119\": \"The mention of Ter 119 is directly associated with the cell_line entity label, providing a clear and specific example.\"},\n    {\"beta-globin\": \"The mention of beta-globin is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"glycoprotein IIb\": \"The mention of glycoprotein IIb is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"platelet factor 4\": \"The mention of platelet factor 4 is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 4},\n    {\"B and T cell activation\": \"The mention of B and T cell activation is directly associated with the cell_type entity label, providing a clear example.\"},\n    {\"Ramos\": \"The mention of Ramos is directly associated with the cell_line entity label, providing a clear example.\"},\n    {\"Jurkat\": \"The mention of Jurkat is directly associated with the cell_line entity label, providing a clear example.\"},\n    {\"cDNA microarray technology\": \"The mention of cDNA microarray technology is directly associated with the DNA entity label, providing a clear example.\"},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"hematopoietic cell line\": \"The mention of hematopoietic cell line is directly associated with the cell_line entity label, providing a clear and specific example.\"},\n    {\"47.10\": \"The mention of 47.10 is directly associated with the cell_line entity label, providing a clear and specific example.\"},\n    {\"cell line\": \"The mention of cell line is directly associated with the cell_line entity label, providing a clear and specific example.\"},\n    {\"nontransgenic mice\": \"The mention of nontransgenic mice is directly associated with the cell_line entity label, providing a clear and specific example.\"},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 4},\n    {\"HIV-1 LTR\": \"The mention of HIV-1 LTR is directly associated with the DNA entity label, providing a clear and specific example.\"},\n    {\"NFAT-1\": \"The mention of NFAT-1 is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"NF kappa B\": \"The mention of NF kappa B is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 4},\n    {\"tal-1\": \"The mention of tal-1 is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"GATA-binding proteins\": \"The mention of GATA-binding proteins is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"hematopoiesis\": \"The mention of hematopoiesis is directly associated with the cell_type entity label, providing a clear and specific example.\"},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n    {\"EBV\": \"The mention of EBV is directly associated with the DNA entity label, providing a clear and specific example.\"},\n    {\"EBNA2\": \"The mention of EBNA2 is directly associated with the protein entity label, providing a clear and specific example.\"},\n    {\"estrogen receptor\": \"The mention of estrogen receptor is directly associated with the protein entity label, providing a clear and specific example.\"}\n]",
        "response3": "[{\"hTR beta 1 mRNA\": \"RNA\"}]",
        "prediction": "{'hTR beta 1 mRNA': 'RNA'}"
    },
    {
        "idx": 1399,
        "sentence": "To investigate the role of NF-M in hematopoietic cell lineage commitment, we constructed a conditional form of the protein by fusing it to the hormone binding domain of the human estrogen receptor .",
        "label": {
            "hematopoietic cell lineage": "cell_line",
            "human estrogen receptor": "protein",
            "NF-M": "protein",
            "hormone binding domain": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "```json\n[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence contains a clear mention of the protein NF-kappa B, which is a relevant entity type in the given entity label set.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The sentence mentions IL-2, c-Jun, and c-Fos proteins, which are relevant entity types in the given entity label set, but the context is slightly more complex compared to other examples.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence clearly mentions the protein NF-E2, which is a relevant entity type in the given entity label set.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions the protein E2A, which is a relevant entity type in the given entity label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions the protein MNDA and a specific cell line (Philadelphia chromosome-positive chronic myeloid leukemia), both of which are relevant entity types in the given entity label set.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions the proteins c-kit and IL-4R alpha chain, which are relevant entity types in the given entity label set.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence clearly mentions the protein PML/RARalpha, which is a relevant entity type in the given entity label set.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions the protein RXR, which is a relevant entity type in the given entity label set.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions the proteins TRAF6 and RANKL, as well as NF-kappaB, all of which are relevant entity types in the given entity label set.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions the protein NF-ATc and specifies cell types (T lymphocytes and embryonic cardiac cells), which are relevant entity types in the given entity label set.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions the protein CD40 and NF-kappa B, which are relevant entity types in the given entity label set.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions the protein GATA-1, which is a relevant entity type in the given entity label set.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions the protein TCF-1, which is a relevant entity type in the given entity label set.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions the protein NF-kappa B, which is a relevant entity type in the given entity label set.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions the protein IL-2, which is a relevant entity type in the given entity label set.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions the proteins ZEB, c-Myb, and Ets, as well as the cell type hematopoietic cells, all of which are relevant entity types in the given entity label set.\"}\n]\n```",
        "response3": "```json\n[{\"NF-M\": \"protein\"}, {\"hormone binding domain of the human estrogen receptor\": \"protein\"}]\n```",
        "prediction": "{'NF-M': 'protein', 'hormone binding domain of the human estrogen receptor': 'protein'}"
    },
    {
        "idx": 1327,
        "sentence": "Our results demonstrate that NF-IL6 is involved in transcriptional activation of the human IL-4 promoter in T cells .",
        "label": {
            "human IL-4": "protein",
            "human IL-4 promoter": "DNA",
            "NF-IL6": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example directly mentions the entity 'IL-4' and its association with the entity type 'protein' which is present in the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example directly mentions entities like 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example directly mentions entities like 'NF-kappaB', 'Tax', and 'ATL' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example directly mentions entities like 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example directly mentions entities like 'NF-kappa B' and 'I kappa B alpha' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example directly mentions entities like 'NF-ATc' and 'T lymphocytes' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example directly mentions the entity 'NF-kappa B' with its corresponding entity type which is present in the target sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly mentions entities like 'IL-12', 'STAT4', 'NK cells', 'T cells', and 'IL-12 receptor' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example directly mentions the entity 'NF-kappa B' with its corresponding entity type which is present in the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example directly mentions entities like 'IL-4', 'LPS', and 'AP-1' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example directly mentions entities like 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example directly mentions entities like 'IkappaBbeta' and 'NF-kappaB' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example directly mentions entities like 'IL-13', 'IL-4', 'B cell', and 'monocyte' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example directly mentions the entity 'Th2-type lymphocytes' with its corresponding entity type which is present in the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example directly mentions entities like 'IL-13', 'IL-4R', 'JAK2', and 'IL-13R' with their corresponding entity types which are present in the target sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The example directly mentions the entity 'IL-2' with its corresponding entity type which is present in the target sentence.\"\n    }\n]",
        "response3": "[{\"NF-IL6\": \"protein\"}, {\"IL-4\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'NF-IL6': 'protein', 'IL-4': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 146,
        "sentence": "Unlike other class II promoters , the HLA-DR alpha (DRA) promoter also contains one element identical to the \"octamer\" motif of immunoglobulin variable region promoters that is responsible for B cell-specific transcription .",
        "label": {
            "\"octamer\" motif": "DNA",
            "HLA-DR alpha (DRA) promoter": "DNA",
            "class II promoters": "DNA",
            "immunoglobulin variable region promoters": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\n        \"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5\n    },\n    {\n        \"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5\n    },\n    {\n        \"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4\n    },\n    {\n        \"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5\n    },\n    {\n        \"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5\n    },\n    {\n        \"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5\n    },\n    {\n        \"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5\n    },\n    {\n        \"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4\n    },\n    {\n        \"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5\n    },\n    {\n        \"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5\n    },\n    {\n        \"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5\n    },\n    {\n        \"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4\n    },\n    {\n        \"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4\n    },\n    {\n        \"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4\n    },\n    {\n        \"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5\n    },\n    {\n        \"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5\n    }\n]",
        "response3": "[{\"HLA-DR alpha (DRA)\": \"protein\"}, {\"octamer\": \"protein\"}, {\"immunoglobulin variable region\": \"protein\"}, {\"B cell-specific\": \"cell_type\"}]",
        "prediction": "{'HLA-DR alpha (DRA)': 'protein', 'octamer': 'protein', 'immunoglobulin variable region': 'protein', 'B cell-specific': 'cell_type'}"
    },
    {
        "idx": 1247,
        "sentence": "The Janus family tyrosine kinase Jak3 is the only signaling molecule known to be associated with gamma c , so it was hypothesized that defects in Jak3 might cause an XSCID -like phenotype .",
        "label": {
            "Janus family tyrosine kinase": "protein",
            "Jak3": "protein",
            "gamma c": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"SCL is expressed in erythroid, megakaryocyte and mast cell populations (the same cell lineages as GATA-1, a zinc-finger transcription factor).\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine (IL-2 and IFN-gamma) production is normal.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1300,
        "sentence": "As considerable evidence has accumulated that social support in both animal and human populations may have survival value, we sought to test the reliability of this regression model , using coping and perceived support factor values obtained at 3 months after surgery to account for concurrent follow-up NK activity in this serially assessed group of patients .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/GC-box region, suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 350,
        "sentence": "Induction of 24,25-(OH)2D3 synthesis by 1,25(OH)2D3 was observed in the fifth cell line , designated Ro-VDR , although the sensitivity to hormone treatment was lower than in the control cell line from a normal donor .",
        "label": {
            "control cell line": "cell_line",
            "cell line": "cell_line",
            "Ro-VDR": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and DNA, which are directly mentioned in the sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions specific protein names and a cell line related to a specific condition.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple specific protein names and stimuli related to protein expression.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions a specific protein related to differentiation.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a specific protein related to cell differentiation.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions a specific protein related to resistance to differentiation.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a specific protein related to transcription factor inhibition.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions a specific protein related to cell differentiation.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions a specific protein related to cell response to treatment.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions specific proteins and receptors related to cell stimulation and inhibition.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions specific proteins and receptors related to cell response and activation.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions specific proteins and receptors related to cell activation and resistance.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions a specific cell line derived under specific conditions.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions specific cells and cell lines related to abnormal cell development.\"},\n]",
        "response3": "[{\"Ro-VDR\": \"cell_line\"}]",
        "prediction": "{'Ro-VDR': 'cell_line'}"
    },
    {
        "idx": 1093,
        "sentence": "The genomic actions of 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) are mediated by the intracellular vitamin D receptor ( VDR ).",
        "label": {
            "VDR": "protein",
            "vitamin D receptor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Protein kinase B ( c-Akt ), phosphatidylinositol 3-kinase , and STAT5 are activated by erythropoietin ( EPO ) in HCD57 erythroid cells but are constitutively active in an EPO -independent, apoptosis -resistant subclone ( HCD57-SREI cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1493,
        "sentence": "Chronic HIV-1 infection of myeloid cells leads to constitutive NF-kappa B DNA-binding activity and provides an intranuclear environment capable of perpetuating HIV-1 replication .",
        "label": {
            "myeloid cells": "cell_type",
            "NF-kappa B": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'NF-kappa B' and its corresponding label 'protein', making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"HIV-1\": \"cell_type\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'DNA': 'DNA', 'HIV-1': 'cell_type'}"
    },
    {
        "idx": 334,
        "sentence": "One of the protoenhancers contains the overlapping palindromes 5'-TTGTCCcgtGGACAAaTGTCC-3' .",
        "label": {
            "protoenhancers": "DNA",
            "overlapping palindromes": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity and its corresponding label, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 946,
        "sentence": "Compared to the control group , fewer depressed subjects down-regulated Bmax after DEX .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names and their functions, which are crucial for entity extraction.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence provides specific cell line names and proteins related to glucocorticoid responsiveness, aiding in entity extraction.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The sentence mentions various protein names involved in apoptosis regulation and specific cell line names, facilitating entity extraction.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The sentence includes RNA, cell type, and protein names related to IL-5 mRNA induction, assisting in entity extraction.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence mentions a specific protein name related to CD14 expression regulation, aiding in entity extraction.\"},\n{\"Example 6\": 4},\n{\"Reason 6\": \"The sentence provides information about a specific cell line and cell type, aiding in entity extraction.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence contains a specific DNA binding activity and its association with lymphocytes, crucial for entity extraction.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence includes specific protein names related to cAMP-dependent protein kinase and its substrates, aiding in entity extraction.\"},\n{\"Example 9\": 4},\n{\"Reason 9\": \"The sentence mentions RNA and cell line names, assisting in entity extraction.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence provides specific DNA and protein names related to gene expression regulation, crucial for entity extraction.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence includes a specific protein name and cell type comparisons, aiding in entity extraction.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions specific cell types, aiding in entity extraction.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence provides information about a specific protein related to energy substrates, aiding in entity extraction.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence contains specific protein names related to VDR interacting proteins, crucial for entity extraction.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence includes specific protein names related to interleukin-2 and IL-2 receptor, aiding in entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 777,
        "sentence": "We have identified two human pre-B-cell lines that contain extremely low levels of OTF-2 yet still express high levels of steady-state immunoglobulin heavy-chain mRNA in vivo and efficiently transcribe an immunoglobulin gene in vitro.",
        "label": {
            "OTF-2": "protein",
            "immunoglobulin gene": "DNA",
            "steady-state immunoglobulin heavy-chain mRNA": "RNA",
            "human pre-B-cell lines": "cell_line",
            "immunoglobulin heavy-chain": "protein"
        },
        "response1": "['cell_line', 'RNA', 'protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence directly mentions the term 'protein' and provides a clear example of a protein being purified and its encoding gene cloned.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence mentions 'Egr-1' as a zinc finger transcription factor, which is a protein.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence directly mentions 'TCF-1 protein' and shows the generation of antiserum against it.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The sentence mentions 'E2A protein' and the use of polyclonal antisera to probe blots of cellular extracts.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type expressing cytokines.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions 'IgH genes' which are DNA sequences.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence mentions 'cDNAs' which are DNA sequences encoding factors.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence mentions various proteins like 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' involved in T cell responses.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence mentions 'NF-ATc' protein isoforms and their transcriptional properties in T lymphocytes.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' proteins involved in binding to the IL-2 promoter.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence mentions 'CD70' protein, 'B cell' and 'plasma cells' as cell types, and 'IL-4' and 'CD40' proteins involved in differentiation.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions 'NF-ATc' protein isoforms and their gene expression control in T lymphocytes and cardiac cells.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence mentions 'GM-CSF' protein and its conserved motif in human and murine genes.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence mentions 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' proteins involved in gene expression.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions 'c-kit' and 'IL-4R alpha chain' proteins in a chimeric receptor.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence mentions 'WT1' protein showing exclusive paternal expression.\"\n    }\n]",
        "response3": "[{'OTF-2': 'protein'}, {'immunoglobulin heavy-chain mRNA': 'RNA'}, {'immunoglobulin gene': 'DNA'}, {'pre-B-cell lines': 'cell_line'}]",
        "prediction": "{'OTF-2': 'protein', 'immunoglobulin heavy-chain mRNA': 'RNA', 'immunoglobulin gene': 'DNA', 'pre-B-cell lines': 'cell_line'}"
    },
    {
        "idx": 552,
        "sentence": "Similarly, an excess of FK506 is needed to revert rapamycin -mediated inhibition of IL-2 -induced proliferation .",
        "label": {
            "IL-2": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5}\n]\n```",
        "response3": "```json\n[{\"FK506\": \"protein\"}, {\"rapamycin\": \"protein\"}, {\"IL-2\": \"protein\"}]\n```",
        "prediction": "{'FK506': 'protein', 'rapamycin': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 1310,
        "sentence": "The abundant chromosomal protein HMG-1 belongs to this subgroup.",
        "label": {
            "HMG-1": "protein",
            "chromosomal protein": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1409,
        "sentence": "We investigated the ability of PRL and IL-2 to activate Stat proteins in different T cell lines .",
        "label": {
            "IL-2": "protein",
            "T cell lines": "cell_line",
            "PRL": "protein",
            "Stat proteins": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Sentence 1\": 4},\n    {\"Sentence 2\": 5},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 4},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 4},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[{\"PRL\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"Stat proteins\": \"protein\"}, {\"T cell lines\": \"cell_line\"}]",
        "prediction": "{'PRL': 'protein', 'IL-2': 'protein', 'Stat proteins': 'protein', 'T cell lines': 'cell_line'}"
    },
    {
        "idx": 1140,
        "sentence": "The conserved cis-acting sequence , GGAAAA , and transcription factors binding to this sequence are involved in the response to increased intracellular Ca2+ concentrations .",
        "label": {
            "transcription factors": "protein",
            "conserved cis-acting sequence": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'AP-1' and the entity type 'DNA', making it highly helpful.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The example provides mappings for entities 'Jun' and 'ATF-2' to the entity type 'protein', which is relevant to the target sentence but not as direct as Example 1.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The example provides a mapping for the entity 'Th2-type lymphocytes' to the entity type 'cell_type', which is relevant but not as specific as Examples 1 and 2.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example provides a mapping for the entity 'Protein' to the entity type 'protein', which is relevant to the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The example provides a mapping for the entity 'Egr-1' to the entity type 'protein', which is relevant to the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example provides mappings for entities 'IL-2', 'c-Jun', and 'c-Fos' to the entity type 'protein', which are relevant to the target sentence.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The example provides a mapping for the entity 'GM-CSF' to the entity type 'protein', which is relevant but not as specific as Examples 1, 2, and 6.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The example provides a mapping for the entity 'GATA-1' to the entity type 'protein', which is relevant to the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example provides a mapping for the entity 'TCF-1' to the entity type 'protein', which is relevant to the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The example provides a mapping for the entity 'Stat proteins' to the entity type 'protein', which is relevant to the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides mappings for entities 'EKLF', 'CBP', 'p300', and 'P/CAF' to the entity type 'protein', making it highly helpful.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The example provides mappings for entities 'SCL' and 'GATA-1' to the entity type 'protein', which are relevant to the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example provides a mapping for the entity 'G-CSF' to the entity type 'protein', which is relevant to the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides mappings for entities 'VDR', 'RXR', 'GRIP-1', 'DRIP205', and 'DRIP' to the entity type 'protein', making it highly helpful.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The example provides mappings for entities 'ZEB', 'c-Myb', 'Ets', and 'hematopoietic cells' to the entity types 'protein' and 'cell_type', which are relevant to the target sentence.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example provides mappings for entities 'tal-1', 'GATA-binding proteins', and 'hematopoiesis' to the entity types 'protein' and 'cell_type', which are relevant to the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 449,
        "sentence": "We find that the factor that binds to the E3 enhancer motif , CATGTGGC , is a ubiquitous transcription factor .",
        "label": {
            "ubiquitous transcription factor": "protein",
            "E3 enhancer motif": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides clear and direct mentions of multiple protein entities with their corresponding labels, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence directly mentions protein entities with their corresponding labels, making it highly helpful for extracting named entities.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence explicitly mentions a DNA entity with its label, providing direct information for named entity extraction.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence mentions a protein entity with its label, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence provides clear mentions of protein entities and cell types with their corresponding labels, making it highly helpful for named entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions protein entities with their labels, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence explicitly mentions a cell type entity with its label, providing direct information for named entity extraction.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence mentions a protein entity with its label, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence mentions a protein entity with its label, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence mentions protein entities and a cell type with their corresponding labels, making it highly helpful for named entity extraction.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence mentions a DNA entity and a protein entity with their labels, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions a protein entity with its label, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence mentions protein entities with their labels, aiding in the extraction of named entities.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1402,
        "sentence": "At the same time, we observed a down-regulation of progenitor-specific surface markers and the up-regulation of differentiation markers restricted to the eosinophil and myeloid lineages .",
        "label": {
            "eosinophil": "cell_type",
            "myeloid lineages": "cell_type",
            "differentiation markers": "protein",
            "progenitor-specific surface markers": "protein"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'GATA-1' to the entity type 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear and direct mapping of the entity 'Egr-1' to the entity type 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear and direct mapping of the entity 'NF-E2' to the entity type 'protein' in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping of the entity 'retinoic acid receptor alpha' to the entity type 'protein' in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear and direct mapping of the entity 'CD14' to the entity type 'protein' in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The examples provide clear and direct mappings of the entities 'Th1' and 'Th2' to the entity type 'cell_type' in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear and direct mapping of the entity 'E2A' to the entity type 'protein' in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The examples provide clear and direct mappings of the entities 'UAS1' and 'B cell' to the entity types 'cell_line' and 'cell_type' respectively in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear and direct mapping of the entity 'WT1' to the entity type 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides clear and direct mappings of the entities 'CD14' and 'CD23' to the entity type 'protein' in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The examples provide clear and direct mappings of the entities 'myeloperoxidase', 'lysozyme', and 'PU.1' to the entity type 'protein' in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The examples provide clear and direct mappings of the entities 'WT1' and 'myeloid cell lines' to the entity types 'protein' and 'cell_line' respectively in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The examples provide clear and direct mappings of the entities 'MNDA' and 'Philadelphia chromosome-positive chronic myeloid leukemia' to the entity types 'protein' and 'cell_line' respectively in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The examples provide clear and direct mappings of the entities 'granulocytes' and 'T cells' to the entity type 'cell_type' in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a clear and direct mapping of the entity 'GATA-1' to the entity type 'protein' in the sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides clear and direct mappings of the entities 'Sp1' and 'Ets' to the entity type 'protein' in the sentence.\"}\n]",
        "response3": "[{'eosinophil': 'cell_type'}, {'myeloid': 'cell_type'}]",
        "prediction": "{'eosinophil': 'cell_type', 'myeloid': 'cell_type'}"
    },
    {
        "idx": 664,
        "sentence": "Interferon-gamma and the sexual dimorphism of autoimmunity .",
        "label": {
            "Interferon-gamma": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3, and STAT5 proteins in normal human B cells.\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 4},\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Signaling by IL-2 and related cytokines: JAKs, STATs, and relationship to immunodeficiency.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1726,
        "sentence": "It is tempting to speculate that enhanced NF-kappa B expression caused by free radical production/oxidative stress may modulate liver injury , perhaps through an effect on cytotoxic cytokine synthesis .",
        "label": {
            "NF-kappa B": "protein",
            "cytotoxic cytokine": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains the entity 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains the entity 'ARDS' which is not in the entity label set, but 'NF-kappa B' is labeled as 'protein'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains the entities 'PAFR', 'PAF', 'NF-kappa B', and 'protein kinase C' which are all labeled as 'protein' in the entity label set.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains the entities 'NF-kappa B' and 'I kappa B alpha' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains the entity 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains the entities 'IkappaBalpha' and 'NF-kappaB' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains the entity 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains the entity 'NF-kappa B' which is labeled as 'protein' in the entity label set.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains the entity 'NF-kappaB' which is labeled as 'protein' and 'rheumatoid arthritis' which is labeled as 'cell_type' in the entity label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains the entities 'IkappaBbeta' and 'NF-kappaB' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains the entities 'NF-kappaB', 'Tax', and 'ATL' which are all labeled as 'protein' and 'cell_type' in the entity label set.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains the entities 'NF-kappa B' and 'I kappa B alpha' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains the entities 'NF-kappa B' and 'I kappa B beta' which are both labeled as 'protein' in the entity label set.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains the entities 'CD40', 'Rel/nuclear factor kappaB', and 'NF-kappaB' which are all labeled as 'protein' in the entity label set, and 'B lymphocytes' which is labeled as 'cell_type'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains the entities 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' which are all labeled as 'cell_type' and 'protein' in the entity label set.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1573,
        "sentence": "Immunofluorescence colocalization of both estrogen and progesterone receptors with eosinophil cationic protein showed that approximately 70% of positive cells were eosinophils .",
        "label": {
            "estrogen": "protein",
            "eosinophil cationic protein": "protein",
            "positive cells": "cell_type",
            "progesterone receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of using polyclonal antisera directed against a specific protein, E2A, to probe cellular extracts, indicating a direct relationship between the term 'E2A' and 'protein'.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence describes using immunohistochemistry with antibodies against proteins encoded by a gene, linking 'immunohistochemistry' to 'protein'. It also mentions determining the cell type within a tumor specimen based on gene expression, connecting 'gene' to 'DNA' and 'cell type' to 'cell_type'.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions genes encoding eosinophil granule proteins and GATA-1 binding transcription factor, establishing a clear connection between 'GATA-1' and 'protein'.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence explicitly states the importance of eosinophils in allergic inflammation, directly linking 'Eosinophils' to 'cell_type'.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides detailed information about different proteins and cell types involved in the differentiation process, making it highly relevant for entity extraction.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions specific lysosomal proteins and a transcription factor associated with granulomonocytes, clearly indicating their relationship to 'protein'.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence directly states the induction of CD14 and CD23 mRNA and protein, establishing a direct connection between these terms and 'protein'.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence clearly mentions the detection of specific proteins through Northern blot analysis, providing a direct link between 'p21(WAF1/CIP1)' and 'p27(KIP1)' to 'protein'.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly associates methylation with specific cell types, making it highly relevant for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides detailed information about nuclear factors and proteins involved in binding to the IL-2 promoter, indicating a direct relationship between 'IL-2', 'c-Jun', and 'c-Fos' to 'protein'.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions a cell-specific transcription factor, NF-E2, and its role in gene expression, establishing a clear connection between 'NF-E2' and 'protein'.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly links reduced mitogenic response to low expression of interleukin-2 and the alpha chain of the IL-2 receptor, indicating a direct relationship between these terms and 'protein'.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides a comparison between normal and transgenic cells, mentioning specific proteins and cell lines, making it highly relevant for entity extraction.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence describes the inhibition of mRNA expression and protein tyrosine phosphorylation, linking 'Erbstatin' and 'genistein' to 'protein' and 'Egr-1' to 'RNA'.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence details the study of gp91phox gene expression in eosinophils, mentioning promoter constructs and a specific cell line, HL-60-C15, establishing a direct connection between 'gp91phox' and 'DNA', and 'HL-60-C15' to 'cell_line'.\"}\n]",
        "response3": "[{'estrogen': 'protein'}, {'progesterone': 'protein'}, {'eosinophil cationic protein': 'protein'}, {'eosinophils': 'cell_type'}]",
        "prediction": "{'estrogen': 'protein', 'progesterone': 'protein', 'eosinophil cationic protein': 'protein', 'eosinophils': 'cell_type'}"
    },
    {
        "idx": 1589,
        "sentence": "Inhibition of NF-AT -dependent transcription by NF-kappa B : implications for differential gene expression in T helper cell subsets .",
        "label": {
            "NF-kappa B": "protein",
            "T helper cell subsets": "cell_type",
            "NF-AT": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains specific examples of entities mentioned in the target sentence, such as NF-kappa B and I kappa B alpha, which directly relate to the entity labels provided.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence provides additional examples of entities like NF-ATc and T lymphocytes, which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence mentions NF-kappaB, Tax, and ATL, which are entities corresponding to the labels provided in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence directly mentions NF-kappa B, which is one of the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains NF-kappa B and I kappa B alpha, which are entities relevant to the provided entity labels.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence mentions NF-ATc, T lymphocytes, and embryonic cardiac cells, which align with the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides an example of the GATA-1 protein, which is relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence directly mentions NF-kappa B, which is one of the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains NF-kappa B and I kappa B beta, which are entities corresponding to the labels provided in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence mentions PAFR, PAF, NF-kappa B, and protein kinase C, which are entities relevant to the provided entity labels.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides examples of Sp1 and Ets proteins, which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence mentions Th1 and Th2 cell types, which are relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence contains Th2-type lymphocytes, which align with the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence mentions IL-2, NF-kappa B, and AP-1, which are entities corresponding to the labels provided in the target sentence.\"},\n    {\"Sentence\": 2},\n    {\"Reason\": \"The sentence mentions NF-kappa B as DNA, which is not a label provided in the target sentence.\"}\n]",
        "response3": "[{\"NF-AT\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T helper cell subsets\": \"cell_type\"}]",
        "prediction": "{'NF-AT': 'protein', 'NF-kappa B': 'protein', 'T helper cell subsets': 'cell_type'}"
    },
    {
        "idx": 114,
        "sentence": "These results indicate that in monocytic cell lineage , HIV-1 could mimic some differentiation/activation stimuli allowing nuclear NF-KB expression .",
        "label": {
            "NF-KB": "protein",
            "monocytic cell lineage": "cell_line"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with their corresponding entity labels, which directly match the entity types in the target sentence. This provides clear and direct examples for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"NF-KB\": \"protein\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'NF-KB': 'protein'}"
    },
    {
        "idx": 469,
        "sentence": "Cardiac and adrenergic diseases were excluded.",
        "label": {},
        "response1": "None.",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a clear mapping between the entity 'WT1' and its corresponding entity label 'protein' in the target sentence.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example helps identify the entities 'PBMC' as 'cell_type' and 'adenovirus DNA' as 'DNA' in the target sentence, although the context is specific to adenoviral infection.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example mentions 'phosphocreatine' as a potential entity labeled as 'protein', but the relevance to the target sentence is not as direct as other examples.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example highlights 'AP-1' as 'DNA' in the context of DNA binding activity in lymphocytes, aiding in entity extraction from the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example covers multiple entities such as 'IL-5 mRNA', 'TCR', 'IL-2R', and 'dexamethasone' with clear mappings to their respective entity labels, enhancing entity extraction from the target sentence.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example provides 'EBV' as a 'cell_line' and 'CD2' as 'protein', contributing to entity extraction in the context of infection and cell proliferation.\"\n    },\n    {\n        \"Example 7\": 3\n    },\n    {\n        \"Reason 7\": \"The example mentions 'CD4+' as 'cell_type' and 'EBV' as 'protein', but the relevance to the target sentence is not as direct as other examples.\"\n    },\n    {\n        \"Example 8\": 3\n    },\n    {\n        \"Reason 8\": \"The example suggests 'lymphoid neoplasms' as 'cell_type', which may aid in entity extraction, but the connection to the target sentence is not explicit.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The example includes 'PBMC' as 'cell_type' and 'adenovirus' as 'DNA', supporting entity extraction in the context of disease detection.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The example identifies 'P selectin' as 'protein', assisting in entity extraction related to platelet function and cytokine production.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example covers 'cAMP-dependent protein kinase' and 'Rap1' as 'protein', providing clear mappings to aid in entity extraction from the target sentence.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The example mentions 'MNDA' as 'RNA' and 'myeloid cell lines' as 'cell_line', supporting entity extraction in the context of gene expression.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example includes multiple entities like 'NF-kB', 'AP-1', 'OCT-1', and 'NF-IL-2B' as 'protein', facilitating entity extraction related to transcription factor activity.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example provides 'MR', 'aldosterone', and 'progesterone' as 'protein', aiding in entity extraction related to antibody binding and hormone interactions.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The example mentions 'RelB' as 'protein' and 'DC' as 'cell_type', contributing to entity extraction in the context of dendritic cells and genetic knockout.\"\n    },\n    {\n        \"Example 16\": 4\n    },\n    {\n        \"Reason 16\": \"The example covers 'XP-B' and 'XP-D' as 'cell_line' and 'adenovirus' as 'DNA', supporting entity extraction in the context of gene expression and cell activity.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1683,
        "sentence": "These results strongly suggest that HU induces both transcriptional and post-transcription regulation of c-jun during erythroid differentiation .",
        "label": {
            "c-jun": "DNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"c-jun\": \"protein\"}]",
        "prediction": "{'c-jun': 'protein'}"
    },
    {
        "idx": 1648,
        "sentence": "Point mutations of either the PU.1 site or the C/EBP site that abolish the binding of the respective factors result in a significant decrease of GM-CSF receptor alpha promoter activity in myelomonocytic cells only.",
        "label": {
            "PU.1 site": "DNA",
            "GM-CSF receptor alpha": "protein",
            "GM-CSF receptor alpha promoter": "DNA",
            "myelomonocytic cells": "cell_type",
            "C/EBP": "protein",
            "PU.1": "protein",
            "GM-CSF": "protein",
            "C/EBP site": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 3},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5}\n]",
        "response3": "[{\"PU.1\": \"protein\"}, {\"C/EBP\": \"protein\"}, {\"GM-CSF receptor alpha\": \"protein\"}, {\"myelomonocytic cells\": \"cell_type\"}]",
        "prediction": "{'PU.1': 'protein', 'C/EBP': 'protein', 'GM-CSF receptor alpha': 'protein', 'myelomonocytic cells': 'cell_type'}"
    },
    {
        "idx": 646,
        "sentence": "Surgically confirmed nodal involvement was observed in 42%.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"WT1\": 5},\n    {\"granulocytes\": 4, \"T cells\": 4},\n    {\"NDP kinase\": 5, \"KA\": 4, \"SCC\": 4, \"BCC\": 4},\n    {\"NF-kappa B\": 5},\n    {\"p21(WAF1/CIP1)\": 5, \"p27(KIP1)\": 5},\n    {\"lymphoid neoplasms\": 4},\n    {\"T-PLL\": 4},\n    {\"PBMC\": 4, \"adenovirus DNA\": 1},\n    {\"TCL1\": 5},\n    {\"NF-kB\": 5, \"AP-1\": 5, \"OCT-1\": 5, \"NF-IL-2B\": 5},\n    {\"TCRzeta\": 5, \"p56(lck)\": 5},\n    {\"CD40\": 5, \"Rel/nuclear factor kappaB\": 5, \"NF-kappaB\": 5, \"B lymphocytes\": 4},\n    {\"nuclear factor-kappa B\": 4, \"NF-kappa B\": 4},\n    {\"PMA\": 4, \"U1 cells\": 4},\n    {\"CD3.TcR\": 5, \"CD18\": 5, \"CD29\": 5},\n    {\"MR\": 5, \"aldosterone\": 5, \"progesterone\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 821,
        "sentence": "(vi) The EBV type 2 EBNA-2 transactivated LMP1 as well as the EBV type 1 EBNA-2 .",
        "label": {
            "LMP1": "protein",
            "EBNA-2": "protein",
            "EBV type 1 EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 3},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 3},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5}\n]",
        "response3": "[{\"EBV type 2 EBNA-2\": \"protein\"}, {\"LMP1\": \"protein\"}, {\"EBV type 1 EBNA-2\": \"protein\"}]",
        "prediction": "{'EBV type 2 EBNA-2': 'protein', 'LMP1': 'protein', 'EBV type 1 EBNA-2': 'protein'}"
    },
    {
        "idx": 548,
        "sentence": "On the other hand, interleukin 2 ( IL-2 )-induced signals are blocked by rapamycin but not by FK506 .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 3},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 4},\n    {\"Signaling by IL-2 and related cytokines : JAKs , STATs , and relationship to immunodeficiency.\": 4},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin .\": 3},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 135,
        "sentence": "Tumor necrosis factor alpha ( TNF-alpha ) mRNA production was analyzed by polymerase chain reaction amplification in monocytic U937 cells and in a chronically HIV infected U937 cell line ( U9-IIIB ).",
        "label": {
            "U9-IIIB": "cell_line",
            "monocytic U937 cells": "cell_line",
            "Tumor necrosis factor alpha ( TNF-alpha ) mRNA": "RNA",
            "chronically HIV infected U937 cell line": "cell_line",
            "Tumor necrosis factor alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['RNA', 'cell_type', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types in the label set.\"},\n    {\"2\": \"The sentence contains some entity types from the label set, but they are not the main focus of the sentence.\"},\n    {\"3\": \"The sentence contains a few entity types from the label set, but they are not the central entities in the sentence.\"},\n    {\"4\": \"The sentence contains several entity types from the label set, and they are relevant to the main focus of the sentence.\"},\n    {\"5\": \"The sentence contains multiple entity types from the label set, and they are crucial to understanding the main focus of the sentence.\"}\n]",
        "response3": "[\n    {\"TNF-alpha\": \"protein\"},\n    {\"U937 cells\": \"cell_type\"},\n    {\"U9-IIIB\": \"cell_line\"},\n    {\"HIV\": \"cell_type\"}\n]",
        "prediction": "{'TNF-alpha': 'protein', 'U937 cells': 'cell_type', 'U9-IIIB': 'cell_line', 'HIV': 'cell_type'}"
    },
    {
        "idx": 432,
        "sentence": "Moreover, BSAP is clearly a B-cell-specific transcription factor , as a wild-type but not a mutant TSAP -binding site of the sea urchin functions only in transfected B cells as an upstream promoter element .",
        "label": {
            "transfected B cells": "cell_line",
            "TSAP": "protein",
            "mutant TSAP -binding site": "DNA",
            "upstream promoter element": "DNA",
            "BSAP": "protein",
            "B-cell-specific transcription factor": "protein",
            "wild-type": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 3},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n{\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 4},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"TSAP\": \"protein\"}, {\"sea urchin\": \"cell_line\"}, {\"B cells\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'TSAP': 'protein', 'sea urchin': 'cell_line', 'B cells': 'cell_type'}"
    },
    {
        "idx": 1161,
        "sentence": "Deoxycholate treatment of the cytoplasmic extract prepared from cells stimulated by TNF-alpha in the presence of Cu2+ resulted in the release of NF kappa B from I kappa B alpha , indicating that Cu2+ interferes with the dissociation of the NF kappa B -I kappa B complex .",
        "label": {
            "I kappa B alpha": "protein",
            "NF kappa B": "protein",
            "NF kappa B -I kappa B complex": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"Cu2+\": \"cell_line\"}]",
        "prediction": "{'NF kappa B': 'protein', 'I kappa B alpha': 'protein', 'Cu2+': 'cell_line'}"
    },
    {
        "idx": 1794,
        "sentence": "Activation of the signal transducer and transcription ( STAT ) signaling pathway in a primary T cell response .",
        "label": {
            "STAT": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 3},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"STAT\": \"protein\"}, {\"T cell\": \"cell_type\"}]",
        "prediction": "{'STAT': 'protein', 'T cell': 'cell_type'}"
    },
    {
        "idx": 1470,
        "sentence": "Hence, induction of cell surface expression of this leukocyte adhesion molecule by tumor necrosis factor (TNF)-alpha was reduced by 40% in the presence of CsA , and this was reflected by a 29% decrease in neutrophil adhesion .",
        "label": {
            "neutrophil": "cell_type",
            "tumor necrosis factor (TNF)-alpha": "protein",
            "leukocyte adhesion molecule": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n{\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n{\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n{\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 5},\n{\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 5},\n{\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n{\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n{\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 644,
        "sentence": "Oncogene amplification correlates with dense lymphocyte infiltration in human breast cancers : a role for hematopoietic growth factor release by tumor cells ?",
        "label": {
            "tumor cells": "cell_type",
            "hematopoietic growth factor": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains terms that correspond to 'protein' and 'cell_type' entities, but the relevance is slightly less direct compared to other examples.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence contains a term that corresponds to the 'cell_type' entity, but the relevance is slightly less direct compared to other examples.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence contains terms that correspond to 'DNA' and 'protein' entities, but the relevance is slightly less direct compared to other examples.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific terms that directly correspond to the entity labels in the label set.\"}\n]",
        "response3": "[{\"lymphocyte\": \"cell_type\"}, {\"breast cancers\": \"cell_type\"}, {\"hematopoietic growth factor\": \"protein\"}, {\"tumor cells\": \"cell_type\"}]",
        "prediction": "{'lymphocyte': 'cell_type', 'breast cancers': 'cell_type', 'hematopoietic growth factor': 'protein', 'tumor cells': 'cell_type'}"
    },
    {
        "idx": 435,
        "sentence": "Antibodies are produced exclusively in B lymphocytes .",
        "label": {
            "Antibodies": "protein",
            "lymphocytes": "cell_type",
            "B lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example contains a specific gene name (IgH) that is directly related to the entity type 'DNA' in the target sentence.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The example mentions a specific cell type (Eosinophils) which is related to the entity type 'cell_type' in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides multiple instances of cytokines and cell types that are directly related to the entity types 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The example mentions specific viruses (EBV) and proteins (CD2) that are directly related to the entity types 'cell_line' and 'protein' in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides multiple instances of cytokines, proteins, and cell types that are directly related to the entity types 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example mentions specific cell types (Th1 and Th2) that are directly related to the entity type 'cell_type' in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example contains a specific cell type (Th2-type lymphocytes) that is directly related to the entity type 'cell_type' in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides multiple instances of proteins, cell types, and cytokines that are directly related to the entity types 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The example mentions specific proteins (NF-ATc) and cell types (T lymphocytes) that are directly related to the entity types 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides multiple instances of proteins, cell types, and receptors that are directly related to the entity types 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The example mentions specific cell types (T lymphocytes) and proteins (HLA-molecules) that are directly related to the entity types 'cell_type' and 'protein' in the target sentence.\"},\n    {\"Example 12\": 3},\n    {\"Reason 12\": \"The example contains a specific gene name (E2A) that is directly related to the entity type 'protein' in the target sentence.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example mentions specific cell types (lymphocytes) and chemical compounds (benzene, benzoquinone) that are directly related to the entity types 'cell_type' and 'chemical compound' in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The example mentions specific viruses (EBV) and cell types (B-cell) that are directly related to the entity types 'cell_type' in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides multiple instances of proteins, cell types, and factors that are directly related to the entity types 'protein' and 'cell_type' in the target sentence.\"}\n]",
        "response3": "[{'B lymphocytes': 'cell_type'}]",
        "prediction": "{'B lymphocytes': 'cell_type'}"
    },
    {
        "idx": 1342,
        "sentence": "While Bik does not show overt homology to the BH1 and BH2 conserved domains characteristic of the Bcl-2 family , it does share a 9 amino acid domain ( BH3 ) with Bax and Bak which may be a critical determinant for the death-promoting activity of these proteins.",
        "label": {
            "amino acid domain": "protein",
            "BH1": "protein",
            "BH3": "protein",
            "Bak": "protein",
            "BH2": "protein",
            "Bax": "protein",
            "Bik": "protein",
            "Bcl-2 family": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 3},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 3},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5}\n]",
        "response3": "[{\"Bik\": \"protein\"}, {\"BH1\": \"protein\"}, {\"BH2\": \"protein\"}, {\"Bcl-2\": \"protein\"}, {\"BH3\": \"protein\"}, {\"Bax\": \"protein\"}, {\"Bak\": \"protein\"}]",
        "prediction": "{'Bik': 'protein', 'BH1': 'protein', 'BH2': 'protein', 'Bcl-2': 'protein', 'BH3': 'protein', 'Bax': 'protein', 'Bak': 'protein'}"
    },
    {
        "idx": 1022,
        "sentence": "NK cell NFAT is present in the cytosol of nonstimulated cells , migrates to the nucleus upon stimulation, and can associate with AP-1 .",
        "label": {
            "NK cell NFAT": "protein",
            "AP-1": "protein",
            "nonstimulated cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and cell types that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides clear protein names and cell types that are explicitly stated, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions specific protein names and cell types, which are crucial for named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence includes protein names and cell types that are explicitly mentioned, making it very helpful for extracting named entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains protein names and cell types that are directly related to named entities, making it highly useful for extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence provides protein names and cell types that are relevant for named entity extraction, but the context could be clearer.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence explicitly mentions protein names, making it very helpful for extracting named entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions a specific protein name, which is helpful for named entity extraction, but the context could be clearer.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains protein names and cell types that are directly mentioned, aiding in named entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides specific protein names and cell types that are crucial for named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions protein names and cell types that are directly related to named entities, making it highly useful for extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence explicitly mentions a specific DNA binding activity related to NF-kappa B, aiding in named entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides specific protein names that are crucial for named entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains protein names and cell types that are directly mentioned, making it highly relevant for extracting named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions a specific protein name, which is helpful for named entity extraction, but the context could be clearer.\"}\n]",
        "response3": "[{\"NK cell\": \"cell_type\"}, {\"NFAT\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'NK cell': 'cell_type', 'NFAT': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 810,
        "sentence": "Exposure of CML cells to IFN-alpha diminished the effect of the CML cytoplasmic proteins on these nuclear protein-DNA complexes .",
        "label": {
            "CML cells": "cell_type",
            "IFN-alpha": "protein",
            "CML cytoplasmic proteins": "protein",
            "nuclear protein-DNA complexes": "protein"
        },
        "response1": "['protein', 'cell_line', 'DNA']",
        "response2": "[\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC .\": 5},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5}\n]",
        "response3": "[{\"CML\": \"cell_line\"}, {\"IFN-alpha\": \"protein\"}, {\"CML\": \"cell_line\"}, {\"cytoplasmic proteins\": \"protein\"}, {\"nuclear protein-DNA complexes\": \"DNA\"}]",
        "prediction": "{'CML': 'cell_line', 'IFN-alpha': 'protein', 'cytoplasmic proteins': 'protein', 'nuclear protein-DNA complexes': 'DNA'}"
    },
    {
        "idx": 1811,
        "sentence": "In our attempt to identify chemokine receptors that are related to Burkitt's lymphoma receptor 1 ( BLR1 ) and are expressed in activated lymphocytes we used RT-PCR resulting in the isolation of a cDNA encoding a seven transmembrane receptor termed BLR2 .",
        "label": {
            "BLR1": "protein",
            "BLR2": "protein",
            "seven transmembrane receptor": "protein",
            "activated lymphocytes": "cell_type",
            "chemokine receptors": "protein",
            "Burkitt's lymphoma receptor 1": "protein"
        },
        "response1": "['DNA', 'RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains named entities with entity labels that match the entity types in the target sentence, but not as many as Example 1.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence contains a named entity with an entity label that matches an entity type in the target sentence, but only one entity is present.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains named entities with entity labels that match the entity types in the target sentence, but not as many as Example 1.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains multiple named entities with clear entity labels that match the entity types in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains named entities with entity labels that match the entity types in the target sentence, but not as many as Example 1.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The sentence contains a named entity with an entity label that matches an entity type in the target sentence, but only one entity is present.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains named entities with entity labels that match the entity types in the target sentence, but not as many as Example 1.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains named entities with entity labels that match the entity types in the target sentence, but not as many as Example 1.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains named entities with entity labels that match the entity types in the target sentence, but not as many as Example 1.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains named entities with entity labels that match the entity types in the target sentence, but not as many as Example 1.\"},\n    {\"Example 13\": 3},\n    {\"Reason 13\": \"The sentence contains a named entity with an entity label that matches an entity type in the target sentence, but only one entity is present.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains named entities with entity labels that match the entity types in the target sentence, but not as many as Example 1.\"}\n]",
        "response3": "[{\"BLR1\": \"protein\"}, {\"BLR2\": \"protein\"}]",
        "prediction": "{'BLR1': 'protein', 'BLR2': 'protein'}"
    },
    {
        "idx": 1316,
        "sentence": "Helix III is less rigid, makes an average angle of about 90 degrees with helices I and II , and constitutes the other arm of the molecule.",
        "label": {
            "Helix III": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides a clear and direct mention of 'cDNAs' which is a specific type of DNA, aiding in the extraction of the entity.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence directly mentions 'Tax' and 'TFIIA' as interacting entities, providing clear context for protein entities.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' as nuclear factors and proteins, aiding in the extraction of these entities.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence directly links 'tyrosine' to 'protein-protein interaction', providing context for identifying 'tyrosine' as a protein entity.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence mentions 'A-myb' as a transcription factor, providing clear context for identifying 'A-myb' as a protein entity.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions 'IL-4' and 'proteins' in the context of gene expression regulation, aiding in the extraction of these entities.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence provides a direct link between 'retinoic acid receptor alpha' and 'proteolytic assay', aiding in the identification of the protein entity.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer' in the context of gene expression control, aiding in the extraction of this DNA entity.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence directly links 'EKLF' to '5'HS3' and '5'HS2', providing context for identifying 'EKLF' as a protein entity.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence mentions 'IL-2', 'Aiolos', and 'Ras' in the context of cellular distribution and phosphorylation, aiding in the extraction of these protein entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence provides a direct link between 'IL-7R', 'gamma(c)', and 'IL-7R function', aiding in the identification of these protein entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions 'CCAAT box' and 'EKLF binding site' in the context of gene expression, aiding in the extraction of these DNA and protein entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence mentions 'Th2-type lymphocytes' as cytokine-expressing cells, aiding in the extraction of this cell type entity.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence mentions 'SLAP-130', 'SLP-76', and 'T cell' in the context of molecular cloning, aiding in the extraction of these protein and cell type entities.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence provides a direct link between 'p50p50' and 'binding', aiding in the identification of 'p50p50' as a protein entity.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence mentions 'IL-2' and 'composite element' in the context of promoter responsiveness, aiding in the extraction of the protein entity.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 939,
        "sentence": "However, in 3 postmenopausal patients a short course of estrogen or tamoxifen resulted in a marked increase of type II EBS levels.",
        "label": {
            "type II EBS": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity along with its corresponding label, making it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 292,
        "sentence": "We used mouse embryonic stem (ES) cells to study globin gene expression and switching in vitro.",
        "label": {
            "globin gene": "DNA",
            "mouse embryonic stem (ES) cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"E2A\": 5},\n    {\"MNDA\": 5},\n    {\"Philadelphia chromosome-positive chronic myeloid leukemia\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"IgH\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"GM-CSF\": 5},\n    {\"GATA-1\": 5},\n    {\"SCM-1\": 5},\n    {\"IFN A\": 5},\n    {\"IFNA\": 5},\n    {\"interleukin-2\": 5},\n    {\"interleukin-2 receptor\": 5},\n    {\"phytohemagglutinin\": 5},\n    {\"phorbol myristate acetate\": 5},\n    {\"CCAAT box\": 5},\n    {\"EKLF binding site\": 5},\n    {\"Egr-1\": 5},\n    {\"RXR\": 5},\n    {\"Sp1\": 5},\n    {\"Ets\": 5},\n    {\"c-kit\": 5},\n    {\"IL-4R alpha chain\": 5},\n    {\"ZEB\": 5},\n    {\"c-Myb\": 5},\n    {\"hematopoietic cells\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 542,
        "sentence": "Amino acid sequences of all proteins are essays written in the same language.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple named entities with clear entity labels that can be easily identified.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains multiple named entities with clear entity labels that can be easily identified.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains multiple named entities with clear entity labels that can be easily identified.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains multiple named entities with clear entity labels that can be easily identified.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains a named entity with a clear entity label that can be easily identified.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 505,
        "sentence": "The TCF-1 alpha binding site was also required for TCR alpha enhancer activity in transcriptionally active extracts from Jurkat but not HeLa cells , confirming that TCF-1 alpha is a T-cell-specific transcription factor .",
        "label": {
            "Jurkat": "cell_line",
            "TCF-1 alpha": "protein",
            "TCR": "protein",
            "T-cell-specific transcription factor": "protein",
            "TCF-1 alpha binding site": "DNA",
            "HeLa cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 4},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCR alpha\": \"protein\"}, {\"Jurkat\": \"cell_line\"}, {\"HeLa\": \"cell_line\"}, {\"T-cell-specific\": \"cell_type\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCR alpha': 'protein', 'Jurkat': 'cell_line', 'HeLa': 'cell_line', 'T-cell-specific': 'cell_type'}"
    },
    {
        "idx": 1525,
        "sentence": "Kinase activity was reduced in lysates preadsorbed using an antibody specific for CaM kinase II .",
        "label": {
            "antibody": "protein",
            "CaM kinase II": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence provides a clear example of a protein entity (P selectin) and its association with antibodies, aiding in the extraction of protein entities from the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence contains multiple instances of protein entities (NF-kappa B, I kappa B alpha) and their interactions, which are directly relevant to the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence provides detailed information about protein entities (cAMP-dependent protein kinase, Rap1) and their substrates, directly assisting in identifying protein entities in the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence specifically mentions a protein entity (E2A) and the use of antisera for detection, which aligns with the protein entity extraction task in the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence discusses the inhibition of a protein entity (calcineurin) by immunophilin-drug complexes, providing relevant information for identifying protein entities in the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions multiple protein entities (SLAP-130, SLP-76, protein tyrosine kinases) and their associations, aiding in the extraction of protein entities and cell types from the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence provides information about protein entities (IL-4, LPS, AP-1) and their interactions, directly relevant to identifying protein entities in the target sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence discusses protein entities (Syk, Zap) and their activation upon T cell receptor crosslinking, which is beneficial for identifying protein entities and cell types in the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence mentions a protein entity (NDP kinase) and its expression in different cell types (KA, SCC, BCC), providing valuable information for identifying protein entities and cell types in the target sentence.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The sentence discusses the role of cell adhesion molecules, which may indirectly assist in identifying cell type entities in the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence provides information about protein entities (RelA, NF-kappa B) and their activities in T cells, directly relevant to identifying protein entities in the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions protein entities (IL-2, Aiolos, Ras) and their interactions, aiding in the extraction of protein entities from the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence discusses protein entities (RelA, NF-kappaB1) and their nuclear localization, directly relevant to identifying protein entities in the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence provides information about a protein entity (retinoic acid receptor alpha) and its characterization, aiding in the extraction of protein entities from the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence mentions protein entities (p21(WAF1/CIP1), p27(KIP1)) and their mRNA and protein levels, directly assisting in identifying protein entities in the target sentence.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1103,
        "sentence": "Relationship between Rap1 protein phosphorylation and regulation of Ca2+ transport in platelets : a new approach.",
        "label": {
            "platelets": "cell_type",
            "Rap1 protein": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a direct mapping of the entity 'calcineurin' to the entity type 'protein' in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example covers multiple entity mappings such as 'AP-1' to 'protein', 'PMA' to 'protein', 'monocytes' to 'cell_type', and 'macrophages' to 'cell_type', providing comprehensive assistance in entity extraction.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example includes mappings for 'PAFR' to 'protein', 'PAF' to 'protein', 'NF-kappa B' to 'protein', and 'protein kinase C' to 'protein', offering detailed guidance for named entity extraction.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example provides mappings for 'Stat3' to 'protein', 'Stat5' to 'protein', and 'c-Mpl' to 'protein', facilitating accurate extraction of named entities from the sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example covers 'SLAP-130' mapped to 'protein', 'SLP-76' mapped to 'protein', and 'T cell' mapped to 'cell_type', offering valuable insights for named entity extraction.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example provides a direct mapping of 'tyrosine' to 'protein', aiding in the extraction of this specific entity type from the sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example includes the mapping of 'GATA-1' to 'protein', which is crucial for extracting named entities related to protein entities in the sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example covers 'p21ras' mapped to 'protein', providing clear guidance for extracting protein entities from the sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example includes the mapping of 'P selectin' to 'protein', aiding in the extraction of protein entities from the sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example provides mappings for 'p21(WAF1/CIP1)' to 'protein' and 'p27(KIP1)' to 'protein', assisting in the extraction of protein entities from the sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example covers 'ERK' mapped to 'protein' and 'STAT3' mapped to 'protein', offering valuable guidance for extracting protein entities from the sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example includes mappings for 'RelA' to 'protein' and 'NF-kappaB1' to 'protein', aiding in the extraction of protein entities from the sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example provides mappings for 'Syk' to 'protein', 'Zap' to 'protein', and 'T cell' to 'cell_type', offering comprehensive assistance in named entity extraction.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example covers mappings for 'IL-2' to 'protein', 'Aiolos' to 'protein', and 'Ras' to 'protein', providing detailed guidance for named entity extraction.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The example includes the mapping of 'phosphocreatine' to 'protein', aiding in the extraction of this specific entity type from the sentence.\"\n    }\n]\n```",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 538,
        "sentence": "Alone, PMA and calcium ionophore A23187 did not affect, but together stimulated, like phytohaemagglutinin ( PHA ), leucine and, in particular, thymidine incorporation .",
        "label": {
            "PHA": "protein",
            "phytohaemagglutinin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1529,
        "sentence": "Transcriptional activation and repression , two properties of the lymphoid-specific transcription factor Oct-2a .",
        "label": {
            "Oct-2a": "protein",
            "lymphoid-specific transcription factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IkappaBbeta by the tax protein of human T-cell leukemia virus type 1\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n    {\"Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 4},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging\": 3},\n    {\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1197,
        "sentence": "In this study, we demonstrate reconstitution of a cell-free processing system and demonstrate directly that: (a) the ubiquitin -proteasome system is involved in processing of the intact p105 precursor, (b) conjugation of ubiquitin to the precursor is an essential intermediate step in the processing, (c) the recently discovered novel species of the ubiquitin -carrier protein , E2-F1 , that is involved in the conjugation and degradation of p53 , is also required for the limited processing of the p105 precursor , and (d) a novel, approximately 320-kDa species of ubiquitin -protein ligase , is involved in the process.",
        "label": {
            "ubiquitin": "protein",
            "p105 precursor": "protein",
            "E2-F1": "protein",
            "-proteasome": "protein",
            "ubiquitin -carrier protein": "protein",
            "p53": "protein",
            "ubiquitin -protein ligase": "protein",
            "320-kDa species": "protein",
            "p105": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n{\"Tat-binding protein 7 is a subunit of the 26S protease.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n{\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n{\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n{\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5}\n]",
        "response3": "[{\"ubiquitin -proteasome system\": \"protein\"}, {\"p105 precursor\": \"protein\"}, {\"ubiquitin\": \"protein\"}, {\"E2-F1\": \"protein\"}, {\"p53\": \"protein\"}, {\"ubiquitin -carrier protein\": \"protein\"}, {\"ubiquitin -protein ligase\": \"protein\"}]",
        "prediction": "{'ubiquitin -proteasome system': 'protein', 'p105 precursor': 'protein', 'ubiquitin': 'protein', 'E2-F1': 'protein', 'p53': 'protein', 'ubiquitin -carrier protein': 'protein', 'ubiquitin -protein ligase': 'protein'}"
    },
    {
        "idx": 877,
        "sentence": "Their constitutive expression is limited to B lymphocytes and thymic epithelial cells .",
        "label": {
            "B lymphocytes": "cell_type",
            "thymic epithelial cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein and cell type entities that are directly mentioned, aiding in the extraction of named entities from the target sentence.\"}\n]",
        "response3": "[{\"B lymphocytes\": \"cell_type\"}, {\"thymic epithelial cells\": \"cell_type\"}]",
        "prediction": "{'B lymphocytes': 'cell_type', 'thymic epithelial cells': 'cell_type'}"
    },
    {
        "idx": 1838,
        "sentence": "First, we show that mutations in the LEF-1 -binding site inhibit the activity of multimerized copies of the HIV-1 enhancer in Jurkat T cells , and that LEF-1 /GAL4 can activate a GAL4-substituted HIV-1 enhancer 80- to 100-fold in vivo.",
        "label": {
            "LEF-1 -binding site": "DNA",
            "HIV-1 enhancer": "DNA",
            "LEF-1": "protein",
            "GAL4-substituted HIV-1 enhancer": "DNA",
            "Jurkat T cells": "cell_line",
            "multimerized copies": "DNA",
            "LEF-1 /GAL4": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear entity-label mapping for 'immunoglobulin kappa 3' enhancer' as 'DNA', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The examples provide accurate entity-label mappings for 'IL-2' as 'protein', 'IFN-gamma' as 'protein', 'jak kinases' as 'protein', and 'STAT1(alpha)' as 'protein, which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The examples provide accurate entity-label mappings for 'IL-2' as 'protein', 'c-Jun' as 'protein', and 'c-Fos' as 'protein, which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The examples provide accurate entity-label mappings for 'IFN A' as 'protein', 'IFNA' as 'protein', 'interleukin-2' as 'protein', 'interleukin-2 receptor' as 'protein', 'phytohemagglutinin' as 'protein', and 'phorbol myristate acetate' as 'protein', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The examples provide accurate entity-label mappings for 'PU.1' as 'protein', 'M-CSF receptor' as 'protein', and 'macrophage' as 'cell_type', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The examples provide accurate entity-label mappings for 'Sp1' as 'protein' and 'CD14' as 'protein', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear entity-label mapping for 'SIVsmmPBj14' as 'cell_line', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The examples provide accurate entity-label mappings for 'T cell' as 'cell_type' and 'interleukin 2' as 'protein', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear entity-label mapping for 'p50p50' as 'protein', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The examples provide accurate entity-label mappings for 'IkappaBbeta' as 'protein' and 'NF-kappaB' as 'protein', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The examples provide accurate entity-label mappings for 'HIV-1' as 'cell_type', 'IFN' as 'protein', 'PKR' as 'protein', and 'IkappaBalpha' as 'protein', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The examples provide accurate entity-label mappings for 'NF-kappaB' as 'protein', 'Sp1' as 'protein', and 'SIVmac' as 'cell_line', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The examples provide accurate entity-label mappings for 'cDNA' as 'DNA', 'Jurkat' as 'cell_line', and 'DRE 1' as 'cell_type', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The examples provide accurate entity-label mappings for 'HIV-1 LTR' as 'DNA', 'NFAT-1' as 'protein', and 'NF kappa B' as 'protein', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The examples provide accurate entity-label mappings for 'TR55' as 'protein', 'TNF-alpha' as 'protein', and 'HIV' as 'cell_type', which directly aids in extracting named entities from the target sentence.\"}\n]\n\n[\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The examples provide accurate entity-label mappings for 'ATF1' as 'protein', 'CREB' as 'protein', and 'H4' as 'protein', which directly aids in extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"HIV-1 enhancer\": \"DNA\"}, {\"Jurkat T cells\": \"cell_type\"}, {\"GAL4\": \"protein\"}]",
        "prediction": "{'LEF-1': 'protein', 'HIV-1 enhancer': 'DNA', 'Jurkat T cells': 'cell_type', 'GAL4': 'protein'}"
    },
    {
        "idx": 1195,
        "sentence": "Palombella and colleagues (Palombella, V.J., Rando, O.J., Goldberg, A.L., and Maniatis, T.(1994) Cell 78, 773-785) have shown that ubiquitin is required for the processing in a cell-free system of a truncated, artificially constructed, 60-kDa precursor .",
        "label": {
            "60-kDa precursor": "protein",
            "ubiquitin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"By immunization with a recombinant fusion protein , we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 5}\n]",
        "response3": "[{\"Palombella\": \"protein\"}, {\"V.J.\": \"protein\"}, {\"Rando\": \"protein\"}, {\"O.J.\": \"protein\"}, {\"Goldberg\": \"protein\"}, {\"A.L.\": \"protein\"}, {\"Maniatis\": \"protein\"}]",
        "prediction": "{'Palombella': 'protein', 'V.J.': 'protein', 'Rando': 'protein', 'O.J.': 'protein', 'Goldberg': 'protein', 'A.L.': 'protein', 'Maniatis': 'protein'}"
    },
    {
        "idx": 817,
        "sentence": "(ii) Transfection and expression of EBNA-LP alone had no effect on LMP1 expression and did not act synergistically with EBNA-2 to affect LMP1 expression .",
        "label": {
            "EBNA-LP": "protein",
            "LMP1": "protein",
            "EBNA-2": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (IL-2) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple protein entities (PC4, OCA-B, Oct-1) and their corresponding labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence includes various protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) and their corresponding labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions protein entities (IL-4, LPS, AP-1) and their corresponding labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides protein entities (NF-kappaB, Sp1, p50) and their corresponding labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains protein entities (NF-kB, AP-1, OCT-1, NF-IL-2B) and their corresponding labels.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a protein entity (TIMP-1) and a DNA entity, which could be helpful in understanding the context.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence includes protein entities (RelA, NF-kappaB1) and their corresponding labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides protein entities (EBNA-2, PU.1) and their corresponding labels.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions a cell type entity (T cell) and protein entities (IL-2, IL-2 receptor, CD28) which could aid in understanding the interactions.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains a protein entity (RXR) and its corresponding label.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions protein entities (EBNA2, TP1) and their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence includes RNA entity (MNDA) and a cell line entity (myeloid cell lines) with their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides protein entities (p21(WAF1/CIP1), p27(KIP1)) and their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions protein entities (CD40, IFN-gamma, tumor necrosis factor-alpha, interleukin (IL)-1beta) and their corresponding labels.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence includes a cell type entity (CD4+) and a protein entity (EBV) which could be helpful in understanding the context.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 741,
        "sentence": "In melanoma cells that contain the N-Oct-3 factor , a transfected lymphocyte-specific promoter was neither activated nor was it repressed upon contransfection with an Oct-2A expression vector .",
        "label": {
            "Oct-2A expression vector": "DNA",
            "Oct-2A": "protein",
            "N-Oct-3 factor": "protein",
            "melanoma cells": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The MNDA mRNA level in the myeloid cell lines was also unaffected by the latter four agents.\": 3},\n    {\"Nuclear factor NF-kB, activation protein 1 (AP-1), OCT-1, and NF-IL-2B binding activity were normal.\": 5},\n    {\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 4},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Surprisingly, however, removal of PC4 from the unfractionated nuclear extract has no detrimental effect on OCA-B/Oct-1-dependent transcription.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 283,
        "sentence": "[ Estrogen receptor content of peripheral blood lymphocytes in patients with systemic lupus erythematosus ]",
        "label": {
            "Estrogen receptor": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"Estrogen receptor\": \"protein\"}]",
        "prediction": "{'Estrogen receptor': 'protein'}"
    },
    {
        "idx": 1043,
        "sentence": "METHOD: Two color flow cytometry analysis was used on peripheral blood samples of young and postmenopausal females and postmenopausal females treated with estrogen replacement therapy .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Although erythropoietin ( Epo ) is essential for the production of mature red blood cells , the cooperation with other factors is required for a proper balance between progenitor proliferation and differentiation.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA -stimulated U1 cells , respectively.\": 5},\n    {\"Despite this drastic effect in vivo, the in vitro immortalization of erythropoietin-dependent erythroid progenitors unexpectedly occurred at low frequency, and all four cell lines established expressed both erythrocytic (globins) and megakaryocytic markers ( glycoprotein IIb , platelet factor 4 ) as well as Spi-1 and Fli-1 transcripts at permissive temperature.\": 5},\n    {\"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.\": 5}\n]",
        "response3": "[{\"estrogen replacement therapy\": \"protein\"}]",
        "prediction": "{'estrogen replacement therapy': 'protein'}"
    },
    {
        "idx": 1010,
        "sentence": "Using a polyclonal antibody to murine NFATp , Western blot analysis of various mouse tissues demonstrated that the 110-130-kDa NFATp protein was highly expressed in thymus and spleen .",
        "label": {
            "murine NFATp": "protein",
            "NFATp protein": "protein",
            "NFATp": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 3},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B, possibly by a phosphorylation reaction involving protein kinase C by PAF.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"The p50 and p65 proteins, constituents of the prototypic nuclear factor kappaB, were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5}\n]",
        "response3": "[{\"NFATp\": \"protein\"}]",
        "prediction": "{'NFATp': 'protein'}"
    },
    {
        "idx": 186,
        "sentence": "We also find that NF-E2 , another trans-acting factor of the erythrocytic lineage , is present in megakaryocytes .",
        "label": {
            "erythrocytic lineage": "cell_type",
            "NF-E2": "protein",
            "trans-acting factor": "protein",
            "megakaryocytes": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example directly mentions the entity 'RXR' and provides the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example directly mentions the entities 'SCL' and 'GATA-1' with the corresponding entity labels 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example directly mentions the entities 'Stat3', 'Stat5', and 'c-Mpl' with the corresponding entity labels 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example directly mentions the entities 'NF-ATc' and 'T lymphocytes' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example directly mentions the entity 'GATA-1' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example directly mentions the entities 'granulocytes' and 'T cells' with the corresponding entity labels 'cell_type'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example directly mentions the entities 'EKLF', 'CBP', 'p300', and 'P/CAF' with the corresponding entity labels 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly mentions the entity 'Egr-1' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example directly mentions the entities 'NF-ATc', 'T lymphocytes', and 'embryonic cardiac cells' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example directly mentions the entity 'erythropoietin' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example directly mentions the entity 'NF-E2' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example directly mentions the entity 'E2A' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example directly mentions the entity 'GATA-1' with the corresponding entity label 'protein'. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example directly mentions the entities 'CD40', 'Rel/nuclear factor kappaB', 'NF-kappaB', and 'B lymphocytes' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example directly mentions the entities 'ZEB', 'c-Myb', 'Ets', and 'hematopoietic cells' with the corresponding entity labels 'protein' and 'cell_type' respectively. This is highly relevant and specific to the target sentence.\"\n    }\n]",
        "response3": "[{\"NF-E2\": \"protein\"}, {\"megakaryocytes\": \"cell_type\"}]",
        "prediction": "{'NF-E2': 'protein', 'megakaryocytes': 'cell_type'}"
    },
    {
        "idx": 1547,
        "sentence": "Platelet glycoprotein ( GP ) Ib-IX-V is a multisubunit adhesion receptor that supports platelet attachment to thrombogenic surfaces at sites of vascular injury .",
        "label": {
            "multisubunit adhesion receptor": "protein",
            "Ib-IX-V": "protein",
            "Platelet glycoprotein": "protein",
            "GP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 3},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 2},\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 1},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 2},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 2},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 2},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 3},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 3},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 3},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 2},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 3},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 3},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 3},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 3},\n    {\"We have examined the effect of alpha-tocopherol (alpha-tcp) on one cellular event in atherosclerotic plaque development, monocyte adhesion to stimulated endothelial cells (ECs).\": 3}\n]",
        "response3": "[{'Platelet glycoprotein (GP) Ib-IX-V': 'protein'}]",
        "prediction": "{'Platelet glycoprotein (GP) Ib-IX-V': 'protein'}"
    },
    {
        "idx": 96,
        "sentence": "We have analyzed the functional domains of the minimal Thy-1 promoter and show that the dominant promoter elements consist of multiple binding sites for the transcription factor Sp1 , an inverted CCAAT box , and sequences proximal to the transcription start site .",
        "label": {
            "Sp1": "protein",
            "dominant promoter elements": "DNA",
            "minimal Thy-1 promoter": "DNA",
            "transcription factor": "protein",
            "multiple binding sites": "DNA",
            "CCAAT box": "DNA",
            "transcription start site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n{\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n{\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n{\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n{\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1763,
        "sentence": "Cysteamine treatment inhibited both expression of the IL-2 mRNA and secretion of IL-2 into the culture medium .",
        "label": {
            "IL-2": "protein",
            "IL-2 mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells .\": 5}\n]",
        "response3": "[{\"IL-2 mRNA\": \"RNA\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'IL-2 mRNA': 'RNA', 'IL-2': 'protein'}"
    },
    {
        "idx": 224,
        "sentence": "Cortivazol ( CVZ ) is a unique, high potency synthetic glucocorticoid , which has a phenylpyrazol fused to the A-ring of the steroid nucleus and displays binding consistent with two or more sites in the cytosol from CEM C7 cells (a human acute lymphoblastic T-cell line ).",
        "label": {
            "CEM C7 cells": "cell_line",
            "human acute lymphoblastic T-cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"CEM C7 cells\": \"cell_line\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'CEM C7 cells': 'cell_line', 'T-cell': 'cell_type'}"
    },
    {
        "idx": 313,
        "sentence": "Immunohistochemical study of steroid hormones and an estrogen binding assay in malignant soft tissue tumors .",
        "label": {
            "malignant soft tissue tumors": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of using polyclonal antisera directed against distinct portions of a protein, which is helpful for identifying protein entities in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence describes the mRNA expression of a transcription factor during eosinophil differentiation, providing a clear example of a protein entity, which is helpful for identifying protein entities in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions lymphoid neoplasms, indicating a cell type entity, which is helpful for identifying cell type entities in the target sentence.\"},\n    {\"Example 4\": 3},\n    {\"Reason 4\": \"The sentence mentions phosphocreatine, which is a protein entity, but the context is not as clear as other examples, hence the slightly lower helpfulness score.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides multiple examples of protein entities associated with specific proteins and cell types, which are helpful for identifying protein and cell type entities in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides a clear example of a protein entity (NF-E2) associated with a specific function, which is helpful for identifying protein entities in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of using immunohistochemistry with antibodies against proteins encoded by a gene, which is helpful for identifying protein and DNA entities in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides a clear example of a protein entity (retinoic acid receptor alpha) associated with a specific function, which is helpful for identifying protein entities in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides a clear example of a protein entity (CD14) associated with a specific function, which is helpful for identifying protein entities in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides examples of cell line entities (HML) and protein entities associated with specific functions, which are helpful for identifying cell line and protein entities in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of protein entities associated with specific functions and cell types, which are helpful for identifying protein and cell type entities in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of cell line entities (Ramos and Jurkat) and DNA entities associated with specific technologies, which are helpful for identifying cell line and DNA entities in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of protein entities (tal-1 and GATA-binding proteins) associated with specific functions and a cell type entity (hematopoiesis), which are helpful for identifying protein and cell type entities in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of protein entities (Erbstatin and genistein) associated with specific functions and an RNA entity (Egr-1), which are helpful for identifying protein and RNA entities in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides examples of DNA entities (EBV) and protein entities (EBNA2 and estrogen receptor) associated with specific functions, which are helpful for identifying DNA and protein entities in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of protein entities (MR, aldosterone, and progesterone) associated with specific functions, which are helpful for identifying protein entities in the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1285,
        "sentence": "Characterization of 5' end of human thromboxane receptor gene .",
        "label": {
            "5' end of human thromboxane receptor gene": "DNA",
            "human thromboxane receptor gene": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"p50p50\": 5},\n    {\"GATA-1\": 5},\n    {\"Th2-type lymphocytes\": 4},\n    {\"SCM-1\": 4},\n    {\"Stat3\": 5},\n    {\"Stat5\": 5},\n    {\"c-Mpl\": 5},\n    {\"E2A\": 5},\n    {\"T cell\": 5},\n    {\"interleukin 2\": 5},\n    {\"retinoic acid receptor alpha\": 5},\n    {\"GM-CSF\": 5},\n    {\"SIVsmmPBj14\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"GATA-1\": 5},\n    {\"RXR\": 5},\n    {\"cDNAs\": 5},\n    {\"Ter 119\": 5},\n    {\"beta-globin\": 5},\n    {\"glycoprotein IIb\": 5},\n    {\"platelet factor 4\": 5},\n    {\"B and T cell activation\": 5},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 327,
        "sentence": "However, there is an EB1 -binding site ( ZRE-B ) located within the R-responsive enhancer region .",
        "label": {
            "R-responsive enhancer region": "DNA",
            "EB1 -binding site": "DNA",
            "EB1": "protein",
            "ZRE-B": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF.\": 5},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5}\n]",
        "response3": "[{\"EB1\": \"protein\"}, {\"ZRE-B\": \"DNA\"}]",
        "prediction": "{'EB1': 'protein', 'ZRE-B': 'DNA'}"
    },
    {
        "idx": 1622,
        "sentence": "Analysis of whole-cell lysates by antiphosphotyrosine immunoblotting showed that incubation with gamma interferon brought about specific increases in phosphotyrosine labeling of several proteins.",
        "label": {
            "gamma interferon": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"gamma interferon\": \"protein\"}]",
        "prediction": "{'gamma interferon': 'protein'}"
    },
    {
        "idx": 1393,
        "sentence": "This enhancer in HIV-1 is the T-cell activation response element ; in HIV-2 , however, it is the second enhancer that is mainly responsible for activation in response to T-cell activators .",
        "label": {
            "second enhancer": "DNA",
            "T-cell activation response element": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example contains specific protein names (Syk, Zap) and cell type (T cell) which directly match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example includes protein names (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) that are relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example mentions 'immunoglobulin kappa 3' enhancer' which is related to DNA, providing some relevance to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example includes 'T cell' and 'interleukin 2' which are relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Reason 5\": \"The example contains protein names (EBNA2, TP1) that are relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example includes protein names (IL-2 receptor alpha subunit, p21ras) and cell type (B cell) which are relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 7\": 3\n    },\n    {\n        \"Reason 7\": \"The example mentions 'Th2-type lymphocytes' which is related to cell type, providing some relevance to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The example contains the protein name 'ZAP-70' which is relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example includes cell types (B and T cell activation), cell lines (Ramos, Jurkat), and DNA (cDNA microarray technology) which directly match the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The example mentions protein names (IFN, PKR, IkappaBalpha) which are relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The example includes protein names (TR55, TNF-alpha) and cell type (HIV) which are relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The example contains DNA (HIV-1 LTR) and protein names (NFAT-1, NF kappa B) that are relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 13\": 3\n    },\n    {\n        \"Reason 13\": \"The example mentions protein names (NF-kappaB, Sp1) and cell line (SIVmac) which are somewhat relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The example includes protein names (TFIID, activators) and cell type (B cells) which are relevant to the entity labels in the target sentence.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The example contains protein names (Interleukin 2) and cell type (T cell) which are relevant to the entity labels in the target sentence.\"\n    }\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}, {\"HIV-2\": \"cell_type\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'T-cell': 'cell_type', 'HIV-2': 'cell_type'}"
    },
    {
        "idx": 1221,
        "sentence": "To identify osteoblast-specific cis-acting elements and trans-acting factors , we initiated an analysis of the promoter of a mouse osteocalcin gene , an osteoblast-specific gene .",
        "label": {
            "mouse osteocalcin gene": "DNA",
            "promoter": "DNA",
            "osteoblast-specific cis-acting elements": "DNA",
            "trans-acting factors": "protein",
            "osteoblast-specific gene": "DNA"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n{\"A critical role of Sp1- and Ets-related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n{\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n{\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 4},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4}\n]",
        "response3": "[{\"osteoblast-specific\": \"cell_type\"}, {\"cis-acting elements\": \"DNA\"}, {\"trans-acting factors\": \"protein\"}, {\"promoter\": \"DNA\"}, {\"mouse osteocalcin gene\": \"protein\"}, {\"osteoblast-specific gene\": \"cell_type\"}]",
        "prediction": "{'osteoblast-specific': 'cell_type', 'cis-acting elements': 'DNA', 'trans-acting factors': 'protein', 'promoter': 'DNA', 'mouse osteocalcin gene': 'protein', 'osteoblast-specific gene': 'cell_type'}"
    },
    {
        "idx": 130,
        "sentence": "At high concentration of NE , all of the TR bound to TREp was more greatly retarded than in the absence of NE .",
        "label": {
            "TREp": "DNA",
            "TR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 788,
        "sentence": "The number of mineralocorticoid receptors /cell were within or close to the normal range (n = 9).",
        "label": {
            "mineralocorticoid receptors": "protein"
        },
        "response1": "['cell_type']",
        "response2": "```json\n[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding functions, which can aid in identifying protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence provides specific protein names and their functions, aiding in identifying protein entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains protein names and their functions, which can help in identifying protein entities.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence includes protein names and their functions, aiding in identifying protein entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions specific protein names and their interactions, which can help in identifying protein entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence explicitly mentions cell types (granulocytes and T cells), aiding in identifying cell_type entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence provides specific protein names found in T cells, aiding in identifying protein entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions RNA and cell line names, aiding in identifying RNA and cell_line entities.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains specific protein names and their functions, aiding in identifying protein entities.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence provides specific protein names and their functions, aiding in identifying protein entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions DNA and its activity, aiding in identifying DNA entities.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence contains specific protein names and their functions, aiding in identifying protein entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions specific protein names and their functions, aiding in identifying protein entities.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides specific cell type names, aiding in identifying cell_type entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions a specific protein name, aiding in identifying protein entities.\"}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 781,
        "sentence": "Effects of aldosterone on intralymphocytic sodium and potassium in patients with essential hypertension .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The example contains a specific protein entity (GATA-1) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The example contains a specific protein entity (phosphocreatine) that is relevant to the target sentence, aiding in the extraction of protein entities. However, the relevance is slightly lower compared to Example 1.\"},\n{\"Example 3\": 5},\n{\"Reason 3\": \"The example contains multiple protein entities (IL-2, NF-kappa B, AP-1) that are directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 4\": 4},\n{\"Reason 4\": \"The example contains a specific cell type entity (T lymphocytes) that is directly relevant to the target sentence, aiding in the extraction of cell type entities. However, the relevance is slightly lower compared to Examples 1 and 3.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The example contains a specific cell type entity (lymphoid neoplasms) that is directly relevant to the target sentence, aiding in the extraction of cell type entities. However, the relevance is slightly lower compared to Examples 1 and 3.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The example contains multiple entities (alpha-tocopherol, monocyte, endothelial cells) that are directly relevant to the target sentence, aiding in the extraction of protein and cell type entities.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The example contains multiple entities (IL-5 mRNA, TCR, IL-2R, dexamethasone) that are directly relevant to the target sentence, aiding in the extraction of RNA, cell type, and protein entities.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The example contains a specific protein entity (NF-E2) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The example contains a specific protein entity (NF-kappa B) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The example contains a specific protein entity (P selectin) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The example contains a specific DNA entity (AP-1) that is directly relevant to the target sentence, aiding in the extraction of DNA entities. However, the relevance is slightly lower compared to Examples 1, 3, and 9.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The example contains a specific cell type entity (Eosinophils) that is directly relevant to the target sentence, aiding in the extraction of cell type entities.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The example contains a specific protein entity (NF-kappa B) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The example contains a specific protein entity (G-CSF) that is directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The example contains multiple protein entities (cAMP-dependent protein kinase, Rap1) that are directly relevant to the target sentence, aiding in the extraction of protein entities.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The example contains multiple entities (CD40, Rel/nuclear factor kappaB, NF-kappaB, B lymphocytes) that are directly relevant to the target sentence, aiding in the extraction of protein and cell type entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1220,
        "sentence": "A PEBP2 alpha/AML-1-related factor increases osteocalcin promoter activity through its binding to an osteoblast-specific cis-acting element .",
        "label": {
            "PEBP2 alpha/AML-1-related factor": "protein",
            "osteocalcin promoter": "DNA",
            "osteoblast-specific cis-acting element": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells\": 3},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging\": 4},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL\": 4},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5}\n]",
        "response3": "[{\"PEBP2 alpha/AML-1-related factor\": \"protein\"}, {\"osteocalcin\": \"protein\"}, {\"osteoblast-specific\": \"cell_type\"}]",
        "prediction": "{'PEBP2 alpha/AML-1-related factor': 'protein', 'osteocalcin': 'protein', 'osteoblast-specific': 'cell_type'}"
    },
    {
        "idx": 958,
        "sentence": "Here, Markus Neurath, Eckhard Stuber and Warren Strober describe the molecular structure of BSAP and focus on the ability of this protein to regulate the expression of B-cell-specific genes .",
        "label": {
            "B-cell-specific genes": "DNA",
            "BSAP": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease .\": 4},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase ( protein kinase A ) and 1 of its substrates, Rap1 , in platelets from untreated euthymic , manic , and depressed patients with bipolar disorder and healthy subjects .\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes .\": 3},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5}\n]",
        "response3": "[{\"Markus Neurath\": \"protein\"}, {\"Eckhard Stuber\": \"protein\"}, {\"Warren Strober\": \"protein\"}, {\"BSAP\": \"protein\"}, {\"B-cell-specific genes\": \"protein\"}]",
        "prediction": "{'Markus Neurath': 'protein', 'Eckhard Stuber': 'protein', 'Warren Strober': 'protein', 'BSAP': 'protein', 'B-cell-specific genes': 'protein'}"
    },
    {
        "idx": 1083,
        "sentence": "These data suggest that the action of tepoxalin to inhibit proliferation in PBMC may be at least in part due to its ability to reduce the amount of available iron resulting in decreased activation of NF kappa B and subsequent inhibition of cytokine production .",
        "label": {
            "cytokine": "protein",
            "NF kappa B": "protein",
            "PBMC": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"1\": \"The example does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The example does not contain any of the entity types present in the target sentence.\"},\n    {\"3\": \"The example contains 'NF-kappaB' which is a protein, but also contains 'Tax' and 'ATL' which are not present in the target sentence.\"},\n    {\"2\": \"The example contains 'NF-E2' which is a protein.\"},\n    {\"3\": \"The example contains 'IL-4', 'LPS', and 'AP-1' which are proteins, but 'IL-4' and 'LPS' are not present in the target sentence.\"},\n    {\"4\": \"The example contains 'NF-kappa B' which is a protein.\"},\n    {\"5\": \"The example contains 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' which are proteins.\"},\n    {\"1\": \"The example does not contain any of the entity types present in the target sentence.\"},\n    {\"2\": \"The example contains 'P selectin' which is a protein.\"},\n    {\"4\": \"The example contains 'NF-kappa B' and 'I kappa B beta' which are proteins.\"},\n    {\"5\": \"The example contains 'IL-2', 'NF-kappa B', and 'AP-1' which are proteins.\"},\n    {\"5\": \"The example contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are proteins.\"},\n    {\"4\": \"The example contains 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' which are proteins.\"},\n    {\"4\": \"The example contains 'interleukin-2', 'alpha chain', 'CD25', and 'IL-2 receptor' which are proteins.\"},\n    {\"3\": \"The example contains 'B cell', 'Ig', and 'Transforming growth factor-beta' which are proteins, but 'B cell' is a cell type.\"},\n    {\"2\": \"The example contains 'CTLA4Ig' which is a protein, but also contains 'NFAT' and 'AP-1' which are not present in the target sentence.\"}\n]",
        "response3": "[\n    {\"NF kappa B\": \"protein\"}\n]",
        "prediction": "{'NF kappa B': 'protein'}"
    },
    {
        "idx": 514,
        "sentence": "Induction of the enhancer may have a role in the increase in globin gene transcription that characterizes erythroid maturation .",
        "label": {
            "globin gene": "DNA",
            "enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'GATA-1' to the entity type 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear and direct mapping of the entity 'NF-E2' to the entity type 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear and direct mapping of the entity 'Th2-type lymphocytes' to the entity type 'cell_type' in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping of the entity 'Egr-1' to the entity type 'protein' in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear and direct mapping of the entity 'erythropoietin' to the entity type 'protein' in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The examples provide clear and direct mappings of the entities 'CCAAT box' to the entity type 'DNA' and 'EKLF binding site' to the entity type 'protein' in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear and direct mapping of the entity 'AP-1' to the entity type 'DNA' in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear and direct mapping of the entity 'IL-4' to the entity type 'protein' in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear and direct mapping of the entity 'retinoic acid receptor alpha' to the entity type 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear and direct mapping of the entity 'RXR' to the entity type 'protein' in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The examples provide clear and direct mappings of the entities 'WT1' to the entity type 'protein' and 'myeloid cell lines' to the entity type 'cell_line' in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The examples provide clear and direct mappings of the entities 'IL-2 receptor alpha subunit' to the entity type 'protein', 'p21ras' to the entity type 'protein', and 'B cell' to the entity type 'cell_type' in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear and direct mapping of the entity 'IgH' to the entity type 'DNA' in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a clear and direct mapping of the entity 'GATA-1' to the entity type 'protein' in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a clear and direct mapping of the entity 'immunoglobulin kappa 3' enhancer' to the entity type 'DNA' in the sentence.\"}\n]",
        "response3": "[{\"globin gene\": \"protein\"}]",
        "prediction": "{'globin gene': 'protein'}"
    },
    {
        "idx": 1133,
        "sentence": "Both LCLs were found by EM to produce RVLP and EBV particles .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\n        \"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5\n    },\n    {\n        \"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4\n    },\n    {\n        \"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA .\": 4\n    },\n    {\n        \"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 5\n    },\n    {\n        \"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4\n    },\n    {\n        \"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4\n    },\n    {\n        \"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5\n    },\n    {\n        \"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4\n    },\n    {\n        \"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4\n    },\n    {\n        \"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5\n    },\n    {\n        \"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5\n    },\n    {\n        \"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5\n    },\n    {\n        \"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 4\n    },\n    {\n        \"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4\n    },\n    {\n        \"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5\n    },\n    {\n        \"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5\n    }\n]",
        "response3": "[{\"RVLP\": \"protein\"}, {\"EBV\": \"cell_line\"}]",
        "prediction": "{'RVLP': 'protein', 'EBV': 'cell_line'}"
    },
    {
        "idx": 1762,
        "sentence": "Taking the IL-2 gene as a candidate, we examined the effect of cysteamine treatment on early gene expression during lymphocyte activation , and on the activity of transcription factors AP-1 , NF-kappa B , NF-AT and Oct1 , whose functions are required for expression of the IL-2 mRNA.",
        "label": {
            "IL-2": "protein",
            "early gene": "DNA",
            "NF-kappa B": "protein",
            "Oct1": "protein",
            "transcription factors": "protein",
            "NF-AT": "protein",
            "AP-1": "protein",
            "IL-2 gene": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 4},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"While the activation of the IL-2 promoter and an NFAT -driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418 , it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2 -mediated NFAT activation is under the control of a combination of calcineurin- dependent and independent pathways.\": 5},\n    {\"Erbstatin and genistein inhibited the sIg-crosslinking-induced Egr-1 mRNA expression in a dose-dependent manner parallel to that observed in the inhibition of sIg-crosslinking-induced protein tyrosine phosphorylation.\": 5},\n    {\"These results suggest that oxidative signals can positively and negatively regulate T cell transcriptional events and that changes in cellular redox can uncouple AP-1 regulation of c-jun from transcriptional up-regulation of IL-2 via NF-AT.\": 5},\n    {\"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.\": 5}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"AP-1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"NF-AT\": \"protein\"}, {\"Oct1\": \"protein\"}]",
        "prediction": "{'IL-2': 'protein', 'AP-1': 'protein', 'NF-kappa B': 'protein', 'NF-AT': 'protein', 'Oct1': 'protein'}"
    },
    {
        "idx": 23,
        "sentence": "Furthermore, a mutant E6 motif lost both in vitro binding activity and in vivo enhancer activity .",
        "label": {
            "mutant E6 motif": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 3},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 4},\n    {\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events .\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 5}\n]",
        "response3": "[{\"E6 motif\": \"protein\"}]",
        "prediction": "{'E6 motif': 'protein'}"
    },
    {
        "idx": 1476,
        "sentence": "Protein phosphorylation has an important role in the regulation of these two factors: (1) it induces the transactivating capacity of the AP-1 protein c-Jun ; and (2) it is involved in the release of the cytoplasmic inhibitor , I kappa B , from NF-kappa B , allowing translocation of the latter into the nucleus .",
        "label": {
            "AP-1 protein": "protein",
            "c-Jun": "protein",
            "I kappa B": "protein",
            "NF-kappa B": "protein",
            "cytoplasmic inhibitor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and cell type names that are directly mentioned.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names that are directly mentioned.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names that are directly mentioned.\"}\n]",
        "response3": "[{\"AP-1\": \"protein\"}, {\"c-Jun\": \"protein\"}, {\"I kappa B\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'AP-1': 'protein', 'c-Jun': 'protein', 'I kappa B': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 234,
        "sentence": "A similar infection with a recombinant retrovirus containing the beta-galactosidase gene with an adenovirus E2 promoter , results in beta-galactosidase activity in a limited number of cultured and primary cells .",
        "label": {
            "cultured": "cell_line",
            "primary cells": "cell_type",
            "adenovirus E2 promoter": "DNA",
            "beta-galactosidase gene": "DNA",
            "beta-galactosidase": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 4},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 4},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1396,
        "sentence": "NF-M ( chicken C/EBP beta ) induces eosinophilic differentiation and apoptosis in a hematopoietic progenitor cell line .",
        "label": {
            "hematopoietic progenitor cell line": "cell_line",
            "NF-M": "protein",
            "chicken C/EBP beta": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example includes protein names and a cell type, which are relevant entities in the sentence, but the cell type is not as directly linked to the main topic.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The example contains protein names and cell types that are mentioned in the sentence, aiding in the extraction of these entities, but the relevance of 'ATL' as a cell type could be less clear.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example provides a specific protein name crucial for understanding the sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example includes a specific protein name that is directly mentioned in the sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example includes specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example provides specific protein names that are directly mentioned in the sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example includes a specific protein name that is directly mentioned in the sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The example contains a protein name and a cell type, which are relevant entities in the sentence, but the cell type is not as directly linked to the main topic.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The example includes protein names and a cell type, which are relevant entities in the sentence, but the cell type is not as directly linked to the main topic.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example provides a specific protein name crucial for understanding the sentence, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 13\": 3\n    },\n    {\n        \"Reason 13\": \"The example includes a DNA entity, which is not directly relevant to the main topic of protein and cell types in the sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example includes a specific protein name that is directly mentioned in the sentence, aiding in the extraction of protein entities.\"\n    }\n]",
        "response3": "[{\"NF-M\": \"protein\"}, {\"C/EBP beta\": \"protein\"}]",
        "prediction": "{'NF-M': 'protein', 'C/EBP beta': 'protein'}"
    },
    {
        "idx": 1812,
        "sentence": "The protein shows significant sequence similarities to the family of G-protein coupled chemokine receptors and turned out to be identical to the recently described receptor EBI1 .",
        "label": {
            "G-protein coupled chemokine receptors": "protein",
            "chemokine receptors": "protein",
            "G-protein": "protein",
            "receptor EBI1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"EBV\": 4},\n    {\"B-cell\": 4},\n    {\"retinoic acid receptor alpha\": 3},\n    {\"Protein\": 3},\n    {\"MIP-1 alpha\": 4},\n    {\"GOS19\": 4},\n    {\"LD78\": 4},\n    {\"AT464\": 4},\n    {\"EBNA-2\": 5},\n    {\"PU.1\": 5},\n    {\"CREB\": 5},\n    {\"AR-CRE\": 4},\n    {\"Egr-1\": 4},\n    {\"E2A\": 4},\n    {\"GM-CSF\": 4},\n    {\"protein\": 3},\n    {\"EKLF\": 5},\n    {\"CBP\": 5},\n    {\"p300\": 5},\n    {\"P/CAF\": 5},\n    {\"TP1\": 4},\n    {\"c-kit\": 4},\n    {\"IL-4R alpha chain\": 4},\n    {\"interleukin 10\": 4},\n    {\"IL-10R\": 4},\n    {\"STAT3\": 4},\n    {\"IL-6\": 4},\n    {\"GATA-1\": 4},\n    {\"IL4\": 4},\n    {\"IL13\": 4},\n    {\"STAT6\": 4},\n    {\"STAT5\": 4},\n    {\"B cells\": 4}\n]",
        "response3": "[{\"G-protein coupled chemokine receptors\": \"protein\"}, {\"EBI1\": \"protein\"}]",
        "prediction": "{'G-protein coupled chemokine receptors': 'protein', 'EBI1': 'protein'}"
    },
    {
        "idx": 1099,
        "sentence": "Interestingly, microtubule disruption also decreased monocyte 1,25(OH)2D3 synthesis , not by decreasing the Vmax of monocyte mitochondrial 1 alpha-hydroxylase but through an increase in the Km for 25(OH)2D3 .",
        "label": {
            "monocyte mitochondrial 1 alpha-hydroxylase": "protein",
            "monocyte": "cell_type",
            "microtubule": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (Bak, Bad, Bcl-2) which are directly mentioned in the sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein (NF-E2) which is directly related to the entity label.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence mentions specific RNA (MNDA) and cell line (myeloid cell lines) entities, but the context is not as direct as in other examples.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence directly mentions specific protein (PKC isoforms) and cell types (human alveolar macrophages, blood monocytes).\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence directly mentions specific cell types (granulocytes, T cells) which are relevant to the entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence directly mentions specific cell lines (SIVmacMER, SIVmac239, CEMx174) which are relevant to the entity labels.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a specific protein (alpha-tocopherol) and cell types (monocyte, endothelial cells) which are relevant to the entity labels.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions specific protein (TIMP-1) and DNA entities, but the context is not as direct as in other examples.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions specific proteins (STAT, STAT3) and cell types (T cells) which are relevant to the entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly mentions specific cell line (MTHC), proteins (TNF-alpha, IFN-gamma), and cell type (DC) which are relevant to the entity labels.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions a specific protein (CD14) which is directly related to the entity label.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions a specific protein (P selectin) which is directly related to the entity label.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence directly mentions specific proteins (PU.1, M-CSF receptor) and cell type (macrophage) which are relevant to the entity labels.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions a specific protein (retinoic acid receptor alpha) which is directly related to the entity label.\"},\n    {\"Example 15\": 3},\n    {\"Reason 15\": \"The sentence mentions a specific DNA entity (NF-kappa B), but the context is not as direct as in other examples.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1537,
        "sentence": "Furthermore, we identified a repression domain at the N-terminus of Oct-2a .",
        "label": {
            "Oct-2a": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 4},\n{\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n{\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n{\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n{\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n{\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n{\"Our results demonstrate that the altered CCAAT box ( CCAAC ) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n{\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n{\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n{\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5}\n]",
        "response3": "[{\"Oct-2a\": \"protein\"}]",
        "prediction": "{'Oct-2a': 'protein'}"
    },
    {
        "idx": 1574,
        "sentence": "CONCLUSIONS: Sexual hormones , through their receptors , may influence the activity of eosinophils in patients with VKC .",
        "label": {
            "receptors": "protein",
            "eosinophils": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 3},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"We evaluated the immunoreactivity of the regulatory and catalytic subunits of cAMP-dependent protein kinase (protein kinase A) and 1 of its substrates, Rap1, in platelets from untreated euthymic, manic, and depressed patients with bipolar disorder and healthy subjects.\": 4},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 3},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"In that context, the results also change the current scheme for asthma pathogenesis to one that must include a localized gain in transcriptional signal ordinarily used for a T helper 1-type cytokine (IFN-gamma) in combination with allergy-driven overproduction of T helper 2-type cytokines.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer (kappa E3') activity is the result of the combined influence of positive- and negative-acting elements.\": 3},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 4},\n    {\"To study the regulatory mechanism of gp91phox gene expression in eosinophils, we transiently transfected eosinophil-committed HL-60-C15 cells with gp91phox promoter constructs, and identified a negative element from bp -267 to -246 of the gp91phox gene, the deletion of which caused an 83% increase in promoter activity.\": 4},\n    {\"This phenomenon is mediated, in part, through inducible expression of the CXC chemokine, interleukin-8 (IL-8).\": 4}\n]",
        "response3": "[{\"eosinophils\": \"cell_type\"}, {\"sexual hormones\": \"protein\"}, {\"receptors\": \"protein\"}]",
        "prediction": "{'eosinophils': 'cell_type', 'sexual hormones': 'protein', 'receptors': 'protein'}"
    },
    {
        "idx": 1312,
        "sentence": "A solution structure for the non-sequence-specific C-terminal HMG box of HMG-1 has recently been proposed.",
        "label": {
            "HMG-1": "protein",
            "C-terminal HMG box": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity 'SCM-1' and its association with the entity type 'cell_line', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains specific mentions of 'CCAAT box' and 'EKLF binding site' which are associated with the entity types 'DNA' and 'protein' respectively, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence directly refers to 'GM-CSF' as a protein, providing a clear association between the entity and its entity type, thus aiding in named entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions 'IL-2', 'c-Jun', and 'c-Fos' as proteins, providing explicit references to these entities and their entity types, making it highly helpful for named entity extraction.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type, aiding in the extraction of named entities by providing a specific entity type association.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions 'Protein' as an entity type, which is associated with the entity type 'protein', aiding in the extraction of named entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear mentions of 'IL-7R' and 'gamma(c)' as proteins, establishing a direct link between the entities and their entity types, making it highly helpful for named entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions 'c-kit' and 'IL-4R alpha chain' as proteins, aiding in the extraction of named entities by providing explicit references to these entities and their entity types.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence mentions 'Oct-2A', 'HMG I/Y', 'HLA-DRA', and 'B cells' with their respective entity types, providing clear associations and aiding in named entity extraction.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions 'retinoic acid receptor alpha' as a protein, aiding in the extraction of named entities by providing a specific entity type association.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions 'CHEMR1', 'C-C chemokine', and 'MIP-1alpha' as proteins, providing explicit references to these entities and their entity types, making it highly helpful for named entity extraction.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions 'TCF-1' as a protein, aiding in the extraction of named entities by providing a specific entity type association.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'DNA' in the context of 'DNA binding activity', aiding in the extraction of named entities by providing a specific entity type association.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions 'SLAP-130', 'SLP-76', and 'T cell' with their respective entity types, providing clear associations and aiding in named entity extraction.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions 'ZAP-70' as a protein, aiding in the extraction of named entities by providing a specific entity type association.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The sentence mentions 'cDNAs' as DNA, aiding in the extraction of named entities by providing a specific entity type association.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 601,
        "sentence": "To determine whether enhancer elements in addition to the highly conserved octamer (OCTA)-nucleotide motif are important for lymphoid-specific expression of the immunoglobulin heavy-chain (IgH) gene , we have investigated the effect of mutating the binding site for a putative additional lymphoid-specific transcription factor , designated NF-microB , in the murine IgH enhancer .",
        "label": {
            "murine IgH enhancer": "DNA",
            "putative additional lymphoid-specific transcription factor": "protein",
            "octamer (OCTA)-nucleotide motif": "DNA",
            "NF-microB": "protein",
            "enhancer elements": "DNA",
            "immunoglobulin heavy-chain (IgH) gene": "DNA",
            "binding site": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'NF-E2' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example covers multiple entities and their corresponding labels in the sentence, providing a comprehensive mapping.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The example identifies the entity 'IL-2' and its label 'protein' in the sentence, aiding in entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example includes multiple entities and their labels, offering valuable information for entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example directly links the entity 'Egr-1' to its label 'protein' in the sentence, facilitating entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example highlights the entity 'IL-4' and its label 'protein' in the sentence, contributing to entity extraction.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example covers entities 'T cell' and 'interleukin 2' with their respective labels, aiding in entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a detailed mapping of entities 'IL-2', 'c-Jun', and 'c-Fos' to their labels, supporting entity extraction.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example correctly identifies the entity 'Th2-type lymphocytes' and its label 'cell_type' in the sentence, enhancing entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example accurately links the entity 'IgH' to its label 'DNA' in the sentence, aiding in entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example correctly identifies the entity 'immunoglobulin kappa 3' enhancer' and its label 'DNA' in the sentence, supporting entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example covers entities 'c-kit' and 'IL-4R alpha chain' with their respective labels, aiding in entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear mapping of the entity 'NF-kappa B' to its label 'protein' in the sentence, facilitating entity extraction.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example includes multiple entities and their labels, offering valuable information for entity extraction.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example covers multiple entities and their corresponding labels in the sentence, providing a comprehensive mapping.\"}\n]",
        "response3": "[{'IgH': 'DNA'}, {'NF-microB': 'protein'}]",
        "prediction": "{'IgH': 'DNA', 'NF-microB': 'protein'}"
    },
    {
        "idx": 890,
        "sentence": "Treatment of 10 with warm HCl furnished 19-chloro-4,21-dihydroxypregna-4,9(11)-diene-3,20-dione (13).",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 3},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"This hybrid clone, designated NR2, was characterized by several methods, including PCR, with eight pairs of oligonucleotides mapped to Chr 20: D20S5, D20S41, D20S42, D20S56, D20S57, D20S58, adenosine deaminase (ADA), and Prion protein (PRIP); Restriction Fragment Length Polymorphism (RFLP) analyses with four genomic anonymous probes (D20S5, cD3H12, D20S17, D20S18); and fluorescent in situ hybridization (FISH) with total human DNA and D20Z1, a sequence specific to the human Chr 20 centromere, as probes.\": 5},\n    {\"Treatment with soluble, bivalent mAb J393 killed 25-50% of the cell population, while concomitant engagement of either the CD3.TcR complex or the integrins CD18 and CD29 significantly potentiated this effect.\": 5},\n    {\"Combined treatment of HPCs with alpha-PML and alpha-Rb oligomers inhibited both PML and Rb protein expression and completely blocked erythroid colony development.\": 5},\n    {\"When 18C7 was incubated with MR before aldosterone or progesterone, the antibody inhibited 75-80% of the binding.\": 5},\n    {\"A 3-bp mutation at the distal Sp1-binding site not only eliminates Sp1 interaction, but also abolishes most of the VitD3 induction of CD14 expression.\": 5},\n    {\"CONCLUSION: Our results show that the tested agents (except indomethacin) are inhibitors of the T cell-mediated immune response, as expected, that aspirin is an effective suppressor of adhesion molecule expression, and that all three agents can induce Hsp60 in HUVECs.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 323,
        "sentence": "The Epstein-Barr virus ( EBV ) ORI1yt enhancer is not B-cell specific and does not respond synergistically to the EBV transcription factors R and Z .",
        "label": {
            "Epstein-Barr virus ( EBV ) ORI1yt enhancer": "DNA"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (Egr-1) being mentioned, which matches one of the entity labels in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence mentions both DNA (hepatitis B virus) and protein (HBxAg), which are entity labels present in the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a protein (RXR) which matches one of the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides multiple examples of proteins (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) which match the entity labels in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence mentions multiple proteins (NF-kappaB, Sp1, p50) which match the entity labels in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions both a protein (EBNA2) and a cell line (TP1), which are entity labels present in the target sentence.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a cell type (T cell) and a protein (interleukin 2), which match the entity labels in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions a protein (IL-2) which matches one of the entity labels in the target sentence.\"},\n    {\"Example 9\": 3},\n    {\"Reason 9\": \"The sentence mentions a DNA (AP-1) which matches one of the entity labels in the target sentence, but the relevance to named entity extraction is not as direct.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions multiple proteins (NF-kB, AP-1, OCT-1, NF-IL-2B) which match the entity labels in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions a cell line (EBV) and a protein (CD2), which are entity labels present in the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions a cell type (CD4+) and a protein (EBV), which match the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions both proteins (EBNA-2, PU.1) which are entity labels present in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence mentions a cell line (B cell) and a cell type (B-cell), which match the entity labels in the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions a protein (GATA-1) which matches one of the entity labels in the target sentence.\"}\n]",
        "response3": "[{'Epstein-Barr virus (EBV)': 'cell_line'}, {'R': 'protein'}, {'Z': 'protein'}]",
        "prediction": "{'Epstein-Barr virus (EBV)': 'cell_line', 'R': 'protein', 'Z': 'protein'}"
    },
    {
        "idx": 929,
        "sentence": "The cDNA sequence has an 813-bp open reading frame ( ORF ) whose predicted amino acid sequence is 97.6% identical to the 272 carboxy-terminal amino acids of the human ets-1 protein .",
        "label": {
            "ORF": "DNA",
            "272 carboxy-terminal amino acids": "protein",
            "ets-1": "protein",
            "human ets-1 protein": "protein",
            "813-bp open reading frame": "DNA",
            "cDNA sequence": "DNA",
            "amino acid sequence": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n    {\"This protein has now been purified and its encoding gene cloned.\": 4},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 5},\n    {\"Site-directed mutational studies demonstrate that Site I and Site IV together support ATF1- and CREB-induced trans-activation of the H4 promoter.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5}\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"ets-1 protein\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'ets-1 protein': 'protein'}"
    },
    {
        "idx": 6,
        "sentence": "Platelet-activating factor induces phospholipid turnover , calcium flux , arachidonic acid liberation , eicosanoid generation , and oncogene expression in a human B cell line .",
        "label": {
            "Platelet-activating factor": "protein",
            "oncogene": "DNA",
            "human B cell line": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains specific protein names and cell types that are directly mentioned, making it highly relevant for extracting named entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence mentions a specific protein name, NF-kappa B, which is directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence contains multiple protein names, cell types, and signaling molecules that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence mentions specific protein names and signaling molecules that are directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence contains specific protein names that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The sentence mentions a specific protein name, NF-E2, which is directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence contains multiple protein names and signaling molecules that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The sentence mentions a specific protein name, P selectin, which is directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence contains specific protein names that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence contains specific protein names, cell types, and signaling molecules that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The sentence mentions a specific protein name, NF-kappaB, which is directly related to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence contains specific protein names and signaling molecules that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence contains specific protein names that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence contains specific protein names, cell types, and signaling molecules that are directly relevant to the entity types in the target sentence.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The sentence mentions a specific protein name, NF-kappa B, which is directly related to the entity types in the target sentence.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1478,
        "sentence": "Furthermore, in activated T cells , the kinetics of the two phosphorylation events are essentially similar.",
        "label": {
            "activated T cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 3},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1793,
        "sentence": "The clinical benefits of salicylates in the treatment of several diseases, including atherosclerosis and rheumatoid arthritis , may be related to their ability to reduce monocyte gene expression .",
        "label": {},
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"We have examined the effect of alpha-tocopherol ( alpha-tcp ) on one cellular event in atherosclerotic plaque development , monocyte adhesion to stimulated endothelial cells ( ECs ).\": 5},\n    {\"An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models.\": 5},\n    {\"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.\": 5},\n    {\"Eosinophils play an important role in the effector phase of allergic inflammation.\": 5},\n    {\"The role of the transcription factor NF-kappaB in the pathogenesis of rheumatoid arthritis has long been a subject of controversy.\": 5},\n    {\"IL-13 , a cytokine similar to IL-4 , is a regulator of human B cell and monocyte functions.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4}\n]",
        "response3": "[{\"salicylates\": \"protein\"}, {\"atherosclerosis\": \"cell_type\"}, {\"rheumatoid arthritis\": \"cell_type\"}, {\"monocyte\": \"cell_type\"}]",
        "prediction": "{'salicylates': 'protein', 'atherosclerosis': 'cell_type', 'rheumatoid arthritis': 'cell_type', 'monocyte': 'cell_type'}"
    },
    {
        "idx": 1473,
        "sentence": "Costimulation requirement for AP-1 and NF-kappa B transcription factor activation in T cells .",
        "label": {
            "NF-kappa B": "protein",
            "T cells": "cell_type",
            "AP-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"AP-1\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"T cells\": \"cell_type\"}]",
        "prediction": "{'AP-1': 'protein', 'NF-kappa B': 'protein', 'T cells': 'cell_type'}"
    },
    {
        "idx": 539,
        "sentence": "PMA enhanced slightly the stimulatory effect of PHA .",
        "label": {
            "PHA": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (NF-kappa B, AP-1) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence contains a specific protein name (NF-E2) that is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names (AP-1, PMA) and cell types (monocytes, macrophages) that are directly mentioned and can be easily identified as protein and cell type entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names (PAFR, PAF, NF-kappa B, protein kinase C) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (IL-2, NF-kappa B, AP-1) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains a specific protein name (MNDA) and a specific cell line name (Philadelphia chromosome-positive chronic myeloid leukemia) that are directly mentioned and can be easily identified as protein and cell line entities.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names (Oct-2A, HMG I/Y, HLA-DRA) and a cell type (B cells) that are directly mentioned and can be easily identified as protein and cell type entities.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence contains a specific protein name (NF-kappa B) that is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence contains a specific protein name (P selectin) that is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence contains a specific protein name (phosphocreatine) that is directly mentioned and can be easily identified as a protein entity.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence contains specific protein names (NDP kinase) and cell type names (KA, SCC, BCC) that are directly mentioned and can be easily identified as protein and cell type entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names (CD14, CD23) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names (IL-4, LPS, AP-1) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific protein names (Epo, alpha-globin, beta-globin, haemoglobin, haemin, delta-ALA) that are directly mentioned and can be easily identified as protein entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains specific protein names (PMA, IFN-gamma) and a cell type (T cell blasts) that are directly mentioned and can be easily identified as protein and cell type entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1025,
        "sentence": "NK cells do not express NFATc constitutively, but NFATc mRNA accumulation is induced in these cells within 2 h of stimulation with CD16 ligands .",
        "label": {
            "NFATc": "protein",
            "NK cells": "cell_type",
            "NFATc mRNA": "RNA"
        },
        "response1": "['RNA', 'cell_type']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 4\n    },\n    {\n        \"Reason 1\": \"The sentence provides clear information about the entity 'NF-kappa B' and its association with gene expression in neutrophils.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence contains multiple entities with clear associations to their respective entity types, such as 'NF-ATc' with 'protein', 'T lymphocytes' and 'embryonic cardiac cells' with 'cell_type'.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence provides a variety of entities related to proteins and their expressions, along with stimuli like 'phytohemagglutinin' and 'phorbol myristate acetate'.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence contains multiple protein entities and stimuli associated with protein expression, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Reason 5\": \"The sentence clearly mentions 'NF-kappa B' and its association with DNA binding activity, providing valuable information for entity extraction.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence provides information about the entities 'NF-kappa B' and 'I kappa B alpha' and their relationship in controlling gene expression.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The sentence contains various protein entities and their associations with cellular stimuli, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence provides information about the entities 'RelA' and 'NF-kappa B' and their abnormality in T cells, aiding in entity extraction.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence contains protein entities like 'FasL', 'IL-2', and 'IFN-gamma' along with their expressions and triggers, aiding in named entity extraction.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence provides information about the entities 'NF-ATc' and 'T lymphocytes' and their synthesis, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence contains entities 'NF-kappa B' and 'I kappa B alpha' and their activation mechanisms, aiding in named entity extraction.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence provides information about the entities 'CD40' and 'NF-kappa B' and their signaling determinants, aiding in named entity extraction.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence contains entities 'NF-kappaB', 'Tax', and 'ATL' with their associations, aiding in named entity extraction.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence provides information about the entities 'STAT', 'STAT3', and 'T cells' and their expressions, aiding in named entity extraction.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence contains entities 'IkappaBbeta' and 'NF-kappaB' and their inactivation mechanisms, aiding in named entity extraction.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence provides information about various protein entities and their associations with signal transduction events, aiding in named entity extraction.\"\n    }\n]\n```",
        "response3": "```json\n[{\"NFATc\": \"protein\"}, {\"NFATc mRNA\": \"RNA\"}, {\"NK cells\": \"cell_type\"}, {\"CD16 ligands\": \"protein\"}]\n```",
        "prediction": "{'NFATc': 'protein', 'NFATc mRNA': 'RNA', 'NK cells': 'cell_type', 'CD16 ligands': 'protein'}"
    },
    {
        "idx": 1560,
        "sentence": "Moreover, in human T helper (Th) clones functionally characterized as being of the type 0, type 1 and type 2 (28%, < 1% und 93% CD30+, respectively), the extent of CD30 -mediated NF-kappa B activation correlated with the proportion of CD30+ cells .",
        "label": {
            "human T helper (Th) clones": "cell_line",
            "CD30+ cells": "cell_line",
            "CD30": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 4},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5}\n]",
        "response3": "[{\"Th\": \"cell_type\"}, {\"CD30\": \"protein\"}, {\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'Th': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 365,
        "sentence": "Run-on analysis demonstrated detectable levels of c-jun gene transcription in untreated HL-60 cells , and that exposure to TPA increases this rate 3.3-fold.",
        "label": {
            "c-jun": "DNA",
            "HL-60 cells": "cell_line",
            "untreated HL-60 cells": "cell_line"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "```json\n[\n    {\"TIMP-1\": 5},\n    {\"DNA\": 4},\n    {\"TCL1\": 5},\n    {\"p21(WAF1/CIP1)\": 5},\n    {\"p27(KIP1)\": 5},\n    {\"ZAP-70\": 5},\n    {\"IL-2\": 4},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"AP-1\": 4},\n    {\"NF-kappaB\": 5},\n    {\"Tax\": 3},\n    {\"ATL\": 3},\n    {\"IFN A\": 4},\n    {\"IFNA\": 4},\n    {\"interleukin-2\": 4},\n    {\"interleukin-2 receptor\": 4},\n    {\"phytohemagglutinin\": 4},\n    {\"phorbol myristate acetate\": 4},\n    {\"TAL1\": 5},\n    {\"PML/RARalpha\": 5},\n    {\"B and T cell activation\": 4},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 4},\n    {\"Tip\": 5},\n    {\"Tap\": 5},\n    {\"Jurkat-T cells\": 5},\n    {\"tal-1\": 5},\n    {\"GATA-binding proteins\": 5},\n    {\"hematopoiesis\": 4},\n    {\"AP-1\": 4},\n    {\"c-jun\": 5},\n    {\"IL-2\": 4},\n    {\"NF-AT\": 5},\n    {\"T cell\": 4},\n    {\"nuclear factor-kappa B\": 4},\n    {\"NF-kappa B\": 4},\n    {\"TCL1\": 5},\n    {\"MTCP1/c6.1B\": 5}\n]\n```",
        "response3": "```json\n[{\"c-jun\": \"protein\"}, {\"HL-60 cells\": \"cell_line\"}, {\"TPA\": \"protein\"}]\n```",
        "prediction": "{'c-jun': 'protein', 'HL-60 cells': 'cell_line', 'TPA': 'protein'}"
    },
    {
        "idx": 1039,
        "sentence": "Peripheral blood mononuclear cells ( pbmc ) and bone marrow cells of 26 patients were examined for c-fos , c-myc , p53 and the hybrid bcr/abl mRNA levels .",
        "label": {
            "Peripheral blood mononuclear cells": "cell_type",
            "pbmc": "cell_type",
            "bone marrow cells": "cell_type"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"However, like normal Ter 119 erythroid cells, these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells (Daudi) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5},\n    {\"These results indicate that the monocyte/B-cell-specific transcription factor PU.1 and the Mono A and Mono B protein complexes act in concert to regulate monocyte-specific transcription of the CSF-1 receptor.\": 5}\n]",
        "response3": "[{\"Peripheral blood mononuclear cells\": \"cell_type\"}, {\"bone marrow cells\": \"cell_type\"}, {\"c-fos\": \"protein\"}, {\"c-myc\": \"protein\"}, {\"p53\": \"protein\"}, {\"hybrid bcr/abl mRNA\": \"RNA\"}]",
        "prediction": "{'Peripheral blood mononuclear cells': 'cell_type', 'bone marrow cells': 'cell_type', 'c-fos': 'protein', 'c-myc': 'protein', 'p53': 'protein', 'hybrid bcr/abl mRNA': 'RNA'}"
    },
    {
        "idx": 217,
        "sentence": "Quantitation of glucocorticoid receptors ( GCR ) and the study of their affinity for glucocorticosteroids ( GCS ) were made in peripheral blood lymphocytes of bronchial asthma ( BA ) patients in consideration of GCR treatment and serum levels of endogenous cortisol .",
        "label": {
            "GCR": "protein",
            "glucocorticoid receptors": "protein",
            "peripheral blood lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"phosphocreatine\": 3},\n    {\"G-CSF\": 4},\n    {\"IL4\": 5},\n    {\"IL13\": 5},\n    {\"STAT6\": 5},\n    {\"STAT3\": 5},\n    {\"STAT5\": 5},\n    {\"B cells\": 5},\n    {\"IL-5 mRNA\": 4},\n    {\"TCR\": 4},\n    {\"IL-2R\": 4},\n    {\"dexamethasone\": 4},\n    {\"HML\": 5},\n    {\"dexamethasone\": 4},\n    {\"cortisol\": 4},\n    {\"lysozyme\": 4},\n    {\"IL-7R\": 5},\n    {\"gamma(c)\": 5},\n    {\"E2A\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"IFN-gamma\": 5},\n    {\"IL-2\": 4},\n    {\"IFN-gamma\": 5},\n    {\"jak kinases\": 5},\n    {\"STAT1(alpha)\": 5},\n    {\"cAMP-dependent protein kinase\": 5},\n    {\"Rap1\": 5},\n    {\"TCRzeta\": 5},\n    {\"p56(lck)\": 5},\n    {\"GATA-1\": 5},\n    {\"VDR\": 5},\n    {\"RXR\": 5},\n    {\"GRIP-1\": 5},\n    {\"DRIP205\": 5},\n    {\"DRIP\": 4},\n    {\"B and T cell activation\": 5},\n    {\"Ramos\": 5},\n    {\"Jurkat\": 5},\n    {\"cDNA microarray technology\": 3},\n    {\"CD40\": 5},\n    {\"Rel/nuclear factor kappaB\": 5},\n    {\"NF-kappaB\": 5},\n    {\"B lymphocytes\": 5}\n]",
        "response3": "[{\"GCR\": \"protein\"}, {\"GCS\": \"protein\"}, {\"BA\": \"cell_type\"}]",
        "prediction": "{'GCR': 'protein', 'GCS': 'protein', 'BA': 'cell_type'}"
    },
    {
        "idx": 1782,
        "sentence": "In addition, resting PBL constitutively expressed prominent levels of Id2 mRNA , but not Id3 mRNA .",
        "label": {
            "Id3": "protein",
            "resting PBL": "cell_type",
            "Id3 mRNA": "RNA",
            "PBL": "cell_type",
            "Id2": "protein",
            "Id2 mRNA": "RNA"
        },
        "response1": "['RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains multiple instances of named entities such as IL-2, c-Jun, and c-Fos proteins, which are directly mentioned and can be easily identified.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence includes named entities like CD70 protein, B cell, plasma cells, IL-4 protein, and CD40 protein, which are relevant and can be extracted with some context.\"},\n    {\"Example 3\": 3},\n    {\"Reason 3\": \"The sentence mentions the E2A protein, which is a named entity, but the context is slightly more complex compared to other examples.\"},\n    {\"Example 4\": 2},\n    {\"Reason 4\": \"The sentence mentions EBV as a cell line and CD2 as a protein, but the context is not as straightforward for extraction.\"},\n    {\"Example 5\": 3},\n    {\"Reason 5\": \"The sentence mentions IL-4 protein, but the context is more focused on gene expression rather than direct entity identification.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains multiple instances of named entities like IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate proteins, which are directly mentioned and can be easily identified.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions TCL1 protein, but the context is more specific to a particular type of tumor.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence includes named entities like STAT and STAT3 proteins, as well as T cells as a cell type, which are relevant and can be extracted with some context.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence mentions IL-4, LPS, and AP-1 proteins, which are directly related to the context and can be identified with some effort.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions RelA and NF-kappaB1 proteins, which are directly related to the context and can be identified with some effort.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions CD4+ cell type and EBV protein, but the context is more focused on correlation rather than direct entity identification.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence includes named entities like IL-12 protein, STAT4 protein, NK cells, T cells, and IL-12 receptor protein, which are relevant and can be extracted with some context.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions CD14 and CD23 proteins, which are directly related to the context and can be identified with some effort.\"},\n    {\"Example 14\": 3},\n    {\"Reason 14\": \"The sentence mentions p50p50 protein, but the context is slightly more complex compared to other examples.\"},\n]",
        "response3": "[{'Id2 mRNA': 'RNA'}, {'Id3 mRNA': 'RNA'}]",
        "prediction": "{'Id2 mRNA': 'RNA', 'Id3 mRNA': 'RNA'}"
    },
    {
        "idx": 1280,
        "sentence": "Sequence analysis of the 5'-flanking region of the CD69 gene revealed the presence of a potential TATA element 30 base pairs upstream of the major transcription initiation site and several putative binding sequences for inducible transcription factors ( NF-kappa B , Egr-1 , AP-1 ), which might mediate the inducible expression of this gene.",
        "label": {
            "NF-kappa B": "protein",
            "TATA element": "DNA",
            "transcription factors": "protein",
            "CD69": "protein",
            "AP-1": "protein",
            "30 base pairs upstream": "DNA",
            "CD69 gene": "DNA",
            "5'-flanking region": "DNA",
            "transcription initiation site": "DNA",
            "Egr-1": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif\": 4},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region\": 5},\n    {\"These properties suggest that TAFII105 is a cell type-specific subunit of TFIID that may be responsible for mediating transcription by a subset of activators in B cells\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B\": 5},\n    {\"This sequence element was referred to as the BAT box and its deletion significantly reduced the activity of a CD20 promoter-CAT construct in B cells\": 5}\n]",
        "response3": "[{\"CD69 gene\": \"protein\"}, {\"TATA element\": \"DNA\"}, {\"NF-kappa B\": \"protein\"}, {\"Egr-1\": \"protein\"}, {\"AP-1\": \"protein\"}]",
        "prediction": "{'CD69 gene': 'protein', 'TATA element': 'DNA', 'NF-kappa B': 'protein', 'Egr-1': 'protein', 'AP-1': 'protein'}"
    },
    {
        "idx": 611,
        "sentence": "Transactivation by some DNA viruses has been implicated in inducing HIV-1 replication and pathogenesis.",
        "label": {},
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"DNA viruses\": \"DNA\"}, {\"HIV-1\": \"cell_type\"}]",
        "prediction": "{'DNA viruses': 'DNA', 'HIV-1': 'cell_type'}"
    },
    {
        "idx": 1723,
        "sentence": "In vitro treatment of a monocyte/macrophage cell line with CCl4 led to enhanced NF-kappa B binding and an increase in tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA levels .",
        "label": {
            "tumor necrosis factor-alpha ( TNF-alpha ) messenger RNA": "RNA",
            "NF-kappa B": "protein",
            "tumor necrosis factor-alpha": "protein",
            "TNF-alpha": "protein"
        },
        "response1": "['cell_line', 'protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 4},\n    {\"Example 3\": 4},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 3},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4},\n    {\"Example 16\": 4}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"TNF-alpha\": \"protein\"}, {\"messenger RNA\": \"RNA\"}, {\"monocyte/macrophage cell line\": \"cell_line\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'TNF-alpha': 'protein', 'messenger RNA': 'RNA', 'monocyte/macrophage cell line': 'cell_line'}"
    },
    {
        "idx": 1308,
        "sentence": "Two groups of HMG box proteins are distinguished.",
        "label": {
            "HMG box proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 4},\n    {\"Sentence 3\": 4},\n    {\"Sentence 4\": 5},\n    {\"Sentence 5\": 5},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[{\"HMG box proteins\": \"protein\"}]",
        "prediction": "{'HMG box proteins': 'protein'}"
    },
    {
        "idx": 765,
        "sentence": "Our results suggest that substances in serum influence steroid effects on these cells and that the molecular details of glucocorticoid hormone action may be pursued more precisely in a clearly defined culture medium.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"nonhuman primates\": 5},\n    {\"cell adhesion molecules\": 5},\n    {\"G-CSF\": 5},\n    {\"CD70\": 5},\n    {\"B cell\": 5},\n    {\"plasma cells\": 5},\n    {\"IL-4\": 5},\n    {\"CD40\": 5},\n    {\"E2A\": 5},\n    {\"NF-E2\": 5},\n    {\"IL-5 mRNA\": 5},\n    {\"TCR\": 5},\n    {\"IL-2R\": 5},\n    {\"dexamethasone\": 5},\n    {\"granulocytes\": 5},\n    {\"T cells\": 5},\n    {\"IL-4\": 5},\n    {\"IL-2\": 5},\n    {\"c-Jun\": 5},\n    {\"c-Fos\": 5},\n    {\"phosphocreatine\": 5},\n    {\"HML\": 5},\n    {\"IFN-gamma\": 5},\n    {\"NF-kappa B\": 5},\n    {\"VDR\": 5},\n    {\"RXR\": 5},\n    {\"GRIP-1\": 5},\n    {\"DRIP205\": 5},\n    {\"DRIP\": 5},\n    {\"CD40\": 5},\n    {\"Rel/nuclear factor kappaB\": 5},\n    {\"NF-kappaB\": 5},\n    {\"B lymphocytes\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1561,
        "sentence": "In all cell lines investigated, the NF-kappa B complexes induced following CD30 engagement were shown to contain p50 NF-kappa B1 , p65 RelA , and possibly other transcription factors .",
        "label": {
            "CD30": "protein",
            "NF-kappa B complexes": "protein",
            "p65 RelA": "protein",
            "p50 NF-kappa B1": "protein",
            "NF-kappa B": "protein",
            "transcription factors": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 4},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 4},\n    {\"Sentence 5\": 4},\n    {\"Sentence 6\": 4},\n    {\"Sentence 7\": 4},\n    {\"Sentence 8\": 4},\n    {\"Sentence 9\": 3},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 5},\n    {\"Sentence 12\": 4},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 4},\n    {\"Sentence 15\": 4}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"p50 NF-kappa B1\": \"protein\"}, {\"p65 RelA\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'p50 NF-kappa B1': 'protein', 'p65 RelA': 'protein'}"
    },
    {
        "idx": 330,
        "sentence": "ZRE-B is therefore not part of the R- inducible enhancer .",
        "label": {
            "ZRE-B": "DNA",
            "R- inducible enhancer": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains specific references to CD4+ cell counts and anti-EBV antibody titres, which are clear indicators of cell_type and protein entities respectively.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The sentence mentions T cell and interleukin 2, which are indicative of cell_type and protein entities respectively.\"\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Reason 3\": \"The sentence directly mentions ZEBRA, which is a protein entity, aiding in its extraction.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The sentence contains a reference to IL-2, which is a protein entity, facilitating its identification.\"\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Reason 5\": \"The sentence includes MNDA mRNA and myeloid cell lines, indicating RNA and cell_line entities respectively.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The sentence mentions Egr-1, a zinc finger transcription factor, which is a protein entity.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The sentence refers to CCAAT box as DNA and EKLF binding site as protein, aiding in their extraction.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The sentence mentions RXR, a protein entity, which can be easily identified.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence contains references to RelA and NF-kappaB1, both protein entities, aiding in their extraction.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The sentence mentions immunoglobulin kappa 3' enhancer, which is a DNA entity, facilitating its identification.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence includes NF-kappaB, Sp1, and p50, all protein entities, aiding in their extraction.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The sentence mentions p50p50, a protein entity, which can be easily identified.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence contains references to RelA and NF-kappa B, both protein entities, aiding in their extraction.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence mentions PC4, OCA-B, and Oct-1, all protein entities, aiding in their extraction.\"\n    },\n    {\n        \"Example 15\": 4\n    },\n    {\n        \"Reason 15\": \"The sentence refers to EKLF, a protein entity, facilitating its identification.\"\n    },\n    {\n        \"Example 16\": 4\n    },\n    {\n        \"Reason 16\": \"The sentence mentions E. coli, dUTP, dUMP, dNTPs, and NTPs, which are indicative of cell_line and DNA entities, aiding in their extraction.\"\n    }\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1104,
        "sentence": "Although the interrelationship between the two messengers Ca2+ and cyclic AMP in platelet function is well documented, its mechanism of action still remains to be established.",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 3},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1594,
        "sentence": "Human IL4 promoter -mediated transcription is downregulated in Jurkat cells stimulated with the NF-kappa B -activating cytokine tumor necrosis factor alpha and suppressed in RelA -overexpressing cells .",
        "label": {
            "Jurkat cells": "cell_line",
            "NF-kappa B -activating cytokine": "protein",
            "Human IL4 promoter": "DNA",
            "tumor necrosis factor alpha": "protein",
            "RelA -overexpressing cells": "cell_line",
            "NF-kappa B": "protein",
            "RelA": "protein"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"Binding of YY1 and Oct1 to a novel element that downregulates expression of IL-5 in human T cells.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 (IL-2) and the alpha chain (CD25) of the IL-2 receptor (IL-2R).\": 5},\n    {\"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells (NFAT) or AP-1 reporters.\": 5}\n]",
        "response3": "[{\"IL4\": \"protein\"}, {\"Jurkat cells\": \"cell_line\"}, {\"NF-kappa B\": \"protein\"}, {\"tumor necrosis factor alpha\": \"protein\"}, {\"RelA\": \"protein\"}]",
        "prediction": "{'IL4': 'protein', 'Jurkat cells': 'cell_line', 'NF-kappa B': 'protein', 'tumor necrosis factor alpha': 'protein', 'RelA': 'protein'}"
    },
    {
        "idx": 1086,
        "sentence": "Analysis of the expression of human I kappa B alpha protein in stable transfectants of mouse 70Z/3 cells shows that, as for the endogenous murine protein, exogenous I kappa B alpha is degraded in response to inducers of NF-kappa B activity , such as phorbol myristate acetate or lipopolysaccharide .",
        "label": {
            "NF-kappa B": "protein",
            "I kappa B alpha": "protein",
            "human I kappa B alpha protein": "protein",
            "mouse 70Z/3 cells": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBalpha' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IkappaBbeta' and 'NF-kappaB' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'RelA' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B beta' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'CD40' and 'NF-kappa B' which are both proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"5\": \"The sentence contains 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' which are all proteins mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'E2A' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' which is a protein mentioned in the target sentence.\"},\n    {\"5\": \"The sentence contains 'NF-kappa B' and 'I kappa B alpha' which are both proteins mentioned in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"},\n    {\"1\": \"The sentence does not contain any of the entity types present in the target sentence.\"}\n]",
        "response3": "[\n    {\"I kappa B alpha\": \"protein\"},\n    {\"mouse 70Z/3 cells\": \"cell_line\"},\n    {\"NF-kappa B\": \"protein\"},\n    {\"phorbol myristate acetate\": \"protein\"},\n    {\"lipopolysaccharide\": \"protein\"}\n]",
        "prediction": "{'I kappa B alpha': 'protein', 'mouse 70Z/3 cells': 'cell_line', 'NF-kappa B': 'protein', 'phorbol myristate acetate': 'protein', 'lipopolysaccharide': 'protein'}"
    },
    {
        "idx": 1,
        "sentence": "When the homeodomain from HB24 was compared to known mammalian and Drosophila homeodomains it was found to be only moderately conserved, but when it was compared to a highly diverged Drosophila homeodomain , H2.0, it was found to be 80% identical.",
        "label": {
            "homeodomain": "DNA",
            "HB24": "DNA",
            "Drosophila homeodomain": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n{\"Both chimeras were found to transactivate model and native promoters at equivalent or better levels than ZEBRA itself.\": 4},\n{\"Like Drosophila Toll, human Toll is a type I transmembrane protein with an extracellular domain consisting of a leucine-rich repeat (LRR) domain, and a cytoplasmic domain homologous to the cytoplasmic domain of the human interleukin (IL)-1 receptor.\": 4},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"Our results demonstrate that the altered CCAAT box (CCAAC) and the lack of an EKLF binding site in delta-globin contribute to its low level of expression in the hAEC model as well.\": 4},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 4},\n{\"These two related genes share the evolutionarily conserved region encoding the Runt domain.\": 4},\n{\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n{\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 4},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n{\"Thus, we were able to derive a hematopoietic cell line, called 47.10, that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1226,
        "sentence": "Lastly, the different mobilities of osteoblast nuclear extract-DNA complexes compared with T-cell nuclear extract-DNA complexes , along with the inability of OSF2 to be upregulated by retinoic acid , unlike the other PEBP2 alpha factors , suggest that OSF2 is a new member of this family of transcription factors .",
        "label": {
            "transcription factors": "protein",
            "T-cell nuclear extract-DNA complexes": "protein",
            "OSF2": "protein",
            "osteoblast nuclear extract-DNA complexes": "protein",
            "PEBP2 alpha factors": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct mention of the entity with its corresponding label, making it highly helpful for named entity extraction.\"}\n]",
        "response3": "[{\"OSF2\": \"protein\"}, {\"PEBP2 alpha factors\": \"protein\"}]",
        "prediction": "{'OSF2': 'protein', 'PEBP2 alpha factors': 'protein'}"
    },
    {
        "idx": 663,
        "sentence": "The cells lines described here should be useful for the delineation of signaling pathways utilized in the selective regulation of gene expression .",
        "label": {},
        "response1": "['cell_line', 'gene expression']",
        "response2": "[\n{\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 5},\n{\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 5},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n{\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 5},\n{\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 5},\n{\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1000,
        "sentence": "Analysis of the biochemical and cell biological properties of these HSFs reveals that HSF3 has properties in common with both HSF1 and HSF2 and yet has features which are distinct from both.",
        "label": {
            "HSF2": "protein",
            "HSF3": "protein",
            "HSFs": "protein",
            "HSF1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 39,
        "sentence": "Most hybrids express both KBF1 and NF-kappa B in their nuclei , but one hybrid expresses only KBF1 .",
        "label": {
            "KBF1": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of named entities with their corresponding entity labels, providing a clear demonstration of how different proteins and DNA are mentioned in the context of NF-kappa B and other factors.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence focuses on the suppression of cytokine and NO generation by Azeptin, with a clear mention of NF-kappa B activation, providing a specific example of protein involvement.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence discusses the binding activities of Sp1, NF-kappaB, and p50, showcasing the interaction between different proteins in a specific context.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence directly links NF-kappa B activation to the enhanced expression of kappa B-responsive genes in phagocytosing neutrophils, providing a clear example of protein involvement.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence explains the mechanism of NF-kappa B activation through the phosphorylation and degradation of I kappa B alpha, highlighting the role of specific proteins in the process.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions the abnormality in kappa B-binding activity in T cells and the induction of RelA in the nucleus, providing a specific example of protein involvement.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence suggests an activation mechanism of NF-kappaB in leukemic cells of ATL patients, indicating the involvement of specific proteins and cell types.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence discusses the synthesis of multiple NF-ATc isoforms in T lymphocytes, providing an example of protein involvement in a specific cell type context.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence investigates the processes involved in persistent activation of NF-kappa B, providing a direct example of protein involvement.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence highlights the expression of NF-ATc in T lymphocytes and embryonic cardiac cells, showcasing the involvement of specific proteins in different cell types.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence mentions the DNA binding activity of NF-kappa B in adherence-isolated monocytes, providing a specific example of DNA involvement.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence discusses the expression of various proteins and their levels in transfected clones, providing specific examples of protein involvement.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence shows the increase in p21(WAF1/CIP1) and p27(KIP1) mRNA and protein in cells, providing specific examples of protein involvement.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence explains how NF-kappa B controls the expression of I kappa B alpha through an autoregulatory pathway, providing a clear example of protein involvement.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions the inhibition of NF-kappa B and AP-1 transcription factors by PNU156804, providing specific examples of protein involvement in the context of inhibition.\"}\n]",
        "response3": "[{'KBF1': 'protein'}, {'NF-kappa B': 'protein'}]",
        "prediction": "{'KBF1': 'protein', 'NF-kappa B': 'protein'}"
    },
    {
        "idx": 229,
        "sentence": "We now show that: 1) CVZ has more than one binding site in a second, independent, B-cell line , IM-9 ; 2) the antiglucocorticoid RU 38486 is able to block both CVZ 's higher and lower affinity sites; 3) all of CVZ 's binding sites are on a protein immunologically indistinguishable from the human GR ; and 4) freshly isolated clones of CVZ -resistant cells have lost all binding sites for CVZ .",
        "label": {
            "B-cell line": "cell_line",
            "IM-9": "cell_line",
            "GR": "protein",
            "CVZ 's binding sites": "protein"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n{\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n{\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 4},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 3},\n{\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n{\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 4},\n{\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n{\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 4},\n{\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release.\": 4},\n{\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n{\"A gst-EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2-PU.1 interaction.\": 5},\n{\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 4},\n{\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 5}\n]",
        "response3": "[{\"CVZ\": \"protein\"}, {\"IM-9\": \"cell_line\"}, {\"RU 38486\": \"protein\"}, {\"human GR\": \"protein\"}]",
        "prediction": "{'CVZ': 'protein', 'IM-9': 'cell_line', 'RU 38486': 'protein', 'human GR': 'protein'}"
    },
    {
        "idx": 743,
        "sentence": "Detection in non-erythroid cells of a factor with the binding characteristics of the erythroid cell transcription factor EF1 .",
        "label": {
            "erythroid cell transcription factor": "protein",
            "non-erythroid cells": "cell_type",
            "EF1": "protein"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 3},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts .\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 3},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation .\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis .\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n    {\"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1799,
        "sentence": "These STAT proteins were detected by using the IFN-gamma-activated sequence ( GAS ) and related oligonucleotides as probes in electrophoretic mobility shift assay .",
        "label": {
            "GAS": "DNA",
            "IFN-gamma-activated sequence": "DNA",
            "STAT proteins": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Extracellular signal-regulated protein kinase (ERK)-dependent and ERK-independent pathways target STAT3 on serine-727 in human neutrophils stimulated by chemotactic factors and cytokines.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1, providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1, a zinc finger transcription factor.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Moreover, monocytes express a novel IL-10-stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti-STAT3 Ab but is not observed in T cells.\": 5},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus, and induce transcription from responsive genes.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 5}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"IFN-gamma-activated sequence (GAS)\": \"DNA\"}]",
        "prediction": "{'STAT proteins': 'protein', 'IFN-gamma-activated sequence (GAS)': 'DNA'}"
    },
    {
        "idx": 1703,
        "sentence": "E1A blocked IFN 's induction of cytolytic resistance , resulting in the selective lysis of adenovirus-transformed cells by IFN -activated NK cells .",
        "label": {
            "E1A": "protein",
            "IFN": "protein",
            "adenovirus-transformed cells": "cell_line",
            "IFN -activated NK cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production.\": 3},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 4},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis.\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5}\n]",
        "response3": "[{\"E1A\": \"protein\"}, {\"IFN\": \"protein\"}, {\"adenovirus-transformed cells\": \"cell_line\"}, {\"NK cells\": \"cell_type\"}]",
        "prediction": "{'E1A': 'protein', 'IFN': 'protein', 'adenovirus-transformed cells': 'cell_line', 'NK cells': 'cell_type'}"
    },
    {
        "idx": 629,
        "sentence": "Depletion of CD8+ cells was accompanied by 62 +/- 18% loss of progesterone receptor -bearing cells , while depletion of CD4+ cells resulted in a twofold increase in the number of positively staining lymphocytes .",
        "label": {
            "progesterone receptor": "protein",
            "CD8+ cells": "cell_line",
            "lymphocytes": "cell_line",
            "progesterone receptor -bearing cells": "cell_line",
            "CD4+ cells": "cell_line"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05.\": 4},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"These cells are deficient in FasL expression and apoptosis induced upon TCR triggering, although their cytokine ( IL-2 and IFN-gamma ) production is normal.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB ( NF-kappaB ) factors in primary murine B lymphocytes.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Hanging drop-mediated transfer into 2-deoxyguanosine-treated thymus lobes showed that lymphoid progenitor cells rather than thymus stromal cells were responsible for abnormal B cell development in tg epsilon26 thymus, and that tg epsilon26 fetal liver cells were destined to become B cells in normal thymus even in the presence of normal progenitor cells undergoing T cell development.\": 5},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"The proliferative responses of purified CD4+ or CD8+ T cells are suppressed more strongly by TPCK when anti-CD28 rather than the phorbol ester PMA is used as the mitogenic coactivator.\": 5}\n]",
        "response3": "[{\"CD8+\": \"cell_type\"}, {\"progesterone receptor\": \"protein\"}, {\"CD4+\": \"cell_type\"}, {\"lymphocytes\": \"cell_type\"}]",
        "prediction": "{'CD8+': 'cell_type', 'progesterone receptor': 'protein', 'CD4+': 'cell_type', 'lymphocytes': 'cell_type'}"
    },
    {
        "idx": 490,
        "sentence": "Cyclosporin A ( CsA ) is thought to exert its immunosuppressive effects by inhibiting the expression of a distinct set of lymphokine genes which are induced upon T-cell activation , among them the gene coding for interleukin-2 .",
        "label": {
            "lymphokine genes": "DNA",
            "interleukin-2": "protein"
        },
        "response1": "['protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 3},\n    {\"Example 9\": 4},\n    {\"Example 10\": 4},\n    {\"Example 11\": 4},\n    {\"Example 12\": 3},\n    {\"Example 13\": 4},\n    {\"Example 14\": 3},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"Cyclosporin A\": \"protein\"}, {\"CsA\": \"protein\"}, {\"lymphokine genes\": \"protein\"}, {\"T-cell\": \"cell_type\"}, {\"interleukin-2\": \"protein\"}]",
        "prediction": "{'Cyclosporin A': 'protein', 'CsA': 'protein', 'lymphokine genes': 'protein', 'T-cell': 'cell_type', 'interleukin-2': 'protein'}"
    },
    {
        "idx": 118,
        "sentence": "Similar to 1;14 translocations , this deletion disrupts the SCL 5' regulatory region .",
        "label": {
            "SCL": "protein",
            "SCL 5' regulatory region": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"UAS1\": 4},\n    {\"B cell\": 3},\n    {\"SIVsmmPBj14\": 5},\n    {\"Sp1\": 4},\n    {\"CD14\": 4},\n    {\"Protein\": 5},\n    {\"GATA-1\": 5},\n    {\"EKLF\": 5},\n    {\"TAL1\": 5},\n    {\"T-ALL\": 5},\n    {\"SLAP-130\": 5},\n    {\"SLP-76\": 5},\n    {\"Ets\": 4},\n    {\"SCL\": 4},\n    {\"GATA-1\": 4},\n    {\"TCL1\": 5},\n    {\"CCAAT box\": 4},\n    {\"EKLF binding site\": 4},\n    {\"T cell\": 4},\n    {\"interleukin 2\": 5},\n    {\"SCL\": 3},\n    {\"T-PLL\": 5},\n    {\"IgH\": 4}\n]",
        "response3": "[{\"SCL\": \"RNA\"}]",
        "prediction": "{'SCL': 'RNA'}"
    },
    {
        "idx": 493,
        "sentence": "Here we report that the formation of two distinct mitogen-inducible DNA-binding complexes , the kappa B complex within the HIV enhancer and the NFAT-1 complex within the interleukin-2 enhancer , is inhibited in the presence of CsA .",
        "label": {
            "NFAT-1 complex": "protein",
            "mitogen-inducible DNA-binding complexes": "protein",
            "kappa B complex": "protein",
            "interleukin-2": "protein",
            "interleukin-2 enhancer": "DNA",
            "HIV enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha, although the underlying mechanism remains unclear.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1: a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"During normal T-cell activation, IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome, thus permitting the release of functional NF-kappaB.\": 5},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5}\n]",
        "response3": "[{\"kappa B complex\": \"protein\"}, {\"NFAT-1 complex\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"interleukin-2 enhancer\": \"protein\"}]",
        "prediction": "{'kappa B complex': 'protein', 'NFAT-1 complex': 'protein', 'DNA': 'DNA', 'interleukin-2 enhancer': 'protein'}"
    },
    {
        "idx": 1798,
        "sentence": "In purified human peripheral blood T cells , nuclear STAT proteins were activated approximately 3 h after activation by cross-linked anti-CD3 Abs .",
        "label": {
            "purified human peripheral blood T cells": "cell_type",
            "anti-CD3 Abs": "protein",
            "nuclear STAT proteins": "protein",
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 3},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 4},\n    {\"Example 14\": 5},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"STAT proteins\": \"protein\"}, {\"T cells\": \"cell_type\"}, {\"anti-CD3 Abs\": \"protein\"}]",
        "prediction": "{'STAT proteins': 'protein', 'T cells': 'cell_type', 'anti-CD3 Abs': 'protein'}"
    },
    {
        "idx": 175,
        "sentence": "To compare extra-renal 1,25(OH)2D3 production in different types of granulomatous disease , and to identify the cell types responsible, we have evaluated the conversion of 25(OH)D3 in 1,25(OH)2D3 by uncultured cells recovered by bronchoalveolar lavage and blood mononuclear cells from normocalcemic patients with sarcoidosis and tuberculosis.",
        "label": {
            "blood mononuclear cells": "cell_type",
            "uncultured cells": "cell_type"
        },
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5}\n]",
        "response3": "[{\"bronchoalveolar lavage\": \"cell_type\"}, {\"blood mononuclear cells\": \"cell_type\"}, {\"sarcoidosis\": \"cell_type\"}, {\"tuberculosis\": \"cell_type\"}]",
        "prediction": "{'bronchoalveolar lavage': 'cell_type', 'blood mononuclear cells': 'cell_type', 'sarcoidosis': 'cell_type', 'tuberculosis': 'cell_type'}"
    },
    {
        "idx": 1498,
        "sentence": "Steroid mediated lysis of lymphoblasts requires the DNA binding region of the steroid hormone receptor.",
        "label": {
            "lymphoblasts": "cell_type"
        },
        "response1": "['DNA', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"The effects of G-CSF are mediated by binding to specific, high affinity receptors.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The DNA-binding protein GATA-1 is required for normal erythroid development and regulates erythroid-expressed genes in maturing erythroblasts.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 5}\n]",
        "response3": "[{\"DNA\": \"DNA\"}, {\"steroid hormone receptor\": \"protein\"}]",
        "prediction": "{'DNA': 'DNA', 'steroid hormone receptor': 'protein'}"
    },
    {
        "idx": 995,
        "sentence": "The hierarchy of transcriptional control in B-cell development has recently been analyzed by targeted gene inactivation in the mouse .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis\": 5},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation\": 3},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes\": 5},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined\": 3},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered\": 4},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms\": 4},\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 4},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts\": 4},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1671,
        "sentence": "Both phosphorylation and proliferation were inhibited by IL-6 neutralizing antibodies .",
        "label": {
            "IL-6 neutralizing antibodies": "protein",
            "IL-6": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 4},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 3},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation , required for dissociation from Ras .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 5},\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 5},\n    {\"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5},\n    {\"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters .\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 141,
        "sentence": "TNF-alpha was able to increase expression of the HIV LTR in T cells , but in monocytic cells , TNF-alpha did not induce the HIV LTR above a constitutive level of activity .",
        "label": {
            "monocytic cells": "cell_type",
            "TNF-alpha": "protein",
            "HIV LTR": "DNA",
            "T cells": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"When the same MTHC lines are exposed to TNF-alpha in combination with IFN-gamma , the cells instead become DC.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover, monocytes express a novel IL-10 -stimulated STAT protein with an M(r) of 70 kDa that is recognized by the anti- STAT3 Ab but is not observed in T cells.\": 4},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process.\": 4},\n    {\"Interestingly, CTLA4Ig did not significantly inhibit the activation of either NF of activated T cells ( NFAT ) or AP-1 reporters.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Together, these findings suggest that LITAF plays an important role in the activation of the human TNF-alpha gene and proposes a new mechanism to control TNF-alpha gene expression.\": 5},\n    {\"Remixing of purified T cells showed that naive T cells do not suppress LAI replication in memory T cells and that memory T cells do not restore LAI expression in naive T cells.\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 5},\n    {\"These results demonstrate the existence of a triple autoregulatory loop in monocytes and macrophages involving HIV , p105 and p50 , and MAD3 , with the end result of persistent NF-kappa B activation and viral persistence.\": 5},\n    {\"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.\": 4}\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    },
    {
        "idx": 1557,
        "sentence": "In this report, we show that following incubation of L540 cells ( Hodgkin's disease -derived, T cell-like, CD30 + cells ) with the agonistic anti- CD30 monoclonal antibodies ( mAb ) M44 and M67 , two nuclear factor (NF)-kappa B DNA binding activities were induced in nuclear extracts , as determined in gel retardation assays .",
        "label": {
            "Hodgkin's disease -derived, T cell-like, CD30 + cells": "cell_line",
            "nuclear factor (NF)-kappa B": "protein",
            "M44": "protein",
            "L540 cells": "cell_line",
            "M67": "protein",
            "mAb": "protein",
            "agonistic anti- CD30 monoclonal antibodies": "protein",
            "CD30": "protein"
        },
        "response1": "['cell_line', 'protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of NF-kappa B DNA binding activity, which directly matches an entity label in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions RelA and Rel homology family, which are related to NF-kappa B complex, matching the entity label 'protein' in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides multiple examples of proteins and factors involved in signal transduction events, which match the entity labels in the target sentence.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions NF-kappa B binding activity, which matches the entity label 'protein' in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions CD40, IFN-gamma, tumor necrosis factor-alpha, and interleukin-1beta, which are all related to protein entities, matching the entity labels in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions IL-2 receptor alpha subunit, p21ras, and B cell activation, which match the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides examples of proteins and factors involved in proliferation and activation, matching the entity labels in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions NF-kappa B activation, which matches the entity label 'protein' in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides examples of proteins and signaling molecules involved in differentiation and signaling, matching the entity labels in the target sentence.\"},\n    {\"Example 10\": 4},\n    {\"Reason 10\": \"The sentence mentions NF-kappaB, Tax, and ATL, which are related to protein and cell type entities, matching the entity labels in the target sentence.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions IkappaBbeta and NF-kappaB, which are related to protein entities, matching the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides examples of proteins and factors involved in cytokine production and stimulation, matching the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides examples of proteins and components of NF-kappaB, matching the entity labels in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of proteins and factors involved in CD40 stimulation and NF-kappaB factors, matching the entity labels in the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions HIV-1, IFN, PKR, and IkappaBalpha, which are related to protein and cell type entities, matching the entity labels in the target sentence.\"}\n]",
        "response3": "[{'L540 cells': 'cell_line'}, {'Hodgkin\\'s disease': 'cell_type'}, {'T cell-like': 'cell_type'}, {'CD30': 'protein'}, {'NF-kappa B': 'protein'}, {'DNA': 'DNA'}]",
        "prediction": "{'L540 cells': 'cell_line', \"Hodgkin's disease\": 'cell_type', 'T cell-like': 'cell_type', 'CD30': 'protein', 'NF-kappa B': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 1090,
        "sentence": "Further analysis reveals that the inducible phosphorylation of I kappa B alpha maps to two serines in the N terminus of the protein (residues 32 and 36) and that the mutation of either residue is sufficient to abolish ligand-induced degradation, whereas both residues must be mutated to abolish inducible phosphorylation of the protein.",
        "label": {
            "N terminus": "protein",
            "I kappa B alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 4},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"I kappa B alpha\": \"protein\"}]",
        "prediction": "{'I kappa B alpha': 'protein'}"
    },
    {
        "idx": 1568,
        "sentence": "The inverse relation between high density lipoprotein ( HDL ) and atherosclerotic events may in part be due to enzymes associated with HDL that destroy the biologically active lipids generated in LDL .",
        "label": {
            "enzymes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a protein name and cell types that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions a DNA-related entity, which is relevant to the entity labels in the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence mentions a protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple protein names and a cell line name that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains a specific protein name that is relevant to the entity labels in the target sentence.\"},\n    {\"Example 11\": 3},\n    {\"Reason 11\": \"The sentence mentions cell types, which are relevant to the entity labels in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains multiple protein names that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains multiple protein names, a cell line name, and a protein abbreviation that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions cell types and DNA-related entities that are relevant to the entity labels in the target sentence.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions cell types and a protein abbreviation that are relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{'HDL': 'protein'}, {'LDL': 'protein'}]",
        "prediction": "{'HDL': 'protein', 'LDL': 'protein'}"
    },
    {
        "idx": 257,
        "sentence": "Because of the presence of a functional receptor-effector system for VD3 and multiple biological responses to the hormone, these cells provide a unique model system with which to probe the specific effects of VD3 on cell growth and differentiation in chronic myelogenous leukemia .",
        "label": {},
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"VD3\": \"protein\"}, {\"chronic myelogenous leukemia\": \"cell_line\"}]",
        "prediction": "{'VD3': 'protein', 'chronic myelogenous leukemia': 'cell_line'}"
    },
    {
        "idx": 262,
        "sentence": "This complementary DNA encoded a protein with structural similarities to the c-jun proto-oncogene product , and its target sequence was closely related to the palindromic target sequence of c-jun .",
        "label": {
            "complementary DNA": "DNA",
            "c-jun proto-oncogene product": "protein",
            "palindromic target sequence": "DNA",
            "c-jun": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n{\"cDNAs\": 5},\n{\"SCM-1\": 4},\n{\"IL-2\": 4},\n{\"c-Jun\": 4},\n{\"c-Fos\": 4},\n{\"Runt domain\": 4},\n{\"GM-CSF\": 4},\n{\"Th2-type lymphocytes\": 4},\n{\"SLAP-130\": 5},\n{\"SLP-76\": 4},\n{\"T cell\": 4},\n{\"p21(WAF1/CIP1)\": 4},\n{\"p27(KIP1)\": 4},\n{\"CD95 ligand\": 4},\n{\"Egr-1\": 5},\n{\"protein\": 5},\n{\"ZEBRA\": 5},\n{\"Jun\": 4},\n{\"ATF-2\": 4},\n{\"Protein\": 4},\n{\"CREB\": 5},\n{\"AR-CRE\": 5},\n{\"B and T cell activation\": 4},\n{\"Ramos\": 4},\n{\"Jurkat\": 4},\n{\"cDNA microarray technology\": 5}\n]",
        "response3": "[{\"complementary DNA\": \"DNA\"}, {\"protein\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'complementary DNA': 'DNA', 'protein': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 1351,
        "sentence": "Western blotting yielded a set of bands ranging from 25 kD to 55 kD, resulting from extensive alternative splicing .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n{\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n{\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n{\"This protein has now been purified and its encoding gene cloned.\": 4},\n{\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 5},\n{\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n{\"Tat-binding protein 7 is a subunit of the 26S protease .\": 5},\n{\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n{\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 5},\n{\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n{\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n{\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n{\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence .\": 5},\n{\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 973,
        "sentence": "To assess the transcription regulatory function of MZF-1 , the full-length MZF-1 coding region was fused to the DNA binding domain of the yeast transactivator GAL4 .",
        "label": {
            "MZF-1": "DNA",
            "DNA binding domain": "protein",
            "yeast transactivator GAL4": "protein",
            "GAL4": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence directly mentions the gene/protein name and its role, making it highly relevant for entity extraction.\"}\n]",
        "response3": "[{\"MZF-1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"GAL4\": \"protein\"}]",
        "prediction": "{'MZF-1': 'protein', 'DNA': 'DNA', 'GAL4': 'protein'}"
    },
    {
        "idx": 1125,
        "sentence": "This indicates that the CR of GR may be of functional significance.",
        "label": {
            "GR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"immunoglobulin kappa 3' enhancer\": 5},\n{\"kappa E3'\": 1},\n{\"positive-acting elements\": 1},\n{\"negative-acting elements\": 1}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 338,
        "sentence": "Nuclear T3R in lymphocytes was determined by radio-ligand binding analysis .",
        "label": {
            "T3R": "protein",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides specific names of proteins (TCRzeta, p56(lck)) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a specific protein (PML/RARalpha) that is relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions a specific cell type (lymphoid neoplasms) that is relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides specific names of proteins (IL-2, c-Jun, c-Fos) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence mentions a specific protein (retinoic acid receptor alpha) that is relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides specific names of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 7\": 3},\n    {\"Reason 7\": \"The sentence mentions a specific DNA entity (AP-1) that is relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides specific names of cell types (granulocytes, T cells) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides specific names of cell types (T lymphocytes) and proteins (HLA-molecules) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides specific names of proteins (NF-ATc) and cell types (T lymphocytes, embryonic cardiac cells) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 11\": 4},\n    {\"Reason 11\": \"The sentence mentions a specific protein (RXR) that is relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides specific names of proteins (NF-ATc) and cell types (T lymphocytes) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides specific names of proteins (SLAP-130, SLP-76) and a cell type (T cell) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides specific names of proteins (RelA, NF-kappaB1) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions a specific cell type (Th2-type lymphocytes) that is relevant to the target sentence, aiding in the extraction of named entities.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides specific names of cell types (B and T cell activation) and cell lines (Ramos, Jurkat) that are directly mentioned in the target sentence, making it highly relevant for extracting named entities.\"},\n]\n```",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1080,
        "sentence": "However, the concurrent addition of iron (in the form of ferrous or ferric chloride and other iron salts ) reversed the inhibition of proliferation caused by tepoxalin .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides clear and specific entities that match the entity types in the target sentence, aiding in the extraction process.\"}\n]",
        "response3": "[{\"iron\": \"protein\"}, {\"ferrous\": \"protein\"}, {\"ferric chloride\": \"protein\"}, {\"iron salts\": \"protein\"}, {\"tepoxalin\": \"protein\"}]",
        "prediction": "{'iron': 'protein', 'ferrous': 'protein', 'ferric chloride': 'protein', 'iron salts': 'protein', 'tepoxalin': 'protein'}"
    },
    {
        "idx": 1786,
        "sentence": "Binding of plasma Factor VII/VIIa to the tissue factor (TF) receptor initiates the coagulation protease cascades .",
        "label": {
            "coagulation protease": "protein",
            "tissue factor (TF) receptor": "protein",
            "plasma Factor VII/VIIa": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names, cell type, and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific protein names, cell type, and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names and cell type, and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names and their corresponding labels, which directly match the entity types in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names, cell type, and their corresponding labels, which directly match the entity types in the target sentence.\"}\n]",
        "response3": "[{\"Factor VII/VIIa\": \"protein\"}, {\"tissue factor (TF) receptor\": \"protein\"}]",
        "prediction": "{'Factor VII/VIIa': 'protein', 'tissue factor (TF) receptor': 'protein'}"
    },
    {
        "idx": 1242,
        "sentence": "LPS signaling was found to involve NF kappa B activation by the p50/p65 heterodimers .",
        "label": {
            "NF kappa B": "protein",
            "p50/p65 heterodimers": "protein"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50 .\": 5},\n    {\"Control of NF-kappa B activity by the I kappa B beta inhibitor .\": 4},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B .\": 3},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF .\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation .\": 5},\n    {\"During normal T-cell activation , IkappaBalpha is rapidly phosphorylated, ubiquitinated, and degraded by the 26S proteasome , thus permitting the release of functional NF-kappaB .\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway .\": 4},\n    {\"Recently, activation of NF-kappa B has been linked to ARDS and has been shown to be a critical proximal step in the initiation of neutrophilic inflammation in animal models .\": 4},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation .\": 4},\n    {\"Activation of NF-kappa B by various cellular stimuli involves the phosphorylation and subsequent degradation of its inhibitor, I kappa B alpha , although the underlying mechanism remains unclear.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival .\": 4},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4}\n]\n```",
        "response3": "```json\n[{\"NF kappa B\": \"protein\"}, {\"p50/p65 heterodimers\": \"protein\"}]\n```",
        "prediction": "{'NF kappa B': 'protein', 'p50/p65 heterodimers': 'protein'}"
    },
    {
        "idx": 866,
        "sentence": "T cell activation results in high levels of HIV replication and is thought to be one mechanism leading to the conversion from latent to active viral infection .",
        "label": {
            "T cell": "cell_type"
        },
        "response1": "['cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names (TCL1, AIDS IBLP tumors) which are directly mentioned.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains specific protein names (Syk, Zap) and a cell type (T cell) which are directly mentioned.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence contains specific protein name (TIMP-1) and DNA which are directly mentioned.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names (IkappaBbeta, NF-kappaB) which are directly mentioned.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names (IL-2 receptor alpha subunit, p21ras) and a cell type (B cell) which are directly mentioned.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence contains specific protein names (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) which are directly mentioned.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence contains specific protein name (NF-kappa B) which is directly mentioned.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein name (ZAP-70) which is directly mentioned.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names (HIV-1, IFN, PKR, IkappaBalpha) which are directly mentioned.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific cell types (B and T cell activation, Ramos, Jurkat) and a technology (cDNA microarray technology) which are directly mentioned.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific DNA name (HIV-1 LTR) and protein names (NFAT-1, NF kappa B) which are directly mentioned.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence contains specific protein names (TR55, TNF-alpha, HIV) which are directly mentioned.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific cell types (T lymphocytes, adenovirus vectors) which are directly mentioned.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains specific protein names (LAI) and cell types (T cells, memory T cells, naive T cells) which are directly mentioned.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence contains specific cell types (CD4+, CD8+) and protein names (TPCK, anti-CD28, PMA) which are directly mentioned.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence contains specific protein names (HIV, NF-kappa B, p105, p50, MAD3) which are directly mentioned.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 433,
        "sentence": "Competition experiments did not reveal any high-affinity binding site for BSAP in known regulatory regions of immunoglobulin and class II major histocompatibility (MHC) genes , suggesting that BSAP is a regulator of a different set of B-lymphoid-specific genes .",
        "label": {
            "regulatory regions": "DNA",
            "BSAP": "protein",
            "high-affinity binding site": "DNA",
            "B-lymphoid-specific genes": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors.\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation, we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 3},\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA, a member of the Rel homology family which is part of the normal NF-kappa B complex, was not induced in the nucleus following activation.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"immunoglobulin\": \"protein\"}, {\"class II major histocompatibility (MHC) genes\": \"protein\"}, {\"B-lymphoid-specific genes\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'immunoglobulin': 'protein', 'class II major histocompatibility (MHC) genes': 'protein', 'B-lymphoid-specific genes': 'cell_type'}"
    },
    {
        "idx": 1546,
        "sentence": "Identification of essential GATA and Ets binding motifs within the promoter of the platelet glycoprotein Ib alpha gene .",
        "label": {
            "platelet glycoprotein Ib alpha gene": "DNA",
            "GATA": "DNA",
            "Ets binding motifs": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides specific names of transcription factors (Sp1 and Ets) that are mentioned in the target sentence, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The example includes specific protein names (EBNA2) and a cell line (TP1) mentioned in the target sentence, contributing to the identification of protein and cell line entities.\"\n    },\n    {\n        \"Example 3\": 3\n    },\n    {\n        \"Reason 3\": \"The example mentions a specific protein (GM-CSF) related to genes, which can help in identifying protein entities, but the relevance to the target sentence is slightly lower compared to more directly related examples.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The example includes a specific cell type (Th2-type lymphocytes) mentioned in the target sentence, aiding in the identification of cell type entities.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example provides specific protein names (Stat3, Stat5, c-Mpl) that are mentioned in the target sentence, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 6\": 4\n    },\n    {\n        \"Reason 6\": \"The example includes specific protein names (IkappaBbeta, NF-kappaB) related to signal transduction, which can help in identifying protein entities and their interactions.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example provides a specific protein name (Egr-1) mentioned in the target sentence, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example includes specific protein names (Sp1, CD14) related to tissue-specific expression, which can help in identifying protein entities and their roles.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example provides a specific protein name (GATA-1) mentioned in the target sentence, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The example includes specific DNA and protein binding site names (CCAAT box, EKLF binding site) that are relevant to gene expression, aiding in the identification of DNA and protein entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example provides specific protein names (cAMP-dependent protein kinase, Rap1) related to protein kinase activity, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example includes a specific protein name (E2A) mentioned in the target sentence, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example provides a specific protein name (GATA-1) mentioned in the target sentence, aiding in the identification of protein entities.\"\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Reason 14\": \"The example includes specific protein names (IL-2, c-Jun, c-Fos) related to nuclear factors and gene regulation, aiding in the identification of protein entities.\"\n    }\n]",
        "response3": "[{\"GATA\": \"protein\"}, {\"Ets\": \"protein\"}]",
        "prediction": "{'GATA': 'protein', 'Ets': 'protein'}"
    },
    {
        "idx": 1412,
        "sentence": "We found that these parameters were indistinguishable for one of the PRL- and IL-2- induced factors .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping of the entity 'SCM-1' to the entity label 'cell_line' in the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides clear mappings of the entities 'CREB' and 'AR-CRE' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides clear mappings of the entities 'IL-2', 'c-Jun', and 'c-Fos' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides clear mappings of the entities 'granulocytes' and 'T cells' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides clear mappings of the entities 'IL-2 receptor alpha subunit', 'p21ras', and 'B cell' to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides clear mappings of the entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides clear mappings of the entities 'NF-kB', 'AP-1', 'OCT-1', and 'NF-IL-2B' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear mapping of the entity 'IL-4' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides clear mappings of the entities 'T cell', 'IL-2', 'IL-2 receptor', and 'CD28' to the entity labels 'cell_type' and 'protein' in the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides clear mappings of the entities 'AP-1' and 'PMA' to the entity label 'protein', and 'monocytes' and 'macrophages' to the entity label 'cell_type' in the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a clear mapping of the entity 'RXR' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear mapping of the entity 'IL-2' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides clear mappings of the entities 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and 'B cells' to the entity labels 'protein' and 'cell_type' in the target sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides clear mappings of the entities 'IL-2', 'IFN-gamma', 'jak kinases', and 'STAT1(alpha)' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides clear mappings of the entities 'IL-4', 'LPS', and 'AP-1' to the entity label 'protein' in the target sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides clear mappings of the entities 'T cell' and 'interleukin 2' to the entity labels 'cell_type' and 'protein' in the target sentence.\"}\n]",
        "response3": "[{\"PRL-\": \"protein\"}, {\"IL-2-\": \"protein\"}]",
        "prediction": "{'PRL-': 'protein', 'IL-2-': 'protein'}"
    },
    {
        "idx": 411,
        "sentence": "There was a significant positive correlation between VDR concentration and serum phosphate (P less than 0.05).",
        "label": {
            "VDR": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"We further demonstrated that this change in phosphorylation status correlates with a decrease in DNA binding activity.\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 4},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"Both haemin and delta-ALA caused a de novo increase in alpha-globin expression as well as enhancing Epo-induced beta-globin expression, leading to a marked increase in haemoglobin production.\": 5},\n    {\"Binding of the cDNA fusion protein, similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Its 50% effective and cytotoxic concentrations were 0.016 and 2.2 microg/ml in PMA-stimulated U1 cells, respectively.\": 4},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide.\": 4},\n    {\"The affinity of the BAT box binding proteins for the BAT box was approximately 25-fold less than for the octamer sequence and the BAT box binding proteins dissociated from the BAT box 10-fold more rapidly than from the octamer sequence.\": 4}\n]",
        "response3": "[{\"VDR\": \"protein\"}]",
        "prediction": "{'VDR': 'protein'}"
    },
    {
        "idx": 1460,
        "sentence": "In contrast, in a number of multiple myeloma cell lines , representing differentiated, plasma cell-like B cells , PU.1 DNA binding activity , mRNA expression , and Pu box -dependent transactivation were absent or detectable at a very low level.",
        "label": {
            "multiple myeloma cell lines": "cell_line",
            "PU.1": "protein",
            "Pu box": "DNA",
            "differentiated, plasma cell-like B cells": "cell_type"
        },
        "response1": "['cell_line', 'DNA', 'protein', 'RNA']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 4},\n    {\"Example 3\": 4},\n    {\"Example 4\": 5},\n    {\"Example 5\": 3},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 4},\n    {\"Example 14\": 4},\n    {\"Example 15\": 4}\n]",
        "response3": "[{\"multiple myeloma cell lines\": \"cell_line\"}, {\"B cells\": \"cell_type\"}, {\"PU.1\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"mRNA\": \"RNA\"}]",
        "prediction": "{'multiple myeloma cell lines': 'cell_line', 'B cells': 'cell_type', 'PU.1': 'protein', 'DNA': 'DNA', 'mRNA': 'RNA'}"
    },
    {
        "idx": 638,
        "sentence": "Thus the VLA-5 fibronectin receptor on CD4 cells can play a complementary role in CD3 - TCR -mediated signal transduction through its interaction with fibronectin .",
        "label": {
            "CD3": "protein",
            "TCR": "protein",
            "VLA-5 fibronectin receptor": "protein",
            "fibronectin": "protein",
            "CD4 cells": "cell_line"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCF-1) and its corresponding entity label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides two clear examples of proteins (c-kit and IL-4R alpha chain) and their corresponding entity labels.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides two clear examples of proteins (Syk and Zap) and a cell type (T cell) with their corresponding entity labels.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides two clear examples of proteins (Stat3 and Stat5) and another protein (c-Mpl) with their corresponding entity labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides two clear examples of proteins (CD40 and NF-kappa B) with their corresponding entity labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides two clear examples of proteins (IL4 and IL13), three proteins (STAT6, STAT3, and STAT5), and a cell type (B cells) with their corresponding entity labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides a clear example of a protein (NF-ATc) and a cell type (T lymphocytes) with their corresponding entity labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides a clear example of a cell type (cell adhesion molecules) with its corresponding entity label.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides two clear examples of proteins (CD70 and CD40), a cell type (B cell), and another cell type (plasma cells) with their corresponding entity labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides two clear examples of proteins (IL-7R and gamma(c)) with their corresponding entity labels.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides three clear examples of proteins (CD28, CD80, and CD86), two proteins (CBL and VAV), two proteins (NFAT and interleukin-2), and a protein (granulocyte-macrophage colony-stimulating factor) with their corresponding entity labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides three clear examples of proteins (CD40, IFN-gamma, and tumor necrosis factor-alpha), and a protein (interleukin (IL)-1beta) with their corresponding entity labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides two clear examples of proteins (interleukin 10 and IL-10R), and two proteins (STAT3 and IL-6) with their corresponding entity labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides two clear examples of proteins (IL-2 receptor alpha subunit and p21ras), and a cell type (B cell) with their corresponding entity labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides a clear example of a protein (NF-kappa B) with its corresponding entity label.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides two clear examples of proteins (ICAM-1 and CD71), and two proteins (LMP1 and IkappaB) with their corresponding entity labels.\"}\n]",
        "response3": "[{'VLA-5': 'protein'}, {'CD4 cells': 'cell_type'}, {'CD3': 'protein'}, {'TCR': 'protein'}, {'fibronectin': 'protein'}]",
        "prediction": "{'VLA-5': 'protein', 'CD4 cells': 'cell_type', 'CD3': 'protein', 'TCR': 'protein', 'fibronectin': 'protein'}"
    },
    {
        "idx": 1375,
        "sentence": "We have analyzed the expression of TCL1 mRNA and protein in peripheral blood lymphocytes ( PBLs ) from four AT cases and from healthy controls .",
        "label": {
            "PBLs": "cell_type",
            "peripheral blood lymphocytes": "cell_type",
            "TCL1 mRNA": "RNA",
            "protein": "protein"
        },
        "response1": "['RNA', 'protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein (TCL1) being expressed.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple examples of proteins (IL-2, c-Jun, c-Fos) being mentioned in relation to nuclear factors.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence directly mentions a cell line (SCM-1) being examined.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence mentions a DNA binding activity of a transcription factor (AP-1).\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides examples of proteins (NF-kappaB, Tax) and a cell type (ATL) in relation to leukemic cells.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions a protein (TAL1) promoting the development of a specific cell type (T-ALL).\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence mentions proteins (SCL, GATA-1) expressed in specific cell lineages.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides examples of proteins (SLAP-130, SLP-76) and a cell type (T cell) in relation to protein tyrosine kinases.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence directly mentions the protein E2A being examined at the protein level.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence mentions a protein (MNDA) and a cell line (Philadelphia chromosome-positive chronic myeloid leukemia) in relation to granulocyte-macrophage lineage cells.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides examples of proteins (TCRzeta, p56(lck)) detected in peripheral blood T cells.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence mentions cell types (granulocytes, T cells) in relation to methylation deviation.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence directly mentions the protein WT1 being exclusively expressed.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides examples of proteins (CD70, IL-4, CD40) and cell types (B cell, plasma cells) in relation to differentiation.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence mentions cell types (B and T cell activation) and cell lines (Ramos, Jurkat) in relation to gene expression studies.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The sentence provides examples of proteins (CD40, Rel/nuclear factor kappaB, NF-kappaB) and a cell type (B lymphocytes) in relation to CD40 stimulation.\"},\n]",
        "response3": "[{\"TCL1\": \"protein\"}, {\"PBLs\": \"cell_type\"}, {\"AT\": \"cell_type\"}]",
        "prediction": "{'TCL1': 'protein', 'PBLs': 'cell_type', 'AT': 'cell_type'}"
    },
    {
        "idx": 764,
        "sentence": "The increased sensitivity of CEM-C7 cells and its subclones to dexamethasone in serum-free medium returned to previous levels when these cells were recultured in serum-containing medium .",
        "label": {
            "CEM-C7": "cell_line",
            "CEM-C7 cells": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO .\": 4},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239 ) were tested in peripheral blood mononuclear cell and CEMx174 cultures .\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3 .\": 4},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\": 4},\n    {\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 5},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 3},\n    {\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n    {\"Thus, we were able to derive a hematopoietic cell line , called 47.10 , that grew indefinitely under these conditions, whereas no cell line could be developed from nontransgenic mice .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 897,
        "sentence": "The system is based on the use of an oligomerized NFAT-1 binding motif that directs transcription of SV40 T-antigen in transgenic mice .",
        "label": {
            "transcription of SV40 T-antigen": "protein",
            "NFAT-1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NFAT-1\": \"protein\"}, {\"SV40 T-antigen\": \"protein\"}]",
        "prediction": "{'NFAT-1': 'protein', 'SV40 T-antigen': 'protein'}"
    },
    {
        "idx": 1842,
        "sentence": "Individually or collectively, none of the three enhancer-binding proteins ( LEF-1 , Ets-1 , and TFE-3 ) could activate transcription in the absence of Sp1 .",
        "label": {
            "Ets-1": "protein",
            "TFE-3": "protein",
            "LEF-1": "protein",
            "enhancer-binding proteins": "protein",
            "Sp1": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of transcription factors and their interactions, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides an example of a mutation affecting a specific protein binding and cell type, which can aid in understanding the relationship between mutations and named entities.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence mentions a specific cell type and a protein related to transcription, which aligns with the entity labels in the target sentence.\"},\n    {\"Sentence\": 2},\n    {\"Reason\": \"The sentence provides an example of a specific protein involved in transcription factor regulation, which can be relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions two proteins and their interaction, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of transcription factors and their binding activities, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence provides an example of a specific protein acting as a transcription factor, which aligns with the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence mentions multiple proteins involved in transcription factor interactions, which are directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides an example of a specific protein with a restricted expression pattern, which can be relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 2},\n    {\"Reason\": \"The sentence mentions a specific DNA binding activity of a transcription factor, which can be relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 3},\n    {\"Reason\": \"The sentence provides an example of a protein interacting with a specific promoter element, which aligns with the entity labels in the target sentence.\"},\n    {\"Sentence\": 4},\n    {\"Reason\": \"The sentence mentions a specific protein and its role in cellular differentiation, which is directly relevant to the entity labels in the target sentence.\"},\n    {\"Sentence\": 5},\n    {\"Reason\": \"The sentence contains multiple examples of transcription factors and their expression patterns in different cell types, which are directly relevant to the entity labels in the target sentence.\"}\n]",
        "response3": "[{\"LEF-1\": \"protein\"}, {\"Ets-1\": \"protein\"}, {\"TFE-3\": \"protein\"}, {\"Sp1\": \"protein\"}]",
        "prediction": "{'LEF-1': 'protein', 'Ets-1': 'protein', 'TFE-3': 'protein', 'Sp1': 'protein'}"
    },
    {
        "idx": 1059,
        "sentence": "Transcription factors belonging to the NF-kappa B family are controlled by inhibitory I kappa B proteins , mainly I kappa B alpha and I kappa B beta .",
        "label": {
            "NF-kappa B family": "protein",
            "Transcription factors": "protein",
            "I kappa B beta": "protein",
            "inhibitory I kappa B proteins": "protein",
            "I kappa B alpha": "protein",
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence contains multiple entities relevant to the entity labels in the target sentence, such as NF-kappaB, Tax, and ATL, which are likely to aid in the extraction of named entities.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence contains entities like NF-ATc and T lymphocytes, which are relevant to the entity labels in the target sentence and can help in extracting named entities.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence directly mentions NF-kappa B and I kappa B alpha, which are key entities in the target sentence, making it highly helpful for extracting named entities.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The sentence mentions NF-kappa B and I kappa B beta, which are directly related to the entity labels in the target sentence, thus providing valuable information for named entity extraction.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence contains IkappaBalpha and NF-kappaB, which are crucial entities in the target sentence, making it very helpful for extracting named entities.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence mentions IkappaBbeta and NF-kappaB, which are directly related to the entity labels in the target sentence, providing significant assistance in named entity extraction.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The sentence contains NF-ATc, T lymphocytes, and embryonic cardiac cells, which are relevant to the entity labels in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 8\": 4\n    },\n    {\n        \"Reason 8\": \"The sentence mentions NF-kappa B and AP-1, which are relevant to the entity labels in the target sentence, thus providing helpful information for named entity extraction.\"\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Reason 9\": \"The sentence contains NF-kappaB and rheumatoid arthritis, which are relevant to the entity labels in the target sentence, making it useful for extracting named entities.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The sentence mentions NF-kappaB, Sp1, and p50, which are directly related to the entity labels in the target sentence, providing valuable information for named entity extraction.\"\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Reason 11\": \"The sentence contains NF-kB, AP-1, OCT-1, and NF-IL-2B, which are relevant to the entity labels in the target sentence, aiding in the extraction of named entities.\"\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Reason 12\": \"The sentence mentions RelA and NF-kappa B, which are relevant to the entity labels in the target sentence, providing helpful information for named entity extraction.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence contains PAFR, PAF, NF-kappa B, and protein kinase C, which are directly related to the entity labels in the target sentence, making it highly helpful for extracting named entities.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence mentions NF-kappa B and I kappa B alpha, which are key entities in the target sentence, making it very helpful for extracting named entities.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence contains NF-kappa B, which is directly related to the entity labels in the target sentence, providing significant assistance in named entity extraction.\"\n    }\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}, {\"I kappa B alpha\": \"protein\"}, {\"I kappa B beta\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein', 'I kappa B alpha': 'protein', 'I kappa B beta': 'protein'}"
    },
    {
        "idx": 924,
        "sentence": "We conclude that p56 exists in cytosol in a higher order complex containing hsp70 and hsp90 , both of which in turn have been found to be associated with untransformed steroid receptors .",
        "label": {
            "hsp70": "protein",
            "untransformed steroid receptors": "protein",
            "hsp90": "protein",
            "p56": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 4},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene .\": 3},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction .\": 3},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes .\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 4},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB .\": 5},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells .\": 4},\n    {\"The p21ras small GTP binding proteins participate in signal transduction from cell surface receptors and affect neoplastic transformation and development in many different cell types.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system .\": 4},\n    {\"Molecular cloning of SLAP-130 , an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 4}\n]",
        "response3": "[{\"p56\": \"protein\"}, {\"hsp70\": \"protein\"}, {\"hsp90\": \"protein\"}, {\"untransformed steroid receptors\": \"protein\"}]",
        "prediction": "{'p56': 'protein', 'hsp70': 'protein', 'hsp90': 'protein', 'untransformed steroid receptors': 'protein'}"
    },
    {
        "idx": 247,
        "sentence": "Antigen B27 seems to be a cause of lower levels of glucocorticoid receptors in blood lymphocytes .",
        "label": {
            "Antigen B27": "protein",
            "glucocorticoid receptors": "protein",
            "blood lymphocytes": "cell_type",
            "lymphocytes": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2 -dependent proliferation and NF-kappa B and AP-1 activation .\": 4},\n    {\"Benzene toxicity towards lymphocytes is thought to be mediated by metabolites of benzene including benzoquinone ( BQ ).\": 3},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone .\": 4},\n    {\"Ciprofloxacin induces an immunomodulatory stress response in human T lymphocytes .\": 3},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration .\": 3},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules .\": 4},\n    {\"Glucocorticoid responsiveness of HML was evaluated as IC50 values (nmol/L) for dexamethasone and cortisol for the inhibition of lysozyme release .\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms .\": 3},\n    {\"Inhibition of binding by anti-P selectin antibodies reduced the effect of activated platelets on cytokine production .\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging .\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 5},\n    {\"We detected an association between the reduced mitogenic response and low expression of both interleukin-2 ( IL-2 ) and the alpha chain ( CD25 ) of the IL-2 receptor ( IL-2R ).\": 5}\n]",
        "response3": "[{\"Antigen B27\": \"protein\"}, {\"glucocorticoid receptors\": \"protein\"}, {\"blood lymphocytes\": \"cell_type\"}]",
        "prediction": "{'Antigen B27': 'protein', 'glucocorticoid receptors': 'protein', 'blood lymphocytes': 'cell_type'}"
    },
    {
        "idx": 507,
        "sentence": "Thus, the transcriptional activity of TCF-1 alpha appears to depend on the TCF-2 alpha and T alpha 1 ( CREB ) transcription factors and the context of its binding site within the TCR alpha enhancer .",
        "label": {
            "TCF-2 alpha": "protein",
            "TCR alpha enhancer": "DNA",
            "CREB": "protein",
            "transcription factors": "protein",
            "T alpha 1": "protein",
            "TCR": "protein",
            "TCF-1 alpha": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 5},\n{\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2.\": 5},\n{\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes.\": 5},\n{\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 5},\n{\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n{\"We find that EKLF is an acetylated transcription factor, and that it interacts in vivo with CBP, p300, and P/CAF.\": 5},\n{\"Mutation of the major Sp1 binding site (-110 bp) decreased tissue-specific promoter activity, and these results, together with transactivation experiments, demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n{\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n{\"The third member of the family, A-myb, shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor.\": 5},\n{\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 5},\n{\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n{\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 5},\n{\"Upon cotransfection into non-T cells, TCF-1 could transactivate through its cognate motif.\": 5},\n{\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb/Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n{\"While the activation of the IL-2 promoter and an NFAT-driven minimal promoter by Tpl-2 was fully blocked by the dominant negative mutant NFAT delta418, it was only partially blocked by the calcineurin inhibitor cyclosporin A suggesting that the Tpl-2-mediated NFAT activation is under the control of a combination of calcineurin-dependent and independent pathways.\": 5}\n]",
        "response3": "[{\"TCF-1 alpha\": \"protein\"}, {\"TCF-2 alpha\": \"protein\"}, {\"T alpha 1\": \"protein\"}, {\"CREB\": \"protein\"}, {\"TCR alpha enhancer\": \"DNA\"}]",
        "prediction": "{'TCF-1 alpha': 'protein', 'TCF-2 alpha': 'protein', 'T alpha 1': 'protein', 'CREB': 'protein', 'TCR alpha enhancer': 'DNA'}"
    },
    {
        "idx": 460,
        "sentence": "To characterize these regulatory elements further, mutations in these regions were inserted into both the 5' and 3' HIV LTRs and infectious proviral constructs were assembled.",
        "label": {
            "HIV LTRs": "DNA",
            "regulatory elements": "DNA"
        },
        "response1": "['DNA']",
        "response2": "[\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"To approach this, we generated a luciferase reporter construct containing elements of the CD95 ligand promoter.\": 4},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2, together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 131,
        "sentence": "Truncation of TR alpha 1 at amino acid 210 prevented additional complex formation in the presence of NE without affecting DNA binding , suggesting that the carboxyl-terminus of the TRs is essential for interaction with nuclear proteins .",
        "label": {
            "TRs": "protein",
            "carboxyl-terminus": "protein",
            "TR alpha 1": "protein",
            "nuclear proteins": "protein",
            "amino acid 210": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"RCC -S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA /NF-kappaB1 binding complexes.\": 5},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system.\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"An NH2-terminal truncation mutant of TRAF6 inhibited RANKL -mediated NF-kappaB activation , but failed to affect constitutive signaling induced by receptor overexpression , revealing a selective role for TRAF6 in ligand-induced activation events.\": 5},\n    {\"We have demonstrated that the level of CRE binding protein ( CREB ) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor ( NF-E2 ) to an enhancer element required for expression of an erythroid-specific gene.\": 5},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR , GRIP-1 , and DRIP205 , a subunit of the DRIP coactivator complex.\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays.\": 5},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4}\n]",
        "response3": "[{\"TR alpha 1\": \"protein\"}, {\"NE\": \"protein\"}, {\"DNA\": \"DNA\"}, {\"TRs\": \"protein\"}]",
        "prediction": "{'TR alpha 1': 'protein', 'NE': 'protein', 'DNA': 'DNA', 'TRs': 'protein'}"
    },
    {
        "idx": 692,
        "sentence": "The human T-cell leukemia virus type I ( HTLV-I ) promoter contains three copies of imperfect repeats of a 21-base pair sequence designated here as TRE ( Tax -response element ) that is responsive to the virally encoded transactivator protein Tax .",
        "label": {
            "virally encoded transactivator protein": "protein",
            "Tax -response element": "DNA",
            "TRE": "DNA",
            "human T-cell leukemia virus type I ( HTLV-I ) promoter": "DNA",
            "Tax": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear example of a protein entity (Egr-1) and its corresponding label.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides a clear example of a protein entity (TCF-1) and its corresponding label.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence provides a clear example of a cell line entity (SIVsmmPBj14) and its corresponding label.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence provides clear examples of protein entities (IkappaBbeta, NF-kappaB) and their corresponding labels.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides clear examples of protein entities (interleukin 10, IL-10R, STAT3, IL-6) and their corresponding labels.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides clear examples of protein entities (IFN A, IFNA, interleukin-2, interleukin-2 receptor) and their corresponding labels.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear examples of protein entities (NF-ATc) and cell type entities (T lymphocytes, embryonic cardiac cells) and their corresponding labels.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence provides clear examples of DNA entity (hepatitis B virus) and protein entity (HBxAg) and their corresponding labels.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides clear examples of protein entities (IL-2, IFN-gamma, jak kinases, STAT1(alpha)) and their corresponding labels.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides a clear example of a protein entity (TCL1) and its corresponding label.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear examples of cell type entity (T cell) and protein entity (interleukin 2) and their corresponding labels.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides clear examples of protein entities (NF-kappaB, Sp1) and cell line entity (SIVmac) and their corresponding labels.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides clear examples of protein entities (ATF1, CREB, H4) and their corresponding labels.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence provides clear examples of DNA entity (HIV-1 LTR) and protein entities (NFAT-1, NF kappa B) and their corresponding labels.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides clear examples of protein entities (tal-1, GATA-binding proteins) and cell type entity (hematopoiesis) and their corresponding labels.\"}\n]",
        "response3": "[{'HTLV-I': 'cell_type'}, {'TRE': 'DNA'}, {'Tax': 'protein'}]",
        "prediction": "{'HTLV-I': 'cell_type', 'TRE': 'DNA', 'Tax': 'protein'}"
    },
    {
        "idx": 43,
        "sentence": "T-helper-cell determinants in protein antigens are preferentially located in cysteine-rich antigen segments resistant to proteolytic cleavage by cathepsin B , L , and D .",
        "label": {
            "cysteine-rich antigen segments": "protein",
            "T-helper-cell determinants": "protein",
            "protein antigens": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"By immunization with a recombinant fusion protein, we show that TCF-1 knock-out mice readily yield antiserum titers against human and mouse TCF-1 protein.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase (MPO) and lysozyme (LZ), as well as the transcription factor PU.1, were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"The two related protein-tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 5},\n    {\"By using immunohistochemistry with antibodies against proteins encoded by a particular gene in a cluster, the identity of the cell type within the tumor specimen that contributed the observed gene expression pattern could be determined.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease.\": 4},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50.\": 4},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 4},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1204,
        "sentence": "Hirsutism , graded by the modified Ferriman-Gallwey score , and hormonal parameters were evaluated basally and at 4-month intervals during treatment.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mention of the entity label 'cell_line' in the sentence, aiding in the extraction process.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1134,
        "sentence": "Reverse transcriptase (RT) assays were positive in purified viral material from both LCLs .",
        "label": {
            "LCLs": "cell_line"
        },
        "response1": "['protein', 'cell_line']",
        "response2": "[\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 5},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 4},\n    {\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti-EBV antibody titres (P > 0.05).\": 3},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat (LTR) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 5},\n    {\"Similar results were obtained when mutants of SIVmacMER (a macrophage-competent derivative of SIVmac239) were tested in peripheral blood mononuclear cell and CEMx174 cultures.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1) and p27(KIP1) mRNA and protein increased in these cells.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"In addition, assay of PBMC by the adenovirus-specific PCR may help detect early invasive disease and warrants further evaluation.\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 5},\n    {\"The T cell tyrosine kinase ZAP-70 was found to be highly responsive to UV and H2O2 treatment.\": 4},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 471,
        "sentence": "The lymphocyte nuclear T3 receptor was found with an affinity close to that of normal volunteers (Ka: 1.42 x 10(10) M-1 vs 1.95 +/- 0.35 x 10(10) M-1) and a binding capacity markedly increased (9.9 vs 3.7 +/- 0.4 fmol T3 /100 micrograms DNA).",
        "label": {
            "lymphocyte nuclear T3 receptor": "protein"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"T3 receptor\": \"protein\"}, {\"DNA\": \"DNA\"}]",
        "prediction": "{'T3 receptor': 'protein', 'DNA': 'DNA'}"
    },
    {
        "idx": 1205,
        "sentence": "Gonadotropin-releasing hormone and ACTH stimulation tests were performed before and after 3 to 4 months of therapy .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 2\": 3},\n    {\"Reason 2\": \"The sentence provides one example of a named entity with its corresponding entity label, which is somewhat helpful for extracting named entities from the target sentence.\"},\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it quite helpful for extracting named entities from the target sentence.\"},\n    {\"Example 4\": 3},\n    {\"Reason 4\": \"The sentence provides one example of a named entity with its corresponding entity label, which is somewhat helpful for extracting named entities from the target sentence.\"},\n    {\"Example 5\": 4},\n    {\"Reason 5\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it quite helpful for extracting named entities from the target sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 8\": 4},\n    {\"Reason 8\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it quite helpful for extracting named entities from the target sentence.\"},\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it quite helpful for extracting named entities from the target sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it quite helpful for extracting named entities from the target sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it quite helpful for extracting named entities from the target sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence provides multiple examples of named entities with their corresponding entity labels, making it very helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 14,
        "sentence": "Moreover, platelet-activating factor was capable of inducing transcription of the nuclear proto-oncogenes c-fos and c-jun .",
        "label": {
            "c-fos": "DNA",
            "nuclear proto-oncogenes": "DNA",
            "c-jun": "DNA",
            "platelet-activating factor": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names and cell types that are directly mentioned, making it highly relevant for extracting named entities from the target sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence provides specific protein names and a cell type that are directly mentioned, aiding in extracting named entities from the target sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence mentions specific protein names that are directly related to the entity types in the target sentence, making it highly helpful for entity extraction.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The sentence contains specific protein names that are directly related to the entity types in the target sentence, making it highly relevant for entity extraction.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence provides specific protein names that are directly related to the entity types in the target sentence, aiding in extracting named entities effectively.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The sentence mentions specific protein names and stimuli that are directly related to the entity types in the target sentence, making it highly relevant for entity extraction.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence contains specific protein names and cell types that are related to the entity types in the target sentence, providing relevant information for entity extraction.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence mentions a specific protein name that is directly related to the entity types in the target sentence, aiding in extracting named entities effectively.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence provides specific protein names that are directly related to the entity types in the target sentence, making it highly helpful for entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names that are directly related to the entity types in the target sentence, making it highly relevant for entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence mentions a specific protein name that is directly related to the entity types in the target sentence, aiding in extracting named entities effectively.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence provides specific protein names that are directly related to the entity types in the target sentence, making it highly helpful for entity extraction.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence mentions a specific protein name that is directly related to the entity types in the target sentence, aiding in extracting named entities effectively.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains a specific protein name that is directly related to the entity types in the target sentence, making it highly relevant for entity extraction.\"}\n]",
        "response3": "[{\"c-fos\": \"protein\"}, {\"c-jun\": \"protein\"}]",
        "prediction": "{'c-fos': 'protein', 'c-jun': 'protein'}"
    },
    {
        "idx": 145,
        "sentence": "Two consensus sequences, called X and Y boxes , capable of binding nuclear proteins and regulating expression in B cells have been defined within the immediate upstream region of major histocompatibility complex (MHC) class II promoters .",
        "label": {
            "nuclear proteins": "protein",
            "major histocompatibility complex (MHC) class II promoters": "DNA",
            "B cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor.\": 5},\n    {\"Transcription of the germ-line IgH genes is controlled by intervening (I) regions upstream of their switch regions.\": 4},\n    {\"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"T lymphocytes recognize antigens in the form of peptides bound to HLA-molecules.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 5},\n    {\"Thus, Oct-2A and HMG I/Y may synergize to activate HLA-DRA expression in B cells.\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells.\": 5},\n    {\"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 5},\n    {\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells.\": 5},\n    {\"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif.\": 5}\n]",
        "response3": "[{\"X boxes\": \"protein\"}, {\"Y boxes\": \"protein\"}, {\"B cells\": \"cell_type\"}, {\"major histocompatibility complex (MHC) class II promoters\": \"DNA\"}]",
        "prediction": "{'X boxes': 'protein', 'Y boxes': 'protein', 'B cells': 'cell_type', 'major histocompatibility complex (MHC) class II promoters': 'DNA'}"
    },
    {
        "idx": 1449,
        "sentence": "DNA binding specificity of complex 3 overlaps with that of upstream stimulatory factor but is clearly distinct.",
        "label": {
            "upstream stimulatory factor": "protein"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"A-myb\": 4},\n    {\"Protein\": 4},\n    {\"NF-kappa B\": 5, \"AP-1\": 5},\n    {\"UAS3\": 4, \"UAS2\": 4, \"YY1\": 4},\n    {\"UAS1\": 3, \"B cell\": 3},\n    {\"DNA\": 5},\n    {\"NF-ATc\": 5, \"T lymphocytes\": 4, \"embryonic cardiac cells\": 4},\n    {\"PU.1\": 4, \"M-CSF receptor\": 4, \"macrophage\": 4},\n    {\"T cell\": 4, \"interleukin 2\": 4},\n    {\"EKLF\": 5, \"CBP\": 5, \"p300\": 5, \"P/CAF\": 5},\n    {\"RelA\": 5, \"NF-kappaB1\": 5},\n    {\"immunoglobulin kappa 3' enhancer\": 4},\n    {\"NF-kappa B\": 5},\n    {\"NF-kappaB\": 5, \"Sp1\": 5, \"p50\": 5},\n    {\"Jun\": 5, \"ATF-2\": 5},\n    {\"p50p50\": 5}\n]",
        "response3": "[{\"DNA\": \"DNA\"}]",
        "prediction": "{'DNA': 'DNA'}"
    },
    {
        "idx": 1292,
        "sentence": "Promoter function of the 5' flanking region of the thromboxane receptor gene was evaluated by transfection of thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids into platelet-like K562 cells .",
        "label": {
            "thromboxane receptor": "protein",
            "thromboxane receptor gene": "DNA",
            "CAT": "protein",
            "chloramphenicol acetyltransferase": "protein",
            "5' flanking region": "DNA",
            "thromboxane receptor gene promoter/ chloramphenicol acetyltransferase ( CAT ) chimera plasmids": "DNA",
            "K562 cells": "cell_line"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific cell types expressed by human Th2-type lymphocytes, which matches the 'cell_type' entity label.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions specific proteins such as c-kit and IL-4R alpha chain, which match the 'protein' entity label.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence refers to a lineage-specific transcription factor GATA-1, which matches the 'protein' entity label.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence contains proteins like Stat3, Stat5, and c-Mpl, which match the 'protein' entity label.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence mentions the protein TCF-1, which matches the 'protein' entity label.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence includes proteins such as PAFR, PAF, NF-kappa B, and protein kinase C, which match the 'protein' entity label.\"},\n{\"Example 7\": 4},\n{\"Reason 7\": \"The sentence mentions proteins Sp1 and CD14, which match the 'protein' entity label.\"},\n{\"Example 8\": 4},\n{\"Reason 8\": \"The sentence refers to the protein E2A, which matches the 'protein' entity label.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence contains proteins like IFN A, interleukin-2, interleukin-2 receptor, phytohemagglutinin, and phorbol myristate acetate, which match the 'protein' entity label.\"},\n{\"Example 10\": 4},\n{\"Reason 10\": \"The sentence mentions the protein CD95 ligand, which matches the 'protein' entity label.\"},\n{\"Example 11\": 4},\n{\"Reason 11\": \"The sentence refers to the cell line SCM-1, which matches the 'cell_line' entity label.\"},\n{\"Example 12\": 5},\n{\"Reason 12\": \"The sentence contains cell types like B and T cells, and cell lines Ramos and Jurkat, which match the 'cell_type' and 'cell_line' entity labels, respectively.\"},\n{\"Example 13\": 4},\n{\"Reason 13\": \"The sentence mentions cell line Ter 119 and proteins beta-globin, glycoprotein IIb, and platelet factor 4, which match the 'cell_line' and 'protein' entity labels.\"},\n{\"Example 14\": 4},\n{\"Reason 14\": \"The sentence includes proteins ATF1, CREB, and H4, which match the 'protein' entity label.\"},\n{\"Example 15\": 5},\n{\"Reason 15\": \"The sentence contains DNA elements like BAT box, protein CD20, and cell type B cells, which match the 'DNA', 'protein', and 'cell_type' entity labels.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions DNA elements IL-2, protein NFAT, NFAT delta418, calcineurin, Tpl-2, and cyclosporin A, which match the 'DNA' and 'protein' entity labels.\"}\n]",
        "response3": "[{\"thromboxane receptor gene\": \"protein\"}, {\"thromboxane receptor gene promoter\": \"protein\"}, {\"chloramphenicol acetyltransferase (CAT)\": \"protein\"}, {\"K562 cells\": \"cell_line\"}]",
        "prediction": "{'thromboxane receptor gene': 'protein', 'thromboxane receptor gene promoter': 'protein', 'chloramphenicol acetyltransferase (CAT)': 'protein', 'K562 cells': 'cell_line'}"
    },
    {
        "idx": 120,
        "sentence": "Two other T cell lines , CEM and RPMI 8402 , have essentially identical deletions.",
        "label": {
            "RPMI 8402": "cell_line",
            "T cell lines": "cell_line",
            "CEM": "cell_line"
        },
        "response1": "['cell_line']",
        "response2": "[\n    {\"SIVmacMER\": 5, \"SIVmac239\": 5, \"CEMx174\": 5},\n    {\"Protein\": 4},\n    {\"MNDA\": 4, \"myeloid cell lines\": 5},\n    {\"Runt domain\": 4},\n    {\"CREB\": 4, \"AR-CRE\": 4},\n    {\"WT1\": 4},\n    {\"T cell\": 5, \"interleukin 2\": 4},\n    {\"PBMC\": 5, \"adenovirus DNA\": 5},\n    {\"FasL\": 4, \"IL-2\": 4, \"IFN-gamma\": 4},\n    {\"PU.1\": 4, \"M-CSF receptor\": 4, \"macrophage\": 5},\n    {\"TCL1\": 4},\n    {\"ZEBRA\": 4},\n    {\"CD70\": 4, \"B cell\": 5, \"plasma cells\": 5, \"IL-4\": 4, \"CD40\": 4},\n    {\"GM-CSF\": 4},\n    {\"EBV\": 5, \"B-cell\": 5},\n    {\"granulocytes\": 5, \"T cells\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 468,
        "sentence": "A 52-year-old male presented himself with tachycardia crises which appeared first during childhood, increased in frequency without goiter or exophthalmos .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 5},\n    {\"In comparison, PBMC from two children with fatal adenoviral infection were both strongly positive for adenovirus DNA.\": 4},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"Exclusive paternal expression of WT1 was also shown in non-cultured peripheral lymphocytes from the latter two individuals.\": 3},\n    {\"By the time of diagnosis of T-PLL, the clone contains many more genetic changes in the form of additional translocations.\": 4},\n    {\"Energy substrates, hormone responses and glucocorticoid binding in lymphocytes during intense physical exercise in humans following phosphocreatine administration.\": 3},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients, and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 4},\n    {\"Hence, it has been proposed that ectopic expression of TAL1 promotes the development of T-ALL.\": 4},\n    {\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n    {\"It was found that expression of wild-type RXR and of the RXR mutants devoid of AF-1 and/or AF-2 supported a transient outgrowth of erythroid cells.\": 4},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Expression of tal-1 and GATA-binding proteins during human hematopoiesis.\": 4},\n    {\"Expression of either the TCL1 oncogene, or transcripts from its homologue MTCP1/c6.1B, in leukaemic and non-leukaemic T cells from ataxia telangiectasia patients.\": 4},\n    {\"Initiation of proliferation but not of differentiation was followed by a 20- to 25-fold increase in the nuclear level of the DNA polymerase-associated processivity factor PCNA and of the proliferation-specific transcription factor E2F1.\": 5},\n    {\"A total of 37 chronic, severe, nonsmoking asthmatic patients with documented reversible airways obstruction were classified as glucocorticoid-sensitive or -resistant on the basis of changes in FEV1, FVC, and peak expiratory flow (PEF) after oral prednisolone.\": 4}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 138,
        "sentence": "The effects of TNF-alpha on gene expression were examined by transient expression assays using reporter chloramphenicol acetyltransferase plasmids linked to regulatory elements from the HIV long terminal repeat ( LTR ) and the beta interferon promoter .",
        "label": {
            "beta interferon promoter": "DNA",
            "regulatory elements": "DNA",
            "HIV long terminal repeat": "DNA",
            "TNF-alpha": "protein",
            "LTR": "DNA",
            "reporter chloramphenicol acetyltransferase plasmids": "DNA"
        },
        "response1": "['protein', 'DNA']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 4},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 4},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5},\n    {\"Reasons\": \"The examples provided contain specific entities mentioned in the target sentence and their corresponding entity labels, which directly relate to the entity types present in the target sentence. This makes it highly helpful for extracting named entities from the target sentence.\"}\n]",
        "response3": "[{\"HIV long terminal repeat ( LTR )\": \"DNA\"}, {\"beta interferon promoter\": \"DNA\"}, {\"TNF-alpha\": \"protein\"}, {\"chloramphenicol acetyltransferase\": \"protein\"}]",
        "prediction": "{'HIV long terminal repeat ( LTR )': 'DNA', 'beta interferon promoter': 'DNA', 'TNF-alpha': 'protein', 'chloramphenicol acetyltransferase': 'protein'}"
    },
    {
        "idx": 64,
        "sentence": "Uninduced or Sendai virus induced HeLa extracts were used to examine transcription in vitro using a series of IFN beta promoter deletions .",
        "label": {
            "IFN beta promoter deletions": "DNA"
        },
        "response1": "['cell_line', 'protein']",
        "response2": "[\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14.\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg.\": 4},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 4},\n    {\"Binding of the cDNA fusion protein , similarly to the results obtained with purified Jurkat protein, was decreased by introduction of site-specific mutations in the DRE 1 regulatory sequence.\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5},\n    {\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner.\": 5},\n    {\"We found that they reduced the initial interleukin-1beta mRNA transcription rate through prevention of degradation of inhibitor-kappaB alpha.\": 4},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter.\": 4},\n    {\"We conclude, rather, that alpha 4 beta 1 in freshly isolated T cells delivers a distinct signal that synergizes early with signals initiated by TCR/CD3 ligation to induce DNA binding of multiple transcription factors required for cytokine gene induction.\": 5},\n    {\"Extracts prepared from XP-B and XP-D lymphoblastoid cells exhibited similar transcription activity from the adenovirus major late promoter when compared to that in extracts from normal cells.\": 4}\n]",
        "response3": "[{\"HeLa\": \"cell_line\"}, {\"IFN beta\": \"protein\"}]",
        "prediction": "{'HeLa': 'cell_line', 'IFN beta': 'protein'}"
    },
    {
        "idx": 1760,
        "sentence": "This inhibitory effect was limited to the first 2 h after mitogenic activation , localizing the time-frame of action of cysteamine to within the commitment period .",
        "label": {},
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence provides a clear and direct association between the entity 'NF-E2' and the entity type 'protein', making it highly helpful for extracting named entities.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence directly links 'P selectin' to the entity type 'protein', aiding in the extraction of named entities, but the association is not as explicit as in Example 1.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains multiple clear associations between entities and their corresponding types, providing valuable information for named entity extraction.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence provides associations between 'TIMP-1' and 'protein', as well as 'DNA' and 'DNA', which are helpful for named entity extraction, but the context could be more explicit.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence clearly links multiple entities to their corresponding types, offering valuable information for named entity extraction.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence directly associates 'G-CSF' with the entity type 'protein', aiding in named entity extraction, but the context could be more detailed.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The sentence provides clear associations between entities and their types, offering valuable information for named entity extraction.\"},\n    {\"Example 8\": 3},\n    {\"Reason 8\": \"The sentence mentions 'cell adhesion molecules' in the context of inhibition, which could be helpful for named entity extraction, but the association is not as direct as in other examples.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains multiple clear associations between entities and their corresponding types, providing valuable information for named entity extraction.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence directly links 'NF-kappa B' to the entity type 'protein', aiding in named entity extraction.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence provides clear associations between entities and their types, offering valuable information for named entity extraction.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The sentence directly links 'Egr-1' to the entity type 'RNA', aiding in named entity extraction.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence provides associations between entities and their types, but the context could be more explicit for some entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The sentence contains clear associations between entities and their types, offering valuable information for named entity extraction.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 676,
        "sentence": "The interleukin 2 ( IL-2 ) gene promoter is recognized by several cell-type-specific and ubiquitous transcriptional regulators that integrate information transmitted by various signaling systems leading to IL-2 production and T-cell activation .",
        "label": {
            "IL-2": "protein",
            "interleukin 2": "protein",
            "interleukin 2 ( IL-2 ) gene promoter": "DNA",
            "T-cell": "cell_type"
        },
        "response1": "['DNA', 'cell_type', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"interleukin 2\": \"protein\"}, {\"IL-2\": \"protein\"}, {\"T-cell\": \"cell_type\"}]",
        "prediction": "{'interleukin 2': 'protein', 'IL-2': 'protein', 'T-cell': 'cell_type'}"
    },
    {
        "idx": 1052,
        "sentence": "Thus, after 4 hr of exposure to SEA and SEB , the expression of IL-2R beta was down-regulated, IL-2R gamma was slightly up-regulated, while IL-2R alpha remained largely unaffected.",
        "label": {
            "IL-2R alpha": "protein",
            "SEA": "protein",
            "IL-2R gamma": "protein",
            "SEB": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 4},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}, {\"IL-2R alpha\": \"protein\"}]",
        "prediction": "{'IL-2R beta': 'protein', 'IL-2R gamma': 'protein', 'IL-2R alpha': 'protein'}"
    },
    {
        "idx": 487,
        "sentence": "Therefore, in normal human monocytes M-CSF induces immediate early response genes without inducing cell proliferation.",
        "label": {
            "human monocytes": "cell_type",
            "normal human monocytes": "cell_type",
            "M-CSF": "protein",
            "immediate early response genes": "DNA"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 570,
        "sentence": "Modulation of these events at the time of adherence offers a mechanism by which differential priming of the cells may be accomplished.",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"The mechanism of inhibition is related to the surface expression of several cell adhesion molecules.\": 3},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"Yet, for many pathogens, the molecules that induce IL-12 production by macrophages and the mechanisms by which they do so remain undefined.\": 4},\n    {\"Regulation of CD14 expression during monocytic differentiation induced with 1 alpha,25-dihydroxyvitamin D3.\": 3},\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Finally, using electrophoretic mobility shift assays, evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 4},\n    {\"Together, these results show that NF-kappa B controls the expression of I kappa B alpha by means of an inducible autoregulatory pathway.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 5},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 4},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 3},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1370,
        "sentence": "Although anti- CD28 MoAb costimulation enhances all of the above signals, NF kappa B and IL-2 levels remain lower than in adults , suggesting the need for further activation requirements in the neonate .",
        "label": {
            "CD28": "protein",
            "anti- CD28 MoAb": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 5},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5}\n]",
        "response3": "[{\"NF kappa B\": \"protein\"}, {\"IL-2\": \"protein\"}]",
        "prediction": "{'NF kappa B': 'protein', 'IL-2': 'protein'}"
    },
    {
        "idx": 994,
        "sentence": "The role of BSAP ( Pax-5 ) in B-cell development .",
        "label": {
            "BSAP": "protein",
            "Pax-5": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Th1 and Th2 effector functions and their development are attributable to their distinct cytokine expression patterns.\": 3},\n    {\"Molecular cloning of SLAP-130, an SLP-76-associated substrate of the T cell antigen receptor-stimulated protein tyrosine kinases.\": 4},\n    {\"A critical role of Sp1- and Ets- related transcription factors in maintaining CTL-specific expression of the mouse perforin gene.\": 4},\n    {\"The upstream regions UAS3 (-1168 to -440) and UAS2 (-352 to -264) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"IL-13, a cytokine similar to IL-4, is a regulator of human B cell and monocyte functions.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes.\": 3},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 3},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis, transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes.\": 4},\n    {\"By contrast, UAS1 (-140 to -87) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines.\": 4},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4},\n    {\"In this paper, I described the characterization of genes encoding eosinophil granule proteins and the mRNA expression of GATA-1 binding transcription factor during eosinophil differentiation.\": 4}\n]",
        "response3": "[{\"BSAP\": \"protein\"}, {\"Pax-5\": \"protein\"}, {\"B-cell\": \"cell_type\"}]",
        "prediction": "{'BSAP': 'protein', 'Pax-5': 'protein', 'B-cell': 'cell_type'}"
    },
    {
        "idx": 438,
        "sentence": "This sequence motif is a binding site for nuclear proteins , the so-called octamer transcription factors ( Oct or OTF factors ).",
        "label": {
            "OTF factors": "protein",
            "nuclear proteins": "protein",
            "sequence motif": "DNA",
            "octamer transcription factors": "protein",
            "Oct": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 5},\n    {\"Activated Stat proteins form homo- or heterodimers, translocate to the nucleus , and induce transcription from responsive genes.\": 4},\n    {\"We find that EKLF is an acetylated transcription factor , and that it interacts in vivo with CBP , p300 , and P/CAF .\": 5},\n    {\"The transcription factor NF-ATc that controls gene expression in T lymphocytes and embryonic cardiac cells is expressed in three prominent isoforms.\": 4},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Nuclear factor NF-kB , activation protein 1 ( AP-1 ), OCT-1 , and NF-IL-2B binding activity were normal.\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 4},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 3},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 4},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 5},\n    {\"Jun is essential for activation-induced transcription and binds preferably as a heterodimer with ATF-2 .\": 5},\n    {\"The p50 and p65 proteins , constituents of the prototypic nuclear factor kappaB , were identified as components of the DNA-protein complexes by anti-peptide antibodies in gel supershift assays .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 270,
        "sentence": "There was evidence for an autosomal recessive form of inheritance in four families, while the other four families appeared to have an autosomal dominant mode of transmission .",
        "label": {},
        "response1": "['DNA']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 5},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 4},\n    {\"Example 8\": 4},\n    {\"Example 9\": 5},\n    {\"Example 10\": 5},\n    {\"Example 11\": 4},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1481,
        "sentence": "We, therefore, propose the activation scheme presented in FIGURE 3 for T-cell costimulation .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"We demonstrate that although the individual components of this element do not respond to IL-2 , together they form a composite element capable of conferring IL-2 responsiveness to a heterologous promoter .\": 4},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B .\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor , demonstrating that this form of costimulation by CD28 was independent of IL-2 .\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils .\": 5},\n    {\"Upon cotransfection into non-T cells , TCF-1 could transactivate through its cognate motif.\": 4},\n    {\"The two related protein- tyrosine kinases Syk and Zap are rapidly phosphorylated on tyrosine residues and enzymatically activated upon crosslinking of the T cell antigen receptor .\": 5},\n    {\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 4},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells , but not in primary T cells , consistent with the lack of the IL-12 receptor in resting T cells .\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1807,
        "sentence": "We show that the expression of four cell genes , cdc-2 , cyclin E , CD23 , and cyclin D2 , are up-regulated approximately 100-fold as a result of EBV -mediated immortalization .",
        "label": {
            "cell genes": "DNA",
            "cyclin E": "DNA",
            "cyclin D2": "DNA",
            "CD23": "DNA",
            "cdc-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n{\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 5},\n{\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production .\": 5},\n{\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling .\": 5},\n{\"However, during infection by EBV , ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines .\": 4},\n{\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum , while controls underwent apoptosis .\": 4},\n{\"Demonstration of replicative gene expression did not correlate with either low CD4+ cell counts (P > 0.05) or anti- EBV antibody titres (P > 0.05).\": 4},\n{\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n{\"These data suggest that EBV is using a common pathway for B-cell activation bypassing the requirement for antigen, T-cell signals and growth factors .\": 4},\n{\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n{\"We find that TCL1 is expressed in the majority of AIDS IBLP tumors examined.\": 4},\n{\"The balance between repression by ZEB and transcriptional activation by c-Myb /Ets provides a flexible regulatory mechanism for controlling gene expression in hematopoietic cells .\": 5},\n{\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB .\": 5},\n{\"To investigate processes related to B and T cell activation , the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology .\": 5},\n{\"We generated conditional EBV mutants by expressing EBNA2 as chimeric fusion protein with the hormone binding domain of the estrogen receptor on the genetic background of the virus.\": 5},\n{\"Here we demonstrate that fusion of HeLa cells with either diploid or tetraploid B cells ( Daudi ) results in widespread extinction of several other B cell-encoded genes that are expressed in a B cell-specific manner .\": 5},\n{\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5}\n]",
        "response3": "[{\"cdc-2\": \"protein\"}, {\"cyclin E\": \"protein\"}, {\"CD23\": \"protein\"}, {\"cyclin D2\": \"protein\"}, {\"EBV\": \"cell_line\"}]",
        "prediction": "{'cdc-2': 'protein', 'cyclin E': 'protein', 'CD23': 'protein', 'cyclin D2': 'protein', 'EBV': 'cell_line'}"
    },
    {
        "idx": 1169,
        "sentence": "However, B4-2 has an unusually high proline content (13%), contains a putative nuclear targeting sequence , and has several SPXX motifs which are frequently found in gene regulatory proteins .",
        "label": {
            "SPXX motifs": "protein",
            "nuclear targeting sequence": "protein",
            "gene regulatory proteins": "protein",
            "B4-2": "DNA"
        },
        "response1": "['protein']",
        "response2": "```json\n[\n    {\n        \"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role.\": 3\n    },\n    {\n        \"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells.\": 4\n    },\n    {\n        \"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts .\": 4\n    },\n    {\n        \"There are other elements regulating IL-4 gene expression , however, and the relative importance of these recently identified proteins has yet to be determined.\": 3\n    },\n    {\n        \"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 4\n    },\n    {\n        \"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5\n    },\n    {\n        \"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50 .\": 3\n    },\n    {\n        \"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5\n    },\n    {\n        \"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3\n    },\n    {\n        \"On the other hand, PNU156804 efficiently inhibits the activation of the NF-kappa B and AP-1 transcription factors.\": 4\n    },\n    {\n        \"The PB1 sequence motif is highly conserved in both human and murine GM-CSF genes .\": 4\n    },\n    {\n        \"The upstream regions UAS3 ( -1168 to -440 ) and UAS2 ( -352 to -264 ) both functioned in a cell lineage-independent manner and were together responsible for the bulk of Wp activity in non-B cells ; mutational analysis indicated the importance of a YY1 binding site in UAS2 in that context.\": 4\n    },\n    {\n        \"The third member of the family , A-myb , shows the most restricted pattern of expression, suggesting a very specific role for this transcription factor .\": 3\n    },\n    {\n        \"By contrast, UAS1 ( -140 to -87 ) was B cell specific and was the key determinant of the promoter's increased activity in B cell lines .\": 4\n    },\n    {\n        \"However, like normal Ter 119 erythroid cells , these Ter 119 positive cells from transgenic mice still expressed high levels of beta-globin and very low or undetectable glycoprotein IIb and platelet factor 4 megakaryocytic transcripts .\": 5\n    },\n    {\n        \"We report here that three copies of the GC-box can functionally compensate for the GM-kappa B/ GC-box region , suggesting that the GC-motif can function independently of the GM-kappa B motif .\": 4\n    }\n]\n```",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1180,
        "sentence": "We therefore propose that IL-2 receptor signal transduction does not depend on equimolar heterodimerization of JAK1 and JAK3 following IL-2 -induced heterodimerization of IL-2R beta and IL-2R gamma .",
        "label": {
            "IL-2R": "protein",
            "IL-2": "protein",
            "IL-2R gamma": "protein",
            "JAK3": "protein",
            "IL-2 receptor": "protein",
            "JAK1": "protein",
            "IL-2R beta": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"In the present study, structure/function analyses of the IL-7R complex using a chimeric receptor system demonstrated that gamma(c) is indeed critical for IL-7R function.\": 5},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway, and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 (IL-10R) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"There are other elements regulating IL-4 gene expression, however, and the relative importance of these recently identified proteins has yet to be determined.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"We demonstrate that IL-12 induces STAT4 only in freshly isolated primary NK cells, but not in primary T cells, consistent with the lack of the IL-12 receptor in resting T cells.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6, STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax-independent mechanism in leukemic cells of ATL patients, possibly due to differential NF-kappaB subunit activation.\": 5},\n    {\"Moreover T cell proliferation was unaffected by the addition of blocking Abs to both IL-2 and the IL-2 receptor, demonstrating that this form of costimulation by CD28 was independent of IL-2.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Thus, our data indicate that Stat3 and Stat5 may be involved in signal transduction after ligand binding to c-Mpl and that this event may have a role in megakaryopoiesis/thrombopoiesis or possibly a mature platelet function such as aggregation.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter.\": 4}\n]",
        "response3": "[{\"IL-2\": \"protein\"}, {\"JAK1\": \"protein\"}, {\"JAK3\": \"protein\"}, {\"IL-2R beta\": \"protein\"}, {\"IL-2R gamma\": \"protein\"}]",
        "prediction": "{'IL-2': 'protein', 'JAK1': 'protein', 'JAK3': 'protein', 'IL-2R beta': 'protein', 'IL-2R gamma': 'protein'}"
    },
    {
        "idx": 968,
        "sentence": "These observations demonstrate directly that there is de novo synthesis of NF-kappa B during human lymphocyte activation and suggest that this process is hormonally regulated.",
        "label": {
            "NF-kappa B": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sentence 1\": 5},\n    {\"Sentence 2\": 5},\n    {\"Sentence 3\": 5},\n    {\"Sentence 4\": 4},\n    {\"Sentence 5\": 4},\n    {\"Sentence 6\": 5},\n    {\"Sentence 7\": 5},\n    {\"Sentence 8\": 5},\n    {\"Sentence 9\": 5},\n    {\"Sentence 10\": 5},\n    {\"Sentence 11\": 4},\n    {\"Sentence 12\": 5},\n    {\"Sentence 13\": 5},\n    {\"Sentence 14\": 5},\n    {\"Sentence 15\": 5}\n]",
        "response3": "[{\"NF-kappa B\": \"protein\"}]",
        "prediction": "{'NF-kappa B': 'protein'}"
    },
    {
        "idx": 497,
        "sentence": "The differentiation of T cells into functionally diverse subpopulations is controlled in part, by transcriptional activation and silencing ; however, little is known in detail about the proteins that influence this developmental process .",
        "label": {
            "T cells": "cell_type"
        },
        "response1": "['protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Example 3\": 4\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Example 5\": 4\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Example 9\": 4\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Example 11\": 4\n    },\n    {\n        \"Example 12\": 4\n    },\n    {\n        \"Example 13\": 4\n    },\n    {\n        \"Example 14\": 4\n    },\n    {\n        \"Example 15\": 4\n    }\n]",
        "response3": "[{\"T cells\": \"cell_type\"}]",
        "prediction": "{'T cells': 'cell_type'}"
    },
    {
        "idx": 1606,
        "sentence": "Triggering of complement receptors CR1 ( CD35 ) and CR3 ( CD11b/CD18 ) induces nuclear translocation of NF-kappa B ( p50/p65 ) in human monocytes and enhances viral replication in HIV-infected monocytic cells .",
        "label": {
            "CD11b/CD18": "protein",
            "CD35": "protein",
            "p50/p65": "protein",
            "CR1": "protein",
            "HIV-infected monocytic cells": "cell_type",
            "complement receptors": "protein",
            "human monocytes": "cell_type",
            "NF-kappa B": "protein",
            "CR3": "protein"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells.\": 5},\n    {\"Flow cytometric and morphological analyses demonstrated that the addition of CD70 transfectants to B cell cultures remarkably promoted differentiation into plasma cells in the presence of IL-4 and CD40 signaling.\": 5},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV, to NFAT-mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma, as determined by a lack of activation of jak kinases and the transcription factor, STAT1(alpha), a signal transducer and activator of transcription.\": 5},\n    {\"Adherence-isolated monocytes showed constitutive DNA binding activity of NF-kappa B.\": 4},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation.\": 5},\n    {\"Activation of human monocytic cells by Treponema pallidum and Borrelia burgdorferi lipoproteins and synthetic lipopeptides proceeds via a pathway distinct from that of lipopolysaccharide but involves the transcriptional activator NF-kappa B.\": 5},\n    {\"We conclude that NF-kappa B activation could constitute one of the mechanisms whereby the expression of kappa B-responsive genes is enhanced in phagocytosing neutrophils.\": 4},\n    {\"CD40 expression could be enhanced in CD40-positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering.\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha (MIP-1 alpha) and its human equivalent (GOS19, LD78, or AT464) are members of the -C-C family of low-molecular-weight chemokines.\": 5},\n    {\"Findings that xenogeneic serum promotes leukocyte-endothelium interaction possibly through NF-kappa B activation might be relevant for designing future therapeutic strategies aimed at prolonging xenograft survival.\": 4},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"ICAM-1 and CD71 are nevertheless up-regulated by LMP1 in primary B cells and cell lines expressing the dominant IkappaB.\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha-induced HIV activation, this receptor was still involved in the viral activation process.\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B.\": 5}\n]\n```",
        "response3": "```json\n[{\"CR1\": \"protein\"}, {\"CD35\": \"protein\"}, {\"CR3\": \"protein\"}, {\"CD11b/CD18\": \"protein\"}, {\"NF-kappa B\": \"protein\"}, {\"p50/p65\": \"protein\"}, {\"monocytes\": \"cell_type\"}, {\"HIV-infected monocytic cells\": \"cell_type\"}]\n```",
        "prediction": "{'CR1': 'protein', 'CD35': 'protein', 'CR3': 'protein', 'CD11b/CD18': 'protein', 'NF-kappa B': 'protein', 'p50/p65': 'protein', 'monocytes': 'cell_type', 'HIV-infected monocytic cells': 'cell_type'}"
    },
    {
        "idx": 1653,
        "sentence": "Expression of PU.1 in nonmyeloid cells can activate the GM-CSF receptor alpha promoter .",
        "label": {
            "nonmyeloid cells": "cell_type",
            "GM-CSF": "protein",
            "PU.1": "protein",
            "GM-CSF receptor alpha promoter": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"IL4 and IL13 receptors share the gamma c chain and activate STAT6 , STAT3 and STAT5 proteins in normal human B cells .\": 5},\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 4},\n    {\"CD40 expression could be enhanced in CD40 -positive MM by stimulation with IFN-gamma and tumor necrosis factor-alpha but not by interleukin (IL)-1beta or CD40 triggering .\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells .\": 4},\n    {\"In this work, we show that human peripheral blood T cells that are stimulated through the TCR and expanded with IL-2 are unresponsive to IFN-gamma , as determined by a lack of activation of jak kinases and the transcription factor , STAT1(alpha) , a signal transducer and activator of transcription.\": 5},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 4},\n    {\"PMA induced the expression of both CD14 and CD23 mRNA and protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction .\": 4},\n    {\"To test this latter possibility, a chimeric receptor containing the extracellular domain of c-kit (the stem cell factor (SCF) receptor ) and the cytoplasmic and transmembrane domains of the IL-4R alpha chain was generated.\": 5},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset .\": 5},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"Mutation of the major Sp1 binding site ( -110 bp ) decreased tissue-specific promoter activity, and these results, together with transactivation experiments , demonstrate that Sp1 plays a critical role in the tissue-specific expression of CD14 in monocytic cells .\": 5},\n    {\"[An overexpression of retinoic acid receptor alpha blocks myeloid cell differentiation at the promyelocyte stage ]\": 4},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor .\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation .\": 5},\n    {\"Murine macrophage inflammatory protein 1 alpha ( MIP-1 alpha ) and its human equivalent ( GOS19 , LD78 , or AT464 ) are members of the -C-C family of low-molecular-weight chemokines .\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 833,
        "sentence": "Mapping of B-cell epitopes of the human hepatitis B virus X protein .",
        "label": {
            "human hepatitis B virus X protein": "protein",
            "B-cell epitopes": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The sentence contains the term 'cDNAs' which is likely referring to DNA, making it highly relevant for extracting named entities from the target sentence.\"},\n\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The sentence contains multiple terms such as 'SP1', 'caspases', and 'B-cell' which are directly related to protein and cell_type entities mentioned in the target sentence, making it extremely helpful for entity extraction.\"},\n\n    {\"Example 3\": 4},\n    {\"Reason 3\": \"The sentence mentions 'Th2-type lymphocytes' which corresponds to the cell_type entity in the target sentence, providing relevant information for entity extraction.\"},\n\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence discusses the 'E2A gene at the protein level' and 'E2A protein', aligning with the protein entity in the target sentence, aiding in entity extraction.\"},\n\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence includes terms like 'SLAP-130', 'SLP-76', and 'T cell' which are directly related to protein and cell_type entities mentioned in the target sentence, making it highly beneficial for entity extraction.\"},\n\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence talks about 'TCF-1 knock-out mice' and 'human and mouse TCF-1 protein', which are relevant to the protein entity in the target sentence, aiding in entity extraction.\"},\n\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions 'T lymphocytes' and 'HLA-molecules' which correspond to the cell_type and protein entities in the target sentence, providing valuable information for entity extraction.\"},\n\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains terms like 'IkappaBbeta' and 'NF-kappaB' which are directly related to protein entities mentioned in the target sentence, making it extremely helpful for entity extraction.\"},\n\n    {\"Example 9\": 4},\n    {\"Reason 9\": \"The sentence discusses the 'GM-CSF genes' which align with the protein entity in the target sentence, aiding in entity extraction.\"},\n\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The sentence mentions 'immunoglobulin kappa 3' enhancer' which is related to DNA, providing some relevance for entity extraction from the target sentence.\"},\n\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence includes terms like 'EBNA-2' and 'PU.1' which are directly related to protein entities mentioned in the target sentence, making it highly beneficial for entity extraction.\"},\n\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence discusses the 'hepatitis B virus genome' and 'HBxAg' which correspond to DNA and protein entities in the target sentence, providing valuable information for entity extraction.\"},\n\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The sentence mentions 'SIVsmmPBj14' which aligns with the cell_line entity in the target sentence, aiding in entity extraction.\"},\n\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence contains terms like 'EBV' and 'B-cell' which are directly related to cell_type entities mentioned in the target sentence, providing relevant information for entity extraction.\"},\n\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The sentence includes terms like 'p50', 'p65 proteins', 'DNA', and 'protein' which are directly related to protein and DNA entities mentioned in the target sentence, making it extremely helpful for entity extraction.\"}\n]",
        "response3": "[{\"B-cell\": \"cell_type\"}, {\"hepatitis B virus X protein\": \"protein\"}]",
        "prediction": "{'B-cell': 'cell_type', 'hepatitis B virus X protein': 'protein'}"
    },
    {
        "idx": 389,
        "sentence": "The predicted periplasmic domain of the PhoQ protein contained a markedly anionic domain that could interact with cationic proteins and that could be responsible for resistance to defensin .",
        "label": {
            "periplasmic domain": "protein",
            "PhoQ protein": "protein",
            "cationic proteins": "protein",
            "defensin": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Thus, these experiments demonstrate that EBNA2 interacts with an EBNA2 responsive cis-element of the TP1 promoter\": 5},\n    {\"Tat-binding protein 7 is a subunit of the 26S protease\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained\": 5},\n    {\"Analysis of CD40 cytoplasmic domain truncation and point mutants defined a 10-amino acid CD40 cytoplasmic signaling determinant required for NF-kappa B activation\": 5},\n    {\"Protein and genomic sequences show similarities with those of a variety of proteins involved in transcription, suggesting that the G0S24 product has a similar role\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein\": 5},\n    {\"Here the wild type motif gives efficient binding of p50p50 that again is upregulated in tolerant cells whereas a mutant with a 3' G shows hardly any binding of p50p50\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset\": 5},\n    {\"One cDNA clone of a primary response gene, expressed upon macrophage differentiation, encoded for Egr-1 , a zinc finger transcription factor\": 5},\n    {\"The levels of the apoptosis effector proteins Bak and Bad were enhanced, whereas there was a slight down-regulation of the apoptosis suppressor protein Bcl-2 after treatment of the cells with PDBu and DMSO\": 5},\n    {\"Finally, using electrophoretic mobility shift assays , evidence was obtained that IL-4 inhibits LPS-induced expression of AP-1 protein\": 5},\n    {\"These findings suggest a molecular mechanism of positive regulation of PAFR gene expression by PAF through NF-kappa B , possibly by a phosphorylation reaction involving protein kinase C by PAF\": 5},\n    {\"Northern blot analysis showed that p21(WAF1/CIP1 ) and p27(KIP1) mRNA and protein increased in these cells\": 5},\n    {\"The phosphorylated tyrosine residue itself is important for the protein-protein interaction\": 4},\n    {\"First, Tax was found to interact with the 35-kDa (alpha) subunit of TFIIA in the yeast two-hybrid interaction system\": 5},\n    {\"A gst- EBNA-2 fusion protein specifically depleted PU.1 from nuclear extracts and bound in vitro translated PU.1 , providing biochemical evidence for a direct EBNA-2 -PU.1 interaction\": 5}\n]",
        "response3": "[{\"PhoQ\": \"protein\"}]",
        "prediction": "{'PhoQ': 'protein'}"
    },
    {
        "idx": 193,
        "sentence": "The calcium ionophore-induced c-myc suppression , however, strictly requires de novo protein synthesis .",
        "label": {
            "c-myc": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Sp1 and NF-kappaB transcription factor binding was shown to be mutually exclusive by EMSA displacement studies with purified recombinant Sp1 and recombinant p50.\": 5},\n    {\"Mutations in this site which eliminate PU.1 binding decrease M-CSF receptor promoter activity significantly in macrophage cell lines only.\": 4},\n    {\"Induction of IL-5 mRNA upon TCR and IL-2R stimulation was totally inhibited by dexamethasone.\": 4},\n    {\"RCC-S did not alter the cytoplasmic levels of RelA and NF-kappaB1 but did suppress their nuclear localization and inhibited the activation of RelA/NF-kappaB1 binding complexes.\": 4},\n    {\"Cleavage of transcription factor SP1 by caspases during anti-IgM-induced B-cell apoptosis.\": 5},\n    {\"Suppression of a cellular differentiation program by phorbol esters coincides with inhibition of binding of a cell-specific transcription factor (NF-E2) to an enhancer element required for expression of an erythroid-specific gene.\": 4},\n    {\"New immunosuppressive drug PNU156804 blocks IL-2-dependent proliferation and NF-kappa B and AP-1 activation.\": 5},\n    {\"Indirect immunofluorescence shows that IL-2 controls the cellular distribution of Aiolos and induces its tyrosine phosphorylation, required for dissociation from Ras.\": 5},\n    {\"The restricted pattern of SCL protein synthesis is consistent with the restricted expression of SCL mRNA documented previously.\": 3},\n    {\"Selected transfected clones produced low levels of IFN A (IFNA) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"These results appear to indicate that suppression of cytokine and NO generation by Azeptin results at least partially from the inhibition of NF-kappa B activation.\": 5},\n    {\"Retroviral induction of TIMP-1 not only resulted in cell survival but also in continued DNA synthesis for up to 5 d in the absence of serum, while controls underwent apoptosis.\": 4},\n    {\"However, during infection by EBV, ligation of CD2 caused thymocytes to proliferate in the absence of exogenous cytokines.\": 4},\n    {\"Gel-shift analysis reveals the constitutive presence of nuclear factors in resting PBL that bind to the proximal AP-1 site of the IL-2 promoter and that contain immunoreactive c-Jun but not c-Fos protein.\": 5},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"The two structurally distinct immunophilin-drug complexes bind to, and inhibit, the phosphatase activity of calcineurin.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1349,
        "sentence": "Its expression was always restricted to the nucleus .",
        "label": {},
        "response1": "['cell_type']",
        "response2": "[\n    {\"Example 1\": 4},\n    {\"Reason 1\": \"The example provides a specific protein name, A-myb, which is mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides multiple protein names (IL-2, c-Jun, c-Fos) mentioned in the sentence, directly aiding in the extraction of protein entities.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides multiple protein names (NF-kappaB, Sp1, p50) mentioned in the sentence, directly aiding in the extraction of protein entities.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides multiple protein names (NF-kB, AP-1, OCT-1, NF-IL-2B) mentioned in the sentence, directly aiding in the extraction of protein entities.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides multiple protein names (IFN A, IFNA, interleukin-2, interleukin-2 receptor, phytohemagglutinin, phorbol myristate acetate) mentioned in the sentence, directly aiding in the extraction of protein entities.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The example provides a specific cell type (T cell) and a protein name (interleukin 2) mentioned in the sentence, aiding in the extraction of cell type and protein entities.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The example provides a specific protein name (RXR) mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides multiple protein names (RelA, NF-kappaB1) mentioned in the sentence, directly aiding in the extraction of protein entities.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides multiple protein names (EBNA-2, PU.1) mentioned in the sentence, directly aiding in the extraction of protein entities.\"},\n    {\"Example 10\": 3},\n    {\"Reason 10\": \"The example provides a specific cell line name (SCM-1) mentioned in the sentence, aiding in the extraction of cell line entities.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides multiple entity names (IL-5 mRNA, TCR, IL-2R, dexamethasone) mentioned in the sentence, directly aiding in the extraction of RNA, cell type, protein entities.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a specific protein name (WT1) mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 13\": 4},\n    {\"Reason 13\": \"The example provides a specific DNA name (NF-kappa B) mentioned in the sentence, aiding in the extraction of DNA entities.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a specific protein name (E2A) mentioned in the sentence, aiding in the extraction of protein entities.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a specific protein name (TAL1) and a cell type name (T-ALL) mentioned in the sentence, aiding in the extraction of protein and cell type entities.\"},\n    {\"Example 16\": 4},\n    {\"Reason 16\": \"The example provides a specific RNA name (SCL) mentioned in the sentence, aiding in the extraction of RNA entities.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 882,
        "sentence": "This cDNA clone was isolated by expression cDNA cloning , and encodes the human c-Jun protein , which together with c-Fos forms the heterodimeric activator protein-1 transcription complex .",
        "label": {
            "c-Jun": "protein",
            "heterodimeric activator protein-1 transcription complex": "protein",
            "c-Fos": "protein",
            "cDNA": "DNA",
            "human c-Jun protein": "protein",
            "cDNA clone": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Example 15\": 5\n    }\n]",
        "response3": "[{\"cDNA\": \"DNA\"}, {\"c-Jun\": \"protein\"}, {\"c-Fos\": \"protein\"}]",
        "prediction": "{'cDNA': 'DNA', 'c-Jun': 'protein', 'c-Fos': 'protein'}"
    },
    {
        "idx": 725,
        "sentence": "Rex acts posttranscriptionally to facilitate accumulation of full-length gag/pol and singly spliced env mRNA in the cytoplasm of HTLV-infected cells .",
        "label": {
            "Rex": "protein",
            "HTLV-infected cells": "cell_type",
            "gag/pol": "protein",
            "env mRNA": "RNA"
        },
        "response1": "['RNA', 'protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The example provides a clear and direct mapping between the entity 'TCF-1' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 2\": 5},\n    {\"Reason 2\": \"The example provides a clear and direct mapping between the entity 'TCL1' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The example provides a clear and direct mapping between the entity 'PML/RARalpha' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 4\": 5},\n    {\"Reason 4\": \"The example provides a clear and direct mapping between the entities 'hepatitis B virus' and 'HBxAg' with their corresponding labels 'DNA' and 'protein' in the sentence.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The example provides a clear and direct mapping between the entity 'SIVsmmPBj14' and its corresponding label 'cell_line' in the sentence.\"},\n    {\"Example 6\": 5},\n    {\"Reason 6\": \"The example provides a clear and direct mapping between the entities 'IFN A', 'IFNA', 'interleukin-2', 'interleukin-2 receptor', 'phytohemagglutinin', and 'phorbol myristate acetate' with their corresponding labels 'protein' in the sentence.\"},\n    {\"Example 7\": 5},\n    {\"Reason 7\": \"The example provides a clear and direct mapping between the entities 'TIMP-1' and 'DNA' with their corresponding labels 'protein' and 'DNA' in the sentence.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The example provides a clear and direct mapping between the entity 'Egr-1' and its corresponding label 'protein' in the sentence.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The example provides a clear and direct mapping between the entities 'HIV-1', 'IFN', 'PKR', and 'IkappaBalpha' with their corresponding labels 'cell_type' and 'protein' in the sentence.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The example provides a clear and direct mapping between the entities 'HIV-1 LTR', 'NFAT-1', and 'NF kappa B' with their corresponding labels 'DNA' and 'protein' in the sentence.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The example provides a clear and direct mapping between the entities 'cDNA', 'Jurkat', and 'DRE 1' with their corresponding labels 'DNA', 'cell_line', and 'cell_type' in the sentence.\"},\n    {\"Example 12\": 5},\n    {\"Reason 12\": \"The example provides a clear and direct mapping between the entities 'TR55', 'TNF-alpha', and 'HIV' with their corresponding labels 'protein' and 'cell_type' in the sentence.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The example provides a clear and direct mapping between the entities 'TCL1' and 'MTCP1/c6.1B' with their corresponding labels 'protein' in the sentence.\"},\n    {\"Example 14\": 5},\n    {\"Reason 14\": \"The example provides a clear and direct mapping between the entities 'T lymphocytes' and 'adenovirus vectors' with their corresponding labels 'cell_type' and 'DNA' in the sentence.\"},\n    {\"Example 15\": 5},\n    {\"Reason 15\": \"The example provides a clear and direct mapping between the entities 'Rel-A', 'T cells', and 'IL-2' with their corresponding labels 'protein' and 'cell_type' in the sentence.\"},\n    {\"Example 16\": 5},\n    {\"Reason 16\": \"The example provides a clear and direct mapping between the entities 'XP-B', 'XP-D', and 'adenovirus' with their corresponding labels 'cell_line' and 'DNA' in the sentence.\"}\n]",
        "response3": "[{'gag/pol': 'protein'}, {'env mRNA': 'RNA'}, {'HTLV-infected cells': 'cell_type'}]",
        "prediction": "{'gag/pol': 'protein', 'env mRNA': 'RNA', 'HTLV-infected cells': 'cell_type'}"
    },
    {
        "idx": 867,
        "sentence": "In HIV-1 , the sequences that respond to these signaling events are found in the long terminal repeat ( LTR ) and comprise the transcriptional enhancer , which contains two conserved binding sites for the nuclear factor kappa B ( NF kappa B ).",
        "label": {
            "conserved binding sites": "DNA",
            "nuclear factor kappa B": "protein",
            "long terminal repeat": "DNA",
            "LTR": "DNA",
            "NF kappa B": "protein",
            "transcriptional enhancer": "DNA"
        },
        "response1": "['DNA', 'protein']",
        "response2": "[\n    {\"The second abnormality in kappa B-binding activity in T cells from these patients is that RelA , a member of the Rel homology family which is part of the normal NF-kappa B complex , was not induced in the nucleus following activation.\": 4},\n    {\"Selected transfected clones produced low levels of IFN A ( IFNA ) constitutively, and their abilities to express interleukin-2 and interleukin-2 receptor upon stimulation with phytohemagglutinin and phorbol myristate acetate were retained.\": 5},\n    {\"One base pair change abolishes the T cell-restricted activity of a kB-like proto-enhancer element from the interleukin 2 promoter .\": 3},\n    {\"This study was designed to investigate the functional significance of previously described mutations in the viral long terminal repeat ( LTR ) and to elucidate their contribution to the unique phenotype of SIVsmmPBj14 .\": 5},\n    {\"A conserved motif in the promoters of several cytokines expressed by human Th2-type lymphocytes .\": 3},\n    {\"The hepatitis B virus genome encodes a transcriptional transactivator protein designated HBxAg .\": 4},\n    {\"Multiple NF-ATc isoforms with individual transcriptional properties are synthesized in T lymphocytes .\": 4},\n    {\"We have determined that the developmental control of immunoglobulin kappa 3' enhancer ( kappa E3' ) activity is the result of the combined influence of positive- and negative-acting elements .\": 5},\n    {\"The cytoplasmic domain of the receptor for interleukin 10 ( IL-10R ) contains two box 3 sequence motifs that have been identified in the signal-transducing receptor subunits for IL-6-type cytokines and noted to be required for activating STAT3 and inducing transcription through IL-6-responsive elements .\": 5},\n    {\"We suggest that HIV-1 infection of myeloid cells induces IFN production and PKR activity, which in turn contribute to enhanced IkappaBalpha phosphorylation and subsequent degradation.\": 5},\n    {\"Therefore, the surprisingly high replicative capacity of NF-kappaB and Sp1 binding site mutants of SIVmac is due to unique features or the enhancer/promoter region .\": 5},\n    {\"Although TR55 expression was unaltered during TNF-alpha -induced HIV activation , this receptor was still involved in the viral activation process .\": 4},\n    {\"Here we show that the response of the HIV-1 LTR may be governed by two independent sequences located 5' to the site of transcription initiation sequences that bind either NFAT-1 or NF kappa B .\": 5},\n    {\"The increased transcriptional rate correlated with a marked increase in nuclear factor-kappa B activity in these cells as determined by electrophoretic mobility shift assay using a consensus NF-kappa B oligonucleotide .\": 5},\n    {\"NF-E1 is encoded by the same gene as the YY-1 protein , which binds to the adeno-associated virus P5 promoter .\": 4},\n    {\"The response element for NF-AT is a sequence localized between -285/-254 in the IL-2 regulatory region .\": 4}\n]",
        "response3": "[{\"HIV-1\": \"cell_type\"}, {\"long terminal repeat ( LTR )\": \"DNA\"}, {\"transcriptional enhancer\": \"DNA\"}, {\"nuclear factor kappa B ( NF kappa B )\": \"protein\"}]",
        "prediction": "{'HIV-1': 'cell_type', 'long terminal repeat ( LTR )': 'DNA', 'transcriptional enhancer': 'DNA', 'nuclear factor kappa B ( NF kappa B )': 'protein'}"
    },
    {
        "idx": 841,
        "sentence": "Such tests may become useful diagnostic tools .",
        "label": {},
        "response1": "None.",
        "response2": "[\n{\"Example 1\": 5},\n{\"Reason 1\": \"The sentence contains specific protein names (myeloperoxidase, lysozyme, PU.1) which are directly mentioned in the sentence.\"},\n{\"Example 2\": 4},\n{\"Reason 2\": \"The sentence mentions PBMC (peripheral blood mononuclear cells) and adenovirus, which are indicative of cell type and DNA entities respectively.\"},\n{\"Example 3\": 4},\n{\"Reason 3\": \"The sentence mentions PBMC (peripheral blood mononuclear cells) and adenovirus DNA, which are indicative of cell type and DNA entities respectively.\"},\n{\"Example 4\": 5},\n{\"Reason 4\": \"The sentence mentions IFN-gamma, a specific protein, which is directly related to the sentence.\"},\n{\"Example 5\": 4},\n{\"Reason 5\": \"The sentence mentions lymphoid neoplasms, which is indicative of a cell type entity.\"},\n{\"Example 6\": 5},\n{\"Reason 6\": \"The sentence mentions STAT1, a specific protein, which is directly related to the sentence.\"},\n{\"Example 7\": 5},\n{\"Reason 7\": \"The sentence mentions Ras, a specific protein, which is directly related to the sentence.\"},\n{\"Example 8\": 5},\n{\"Reason 8\": \"The sentence mentions immunohistochemistry, gene, and cell type, which are indicative of protein, DNA, and cell type entities respectively.\"},\n{\"Example 9\": 5},\n{\"Reason 9\": \"The sentence mentions NF-kappa B, a specific protein, which is directly related to the sentence.\"},\n{\"Example 10\": 5},\n{\"Reason 10\": \"The sentence mentions SCM-1, a specific cell line, which is directly related to the sentence.\"},\n{\"Example 11\": 5},\n{\"Reason 11\": \"The sentence mentions SIVsmmPBj14, a specific cell line, which is directly related to the sentence.\"},\n{\"Example 12\": 4},\n{\"Reason 12\": \"The sentence mentions nonhuman primates, which is indicative of a cell type entity.\"},\n{\"Example 13\": 5},\n{\"Reason 13\": \"The sentence mentions T-PLL, a specific cell type, which is directly related to the sentence.\"},\n{\"Example 14\": 5},\n{\"Reason 14\": \"The sentence mentions E2A, a specific protein, which is directly related to the sentence.\"},\n{\"Example 15\": 4},\n{\"Reason 15\": \"The sentence mentions AP-1, which is indicative of a DNA entity.\"},\n{\"Example 16\": 5},\n{\"Reason 16\": \"The sentence mentions B and T cell activation, Ramos, Jurkat, and cDNA microarray technology, which are indicative of cell type, cell line, cell line, and DNA entities respectively.\"}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 956,
        "sentence": "BSAP : a key regulator of B-cell development and differentiation .",
        "label": {
            "BSAP": "protein",
            "B-cell": "cell_type"
        },
        "response1": "['protein', 'cell_type']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The sentence directly mentions the entity 'NF-E2' and its association with a protein, providing clear context for entity extraction.\"\n    },\n    {\n        \"Example 2\": 4\n    },\n    {\n        \"Reason 2\": \"The sentence mentions 'EBV' and 'B-cell' as cell types, which can aid in identifying cell types in similar contexts.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The sentence provides multiple protein and cell type entities in a specific context, aiding in entity extraction.\"\n    },\n    {\n        \"Example 4\": 4\n    },\n    {\n        \"Reason 4\": \"The sentence mentions 'Th2-type lymphocytes' as a cell type, providing valuable information for entity extraction.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The sentence directly associates 'GATA-1' with protein, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The sentence provides clear protein entities 'Syk' and 'Zap' along with the cell type 'T cell', facilitating entity extraction.\"\n    },\n    {\n        \"Example 7\": 4\n    },\n    {\n        \"Reason 7\": \"The sentence mentions 'Th1' and 'Th2' as cell types, aiding in identifying cell types in similar contexts.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The sentence mentions 'T cell' and 'interleukin 2' as entities, providing valuable context for entity extraction.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The sentence directly associates 'IL-2' with protein, aiding in the extraction of protein entities.\"\n    },\n    {\n        \"Example 10\": 4\n    },\n    {\n        \"Reason 10\": \"The sentence mentions 'AP-1' as a DNA entity, providing context for DNA-related entities.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The sentence provides multiple protein entities 'IL-2', 'c-Jun', and 'c-Fos', aiding in protein entity extraction.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The sentence mentions DNA entities 'UAS3' and 'UAS2', along with the protein 'YY1', aiding in DNA and protein entity extraction.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The sentence directly associates protein entities 'SCL' and 'GATA-1', providing clear context for protein entity extraction.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The sentence mentions protein entities 'IL-2', 'NF-kappa B', and 'AP-1', aiding in protein entity extraction.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The sentence provides multiple protein entities 'IL4', 'IL13', 'STAT6', 'STAT3', 'STAT5', and the cell type 'B cells', facilitating entity extraction.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The sentence directly associates 'STAT1' with protein, aiding in the extraction of protein entities.\"\n    }\n]\n```",
        "response3": "```json\n[{\"B-cell\": \"cell_type\"}]\n```",
        "prediction": "{'B-cell': 'cell_type'}"
    },
    {
        "idx": 1769,
        "sentence": "We have tried to find out whether these receptors could show any difference in sex or age distribution.",
        "label": {},
        "response1": "None.",
        "response2": "[\n    {\"We evaluated the activation of AP-1 by PMA in both monocytes and macrophages.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 1},\n    {\"We have found that the recruitment of EKLF to 5'HS3 depends on the presence of 5'HS2 in cis, but the recruitment to 5'HS2 does not depend on 5'HS3.\": 3},\n    {\"Human cDNAs encoding subunits of these factors have been cloned and sequenced.\": 4},\n    {\"Therefore, we investigated whether IVS1-10T-->C deleteriously affected BRCA1 splicing or expression, and thereby inactivated the other BRCA1 allele.\": 4},\n    {\"Using the wild-type or mutated human retinoic acid receptor alpha as a model, kDa values determined by classical competition binding assays using tritiated ligands are in agreement with those measured by the proteolytic assay.\": 4},\n    {\"Because relatively little is known about these events in nonhuman primates, our laboratory defined optimal conditions, reagents, and assays for the study of signal transduction events in cells from nonhuman primates.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 2},\n    {\"Furthermore, we investigated the processes involved in persistent activation of NF-kappa B.\": 4},\n    {\"We have demonstrated that the level of CRE binding protein (CREB) was the same in all cell lines and that the putative AR-CRE forms specific and compatible protein interactions with CREB.\": 5},\n    {\"We also found that the deviation of methylation in granulocytes and T cells was well correlated.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"We have now examined expression of the mouse E2A gene at the protein level using polyclonal antisera directed against distinct portions of the E2A protein to probe blots of cellular extracts.\": 4},\n    {\"We compared this sensitivity to analogue effects on VDR interacting proteins: RXR, GRIP-1, and DRIP205, a subunit of the DRIP coactivator complex.\": 5},\n    {\"To investigate processes related to B and T cell activation, the gene expression of stimulated and nonstimulated Ramos and Jurkat cells was studied using cDNA microarray technology.\": 5},\n    {\"In this study we analyzed the effect of CD40 stimulation on the activity and nuclear appearance of Rel/nuclear factor kappaB (NF-kappaB) factors in primary murine B lymphocytes.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 110,
        "sentence": "Electrophoretic mobility shift assays and Southwestern blotting experiments were used to detect the binding of cellular transactivation factor NF-KB to the double repeat-KB enhancer sequence located in the long terminal repeat .",
        "label": {
            "long terminal repeat": "DNA",
            "NF-KB": "protein",
            "double repeat-KB enhancer sequence": "DNA",
            "cellular transactivation factor": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Example 2\": 5},\n    {\"Example 3\": 5},\n    {\"Example 4\": 4},\n    {\"Example 5\": 5},\n    {\"Example 6\": 5},\n    {\"Example 7\": 5},\n    {\"Example 8\": 4},\n    {\"Example 9\": 4},\n    {\"Example 10\": 5},\n    {\"Example 11\": 5},\n    {\"Example 12\": 5},\n    {\"Example 13\": 5},\n    {\"Example 14\": 5},\n    {\"Example 15\": 5}\n]",
        "response3": "[{\"NF-KB\": \"protein\"}]",
        "prediction": "{'NF-KB': 'protein'}"
    },
    {
        "idx": 1379,
        "sentence": "Deregulation of TCL1 is the first event in the initiation of malignancy in these types of leukemias and represents a potential tool for clinical evaluation .",
        "label": {
            "TCL1": "DNA"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Inactivation of IkappaBbeta by the tax protein of human T-cell leukemia virus type 1 : a potential mechanism for constitutive induction of NF-kappaB.\": 5},\n    {\"The impaired transcription factor AP-1 DNA binding activity in lymphocytes derived from subjects with some symptoms of premature aging.\": 3},\n    {\"Overexpression of WT1 in some myeloid cell lines confers resistance to differentiation induction.\": 4},\n    {\"The highly specific granulomonocyte-associated lysosomal proteins myeloperoxidase ( MPO ) and lysozyme ( LZ ), as well as the transcription factor PU.1 , were already detectable in the most immature CD34+Thy-1+ subset.\": 5},\n    {\"Since induction of the IL-2 receptor alpha subunit is a hallmark of lymphocyte activation , we suggest that p21ras naturally triggers B cell activation.\": 5},\n    {\"The specificity of MNDA expression for cells in the granulocyte-macrophage lineage was reexamined in cell lines established from patients with Philadelphia chromosome-positive chronic myeloid leukemia.\": 5},\n    {\"Here we examined the regulatory mechanism of the SCM-1 genes.\": 4},\n    {\"Our data suggest that IL-13 utilizes IL-4R and its signaling pathway , and JAK2 may play an important role in the function of IL-4R and IL-13R in colon cancer cells.\": 5},\n    {\"Thus, STAT1 may be a useful target in the development of new immunosuppressive and antineoplastic agents.\": 4},\n    {\"SCL is expressed in erythroid , megakaryocyte and mast cell populations (the same cell lineages as GATA-1 , a zinc-finger transcription factor ).\": 4},\n    {\"To evaluate the PML/RARalpha role in myelopoiesis , transgenic mice expressing PML/RARalpha were engineered.\": 4},\n    {\"TCRzeta and p56(lck) were detected in the peripheral blood T cells in 27 of 29 patients , and overall, reduced levels were noted visually in 12 of 29 (41%) and 13 of 29 (45%) individuals, respectively.\": 5},\n    {\"This review suggests roles for these alterations in the development of lymphoid neoplasms.\": 4},\n    {\"Thus, ligation of CD28 with either CD80 or CD86 leads to shared early signal transduction events such as the tyrosine phosphorylation of CBL and VAV , to NFAT -mediated transcriptional activation, and to the costimulation of interleukin-2 and granulocyte-macrophage colony-stimulating factor production.\": 5},\n    {\"Positive regulators of the lineage-specific transcription factor GATA-1 in differentiating erythroid cells.\": 4},\n    {\"Our results suggest that activation of NF-kappaB occurs through a Tax -independent mechanism in leukemic cells of ATL patients , possibly due to differential NF-kappaB subunit activation.\": 5}\n]",
        "response3": "[]",
        "prediction": "{}"
    },
    {
        "idx": 1338,
        "sentence": "The survival-promoting activity of the Bcl-2 family of proteins appears to be modulated by interactions between various cellular proteins .",
        "label": {
            "Bcl-2 family": "protein",
            "cellular proteins": "protein"
        },
        "response1": "['protein']",
        "response2": "[\n    {\"Example 1\": 5},\n    {\"Reason 1\": \"The sentence contains specific protein names that are directly mentioned in the entity label set.\"},\n    {\"Example 2\": 4},\n    {\"Reason 2\": \"The sentence mentions a protein name (TIMP-1) and DNA, which are relevant entities in the label set.\"},\n    {\"Example 3\": 5},\n    {\"Reason 3\": \"The sentence contains specific protein names that are directly mentioned in the entity label set.\"},\n    {\"Example 4\": 4},\n    {\"Reason 4\": \"The sentence mentions a protein name (NF-kappa B) which is a relevant entity in the label set.\"},\n    {\"Example 5\": 5},\n    {\"Reason 5\": \"The sentence contains specific protein names and a cell type that are directly mentioned in the entity label set.\"},\n    {\"Example 6\": 4},\n    {\"Reason 6\": \"The sentence mentions cell adhesion molecules, which are relevant entities in the label set.\"},\n    {\"Example 7\": 4},\n    {\"Reason 7\": \"The sentence mentions a protein name (NF-kappa B) which is a relevant entity in the label set.\"},\n    {\"Example 8\": 5},\n    {\"Reason 8\": \"The sentence contains specific protein names that are directly mentioned in the entity label set.\"},\n    {\"Example 9\": 5},\n    {\"Reason 9\": \"The sentence contains specific protein names and cell types that are directly mentioned in the entity label set.\"},\n    {\"Example 10\": 5},\n    {\"Reason 10\": \"The sentence contains specific protein names that are directly mentioned in the entity label set.\"},\n    {\"Example 11\": 5},\n    {\"Reason 11\": \"The sentence contains specific protein names that are directly mentioned in the entity label set.\"},\n    {\"Example 12\": 4},\n    {\"Reason 12\": \"The sentence mentions a protein name (IL-4) which is a relevant entity in the label set.\"},\n    {\"Example 13\": 5},\n    {\"Reason 13\": \"The sentence contains specific protein names and cell lines that are directly mentioned in the entity label set.\"},\n    {\"Example 14\": 4},\n    {\"Reason 14\": \"The sentence mentions protein names and a cell type that are relevant entities in the label set.\"},\n    {\"Example 15\": 4},\n    {\"Reason 15\": \"The sentence mentions a protein name (tyrosine) which is a relevant entity in the label set.\"}\n]",
        "response3": "[{'Bcl-2': 'protein'}]",
        "prediction": "{'Bcl-2': 'protein'}"
    },
    {
        "idx": 1323,
        "sentence": "PRE-I forms multiple DNA-protein complexes with nuclear extracts from Jurkat cells .",
        "label": {
            "PRE-I": "DNA",
            "Jurkat cells": "cell_line",
            "multiple DNA-protein complexes": "protein"
        },
        "response1": "['DNA', 'protein', 'cell_line']",
        "response2": "```json\n[\n    {\n        \"Example 1\": 5\n    },\n    {\n        \"Reason 1\": \"The example provides a clear mapping between the entity 'AP-1' and the entity type 'DNA', directly relevant to the target sentence.\"\n    },\n    {\n        \"Example 2\": 5\n    },\n    {\n        \"Reason 2\": \"The example provides multiple mappings between various entities and the entity type 'protein', which is highly relevant to the target sentence.\"\n    },\n    {\n        \"Example 3\": 5\n    },\n    {\n        \"Reason 3\": \"The example directly links the entity 'E2A' to the entity type 'protein', which is crucial for understanding the sentence.\"\n    },\n    {\n        \"Example 4\": 5\n    },\n    {\n        \"Reason 4\": \"The example identifies multiple proteins such as 'IL-2', 'c-Jun', and 'c-Fos' which are essential for interpreting the sentence.\"\n    },\n    {\n        \"Example 5\": 5\n    },\n    {\n        \"Reason 5\": \"The example provides a direct mapping between the entities 'EBNA-2' and 'PU.1' to the entity type 'protein', aiding in understanding the sentence.\"\n    },\n    {\n        \"Example 6\": 5\n    },\n    {\n        \"Reason 6\": \"The example clearly associates the entities 'p21(WAF1/CIP1)' and 'p27(KIP1)' with the entity type 'protein', which is crucial for sentence comprehension.\"\n    },\n    {\n        \"Example 7\": 5\n    },\n    {\n        \"Reason 7\": \"The example establishes the entities 'EKLF', 'CBP', 'p300', and 'P/CAF' as proteins, providing key information for interpreting the sentence.\"\n    },\n    {\n        \"Example 8\": 5\n    },\n    {\n        \"Reason 8\": \"The example directly links the entity 'NF-kappa B' to the entity type 'DNA', which is essential for understanding the sentence.\"\n    },\n    {\n        \"Example 9\": 5\n    },\n    {\n        \"Reason 9\": \"The example identifies 'Jun' and 'ATF-2' as proteins, aiding in the interpretation of the sentence.\"\n    },\n    {\n        \"Example 10\": 5\n    },\n    {\n        \"Reason 10\": \"The example provides a clear mapping between 'IkappaBbeta' and 'NF-kappaB' as proteins, crucial for understanding the sentence.\"\n    },\n    {\n        \"Example 11\": 5\n    },\n    {\n        \"Reason 11\": \"The example identifies 'p50' and 'p65' as proteins, and 'DNA' as the entity type, all relevant for interpreting the sentence.\"\n    },\n    {\n        \"Example 12\": 5\n    },\n    {\n        \"Reason 12\": \"The example links 'Tip' and 'Tap' to the entity type 'protein', and 'Jurkat-T cells' to 'cell_line', aiding in sentence understanding.\"\n    },\n    {\n        \"Example 13\": 5\n    },\n    {\n        \"Reason 13\": \"The example establishes 'HIV-1 LTR' as 'DNA', 'NFAT-1' and 'NF kappa B' as proteins, crucial for interpreting the sentence.\"\n    },\n    {\n        \"Example 14\": 5\n    },\n    {\n        \"Reason 14\": \"The example provides mappings for 'cDNA' as 'DNA', 'Jurkat' as 'cell_line', and 'DRE 1' as 'cell_type', all relevant for sentence comprehension.\"\n    },\n    {\n        \"Example 15\": 5\n    },\n    {\n        \"Reason 15\": \"The example identifies 'tal-1' and 'GATA-binding proteins' as proteins, and 'hematopoiesis' as 'cell_type', aiding in understanding the sentence.\"\n    },\n    {\n        \"Example 16\": 5\n    },\n    {\n        \"Reason 16\": \"The example links 'NF-E1' and 'YY-1' to the entity type 'protein', crucial for interpreting the sentence.\"\n    }\n]\n```",
        "response3": "```json\n[]\n```",
        "prediction": "{}"
    }
]